data_1jjj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jjj _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.501 2.107 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . 0.252 6.6 tt0 -67.59 -14.86 63.3 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -35.1 71.06 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 155.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.0 mt -82.9 2.87 32.29 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -92.04 148.57 22.09 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 122.089 2.222 . . . . 0.0 113.634 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.31 178.69 15.61 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.8 ttm105 -85.84 122.88 30.54 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.816 -0.814 . . . . 0.0 110.311 166.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -119.66 114.4 22.13 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -172.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -105.07 124.41 49.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.751 0.82 . . . . 0.0 112.83 -163.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.1 tp -66.66 128.63 36.99 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.253 6.1 m -115.6 -69.09 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 C-N-CA 124.148 0.979 . . . . 0.0 109.566 173.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -92.57 149.93 21.05 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 124.439 1.096 . . . . 0.0 112.718 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -152.16 59.3 0.84 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.461 -1.399 . . . . 0.0 114.684 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -72.47 133.01 44.61 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.5 -13.99 53.09 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 118.515 2.166 . . . . 0.0 118.515 -166.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -67.39 -35.14 78.72 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.477 ' CG ' HH12 ' A' ' 33' ' ' ARG . 9.2 t70 -53.28 -54.24 39.14 Favored 'General case' 0 CA--C 1.576 1.942 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 166.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -60.77 -46.71 89.42 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -58.52 -47.08 85.36 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.7 mtm -62.44 -40.66 97.31 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 120.784 1.629 . . . . 0.0 114.945 170.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -47.99 -53.2 16.94 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 161.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -74.78 -33.69 62.3 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.8 mt -46.76 -40.33 13.33 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 118.403 2.742 . . . . 0.0 118.403 158.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.07 67.81 1.01 Allowed Glycine 0 N--CA 1.487 2.063 0 CA-C-N 118.34 0.518 . . . . 0.0 113.423 -161.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.86 123.98 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.45 152.04 52.26 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 115.581 0.992 . . . . 0.0 115.581 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 pt -53.48 -44.3 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 117.911 2.559 . . . . 0.0 117.911 -172.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.05 -42.93 86.48 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 166.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.56 -39.6 94.04 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.527 ' HB3' HH11 ' A' ' 33' ' ' ARG . 13.9 mtm105 -59.32 -47.78 84.12 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 168.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -56.81 -51.99 66.8 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 168.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.9 ttp -46.84 -61.16 1.98 Allowed 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.06 -41.91 79.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 118.904 2.322 . . . . 0.0 118.904 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.51 -51.9 51.71 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 169.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.8 ptm -74.0 -31.65 63.04 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.37 -25.1 63.95 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 119.284 3.068 . . . . 0.0 119.284 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.65 67.4 1.55 Allowed Pre-proline 0 CA--C 1.581 2.172 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -66.69 142.41 63.86 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 N-CA-C 119.329 2.78 . . . . 0.0 119.329 -170.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.7 113.5 26.01 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.127 165.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 51.6 t -92.0 110.62 21.99 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.933 0.893 . . . . 0.0 111.261 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.36 110.24 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 87.8 mt -102.4 129.31 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.1 m -150.99 127.04 10.44 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.658 -1.276 . . . . 0.0 110.294 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.6 t -102.14 130.06 48.66 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -82.0 -56.26 4.06 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.733 -0.604 . . . . 0.0 111.993 159.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.71 -84.72 0.05 OUTLIER Glycine 0 N--CA 1.485 1.947 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -83.2 -37.45 23.61 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 161.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -74.65 104.39 5.31 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 121.095 1.771 . . . . 0.0 111.505 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.463 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 32.5 tp -99.84 111.9 24.19 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.79 0.836 . . . . 0.0 109.1 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.5 m -81.78 115.87 21.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.786 -0.571 . . . . 0.0 110.401 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.1 mt -119.05 106.2 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.646 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -98.29 127.4 44.21 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.106 0.563 . . . . 0.0 110.658 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -99.27 97.81 8.84 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -89.29 97.2 11.06 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.251 0.62 . . . . 0.0 109.905 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 p -104.32 150.8 24.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.302 -0.874 . . . . 0.0 111.815 171.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.6 p -78.08 49.24 0.79 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 179.72 -61.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.288 1.435 . . . . 0.0 109.404 -164.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -131.04 168.69 16.97 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.356 1.074 . . . . 0.0 111.598 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.4 m -149.62 149.23 30.35 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 119.422 -2.049 . . . . 0.0 110.743 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.9 m -152.95 139.5 18.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.558 -1.338 . . . . 0.0 109.685 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -134.48 131.51 38.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.446 -0.784 . . . . 0.0 110.428 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -147.85 144.78 28.37 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.257 0.551 . . . . 0.0 112.393 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.9 p -99.95 103.05 14.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.374 -0.829 . . . . 0.0 110.635 170.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 52' ' ' LEU . 28.4 p -85.71 124.67 32.49 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -79.41 108.25 12.79 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.618 0.723 . . . . 0.0 110.532 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.3 tp -81.3 119.56 23.81 Favored 'General case' 0 CA--C 1.563 1.444 0 O-C-N 121.591 -0.693 . . . . 0.0 112.543 -167.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.85 50.62 18.11 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 115.228 0.851 . . . . 0.0 115.228 -159.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.48 160.82 0.79 Allowed 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.736 1.615 . . . . 0.0 109.139 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -93.08 153.37 18.73 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 168.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -142.04 161.72 37.27 Favored 'General case' 0 CA--C 1.572 1.792 0 C-N-CA 124.174 0.989 . . . . 0.0 110.286 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -81.58 106.91 13.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.097 -1.627 . . . . 0.0 110.505 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -83.31 144.9 29.39 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 122.685 1.231 . . . . 0.0 111.062 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.8 m -113.05 120.45 41.39 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 162.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 78.1 p -68.22 154.1 42.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.07 -29.06 60.0 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 167.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -68.69 -47.89 65.3 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.89 -33.15 1.53 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 117.337 1.695 . . . . 0.0 117.337 -165.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -63.5 141.19 58.86 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 119.485 1.643 . . . . 0.0 112.923 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -110.58 131.02 55.41 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.166 0.586 . . . . 0.0 109.897 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.1 p -128.5 136.54 50.94 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.551 0.691 . . . . 0.0 111.191 -165.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -83.7 102.74 12.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.586 -1.321 . . . . 0.0 109.729 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.5 m -112.08 109.74 19.64 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.658 -0.651 . . . . 0.0 110.752 -158.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.1 p -86.86 120.92 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 122.714 0.406 . . . . 0.0 111.181 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.4 m -108.77 122.66 47.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -132.95 126.54 32.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.515 -0.741 . . . . 0.0 111.723 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -91.88 112.43 24.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.739 -0.6 . . . . 0.0 110.488 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -102.79 86.79 2.81 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.974 0.51 . . . . 0.0 110.643 171.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.265 12.1 t70 25.4 70.8 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.868 2.914 . . . . 0.0 118.868 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.71 -44.49 1.31 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 -168.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.63 119.93 37.73 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 118.448 1.124 . . . . 0.0 113.556 -172.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.46 107.06 18.92 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.553 0.741 . . . . 0.0 111.136 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.91 109.97 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -94.46 106.37 18.35 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 170.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -100.29 104.95 16.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.722 -0.611 . . . . 0.0 111.403 -171.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -99.6 107.31 19.42 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.459 0.703 . . . . 0.0 111.438 -162.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -102.12 121.33 41.99 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.914 0.779 . . . . 0.0 111.923 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -148.76 129.84 14.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.006 -1.059 . . . . 0.0 110.881 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 52.54 41.11 30.95 Favored 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.56 32.24 82.59 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 119.026 2.37 . . . . 0.0 119.026 -165.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -136.09 124.1 22.85 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 118.371 1.086 . . . . 0.0 108.154 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.44 142.48 32.76 Favored 'General case' 0 CA--C 1.563 1.481 0 CA-C-O 121.878 0.847 . . . . 0.0 112.256 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.9 t -125.13 130.6 52.53 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.941 0.877 . . . . 0.0 109.889 159.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.6 p -113.09 107.95 16.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.3 mm -104.7 102.06 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.011 -1.056 . . . . 0.0 108.686 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 m -97.2 96.25 8.3 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.22 0.918 . . . . 0.0 109.916 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -87.27 110.2 20.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.561 -0.712 . . . . 0.0 110.501 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -134.58 146.14 49.34 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.555 1.07 . . . . 0.0 113.646 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 114.84 24.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.559 -0.713 . . . . 0.0 112.241 -169.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -131.72 113.47 13.59 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.598 0.759 . . . . 0.0 108.995 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.263 35.4 t70 60.57 34.47 20.25 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.47 9.43 61.43 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 119.123 2.409 . . . . 0.0 119.123 -165.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -109.13 143.41 38.54 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 119.26 1.53 . . . . 0.0 108.812 172.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.4 tp -84.03 102.32 12.4 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.808 0.814 . . . . 0.0 108.897 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.7 t -96.31 112.53 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.24 95.94 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -172.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -93.62 94.75 8.79 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.243 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.0 OUTLIER -92.11 148.5 22.12 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 121.36 -0.837 . . . . 0.0 112.025 177.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.3 128.65 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.54 0.686 . . . . 0.0 110.288 166.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.1 tpt -69.0 -65.87 0.65 Allowed 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 123.422 0.689 . . . . 0.0 112.298 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.251 15.5 p30 -143.67 -73.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -86.78 -38.64 16.69 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 159.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.1 t -85.99 128.33 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 119.921 1.237 . . . . 0.0 111.067 -163.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 66.3 p -110.04 156.59 20.32 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.492 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 2.3 p -131.99 133.55 44.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.011 -1.056 . . . . 0.0 111.161 156.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.4 m -109.47 98.0 7.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -102.67 120.76 41.12 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.207 0.603 . . . . 0.0 111.603 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.93 125.12 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -119.75 125.66 49.16 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 123.43 0.692 . . . . 0.0 110.498 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -93.3 143.65 26.06 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HZ1' ' CD ' ' A' ' 135' ' ' GLU . 23.0 tttt -74.82 120.16 19.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.535 -1.353 . . . . 0.0 113.498 -175.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.67 89.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.527 ' CD ' ' HZ1' ' A' ' 133' ' ' LYS . 25.4 pt-20 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 124.353 1.061 . . . . 0.0 109.657 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.5 2.044 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.28 -34.16 76.04 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 161.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -66.12 -27.22 67.88 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.3 mt -70.21 -2.4 13.1 Favored 'General case' 0 CA--C 1.581 2.142 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -68.71 138.5 54.97 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 121.054 1.752 . . . . 0.0 114.541 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.33 -178.64 18.25 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 115.814 1.086 . . . . 0.0 115.814 168.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -89.64 125.56 35.29 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.678 -0.761 . . . . 0.0 109.857 169.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -121.1 109.62 15.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.667 -0.646 . . . . 0.0 109.599 -168.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.5 ttm105 -91.64 127.48 37.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.677 -1.264 . . . . 0.0 113.207 -176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.21 126.49 27.56 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.293 9.3 m -110.73 -72.22 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 123.484 0.714 . . . . 0.0 109.158 173.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -87.05 143.58 27.26 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 119.093 0.86 . . . . 0.0 111.785 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.2 p -139.18 65.35 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.334 162.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -72.16 128.02 34.36 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.3 2.12 86.99 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 119.294 2.478 . . . . 0.0 119.294 -169.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -69.79 -48.7 58.21 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -169.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -55.4 -43.3 75.11 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -64.2 -35.99 82.59 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 164.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 59.6 t80 -61.2 -50.78 71.74 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 120.884 1.675 . . . . 0.0 114.499 169.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.9 ptm -61.76 -37.23 83.52 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -50.48 -48.64 56.7 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 158.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.52 -39.94 95.73 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.38 -42.01 77.19 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 163.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.86 69.83 0.45 Allowed Glycine 0 N--CA 1.487 2.039 0 C-N-CA 124.249 0.928 . . . . 0.0 113.029 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.64 126.06 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -171.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.53 164.5 52.23 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 pt -53.73 -47.38 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 118.315 2.709 . . . . 0.0 118.315 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.63 98.34 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 172.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.97 -39.61 93.74 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 167.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -60.15 -49.92 75.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -51.94 -52.15 52.14 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 167.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -53.9 -55.19 29.15 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.98 99.38 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 118.799 2.279 . . . . 0.0 118.799 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.31 83.22 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.0 ptm -71.33 -26.05 62.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.89 127.27 31.38 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.82 77.05 4.52 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 118.224 -0.893 . . . . 0.0 109.525 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.88 140.55 20.58 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.283 1.989 . . . . 0.0 116.617 -167.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.11 91.32 8.67 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.882 162.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -90.05 115.09 27.06 Favored 'General case' 0 CA--C 1.559 1.325 0 O-C-N 120.804 -1.185 . . . . 0.0 112.444 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -92.17 118.7 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 109.406 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.7 mt -105.75 122.31 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m -140.42 134.12 30.34 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.396 0.617 . . . . 0.0 111.512 163.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.5 p -107.44 141.8 38.27 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . 0.268 17.0 t70 -101.37 -116.72 0.18 Allowed 'General case' 0 CA--C 1.578 2.047 0 C-N-CA 123.743 0.817 . . . . 0.0 108.798 166.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.19 -83.98 1.3 Allowed Glycine 0 N--CA 1.492 2.38 0 CA-C-N 120.516 1.507 . . . . 0.0 112.873 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -85.65 -37.7 19.19 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 160.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -72.58 117.16 13.91 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.511 1.505 . . . . 0.0 112.901 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 tt -123.6 118.32 27.04 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.925 0.89 . . . . 0.0 108.718 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.9 m -94.47 123.64 38.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.709 -0.62 . . . . 0.0 110.373 -170.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.8 mt -116.8 106.26 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -109.71 117.83 34.94 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.091 0.556 . . . . 0.0 111.039 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 m -85.94 109.48 18.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.397 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -98.79 92.11 5.41 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.822 1.192 . . . . 0.0 110.912 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -126.96 139.32 53.13 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.906 0.882 . . . . 0.0 110.21 166.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 p -76.86 49.8 0.67 Allowed 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 172.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.7 mt -150.48 -52.01 0.14 Allowed 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 126.231 1.812 . . . . 0.0 109.296 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -153.91 115.78 4.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.143 1.338 . . . . 0.0 110.923 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.6 p -97.42 92.22 5.85 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.293 0.637 . . . . 0.0 110.865 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.0 m -89.11 117.63 28.24 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.042 0.925 . . . . 0.0 108.9 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.21 141.76 50.62 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.8 0.84 . . . . 0.0 111.923 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -156.26 145.31 20.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.567 -0.708 . . . . 0.0 112.734 -174.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.5 p -101.35 108.12 19.65 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.344 0.658 . . . . 0.0 110.093 167.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.1 p -92.47 131.16 37.85 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.65 -0.656 . . . . 0.0 112.367 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.04 122.99 26.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.897 -1.127 . . . . 0.0 110.673 168.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.4 tp -75.91 129.85 37.59 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.56 0.744 . . . . 0.0 112.62 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.44 -28.18 5.92 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 117.606 1.802 . . . . 0.0 117.606 -159.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -105.25 158.34 16.68 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 119.418 1.609 . . . . 0.0 112.908 -166.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -95.65 116.27 28.62 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.914 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -126.96 148.1 50.08 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 124.014 0.926 . . . . 0.0 110.988 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -82.05 101.69 10.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.2 -1.563 . . . . 0.0 113.499 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -88.63 120.42 30.01 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-O 121.973 0.892 . . . . 0.0 110.691 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.8 m -89.43 96.47 10.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.33 -0.856 . . . . 0.0 110.077 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.6 p -69.42 158.13 35.74 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.87 -36.91 12.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 119.529 3.159 . . . . 0.0 119.529 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.3 -36.93 82.51 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 170.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.76 -10.48 9.0 Favored Glycine 0 CA--C 1.552 2.356 0 N-CA-C 118.03 1.972 . . . . 0.0 118.03 -159.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -71.7 115.61 11.1 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 121.085 2.443 . . . . 0.0 110.204 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -87.92 108.6 19.26 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.663 0.744 . . . . 0.0 109.567 172.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.9 p -106.81 111.78 24.45 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.684 0.754 . . . . 0.0 109.609 -166.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -69.12 101.84 1.53 Allowed 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 122.483 1.135 . . . . 0.0 109.807 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.2 m -112.84 112.46 23.96 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -156.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.329 10.4 p -81.36 113.38 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-N 118.996 0.816 . . . . 0.0 110.013 168.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 64.0 m -96.79 109.93 22.51 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 120.58 0.229 . . . . 0.0 110.583 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -133.43 121.42 22.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.549 -0.719 . . . . 0.0 112.006 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -87.59 137.21 32.54 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 121.493 -0.754 . . . . 0.0 112.997 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.0 t -137.75 113.13 9.37 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.384 0.674 . . . . 0.0 111.05 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.322 22.4 t70 66.9 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 171.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.95 43.26 1.28 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 166.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.87 118.33 6.49 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.554 0.741 . . . . 0.0 111.077 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.7 tp -90.23 109.75 20.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 110.089 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.21 108.12 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -86.94 94.17 9.53 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -91.85 97.87 11.25 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.61 -0.681 . . . . 0.0 109.925 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -87.5 116.74 25.81 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.219 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.45 125.68 45.38 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.559 1.072 . . . . 0.0 110.622 -176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -144.54 120.23 10.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.558 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 63.23 14.96 8.2 Favored 'General case' 0 CA--C 1.587 2.368 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.1 -14.64 26.29 Favored Glycine 0 CA--C 1.559 2.833 0 N-CA-C 118.947 2.339 . . . . 0.0 118.947 -156.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -77.33 129.55 35.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.188 1.494 . . . . 0.0 109.056 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -140.85 147.98 39.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -173.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 t -118.61 138.28 52.69 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 122.294 1.045 . . . . 0.0 111.759 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.7 p -110.61 112.5 24.43 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 76.0 mt -120.79 98.17 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -167.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 55.3 m -94.25 101.72 13.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.74 -0.6 . . . . 0.0 110.037 -173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -87.66 96.46 10.43 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 123.397 0.679 . . . . 0.0 110.188 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -127.86 149.52 50.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -172.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.9 123.03 45.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 112.343 -158.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.03 121.94 27.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.74 -0.6 . . . . 0.0 109.492 171.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 58.93 44.49 16.46 Favored 'General case' 0 N--CA 1.509 2.495 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 165.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.57 35.71 74.48 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -163.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -137.67 127.77 25.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 tp -88.15 106.82 18.43 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-O 121.996 0.903 . . . . 0.0 109.287 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.4 t -98.16 106.94 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.51 98.03 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -170.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -91.93 113.12 25.3 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.713 0.805 . . . . 0.0 109.399 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.967 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.6 p -126.73 122.1 33.89 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.654 0.781 . . . . 0.0 111.739 -162.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.39 136.95 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.498 -0.751 . . . . 0.0 110.003 -175.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.5 ttt -89.58 -76.73 0.41 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 120.634 0.254 . . . . 0.0 110.59 168.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -140.11 -62.93 0.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.11 0.964 . . . . 0.0 110.247 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -79.36 -54.82 5.57 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 125.015 1.326 . . . . 0.0 113.827 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.78 123.91 49.31 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-N 119.783 1.174 . . . . 0.0 110.984 -164.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.3 p -102.15 114.09 27.92 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.864 0.865 . . . . 0.0 110.496 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.967 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 13.4 p -100.45 157.26 16.76 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 122.113 0.958 . . . . 0.0 113.174 170.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.4 m -130.43 118.03 20.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.832 -1.168 . . . . 0.0 109.223 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -107.42 111.76 24.23 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.15 0.58 . . . . 0.0 109.843 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.1 mm -96.47 123.65 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -120.35 127.86 52.71 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 121.939 -0.475 . . . . 0.0 111.467 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -85.14 141.28 30.31 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -75.97 121.04 22.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.296 -0.877 . . . . 0.0 113.065 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.42 99.16 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.272 -173.134 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.26 9.9 p . . . . . 0 N--CA 1.505 2.314 0 CA-C-O 122.657 1.218 . . . . 0.0 114.136 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -113.56 -47.16 3.01 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.848 1.659 . . . . 0.0 111.778 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -58.89 -29.32 66.94 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 171.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.8 mt -66.78 -13.14 61.12 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 164.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -74.22 136.14 42.74 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 120.743 1.61 . . . . 0.0 112.689 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.09 -179.37 25.95 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 117.956 1.942 . . . . 0.0 117.956 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -92.16 116.43 28.93 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.316 -0.942 . . . . 0.0 110.196 169.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -123.88 108.63 12.66 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.794 0.438 . . . . 0.0 109.885 -166.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -94.83 129.57 41.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.419 -1.426 . . . . 0.0 114.078 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.4 tp -63.85 124.82 22.51 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.273 11.0 m -113.09 -65.97 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.938 0.895 . . . . 0.0 110.781 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -101.21 148.15 25.44 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.497 1.498 . . . . 0.0 111.533 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.2 p -133.63 83.08 2.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.662 -0.649 . . . . 0.0 110.615 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.35 96.96 10.81 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.269 0.557 . . . . 0.0 110.452 -166.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.67 10.79 56.34 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 118.914 2.326 . . . . 0.0 118.914 -169.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -71.44 -47.38 56.14 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -170.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -55.96 -43.94 78.01 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.429 ' CD ' ' HZ2' ' A' ' 24' ' ' LYS . 36.8 mm-40 -53.64 -47.0 70.71 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 167.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.436 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 67.9 t80 -53.35 -54.58 34.52 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 166.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.285 3.1 ptt? -69.38 -27.39 65.27 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 174.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HZ2' ' CD ' ' A' ' 21' ' ' GLU . 51.7 mtpt -54.17 -52.02 62.49 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 154.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -60.9 -38.75 86.8 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -52.5 -52.52 54.08 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.17 -1.581 . . . . 0.0 115.178 163.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.55 69.58 0.72 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 124.403 1.001 . . . . 0.0 112.467 -169.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.1 t -127.57 130.52 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.92 164.39 49.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 117.418 1.727 . . . . 0.0 117.418 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -56.54 -47.46 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.87 94.86 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -67.31 -40.1 85.97 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -57.15 -46.49 82.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 163.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -55.97 -48.51 75.68 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 167.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 46.2 mtp -73.59 51.28 0.35 Allowed 'General case' 0 CA--C 1.583 2.232 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 165.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.69 -61.55 0.04 OUTLIER Glycine 0 N--CA 1.485 1.926 0 O-C-N 121.037 -1.039 . . . . 0.0 111.63 -171.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.5 -47.89 80.71 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 23.1 ptp -95.31 -6.8 40.41 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.82 110.99 16.86 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 120.365 1.439 . . . . 0.0 111.041 168.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -110.17 93.22 14.91 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.871 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.03 156.42 13.23 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.35 2.033 . . . . 0.0 116.811 -167.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.27 97.04 8.08 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.685 161.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.3 t -86.46 107.17 17.95 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 121.116 -0.99 . . . . 0.0 111.928 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.6 mt -91.81 106.51 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.5 mt -96.49 110.08 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -110.47 123.8 50.59 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 122.862 0.465 . . . . 0.0 110.303 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.7 p -116.57 94.3 4.56 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.558 0.743 . . . . 0.0 112.561 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -91.12 74.64 6.28 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 122.306 1.05 . . . . 0.0 110.697 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.17 -84.33 0.12 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 116.47 1.348 . . . . 0.0 116.47 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -101.42 -46.33 5.03 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -76.56 116.06 16.89 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-N 119.213 0.915 . . . . 0.0 112.019 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.4 tt -132.09 112.79 12.64 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.481 0.712 . . . . 0.0 109.577 -161.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.3 m -104.58 126.21 51.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.597 -1.314 . . . . 0.0 111.366 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -113.2 101.18 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.02 105.82 16.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.171 0.988 . . . . 0.0 109.611 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.2 m -97.45 106.47 18.8 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.834 0.854 . . . . 0.0 110.791 -171.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -104.93 98.66 8.34 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 122.924 0.489 . . . . 0.0 111.179 -167.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p -128.66 144.82 51.24 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.235 -0.916 . . . . 0.0 111.647 166.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -62.51 -44.77 95.55 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.9 mt -57.16 -43.57 82.65 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 165.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -155.29 125.33 6.63 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 119.348 0.976 . . . . 0.0 111.002 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.9 m -111.41 141.8 44.49 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.771 0.828 . . . . 0.0 110.251 173.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.4 t -144.7 158.46 43.77 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.824 0.821 . . . . 0.0 112.574 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -142.49 125.41 16.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.679 -1.263 . . . . 0.0 110.016 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -118.43 143.01 46.99 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.52 0.676 . . . . 0.0 111.126 163.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.1 m -112.18 110.99 21.56 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.104 0.954 . . . . 0.0 109.999 174.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.5 t -89.5 157.96 17.88 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.862 1.265 . . . . 0.0 114.02 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.4 m -113.86 119.8 38.55 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 159.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.6 tp -70.62 132.03 44.83 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 123.856 0.862 . . . . 0.0 112.849 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.25 -53.09 1.58 Allowed Glycine 0 N--CA 1.49 2.288 0 O-C-N 121.198 -0.939 . . . . 0.0 114.503 -161.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.99 163.47 15.53 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 124.023 1.868 . . . . 0.0 114.139 -169.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -88.74 108.79 19.68 Favored 'General case' 0 CA--C 1.564 1.489 0 CA-C-N 112.445 -2.161 . . . . 0.0 110.147 169.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -103.12 175.9 5.32 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.855 0.836 . . . . 0.0 112.695 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -92.38 107.04 18.92 Favored 'General case' 0 CA--C 1.568 1.646 0 O-C-N 120.725 -1.234 . . . . 0.0 111.338 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -79.16 129.1 34.11 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 110.094 163.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.8 m -107.51 110.99 23.05 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 165.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.6 p -72.98 162.29 29.67 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.89 -43.83 59.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 167.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.2 -36.09 83.11 Favored 'General case' 0 CA--C 1.573 1.847 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 169.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.73 26.94 1.5 Allowed Glycine 0 CA--C 1.551 2.297 0 N-CA-C 118.09 1.996 . . . . 0.0 118.09 -176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -90.74 140.57 29.66 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.038 1.919 . . . . 0.0 110.94 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -93.3 109.26 20.8 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 162.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . 0.268 0.9 OUTLIER -113.9 119.83 38.62 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.704 0.684 . . . . 0.0 110.383 -179.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -73.2 99.54 2.87 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-O 122.087 0.946 . . . . 0.0 110.671 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.9 m -110.07 106.74 16.35 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.199 -0.938 . . . . 0.0 109.872 -156.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.276 7.2 p -88.83 118.56 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.827 -0.546 . . . . 0.0 110.719 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.26 123.62 48.33 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -131.71 131.01 42.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.501 -0.749 . . . . 0.0 111.344 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -85.54 133.69 34.06 Favored 'General case' 0 CA--C 1.569 1.711 0 O-C-N 121.384 -0.823 . . . . 0.0 112.084 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -132.5 131.4 41.59 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.103 0.561 . . . . 0.0 110.342 164.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.277 4.1 m-20 71.74 -86.72 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 161.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.04 52.27 0.64 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 123.439 0.542 . . . . 0.0 113.022 160.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -156.03 124.2 5.75 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.904 0.882 . . . . 0.0 111.086 -164.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.7 tp -95.46 110.69 22.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.588 -0.695 . . . . 0.0 110.207 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.8 t -91.87 105.87 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -99.92 106.98 18.85 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 124.306 1.042 . . . . 0.0 109.466 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -97.45 102.0 13.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.489 -0.757 . . . . 0.0 111.358 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -83.43 125.59 31.86 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 124.768 1.227 . . . . 0.0 111.163 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.15 117.3 21.34 Favored 'General case' 0 CA--C 1.573 1.855 0 CA-C-N 119.459 1.027 . . . . 0.0 111.001 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -165.0 149.14 8.84 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.248 -0.908 . . . . 0.0 112.339 -171.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 48.55 41.94 18.09 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 158.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.8 30.11 71.96 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 119.55 2.58 . . . . 0.0 119.55 -166.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -142.32 138.53 31.34 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.439 1.095 . . . . 0.0 109.394 -166.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -129.81 126.84 39.04 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 121.491 0.662 . . . . 0.0 111.76 171.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.3 t -120.67 119.06 31.74 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.924 0.89 . . . . 0.0 109.572 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 71.6 p -93.01 128.29 38.83 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.184 0.594 . . . . 0.0 110.258 172.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.9 mm -112.93 116.55 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 169.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.4 m -99.79 98.54 9.34 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.43 -0.794 . . . . 0.0 109.046 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -90.84 99.12 12.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.22 147.52 50.58 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -163.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.97 121.46 31.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 112.64 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.328 40.2 mttt -106.16 -113.75 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.315 0.646 . . . . 0.0 109.92 169.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -84.85 51.85 2.26 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -168.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.95 31.76 79.0 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 117.516 1.766 . . . . 0.0 117.516 -156.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -137.27 135.0 36.76 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -169.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 tp -85.93 104.41 15.54 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.434 1.112 . . . . 0.0 108.957 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 87.1 t -99.99 109.42 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.7 t -102.98 106.62 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -116.62 99.16 6.95 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -164.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.959 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.8 p -93.31 157.12 16.4 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.57 130.41 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.852 -0.53 . . . . 0.0 109.986 158.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 4.9 ttt -102.81 -102.47 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -106.31 85.12 2.13 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.272 49.8 m-80 75.6 -43.19 0.49 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -169.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.4 t -82.29 123.43 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 111.193 -163.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.2 p -109.65 138.98 45.23 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.775 0.83 . . . . 0.0 112.539 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.959 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 11.1 p -127.37 117.4 22.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 169.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.1 m -93.98 105.99 17.98 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 168.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -116.52 129.73 56.36 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 122.044 0.926 . . . . 0.0 111.843 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 24.3 mm -104.38 126.34 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 124.273 1.029 . . . . 0.0 109.299 -159.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -123.08 126.35 46.91 Favored 'General case' 0 CA--C 1.577 1.995 0 O-C-N 121.68 -0.637 . . . . 0.0 112.172 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -87.3 139.96 30.03 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -74.69 118.27 17.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 112.136 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.82 61.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.771 -0.58 . . . . 0.0 110.115 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.029 -1.045 . . . . 0.0 109.03 -158.276 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.257 9.0 p . . . . . 0 N--CA 1.504 2.269 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -52.55 -28.19 19.79 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 167.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -51.69 -39.69 58.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.92 -6.11 42.97 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 171.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -90.74 135.53 33.66 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 121.213 1.824 . . . . 0.0 112.483 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.01 -176.19 29.64 Favored Glycine 0 N--CA 1.485 1.912 0 CA-C-O 122.642 1.134 . . . . 0.0 114.503 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -94.32 119.33 32.92 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.985 -0.608 . . . . 0.0 109.541 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -121.07 118.11 28.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 122.085 -0.385 . . . . 0.0 110.977 -166.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -105.91 126.45 52.19 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.287 -0.883 . . . . 0.0 112.908 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.03 124.56 24.68 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.714 0.769 . . . . 0.0 112.939 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.45 -55.51 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 124.117 0.967 . . . . 0.0 112.229 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -110.12 99.13 8.26 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 119.186 0.903 . . . . 0.0 109.173 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.0 p -113.87 95.68 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.081 0.953 . . . . 0.0 111.887 -174.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -107.41 123.41 48.35 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.139 -0.976 . . . . 0.0 111.736 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.76 66.34 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 119.657 2.623 . . . . 0.0 119.657 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -79.55 -41.2 27.75 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 120.29 2.045 . . . . 0.0 115.671 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.19 -43.23 74.2 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 120.443 1.474 . . . . 0.0 114.594 160.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.71 -47.97 82.73 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -51.27 -55.59 17.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 165.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -61.39 -23.5 65.84 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 171.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -64.53 -46.77 81.43 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 160.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -61.7 -37.59 84.71 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 121.615 2.007 . . . . 0.0 115.116 167.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.65 -51.75 67.52 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 164.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.54 72.33 1.05 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.428 -0.795 . . . . 0.0 112.538 -168.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.9 t -119.83 136.96 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.94 153.12 50.55 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 116.874 1.51 . . . . 0.0 116.874 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 mp -59.11 -48.59 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -168.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.54 88.64 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 167.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.17 -45.98 91.25 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 170.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -61.97 -45.07 95.25 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 167.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -55.34 -42.55 74.0 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 74.4 mtm -62.3 -44.96 95.3 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 165.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -48.54 58.29 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.521 2.168 . . . . 0.0 118.521 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.65 -47.37 86.55 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -85.86 10.27 14.32 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.38 35.29 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 120.463 -1.398 . . . . 0.0 113.65 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -109.42 74.77 0.69 Allowed Pre-proline 0 CA--C 1.575 1.94 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.849 167.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.46 158.22 48.23 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.723 2.282 . . . . 0.0 115.913 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.05 98.24 10.3 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 162.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.2 t -88.84 101.62 14.22 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 122.063 0.935 . . . . 0.0 110.61 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -93.56 113.71 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -113.68 125.08 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -152.17 133.95 14.78 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.778 -1.202 . . . . 0.0 109.5 171.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.7 p -100.41 123.9 45.23 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -82.62 74.9 9.55 Favored 'General case' 0 CA--C 1.576 1.943 0 CA-C-O 122.309 1.052 . . . . 0.0 110.18 162.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.63 -89.04 0.08 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -88.49 -29.06 20.41 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 163.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -81.35 88.3 6.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 121.713 2.052 . . . . 0.0 111.841 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.34 109.45 16.6 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-O 122.125 0.964 . . . . 0.0 110.108 -173.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.1 m -101.33 113.35 26.34 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.332 -162.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.7 mt -111.49 113.1 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -110.77 105.34 14.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.823 -0.548 . . . . 0.0 109.881 170.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.0 m -90.95 101.29 14.05 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.557 0.743 . . . . 0.0 109.204 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -94.25 117.92 30.82 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.622 0.769 . . . . 0.0 111.779 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.9 t -154.49 139.47 17.31 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.704 0.801 . . . . 0.0 111.852 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.4 p -60.53 -34.56 74.29 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 165.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.8 -55.18 18.52 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-N 119.486 1.039 . . . . 0.0 113.671 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.54 110.45 3.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.606 -1.309 . . . . 0.0 111.636 167.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.6 m -80.75 146.32 31.07 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.963 0.887 . . . . 0.0 111.287 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.5 m -155.55 136.61 13.74 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.299 -1.501 . . . . 0.0 109.594 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -142.32 146.32 34.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -158.42 150.87 21.97 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.9 p -108.28 107.43 18.02 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.5 0.72 . . . . 0.0 110.943 169.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.0 p -99.07 115.29 28.65 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.588 0.708 . . . . 0.0 112.698 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.9 m -72.47 110.58 6.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.468 -0.77 . . . . 0.0 110.392 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.5 tp -71.05 110.31 5.66 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -162.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.12 -54.32 0.75 Allowed Glycine 0 CA--C 1.547 2.089 0 C-N-CA 123.594 0.616 . . . . 0.0 114.107 -159.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.91 -177.78 4.0 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 123.712 1.72 . . . . 0.0 113.579 -169.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -99.7 130.45 45.92 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 113.857 -1.52 . . . . 0.0 112.6 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -123.06 -175.8 3.26 Favored 'General case' 0 CA--C 1.578 2.032 0 C-N-CA 125.168 1.387 . . . . 0.0 111.45 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -109.73 119.51 39.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.322 -1.486 . . . . 0.0 111.221 165.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -81.36 131.88 35.31 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 121.368 -0.832 . . . . 0.0 109.051 158.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.0 m -100.7 107.12 18.65 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 167.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.6 p -70.48 162.3 29.0 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.77 -31.91 59.33 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 166.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.17 -47.99 80.29 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.95 57.19 0.25 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 124.104 0.859 . . . . 0.0 113.903 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -131.31 124.32 30.18 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -173.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.53 109.58 17.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.679 -0.638 . . . . 0.0 110.115 171.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.4 p -116.14 112.67 22.03 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.372 0.606 . . . . 0.0 111.018 -169.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -70.82 101.18 2.06 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.279 1.038 . . . . 0.0 110.937 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.8 m -122.71 122.13 38.02 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.138 -153.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.42 125.81 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.651 -0.656 . . . . 0.0 111.476 170.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.9 m -99.5 123.63 43.95 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 173.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -133.0 133.91 43.76 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 118.8 0.727 . . . . 0.0 111.167 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -95.38 130.5 42.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.092 -1.005 . . . . 0.0 111.54 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.9 t -143.47 141.78 30.92 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 122.943 0.497 . . . . 0.0 110.281 165.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 62.11 35.28 15.84 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 160.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.11 25.86 74.87 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -165.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.53 135.59 22.56 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-N 118.909 1.354 . . . . 0.0 113.249 -174.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.12 112.69 22.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.432 -0.793 . . . . 0.0 110.479 166.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 67.0 t -93.68 103.11 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -101.6 103.86 14.7 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.49 0.716 . . . . 0.0 109.981 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -91.22 107.26 19.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.514 -0.741 . . . . 0.0 110.693 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -79.72 144.93 33.22 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.879 0.871 . . . . 0.0 111.975 169.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -143.24 124.69 14.75 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.651 0.781 . . . . 0.0 109.781 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 7.9 p90 -155.3 125.83 6.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.252 30.0 t70 49.14 45.26 23.21 Favored 'General case' 0 CA--C 1.584 2.252 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.63 26.37 66.62 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 119.612 2.605 . . . . 0.0 119.612 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -131.96 130.83 42.0 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.628 1.214 . . . . 0.0 108.462 -171.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.58 150.09 38.58 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -166.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 t -139.17 131.93 29.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.594 -0.691 . . . . 0.0 112.079 164.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.8 p -104.22 109.4 21.21 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.102 0.561 . . . . 0.0 110.106 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.0 mm -95.61 104.04 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.7 m -100.52 102.5 13.7 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.644 -0.66 . . . . 0.0 109.81 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -99.48 87.18 3.53 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.163 0.585 . . . . 0.0 110.454 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -110.08 135.89 50.18 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -166.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.87 113.56 22.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.122 -0.986 . . . . 0.0 112.902 -173.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -141.23 133.56 28.16 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.491 0.717 . . . . 0.0 109.287 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 60.11 39.24 19.83 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.13 13.25 41.21 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 119.635 2.614 . . . . 0.0 119.635 -163.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -133.16 144.18 49.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.628 1.214 . . . . 0.0 110.178 -162.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.0 tp -88.03 103.97 16.21 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.868 0.842 . . . . 0.0 109.734 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.6 t -89.92 103.09 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.5 t -96.57 98.23 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -98.09 106.83 19.18 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.992 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.3 p -106.7 121.92 45.31 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.538 0.335 . . . . 0.0 111.839 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 p -121.73 137.1 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.265 0.626 . . . . 0.0 109.936 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.7 ttt -81.08 -79.42 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 122.219 -0.301 . . . . 0.0 110.246 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -122.1 -60.73 1.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.272 0.629 . . . . 0.0 110.885 167.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -97.63 -43.13 7.33 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.58 127.69 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 CA-C-O 122.38 1.086 . . . . 0.0 109.9 -156.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 73.6 p -110.6 139.21 46.07 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.993 -167.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.992 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.8 OUTLIER -106.34 132.07 52.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.835 . . . . 0.0 110.633 158.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.5 m -109.1 107.06 17.23 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -110.5 113.49 26.16 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.11 0.564 . . . . 0.0 110.835 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 mm -91.13 116.65 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.192 -0.943 . . . . 0.0 108.567 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -107.66 125.27 51.15 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.206 0.602 . . . . 0.0 110.727 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -92.27 142.65 27.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -81.57 116.32 21.28 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.911 0.885 . . . . 0.0 112.207 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.3 t -101.29 93.13 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -171.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 124.031 0.932 . . . . 0.0 110.451 -174.688 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.522 0.8 OUTLIER . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 118.755 2.872 . . . . 0.0 118.755 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -38.17 90.13 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 174.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -62.36 -25.69 68.05 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 167.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.7 mt -70.36 -7.57 43.88 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 164.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.83 142.59 31.41 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-N 121.319 1.872 . . . . 0.0 112.79 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.56 171.19 18.56 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 -86.98 103.63 15.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 165.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -101.66 101.86 12.45 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -170.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.33 142.58 27.62 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.588 0.755 . . . . 0.0 112.871 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.1 tp -71.01 127.96 34.35 Favored 'General case' 0 CA--C 1.571 1.776 0 O-C-N 120.677 -1.264 . . . . 0.0 113.446 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.95 -55.41 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 C-N-CA 124.082 0.953 . . . . 0.0 112.399 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -117.65 151.28 37.54 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 119.642 1.11 . . . . 0.0 110.567 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -144.47 59.22 1.33 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.997 0.903 . . . . 0.0 113.046 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -75.6 119.62 19.89 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -167.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.52 -6.76 71.22 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 -170.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.252 22.6 t80 -59.27 -31.6 69.25 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.816 2.524 . . . . 0.0 117.816 -174.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -52.46 -54.59 30.33 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 164.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.99 -45.39 83.0 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -58.65 -49.54 77.14 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 19.8 ptp -56.26 -37.65 70.06 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 167.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -63.62 -47.16 82.53 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 168.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.414 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 5.9 tp10 -67.63 -37.95 83.21 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 170.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.1 mt -53.45 -35.94 61.06 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 117.576 2.435 . . . . 0.0 117.576 167.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.76 62.79 1.07 Allowed Glycine 0 N--CA 1.487 2.073 0 C-N-CA 123.438 0.542 . . . . 0.0 114.041 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.51 125.12 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -172.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.17 162.16 51.78 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.62 -50.97 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -168.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.38 94.86 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.4 mt -57.77 -41.7 82.54 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.734 1.754 . . . . 0.0 115.734 167.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -60.81 -49.68 76.5 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.22 -46.92 87.19 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.5 ttp -53.64 -55.21 27.87 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 167.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.29 96.04 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 118.618 2.207 . . . . 0.0 118.618 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.6 94.59 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.9 ptp -75.47 -22.15 57.48 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 170.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.93 133.1 47.75 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -174.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -103.08 87.28 1.22 Allowed Pre-proline 0 CA--C 1.576 1.945 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.749 166.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.96 142.96 22.63 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.46 2.107 . . . . 0.0 115.168 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -95.44 103.34 15.21 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.18 168.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 50.6 t -81.14 101.11 9.44 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-O 121.836 0.827 . . . . 0.0 110.903 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mt -94.96 104.36 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -170.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.83 130.78 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.258 7.7 t -136.84 149.88 47.98 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.776 -0.577 . . . . 0.0 112.312 159.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.4 t -141.83 128.74 20.63 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -68.68 -46.2 69.7 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 165.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.66 -78.68 0.15 Allowed Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -171.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -80.82 -26.07 37.35 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 160.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -88.63 138.75 31.14 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 122.842 2.565 . . . . 0.0 112.931 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -139.57 125.21 19.38 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.436 0.694 . . . . 0.0 110.463 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 m -109.37 133.86 52.53 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.376 1.07 . . . . 0.0 110.433 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.8 mt -123.12 119.68 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -103.94 110.17 22.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.685 -0.634 . . . . 0.0 110.145 163.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.7 m -83.71 99.17 10.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.277 -0.89 . . . . 0.0 109.102 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.44 125.74 35.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.663 0.744 . . . . 0.0 112.24 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 t -147.1 135.28 21.58 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 166.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.4 p -56.39 -26.05 51.79 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.5 mt -73.47 -54.51 8.09 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 165.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.71 114.75 3.54 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.563 1.529 . . . . 0.0 111.612 173.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.4 m -84.19 141.46 31.02 Favored 'General case' 0 CA--C 1.575 1.928 0 C-N-CA 123.457 0.703 . . . . 0.0 111.851 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 t -134.17 145.48 49.29 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.156 -0.965 . . . . 0.0 111.27 164.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -135.47 133.99 39.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.776 -1.202 . . . . 0.0 111.849 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.92 160.62 41.02 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 122.061 0.934 . . . . 0.0 112.964 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 m -139.13 137.49 36.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.089 -1.007 . . . . 0.0 111.153 170.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 36.4 t -135.4 143.0 45.77 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.813 1.292 . . . . 0.0 112.635 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.2 m -91.48 115.41 28.02 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.195 171.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -64.38 134.4 54.53 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.95 -49.09 0.87 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 -154.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -98.47 164.98 12.05 Favored 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 123.595 1.664 . . . . 0.0 113.228 -163.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 99' ' ' GLU . 19.2 tttp -110.58 128.76 55.8 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.396 -174.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -129.62 166.14 20.35 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.46 105.99 10.1 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 122.055 0.931 . . . . 0.0 111.467 169.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -103.12 97.43 7.52 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.426 1.091 . . . . 0.0 109.104 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.8 m -80.06 109.12 14.21 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 121.821 0.82 . . . . 0.0 109.471 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.6 p -69.6 176.14 3.71 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.95 -43.28 29.13 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 168.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.76 -43.51 97.92 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.268 2.322 . . . . 0.0 117.268 165.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.98 3.15 13.58 Favored Glycine 0 CA--C 1.556 2.634 0 N-CA-C 119.097 2.399 . . . . 0.0 119.097 -162.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.3 mtm-85 -69.89 128.54 36.72 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 120.979 2.389 . . . . 0.0 112.204 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -86.54 93.54 9.2 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.791 0.805 . . . . 0.0 108.9 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 p -99.28 125.24 44.87 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.712 -170.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -79.92 97.55 6.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.656 -1.278 . . . . 0.0 110.082 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.4 m -104.97 116.7 32.41 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.749 0.42 . . . . 0.0 110.408 -166.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.13 118.91 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.97 -0.456 . . . . 0.0 110.087 167.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.9 m -100.1 131.42 46.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.967 -0.458 . . . . 0.0 111.58 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -142.04 115.4 8.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 110.265 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -78.96 129.4 34.44 Favored 'General case' 0 CA--C 1.57 1.721 0 O-C-N 120.977 -1.077 . . . . 0.0 111.6 166.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 t -146.1 142.78 28.86 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.251 0.62 . . . . 0.0 110.201 165.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 60.63 36.92 19.55 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 159.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.3 21.15 79.45 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 -166.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.52 139.62 24.33 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-N 119.02 1.41 . . . . 0.0 112.596 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 67.3 tp -96.61 115.13 26.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -0.804 . . . . 0.0 110.615 171.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.9 t -89.28 103.35 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -98.31 95.56 7.46 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -96.72 99.74 11.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.968 . . . . 0.0 110.095 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -100.43 126.9 46.87 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -170.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 72' ' ' LYS . 7.7 mt-10 -129.78 131.1 46.11 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.207 0.603 . . . . 0.0 111.388 -167.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -152.64 120.9 6.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.624 -1.298 . . . . 0.0 111.438 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.6 t70 42.99 54.22 4.86 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.9 -45.43 2.69 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 117.902 1.921 . . . . 0.0 117.902 -169.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -89.92 141.78 28.32 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 118.19 0.995 . . . . 0.0 113.345 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -127.92 159.68 34.19 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.682 0.753 . . . . 0.0 112.991 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.4 t -135.54 141.51 45.24 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.429 1.109 . . . . 0.0 112.01 162.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.6 p -106.38 109.99 22.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 mm -103.09 94.51 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -172.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.1 m -97.82 105.36 17.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.0 109.719 -172.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.9 mtp85 -103.23 89.33 3.37 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.234 0.614 . . . . 0.0 110.544 -167.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.404 ' HZ1' ' CD ' ' A' ' 119' ' ' GLU . 44.9 pttt -105.86 138.25 42.37 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -168.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.4 123.88 33.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 113.209 -173.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -150.92 121.83 7.61 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.519 0.728 . . . . 0.0 109.266 -170.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.1 t70 61.06 28.2 17.97 Favored 'General case' 0 N--CA 1.514 2.754 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.58 33.12 66.09 Favored Glycine 0 CA--C 1.56 2.849 0 O-C-N 119.274 -2.141 . . . . 0.0 117.584 -158.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -133.08 131.17 40.27 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -174.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.2 tp -86.52 105.12 16.59 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.849 -1.157 . . . . 0.0 109.831 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.2 t -91.95 106.17 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t -100.5 99.29 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.404 ' CD ' ' HZ1' ' A' ' 110' ' ' LYS . 84.3 mt-10 -87.52 93.85 9.54 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.471 1.129 . . . . 0.0 108.499 173.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.3 p -104.82 97.39 7.28 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.7 -176.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.48 146.34 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.519 1.152 . . . . 0.0 109.927 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.414 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 11.3 ttt -97.71 -60.12 1.63 Allowed 'General case' 0 CA--C 1.565 1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 112.972 174.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.273 12.9 p30 -139.65 -92.99 0.17 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -81.28 -13.71 58.17 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 154.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -96.73 133.89 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 C-N-CA 124.72 1.208 . . . . 0.0 109.67 -166.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.0 p -132.76 146.83 52.17 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -152.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 6.1 p -136.92 121.12 17.91 Favored 'General case' 0 CA--C 1.563 1.468 0 O-C-N 121.533 -0.73 . . . . 0.0 110.711 158.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.2 m -97.76 101.7 13.28 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -108.9 110.53 21.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.701 -0.624 . . . . 0.0 110.306 -168.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.9 mm -94.39 124.69 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -122.28 120.38 33.92 Favored 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.04 0.536 . . . . 0.0 110.379 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -90.74 150.51 21.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.781 -1.199 . . . . 0.0 113.447 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -78.4 128.64 33.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.915 -1.116 . . . . 0.0 113.55 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.2 t -86.56 104.65 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 165.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 N--CA 1.487 1.395 0 C-N-CA 123.802 0.841 . . . . 0.0 110.543 178.451 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.274 4.8 p . . . . . 0 N--CA 1.503 2.2 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.53 -33.28 72.42 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 163.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -63.49 -33.83 76.44 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 165.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.94 -4.06 11.85 Favored 'General case' 0 CA--C 1.581 2.151 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 164.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.05 122.02 25.68 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 121.955 2.161 . . . . 0.0 112.596 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.19 -179.95 34.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.3 ttm105 -93.84 108.06 19.88 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.159 0.584 . . . . 0.0 109.592 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -109.94 107.56 17.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.376 -0.827 . . . . 0.0 110.49 -165.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -91.82 130.78 37.53 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.788 -1.195 . . . . 0.0 112.794 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 48.0 tp -64.18 125.53 24.84 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 170.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.261 5.6 m -126.86 -60.01 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 123.097 0.559 . . . . 0.0 112.246 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -104.21 137.23 42.43 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 119.332 0.969 . . . . 0.0 110.338 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 p -147.97 93.57 2.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.477 -0.764 . . . . 0.0 111.725 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.46 128.9 48.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.816 -0.552 . . . . 0.0 111.772 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.6 -1.12 88.58 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 118.901 2.32 . . . . 0.0 118.901 -168.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -71.53 -51.19 24.84 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.046 1.923 . . . . 0.0 115.555 -170.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.09 -38.53 62.64 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 167.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.71 -49.28 75.69 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -54.24 -45.04 72.24 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 164.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.1 mtp -57.84 -42.75 85.02 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 169.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -55.5 -48.63 74.31 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 163.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.8 -43.4 98.19 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 172.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.7 mt -55.23 -38.58 68.65 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 117.889 2.552 . . . . 0.0 117.889 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.6 55.93 1.13 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 -165.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.69 118.57 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.682 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.65 165.29 41.08 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.94 -48.92 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -169.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.46 98.56 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.45 -42.39 91.85 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -57.53 -51.44 69.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -54.96 -54.3 44.53 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 169.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.2 ttp -52.93 -57.01 11.74 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.81 -40.85 90.3 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 118.926 2.33 . . . . 0.0 118.926 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.54 -51.79 52.75 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 169.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -72.61 -30.36 64.29 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.81 85.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.338 62.7 pttt 47.25 66.39 5.71 Favored Pre-proline 0 CA--C 1.585 2.306 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.79 154.84 23.47 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 N-CA-C 117.025 1.894 . . . . 0.0 117.025 -159.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.83 97.97 7.61 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.028 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.0 t -90.9 103.25 15.98 Favored 'General case' 0 CA--C 1.556 1.183 0 O-C-N 121.148 -0.97 . . . . 0.0 112.198 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.88 110.18 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.8 mt -97.95 114.8 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.2 m -134.63 117.91 16.62 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.5 t -121.82 118.54 29.25 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -172.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -86.19 60.24 6.12 Favored 'General case' 0 CA--C 1.576 1.951 0 CA-C-O 121.991 0.901 . . . . 0.0 111.557 170.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.64 -71.24 0.68 Allowed Glycine 0 N--CA 1.492 2.412 0 O-C-N 120.145 -1.597 . . . . 0.0 116.431 -170.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -99.89 -46.23 5.44 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.76 105.35 10.99 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 121.053 1.752 . . . . 0.0 111.387 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.66 111.61 23.87 Favored 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.139 0.971 . . . . 0.0 109.832 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.1 m -93.98 116.48 28.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.891 0.876 . . . . 0.0 109.165 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.4 104.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -105.43 104.02 13.66 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.321 0.581 . . . . 0.0 109.683 171.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.7 m -89.25 100.16 13.01 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.851 0.86 . . . . 0.0 110.124 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.72 111.84 23.7 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.088 0.947 . . . . 0.0 111.498 -173.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.1 p -148.51 153.12 38.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.628 -0.67 . . . . 0.0 110.601 157.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.6 p -61.98 -43.93 97.81 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 171.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.5 mt -61.97 -41.41 97.98 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 168.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -145.31 110.63 5.28 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.836 1.198 . . . . 0.0 110.72 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.53 118.81 36.14 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.2 p -139.72 142.61 36.83 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.009 -1.057 . . . . 0.0 111.91 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -139.14 133.44 31.48 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.742 -1.224 . . . . 0.0 111.821 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -146.65 147.31 30.9 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.678 0.751 . . . . 0.0 112.887 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.3 p -105.53 106.29 16.72 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.577 0.751 . . . . 0.0 110.846 172.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.3 p -94.45 125.23 38.96 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 121.515 0.674 . . . . 0.0 112.33 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.5 m -77.8 123.17 26.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.318 -0.864 . . . . 0.0 110.068 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.79 132.03 37.87 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -167.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.71 37.38 94.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 116.792 1.477 . . . . 0.0 116.792 -159.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.73 155.75 24.32 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.429 1.109 . . . . 0.0 111.136 -171.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HZ3' ' CD ' ' A' ' 99' ' ' GLU . 10.9 tttp -109.73 121.56 45.5 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.787 -169.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -121.59 162.15 21.15 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.46 0.704 . . . . 0.0 112.502 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -75.84 106.08 7.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.783 -1.198 . . . . 0.0 110.971 166.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -90.98 116.54 28.86 Favored 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.8 m -86.74 93.97 9.39 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.8 p -68.94 159.93 31.77 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -43.46 -42.93 5.06 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.99 -35.8 66.92 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 171.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.91 -14.9 3.32 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 117.94 1.936 . . . . 0.0 117.94 -166.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -71.81 131.34 42.92 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.495 2.147 . . . . 0.0 112.651 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -81.97 110.5 17.29 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.205 0.602 . . . . 0.0 110.364 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.6 p -114.96 128.26 56.17 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.136 0.493 . . . . 0.0 109.816 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -78.82 92.25 4.83 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.759 0.79 . . . . 0.0 109.64 172.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.4 m -98.15 114.31 26.48 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.894 -164.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.264 12.5 p -91.74 117.11 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 122.019 -0.426 . . . . 0.0 110.82 171.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.6 m -101.5 112.99 25.71 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.136 -0.352 . . . . 0.0 111.849 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -123.0 125.56 45.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.656 -0.652 . . . . 0.0 111.114 -171.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -88.33 130.55 35.1 Favored 'General case' 0 CA--C 1.568 1.663 0 O-C-N 121.131 -0.98 . . . . 0.0 112.393 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -141.29 107.61 5.26 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.466 0.706 . . . . 0.0 110.218 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 45.34 70.45 0.35 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 171.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.33 -0.03 60.82 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 119.896 2.718 . . . . 0.0 119.896 -171.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.39 126.58 39.15 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 119.985 1.892 . . . . 0.0 113.009 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.2 tp -93.39 108.82 20.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.614 -0.679 . . . . 0.0 110.621 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -90.29 107.93 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -101.11 98.37 8.81 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.284 1.034 . . . . 0.0 109.521 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -100.3 103.14 14.54 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.565 0.746 . . . . 0.0 110.477 -171.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -100.19 105.97 17.61 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.896 0.878 . . . . 0.0 111.215 -164.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.441 ' CD ' ' HZ3' ' A' ' 72' ' ' LYS . 17.8 mt-10 -108.19 126.08 52.38 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.192 -0.942 . . . . 0.0 113.539 -166.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -154.71 141.02 18.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.221 -0.925 . . . . 0.0 110.606 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.2 t70 51.14 45.44 27.83 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 159.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.9 68.63 Favored Glycine 0 CA--C 1.559 2.829 0 N-CA-C 120.238 2.855 . . . . 0.0 120.238 -167.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -137.01 150.06 47.87 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.141 1.471 . . . . 0.0 110.434 -167.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -124.18 147.56 47.91 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.249 0.547 . . . . 0.0 112.374 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.8 t -126.3 115.63 19.99 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 164.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.8 m -123.74 113.14 18.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.067 -1.021 . . . . 0.0 108.732 -160.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.0 mt -122.09 112.17 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -164.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 58.6 m -95.32 101.31 13.03 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.187 0.517 . . . . 0.0 109.666 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -93.08 101.17 13.48 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.376 0.67 . . . . 0.0 109.271 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 pttp -126.39 140.4 52.52 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -169.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.18 116.39 15.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 111.203 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.286 24.9 tptp -103.24 -126.72 0.22 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.081 0.552 . . . . 0.0 110.049 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -91.9 64.93 4.81 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 122.231 1.015 . . . . 0.0 109.51 -165.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.66 -24.11 13.73 Favored Glycine 0 CA--C 1.556 2.645 0 N-CA-C 119.045 2.378 . . . . 0.0 119.045 -162.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -129.89 161.16 31.47 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.078 1.939 . . . . 0.0 112.306 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.5 tp -85.02 116.08 23.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.794 -1.191 . . . . 0.0 111.406 -173.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.7 t -91.81 120.2 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 64.0 t -110.34 100.01 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -95.66 102.67 14.49 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.966 0.906 . . . . 0.0 108.972 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.964 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 0.9 OUTLIER -98.85 150.89 21.42 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.1 137.29 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 123.221 0.608 . . . . 0.0 109.609 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.268 10.7 ttt -98.25 -77.35 0.51 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 0.0 111.118 163.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -123.48 -70.89 0.75 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.388 -0.82 . . . . 0.0 110.934 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -99.58 -31.32 11.66 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 170.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.2 t -99.74 129.49 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-N 120.365 1.438 . . . . 0.0 110.148 -164.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.8 p -106.34 154.89 20.14 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.328 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.964 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.6 OUTLIER -130.17 139.16 50.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 112.328 162.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.1 m -106.74 109.43 21.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -107.31 124.82 50.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.331 0.653 . . . . 0.0 110.996 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.8 mm -92.38 122.73 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -113.57 122.78 48.28 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.757 0.823 . . . . 0.0 109.973 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -92.72 137.92 31.94 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -77.52 111.95 13.78 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.72 0.772 . . . . 0.0 112.691 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.9 t -103.95 128.47 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.015 -1.053 . . . . 0.0 108.832 -175.514 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.503 1.2 p . . . . . 0 N--CA 1.503 2.181 0 N-CA-C 118.38 2.733 . . . . 0.0 118.38 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.37 -36.32 53.52 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 169.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -54.49 -37.06 64.85 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 169.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.9 mt -70.74 -2.58 15.13 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 171.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -81.72 134.84 35.5 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 121.258 1.844 . . . . 0.0 112.937 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.79 177.95 29.51 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 117.757 1.863 . . . . 0.0 117.757 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -93.43 102.54 14.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.096 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.34 101.84 11.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.954 -0.466 . . . . 0.0 110.018 -168.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -90.01 125.82 35.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.206 1.002 . . . . 0.0 113.45 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.9 tp -64.41 125.09 23.53 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.41 -44.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.321 1.048 . . . . 0.0 113.162 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -128.49 155.66 44.49 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 120.291 1.405 . . . . 0.0 111.834 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.5 p -153.62 84.38 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 0.0 111.365 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.14 138.76 39.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.513 -0.742 . . . . 0.0 112.758 176.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.45 23.32 70.19 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 119.693 2.637 . . . . 0.0 119.693 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -85.83 -43.62 13.14 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -168.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -50.13 -46.4 53.82 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 162.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -53.98 -48.98 69.81 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 166.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -61.2 -47.47 85.98 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.05 -32.79 74.46 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 169.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -58.23 -48.44 80.39 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 121.507 1.958 . . . . 0.0 115.814 158.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -60.21 -40.6 90.7 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.5 mt -57.7 -50.3 73.64 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 161.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.14 56.11 0.28 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 124.346 0.974 . . . . 0.0 115.134 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.31 130.28 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-N 117.607 0.703 . . . . 0.0 109.423 -171.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.51 159.87 51.8 Favored Glycine 0 CA--C 1.553 2.431 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.88 -48.65 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.61 88.72 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 171.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.09 -40.03 94.03 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 170.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.1 mtm-85 -63.69 -42.71 97.96 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 166.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -54.29 -49.82 68.72 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 166.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.6 ttp -52.86 -55.29 24.28 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 164.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.48 -37.73 67.8 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 119.766 2.666 . . . . 0.0 119.766 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.34 -51.04 61.32 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.2 ptp -77.28 -20.44 55.07 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.24 115.22 7.45 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 120.163 1.347 . . . . 0.0 112.184 165.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.93 84.42 3.46 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.139 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.86 151.49 31.46 Favored 'Trans proline' 0 C--N 1.372 1.772 0 N-CA-C 117.395 2.036 . . . . 0.0 117.395 -168.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -84.4 102.38 12.71 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.532 162.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.3 t -77.78 100.53 6.32 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 121.951 0.881 . . . . 0.0 110.76 170.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.7 mt -95.93 101.68 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -170.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 81.2 mt -99.33 130.64 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.6 t -136.23 140.22 43.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.824 -0.548 . . . . 0.0 111.666 157.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 43.0 t -119.65 103.57 9.51 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.683 0.793 . . . . 0.0 111.961 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.65 75.85 9.53 Favored 'General case' 0 CA--C 1.572 1.798 0 CA-C-O 122.189 0.995 . . . . 0.0 110.686 170.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.7 -83.29 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 116.733 1.453 . . . . 0.0 116.733 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -105.59 -16.6 14.66 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -101.9 116.97 33.86 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 122.214 2.279 . . . . 0.0 110.523 175.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -112.43 116.78 30.84 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.947 0.879 . . . . 0.0 109.938 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.6 m -99.4 125.74 45.16 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.987 0.915 . . . . 0.0 109.73 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 mt -119.4 112.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -98.14 109.83 22.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.764 -0.585 . . . . 0.0 109.941 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 m -90.9 103.3 16.03 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.435 -0.79 . . . . 0.0 109.456 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -101.43 116.85 33.72 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -143.24 140.47 30.69 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.087 0.555 . . . . 0.0 110.091 167.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -50.83 -44.33 59.25 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.21 -40.72 97.05 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.34 103.84 1.25 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.47 1.487 . . . . 0.0 111.076 -175.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.0 m -90.25 145.67 24.82 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.991 0.901 . . . . 0.0 111.459 170.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.7 m -148.24 136.14 20.96 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.056 -1.653 . . . . 0.0 110.63 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -126.99 133.37 50.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.413 -0.804 . . . . 0.0 111.75 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -136.38 152.06 50.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 172.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.3 p -117.98 103.95 10.42 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.802 0.841 . . . . 0.0 109.905 170.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 24.1 p -95.34 152.1 18.68 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.8 m -91.37 130.81 37.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.824 -1.172 . . . . 0.0 109.582 168.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tp -69.53 131.31 44.49 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 112.878 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.13 -6.98 8.56 Favored Glycine 0 CA--C 1.553 2.458 0 N-CA-C 119.558 2.583 . . . . 0.0 119.558 -164.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.78 172.02 10.18 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-N 119.303 1.552 . . . . 0.0 112.007 -174.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.448 ' HZ3' ' CD ' ' A' ' 99' ' ' GLU . 8.9 tttp -113.46 110.79 20.87 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.495 -156.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -105.76 160.75 14.98 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.655 0.782 . . . . 0.0 112.296 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.53 106.68 14.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.93 -1.731 . . . . 0.0 111.658 169.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -89.15 102.08 14.74 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 169.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.4 m -77.95 110.82 13.2 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.094 0.949 . . . . 0.0 109.593 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -75.43 134.38 40.9 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.797 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.94 63.77 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 119.721 3.23 . . . . 0.0 119.721 -170.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.31 -27.08 65.98 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.51 -35.7 0.47 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 118.715 2.246 . . . . 0.0 118.715 167.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -75.07 136.54 41.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -163.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -93.55 115.04 27.53 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.173 0.989 . . . . 0.0 109.021 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.4 p -119.36 111.41 18.14 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.784 0.802 . . . . 0.0 111.168 -164.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -71.78 98.27 1.94 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.324 1.05 . . . . 0.0 110.581 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.4 m -112.99 108.47 17.39 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.285 -0.884 . . . . 0.0 109.922 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.258 12.7 p -88.88 122.61 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 122.96 0.504 . . . . 0.0 111.382 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 55.7 m -105.51 88.11 2.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -169.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -102.18 119.34 38.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.541 -1.349 . . . . 0.0 111.941 -168.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -80.17 131.9 35.8 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.004 -1.06 . . . . 0.0 112.712 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -133.11 97.47 4.01 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.583 0.753 . . . . 0.0 110.414 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.331 9.8 t70 68.6 -73.56 0.09 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 172.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.39 35.43 2.17 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 116.587 1.395 . . . . 0.0 116.587 167.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -153.93 139.24 17.58 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 118.581 1.19 . . . . 0.0 112.957 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 tp -97.84 115.4 27.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.68 -0.637 . . . . 0.0 110.854 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -88.01 101.8 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.56 94.52 9.91 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 124.396 1.078 . . . . 0.0 109.009 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -96.1 98.13 10.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.728 . . . . 0.0 112.159 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -71.05 137.42 48.95 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.062 0.945 . . . . 0.0 113.063 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.448 ' CD ' ' HZ3' ' A' ' 72' ' ' LYS . 19.7 mt-10 -136.83 121.61 18.64 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.497 0.719 . . . . 0.0 109.931 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -158.35 127.1 5.5 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.626 -1.296 . . . . 0.0 111.11 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 54.08 37.83 27.77 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 164.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.72 -43.23 3.08 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 -165.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -75.35 154.57 37.2 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -151.58 155.01 37.57 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.059 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 t -144.32 121.87 11.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.219 -0.926 . . . . 0.0 112.897 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.1 p -86.55 131.34 34.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 0.0 111.278 168.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.2 mt -123.32 101.28 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 84.9 m -93.71 108.08 19.87 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.546 0.739 . . . . 0.0 110.056 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -97.98 87.91 4.1 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.268 0.627 . . . . 0.0 110.041 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.18 142.32 29.22 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -171.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 120.86 27.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.505 -0.747 . . . . 0.0 112.366 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.274 41.0 tttm -134.85 -130.92 0.16 Allowed 'General case' 0 CA--C 1.569 1.706 0 O-C-N 121.979 -0.45 . . . . 0.0 112.03 -172.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -82.86 67.91 9.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.497 -1.377 . . . . 0.0 113.464 -161.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.95 16.82 57.72 Favored Glycine 0 CA--C 1.565 3.194 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -157.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -137.86 131.75 31.5 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.098 1.359 . . . . 0.0 108.146 -164.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.3 tp -82.03 108.55 15.61 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 121.701 0.762 . . . . 0.0 109.259 164.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -96.67 110.13 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -175.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.0 t -103.29 100.35 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -167.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -95.62 108.43 20.7 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.545 1.138 . . . . 0.0 108.568 -171.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.918 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.2 p -126.42 129.35 48.57 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 121.921 0.867 . . . . 0.0 112.382 -158.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.37 146.29 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 123.396 0.678 . . . . 0.0 109.964 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.265 18.6 ttt -118.24 -94.16 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.575 -0.703 . . . . 0.0 111.327 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -105.87 -52.21 2.85 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.758 0.823 . . . . 0.0 111.828 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -119.1 -39.32 2.93 Favored 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 125.485 1.514 . . . . 0.0 112.142 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t -87.39 121.8 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 O-C-N 121.274 -0.892 . . . . 0.0 110.364 -164.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 46.7 p -93.34 103.49 15.72 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.914 0.864 . . . . 0.0 110.204 165.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.918 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 18.5 p -85.69 160.94 19.43 Favored 'General case' 0 CA--C 1.57 1.739 0 CA-C-O 122.624 1.202 . . . . 0.0 111.537 163.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.8 m -150.44 119.01 6.48 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 119.26 -2.15 . . . . 0.0 108.031 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -125.78 132.24 52.32 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-O 121.836 0.827 . . . . 0.0 111.757 -168.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.2 mm -111.63 117.43 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -162.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -116.8 129.68 56.24 Favored 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 123.037 0.535 . . . . 0.0 111.216 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -106.63 146.91 30.14 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -71.94 106.09 4.1 Favored 'General case' 0 CA--C 1.57 1.742 0 O-C-N 121.046 -1.034 . . . . 0.0 113.106 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.05 85.56 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--O 1.256 1.446 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -171.456 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.505 2.289 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -46.25 -34.06 4.14 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 165.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -63.74 -22.19 66.78 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 172.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.1 mt -74.89 -5.78 45.55 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 117.722 2.49 . . . . 0.0 117.722 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 164.0 26.94 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -172.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.35 -179.37 24.68 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 171.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 -84.22 126.16 32.88 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.153 -0.616 . . . . 0.0 111.201 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -126.31 113.81 17.42 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -89.75 134.9 33.93 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.0 tp -68.61 121.78 17.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -112.28 -55.15 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 123.952 0.901 . . . . 0.0 112.603 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -106.69 140.2 39.92 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 120.244 1.383 . . . . 0.0 110.228 168.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -136.5 79.7 1.78 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.728 1.252 . . . . 0.0 110.167 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -99.03 100.82 12.03 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.562 -0.712 . . . . 0.0 110.938 -158.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.5 22.07 20.08 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 118.309 2.084 . . . . 0.0 118.309 -167.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -74.27 -49.74 21.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -37.9 74.69 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 167.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -57.73 -45.13 86.24 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 166.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -57.3 -49.36 76.35 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 164.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 73.5 mtm -60.76 -35.35 76.2 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 172.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -55.44 -55.23 34.09 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 161.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.415 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 31.6 tp10 -64.91 -36.6 84.89 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -53.65 -44.03 69.27 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 159.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.8 56.59 1.22 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -172.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -98.02 137.71 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 123.327 0.651 . . . . 0.0 110.091 -172.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.26 153.33 48.64 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 pt -57.37 -48.82 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 -171.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.58 87.76 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 167.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 mt -66.52 -37.68 85.56 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 169.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -57.65 -48.82 78.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 162.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -57.52 -48.97 77.84 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 169.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -50.7 -51.46 49.46 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 167.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.2 -46.17 93.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 118.116 2.007 . . . . 0.0 118.116 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.47 -45.02 94.94 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -79.81 -5.23 54.99 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 118.048 2.611 . . . . 0.0 118.048 173.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.05 135.8 39.93 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.25 92.33 2.09 Favored Pre-proline 0 CA--C 1.573 1.857 0 O-C-N 121.369 -0.832 . . . . 0.0 110.853 160.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.35 136.53 26.62 Favored 'Trans proline' 0 CA--C 1.559 1.774 0 CA-C-N 122.935 2.084 . . . . 0.0 114.548 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -100.54 101.93 12.98 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.392 167.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.2 t -74.76 111.96 10.49 Favored 'General case' 0 CA--C 1.558 1.274 0 O-C-N 121.627 -0.671 . . . . 0.0 110.689 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mt -104.88 105.16 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 83.9 mt -95.47 129.46 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.0 p -119.0 111.94 18.95 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.5 p -98.56 111.45 23.81 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -170.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -84.78 176.75 8.33 Favored 'General case' 0 CA--C 1.578 2.035 0 CA-C-O 124.106 1.908 . . . . 0.0 110.346 159.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.18 -40.99 92.52 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.402 2.121 . . . . 0.0 118.402 158.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -123.06 -47.77 2.02 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 166.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -86.63 82.74 7.79 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 120.953 1.706 . . . . 0.0 111.518 -166.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.61 112.7 24.34 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.885 -1.134 . . . . 0.0 109.221 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.2 m -98.31 119.62 37.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.532 -0.73 . . . . 0.0 110.576 -168.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.3 mt -112.0 105.76 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -99.99 103.3 14.84 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.3 m -90.56 100.34 13.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.61 -0.681 . . . . 0.0 110.011 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.16 118.8 30.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.6 t -138.21 144.4 40.62 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.197 0.599 . . . . 0.0 110.017 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.5 p -75.78 42.32 0.23 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.1 mt -152.91 -54.64 0.12 Allowed 'General case' 0 CA--C 1.572 1.821 0 C-N-CA 126.791 2.036 . . . . 0.0 108.654 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -143.44 117.0 9.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.024 -1.048 . . . . 0.0 110.838 167.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.3 m -84.75 120.08 26.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.676 -0.64 . . . . 0.0 109.61 166.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.0 p -111.97 103.03 11.23 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -102.72 128.95 49.23 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.35 0.66 . . . . 0.0 111.374 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -145.34 141.6 28.65 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.02 0.914 . . . . 0.0 112.954 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.8 p -97.47 105.29 17.41 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.739 0.816 . . . . 0.0 110.886 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 30.1 p -92.96 122.55 35.44 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.566 0.698 . . . . 0.0 111.99 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.0 m -85.72 115.41 23.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.483 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.27 118.29 19.62 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.541 0.737 . . . . 0.0 112.764 -166.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.1 55.17 8.16 Favored Glycine 0 CA--C 1.549 2.192 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.945 -156.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.49 154.71 2.63 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 124.429 1.092 . . . . 0.0 111.403 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -109.59 123.56 49.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.135 0.974 . . . . 0.0 112.916 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -127.65 164.48 21.95 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 124.17 0.988 . . . . 0.0 112.293 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -78.39 107.73 11.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 119.842 -1.787 . . . . 0.0 111.712 164.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -77.95 147.65 34.85 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.294 155.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.0 m -113.17 114.73 27.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.769 171.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.3 p -70.49 138.68 51.29 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 122.825 0.45 . . . . 0.0 111.62 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.62 -29.45 10.98 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 120.309 3.448 . . . . 0.0 120.309 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -84.15 -29.75 26.43 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 170.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.15 -37.39 0.37 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 119.96 2.744 . . . . 0.0 119.96 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -68.25 127.92 34.68 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 119.578 1.689 . . . . 0.0 112.675 -174.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -93.72 128.84 40.13 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.121 0.486 . . . . 0.0 110.744 171.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.8 p -120.44 126.01 49.36 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.254 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -67.77 103.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.208 1.004 . . . . 0.0 111.319 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.3 m -114.53 101.38 9.07 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -158.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.299 14.6 p -87.05 106.17 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.404 0.621 . . . . 0.0 110.331 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 63.6 m -92.12 120.71 32.98 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -140.01 126.92 20.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.87 -0.519 . . . . 0.0 111.265 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -92.21 123.52 35.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 111.488 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 t -139.51 138.41 36.31 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.235 0.614 . . . . 0.0 109.832 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 61.79 36.93 15.91 Favored 'General case' 0 N--CA 1.506 2.334 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 162.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.7 12.63 83.68 Favored Glycine 0 CA--C 1.557 2.69 0 N-CA-C 119.354 2.502 . . . . 0.0 119.354 -165.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.35 125.47 24.53 Favored 'General case' 0 CA--C 1.561 1.392 0 CA-C-N 119.668 1.734 . . . . 0.0 112.743 -169.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 tp -86.4 106.9 17.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.529 -0.732 . . . . 0.0 110.945 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 66.7 t -92.95 108.66 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.854 0.862 . . . . 0.0 108.765 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -93.27 95.0 9.08 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.627 0.771 . . . . 0.0 110.024 173.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -91.08 102.49 15.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 110.751 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -94.56 126.07 39.61 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.699 1.2 . . . . 0.0 111.31 -172.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -125.26 122.81 38.0 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.341 0.656 . . . . 0.0 110.466 -169.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -157.38 118.81 3.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.807 -1.183 . . . . 0.0 111.32 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 45.14 51.34 9.1 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 168.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.5 -42.77 3.08 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 117.699 1.84 . . . . 0.0 117.699 -171.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -79.49 142.68 35.6 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.15 139.12 39.24 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.131 0.967 . . . . 0.0 113.063 173.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.7 t -120.68 130.08 53.95 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.548 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 67.5 m -117.7 117.07 28.36 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.097 -1.002 . . . . 0.0 108.746 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.2 mt -114.17 104.83 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.2 m -100.69 103.27 14.53 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.88 0.872 . . . . 0.0 109.752 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.8 mtt85 -95.75 104.22 16.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.859 -0.526 . . . . 0.0 110.647 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -121.12 147.14 45.97 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.31 108.78 20.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.827 -0.546 . . . . 0.0 111.611 -171.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -137.02 129.3 29.72 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.343 0.657 . . . . 0.0 109.312 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.0 t0 57.49 44.31 21.45 Favored 'General case' 0 N--CA 1.507 2.404 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 51.82 30.68 29.55 Favored Glycine 0 CA--C 1.559 2.801 0 N-CA-C 119.298 2.479 . . . . 0.0 119.298 -164.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -140.61 149.5 42.41 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.502 1.144 . . . . 0.0 109.537 -167.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.5 tp -92.5 106.12 18.17 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-O 121.912 0.863 . . . . 0.0 109.857 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 82.7 t -93.31 106.07 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.3 t -102.65 90.52 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -170.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -88.28 93.43 9.51 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.717 1.246 . . . . 0.0 110.062 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.922 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 9.4 t -80.64 135.87 36.12 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.823 170.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.6 123.22 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.598 -0.689 . . . . 0.0 109.452 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.415 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 26.8 ttt -117.02 103.97 10.79 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.859 0.464 . . . . 0.0 110.061 175.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.3 76.5 m-20 66.57 -93.57 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.868 0.867 . . . . 0.0 111.297 -174.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -111.89 0.44 16.12 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 162.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.9 t -92.95 105.86 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 120.49 1.495 . . . . 0.0 108.714 -167.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 53.6 p -90.74 140.1 30.1 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.404 1.097 . . . . 0.0 113.02 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.922 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -136.52 85.08 2.12 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -174.056 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 61.7 m -88.98 110.24 20.95 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.514 -1.366 . . . . 0.0 110.286 -171.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -114.4 108.34 16.76 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -168.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.7 mm -92.72 114.64 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -116.41 114.55 24.42 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.197 0.599 . . . . 0.0 109.718 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.68 152.39 22.55 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.447 ' HZ1' ' CD ' ' A' ' 135' ' ' GLU . 6.3 tttt -77.83 127.43 32.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.483 -1.386 . . . . 0.0 114.696 -161.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.74 86.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.447 ' CD ' ' HZ1' ' A' ' 133' ' ' LYS . 97.5 mt-10 . . . . . 0 N--CA 1.489 1.498 0 C-N-CA 123.928 0.891 . . . . 0.0 108.6 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.265 7.7 p . . . . . 0 N--CA 1.503 2.179 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -38.58 90.41 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 162.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -63.83 -38.37 90.86 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.5 mt -59.81 -23.79 63.62 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 163.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 107.64 3.93 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.188 1.813 . . . . 0.0 113.426 -171.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.64 -173.85 36.42 Favored Glycine 0 N--CA 1.489 2.215 0 CA-C-O 121.712 0.618 . . . . 0.0 114.628 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -94.92 137.84 33.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.009 -0.701 . . . . 0.0 110.981 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -135.55 116.82 14.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.55 -0.719 . . . . 0.0 110.994 -170.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.9 ttm105 -97.49 134.09 41.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.002 -1.686 . . . . 0.0 113.85 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.1 tp -67.82 123.51 20.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.254 4.4 m -113.06 -60.95 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 123.818 0.847 . . . . 0.0 112.223 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -106.36 151.5 24.79 Favored 'General case' 0 CA--C 1.571 1.782 0 CA-C-N 119.688 1.131 . . . . 0.0 111.006 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -154.28 65.56 0.7 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 136.11 54.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.485 -0.759 . . . . 0.0 112.988 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.74 2.59 51.69 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 120.086 2.794 . . . . 0.0 120.086 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.14 -34.03 72.54 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.27 -54.91 17.87 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 163.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.44 -49.57 72.1 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -57.25 -48.13 79.64 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 76.5 mtm -59.5 -35.27 73.82 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 168.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -64.17 -48.06 77.41 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.405 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 22.0 tp10 -66.0 -37.91 87.16 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 173.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.1 -42.72 66.22 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 159.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.31 53.93 1.21 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 115.137 0.815 . . . . 0.0 115.137 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.18 134.78 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.412 0.685 . . . . 0.0 109.788 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.95 154.09 49.83 Favored Glycine 0 CA--C 1.55 2.244 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.1 pt -55.55 -48.25 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -172.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.61 -43.59 97.28 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.34 -40.0 96.1 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 170.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.9 mtp85 -55.2 -50.33 69.64 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 162.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -56.94 -47.7 80.04 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 170.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.0 mtm -58.0 -55.27 37.07 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 168.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.97 -36.97 76.16 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 119.41 2.524 . . . . 0.0 119.41 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.97 -54.42 30.84 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.8 ptp -85.9 -26.38 25.63 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.01 73.21 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 119.639 3.2 . . . . 0.0 119.639 -168.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt 63.32 66.42 1.16 Allowed Pre-proline 0 CA--C 1.581 2.141 0 C-N-CA 124.437 1.095 . . . . 0.0 113.612 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -73.25 143.77 35.99 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 122.513 2.142 . . . . 0.0 116.869 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.44 101.51 13.21 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.271 1.028 . . . . 0.0 110.045 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.0 116.82 29.25 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 124.378 1.071 . . . . 0.0 112.108 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mp -92.13 119.67 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.9 mt -105.88 117.68 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 168.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.1 m -136.84 130.4 31.74 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 118.879 0.763 . . . . 0.0 111.046 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.6 p -105.98 137.45 43.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -169.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.34 86.37 2.32 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 121.882 0.849 . . . . 0.0 108.878 166.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.57 -99.26 0.45 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -85.15 -25.91 27.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 165.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -86.27 138.17 32.05 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 120.719 1.6 . . . . 0.0 112.001 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.451 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 21.8 tp -133.7 112.98 11.85 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 121.883 0.849 . . . . 0.0 108.787 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -87.29 119.57 27.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.491 0.717 . . . . 0.0 109.567 -175.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mm -111.47 98.73 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 44.4 tttt -112.53 105.93 14.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.557 -0.714 . . . . 0.0 110.104 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.4 m -93.12 101.24 13.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.399 -0.813 . . . . 0.0 109.817 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.406 ' CD ' ' HZ2' ' A' ' 55' ' ' LYS . 40.1 mt-10 -98.24 125.53 43.35 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.023 0.929 . . . . 0.0 110.704 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 t -137.66 160.8 38.19 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.41 1.1 . . . . 0.0 113.437 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.7 p -59.93 -48.25 82.45 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 163.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.7 mt -97.02 -38.86 9.61 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -146.52 105.37 3.85 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 121.187 1.812 . . . . 0.0 112.715 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.419 ' C ' ' HG1' ' A' ' 63' ' ' THR . 32.3 m -86.26 142.44 28.55 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.657 0.783 . . . . 0.0 111.545 172.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.419 ' HG1' ' C ' ' A' ' 62' ' ' THR . 86.5 m -157.89 143.09 16.8 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.235 -1.54 . . . . 0.0 109.839 175.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.51 154.77 51.27 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.285 -1.51 . . . . 0.0 114.229 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -150.65 142.1 23.42 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.553 0.692 . . . . 0.0 111.771 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.0 p -100.26 105.25 16.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.943 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 52' ' ' LEU . 20.9 p -93.79 164.51 13.1 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.5 m -130.43 128.46 41.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.2 111.72 9.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.292 -0.88 . . . . 0.0 111.982 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.37 -62.3 0.54 Allowed Glycine 0 N--CA 1.488 2.11 0 CA-C-O 120.055 -0.303 . . . . 0.0 113.488 -162.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -89.47 162.17 15.86 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 124.068 1.89 . . . . 0.0 114.914 -164.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -106.95 132.86 52.42 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 112.563 -2.108 . . . . 0.0 111.394 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.89 160.38 40.45 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -169.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.99 113.53 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 112.48 167.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -102.2 95.82 6.57 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.1 m -76.96 92.07 3.65 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.341 1.067 . . . . 0.0 110.445 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -67.38 148.28 51.81 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.158 0.983 . . . . 0.0 113.293 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.07 -39.48 5.85 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.948 3.314 . . . . 0.0 119.948 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.95 -34.27 59.84 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.12 -25.32 0.61 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 119.563 2.585 . . . . 0.0 119.563 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.2 mtm-85 -72.65 119.74 17.3 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 120.124 1.962 . . . . 0.0 112.091 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 94.6 9.71 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 167.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.5 p -87.4 149.53 24.4 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.146 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -81.98 87.15 6.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.084 -1.01 . . . . 0.0 109.589 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -88.79 117.35 27.72 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.264 14.9 p -88.97 118.08 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 161.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.3 m -96.21 135.17 38.39 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 120.834 0.35 . . . . 0.0 111.655 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -148.05 121.7 9.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.804 -0.56 . . . . 0.0 109.611 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -83.24 123.39 29.53 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 120.852 -1.155 . . . . 0.0 111.259 169.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -133.31 110.4 10.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 63.69 56.19 1.58 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 148.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.52 -25.94 11.83 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 118.453 2.141 . . . . 0.0 118.453 -164.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.77 135.0 55.03 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 119.909 1.855 . . . . 0.0 114.314 -167.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.9 tp -82.37 113.71 20.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.196 158.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.0 t -88.89 106.73 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -102.04 98.74 8.89 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -99.2 96.31 7.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.638 -0.664 . . . . 0.0 110.561 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -83.4 128.54 34.59 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.683 0.793 . . . . 0.0 111.572 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -130.32 123.94 31.16 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.107 0.563 . . . . 0.0 110.009 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.2 p90 -156.6 119.51 4.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.696 -1.252 . . . . 0.0 112.139 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.263 5.5 t70 34.31 58.16 0.64 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 118.699 2.852 . . . . 0.0 118.699 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.72 -46.94 1.9 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 117.639 1.816 . . . . 0.0 117.639 -172.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -80.51 140.94 35.62 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -133.3 148.38 51.92 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 168.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.6 t -131.99 138.65 48.35 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.688 0.756 . . . . 0.0 111.802 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -111.7 98.11 7.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.71 111.09 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -175.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.7 m -101.71 103.6 14.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.622 -0.673 . . . . 0.0 109.802 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -95.42 101.66 13.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.403 -0.811 . . . . 0.0 109.9 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -132.91 156.9 46.39 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.91 123.22 26.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 111.877 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.09 114.19 24.19 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 159.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.89 51.16 9.39 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 166.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.47 -22.77 5.21 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 119.357 2.503 . . . . 0.0 119.357 -170.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -103.27 140.09 37.86 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.628 1.714 . . . . 0.0 111.21 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.9 tp -75.77 134.79 40.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.96 . . . . 0.0 110.361 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.29 106.78 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.6 t -92.73 102.94 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -111.28 105.18 13.76 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -171.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.951 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 3.1 p -97.08 145.79 25.64 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.51 128.66 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.412 0.625 . . . . 0.0 109.405 162.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.405 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 24.4 ttt -98.21 -88.44 0.32 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.214 0.606 . . . . 0.0 110.253 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -129.89 78.16 1.83 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.052 0.941 . . . . 0.0 108.732 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.283 0.7 OUTLIER 69.4 -26.53 0.15 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 -162.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 82.6 t -75.78 116.41 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 CA-C-N 120.085 1.311 . . . . 0.0 109.835 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.3 p -120.11 134.76 55.17 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 123.638 0.775 . . . . 0.0 112.729 -170.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.951 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.3 p -120.93 128.01 52.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.962 -0.461 . . . . 0.0 111.993 167.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.3 m -109.25 111.45 23.04 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -112.14 118.76 36.24 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.57 0.748 . . . . 0.0 110.248 -172.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mm -96.71 130.47 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 123.455 0.702 . . . . 0.0 109.426 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -130.12 121.63 26.7 Favored 'General case' 0 CA--C 1.572 1.82 0 C-N-CA 123.483 0.713 . . . . 0.0 112.385 -165.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -95.32 134.88 37.61 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.447 ' HZ3' ' CD ' ' A' ' 135' ' ' GLU . 11.7 tttm -80.25 125.29 29.67 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.104 -0.997 . . . . 0.0 113.369 -172.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.6 t -114.79 94.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -168.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.447 ' CD ' ' HZ3' ' A' ' 133' ' ' LYS . 9.6 mm-40 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 122.489 0.315 . . . . 0.0 110.207 -165.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.308 12.1 p . . . . . 0 N--CA 1.501 2.089 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.3 -22.51 63.26 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.592 2.441 . . . . 0.0 117.592 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.1 mp0 -56.96 -27.18 60.97 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 163.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.21 -12.59 61.24 Favored 'General case' 0 CA--C 1.582 2.206 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 164.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.43 114.17 14.84 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 120.774 1.625 . . . . 0.0 113.398 -166.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.45 -166.55 28.63 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 167.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -86.15 129.78 34.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.078 -0.66 . . . . 0.0 112.33 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -127.77 114.73 17.65 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.262 0.625 . . . . 0.0 110.301 -172.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -89.91 133.52 34.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.471 -1.393 . . . . 0.0 113.3 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.6 tp -72.88 131.07 41.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.8 -0.563 . . . . 0.0 112.439 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.277 3.3 m -116.68 -73.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 123.369 0.668 . . . . 0.0 109.895 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -89.68 142.05 28.04 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 118.919 0.781 . . . . 0.0 110.802 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.4 t -148.02 51.96 1.03 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -79.84 134.81 36.34 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.44 -9.43 67.58 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 118.628 2.211 . . . . 0.0 118.628 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -70.69 -42.26 70.91 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -171.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -52.62 -51.66 58.98 Favored 'General case' 0 CA--C 1.579 2.06 0 CA-C-N 120.079 1.309 . . . . 0.0 114.339 167.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.74 -39.51 84.97 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 170.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -58.64 -46.3 87.4 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 169.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.476 ' SD ' ' HA ' ' A' ' 33' ' ' ARG . 16.3 ptp -62.03 -25.79 67.87 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 167.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -58.7 -52.92 63.65 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 157.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.03 -42.05 98.76 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.3 mt -53.28 -38.77 63.39 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 169.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.04 64.62 0.99 Allowed Glycine 0 N--CA 1.486 1.989 0 C-N-CA 123.362 0.506 . . . . 0.0 113.751 -166.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.5 t -114.33 130.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.62 158.65 49.25 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.275 2.4 pp -55.26 -49.02 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -171.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.76 99.34 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 168.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.06 -41.88 89.01 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 20.0 mtp-105 -61.27 -51.05 70.55 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 120.177 1.353 . . . . 0.0 114.546 170.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -54.74 -47.65 73.56 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 170.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.8 ttp -54.42 -60.67 3.03 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 165.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.91 -40.32 92.99 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 119.573 2.589 . . . . 0.0 119.573 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.59 -45.02 88.8 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 172.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -78.26 -29.87 48.29 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 172.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.74 123.22 18.79 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 119.833 1.197 . . . . 0.0 114.17 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -103.5 107.89 57.5 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 117.667 -1.158 . . . . 0.0 109.66 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -92.34 145.73 2.79 Favored 'Trans proline' 0 CA--C 1.563 1.948 0 CA-C-N 122.48 1.921 . . . . 0.0 116.455 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.74 100.53 13.0 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 114.493 -1.231 . . . . 0.0 108.641 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.9 t -91.32 112.83 24.9 Favored 'General case' 0 CA--C 1.557 1.217 0 O-C-N 120.875 -1.141 . . . . 0.0 112.559 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mt -84.14 104.26 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 60.5 mt -99.78 111.49 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.5 m -117.16 102.5 9.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.6 p -113.87 91.4 3.62 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 123.737 0.815 . . . . 0.0 111.424 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -93.54 65.31 3.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.34 -0.85 . . . . 0.0 111.836 -171.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.36 -61.58 1.87 Allowed Glycine 0 N--CA 1.494 2.51 0 O-C-N 120.117 -1.614 . . . . 0.0 117.089 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -121.52 -46.43 2.27 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -71.7 137.59 47.91 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 121.58 1.991 . . . . 0.0 112.925 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -138.52 112.31 8.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.468 -0.77 . . . . 0.0 111.226 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.2 m -114.77 123.53 49.47 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.463 0.705 . . . . 0.0 109.715 -175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.77 109.03 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -114.23 101.61 9.35 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.996 0.918 . . . . 0.0 109.859 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.0 m -87.09 112.48 21.94 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.673 0.789 . . . . 0.0 110.391 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -112.3 100.63 8.95 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 118.773 0.715 . . . . 0.0 112.138 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -123.46 158.34 31.47 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.084 0.945 . . . . 0.0 111.192 163.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.2 p -63.29 -44.82 93.95 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 172.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.3 mt -64.07 -38.04 89.63 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.09 130.64 13.94 Favored 'General case' 0 CA--C 1.563 1.453 0 CA-C-N 119.938 1.244 . . . . 0.0 111.164 166.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 m -113.95 133.75 55.27 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 166.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.1 m -155.6 139.65 16.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.391 -1.443 . . . . 0.0 109.541 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.85 158.39 39.62 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.36 137.5 30.54 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-O 121.991 0.901 . . . . 0.0 110.451 161.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -109.93 105.26 14.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.028 0.931 . . . . 0.0 109.499 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 30.3 p -132.19 -152.51 0.5 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.54 0.736 . . . . 0.0 112.413 -168.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.39 147.42 50.48 Favored 'General case' 0 CA--C 1.571 1.761 0 O-C-N 120.957 -1.089 . . . . 0.0 111.306 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -78.58 148.01 33.49 Favored 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 124.221 1.008 . . . . 0.0 113.045 162.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.35 28.45 73.59 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 117.921 1.928 . . . . 0.0 117.921 -173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -152.11 141.09 21.16 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-O 121.51 0.671 . . . . 0.0 109.437 -162.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -93.45 124.29 37.34 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.253 174.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -130.92 154.4 48.15 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.043 0.937 . . . . 0.0 111.721 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -80.12 101.31 8.69 Favored 'General case' 0 CA--C 1.569 1.704 0 O-C-N 120.95 -1.094 . . . . 0.0 111.512 172.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -85.32 94.28 8.91 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.997 0.919 . . . . 0.0 110.011 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.8 m -81.64 96.57 7.55 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.925 0.869 . . . . 0.0 110.478 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.9 p -71.14 152.42 43.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.381 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.01 -30.05 14.2 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -54.81 -42.73 72.22 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 118.419 2.748 . . . . 0.0 118.419 162.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.63 -19.49 9.71 Favored Glycine 0 CA--C 1.553 2.466 0 N-CA-C 117.81 1.884 . . . . 0.0 117.81 -155.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -74.47 112.1 10.31 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 121.122 2.461 . . . . 0.0 110.65 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.264 0.1 OUTLIER -102.34 99.48 9.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.655 0.74 . . . . 0.0 111.225 178.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.7 p -99.56 141.88 31.78 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.176 -163.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -77.49 88.49 3.84 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.581 172.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.7 m -97.2 114.52 26.25 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 121.694 -0.629 . . . . 0.0 109.503 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.282 14.2 p -90.56 119.87 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.726 -0.609 . . . . 0.0 110.693 165.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.9 m -98.47 113.21 25.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.189 -0.319 . . . . 0.0 111.673 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -123.68 140.52 52.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.786 -0.571 . . . . 0.0 110.545 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -84.1 127.44 33.91 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 120.877 -1.139 . . . . 0.0 111.469 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -146.06 142.08 28.24 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.394 0.678 . . . . 0.0 110.278 168.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.81 43.58 9.38 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 161.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.14 23.71 69.92 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 118.817 2.287 . . . . 0.0 118.817 -166.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.78 148.47 29.24 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 118.849 1.325 . . . . 0.0 113.608 -166.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.0 tp -89.42 112.33 23.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.559 -0.713 . . . . 0.0 110.254 162.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 p -89.36 125.23 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 CA-C-O 123.038 1.399 . . . . 0.0 109.819 168.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -114.18 103.02 10.69 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.732 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -99.68 93.66 5.95 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 120.999 0.428 . . . . 0.0 111.254 -170.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -79.21 130.26 35.29 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.195 0.998 . . . . 0.0 111.953 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.4 121.72 26.45 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.713 0.688 . . . . 0.0 110.375 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -155.74 130.08 8.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.493 -1.379 . . . . 0.0 112.143 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 t70 51.65 50.09 19.49 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 166.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.48 16.34 58.38 Favored Glycine 0 CA--C 1.561 2.923 0 N-CA-C 120.342 2.897 . . . . 0.0 120.342 -167.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -131.84 150.47 52.14 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.917 1.359 . . . . 0.0 110.276 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.54 151.73 44.98 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.5 t -141.96 138.7 32.13 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.059 0.933 . . . . 0.0 112.61 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 p -110.57 117.18 32.84 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.653 0.781 . . . . 0.0 109.262 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.6 mm -101.8 109.58 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.7 m -96.96 106.33 18.64 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.543 0.687 . . . . 0.0 109.255 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -98.17 84.01 3.19 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.552 0.741 . . . . 0.0 109.972 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -95.67 132.98 40.27 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.9 103.49 12.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.359 -0.838 . . . . 0.0 110.434 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.258 45.6 tttm -117.9 -105.26 0.4 Allowed 'General case' 0 CA--C 1.559 1.301 0 O-C-N 121.933 -0.479 . . . . 0.0 111.071 -164.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.98 60.79 6.05 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-O 122.339 1.066 . . . . 0.0 112.67 -163.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 49.0 37.83 23.31 Favored Glycine 0 CA--C 1.558 2.775 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -153.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.12 139.95 8.72 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -155.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.1 tp -86.34 117.23 25.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.773 -1.204 . . . . 0.0 110.163 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.8 t -103.57 108.68 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.49 104.94 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -170.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -106.28 107.65 18.77 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -169.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.953 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.8 p -101.62 144.71 30.02 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.73 145.2 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 123.034 0.534 . . . . 0.0 110.234 166.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.5 ttt -110.74 -80.33 0.58 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.053 -1.029 . . . . 0.0 110.561 168.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -111.73 -66.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 118.679 0.672 . . . . 0.0 110.912 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -122.52 -14.25 7.83 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -97.98 134.0 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-N 121.403 1.911 . . . . 0.0 110.062 -174.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 77.5 p -112.47 153.2 27.78 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.912 0.885 . . . . 0.0 112.68 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.953 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.8 OUTLIER -130.76 142.17 50.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.311 -0.868 . . . . 0.0 112.391 161.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.6 m -109.64 108.61 19.08 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -104.23 109.72 21.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.617 0.767 . . . . 0.0 109.992 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.2 mm -89.26 124.11 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -120.06 118.53 30.85 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.574 0.749 . . . . 0.0 111.124 -174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -86.79 140.17 29.98 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.117 0.967 . . . . 0.0 112.94 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -78.29 134.78 37.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.266 -1.521 . . . . 0.0 113.62 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.9 95.76 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.981 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.253 9.0 p . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -58.58 -35.62 72.67 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.315 1.968 . . . . 0.0 116.315 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -64.42 -31.72 73.04 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 165.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.78 -20.56 65.97 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 163.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.2 117.25 22.19 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.285 1.857 . . . . 0.0 112.283 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.71 -178.7 39.78 Favored Glycine 0 N--CA 1.484 1.897 0 CA-C-O 122.098 0.832 . . . . 0.0 114.577 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -84.89 114.8 22.38 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.019 0.528 . . . . 0.0 110.777 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -110.58 104.54 13.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.949 -0.469 . . . . 0.0 111.97 -171.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -82.73 124.26 30.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.365 -0.834 . . . . 0.0 112.424 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.0 130.52 44.37 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.023 -1.048 . . . . 0.0 113.444 173.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.292 15.7 m -120.03 -63.7 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.617 173.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -92.76 149.81 21.06 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.431 1.469 . . . . 0.0 112.007 170.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p -148.34 79.14 1.44 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.912 166.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.44 119.13 19.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.554 -0.716 . . . . 0.0 110.936 -176.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.82 37.06 93.7 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 119.708 2.643 . . . . 0.0 119.708 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.6 -42.61 51.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 175.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -51.94 -50.04 61.97 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 163.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -48.54 -54.58 13.87 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 168.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -55.25 -53.61 53.92 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 170.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 31.7 mtm -67.75 -34.05 76.06 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -47.82 -44.09 28.55 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 158.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -41.72 81.7 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 169.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.3 mt -51.7 -50.42 60.53 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 165.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.44 40.39 0.23 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 m -112.67 144.19 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.686 0 CA-C-N 118.724 1.262 . . . . 0.0 112.463 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.33 -179.64 50.96 Favored Glycine 0 CA--C 1.551 2.33 0 CA-C-O 122.814 1.23 . . . . 0.0 115.989 168.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 pt -57.23 -46.25 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 117.921 2.564 . . . . 0.0 117.921 -171.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.65 -40.63 95.61 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.02 -39.02 86.94 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 -63.78 -42.93 97.66 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 166.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -50.57 -50.49 53.47 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 161.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.6 mtp -72.3 58.37 0.39 Allowed 'General case' 0 CA--C 1.581 2.161 0 CA-C-O 123.028 1.394 . . . . 0.0 114.632 166.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.12 -63.72 0.08 OUTLIER Glycine 0 CA--C 1.543 1.809 0 O-C-N 121.349 -0.845 . . . . 0.0 111.56 -172.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.93 78.48 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 170.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . 0.26 19.2 ptt? -86.44 -17.89 33.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 170.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.07 121.24 22.51 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.172 1.351 . . . . 0.0 113.707 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -96.36 113.46 62.51 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.365 170.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -86.12 146.72 8.91 Favored 'Trans proline' 0 CA--C 1.561 1.828 0 C-N-CA 122.284 1.989 . . . . 0.0 115.052 168.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.57 97.97 10.86 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.265 158.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.8 t -87.65 104.64 16.72 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.139 0.976 . . . . 0.0 111.713 -174.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.0 mt -92.12 106.44 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.6 mt -96.86 128.99 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.4 m -156.46 130.49 8.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.274 -1.516 . . . . 0.0 109.938 171.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.8 p -118.75 130.01 55.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -97.72 93.03 6.16 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 121.802 0.81 . . . . 0.0 108.978 166.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.13 -75.46 1.14 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 116.67 1.428 . . . . 0.0 116.67 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -127.73 -30.63 2.51 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.69 100.99 5.59 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 120.909 1.686 . . . . 0.0 111.757 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -93.84 116.19 28.64 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.341 1.056 . . . . 0.0 109.945 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.3 m -93.38 123.77 36.9 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.662 0.785 . . . . 0.0 109.62 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 mt -115.79 107.38 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -103.68 103.5 13.42 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.646 0.779 . . . . 0.0 109.547 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.6 m -94.18 100.17 12.3 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.322 1.049 . . . . 0.0 110.686 -171.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -100.09 102.55 13.9 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.081 0.553 . . . . 0.0 111.746 -165.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 t -138.7 139.85 38.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.478 -0.764 . . . . 0.0 111.451 173.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.0 p -63.93 -33.55 75.96 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.4 mt -67.26 -45.97 75.09 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 167.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -155.12 114.67 3.69 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.471 1.487 . . . . 0.0 111.376 170.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.8 m -94.24 141.05 29.01 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.586 0.708 . . . . 0.0 111.399 172.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.1 p -138.48 154.97 48.83 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 123.93 0.892 . . . . 0.0 111.112 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.0 146.13 32.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.351 -1.468 . . . . 0.0 112.906 172.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -152.44 151.62 30.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.586 -0.696 . . . . 0.0 112.807 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -110.54 115.73 30.13 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.503 0.721 . . . . 0.0 110.85 166.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.8 p -104.5 134.04 48.35 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.553 -0.717 . . . . 0.0 112.739 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 88.6 m -81.25 113.08 19.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.865 -1.147 . . . . 0.0 110.336 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -69.85 120.83 16.18 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -172.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.7 -36.31 3.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 -166.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.41 -169.92 2.62 Favored 'General case' 0 CA--C 1.575 1.905 0 CA-C-N 119.128 1.464 . . . . 0.0 111.953 -176.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -86.34 142.02 28.79 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -117.24 163.33 16.47 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.38 159.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -82.24 103.56 11.92 Favored 'General case' 0 CA--C 1.565 1.554 0 O-C-N 120.6 -1.312 . . . . 0.0 110.045 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -87.28 104.84 16.78 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.5 m -82.31 104.41 12.59 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 165.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.6 p -76.22 159.16 30.91 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -164.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.46 -38.93 56.19 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 165.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.276 2.7 t0 -44.35 -47.32 9.62 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 157.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.02 -31.75 4.41 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -164.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -62.44 137.01 58.17 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.8 1.8 . . . . 0.0 114.781 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -76.59 121.57 23.38 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.721 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.7 p -132.72 118.46 19.1 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.595 0.712 . . . . 0.0 111.015 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -76.98 101.3 5.93 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.61 0.764 . . . . 0.0 109.442 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.1 m -116.51 107.15 14.4 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.461 -154.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.5 t -81.02 117.56 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 122.893 0.477 . . . . 0.0 109.871 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.4 m -101.46 108.79 20.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.137 -0.352 . . . . 0.0 111.326 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -126.24 124.19 39.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.777 -0.577 . . . . 0.0 111.446 -175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -85.13 126.85 33.96 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.455 -0.778 . . . . 0.0 111.567 168.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -143.02 137.04 29.0 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 122.994 0.518 . . . . 0.0 109.773 165.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.83 39.49 16.98 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 159.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.62 20.27 79.51 Favored Glycine 0 CA--C 1.557 2.669 0 N-CA-C 119.23 2.452 . . . . 0.0 119.23 -166.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.83 131.63 21.42 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 119.295 1.548 . . . . 0.0 112.922 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.9 tp -94.45 109.92 21.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.667 -0.646 . . . . 0.0 110.645 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.18 108.71 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.675 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -95.39 102.4 14.2 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 124.166 0.986 . . . . 0.0 108.961 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -102.04 93.23 5.14 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.404 0.681 . . . . 0.0 111.997 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -77.07 117.07 18.28 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.786 0.834 . . . . 0.0 112.569 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.5 135.56 50.32 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.867 0.842 . . . . 0.0 110.12 166.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -152.28 117.22 5.15 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.256 27.5 t70 49.87 45.06 25.23 Favored 'General case' 0 CA--C 1.587 2.367 0 N-CA-C 117.141 2.275 . . . . 0.0 117.141 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.93 27.1 68.09 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 119.894 2.718 . . . . 0.0 119.894 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -135.43 100.05 4.4 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -172.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -115.3 142.68 46.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -165.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.5 t -117.31 137.28 52.53 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.802 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 p -114.69 109.15 17.77 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.4 mp -103.4 98.11 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 m -94.0 105.57 17.57 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.598 0.759 . . . . 0.0 109.975 -175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -94.3 88.48 5.57 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 123.627 0.771 . . . . 0.0 110.156 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -105.16 137.42 42.96 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -168.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 116.81 29.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.9 -1.125 . . . . 0.0 112.81 -172.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.75 84.27 3.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.591 -0.693 . . . . 0.0 109.714 167.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.276 25.1 m-20 7.5 62.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 120.608 3.559 . . . . 0.0 120.608 -173.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 138.78 -49.38 0.83 Allowed Glycine 0 N--CA 1.49 2.275 0 CA-C-N 114.515 -1.22 . . . . 0.0 115.503 -167.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -112.77 138.55 49.44 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 117.802 0.801 . . . . 0.0 110.557 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.19 116.32 28.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.889 -1.132 . . . . 0.0 109.6 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.9 t -93.95 109.57 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 80.5 t -98.8 105.55 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -96.67 100.78 12.32 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.746 0.819 . . . . 0.0 109.378 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.7 p -97.31 131.59 43.86 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.62 -0.675 . . . . 0.0 111.169 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.87 123.67 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.836 -0.54 . . . . 0.0 110.598 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 10.6 ttt -115.55 114.76 25.39 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 164.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.7 m120 55.23 55.92 7.01 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.297 40.3 m-80 76.65 -30.16 0.18 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -171.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.0 t -86.42 123.63 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 120.885 1.675 . . . . 0.0 109.949 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 72.4 p -113.6 144.28 43.16 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -163.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.5 OUTLIER -111.93 136.56 51.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 0.0 110.939 151.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.1 m -114.4 111.18 21.03 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 170.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.407 ' HG3' ' SG ' ' A' ' 127' ' ' CYS . 74.1 mtp180 -114.69 116.18 28.29 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.741 0.416 . . . . 0.0 110.327 -170.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.86 128.17 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -122.35 140.55 52.54 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.77 0.828 . . . . 0.0 111.879 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.86 135.84 42.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.474 ' HZ3' ' CD ' ' A' ' 135' ' ' GLU . 19.1 tttm -76.78 113.08 14.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.074 -1.016 . . . . 0.0 111.641 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.0 t -106.07 92.86 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -173.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.474 ' CD ' ' HZ3' ' A' ' 133' ' ' LYS . 82.2 mt-10 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.017 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.478 5.3 p . . . . . 0 N--CA 1.507 2.39 0 N-CA-C 118.704 2.853 . . . . 0.0 118.704 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -52.22 -42.64 63.74 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -67.85 -18.79 64.93 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 172.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.54 -9.69 58.61 Favored 'General case' 0 CA--C 1.577 1.999 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 160.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.37 140.64 29.33 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 121.541 1.973 . . . . 0.0 112.944 -171.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.81 -177.82 23.05 Favored Glycine 0 N--CA 1.488 2.162 0 CA-C-O 122.145 0.859 . . . . 0.0 114.607 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -87.9 121.11 29.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.984 -0.715 . . . . 0.0 110.083 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -124.86 110.6 14.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.78 -0.575 . . . . 0.0 110.122 -169.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.3 ttm105 -98.56 134.7 41.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.831 -1.168 . . . . 0.0 113.251 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.91 133.0 49.97 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.28 21.7 m -124.35 -60.5 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 123.722 0.809 . . . . 0.0 112.281 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -89.43 148.35 23.52 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.346 1.43 . . . . 0.0 111.298 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 m -148.7 58.15 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.215 1.007 . . . . 0.0 113.218 165.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -72.88 123.5 23.53 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.294 -0.878 . . . . 0.0 113.083 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.77 2.58 81.43 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 118.85 2.3 . . . . 0.0 118.85 -167.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -72.12 -42.61 65.86 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.406 2.103 . . . . 0.0 116.65 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.62 -49.65 74.32 Favored 'General case' 0 CA--C 1.578 2.057 0 CA-C-N 120.962 1.71 . . . . 0.0 114.563 170.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -49.59 -44.93 47.41 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 164.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 74.5 t80 -59.71 -52.27 66.23 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 170.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.294 18.4 ptt? -70.31 -24.34 63.0 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -63.15 -39.84 95.83 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 121.523 1.965 . . . . 0.0 115.303 154.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -72.64 -40.01 66.73 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.0 mt -50.29 -41.81 51.44 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 117.989 2.588 . . . . 0.0 117.989 168.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.88 66.43 0.8 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 123.443 0.544 . . . . 0.0 113.648 -168.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -128.82 133.53 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -171.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.94 155.3 52.75 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 116.483 1.353 . . . . 0.0 116.483 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.262 2.7 pp -54.14 -44.07 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 N-CA-C 117.898 2.555 . . . . 0.0 117.898 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.99 88.14 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 168.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.36 -42.01 98.0 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 167.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -59.67 -47.51 85.35 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 120.352 1.433 . . . . 0.0 114.398 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.36 -46.83 88.54 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 169.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.1 ttp -52.48 -55.11 24.22 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 165.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.64 74.91 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 119.236 2.455 . . . . 0.0 119.236 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.95 91.21 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.4 ptp -77.24 -27.36 53.27 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.21 108.94 5.63 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.906 1.23 . . . . 0.0 113.731 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -102.3 93.96 4.42 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 118.196 -0.906 . . . . 0.0 110.649 168.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.84 153.31 25.71 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.474 2.116 . . . . 0.0 115.59 -173.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.69 105.27 17.25 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.643 0.735 . . . . 0.0 109.302 165.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.2 t -95.02 110.5 22.41 Favored 'General case' 0 CA--C 1.56 1.344 0 O-C-N 120.909 -1.119 . . . . 0.0 111.735 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mp -89.47 106.83 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.63 126.94 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.1 m -150.75 128.84 11.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.628 -1.295 . . . . 0.0 109.846 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.6 t -120.7 114.23 21.37 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-O 121.899 0.857 . . . . 0.0 112.019 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -79.95 76.08 6.67 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 122.054 0.93 . . . . 0.0 110.45 167.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.73 -82.25 0.09 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -105.23 -16.43 14.77 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 167.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -88.81 106.06 18.13 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 120.982 1.719 . . . . 0.0 109.9 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.49 116.01 31.59 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 111.344 -168.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.9 m -108.37 128.46 54.79 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.041 0.936 . . . . 0.0 109.493 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.73 122.18 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -109.98 111.96 23.67 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.055 0.542 . . . . 0.0 110.073 168.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.8 m -87.87 99.53 12.2 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -86.19 116.91 24.68 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.153 0.978 . . . . 0.0 111.594 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.1 t -147.06 135.05 21.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.85 0.86 . . . . 0.0 109.764 169.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 64.5 p -59.32 -30.37 68.31 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 165.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.3 mt -71.58 -53.06 14.98 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 170.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -153.04 100.04 2.45 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 120.284 1.402 . . . . 0.0 110.593 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.4 ' C ' ' HG1' ' A' ' 63' ' ' THR . 26.6 m -77.83 146.1 35.93 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.012 0.91 . . . . 0.0 111.669 171.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.4 ' HG1' ' C ' ' A' ' 62' ' ' THR . 89.7 m -152.16 134.01 14.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.091 -1.631 . . . . 0.0 109.857 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -131.5 138.77 49.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 111.577 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -141.91 152.63 43.73 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 174.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.7 p -135.78 109.49 8.05 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.924 0.89 . . . . 0.0 110.029 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.2 t -134.82 154.21 51.72 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.556 0.742 . . . . 0.0 112.242 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.92 140.07 47.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.433 -1.417 . . . . 0.0 110.603 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.9 tp -68.89 118.98 12.51 Favored 'General case' 0 CA--C 1.579 2.088 0 O-C-N 120.69 -1.256 . . . . 0.0 111.442 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.35 -40.92 2.34 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 116.988 1.555 . . . . 0.0 116.988 -157.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.8 154.86 24.51 Favored 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 125.194 1.398 . . . . 0.0 113.416 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.3 152.64 21.3 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 166.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -138.62 162.47 34.54 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.761 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.84 100.58 2.93 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.878 0.847 . . . . 0.0 111.519 166.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -92.81 98.27 11.29 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.6 m -79.79 95.73 6.09 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 163.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.2 p -61.75 170.65 1.91 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -160.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.92 -41.04 58.43 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 164.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -50.43 -61.35 2.23 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 159.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.67 -30.49 3.1 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 120.588 -1.32 . . . . 0.0 116.303 -151.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -60.56 134.95 57.58 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 118.703 1.252 . . . . 0.0 112.63 173.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -85.81 129.15 34.91 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.344 0.592 . . . . 0.0 111.197 168.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.4 p -130.29 136.86 49.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.681 0.753 . . . . 0.0 109.217 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -87.62 96.16 10.31 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 120.692 -1.255 . . . . 0.0 108.956 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.9 m -103.64 115.61 30.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.641 -0.662 . . . . 0.0 110.65 -161.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.5 p -85.44 124.5 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-N 118.696 0.68 . . . . 0.0 112.024 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.1 m -94.0 111.85 23.61 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.376 0.67 . . . . 0.0 111.398 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -139.76 124.76 18.63 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 119.828 1.194 . . . . 0.0 112.847 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -95.2 130.36 41.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.136 -0.977 . . . . 0.0 111.71 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 t -147.69 136.33 21.81 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.222 0.609 . . . . 0.0 110.16 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 62.72 33.72 15.27 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 160.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.93 -13.77 55.38 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 -164.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -109.78 128.62 55.42 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 119.644 1.722 . . . . 0.0 113.167 -176.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.7 tp -86.7 108.5 18.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.416 -0.803 . . . . 0.0 109.637 161.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.6 t -91.75 112.19 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 98.73 10.7 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 169.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -91.12 99.39 12.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 111.355 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -70.02 125.3 26.37 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.852 0.861 . . . . 0.0 112.05 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -124.37 117.22 23.99 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -150.18 120.54 7.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.683 -1.261 . . . . 0.0 112.645 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.255 39.1 t70 50.61 44.28 27.43 Favored 'General case' 0 CA--C 1.585 2.317 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.91 -30.32 2.93 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 119.06 2.384 . . . . 0.0 119.06 -166.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -83.63 144.78 29.2 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.696 1.198 . . . . 0.0 112.79 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -140.52 156.82 46.2 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.1 t -146.94 142.28 27.4 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.445 0.698 . . . . 0.0 111.663 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.0 p -102.04 113.5 26.79 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.279 -0.888 . . . . 0.0 110.864 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.4 mm -88.19 95.68 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.1 m -96.67 92.32 6.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.554 -0.716 . . . . 0.0 110.53 -167.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -90.57 97.7 11.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.302 0.641 . . . . 0.0 111.673 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -119.2 137.34 53.7 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.725 0.81 . . . . 0.0 112.742 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.47 121.57 24.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 111.613 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -109.76 -144.67 0.39 Allowed 'General case' 0 CA--C 1.562 1.404 0 CA-C-O 121.231 0.539 . . . . 0.0 111.868 -171.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.414 ' H ' ' HG3' ' A' ' 112' ' ' LYS . 15.1 m-20 -87.2 66.09 9.1 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 120.973 -1.079 . . . . 0.0 109.954 -167.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.81 -18.11 58.1 Favored Glycine 0 CA--C 1.557 2.664 0 N-CA-C 119.67 2.628 . . . . 0.0 119.67 -168.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.65 166.53 24.34 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.629 2.215 . . . . 0.0 110.986 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.9 tp -87.15 120.68 28.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.061 -1.649 . . . . 0.0 111.318 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.8 t -87.15 115.57 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -109.21 93.07 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -84.66 95.09 8.79 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.905 1.336 . . . . 0.0 109.593 173.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.989 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.4 p -89.46 99.72 12.66 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.603 176.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 p -113.56 126.03 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.647 0.737 . . . . 0.0 110.534 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.0 tpt -73.51 -60.76 2.1 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.564 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.258 12.5 p30 -153.46 -80.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -79.77 -32.75 40.99 Favored 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 159.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.25 106.69 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 CA-C-N 120.022 1.283 . . . . 0.0 110.607 -169.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.9 p -102.12 121.55 42.42 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.138 0.975 . . . . 0.0 111.305 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.989 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.3 p -100.9 117.21 34.52 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 118.195 0.452 . . . . 0.0 111.03 162.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 m -89.32 106.78 18.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.594 -0.691 . . . . 0.0 109.173 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -106.68 106.94 17.71 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.3 mm -91.28 132.41 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -120.93 131.79 54.56 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 121.267 0.556 . . . . 0.0 112.095 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -81.42 134.13 35.51 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -75.39 117.12 16.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.265 -0.897 . . . . 0.0 111.623 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.5 t -95.29 106.22 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 123.222 0.609 . . . . 0.0 110.264 -170.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.258 9.3 p . . . . . 0 N--CA 1.505 2.282 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.47 -36.97 56.06 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 162.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -64.59 -26.37 68.38 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.623 2.082 . . . . 0.0 116.623 170.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.1 mt -65.08 -20.77 66.64 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 161.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -76.81 123.13 25.77 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.747 1.612 . . . . 0.0 112.127 -170.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.29 -179.79 26.73 Favored Glycine 0 N--CA 1.489 2.17 0 CA-C-O 122.162 0.868 . . . . 0.0 115.109 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -93.33 132.69 37.31 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.031 0.532 . . . . 0.0 111.042 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -124.98 110.45 14.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.968 -0.457 . . . . 0.0 111.286 -168.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -95.88 128.61 42.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.729 -1.232 . . . . 0.0 113.516 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.19 129.27 38.48 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.277 10.3 m -118.52 -64.23 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 118.51 -0.757 . . . . 0.0 111.749 178.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -101.93 157.3 16.96 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 123.352 1.548 . . . . 0.0 112.158 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -155.95 72.35 0.77 Allowed 'General case' 0 CA--C 1.562 1.438 0 O-C-N 120.891 -1.131 . . . . 0.0 110.878 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.11 129.87 41.3 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.156 -0.965 . . . . 0.0 112.437 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.54 11.06 61.66 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 119.953 2.741 . . . . 0.0 119.953 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -68.79 -35.59 77.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.313 1.968 . . . . 0.0 116.313 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -53.46 -54.81 31.65 Favored 'General case' 0 CA--C 1.575 1.917 0 CA-C-N 119.964 1.256 . . . . 0.0 114.22 167.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -54.44 -40.1 68.03 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 168.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.5 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 78.9 t80 -60.5 -45.51 93.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 166.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.3 9.6 ptt? -73.21 -30.3 63.41 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -42.72 91.58 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-N 121.192 1.814 . . . . 0.0 115.271 155.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -61.48 -42.65 99.11 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.7 mt -58.23 -44.54 88.27 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 165.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.58 44.07 2.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 117.654 1.822 . . . . 0.0 117.654 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.92 139.55 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 C-N-CA 124.054 0.942 . . . . 0.0 110.022 162.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.03 171.68 47.91 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 116.245 1.258 . . . . 0.0 116.245 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 pt -53.07 -47.3 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 -172.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.36 95.9 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.46 -40.33 95.51 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 168.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 mtp-105 -61.0 -44.82 96.86 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 166.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.73 -46.6 81.23 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.8 ttm -51.13 -59.6 4.01 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 163.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.68 -36.45 48.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 119.96 2.744 . . . . 0.0 119.96 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.43 70.43 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 21.4 ptp -85.54 -26.47 26.17 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.93 106.81 3.32 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 120.262 1.392 . . . . 0.0 113.308 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -109.47 90.54 8.73 Favored Pre-proline 0 CA--C 1.571 1.758 0 C-N-CA 123.778 0.831 . . . . 0.0 109.84 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.47 160.92 14.82 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.409 2.073 . . . . 0.0 116.288 -167.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -93.7 97.96 10.8 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.152 166.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.8 t -89.9 110.51 21.45 Favored 'General case' 0 CA--C 1.558 1.273 0 O-C-N 121.185 -0.947 . . . . 0.0 112.087 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 mt -90.4 114.75 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 108.666 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 91.9 mt -94.7 123.74 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 166.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.1 m -150.28 126.71 10.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.98 -1.075 . . . . 0.0 109.846 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -122.08 116.39 24.16 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.08 84.28 7.05 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.347 1.07 . . . . 0.0 110.579 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.6 -75.3 1.24 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -125.23 -20.97 4.71 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 170.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.73 103.89 11.74 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 121.808 2.095 . . . . 0.0 111.222 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tt -98.0 117.71 32.96 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.073 0.949 . . . . 0.0 110.237 -171.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.7 m -96.83 126.41 41.97 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.798 0.839 . . . . 0.0 110.066 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.5 mt -110.03 102.3 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -101.86 104.22 14.94 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.281 0.632 . . . . 0.0 110.115 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.4 m -86.86 106.48 17.77 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.797 0.839 . . . . 0.0 109.984 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -94.79 115.54 27.62 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.535 0.683 . . . . 0.0 111.573 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.2 t -153.59 136.82 15.67 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.422 0.689 . . . . 0.0 110.55 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.2 p -59.32 -33.96 71.76 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 mt -64.44 -50.32 68.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 166.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.06 105.66 2.56 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 119.85 1.204 . . . . 0.0 111.663 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.1 m -90.91 133.87 34.91 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 123.033 0.533 . . . . 0.0 110.636 172.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -137.64 146.69 44.2 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 123.355 0.662 . . . . 0.0 111.149 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 129.55 22.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.744 -1.223 . . . . 0.0 111.483 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.84 143.71 47.17 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.616 0.766 . . . . 0.0 111.102 172.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.6 m -130.05 126.06 36.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 0.0 111.259 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.46 146.26 33.28 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -169.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.51 134.33 43.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.698 -1.251 . . . . 0.0 110.856 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -72.84 117.21 14.27 Favored 'General case' 0 CA--C 1.574 1.883 0 O-C-N 120.671 -1.268 . . . . 0.0 112.88 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.7 -34.93 5.41 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 117.23 1.652 . . . . 0.0 117.23 -158.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.71 158.32 31.06 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 122.787 1.279 . . . . 0.0 113.376 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -115.74 140.97 48.7 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.705 173.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -152.15 153.53 34.05 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.945 0.898 . . . . 0.0 110.917 -162.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -83.14 87.23 6.92 Favored 'General case' 0 CA--C 1.574 1.882 0 O-C-N 120.487 -1.383 . . . . 0.0 113.778 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.38 115.2 12.46 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.151 0.977 . . . . 0.0 110.525 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.8 m -101.12 100.53 11.11 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.488 -170.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 p -73.06 159.86 32.94 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -161.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.73 -32.88 6.32 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 119.123 3.009 . . . . 0.0 119.123 169.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -58.61 -51.23 70.79 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 161.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.02 -30.24 2.85 Favored Glycine 0 CA--C 1.551 2.343 0 N-CA-C 116.96 1.544 . . . . 0.0 116.96 -157.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 -58.65 129.68 43.27 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.351 2.076 . . . . 0.0 114.816 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.86 101.6 11.77 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.803 0.841 . . . . 0.0 109.427 172.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.0 p -109.51 105.58 14.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.048 -1.032 . . . . 0.0 110.088 -168.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -70.38 105.31 2.98 Favored 'General case' 0 CA--C 1.565 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.445 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.0 m -130.85 120.35 23.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.003 . . . . 0.0 110.279 -151.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.76 126.79 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 118.829 0.741 . . . . 0.0 111.736 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.4 m -105.69 112.12 25.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.942 -0.474 . . . . 0.0 111.807 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -125.08 131.03 53.38 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.303 0.641 . . . . 0.0 111.112 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -88.49 127.06 35.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.959 . . . . 0.0 111.617 168.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.1 t -143.22 140.35 30.66 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.157 0.583 . . . . 0.0 110.139 167.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 61.67 36.71 16.4 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 160.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.43 16.84 80.38 Favored Glycine 0 CA--C 1.557 2.691 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -165.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.75 136.07 26.87 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 119.664 1.732 . . . . 0.0 113.919 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.0 tp -92.8 112.42 24.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.699 -0.626 . . . . 0.0 110.916 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.09 109.04 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -89.22 98.79 11.97 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.251 0.62 . . . . 0.0 109.339 167.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -89.84 104.14 16.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.605 -0.684 . . . . 0.0 110.232 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -91.62 131.97 36.65 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.154 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -127.94 126.29 41.17 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 119.035 0.834 . . . . 0.0 110.197 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -148.14 120.81 8.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.575 -1.328 . . . . 0.0 110.451 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.8 t70 49.7 51.06 17.22 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.72 -24.91 2.19 Favored Glycine 0 CA--C 1.557 2.688 0 N-CA-C 119.596 2.598 . . . . 0.0 119.596 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -93.67 140.96 29.02 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.994 1.397 . . . . 0.0 111.55 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -129.32 146.85 51.14 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 175.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.7 t -143.4 111.24 6.01 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.037 0.535 . . . . 0.0 110.385 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.3 t -98.65 146.3 25.98 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.8 mt -127.91 108.31 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -169.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.6 m -97.63 106.23 18.51 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.548 0.739 . . . . 0.0 110.214 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -93.0 85.87 5.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 111.237 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -100.37 130.13 46.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -167.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.89 117.24 21.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 112.288 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -145.78 121.88 10.77 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.519 0.728 . . . . 0.0 109.684 -171.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 59.5 47.99 10.29 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 168.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.75 35.04 80.03 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -166.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.48 139.6 16.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.452 0.701 . . . . 0.0 109.781 -162.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.11 112.46 24.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.172 -0.955 . . . . 0.0 108.757 172.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.2 t -99.16 101.82 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.37 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -165.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -100.1 100.98 11.91 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.987 0.899 . . . . 0.0 109.798 -170.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.994 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.5 p -101.72 127.25 48.57 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.158 0.983 . . . . 0.0 111.517 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.71 143.62 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 123.316 0.646 . . . . 0.0 111.518 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.7 ttt -124.17 -103.13 0.38 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.336 -0.852 . . . . 0.0 108.732 165.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -87.66 70.51 9.71 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 120.571 1.532 . . . . 0.0 111.264 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.253 0.7 OUTLIER 62.88 0.13 0.65 Allowed 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 118.169 2.655 . . . . 0.0 118.169 -165.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.47 93.94 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.253 -1.529 . . . . 0.0 108.644 -171.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.6 p -92.62 117.59 30.13 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.252 0.548 . . . . 0.0 111.761 -171.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.994 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 4.1 p -108.12 119.91 40.81 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.437 0.695 . . . . 0.0 111.339 171.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.6 m -101.96 107.57 18.75 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -101.67 114.1 27.84 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.483 0.713 . . . . 0.0 109.833 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.47 124.94 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.344 -0.848 . . . . 0.0 108.924 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -122.95 131.76 53.86 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -86.21 132.13 34.07 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.253 1.421 . . . . 0.0 113.725 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -73.36 111.13 8.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.877 -1.139 . . . . 0.0 112.102 174.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.2 t -103.62 95.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.253 1.286 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.738 -178.039 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.519 3.9 p . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.95 -47.66 84.28 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -64.94 -15.96 62.74 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 171.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.61 -11.74 61.0 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 163.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -83.9 125.25 31.82 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 121.422 1.919 . . . . 0.0 113.091 -165.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.6 -170.6 26.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 115.856 1.102 . . . . 0.0 115.856 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -90.49 122.52 33.41 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.536 0.734 . . . . 0.0 110.894 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -123.55 110.89 15.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.613 -0.679 . . . . 0.0 110.857 -172.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -90.15 130.63 36.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.591 -1.318 . . . . 0.0 113.37 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 46.8 tp -65.0 128.65 36.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 173.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.275 8.8 m -121.46 -61.4 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.129 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -96.43 149.51 21.64 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.491 1.496 . . . . 0.0 111.41 167.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.4 p -145.81 65.76 1.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.166 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.23 126.96 31.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.726 -1.234 . . . . 0.0 112.386 -175.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.64 23.14 62.6 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 119.248 2.459 . . . . 0.0 119.248 -171.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -75.1 -46.81 32.09 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 119.002 1.401 . . . . 0.0 114.455 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.69 -44.14 63.03 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 163.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -52.8 -48.54 66.83 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.499 ' HH ' ' CB ' ' A' ' 105' ' ' SER . 86.7 t80 -58.82 -51.29 70.63 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 167.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 50.0 mtm -68.35 -42.62 78.95 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.34 -37.28 23.93 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 116.207 1.928 . . . . 0.0 116.207 164.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.76 -39.39 76.73 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 171.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.5 mt -51.04 -45.09 61.21 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 162.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.9 46.92 1.06 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 117.114 1.605 . . . . 0.0 117.114 -172.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 m -91.78 143.03 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 C-N-CA 124.519 1.128 . . . . 0.0 110.676 166.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.55 174.5 42.03 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 2.6 pp -55.81 -44.94 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.25 84.32 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.8 mt -64.9 -43.24 93.48 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -52.46 -54.6 30.23 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 164.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -59.49 -52.31 66.14 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.2 ttp -56.15 -49.78 73.02 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 172.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.39 -44.8 97.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 118.23 2.052 . . . . 0.0 118.23 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.23 96.94 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.1 ptp -76.98 -16.72 59.25 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.148 2.648 . . . . 0.0 118.148 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.14 145.39 46.43 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.29 73.07 5.17 Favored Pre-proline 0 CA--C 1.577 1.984 0 CA-C-O 118.546 -0.74 . . . . 0.0 110.627 171.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.32 146.8 57.78 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.134 2.556 . . . . 0.0 116.001 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -83.07 100.8 10.72 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.097 165.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.4 t -79.19 101.9 8.22 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.839 0.828 . . . . 0.0 110.545 167.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mt -96.2 106.36 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.31 128.65 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.0 m -146.32 113.15 6.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.395 -0.816 . . . . 0.0 108.821 170.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.7 95.64 10.0 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 121.276 -0.89 . . . . 0.0 111.062 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.56 76.77 9.98 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-O 122.393 1.092 . . . . 0.0 110.063 -171.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.59 -101.11 1.62 Allowed Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.143 -0.973 . . . . 0.0 113.642 -167.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -94.97 -11.94 27.63 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 156.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -84.57 96.5 9.18 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 122.023 2.192 . . . . 0.0 110.556 -167.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.3 tp -73.22 108.62 6.2 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 121.941 0.876 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.2 m -98.34 105.39 17.53 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.7 103.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -102.85 115.88 31.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.579 0.752 . . . . 0.0 109.687 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.8 m -100.3 97.29 8.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.699 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -89.34 119.72 30.06 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.88 0.848 . . . . 0.0 112.313 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.1 t -150.66 134.76 16.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.673 0.789 . . . . 0.0 110.054 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.4 p -59.12 -33.31 70.71 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.04 -47.84 73.05 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 166.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -158.27 104.94 1.88 Allowed 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.145 1.338 . . . . 0.0 111.173 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.2 m -92.39 137.53 32.28 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.708 -0.62 . . . . 0.0 111.55 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -144.25 164.47 30.65 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.428 0.691 . . . . 0.0 111.686 168.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -154.46 149.72 27.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 119.897 -1.752 . . . . 0.0 114.285 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -138.93 141.21 38.47 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.424 0.63 . . . . 0.0 112.122 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.7 p -126.41 105.15 8.58 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.767 0.827 . . . . 0.0 109.923 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.3 p -136.85 142.13 42.83 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -166.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 m -72.07 118.98 15.62 Favored 'General case' 0 CA--C 1.574 1.871 0 O-C-N 120.575 -1.328 . . . . 0.0 111.768 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 tp -69.48 122.87 19.86 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -166.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.44 -38.08 3.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -158.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -99.23 164.45 12.13 Favored 'General case' 0 CA--C 1.574 1.9 0 CA-C-O 123.519 1.628 . . . . 0.0 113.405 -166.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -103.28 125.69 50.06 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 113.622 -1.626 . . . . 0.0 112.446 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -125.02 164.69 19.61 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.944 0.897 . . . . 0.0 113.377 -174.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -76.64 104.91 7.39 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.71 1.243 . . . . 0.0 111.516 167.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.82 115.89 27.5 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.229 1.012 . . . . 0.0 109.349 175.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.1 m -90.04 97.17 11.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.9 p -71.05 147.76 48.23 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.69 -37.02 7.75 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -65.41 -49.13 70.38 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 166.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.73 -14.26 1.19 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 118.478 2.151 . . . . 0.0 118.478 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -69.5 133.09 47.28 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 120.375 2.088 . . . . 0.0 112.84 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -86.73 102.05 13.87 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.065 165.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.4 p -104.26 143.08 33.44 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.49 -0.756 . . . . 0.0 110.591 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -79.23 95.6 5.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.478 -1.389 . . . . 0.0 110.494 166.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.2 m -92.46 116.65 29.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 0.0 110.132 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.315 11.6 p -87.82 109.46 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 118.264 0.483 . . . . 0.0 109.884 160.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 56.4 m -92.07 110.32 21.69 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -133.41 126.68 31.76 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.007 0.523 . . . . 0.0 111.627 -169.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -90.25 113.44 25.26 Favored 'General case' 0 CA--C 1.563 1.454 0 O-C-N 121.551 -0.718 . . . . 0.0 110.17 170.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 t -97.29 57.99 1.48 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.3 47.8 m-20 45.68 57.32 5.11 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 146.07 -61.13 0.47 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.829 -170.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.59 133.78 51.54 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.841 0.829 . . . . 0.0 112.86 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.7 tp -95.18 107.55 19.64 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.714 0.806 . . . . 0.0 110.669 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.5 114.97 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.569 0.748 . . . . 0.0 109.031 -172.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -89.09 98.18 11.62 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 166.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -95.53 92.22 6.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.854 -0.529 . . . . 0.0 111.354 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -83.23 123.25 29.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.146 0.978 . . . . 0.0 111.389 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -123.29 121.75 36.62 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.392 0.542 . . . . 0.0 110.625 -173.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -150.33 127.1 10.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.667 -1.27 . . . . 0.0 111.613 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.299 17.5 t70 52.85 49.74 19.57 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 162.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.24 0.07 19.72 Favored Glycine 0 CA--C 1.561 2.93 0 N-CA-C 120.145 2.818 . . . . 0.0 120.145 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -123.1 145.25 48.73 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 119.274 1.537 . . . . 0.0 109.854 -173.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -133.43 169.79 16.44 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.499 ' CB ' ' HH ' ' A' ' 22' ' ' TYR . 0.6 OUTLIER -154.03 121.33 5.76 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.751 -1.218 . . . . 0.0 111.596 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.54 103.56 12.46 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -172.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.0 mm -95.57 100.45 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 98.4 m -99.26 101.2 12.44 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.281 0.632 . . . . 0.0 110.252 -168.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -93.36 109.55 21.11 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.724 0.81 . . . . 0.0 110.793 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -125.15 144.35 50.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 112.766 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.75 122.91 28.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.348 -0.845 . . . . 0.0 110.821 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.293 42.0 tttm -124.7 -118.87 0.28 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 122.08 -0.388 . . . . 0.0 109.957 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -84.19 68.23 10.05 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.19 0.995 . . . . 0.0 112.651 -166.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.9 -13.61 5.27 Favored Glycine 0 CA--C 1.556 2.599 0 N-CA-C 119.477 2.551 . . . . 0.0 119.477 -166.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -124.71 158.12 33.99 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 119.096 1.448 . . . . 0.0 110.285 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.52 111.16 19.25 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.651 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 75.4 t -90.13 114.39 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.8 t -115.7 99.69 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 -167.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -99.34 108.6 21.15 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.425 0.69 . . . . 0.0 109.279 -171.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.963 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.7 p -103.74 122.69 45.59 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.71 -0.619 . . . . 0.0 111.938 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.39 136.16 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.385 0.612 . . . . 0.0 110.911 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 12.4 ttt -86.01 -76.1 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 122.722 0.409 . . . . 0.0 110.887 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -126.88 -73.08 0.62 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 166.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -89.97 -30.05 18.06 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.9 t -85.15 107.06 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 119.919 1.236 . . . . 0.0 110.537 -166.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 69.7 p -105.17 113.11 26.51 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.544 0.738 . . . . 0.0 111.344 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.963 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.4 OUTLIER -87.47 157.19 19.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 166.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.0 m -127.97 109.14 11.29 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 166.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -98.38 123.96 42.79 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.527 0.731 . . . . 0.0 110.64 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.9 mm -99.19 116.34 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -114.35 130.86 56.69 Favored 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 122.854 0.462 . . . . 0.0 110.826 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -107.83 143.96 35.68 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -74.28 118.36 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.662 -0.649 . . . . 0.0 112.708 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.3 t -90.06 95.68 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 118.436 -0.792 . . . . 0.0 109.781 -174.253 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.581 2.159 0 CA-C-O 121.383 0.611 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -136.97 70.51 1.4 Allowed 'General case' 0 CA--C 1.57 1.743 0 O-C-N 120.686 -1.259 . . . . 0.0 110.063 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -163.94 -52.33 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 125.87 1.668 . . . . 0.0 110.407 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.3 mt -75.87 0.27 18.78 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.42 143.72 29.24 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-N 120.736 1.607 . . . . 0.0 112.314 -171.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.62 -173.78 17.04 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 115.894 1.117 . . . . 0.0 115.894 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -87.24 112.7 22.28 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.469 0.708 . . . . 0.0 111.596 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -112.61 112.88 24.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 122.122 -0.361 . . . . 0.0 110.718 -175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -94.01 134.09 36.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.635 -1.291 . . . . 0.0 112.746 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.49 126.77 30.77 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.597 -0.689 . . . . 0.0 111.92 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.258 3.6 m -113.1 -66.49 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.836 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -111.43 107.96 17.36 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.575 1.079 . . . . 0.0 110.347 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.6 p -89.56 81.62 6.49 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.617 -0.677 . . . . 0.0 111.449 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.27 107.28 14.83 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -163.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.18 16.43 78.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 118.439 2.136 . . . . 0.0 118.439 -168.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -86.29 68.78 10.35 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-N 120.102 1.951 . . . . 0.0 112.868 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -141.73 -51.7 0.42 Allowed 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.778 153.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -45.1 -46.81 11.94 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 167.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.403 ' CD2' ' SG ' ' A' ' 127' ' ' CYS . 57.9 t80 -54.55 -57.62 10.68 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 171.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 ptt? -61.74 -43.98 97.79 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.33 -46.89 55.92 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 162.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -67.87 -39.13 83.77 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.913 1.819 . . . . 0.0 115.913 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -50.03 -40.83 46.04 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 159.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.15 50.0 0.6 Allowed Glycine 0 N--CA 1.486 2.015 0 C-N-CA 124.738 1.161 . . . . 0.0 114.978 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.8 t -99.78 131.7 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.578 0.751 . . . . 0.0 109.197 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.26 160.74 48.69 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 116.888 1.515 . . . . 0.0 116.888 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.281 2.6 pp -58.23 -46.34 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -173.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.17 95.28 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 167.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -41.23 89.34 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 170.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -54.97 -49.54 71.15 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 162.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -54.88 -49.73 70.45 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 170.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -52.83 -55.93 19.45 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 165.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.02 -43.79 96.69 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 118.85 2.3 . . . . 0.0 118.85 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.04 95.01 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . 0.269 14.4 ptt? -70.23 -40.03 74.73 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 170.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.43 133.93 56.57 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.51 92.75 41.57 Favored Pre-proline 0 CA--C 1.571 1.786 0 CA-C-O 118.027 -0.987 . . . . 0.0 108.564 166.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.84 158.48 27.74 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.505 2.137 . . . . 0.0 115.713 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -94.22 107.41 19.36 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.531 165.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.65 102.5 15.02 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 121.142 -0.973 . . . . 0.0 111.16 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -90.91 119.66 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 81.0 mt -108.81 126.74 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -138.18 116.08 11.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.827 -1.171 . . . . 0.0 109.121 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.8 p -117.97 111.51 19.06 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -89.86 68.43 7.4 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 122.128 0.966 . . . . 0.0 110.594 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.45 -75.68 0.67 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 120.478 -1.389 . . . . 0.0 115.754 -170.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -104.16 -44.16 5.05 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -74.28 110.01 8.23 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 121.281 1.855 . . . . 0.0 111.792 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 tt -112.82 112.85 24.64 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 122.379 1.085 . . . . 0.0 109.053 -172.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.5 m -99.13 115.92 30.15 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.733 0.813 . . . . 0.0 109.108 -172.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mt -106.58 105.89 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -102.72 105.93 16.46 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.285 0.634 . . . . 0.0 109.89 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.0 m -88.68 103.03 15.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.458 -0.776 . . . . 0.0 109.322 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.88 117.19 29.77 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.967 0.889 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -156.4 137.41 13.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.561 0.744 . . . . 0.0 110.055 168.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.3 p -58.57 -34.66 71.3 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 167.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.5 -47.42 73.05 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 168.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -156.35 104.78 2.24 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 120.077 1.308 . . . . 0.0 110.794 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 m -93.06 132.43 37.19 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.137 0.575 . . . . 0.0 110.935 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.1 p -142.53 115.49 8.78 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.767 -0.583 . . . . 0.0 110.668 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -109.96 135.56 50.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.36 0.664 . . . . 0.0 112.016 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -142.17 144.64 33.52 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.815 0.817 . . . . 0.0 112.699 170.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.8 p -106.16 105.75 15.93 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.662 0.785 . . . . 0.0 110.769 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.5 p -102.53 135.35 44.32 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 m -75.73 130.81 39.25 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 120.752 -1.218 . . . . 0.0 110.454 171.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 tp -77.67 124.74 28.34 Favored 'General case' 0 CA--C 1.57 1.736 0 O-C-N 121.377 -0.827 . . . . 0.0 112.377 175.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.98 39.54 11.54 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 117.452 1.741 . . . . 0.0 117.452 -169.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -171.92 147.53 2.18 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.807 1.243 . . . . 0.0 108.522 -167.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.257 11.6 ptpt -100.18 146.97 26.22 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 171.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -137.88 161.08 37.57 Favored 'General case' 0 CA--C 1.571 1.757 0 C-N-CA 124.893 1.277 . . . . 0.0 110.513 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -80.74 104.26 11.14 Favored 'General case' 0 CA--C 1.572 1.825 0 O-C-N 119.972 -1.705 . . . . 0.0 112.228 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -88.16 109.49 19.94 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.14 0.976 . . . . 0.0 110.707 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.3 m -76.08 99.54 4.67 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.772 . . . . 0.0 110.205 170.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 p -69.66 148.12 49.71 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.574 0.749 . . . . 0.0 112.717 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.14 -41.91 18.43 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.42 -43.91 76.17 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 170.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.82 -31.05 0.29 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.8 mtm-85 -67.75 126.86 30.74 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.071 1.936 . . . . 0.0 113.038 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -88.73 117.13 27.49 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.08 0.467 . . . . 0.0 109.777 166.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.0 p -123.82 129.07 50.45 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.479 0.657 . . . . 0.0 110.338 -163.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -83.64 105.4 14.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.525 -1.36 . . . . 0.0 109.679 -170.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.7 m -121.6 105.53 10.53 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.96 -0.463 . . . . 0.0 110.98 -148.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.44 120.84 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 120.89 0.376 . . . . 0.0 111.443 172.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 45.4 m -95.35 109.38 21.55 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.123 0.487 . . . . 0.0 109.732 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -136.31 124.0 22.43 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.141 0.576 . . . . 0.0 110.932 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -85.88 132.69 34.04 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.093 -1.005 . . . . 0.0 112.188 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 t -139.87 143.52 36.77 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.148 0.579 . . . . 0.0 110.101 163.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 62.27 35.69 15.14 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 162.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.14 29.06 73.17 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -164.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.08 134.28 18.27 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 118.519 1.16 . . . . 0.0 112.907 -170.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.9 tp -88.04 115.46 25.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.782 -0.574 . . . . 0.0 111.216 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.31 108.06 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -94.44 90.11 6.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -89.84 108.13 19.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.903 -0.498 . . . . 0.0 110.863 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -106.6 130.5 54.34 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -169.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -129.36 127.48 41.13 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 123.622 0.769 . . . . 0.0 111.747 -166.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -153.04 134.87 14.62 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.274 -1.516 . . . . 0.0 111.159 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.2 t70 48.29 48.3 18.97 Favored 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 166.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.32 19.06 66.04 Favored Glycine 0 CA--C 1.558 2.764 0 N-CA-C 120.384 2.913 . . . . 0.0 120.384 -167.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -136.54 137.1 39.91 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.216 1.508 . . . . 0.0 109.193 -168.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -128.59 143.86 51.04 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 123.13 1.443 . . . . 0.0 114.57 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.6 t -133.2 164.61 26.66 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.473 167.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -142.72 139.07 30.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.013 -1.68 . . . . 0.0 113.234 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.1 mm -104.97 103.27 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.9 m -99.13 102.02 13.57 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.347 0.594 . . . . 0.0 109.628 -175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -93.88 95.64 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.676 -0.64 . . . . 0.0 110.833 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -104.14 134.97 46.49 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 118.514 0.597 . . . . 0.0 112.487 -176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 109.75 12.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.966 -1.084 . . . . 0.0 110.189 173.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -144.84 128.75 17.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.555 -0.715 . . . . 0.0 110.783 -170.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 60.36 40.71 17.18 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.61 -15.3 25.67 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 119.814 2.686 . . . . 0.0 119.814 -169.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.8 169.2 17.42 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.081 1.94 . . . . 0.0 112.261 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.5 tp -88.06 116.08 25.99 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 120.551 -1.343 . . . . 0.0 110.109 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.6 t -99.03 108.92 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.9 t -102.42 96.51 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -169.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -87.49 100.95 13.14 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.219 1.009 . . . . 0.0 109.673 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.984 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.6 p -107.48 108.4 19.7 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.924 0.889 . . . . 0.0 110.352 -173.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.79 137.71 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.865 0.866 . . . . 0.0 111.618 -168.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.1 ttt -113.93 106.7 14.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 162.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.303 6.3 m120 68.52 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.987 0.915 . . . . 0.0 112.856 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -125.42 -3.12 7.4 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 164.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.7 t -90.32 100.1 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 121.906 2.139 . . . . 0.0 109.567 -170.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.5 p -99.2 123.62 43.63 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.807 0.843 . . . . 0.0 112.8 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.984 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.4 p -103.09 133.06 48.83 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 120.937 0.399 . . . . 0.0 111.349 157.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.7 m -106.49 101.46 10.92 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -95.01 114.7 26.54 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.499 -0.751 . . . . 0.0 110.603 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.4 mm -88.19 124.2 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -123.9 122.44 37.99 Favored 'General case' 0 CA--C 1.569 1.709 0 C-N-CA 123.534 0.734 . . . . 0.0 111.433 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -97.18 142.65 28.83 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -78.58 117.59 19.9 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.702 -1.248 . . . . 0.0 112.568 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 32.9 t -117.21 81.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.653 -0.654 . . . . 0.0 109.337 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.256 1.413 0 C-N-CA 123.558 0.743 . . . . 0.0 110.787 -178.043 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.408 HG22 ' SG ' ' A' ' 47' ' ' CYS 0.262 4.6 p . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -41.78 98.73 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 166.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -57.28 -23.66 49.87 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.41 -6.46 7.24 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 164.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -64.05 161.01 16.83 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 122.615 2.461 . . . . 0.0 115.274 171.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.42 169.3 12.88 Favored Glycine 0 N--CA 1.49 2.272 0 O-C-N 121.264 -0.898 . . . . 0.0 115.28 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -83.73 96.28 8.67 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.936 0.495 . . . . 0.0 110.858 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -97.18 100.16 11.64 Favored 'General case' 0 CA--C 1.566 1.566 0 O-C-N 121.422 -0.799 . . . . 0.0 110.982 -170.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -77.12 127.28 32.37 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.879 -1.138 . . . . 0.0 112.973 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.2 tp -67.07 121.83 16.45 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.985 0.811 . . . . 0.0 113.033 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.56 -46.58 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -120.95 131.42 54.32 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.48 1.112 . . . . 0.0 109.404 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.8 p -131.83 70.79 1.46 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 172.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -82.38 127.23 33.05 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.21 17.35 61.03 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 118.578 2.191 . . . . 0.0 118.578 -170.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -84.93 -42.47 14.94 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -166.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -60.54 -39.25 87.23 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 121.19 1.814 . . . . 0.0 115.073 169.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.251 14.7 pt-20 -59.7 -49.22 78.58 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 167.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.457 ' CD2' ' SG ' ' A' ' 127' ' ' CYS . 76.7 t80 -55.32 -49.84 71.15 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 169.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.2 mtm -64.26 -36.54 84.42 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -58.53 -45.9 87.92 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 121.514 1.961 . . . . 0.0 115.542 162.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.09 -44.1 95.05 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 171.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.4 mt -55.3 -37.78 67.81 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.24 59.19 0.77 Allowed Glycine 0 N--CA 1.487 2.066 0 C-N-CA 124.13 0.871 . . . . 0.0 114.54 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.6 t -115.27 125.13 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -172.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 164.03 50.85 Favored Glycine 0 CA--C 1.551 2.336 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.262 2.4 pp -55.04 -48.75 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 N-CA-C 117.226 2.306 . . . . 0.0 117.226 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.12 94.98 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.81 -44.25 94.09 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -66.0 -44.18 85.53 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 171.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -56.4 -48.88 76.03 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 168.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.9 ttp -52.96 -58.11 8.07 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 163.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.21 -44.06 89.04 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 119.311 2.484 . . . . 0.0 119.311 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.35 -45.24 95.22 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.3 ptp -74.32 -28.79 61.32 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 168.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.58 102.74 1.54 Allowed 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 119.593 1.088 . . . . 0.0 113.035 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -103.09 92.77 3.95 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.449 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -80.48 160.2 22.47 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.222 1.948 . . . . 0.0 116.08 -172.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -85.36 104.48 15.22 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.294 157.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.2 t -86.85 96.31 10.17 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 124.048 0.939 . . . . 0.0 110.872 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.38 106.11 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.2 mt -97.08 144.81 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 CA-C-O 122.814 1.292 . . . . 0.0 108.454 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -147.1 115.43 6.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.06 -1.65 . . . . 0.0 108.522 167.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.408 ' SG ' HG22 ' A' ' 4' ' ' VAL . 38.5 t -114.39 107.12 15.13 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.971 0.508 . . . . 0.0 111.65 174.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -99.63 79.81 2.3 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 122.408 1.099 . . . . 0.0 109.746 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.34 -89.7 0.43 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -99.43 -15.51 18.71 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -106.41 129.21 54.44 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 122.038 2.199 . . . . 0.0 111.113 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 tt -125.5 116.82 22.4 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.295 0.638 . . . . 0.0 110.224 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.1 m -107.58 134.18 50.96 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.917 0.887 . . . . 0.0 109.715 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.9 mt -124.76 111.2 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -87.71 159.57 18.44 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 122.023 0.916 . . . . 0.0 111.182 160.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -148.24 102.86 3.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 119.525 -1.984 . . . . 0.0 107.664 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -98.27 114.31 26.55 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.689 0.795 . . . . 0.0 111.917 -172.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -147.36 140.16 24.93 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.669 0.787 . . . . 0.0 110.484 168.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.0 t -54.4 -28.99 47.38 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 167.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.8 mt -85.14 -47.0 10.58 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 124.122 0.969 . . . . 0.0 113.342 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.1 106.02 3.85 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.881 1.219 . . . . 0.0 110.914 168.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.7 m -90.05 134.66 34.12 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.159 0.584 . . . . 0.0 110.719 170.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -134.83 158.44 44.21 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.931 0.872 . . . . 0.0 111.525 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -150.2 130.93 14.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.538 -1.351 . . . . 0.0 110.802 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -144.2 160.89 40.17 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.881 0.848 . . . . 0.0 112.913 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -139.43 145.83 39.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 112.784 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -132.97 160.04 38.24 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-O 122.448 1.118 . . . . 0.0 112.445 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.7 m -90.56 132.9 35.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 164.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -73.58 128.73 36.3 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -170.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.65 -55.96 0.89 Allowed Glycine 0 N--CA 1.494 2.508 0 O-C-N 121.857 -0.527 . . . . 0.0 114.019 -162.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.26 179.68 7.26 Favored 'General case' 0 CA--C 1.575 1.922 0 CA-C-O 122.94 1.352 . . . . 0.0 113.039 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 149.23 32.74 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -111.64 -172.27 2.0 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.664 164.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -115.41 109.52 18.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.671 -1.268 . . . . 0.0 109.922 163.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -84.37 102.81 13.02 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.746 0.818 . . . . 0.0 109.743 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 75.3 m -77.58 100.29 6.06 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.991 0.901 . . . . 0.0 109.465 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.7 p -72.26 159.67 33.69 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -171.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.1 -41.06 7.47 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 119.233 3.049 . . . . 0.0 119.233 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.27 -39.09 93.6 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 169.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.43 -17.22 5.89 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 118.067 1.987 . . . . 0.0 118.067 -160.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.1 mtm-85 -69.06 118.88 12.53 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.841 2.32 . . . . 0.0 111.05 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -91.61 108.61 20.03 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.237 0.542 . . . . 0.0 109.834 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -111.19 111.46 22.55 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.664 0.745 . . . . 0.0 110.467 -162.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -72.31 97.81 2.09 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.478 1.111 . . . . 0.0 109.643 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.1 m -116.79 119.79 36.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 110.855 -152.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.42 130.05 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.93 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 74.8 m -106.74 95.5 5.78 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.172 0.896 . . . . 0.0 109.947 167.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -126.86 124.65 40.08 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.586 -0.696 . . . . 0.0 111.68 -171.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -89.12 140.79 29.1 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -136.13 115.39 12.54 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.447 0.699 . . . . 0.0 110.988 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.325 21.8 t70 64.26 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 170.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.37 30.32 3.66 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 168.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.51 129.88 15.74 Favored 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 118.8 1.3 . . . . 0.0 112.58 -170.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.7 tp -87.43 120.5 28.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.451 -0.78 . . . . 0.0 110.68 167.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.05 103.07 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.602 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -89.34 88.83 7.64 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -91.8 98.04 11.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.743 . . . . 0.0 110.551 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.6 131.94 36.13 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.097 0.959 . . . . 0.0 111.715 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.84 126.07 33.37 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.982 0.81 . . . . 0.0 109.758 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -143.02 122.21 12.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.838 -1.164 . . . . 0.0 110.393 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.288 38.9 t70 50.4 44.53 26.77 Favored 'General case' 0 CA--C 1.588 2.421 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 173.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.58 25.81 72.82 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 119.812 2.685 . . . . 0.0 119.812 -168.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -135.71 128.71 31.46 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.136 1.374 . . . . 0.0 107.765 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -126.85 146.76 50.16 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.9 t -134.33 126.14 29.06 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.644 0.735 . . . . 0.0 111.031 170.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 m -102.8 129.68 49.54 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 121.178 -0.951 . . . . 0.0 110.067 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.8 mt -120.69 97.99 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -172.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 79.4 m -94.56 103.29 15.24 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.717 . . . . 0.0 109.967 -171.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -93.91 100.21 12.42 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.506 0.723 . . . . 0.0 109.906 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -115.73 138.09 51.45 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.14 112.37 16.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.817 -0.552 . . . . 0.0 111.052 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.269 20.3 tptp -105.62 -138.54 0.36 Allowed 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.619 0.767 . . . . 0.0 111.199 -177.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -90.83 68.08 6.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.521 -1.362 . . . . 0.0 110.225 -159.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.18 36.94 93.86 Favored Glycine 0 CA--C 1.558 2.725 0 N-CA-C 117.577 1.791 . . . . 0.0 117.577 -159.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -165.92 134.39 3.06 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -161.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 21.9 tp -90.22 119.34 30.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.926 -1.734 . . . . 0.0 110.859 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.5 t -94.13 113.87 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.1 t -109.46 101.99 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -89.1 97.39 11.17 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.001 0.905 . . . . 0.0 109.249 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 0.8 OUTLIER -101.1 110.4 22.42 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.195 0.998 . . . . 0.0 110.533 -176.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 p -129.02 144.86 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.751 0.82 . . . . 0.0 110.53 -170.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.284 28.1 ttt -102.98 -104.32 0.28 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.41 -0.806 . . . . 0.0 108.922 166.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -108.02 97.46 7.16 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.644 1.111 . . . . 0.0 108.546 172.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.28 20.0 m120 68.26 -29.04 0.15 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 -172.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.43 107.71 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 CA-C-N 120.203 1.365 . . . . 0.0 109.776 -172.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 68.4 p -107.29 123.1 47.83 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.594 0.758 . . . . 0.0 112.124 -169.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 7.7 p -96.22 129.34 43.56 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 121.268 0.556 . . . . 0.0 111.346 156.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.4 m -105.6 99.45 9.06 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.235 -0.916 . . . . 0.0 108.567 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -96.01 123.19 39.51 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 122.022 -0.424 . . . . 0.0 111.228 -176.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.9 mm -101.44 122.92 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -120.65 148.23 44.19 Favored 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 123.24 0.616 . . . . 0.0 111.794 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -123.0 138.57 54.65 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.408 ' HZ1' ' CD ' ' A' ' 135' ' ' GLU . 19.6 tttm -76.08 111.04 11.07 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.596 0.759 . . . . 0.0 112.139 -172.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.71 94.66 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -171.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.408 ' CD ' ' HZ1' ' A' ' 133' ' ' LYS . 8.6 pt-20 . . . . . 0 C--O 1.256 1.415 0 C-N-CA 123.639 0.775 . . . . 0.0 109.636 -173.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.504 2.225 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -57.03 -22.84 41.99 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 171.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -41.92 -43.13 2.98 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 117.333 2.346 . . . . 0.0 117.333 154.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.9 3.12 39.55 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -82.35 129.83 34.96 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 121.256 1.843 . . . . 0.0 111.844 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.98 173.68 26.71 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 118.492 2.157 . . . . 0.0 118.492 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -82.91 103.04 12.07 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.067 0.547 . . . . 0.0 110.256 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -109.43 106.88 16.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 122.043 -0.411 . . . . 0.0 110.556 -172.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -83.72 129.79 34.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.395 -1.441 . . . . 0.0 112.553 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.1 tp -65.75 134.34 52.95 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.082 0.468 . . . . 0.0 112.14 172.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.301 6.8 m -123.91 -78.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -84.59 147.14 27.15 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.776 1.171 . . . . 0.0 111.38 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.5 p -139.79 74.86 1.48 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.035 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 137.73 50.62 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.79 15.77 49.39 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 119.67 2.628 . . . . 0.0 119.67 -170.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -81.67 64.85 6.56 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.979 1.889 . . . . 0.0 112.912 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -153.87 -53.73 0.1 Allowed 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 125.624 1.569 . . . . 0.0 109.36 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.46 -48.72 37.46 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 165.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -52.66 -54.99 25.82 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 169.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.298 23.2 ptt? -69.81 -24.45 63.48 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 174.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -64.43 -48.54 74.93 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 159.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -62.0 -37.99 86.9 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.4 mt -53.74 -40.71 66.38 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 159.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.81 57.78 1.58 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 123.797 0.713 . . . . 0.0 114.348 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.8 t -102.1 132.27 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -169.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.84 153.9 40.5 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.259 2.4 pp -56.39 -47.39 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.28 96.7 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 168.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.9 -39.08 90.28 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.8 mtp-105 -56.16 -48.7 75.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 163.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -54.1 -51.69 63.37 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 167.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -51.19 -52.32 45.43 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 166.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.64 -41.48 93.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 119.003 2.361 . . . . 0.0 119.003 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.06 -47.28 87.11 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -78.93 -28.51 43.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.4 115.19 9.29 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 120.198 1.363 . . . . 0.0 113.469 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.59 84.65 4.16 Favored Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.101 174.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.38 161.56 25.56 Favored 'Trans proline' 0 CA--C 1.563 1.971 0 C-N-CA 122.731 2.287 . . . . 0.0 116.84 -173.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -90.74 100.61 13.44 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.158 0.98 . . . . 0.0 109.794 169.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.44 100.15 10.54 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.5 1.12 . . . . 0.0 112.039 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.08 99.24 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.9 mt -90.74 114.89 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.4 p -115.5 106.78 14.35 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.54 112.73 8.18 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.692 -0.63 . . . . 0.0 111.89 -168.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -82.61 -47.68 11.82 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.77 -69.0 0.04 OUTLIER Glycine 0 N--CA 1.486 1.97 0 O-C-N 121.554 -0.716 . . . . 0.0 112.778 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -102.07 -36.51 8.54 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 166.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -76.24 136.45 39.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 120.053 1.297 . . . . 0.0 113.524 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 tt -142.81 120.71 12.0 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-O 121.411 0.624 . . . . 0.0 110.525 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.5 m -120.0 121.95 40.07 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.492 0.717 . . . . 0.0 109.558 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.3 127.96 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -118.89 102.8 9.06 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.831 0.852 . . . . 0.0 109.787 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.1 m -96.66 107.64 20.13 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.598 0.759 . . . . 0.0 110.781 -173.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -101.94 120.45 40.42 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.474 0.654 . . . . 0.0 112.602 -163.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.7 t -155.8 142.53 18.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.75 0.82 . . . . 0.0 111.208 168.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.4 p -60.23 -29.81 68.99 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.11 -53.09 42.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 167.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.95 115.51 3.29 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.987 1.267 . . . . 0.0 110.379 169.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.8 m -91.97 128.95 38.0 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 123.162 0.585 . . . . 0.0 110.752 173.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.1 p -133.49 116.04 15.5 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.533 -0.729 . . . . 0.0 110.233 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.9 150.25 38.76 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -153.25 149.28 27.78 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.3 p -131.75 115.57 16.17 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.953 0.901 . . . . 0.0 111.751 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.5 t -149.92 157.14 42.87 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.561 1.172 . . . . 0.0 113.926 -176.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -89.27 150.97 22.38 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.936 1.351 . . . . 0.0 111.023 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.84 120.11 11.91 Favored 'General case' 0 CA--C 1.571 1.767 0 O-C-N 120.706 -1.246 . . . . 0.0 112.452 170.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.26 -27.31 19.1 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 -162.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -89.44 143.31 26.92 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 118.731 1.266 . . . . 0.0 112.712 -174.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -94.8 145.65 24.74 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.143 0.973 . . . . 0.0 113.552 167.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -130.63 162.02 30.28 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.115 0.966 . . . . 0.0 111.47 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -80.04 100.81 8.35 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 120.911 -1.118 . . . . 0.0 111.192 167.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -80.49 139.11 36.56 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.87 0.843 . . . . 0.0 109.607 162.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.5 m -117.46 110.49 18.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 170.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 p -64.61 140.87 58.91 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.174 -0.329 . . . . 0.0 111.402 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.14 -24.74 2.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 119.954 3.316 . . . . 0.0 119.954 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.253 1.4 t70 -91.91 -24.35 19.33 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 169.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.65 -49.47 0.22 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 119.996 2.758 . . . . 0.0 119.996 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.2 mtm-85 -64.02 138.62 58.54 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -162.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -87.18 107.69 18.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.589 0.756 . . . . 0.0 110.705 170.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . 0.263 3.0 p -112.95 119.16 36.98 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.499 1.142 . . . . 0.0 111.372 -173.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -71.88 95.09 1.5 Allowed 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.44 1.096 . . . . 0.0 110.481 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.5 m -100.69 101.95 12.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.202 -0.936 . . . . 0.0 109.759 -161.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.97 117.22 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.099 0.476 . . . . 0.0 110.479 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 57.8 m -90.25 113.29 25.08 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 122.789 0.436 . . . . 0.0 110.601 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -128.68 124.49 35.81 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.963 -1.086 . . . . 0.0 111.1 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -86.7 116.74 25.0 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 121.124 -0.985 . . . . 0.0 112.037 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.7 t -156.9 140.12 15.56 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.041 0.936 . . . . 0.0 110.663 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.11 54.84 5.58 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 48.79 38.15 22.45 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 118.517 2.167 . . . . 0.0 118.517 -169.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.72 144.42 20.39 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -161.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.84 106.84 18.79 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 163.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.2 t -80.2 95.79 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -88.2 92.3 9.1 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.41 ' HE2' ' CD ' ' A' ' 104' ' ' GLU . 26.8 t-80 -90.35 106.48 18.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.704 -0.622 . . . . 0.0 110.559 -174.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -89.18 119.97 30.15 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.253 1.021 . . . . 0.0 110.264 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -124.38 124.53 42.56 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.783 0.833 . . . . 0.0 111.012 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -157.49 117.8 3.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.438 -1.414 . . . . 0.0 112.918 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.262 6.5 t70 32.16 56.57 0.36 Allowed 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 118.918 2.933 . . . . 0.0 118.918 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.97 -52.41 1.11 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -77.18 146.68 36.92 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.41 ' CD ' ' HE2' ' A' ' 97' ' ' HIS . 2.6 pt-20 -142.57 153.04 43.17 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 175.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 t -132.96 123.01 25.11 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 74.2 p -88.67 114.02 24.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.631 -0.668 . . . . 0.0 110.174 170.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 36.2 mm -106.51 93.4 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.9 m -94.65 99.44 11.56 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.099 -1.001 . . . . 0.0 110.747 -170.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -88.17 89.15 7.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.585 -0.697 . . . . 0.0 111.276 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.0 141.93 47.92 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -168.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.86 114.23 20.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 111.347 -177.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -134.02 124.28 25.98 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.05 49.75 15.06 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 170.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.32 -34.26 3.09 Favored Glycine 0 CA--C 1.553 2.455 0 N-CA-C 118.917 2.327 . . . . 0.0 118.917 -169.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -115.47 158.93 21.84 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 119.405 1.602 . . . . 0.0 112.781 -165.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.2 tp -83.44 111.11 18.74 Favored 'General case' 0 CA--C 1.561 1.388 0 O-C-N 121.147 -0.971 . . . . 0.0 110.225 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.34 110.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -95.94 96.53 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -87.07 99.25 11.77 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 5.3 p -119.55 95.54 4.83 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.225 -159.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 p -107.75 140.78 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.098 0.951 . . . . 0.0 110.016 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttt -119.41 112.43 19.4 Favored 'General case' 0 CA--C 1.559 1.314 0 O-C-N 121.376 -0.828 . . . . 0.0 109.324 167.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 54.2 50.27 16.84 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.297 3.3 t-20 67.82 -2.93 1.27 Allowed 'General case' 0 CA--C 1.584 2.286 0 N-CA-C 118.435 2.754 . . . . 0.0 118.435 -166.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.77 129.56 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 120.82 1.646 . . . . 0.0 108.138 -175.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.4 p -120.18 137.79 53.98 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.367 1.618 . . . . 0.0 115.367 -144.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 25.1 p -132.82 167.62 19.85 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 123.088 1.423 . . . . 0.0 112.461 153.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.2 m -144.79 123.22 12.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 119.395 -2.066 . . . . 0.0 108.836 167.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -110.36 121.35 45.08 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.464 0.705 . . . . 0.0 110.807 -171.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.3 mm -92.58 118.48 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -118.02 127.47 53.84 Favored 'General case' 0 CA--C 1.569 1.693 0 C-N-CA 123.836 0.855 . . . . 0.0 110.292 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -112.03 144.48 41.31 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.481 ' HZ1' ' CD ' ' A' ' 135' ' ' GLU . 11.0 tttm -76.51 119.94 21.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 112.946 -174.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.7 t -96.16 73.35 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.481 ' CD ' ' HZ1' ' A' ' 133' ' ' LYS . 44.7 mt-10 . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -171.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.266 9.7 p . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.01 -37.29 76.55 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 169.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -30.86 56.64 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 164.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.87 -19.97 61.05 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 162.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.254 5.8 pt-20 -91.06 144.85 25.21 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 121.67 2.032 . . . . 0.0 113.688 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.34 -179.5 19.48 Favored Glycine 0 CA--C 1.55 2.239 0 C-N-CA 123.975 0.798 . . . . 0.0 114.187 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.3 ttm-85 -87.35 110.48 20.27 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.424 -1.045 . . . . 0.0 111.072 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -112.72 107.47 16.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.635 -0.665 . . . . 0.0 111.979 -170.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -90.61 129.53 36.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.981 -1.074 . . . . 0.0 113.429 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.1 tp -72.28 121.69 19.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.256 13.0 m -107.8 -57.44 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.686 0.794 . . . . 0.0 112.007 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.7 133.87 48.81 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 119.806 1.184 . . . . 0.0 110.408 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.5 p -119.21 63.94 0.79 Allowed 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 121.615 0.721 . . . . 0.0 112.71 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -60.54 127.59 32.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 0.0 113.494 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.3 21.1 59.33 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 119.993 2.757 . . . . 0.0 119.993 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.14 -41.64 61.23 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 119.115 1.458 . . . . 0.0 114.87 -173.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -49.63 -46.3 49.32 Favored 'General case' 0 CA--C 1.578 2.019 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 163.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -55.86 -49.55 73.02 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 168.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 68.2 t80 -58.05 -48.34 80.38 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 170.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -59.61 -34.03 72.23 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 168.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -58.75 -52.11 67.12 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 163.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -59.11 -44.67 92.0 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.8 mt -50.31 -50.64 50.13 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 162.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.8 49.52 0.58 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 124.143 0.878 . . . . 0.0 115.219 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.1 t -99.14 145.35 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 123.945 0.898 . . . . 0.0 109.461 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.92 -126.31 0.03 OUTLIER Glycine 0 CA--C 1.553 2.426 0 N-CA-C 117.526 1.77 . . . . 0.0 117.526 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.265 9.9 pt -119.1 -61.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.901 -0.764 . . . . 0.0 112.622 -176.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.72 90.75 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.1 mt -66.84 -34.67 78.32 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 170.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -63.87 -47.3 81.24 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 120.256 1.389 . . . . 0.0 114.371 164.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -53.11 -50.58 64.19 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER -59.43 -49.9 76.0 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 170.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.41 -41.42 97.02 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.585 2.194 . . . . 0.0 118.585 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.79 -46.32 82.57 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 169.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -77.16 -32.46 56.23 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.805 2.521 . . . . 0.0 117.805 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.51 144.92 55.48 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -110.93 86.37 5.88 Favored Pre-proline 0 CA--C 1.57 1.713 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -73.77 143.34 33.36 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 122.458 2.105 . . . . 0.0 116.182 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -90.87 100.47 13.33 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.951 165.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.8 t -81.86 95.9 7.47 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 122.468 1.127 . . . . 0.0 110.759 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mt -91.33 101.83 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 85.6 mt -94.73 133.25 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -149.1 126.16 11.32 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 119.863 -1.773 . . . . 0.0 110.508 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.3 t -103.52 110.97 23.22 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -171.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.08 76.01 9.37 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-O 122.129 0.966 . . . . 0.0 110.206 162.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.86 -90.23 0.16 Allowed Glycine 0 N--CA 1.493 2.466 0 O-C-N 120.994 -1.066 . . . . 0.0 115.681 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -89.93 -25.89 20.7 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 160.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -88.56 99.83 12.61 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.35 1.432 . . . . 0.0 110.177 -165.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.3 tp -94.35 110.87 22.6 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.398 0.679 . . . . 0.0 110.777 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.6 m -89.62 117.41 28.49 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -111.88 102.13 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -94.25 114.98 27.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.856 -0.527 . . . . 0.0 109.873 171.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 m -97.34 88.69 4.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.212 -0.93 . . . . 0.0 109.767 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -80.98 125.55 30.29 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.876 0.87 . . . . 0.0 112.795 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 t -155.28 153.77 31.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.473 -0.767 . . . . 0.0 110.813 165.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.9 p -57.98 -43.41 86.53 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 171.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.78 -32.46 67.67 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 123.07 7.76 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 119.827 1.194 . . . . 0.0 109.376 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 m -119.17 124.66 47.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.325 -0.859 . . . . 0.0 109.756 168.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 t -146.14 167.72 22.73 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.57 -0.707 . . . . 0.0 112.673 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -142.65 140.15 31.49 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.01 -1.056 . . . . 0.0 112.66 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -135.28 156.27 49.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 168.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 90.9 p -128.93 112.92 14.59 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.742 0.817 . . . . 0.0 111.214 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.8 t -115.79 132.49 56.62 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.0 m -82.48 117.34 22.42 Favored 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 123.46 0.704 . . . . 0.0 109.912 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mp -59.7 127.61 32.84 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -168.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.94 -33.91 5.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 116.986 1.555 . . . . 0.0 116.986 -164.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -98.7 165.64 11.7 Favored 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 123.797 1.76 . . . . 0.0 113.386 -172.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -82.57 139.88 33.57 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.183 -1.826 . . . . 0.0 113.154 171.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -131.21 162.63 29.55 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 121.657 0.741 . . . . 0.0 111.356 166.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.4 112.0 16.21 Favored 'General case' 0 CA--C 1.568 1.66 0 O-C-N 120.474 -1.391 . . . . 0.0 111.403 170.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -103.73 95.3 5.94 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 121.775 0.798 . . . . 0.0 109.683 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.0 m -72.5 104.73 3.92 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.946 0.879 . . . . 0.0 109.994 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 p -73.5 141.19 46.79 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.336 0.655 . . . . 0.0 111.692 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.85 -29.47 28.14 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 119.614 3.19 . . . . 0.0 119.614 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.79 -28.83 58.52 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 167.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.05 -29.93 0.99 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 118.973 2.349 . . . . 0.0 118.973 172.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.7 mtm-85 -70.48 126.55 29.96 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 119.813 1.807 . . . . 0.0 112.975 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -94.91 106.71 18.72 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.497 0.719 . . . . 0.0 110.052 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.3 p -104.56 122.17 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.457 0.646 . . . . 0.0 110.465 -166.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -77.42 98.52 5.3 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.997 0.903 . . . . 0.0 108.898 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.0 m -111.63 109.68 19.7 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -152.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.4 111.95 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 122.802 0.441 . . . . 0.0 110.853 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.1 m -105.31 105.21 15.15 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -119.37 125.18 48.39 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.467 0.707 . . . . 0.0 112.098 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -91.84 130.09 37.68 Favored 'General case' 0 CA--C 1.564 1.496 0 O-C-N 121.604 -0.685 . . . . 0.0 112.086 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 t -145.63 136.69 24.69 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.339 0.655 . . . . 0.0 109.982 167.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 62.18 34.52 16.11 Favored 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 160.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.27 15.88 80.92 Favored Glycine 0 CA--C 1.558 2.728 0 N-CA-C 119.326 2.49 . . . . 0.0 119.326 -165.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.35 125.2 22.58 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-N 118.616 1.208 . . . . 0.0 110.88 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -97.46 110.59 23.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.492 -0.755 . . . . 0.0 110.3 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.7 t -89.29 104.51 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -86.19 97.1 10.16 Favored 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 124.22 1.008 . . . . 0.0 109.019 171.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -92.66 97.26 10.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.055 -1.028 . . . . 0.0 110.754 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -70.0 127.59 33.38 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.441 0.696 . . . . 0.0 111.698 170.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -135.41 111.81 9.83 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 118.627 0.649 . . . . 0.0 109.96 -171.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.4 p90 -151.92 118.28 5.63 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.659 -1.276 . . . . 0.0 112.269 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.1 t70 39.77 55.16 2.51 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 117.807 2.521 . . . . 0.0 117.807 174.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.98 -44.19 3.32 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 117.755 1.862 . . . . 0.0 117.755 -171.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -78.26 144.3 36.3 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.61 147.18 26.45 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 121.719 0.771 . . . . 0.0 112.998 -175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 t -134.05 127.39 32.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.714 -0.616 . . . . 0.0 112.549 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.1 p -92.29 129.81 38.14 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.858 0.837 . . . . 0.0 110.891 168.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.1 mt -123.07 97.92 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.2 m -92.81 99.98 12.54 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.843 0.83 . . . . 0.0 109.448 -173.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -89.17 100.46 13.24 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.729 0.812 . . . . 0.0 109.204 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.88 142.63 51.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.41 115.89 21.63 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 121.776 0.798 . . . . 0.0 111.379 -172.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -91.68 -178.17 4.99 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-O 122.302 1.049 . . . . 0.0 112.307 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.62 73.18 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.061 0 CA-C-O 123.426 1.584 . . . . 0.0 115.037 167.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.22 28.6 24.82 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 118.996 2.358 . . . . 0.0 118.996 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -165.44 145.22 6.69 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 119.543 1.671 . . . . 0.0 110.374 -171.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.9 tp -89.86 114.89 26.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 119.905 -1.747 . . . . 0.0 109.316 168.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.2 t -96.05 112.87 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -104.98 95.57 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -85.85 102.16 13.46 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.345 1.069 . . . . 0.0 109.554 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.1 p -115.65 115.42 26.36 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.664 -165.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.58 134.44 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 122.968 0.507 . . . . 0.0 110.119 -169.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.9 ttt -127.19 114.0 17.1 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.275 39.8 m-20 66.2 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.273 1.029 . . . . 0.0 113.237 176.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -118.83 -13.02 9.55 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 166.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.9 t -102.3 112.72 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 121.121 1.782 . . . . 0.0 109.843 -157.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 70.1 p -99.43 107.65 19.93 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.373 0.669 . . . . 0.0 112.705 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 18.4 p -90.11 151.98 21.34 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 121.725 0.774 . . . . 0.0 111.901 160.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.4 m -129.28 109.68 11.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.876 -1.14 . . . . 0.0 108.002 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -103.35 118.8 37.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.917 -0.489 . . . . 0.0 110.356 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.8 mm -102.83 118.16 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -120.18 143.53 48.18 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -117.92 143.64 46.17 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -80.27 113.21 18.28 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.767 -0.583 . . . . 0.0 112.185 -169.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.7 t -97.71 83.38 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--O 1.257 1.448 0 C-N-CA 124.232 1.013 . . . . 0.0 109.49 -175.574 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.543 3.1 p . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.42 58.16 2.56 Favored 'General case' 0 CA--C 1.578 2.054 0 CA-C-O 122.868 1.318 . . . . 0.0 114.27 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -148.6 -40.31 0.16 Allowed 'General case' 0 CA--C 1.572 1.792 0 C-N-CA 125.876 1.67 . . . . 0.0 111.222 172.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.0 -6.22 12.09 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 166.45 15.92 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.59 179.7 18.71 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.191 -0.943 . . . . 0.0 115.21 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.1 ttm105 -94.37 118.31 31.42 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.2 0.6 . . . . 0.0 109.687 173.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -118.85 110.2 16.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.227 -0.92 . . . . 0.0 110.625 -164.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -99.46 129.72 45.67 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.495 -0.753 . . . . 0.0 112.326 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.8 tp -67.43 126.2 28.55 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 m -115.69 -53.16 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -117.04 118.08 31.4 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 119.373 0.988 . . . . 0.0 108.899 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.4 p -112.91 68.17 0.67 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -79.42 124.05 28.09 Favored 'General case' 0 CA--C 1.567 1.617 0 O-C-N 121.48 -0.762 . . . . 0.0 112.868 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.88 -2.37 85.69 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 118.892 2.317 . . . . 0.0 118.892 -169.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.251 13.3 t80 -68.57 -37.68 80.08 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.651 2.225 . . . . 0.0 116.352 -173.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.47 -47.91 81.94 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-N 121.058 1.754 . . . . 0.0 115.03 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.254 7.5 pt-20 -49.14 -48.98 44.3 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 121.645 2.02 . . . . 0.0 116.0 166.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.43 -44.4 89.09 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.637 1.718 . . . . 0.0 115.637 170.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 76.9 mtm -61.25 -43.77 98.33 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -53.15 -51.61 61.44 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 121.166 1.803 . . . . 0.0 115.116 164.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.82 -37.49 84.6 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.99 -37.89 69.72 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 161.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.33 61.28 0.81 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 123.999 0.809 . . . . 0.0 114.176 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -110.97 125.12 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.57 162.3 50.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.54 -44.8 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -171.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.96 90.32 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 168.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.2 mt -67.59 -37.79 83.09 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -57.74 -49.56 76.15 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 165.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -51.82 -52.14 51.36 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 165.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.5 ttp -52.21 -56.14 16.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 170.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.46 -42.52 89.78 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.78 2.272 . . . . 0.0 118.78 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.83 83.89 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 170.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.4 ptm -76.97 -29.71 55.67 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.19 122.99 22.79 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 119.62 1.1 . . . . 0.0 113.77 175.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.34 92.61 11.82 Favored Pre-proline 0 CA--C 1.568 1.657 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.291 170.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.95 142.62 25.26 Favored 'Trans proline' 0 CA--C 1.562 1.892 0 C-N-CA 122.3 2.0 . . . . 0.0 115.034 -174.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.37 100.62 13.17 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.011 0.91 . . . . 0.0 109.292 170.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.8 t -94.15 104.79 16.8 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.431 -0.793 . . . . 0.0 112.815 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 mt -81.1 106.43 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.4 mt -103.96 117.7 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.5 t -119.28 124.37 46.51 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.4 p -120.42 102.72 8.65 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-O 121.613 0.72 . . . . 0.0 112.751 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.15 69.39 10.77 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 121.846 0.832 . . . . 0.0 111.153 171.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.24 -84.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 117.249 1.66 . . . . 0.0 117.249 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -85.86 -23.52 27.07 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 166.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -103.08 107.75 18.67 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.525 1.511 . . . . 0.0 109.966 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 tt -117.15 125.55 51.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.832 -1.168 . . . . 0.0 111.665 -169.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -113.53 125.76 54.56 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.404 0.682 . . . . 0.0 110.574 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.0 mt -110.28 109.03 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -107.22 89.06 2.88 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.02 0.928 . . . . 0.0 109.284 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.2 m -84.71 103.39 13.76 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 124.034 0.934 . . . . 0.0 110.758 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -102.39 124.85 48.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -171.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.3 t -147.23 141.23 25.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.542 0.687 . . . . 0.0 110.413 167.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.4 p -55.29 -29.49 58.29 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 164.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.0 mt -74.42 -48.2 29.11 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 165.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -157.2 108.4 2.33 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 121.022 1.737 . . . . 0.0 112.533 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.3 m -77.35 135.28 38.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.641 -0.662 . . . . 0.0 111.137 164.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -134.61 120.5 19.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.215 -0.928 . . . . 0.0 108.537 170.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -124.74 128.89 49.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 110.865 -173.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -146.99 152.55 38.79 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.1 p -136.36 118.0 14.95 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.852 0.861 . . . . 0.0 111.268 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.6 t -145.44 153.84 41.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.585 1.183 . . . . 0.0 113.308 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -84.81 149.04 25.99 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 122.431 1.11 . . . . 0.0 110.83 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 mp -67.12 115.79 7.21 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.465 -1.397 . . . . 0.0 112.587 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.77 -30.08 11.06 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 117.937 1.935 . . . . 0.0 117.937 -161.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -82.87 150.24 26.65 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 118.653 1.227 . . . . 0.0 112.443 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -109.78 151.31 27.13 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.518 1.152 . . . . 0.0 114.087 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -138.05 167.17 22.35 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.16 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.69 102.91 11.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.947 -1.095 . . . . 0.0 111.101 170.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -92.04 99.6 12.4 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-O 121.912 0.863 . . . . 0.0 109.757 172.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.2 m -78.81 105.1 9.88 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 166.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -65.94 176.16 1.75 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.86 -41.06 31.92 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.62 -44.94 73.19 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 165.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.71 -11.52 5.17 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 -160.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 68.5 mtm-85 -63.27 131.82 49.61 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 121.331 2.565 . . . . 0.0 112.885 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -79.92 112.46 17.23 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.642 0.777 . . . . 0.0 111.125 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.8 p -123.78 124.22 42.22 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.967 0.507 . . . . 0.0 110.35 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -83.39 96.17 8.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.622 -1.299 . . . . 0.0 110.377 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.3 m -96.74 115.62 27.74 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 122.077 -0.39 . . . . 0.0 110.376 -168.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.69 125.1 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.817 -0.552 . . . . 0.0 111.037 169.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.56 117.07 29.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.801 -0.562 . . . . 0.0 111.756 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -131.49 116.12 17.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.233 -0.917 . . . . 0.0 111.138 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -83.82 134.98 34.69 Favored 'General case' 0 CA--C 1.568 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 111.945 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.1 t -135.89 129.61 32.56 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.02 0.528 . . . . 0.0 109.979 162.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.296 4.2 m-20 72.85 -82.64 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 159.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.9 48.61 0.71 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 123.466 0.555 . . . . 0.0 113.984 159.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -154.63 127.2 8.0 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.723 0.809 . . . . 0.0 110.92 -166.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.7 tp -97.14 113.72 25.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.67 -0.644 . . . . 0.0 110.166 171.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.45 101.7 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.682 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -90.53 99.82 12.78 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -101.93 100.3 10.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.551 -0.718 . . . . 0.0 111.76 -164.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.67 132.39 37.01 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.437 0.695 . . . . 0.0 112.841 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -130.72 118.04 20.3 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 123.224 0.61 . . . . 0.0 109.922 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -159.21 142.12 14.28 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.716 -1.24 . . . . 0.0 112.281 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t0 51.62 41.89 29.18 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 161.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.37 27.18 72.18 Favored Glycine 0 CA--C 1.559 2.782 0 N-CA-C 119.5 2.56 . . . . 0.0 119.5 -167.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -142.83 151.84 41.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 118.787 1.294 . . . . 0.0 109.699 -168.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -134.18 155.44 50.12 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.1 t -147.29 131.42 17.33 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.855 0.836 . . . . 0.0 111.773 172.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 p -105.17 113.76 27.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.856 -0.528 . . . . 0.0 109.928 -169.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.1 mm -98.64 101.75 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.7 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.2 m -95.9 98.53 10.48 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.096 -1.002 . . . . 0.0 110.105 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.1 mtp85 -89.06 102.55 15.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.635 0.774 . . . . 0.0 109.429 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -133.77 147.88 51.33 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.49 114.99 22.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.623 -0.673 . . . . 0.0 112.123 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -131.46 110.81 11.28 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.252 20.1 t70 55.76 57.8 4.96 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.67 -8.61 2.23 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 120.071 2.789 . . . . 0.0 120.071 -170.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -113.45 140.55 48.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.745 1.272 . . . . 0.0 110.618 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -83.22 104.42 13.38 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 122.219 1.009 . . . . 0.0 108.573 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 99.3 t -96.05 106.16 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.1 t -95.7 98.67 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -172.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.74 100.7 12.38 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.857 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.5 p -92.72 144.65 25.09 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.4 p -135.47 136.48 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.611 0.72 . . . . 0.0 110.762 169.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.5 tpt -92.86 -58.43 2.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.48 -0.762 . . . . 0.0 111.94 163.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.256 16.3 p30 -141.71 -90.57 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.004 0.922 . . . . 0.0 108.719 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -90.81 -15.88 29.29 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 153.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.4 t -79.78 129.47 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 CA-C-N 120.044 1.293 . . . . 0.0 109.905 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 61.1 p -137.4 153.59 50.14 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -166.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 1.9 p -132.92 130.32 39.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.403 -0.811 . . . . 0.0 111.349 163.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.4 m -104.08 101.33 11.09 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -102.99 117.06 33.75 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.141 0.496 . . . . 0.0 111.358 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.1 mm -92.26 120.39 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -113.92 131.02 56.45 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 121.265 0.555 . . . . 0.0 110.865 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -86.6 131.38 34.17 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -74.02 106.27 5.64 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.96 0.886 . . . . 0.0 111.356 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.28 129.24 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -176.083 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.505 2.276 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -56.28 -39.32 72.49 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 159.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -71.12 -30.47 66.54 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 169.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 mt -68.91 -10.22 56.0 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 161.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.87 132.45 34.39 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 120.507 1.503 . . . . 0.0 112.019 -166.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.35 -162.83 20.46 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 115.146 0.818 . . . . 0.0 115.146 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -92.01 130.57 37.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.94 -0.741 . . . . 0.0 112.88 -172.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -134.56 112.23 10.7 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.416 0.687 . . . . 0.0 109.291 -171.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.7 ttp-105 -94.32 133.16 38.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 119.963 -1.711 . . . . 0.0 112.575 173.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.15 131.4 50.7 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.292 16.0 m -130.76 -60.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.637 -0.664 . . . . 0.0 112.201 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.27 106.37 17.17 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 119.601 1.091 . . . . 0.0 109.106 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 p -108.15 68.94 0.71 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -83.17 129.07 34.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.48 2.12 90.38 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 -168.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -70.68 -51.9 24.64 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-N 120.179 1.99 . . . . 0.0 115.856 -169.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -54.38 -39.82 67.56 Favored 'General case' 0 CA--C 1.58 2.096 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 170.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.03 -47.7 77.36 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 164.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -58.42 -51.01 71.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 171.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.347 16.5 ptt? -65.22 -23.74 67.16 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 170.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -59.98 -51.86 67.84 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 154.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -59.21 -43.93 92.28 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 171.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.43 ' HA ' ' SD ' ' A' ' 122' ' ' MET . 83.5 mt -57.2 -44.57 83.77 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 171.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.75 62.15 0.36 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 123.883 0.754 . . . . 0.0 114.388 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.4 t -128.49 127.53 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -166.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.48 164.94 53.83 Favored Glycine 0 CA--C 1.55 2.246 0 N-CA-C 117.611 1.804 . . . . 0.0 117.611 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.78 -47.97 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -171.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.11 80.7 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 173.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.98 -38.56 91.51 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 169.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -62.74 -48.18 80.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.513 1.506 . . . . 0.0 114.85 168.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.46 -41.99 77.42 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 168.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -58.69 -59.52 5.27 Favored 'General case' 0 CA--C 1.569 1.673 0 CA-C-N 119.784 1.174 . . . . 0.0 113.869 164.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.96 -39.4 78.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 119.622 2.609 . . . . 0.0 119.622 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.31 86.71 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 171.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -83.96 -29.25 27.19 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 167.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.5 106.96 4.17 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-N 119.744 1.156 . . . . 0.0 113.359 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -105.46 91.81 5.23 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.068 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.33 147.77 18.35 Favored 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.313 2.009 . . . . 0.0 115.887 -171.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 99.61 9.29 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 121.681 0.753 . . . . 0.0 109.166 169.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.5 t -101.9 109.68 21.48 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.976 -1.077 . . . . 0.0 112.84 -167.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mt -97.59 104.42 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -170.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 97.0 mt -85.89 104.87 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.5 p -107.08 117.14 33.28 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.29 0.636 . . . . 0.0 109.813 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -113.49 100.07 8.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.022 -1.049 . . . . 0.0 113.179 -173.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.91 65.16 8.86 Favored 'General case' 0 CA--C 1.575 1.938 0 CA-C-O 122.039 0.923 . . . . 0.0 111.381 166.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.52 -88.49 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 116.6 1.4 . . . . 0.0 116.6 -177.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -81.95 -39.29 23.91 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 169.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -90.43 102.27 15.0 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 120.305 1.411 . . . . 0.0 109.786 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 tt -108.69 111.82 23.81 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 121.621 0.724 . . . . 0.0 109.049 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.7 m -105.88 117.08 33.11 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.558 0.743 . . . . 0.0 109.7 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.1 112.01 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -101.89 94.23 5.7 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.508 0.723 . . . . 0.0 110.871 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.6 m -88.58 103.06 15.55 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.315 0.646 . . . . 0.0 110.682 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -100.52 115.4 30.03 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.7 t -147.31 141.54 26.2 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.528 0.731 . . . . 0.0 110.82 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.2 p -58.81 -32.46 69.39 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 165.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.23 -48.81 64.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 167.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.21 108.07 2.53 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.568 1.531 . . . . 0.0 111.354 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.3 m -91.07 128.19 36.8 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.715 -0.616 . . . . 0.0 110.988 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.5 p -131.55 109.06 9.98 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.431 -0.793 . . . . 0.0 110.772 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -104.98 119.94 40.24 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.27 0.628 . . . . 0.0 110.83 175.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -133.13 143.96 49.6 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.7 p -102.04 113.08 26.0 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.882 0.873 . . . . 0.0 111.631 173.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.8 p -102.95 123.96 47.56 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-O 121.516 0.674 . . . . 0.0 111.382 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 m -81.29 121.42 26.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.195 -0.941 . . . . 0.0 109.065 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -73.0 129.65 38.57 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -164.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.1 -41.48 2.97 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 116.812 1.485 . . . . 0.0 116.812 -160.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -89.33 173.15 8.54 Favored 'General case' 0 CA--C 1.572 1.797 0 C-N-CA 124.798 1.239 . . . . 0.0 113.185 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.54 157.69 21.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -142.82 163.72 32.03 Favored 'General case' 0 CA--C 1.573 1.865 0 C-N-CA 124.723 1.209 . . . . 0.0 111.725 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.33 104.96 11.23 Favored 'General case' 0 CA--C 1.569 1.704 0 O-C-N 120.916 -1.115 . . . . 0.0 111.716 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -99.19 114.73 27.66 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.008 0.923 . . . . 0.0 109.678 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.8 m -93.71 106.94 18.87 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.92 -1.112 . . . . 0.0 108.36 166.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -77.66 157.16 30.3 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -169.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.86 -31.98 63.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 168.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.46 10.41 2.6 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 164.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.09 45.57 10.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.08 1.992 . . . . 0.0 118.08 172.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.3 mtm105 -134.01 130.34 37.44 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 117.998 0.899 . . . . 0.0 109.348 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -90.05 112.14 23.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.968 -0.458 . . . . 0.0 110.077 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.2 p -125.3 134.43 52.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.402 0.681 . . . . 0.0 109.667 -169.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -81.85 99.97 9.33 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 171.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.8 m -107.51 112.39 25.13 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.861 -0.524 . . . . 0.0 110.994 -159.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -88.9 124.37 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 122.961 0.504 . . . . 0.0 111.452 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 19.3 m -108.45 114.07 27.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.73 -0.606 . . . . 0.0 111.887 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -124.17 120.66 32.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.789 -0.569 . . . . 0.0 110.589 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -89.32 119.17 29.55 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 111.609 171.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 t -98.91 156.83 16.69 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 122.974 0.51 . . . . 0.0 110.027 155.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.23 95.82 0.04 OUTLIER 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.01 -16.02 20.76 Favored Glycine 0 CA--C 1.553 2.444 0 N-CA-C 118.421 2.128 . . . . 0.0 118.421 -170.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.57 126.01 15.77 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 120.331 2.066 . . . . 0.0 112.927 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.5 tp -90.88 107.39 19.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 110.059 168.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.8 106.91 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -91.12 100.51 13.34 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.152 0.581 . . . . 0.0 109.537 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -93.52 104.19 16.33 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -104.3 125.25 50.39 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -174.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.84 127.19 51.68 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.68 0.792 . . . . 0.0 111.036 -165.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -153.79 125.67 7.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.425 -1.422 . . . . 0.0 112.248 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.0 t70 49.82 51.02 17.36 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.04 -14.17 6.52 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 119.903 2.721 . . . . 0.0 119.903 -167.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -103.81 152.28 22.08 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 119.138 1.469 . . . . 0.0 111.955 -173.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -143.61 150.72 39.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.7 t -136.76 132.65 35.06 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.349 0.66 . . . . 0.0 111.289 174.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.5 p -91.48 130.36 37.32 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.789 0.804 . . . . 0.0 110.455 169.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 80.2 mt -124.38 98.17 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -98.41 101.79 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.781 -0.574 . . . . 0.0 110.141 -170.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -88.04 98.06 11.31 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 121.79 -0.569 . . . . 0.0 110.149 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.11 145.78 47.84 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -171.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.59 113.29 25.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.0 112.363 -171.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -134.22 115.05 13.71 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.597 -0.689 . . . . 0.0 109.164 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 58.0 58.31 3.65 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 47.16 41.53 15.43 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 118.455 2.142 . . . . 0.0 118.455 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.55 128.77 9.75 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -163.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.63 106.2 17.86 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 122.184 0.993 . . . . 0.0 109.674 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.4 t -95.27 109.0 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.7 t -95.04 100.32 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -93.7 101.19 13.32 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.965 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.0 p -120.58 131.49 54.68 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 121.774 0.797 . . . . 0.0 111.991 -163.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.61 140.64 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.464 0.65 . . . . 0.0 110.505 -166.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' A' ' 26' ' ' LEU . 19.3 ttt -106.09 -74.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.759 -0.588 . . . . 0.0 110.567 171.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -129.5 -65.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.654 0.661 . . . . 0.0 110.937 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -94.79 -44.89 7.56 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.06 0.944 . . . . 0.0 112.639 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.68 120.91 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 CA-C-N 119.248 0.931 . . . . 0.0 110.316 -161.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 39.9 p -102.4 114.5 28.74 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.492 0.717 . . . . 0.0 109.959 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.965 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.5 p -98.76 132.86 43.8 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.475 0.71 . . . . 0.0 111.213 171.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.6 m -109.7 104.62 13.65 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -103.68 113.01 26.2 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 122.905 0.482 . . . . 0.0 110.683 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.18 129.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.454 -0.779 . . . . 0.0 109.381 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -118.48 124.39 47.48 Favored 'General case' 0 CA--C 1.571 1.768 0 CA-C-O 121.203 0.525 . . . . 0.0 112.163 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.4 136.49 42.4 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.158 0.983 . . . . 0.0 113.613 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -76.32 116.37 16.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.371 -1.456 . . . . 0.0 111.208 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.36 69.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.209 -0.932 . . . . 0.0 110.84 -171.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.12 -0.987 . . . . 0.0 108.771 -164.138 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p -63.84 -22.89 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . 0.252 6.6 tt0 -67.59 -14.86 63.3 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -35.1 71.06 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 155.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.0 mt -82.9 2.87 32.29 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -92.04 148.57 22.09 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 122.089 2.222 . . . . 0.0 113.634 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.31 178.69 15.61 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.8 ttm105 -85.84 122.88 30.54 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.816 -0.814 . . . . 0.0 110.311 166.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -119.66 114.4 22.13 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -172.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -105.07 124.41 49.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.751 0.82 . . . . 0.0 112.83 -163.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.1 tp -66.66 128.63 36.99 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.253 6.1 m -115.6 -69.09 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 C-N-CA 124.148 0.979 . . . . 0.0 109.566 173.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -92.57 149.93 21.05 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 124.439 1.096 . . . . 0.0 112.718 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -152.16 59.3 0.84 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.461 -1.399 . . . . 0.0 114.684 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -72.47 133.01 44.61 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.5 -13.99 53.09 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 118.515 2.166 . . . . 0.0 118.515 -166.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -67.39 -35.14 78.72 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.477 ' CG ' HH12 ' A' ' 33' ' ' ARG . 9.2 t70 -53.28 -54.24 39.14 Favored 'General case' 0 CA--C 1.576 1.942 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 166.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -60.77 -46.71 89.42 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -58.52 -47.08 85.36 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.7 mtm -62.44 -40.66 97.31 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 120.784 1.629 . . . . 0.0 114.945 170.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -47.99 -53.2 16.94 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 161.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -74.78 -33.69 62.3 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.8 mt -46.76 -40.33 13.33 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 118.403 2.742 . . . . 0.0 118.403 158.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.07 67.81 1.01 Allowed Glycine 0 N--CA 1.487 2.063 0 CA-C-N 118.34 0.518 . . . . 0.0 113.423 -161.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.86 123.98 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.45 152.04 52.26 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 115.581 0.992 . . . . 0.0 115.581 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 pt -53.48 -44.3 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 117.911 2.559 . . . . 0.0 117.911 -172.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.05 -42.93 86.48 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 166.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.56 -39.6 94.04 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.527 ' HB3' HH11 ' A' ' 33' ' ' ARG . 13.9 mtm105 -59.32 -47.78 84.12 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 168.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -56.81 -51.99 66.8 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 168.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.9 ttp -46.84 -61.16 1.98 Allowed 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.06 -41.91 79.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 118.904 2.322 . . . . 0.0 118.904 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.51 -51.9 51.71 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 169.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.8 ptm -74.0 -31.65 63.04 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.37 -25.1 63.95 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 119.284 3.068 . . . . 0.0 119.284 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.65 67.4 1.55 Allowed Pre-proline 0 CA--C 1.581 2.172 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -66.69 142.41 63.86 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 N-CA-C 119.329 2.78 . . . . 0.0 119.329 -170.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.7 113.5 26.01 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.127 165.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 51.6 t -92.0 110.62 21.99 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.933 0.893 . . . . 0.0 111.261 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.36 110.24 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 87.8 mt -102.4 129.31 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.1 m -150.99 127.04 10.44 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.658 -1.276 . . . . 0.0 110.294 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.6 t -102.14 130.06 48.66 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -82.0 -56.26 4.06 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.733 -0.604 . . . . 0.0 111.993 159.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.71 -84.72 0.05 OUTLIER Glycine 0 N--CA 1.485 1.947 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -83.2 -37.45 23.61 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 161.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -74.65 104.39 5.31 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 121.095 1.771 . . . . 0.0 111.505 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.463 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 32.5 tp -99.84 111.9 24.19 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.79 0.836 . . . . 0.0 109.1 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.5 m -81.78 115.87 21.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.786 -0.571 . . . . 0.0 110.401 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.1 mt -119.05 106.2 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.646 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -98.29 127.4 44.21 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.106 0.563 . . . . 0.0 110.658 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -99.27 97.81 8.84 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -89.29 97.2 11.06 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.251 0.62 . . . . 0.0 109.905 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 p -104.32 150.8 24.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.302 -0.874 . . . . 0.0 111.815 171.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.6 p -78.08 49.24 0.79 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 179.72 -61.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.288 1.435 . . . . 0.0 109.404 -164.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -131.04 168.69 16.97 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.356 1.074 . . . . 0.0 111.598 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.4 m -149.62 149.23 30.35 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 119.422 -2.049 . . . . 0.0 110.743 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.9 m -152.95 139.5 18.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.558 -1.338 . . . . 0.0 109.685 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -134.48 131.51 38.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.446 -0.784 . . . . 0.0 110.428 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -147.85 144.78 28.37 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.257 0.551 . . . . 0.0 112.393 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.9 p -99.95 103.05 14.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.374 -0.829 . . . . 0.0 110.635 170.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 52' ' ' LEU . 28.4 p -85.71 124.67 32.49 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -79.41 108.25 12.79 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.618 0.723 . . . . 0.0 110.532 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.3 tp -81.3 119.56 23.81 Favored 'General case' 0 CA--C 1.563 1.444 0 O-C-N 121.591 -0.693 . . . . 0.0 112.543 -167.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.85 50.62 18.11 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 115.228 0.851 . . . . 0.0 115.228 -159.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.48 160.82 0.79 Allowed 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.736 1.615 . . . . 0.0 109.139 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -93.08 153.37 18.73 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 168.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -142.04 161.72 37.27 Favored 'General case' 0 CA--C 1.572 1.792 0 C-N-CA 124.174 0.989 . . . . 0.0 110.286 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -81.58 106.91 13.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.097 -1.627 . . . . 0.0 110.505 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -83.31 144.9 29.39 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 122.685 1.231 . . . . 0.0 111.062 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.8 m -113.05 120.45 41.39 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 162.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 78.1 p -68.22 154.1 42.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.07 -29.06 60.0 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 167.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -68.69 -47.89 65.3 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.89 -33.15 1.53 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 117.337 1.695 . . . . 0.0 117.337 -165.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -63.5 141.19 58.86 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 119.485 1.643 . . . . 0.0 112.923 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -110.58 131.02 55.41 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.166 0.586 . . . . 0.0 109.897 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.1 p -128.5 136.54 50.94 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.551 0.691 . . . . 0.0 111.191 -165.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -83.7 102.74 12.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.586 -1.321 . . . . 0.0 109.729 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.5 m -112.08 109.74 19.64 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.658 -0.651 . . . . 0.0 110.752 -158.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.1 p -86.86 120.92 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 122.714 0.406 . . . . 0.0 111.181 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.4 m -108.77 122.66 47.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -132.95 126.54 32.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.515 -0.741 . . . . 0.0 111.723 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -91.88 112.43 24.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.739 -0.6 . . . . 0.0 110.488 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -102.79 86.79 2.81 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.974 0.51 . . . . 0.0 110.643 171.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.265 12.1 t70 25.4 70.8 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.868 2.914 . . . . 0.0 118.868 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.71 -44.49 1.31 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 -168.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.63 119.93 37.73 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 118.448 1.124 . . . . 0.0 113.556 -172.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.46 107.06 18.92 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.553 0.741 . . . . 0.0 111.136 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.91 109.97 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -94.46 106.37 18.35 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 170.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -100.29 104.95 16.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.722 -0.611 . . . . 0.0 111.403 -171.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -99.6 107.31 19.42 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.459 0.703 . . . . 0.0 111.438 -162.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -102.12 121.33 41.99 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.914 0.779 . . . . 0.0 111.923 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -148.76 129.84 14.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.006 -1.059 . . . . 0.0 110.881 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 52.54 41.11 30.95 Favored 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.56 32.24 82.59 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 119.026 2.37 . . . . 0.0 119.026 -165.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -136.09 124.1 22.85 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 118.371 1.086 . . . . 0.0 108.154 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.44 142.48 32.76 Favored 'General case' 0 CA--C 1.563 1.481 0 CA-C-O 121.878 0.847 . . . . 0.0 112.256 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.9 t -125.13 130.6 52.53 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.941 0.877 . . . . 0.0 109.889 159.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.6 p -113.09 107.95 16.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.3 mm -104.7 102.06 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.011 -1.056 . . . . 0.0 108.686 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 m -97.2 96.25 8.3 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.22 0.918 . . . . 0.0 109.916 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -87.27 110.2 20.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.561 -0.712 . . . . 0.0 110.501 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -134.58 146.14 49.34 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.555 1.07 . . . . 0.0 113.646 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.43 114.84 24.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.559 -0.713 . . . . 0.0 112.241 -169.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -131.72 113.47 13.59 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.598 0.759 . . . . 0.0 108.995 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.263 35.4 t70 60.57 34.47 20.25 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.47 9.43 61.43 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 119.123 2.409 . . . . 0.0 119.123 -165.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -109.13 143.41 38.54 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 119.26 1.53 . . . . 0.0 108.812 172.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.4 tp -84.03 102.32 12.4 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.808 0.814 . . . . 0.0 108.897 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.7 t -96.31 112.53 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.24 95.94 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -172.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -93.62 94.75 8.79 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.243 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.0 OUTLIER -92.11 148.5 22.12 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 121.36 -0.837 . . . . 0.0 112.025 177.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.3 128.65 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.54 0.686 . . . . 0.0 110.288 166.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.1 tpt -69.0 -65.87 0.65 Allowed 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 123.422 0.689 . . . . 0.0 112.298 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.251 15.5 p30 -143.67 -73.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -86.78 -38.64 16.69 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 159.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.1 t -85.99 128.33 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 119.921 1.237 . . . . 0.0 111.067 -163.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 66.3 p -110.04 156.59 20.32 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.492 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 2.3 p -131.99 133.55 44.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.011 -1.056 . . . . 0.0 111.161 156.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.4 m -109.47 98.0 7.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -102.67 120.76 41.12 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.207 0.603 . . . . 0.0 111.603 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.93 125.12 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -119.75 125.66 49.16 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 123.43 0.692 . . . . 0.0 110.498 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -93.3 143.65 26.06 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.527 ' HZ1' ' CD ' ' A' ' 135' ' ' GLU . 23.0 tttt -74.82 120.16 19.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.535 -1.353 . . . . 0.0 113.498 -175.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.67 89.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.527 ' CD ' ' HZ1' ' A' ' 133' ' ' LYS . 25.4 pt-20 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 124.353 1.061 . . . . 0.0 109.657 171.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.1 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p -67.95 -31.26 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 166.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.28 -34.16 76.04 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 161.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -66.12 -27.22 67.88 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.3 mt -70.21 -2.4 13.1 Favored 'General case' 0 CA--C 1.581 2.142 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -68.71 138.5 54.97 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 121.054 1.752 . . . . 0.0 114.541 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.33 -178.64 18.25 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 115.814 1.086 . . . . 0.0 115.814 168.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -89.64 125.56 35.29 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.678 -0.761 . . . . 0.0 109.857 169.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -121.1 109.62 15.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.667 -0.646 . . . . 0.0 109.599 -168.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.5 ttm105 -91.64 127.48 37.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.677 -1.264 . . . . 0.0 113.207 -176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.21 126.49 27.56 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.293 9.3 m -110.73 -72.22 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 123.484 0.714 . . . . 0.0 109.158 173.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -87.05 143.58 27.26 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 119.093 0.86 . . . . 0.0 111.785 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.2 p -139.18 65.35 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.334 162.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -72.16 128.02 34.36 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.3 2.12 86.99 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 119.294 2.478 . . . . 0.0 119.294 -169.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -69.79 -48.7 58.21 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -169.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -55.4 -43.3 75.11 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -64.2 -35.99 82.59 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 164.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 59.6 t80 -61.2 -50.78 71.74 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 120.884 1.675 . . . . 0.0 114.499 169.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.9 ptm -61.76 -37.23 83.52 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -50.48 -48.64 56.7 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 158.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.52 -39.94 95.73 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.38 -42.01 77.19 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 163.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.86 69.83 0.45 Allowed Glycine 0 N--CA 1.487 2.039 0 C-N-CA 124.249 0.928 . . . . 0.0 113.029 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.64 126.06 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -171.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.53 164.5 52.23 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 pt -53.73 -47.38 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 118.315 2.709 . . . . 0.0 118.315 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.63 98.34 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 172.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.97 -39.61 93.74 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 167.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -60.15 -49.92 75.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -51.94 -52.15 52.14 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 167.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -53.9 -55.19 29.15 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.98 99.38 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 118.799 2.279 . . . . 0.0 118.799 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.31 83.22 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.0 ptm -71.33 -26.05 62.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.89 127.27 31.38 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.82 77.05 4.52 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 118.224 -0.893 . . . . 0.0 109.525 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.88 140.55 20.58 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.283 1.989 . . . . 0.0 116.617 -167.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.11 91.32 8.67 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.882 162.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -90.05 115.09 27.06 Favored 'General case' 0 CA--C 1.559 1.325 0 O-C-N 120.804 -1.185 . . . . 0.0 112.444 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -92.17 118.7 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 109.406 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.7 mt -105.75 122.31 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m -140.42 134.12 30.34 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.396 0.617 . . . . 0.0 111.512 163.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.5 p -107.44 141.8 38.27 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . 0.268 17.0 t70 -101.37 -116.72 0.18 Allowed 'General case' 0 CA--C 1.578 2.047 0 C-N-CA 123.743 0.817 . . . . 0.0 108.798 166.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.19 -83.98 1.3 Allowed Glycine 0 N--CA 1.492 2.38 0 CA-C-N 120.516 1.507 . . . . 0.0 112.873 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -85.65 -37.7 19.19 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 160.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -72.58 117.16 13.91 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.511 1.505 . . . . 0.0 112.901 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 tt -123.6 118.32 27.04 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.925 0.89 . . . . 0.0 108.718 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.9 m -94.47 123.64 38.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.709 -0.62 . . . . 0.0 110.373 -170.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.8 mt -116.8 106.26 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -109.71 117.83 34.94 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.091 0.556 . . . . 0.0 111.039 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 m -85.94 109.48 18.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.397 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -98.79 92.11 5.41 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.822 1.192 . . . . 0.0 110.912 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -126.96 139.32 53.13 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.906 0.882 . . . . 0.0 110.21 166.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 p -76.86 49.8 0.67 Allowed 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 172.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.7 mt -150.48 -52.01 0.14 Allowed 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 126.231 1.812 . . . . 0.0 109.296 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -153.91 115.78 4.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.143 1.338 . . . . 0.0 110.923 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.6 p -97.42 92.22 5.85 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.293 0.637 . . . . 0.0 110.865 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.0 m -89.11 117.63 28.24 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.042 0.925 . . . . 0.0 108.9 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.21 141.76 50.62 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.8 0.84 . . . . 0.0 111.923 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -156.26 145.31 20.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.567 -0.708 . . . . 0.0 112.734 -174.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.5 p -101.35 108.12 19.65 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.344 0.658 . . . . 0.0 110.093 167.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.1 p -92.47 131.16 37.85 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.65 -0.656 . . . . 0.0 112.367 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.04 122.99 26.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.897 -1.127 . . . . 0.0 110.673 168.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.4 tp -75.91 129.85 37.59 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.56 0.744 . . . . 0.0 112.62 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.44 -28.18 5.92 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 117.606 1.802 . . . . 0.0 117.606 -159.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -105.25 158.34 16.68 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 119.418 1.609 . . . . 0.0 112.908 -166.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -95.65 116.27 28.62 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.914 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -126.96 148.1 50.08 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 124.014 0.926 . . . . 0.0 110.988 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -82.05 101.69 10.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.2 -1.563 . . . . 0.0 113.499 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -88.63 120.42 30.01 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-O 121.973 0.892 . . . . 0.0 110.691 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.8 m -89.43 96.47 10.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.33 -0.856 . . . . 0.0 110.077 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.6 p -69.42 158.13 35.74 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.87 -36.91 12.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 119.529 3.159 . . . . 0.0 119.529 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.3 -36.93 82.51 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 170.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.76 -10.48 9.0 Favored Glycine 0 CA--C 1.552 2.356 0 N-CA-C 118.03 1.972 . . . . 0.0 118.03 -159.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -71.7 115.61 11.1 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 121.085 2.443 . . . . 0.0 110.204 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -87.92 108.6 19.26 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.663 0.744 . . . . 0.0 109.567 172.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.9 p -106.81 111.78 24.45 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.684 0.754 . . . . 0.0 109.609 -166.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -69.12 101.84 1.53 Allowed 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 122.483 1.135 . . . . 0.0 109.807 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.2 m -112.84 112.46 23.96 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -156.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.329 10.4 p -81.36 113.38 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-N 118.996 0.816 . . . . 0.0 110.013 168.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 64.0 m -96.79 109.93 22.51 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 120.58 0.229 . . . . 0.0 110.583 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -133.43 121.42 22.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.549 -0.719 . . . . 0.0 112.006 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -87.59 137.21 32.54 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 121.493 -0.754 . . . . 0.0 112.997 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.0 t -137.75 113.13 9.37 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.384 0.674 . . . . 0.0 111.05 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.322 22.4 t70 66.9 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 171.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.95 43.26 1.28 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 166.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.87 118.33 6.49 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.554 0.741 . . . . 0.0 111.077 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.7 tp -90.23 109.75 20.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 110.089 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.21 108.12 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -86.94 94.17 9.53 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -91.85 97.87 11.25 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.61 -0.681 . . . . 0.0 109.925 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -87.5 116.74 25.81 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.219 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.45 125.68 45.38 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.559 1.072 . . . . 0.0 110.622 -176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -144.54 120.23 10.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.558 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 63.23 14.96 8.2 Favored 'General case' 0 CA--C 1.587 2.368 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.1 -14.64 26.29 Favored Glycine 0 CA--C 1.559 2.833 0 N-CA-C 118.947 2.339 . . . . 0.0 118.947 -156.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -77.33 129.55 35.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.188 1.494 . . . . 0.0 109.056 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -140.85 147.98 39.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -173.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 t -118.61 138.28 52.69 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 122.294 1.045 . . . . 0.0 111.759 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.7 p -110.61 112.5 24.43 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 76.0 mt -120.79 98.17 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -167.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 55.3 m -94.25 101.72 13.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.74 -0.6 . . . . 0.0 110.037 -173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -87.66 96.46 10.43 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 123.397 0.679 . . . . 0.0 110.188 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -127.86 149.52 50.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -172.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.9 123.03 45.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 112.343 -158.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.03 121.94 27.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.74 -0.6 . . . . 0.0 109.492 171.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 58.93 44.49 16.46 Favored 'General case' 0 N--CA 1.509 2.495 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 165.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.57 35.71 74.48 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -163.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -137.67 127.77 25.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 tp -88.15 106.82 18.43 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-O 121.996 0.903 . . . . 0.0 109.287 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.4 t -98.16 106.94 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.51 98.03 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -170.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -91.93 113.12 25.3 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.713 0.805 . . . . 0.0 109.399 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.967 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.6 p -126.73 122.1 33.89 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.654 0.781 . . . . 0.0 111.739 -162.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.39 136.95 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.498 -0.751 . . . . 0.0 110.003 -175.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.5 ttt -89.58 -76.73 0.41 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 120.634 0.254 . . . . 0.0 110.59 168.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -140.11 -62.93 0.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.11 0.964 . . . . 0.0 110.247 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -79.36 -54.82 5.57 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 125.015 1.326 . . . . 0.0 113.827 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.78 123.91 49.31 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-N 119.783 1.174 . . . . 0.0 110.984 -164.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.3 p -102.15 114.09 27.92 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.864 0.865 . . . . 0.0 110.496 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.967 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 13.4 p -100.45 157.26 16.76 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 122.113 0.958 . . . . 0.0 113.174 170.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.4 m -130.43 118.03 20.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.832 -1.168 . . . . 0.0 109.223 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -107.42 111.76 24.23 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.15 0.58 . . . . 0.0 109.843 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.1 mm -96.47 123.65 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -120.35 127.86 52.71 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 121.939 -0.475 . . . . 0.0 111.467 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -85.14 141.28 30.31 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -75.97 121.04 22.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.296 -0.877 . . . . 0.0 113.065 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.42 99.16 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.272 -173.134 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.4 p . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.948 -0.548 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.26 9.9 p -77.88 39.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 CA-C-N 120.102 1.319 . . . . 0.0 114.136 171.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -113.56 -47.16 3.01 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.848 1.659 . . . . 0.0 111.778 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -58.89 -29.32 66.94 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 171.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.8 mt -66.78 -13.14 61.12 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 164.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -74.22 136.14 42.74 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 120.743 1.61 . . . . 0.0 112.689 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.09 -179.37 25.95 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 117.956 1.942 . . . . 0.0 117.956 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -92.16 116.43 28.93 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.316 -0.942 . . . . 0.0 110.196 169.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -123.88 108.63 12.66 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.794 0.438 . . . . 0.0 109.885 -166.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -94.83 129.57 41.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.419 -1.426 . . . . 0.0 114.078 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.4 tp -63.85 124.82 22.51 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.273 11.0 m -113.09 -65.97 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.938 0.895 . . . . 0.0 110.781 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -101.21 148.15 25.44 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.497 1.498 . . . . 0.0 111.533 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.2 p -133.63 83.08 2.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.662 -0.649 . . . . 0.0 110.615 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.35 96.96 10.81 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.269 0.557 . . . . 0.0 110.452 -166.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.67 10.79 56.34 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 118.914 2.326 . . . . 0.0 118.914 -169.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -71.44 -47.38 56.14 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -170.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -55.96 -43.94 78.01 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' CD ' ' HZ2' ' A' ' 24' ' ' LYS . 36.8 mm-40 -53.64 -47.0 70.71 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 167.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.436 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 67.9 t80 -53.35 -54.58 34.52 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 166.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.285 3.1 ptt? -69.38 -27.39 65.27 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 174.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HZ2' ' CD ' ' A' ' 21' ' ' GLU . 51.7 mtpt -54.17 -52.02 62.49 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 154.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -60.9 -38.75 86.8 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -52.5 -52.52 54.08 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.17 -1.581 . . . . 0.0 115.178 163.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.55 69.58 0.72 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 124.403 1.001 . . . . 0.0 112.467 -169.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.1 t -127.57 130.52 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.92 164.39 49.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 117.418 1.727 . . . . 0.0 117.418 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -56.54 -47.46 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.87 94.86 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -67.31 -40.1 85.97 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -57.15 -46.49 82.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 163.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -55.97 -48.51 75.68 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 167.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 46.2 mtp -73.59 51.28 0.35 Allowed 'General case' 0 CA--C 1.583 2.232 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 165.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.69 -61.55 0.04 OUTLIER Glycine 0 N--CA 1.485 1.926 0 O-C-N 121.037 -1.039 . . . . 0.0 111.63 -171.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.5 -47.89 80.71 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 23.1 ptp -95.31 -6.8 40.41 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.82 110.99 16.86 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 120.365 1.439 . . . . 0.0 111.041 168.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -110.17 93.22 14.91 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.871 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.03 156.42 13.23 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.35 2.033 . . . . 0.0 116.811 -167.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.27 97.04 8.08 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.685 161.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.3 t -86.46 107.17 17.95 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 121.116 -0.99 . . . . 0.0 111.928 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.6 mt -91.81 106.51 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.5 mt -96.49 110.08 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -110.47 123.8 50.59 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 122.862 0.465 . . . . 0.0 110.303 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.7 p -116.57 94.3 4.56 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.558 0.743 . . . . 0.0 112.561 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -91.12 74.64 6.28 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 122.306 1.05 . . . . 0.0 110.697 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.17 -84.33 0.12 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 116.47 1.348 . . . . 0.0 116.47 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -101.42 -46.33 5.03 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -76.56 116.06 16.89 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-N 119.213 0.915 . . . . 0.0 112.019 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.4 tt -132.09 112.79 12.64 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.481 0.712 . . . . 0.0 109.577 -161.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.3 m -104.58 126.21 51.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.597 -1.314 . . . . 0.0 111.366 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -113.2 101.18 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.02 105.82 16.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.171 0.988 . . . . 0.0 109.611 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.2 m -97.45 106.47 18.8 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.834 0.854 . . . . 0.0 110.791 -171.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -104.93 98.66 8.34 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 122.924 0.489 . . . . 0.0 111.179 -167.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p -128.66 144.82 51.24 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.235 -0.916 . . . . 0.0 111.647 166.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -62.51 -44.77 95.55 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.9 mt -57.16 -43.57 82.65 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 165.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -155.29 125.33 6.63 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 119.348 0.976 . . . . 0.0 111.002 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.9 m -111.41 141.8 44.49 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.771 0.828 . . . . 0.0 110.251 173.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.4 t -144.7 158.46 43.77 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.824 0.821 . . . . 0.0 112.574 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -142.49 125.41 16.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.679 -1.263 . . . . 0.0 110.016 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -118.43 143.01 46.99 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.52 0.676 . . . . 0.0 111.126 163.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.1 m -112.18 110.99 21.56 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.104 0.954 . . . . 0.0 109.999 174.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.5 t -89.5 157.96 17.88 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.862 1.265 . . . . 0.0 114.02 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.4 m -113.86 119.8 38.55 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 159.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.6 tp -70.62 132.03 44.83 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 123.856 0.862 . . . . 0.0 112.849 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.25 -53.09 1.58 Allowed Glycine 0 N--CA 1.49 2.288 0 O-C-N 121.198 -0.939 . . . . 0.0 114.503 -161.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.99 163.47 15.53 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 124.023 1.868 . . . . 0.0 114.139 -169.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -88.74 108.79 19.68 Favored 'General case' 0 CA--C 1.564 1.489 0 CA-C-N 112.445 -2.161 . . . . 0.0 110.147 169.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -103.12 175.9 5.32 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.855 0.836 . . . . 0.0 112.695 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -92.38 107.04 18.92 Favored 'General case' 0 CA--C 1.568 1.646 0 O-C-N 120.725 -1.234 . . . . 0.0 111.338 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -79.16 129.1 34.11 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 110.094 163.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.8 m -107.51 110.99 23.05 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 165.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.6 p -72.98 162.29 29.67 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.89 -43.83 59.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 167.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.2 -36.09 83.11 Favored 'General case' 0 CA--C 1.573 1.847 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 169.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.73 26.94 1.5 Allowed Glycine 0 CA--C 1.551 2.297 0 N-CA-C 118.09 1.996 . . . . 0.0 118.09 -176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -90.74 140.57 29.66 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.038 1.919 . . . . 0.0 110.94 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -93.3 109.26 20.8 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 162.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . 0.268 0.9 OUTLIER -113.9 119.83 38.62 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.704 0.684 . . . . 0.0 110.383 -179.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -73.2 99.54 2.87 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-O 122.087 0.946 . . . . 0.0 110.671 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.9 m -110.07 106.74 16.35 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.199 -0.938 . . . . 0.0 109.872 -156.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.276 7.2 p -88.83 118.56 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.827 -0.546 . . . . 0.0 110.719 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.26 123.62 48.33 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -131.71 131.01 42.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.501 -0.749 . . . . 0.0 111.344 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -85.54 133.69 34.06 Favored 'General case' 0 CA--C 1.569 1.711 0 O-C-N 121.384 -0.823 . . . . 0.0 112.084 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -132.5 131.4 41.59 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.103 0.561 . . . . 0.0 110.342 164.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.277 4.1 m-20 71.74 -86.72 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 161.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.04 52.27 0.64 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 123.439 0.542 . . . . 0.0 113.022 160.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -156.03 124.2 5.75 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.904 0.882 . . . . 0.0 111.086 -164.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.7 tp -95.46 110.69 22.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.588 -0.695 . . . . 0.0 110.207 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.8 t -91.87 105.87 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -99.92 106.98 18.85 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 124.306 1.042 . . . . 0.0 109.466 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -97.45 102.0 13.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.489 -0.757 . . . . 0.0 111.358 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -83.43 125.59 31.86 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 124.768 1.227 . . . . 0.0 111.163 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.15 117.3 21.34 Favored 'General case' 0 CA--C 1.573 1.855 0 CA-C-N 119.459 1.027 . . . . 0.0 111.001 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -165.0 149.14 8.84 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.248 -0.908 . . . . 0.0 112.339 -171.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 48.55 41.94 18.09 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 158.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.8 30.11 71.96 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 119.55 2.58 . . . . 0.0 119.55 -166.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -142.32 138.53 31.34 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.439 1.095 . . . . 0.0 109.394 -166.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -129.81 126.84 39.04 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 121.491 0.662 . . . . 0.0 111.76 171.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.3 t -120.67 119.06 31.74 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.924 0.89 . . . . 0.0 109.572 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 71.6 p -93.01 128.29 38.83 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.184 0.594 . . . . 0.0 110.258 172.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.9 mm -112.93 116.55 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 169.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.4 m -99.79 98.54 9.34 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.43 -0.794 . . . . 0.0 109.046 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -90.84 99.12 12.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.22 147.52 50.58 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -163.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.97 121.46 31.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 112.64 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.328 40.2 mttt -106.16 -113.75 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.315 0.646 . . . . 0.0 109.92 169.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -84.85 51.85 2.26 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -168.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.95 31.76 79.0 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 117.516 1.766 . . . . 0.0 117.516 -156.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -137.27 135.0 36.76 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -169.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 tp -85.93 104.41 15.54 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.434 1.112 . . . . 0.0 108.957 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 87.1 t -99.99 109.42 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.7 t -102.98 106.62 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -116.62 99.16 6.95 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -164.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.959 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.8 p -93.31 157.12 16.4 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.57 130.41 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.852 -0.53 . . . . 0.0 109.986 158.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 4.9 ttt -102.81 -102.47 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -106.31 85.12 2.13 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.272 49.8 m-80 75.6 -43.19 0.49 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -169.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.4 t -82.29 123.43 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 111.193 -163.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.2 p -109.65 138.98 45.23 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.775 0.83 . . . . 0.0 112.539 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.959 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 11.1 p -127.37 117.4 22.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 169.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.1 m -93.98 105.99 17.98 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 168.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -116.52 129.73 56.36 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 122.044 0.926 . . . . 0.0 111.843 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 24.3 mm -104.38 126.34 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 124.273 1.029 . . . . 0.0 109.299 -159.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -123.08 126.35 46.91 Favored 'General case' 0 CA--C 1.577 1.995 0 O-C-N 121.68 -0.637 . . . . 0.0 112.172 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -87.3 139.96 30.03 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -74.69 118.27 17.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 112.136 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.82 61.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.771 -0.58 . . . . 0.0 110.115 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.029 -1.045 . . . . 0.0 109.03 -158.276 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 119.045 -0.502 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.257 9.0 p -67.33 -33.75 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 161.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -52.55 -28.19 19.79 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 167.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -51.69 -39.69 58.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.92 -6.11 42.97 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 171.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -90.74 135.53 33.66 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 121.213 1.824 . . . . 0.0 112.483 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.01 -176.19 29.64 Favored Glycine 0 N--CA 1.485 1.912 0 CA-C-O 122.642 1.134 . . . . 0.0 114.503 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -94.32 119.33 32.92 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.985 -0.608 . . . . 0.0 109.541 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -121.07 118.11 28.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 122.085 -0.385 . . . . 0.0 110.977 -166.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -105.91 126.45 52.19 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.287 -0.883 . . . . 0.0 112.908 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.03 124.56 24.68 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.714 0.769 . . . . 0.0 112.939 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.45 -55.51 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 124.117 0.967 . . . . 0.0 112.229 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -110.12 99.13 8.26 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 119.186 0.903 . . . . 0.0 109.173 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.0 p -113.87 95.68 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.081 0.953 . . . . 0.0 111.887 -174.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -107.41 123.41 48.35 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.139 -0.976 . . . . 0.0 111.736 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.76 66.34 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 119.657 2.623 . . . . 0.0 119.657 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -79.55 -41.2 27.75 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 120.29 2.045 . . . . 0.0 115.671 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.19 -43.23 74.2 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 120.443 1.474 . . . . 0.0 114.594 160.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.71 -47.97 82.73 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -51.27 -55.59 17.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 165.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -61.39 -23.5 65.84 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 171.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -64.53 -46.77 81.43 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 160.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -61.7 -37.59 84.71 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 121.615 2.007 . . . . 0.0 115.116 167.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.65 -51.75 67.52 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 164.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.54 72.33 1.05 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.428 -0.795 . . . . 0.0 112.538 -168.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.9 t -119.83 136.96 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.94 153.12 50.55 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 116.874 1.51 . . . . 0.0 116.874 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 mp -59.11 -48.59 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -168.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.54 88.64 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 167.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.17 -45.98 91.25 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 170.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -61.97 -45.07 95.25 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 167.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -55.34 -42.55 74.0 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 74.4 mtm -62.3 -44.96 95.3 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 165.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -48.54 58.29 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.521 2.168 . . . . 0.0 118.521 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.65 -47.37 86.55 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -85.86 10.27 14.32 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.38 35.29 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 120.463 -1.398 . . . . 0.0 113.65 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -109.42 74.77 0.69 Allowed Pre-proline 0 CA--C 1.575 1.94 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.849 167.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.46 158.22 48.23 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.723 2.282 . . . . 0.0 115.913 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.05 98.24 10.3 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 162.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.2 t -88.84 101.62 14.22 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 122.063 0.935 . . . . 0.0 110.61 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -93.56 113.71 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -113.68 125.08 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -152.17 133.95 14.78 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.778 -1.202 . . . . 0.0 109.5 171.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.7 p -100.41 123.9 45.23 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -82.62 74.9 9.55 Favored 'General case' 0 CA--C 1.576 1.943 0 CA-C-O 122.309 1.052 . . . . 0.0 110.18 162.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.63 -89.04 0.08 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -88.49 -29.06 20.41 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 163.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -81.35 88.3 6.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 121.713 2.052 . . . . 0.0 111.841 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.34 109.45 16.6 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-O 122.125 0.964 . . . . 0.0 110.108 -173.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.1 m -101.33 113.35 26.34 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.332 -162.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.7 mt -111.49 113.1 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -110.77 105.34 14.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.823 -0.548 . . . . 0.0 109.881 170.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.0 m -90.95 101.29 14.05 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.557 0.743 . . . . 0.0 109.204 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -94.25 117.92 30.82 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.622 0.769 . . . . 0.0 111.779 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.9 t -154.49 139.47 17.31 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.704 0.801 . . . . 0.0 111.852 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.4 p -60.53 -34.56 74.29 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 165.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.8 -55.18 18.52 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-N 119.486 1.039 . . . . 0.0 113.671 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.54 110.45 3.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.606 -1.309 . . . . 0.0 111.636 167.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.6 m -80.75 146.32 31.07 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.963 0.887 . . . . 0.0 111.287 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.5 m -155.55 136.61 13.74 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.299 -1.501 . . . . 0.0 109.594 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -142.32 146.32 34.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -158.42 150.87 21.97 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.9 p -108.28 107.43 18.02 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.5 0.72 . . . . 0.0 110.943 169.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.0 p -99.07 115.29 28.65 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.588 0.708 . . . . 0.0 112.698 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.9 m -72.47 110.58 6.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.468 -0.77 . . . . 0.0 110.392 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.5 tp -71.05 110.31 5.66 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -162.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.12 -54.32 0.75 Allowed Glycine 0 CA--C 1.547 2.089 0 C-N-CA 123.594 0.616 . . . . 0.0 114.107 -159.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.91 -177.78 4.0 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 123.712 1.72 . . . . 0.0 113.579 -169.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -99.7 130.45 45.92 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 113.857 -1.52 . . . . 0.0 112.6 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -123.06 -175.8 3.26 Favored 'General case' 0 CA--C 1.578 2.032 0 C-N-CA 125.168 1.387 . . . . 0.0 111.45 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -109.73 119.51 39.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.322 -1.486 . . . . 0.0 111.221 165.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -81.36 131.88 35.31 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 121.368 -0.832 . . . . 0.0 109.051 158.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.0 m -100.7 107.12 18.65 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 167.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.6 p -70.48 162.3 29.0 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.77 -31.91 59.33 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 166.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.17 -47.99 80.29 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.95 57.19 0.25 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 124.104 0.859 . . . . 0.0 113.903 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -131.31 124.32 30.18 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -173.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.53 109.58 17.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.679 -0.638 . . . . 0.0 110.115 171.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.4 p -116.14 112.67 22.03 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.372 0.606 . . . . 0.0 111.018 -169.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -70.82 101.18 2.06 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.279 1.038 . . . . 0.0 110.937 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.8 m -122.71 122.13 38.02 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.138 -153.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.42 125.81 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.651 -0.656 . . . . 0.0 111.476 170.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.9 m -99.5 123.63 43.95 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 173.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -133.0 133.91 43.76 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 118.8 0.727 . . . . 0.0 111.167 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -95.38 130.5 42.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.092 -1.005 . . . . 0.0 111.54 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.9 t -143.47 141.78 30.92 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 122.943 0.497 . . . . 0.0 110.281 165.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 62.11 35.28 15.84 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 160.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.11 25.86 74.87 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -165.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.53 135.59 22.56 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-N 118.909 1.354 . . . . 0.0 113.249 -174.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.12 112.69 22.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.432 -0.793 . . . . 0.0 110.479 166.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 67.0 t -93.68 103.11 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -101.6 103.86 14.7 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.49 0.716 . . . . 0.0 109.981 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -91.22 107.26 19.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.514 -0.741 . . . . 0.0 110.693 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -79.72 144.93 33.22 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.879 0.871 . . . . 0.0 111.975 169.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -143.24 124.69 14.75 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.651 0.781 . . . . 0.0 109.781 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 7.9 p90 -155.3 125.83 6.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.252 30.0 t70 49.14 45.26 23.21 Favored 'General case' 0 CA--C 1.584 2.252 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.63 26.37 66.62 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 119.612 2.605 . . . . 0.0 119.612 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -131.96 130.83 42.0 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.628 1.214 . . . . 0.0 108.462 -171.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.58 150.09 38.58 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -166.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 t -139.17 131.93 29.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.594 -0.691 . . . . 0.0 112.079 164.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.8 p -104.22 109.4 21.21 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.102 0.561 . . . . 0.0 110.106 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.0 mm -95.61 104.04 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.7 m -100.52 102.5 13.7 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.644 -0.66 . . . . 0.0 109.81 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -99.48 87.18 3.53 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.163 0.585 . . . . 0.0 110.454 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -110.08 135.89 50.18 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -166.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.87 113.56 22.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.122 -0.986 . . . . 0.0 112.902 -173.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -141.23 133.56 28.16 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.491 0.717 . . . . 0.0 109.287 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 60.11 39.24 19.83 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.13 13.25 41.21 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 119.635 2.614 . . . . 0.0 119.635 -163.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -133.16 144.18 49.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.628 1.214 . . . . 0.0 110.178 -162.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.0 tp -88.03 103.97 16.21 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.868 0.842 . . . . 0.0 109.734 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.6 t -89.92 103.09 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.5 t -96.57 98.23 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -98.09 106.83 19.18 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.992 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.3 p -106.7 121.92 45.31 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.538 0.335 . . . . 0.0 111.839 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 p -121.73 137.1 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.265 0.626 . . . . 0.0 109.936 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.7 ttt -81.08 -79.42 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 122.219 -0.301 . . . . 0.0 110.246 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -122.1 -60.73 1.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.272 0.629 . . . . 0.0 110.885 167.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -97.63 -43.13 7.33 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.58 127.69 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 CA-C-O 122.38 1.086 . . . . 0.0 109.9 -156.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 73.6 p -110.6 139.21 46.07 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.993 -167.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.992 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.8 OUTLIER -106.34 132.07 52.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.835 . . . . 0.0 110.633 158.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.5 m -109.1 107.06 17.23 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -110.5 113.49 26.16 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.11 0.564 . . . . 0.0 110.835 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 mm -91.13 116.65 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.192 -0.943 . . . . 0.0 108.567 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -107.66 125.27 51.15 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.206 0.602 . . . . 0.0 110.727 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -92.27 142.65 27.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -81.57 116.32 21.28 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.911 0.885 . . . . 0.0 112.207 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.3 t -101.29 93.13 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -171.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 124.031 0.932 . . . . 0.0 110.451 -174.688 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 119.01 -0.519 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.522 0.8 OUTLIER 63.31 -48.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 118.755 2.872 . . . . 0.0 118.755 178.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -38.17 90.13 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 174.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -62.36 -25.69 68.05 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 167.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.7 mt -70.36 -7.57 43.88 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 164.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.83 142.59 31.41 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-N 121.319 1.872 . . . . 0.0 112.79 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.56 171.19 18.56 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 -86.98 103.63 15.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 165.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -101.66 101.86 12.45 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -170.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.33 142.58 27.62 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.588 0.755 . . . . 0.0 112.871 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.1 tp -71.01 127.96 34.35 Favored 'General case' 0 CA--C 1.571 1.776 0 O-C-N 120.677 -1.264 . . . . 0.0 113.446 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.95 -55.41 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 C-N-CA 124.082 0.953 . . . . 0.0 112.399 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -117.65 151.28 37.54 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 119.642 1.11 . . . . 0.0 110.567 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -144.47 59.22 1.33 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.997 0.903 . . . . 0.0 113.046 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -75.6 119.62 19.89 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -167.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.52 -6.76 71.22 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 -170.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.252 22.6 t80 -59.27 -31.6 69.25 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.816 2.524 . . . . 0.0 117.816 -174.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -52.46 -54.59 30.33 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 164.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.99 -45.39 83.0 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -58.65 -49.54 77.14 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 19.8 ptp -56.26 -37.65 70.06 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 167.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -63.62 -47.16 82.53 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 168.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.414 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 5.9 tp10 -67.63 -37.95 83.21 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 170.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.1 mt -53.45 -35.94 61.06 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 117.576 2.435 . . . . 0.0 117.576 167.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.76 62.79 1.07 Allowed Glycine 0 N--CA 1.487 2.073 0 C-N-CA 123.438 0.542 . . . . 0.0 114.041 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.51 125.12 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -172.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.17 162.16 51.78 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.62 -50.97 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -168.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.38 94.86 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.4 mt -57.77 -41.7 82.54 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.734 1.754 . . . . 0.0 115.734 167.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -60.81 -49.68 76.5 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.22 -46.92 87.19 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.5 ttp -53.64 -55.21 27.87 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 167.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.29 96.04 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 118.618 2.207 . . . . 0.0 118.618 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.6 94.59 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.9 ptp -75.47 -22.15 57.48 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 170.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.93 133.1 47.75 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -174.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -103.08 87.28 1.22 Allowed Pre-proline 0 CA--C 1.576 1.945 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.749 166.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.96 142.96 22.63 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.46 2.107 . . . . 0.0 115.168 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -95.44 103.34 15.21 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.18 168.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 50.6 t -81.14 101.11 9.44 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-O 121.836 0.827 . . . . 0.0 110.903 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mt -94.96 104.36 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -170.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.83 130.78 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.258 7.7 t -136.84 149.88 47.98 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.776 -0.577 . . . . 0.0 112.312 159.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.4 t -141.83 128.74 20.63 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -68.68 -46.2 69.7 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 165.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.66 -78.68 0.15 Allowed Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -171.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -80.82 -26.07 37.35 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 160.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -88.63 138.75 31.14 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 122.842 2.565 . . . . 0.0 112.931 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -139.57 125.21 19.38 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.436 0.694 . . . . 0.0 110.463 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 m -109.37 133.86 52.53 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.376 1.07 . . . . 0.0 110.433 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.8 mt -123.12 119.68 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -103.94 110.17 22.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.685 -0.634 . . . . 0.0 110.145 163.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.7 m -83.71 99.17 10.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.277 -0.89 . . . . 0.0 109.102 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.44 125.74 35.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.663 0.744 . . . . 0.0 112.24 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 t -147.1 135.28 21.58 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 166.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.4 p -56.39 -26.05 51.79 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.5 mt -73.47 -54.51 8.09 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 165.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.71 114.75 3.54 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.563 1.529 . . . . 0.0 111.612 173.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.4 m -84.19 141.46 31.02 Favored 'General case' 0 CA--C 1.575 1.928 0 C-N-CA 123.457 0.703 . . . . 0.0 111.851 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 t -134.17 145.48 49.29 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.156 -0.965 . . . . 0.0 111.27 164.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -135.47 133.99 39.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.776 -1.202 . . . . 0.0 111.849 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.92 160.62 41.02 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 122.061 0.934 . . . . 0.0 112.964 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 m -139.13 137.49 36.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.089 -1.007 . . . . 0.0 111.153 170.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 36.4 t -135.4 143.0 45.77 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.813 1.292 . . . . 0.0 112.635 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.2 m -91.48 115.41 28.02 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.195 171.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -64.38 134.4 54.53 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.95 -49.09 0.87 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 -154.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -98.47 164.98 12.05 Favored 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 123.595 1.664 . . . . 0.0 113.228 -163.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 99' ' ' GLU . 19.2 tttp -110.58 128.76 55.8 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.396 -174.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -129.62 166.14 20.35 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.46 105.99 10.1 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 122.055 0.931 . . . . 0.0 111.467 169.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -103.12 97.43 7.52 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.426 1.091 . . . . 0.0 109.104 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.8 m -80.06 109.12 14.21 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 121.821 0.82 . . . . 0.0 109.471 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.6 p -69.6 176.14 3.71 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.95 -43.28 29.13 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 168.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.76 -43.51 97.92 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.268 2.322 . . . . 0.0 117.268 165.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.98 3.15 13.58 Favored Glycine 0 CA--C 1.556 2.634 0 N-CA-C 119.097 2.399 . . . . 0.0 119.097 -162.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.3 mtm-85 -69.89 128.54 36.72 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 120.979 2.389 . . . . 0.0 112.204 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -86.54 93.54 9.2 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.791 0.805 . . . . 0.0 108.9 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 p -99.28 125.24 44.87 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.712 -170.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -79.92 97.55 6.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.656 -1.278 . . . . 0.0 110.082 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.4 m -104.97 116.7 32.41 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.749 0.42 . . . . 0.0 110.408 -166.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.13 118.91 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.97 -0.456 . . . . 0.0 110.087 167.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 70.9 m -100.1 131.42 46.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.967 -0.458 . . . . 0.0 111.58 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -142.04 115.4 8.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 110.265 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -78.96 129.4 34.44 Favored 'General case' 0 CA--C 1.57 1.721 0 O-C-N 120.977 -1.077 . . . . 0.0 111.6 166.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 t -146.1 142.78 28.86 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.251 0.62 . . . . 0.0 110.201 165.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 60.63 36.92 19.55 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 159.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.3 21.15 79.45 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 -166.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.52 139.62 24.33 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-N 119.02 1.41 . . . . 0.0 112.596 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 67.3 tp -96.61 115.13 26.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -0.804 . . . . 0.0 110.615 171.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.9 t -89.28 103.35 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -98.31 95.56 7.46 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -96.72 99.74 11.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.968 . . . . 0.0 110.095 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -100.43 126.9 46.87 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -170.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 72' ' ' LYS . 7.7 mt-10 -129.78 131.1 46.11 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.207 0.603 . . . . 0.0 111.388 -167.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -152.64 120.9 6.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.624 -1.298 . . . . 0.0 111.438 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.6 t70 42.99 54.22 4.86 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.9 -45.43 2.69 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 117.902 1.921 . . . . 0.0 117.902 -169.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -89.92 141.78 28.32 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 118.19 0.995 . . . . 0.0 113.345 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -127.92 159.68 34.19 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.682 0.753 . . . . 0.0 112.991 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.4 t -135.54 141.51 45.24 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.429 1.109 . . . . 0.0 112.01 162.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.6 p -106.38 109.99 22.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 mm -103.09 94.51 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -172.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.1 m -97.82 105.36 17.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.0 109.719 -172.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.9 mtp85 -103.23 89.33 3.37 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.234 0.614 . . . . 0.0 110.544 -167.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.404 ' HZ1' ' CD ' ' A' ' 119' ' ' GLU . 44.9 pttt -105.86 138.25 42.37 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -168.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.4 123.88 33.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 113.209 -173.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -150.92 121.83 7.61 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.519 0.728 . . . . 0.0 109.266 -170.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.1 t70 61.06 28.2 17.97 Favored 'General case' 0 N--CA 1.514 2.754 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.58 33.12 66.09 Favored Glycine 0 CA--C 1.56 2.849 0 O-C-N 119.274 -2.141 . . . . 0.0 117.584 -158.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -133.08 131.17 40.27 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -174.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.2 tp -86.52 105.12 16.59 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.849 -1.157 . . . . 0.0 109.831 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.2 t -91.95 106.17 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t -100.5 99.29 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.404 ' CD ' ' HZ1' ' A' ' 110' ' ' LYS . 84.3 mt-10 -87.52 93.85 9.54 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.471 1.129 . . . . 0.0 108.499 173.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.3 p -104.82 97.39 7.28 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.7 -176.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.48 146.34 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.519 1.152 . . . . 0.0 109.927 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.414 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 11.3 ttt -97.71 -60.12 1.63 Allowed 'General case' 0 CA--C 1.565 1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 112.972 174.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.273 12.9 p30 -139.65 -92.99 0.17 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -81.28 -13.71 58.17 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 154.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -96.73 133.89 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 C-N-CA 124.72 1.208 . . . . 0.0 109.67 -166.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.0 p -132.76 146.83 52.17 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -152.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 6.1 p -136.92 121.12 17.91 Favored 'General case' 0 CA--C 1.563 1.468 0 O-C-N 121.533 -0.73 . . . . 0.0 110.711 158.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.2 m -97.76 101.7 13.28 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -108.9 110.53 21.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.701 -0.624 . . . . 0.0 110.306 -168.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.9 mm -94.39 124.69 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -122.28 120.38 33.92 Favored 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.04 0.536 . . . . 0.0 110.379 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -90.74 150.51 21.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.781 -1.199 . . . . 0.0 113.447 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -78.4 128.64 33.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.915 -1.116 . . . . 0.0 113.55 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.2 t -86.56 104.65 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 165.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 N--CA 1.487 1.395 0 C-N-CA 123.802 0.841 . . . . 0.0 110.543 178.451 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 122.04 0.924 . . . . 0.0 112.886 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.274 4.8 p -62.59 -32.15 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.53 -33.28 72.42 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 163.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -63.49 -33.83 76.44 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 165.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.94 -4.06 11.85 Favored 'General case' 0 CA--C 1.581 2.151 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 164.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.05 122.02 25.68 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 121.955 2.161 . . . . 0.0 112.596 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.19 -179.95 34.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.3 ttm105 -93.84 108.06 19.88 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.159 0.584 . . . . 0.0 109.592 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -109.94 107.56 17.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.376 -0.827 . . . . 0.0 110.49 -165.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -91.82 130.78 37.53 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.788 -1.195 . . . . 0.0 112.794 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 48.0 tp -64.18 125.53 24.84 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 170.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.261 5.6 m -126.86 -60.01 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 123.097 0.559 . . . . 0.0 112.246 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -104.21 137.23 42.43 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 119.332 0.969 . . . . 0.0 110.338 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 p -147.97 93.57 2.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.477 -0.764 . . . . 0.0 111.725 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.46 128.9 48.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.816 -0.552 . . . . 0.0 111.772 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.6 -1.12 88.58 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 118.901 2.32 . . . . 0.0 118.901 -168.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -71.53 -51.19 24.84 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.046 1.923 . . . . 0.0 115.555 -170.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.09 -38.53 62.64 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 167.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.71 -49.28 75.69 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -54.24 -45.04 72.24 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 164.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.1 mtp -57.84 -42.75 85.02 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 169.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -55.5 -48.63 74.31 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 163.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.8 -43.4 98.19 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 172.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.7 mt -55.23 -38.58 68.65 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 117.889 2.552 . . . . 0.0 117.889 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.6 55.93 1.13 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 -165.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.69 118.57 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.682 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.65 165.29 41.08 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.94 -48.92 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -169.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.46 98.56 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.45 -42.39 91.85 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -57.53 -51.44 69.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -54.96 -54.3 44.53 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 169.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.2 ttp -52.93 -57.01 11.74 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.81 -40.85 90.3 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 118.926 2.33 . . . . 0.0 118.926 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.54 -51.79 52.75 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 169.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -72.61 -30.36 64.29 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.81 85.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.338 62.7 pttt 47.25 66.39 5.71 Favored Pre-proline 0 CA--C 1.585 2.306 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.79 154.84 23.47 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 N-CA-C 117.025 1.894 . . . . 0.0 117.025 -159.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.83 97.97 7.61 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.028 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.0 t -90.9 103.25 15.98 Favored 'General case' 0 CA--C 1.556 1.183 0 O-C-N 121.148 -0.97 . . . . 0.0 112.198 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.88 110.18 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.8 mt -97.95 114.8 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.2 m -134.63 117.91 16.62 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.5 t -121.82 118.54 29.25 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -172.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -86.19 60.24 6.12 Favored 'General case' 0 CA--C 1.576 1.951 0 CA-C-O 121.991 0.901 . . . . 0.0 111.557 170.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.64 -71.24 0.68 Allowed Glycine 0 N--CA 1.492 2.412 0 O-C-N 120.145 -1.597 . . . . 0.0 116.431 -170.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -99.89 -46.23 5.44 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.76 105.35 10.99 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 121.053 1.752 . . . . 0.0 111.387 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.66 111.61 23.87 Favored 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.139 0.971 . . . . 0.0 109.832 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.1 m -93.98 116.48 28.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.891 0.876 . . . . 0.0 109.165 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.4 104.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -105.43 104.02 13.66 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.321 0.581 . . . . 0.0 109.683 171.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.7 m -89.25 100.16 13.01 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.851 0.86 . . . . 0.0 110.124 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.72 111.84 23.7 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.088 0.947 . . . . 0.0 111.498 -173.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.1 p -148.51 153.12 38.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.628 -0.67 . . . . 0.0 110.601 157.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.6 p -61.98 -43.93 97.81 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 171.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.5 mt -61.97 -41.41 97.98 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 168.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -145.31 110.63 5.28 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.836 1.198 . . . . 0.0 110.72 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.53 118.81 36.14 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.2 p -139.72 142.61 36.83 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.009 -1.057 . . . . 0.0 111.91 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -139.14 133.44 31.48 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.742 -1.224 . . . . 0.0 111.821 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -146.65 147.31 30.9 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.678 0.751 . . . . 0.0 112.887 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.3 p -105.53 106.29 16.72 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.577 0.751 . . . . 0.0 110.846 172.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.3 p -94.45 125.23 38.96 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 121.515 0.674 . . . . 0.0 112.33 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.5 m -77.8 123.17 26.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.318 -0.864 . . . . 0.0 110.068 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.79 132.03 37.87 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -167.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.71 37.38 94.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 116.792 1.477 . . . . 0.0 116.792 -159.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.73 155.75 24.32 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.429 1.109 . . . . 0.0 111.136 -171.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.441 ' HZ3' ' CD ' ' A' ' 99' ' ' GLU . 10.9 tttp -109.73 121.56 45.5 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.787 -169.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -121.59 162.15 21.15 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.46 0.704 . . . . 0.0 112.502 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -75.84 106.08 7.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.783 -1.198 . . . . 0.0 110.971 166.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -90.98 116.54 28.86 Favored 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.8 m -86.74 93.97 9.39 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.8 p -68.94 159.93 31.77 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -43.46 -42.93 5.06 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.99 -35.8 66.92 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 171.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.91 -14.9 3.32 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 117.94 1.936 . . . . 0.0 117.94 -166.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -71.81 131.34 42.92 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.495 2.147 . . . . 0.0 112.651 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -81.97 110.5 17.29 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.205 0.602 . . . . 0.0 110.364 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.6 p -114.96 128.26 56.17 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.136 0.493 . . . . 0.0 109.816 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -78.82 92.25 4.83 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.759 0.79 . . . . 0.0 109.64 172.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.4 m -98.15 114.31 26.48 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.894 -164.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.264 12.5 p -91.74 117.11 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 122.019 -0.426 . . . . 0.0 110.82 171.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.6 m -101.5 112.99 25.71 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.136 -0.352 . . . . 0.0 111.849 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -123.0 125.56 45.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.656 -0.652 . . . . 0.0 111.114 -171.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -88.33 130.55 35.1 Favored 'General case' 0 CA--C 1.568 1.663 0 O-C-N 121.131 -0.98 . . . . 0.0 112.393 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -141.29 107.61 5.26 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.466 0.706 . . . . 0.0 110.218 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 45.34 70.45 0.35 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 171.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.33 -0.03 60.82 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 119.896 2.718 . . . . 0.0 119.896 -171.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.39 126.58 39.15 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 119.985 1.892 . . . . 0.0 113.009 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.2 tp -93.39 108.82 20.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.614 -0.679 . . . . 0.0 110.621 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -90.29 107.93 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -101.11 98.37 8.81 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.284 1.034 . . . . 0.0 109.521 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -100.3 103.14 14.54 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.565 0.746 . . . . 0.0 110.477 -171.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -100.19 105.97 17.61 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.896 0.878 . . . . 0.0 111.215 -164.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.441 ' CD ' ' HZ3' ' A' ' 72' ' ' LYS . 17.8 mt-10 -108.19 126.08 52.38 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.192 -0.942 . . . . 0.0 113.539 -166.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -154.71 141.02 18.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.221 -0.925 . . . . 0.0 110.606 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.2 t70 51.14 45.44 27.83 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 159.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.9 68.63 Favored Glycine 0 CA--C 1.559 2.829 0 N-CA-C 120.238 2.855 . . . . 0.0 120.238 -167.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -137.01 150.06 47.87 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.141 1.471 . . . . 0.0 110.434 -167.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -124.18 147.56 47.91 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.249 0.547 . . . . 0.0 112.374 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.8 t -126.3 115.63 19.99 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 164.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.8 m -123.74 113.14 18.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.067 -1.021 . . . . 0.0 108.732 -160.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.0 mt -122.09 112.17 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -164.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 58.6 m -95.32 101.31 13.03 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.187 0.517 . . . . 0.0 109.666 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -93.08 101.17 13.48 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.376 0.67 . . . . 0.0 109.271 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 pttp -126.39 140.4 52.52 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -169.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.18 116.39 15.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 111.203 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.286 24.9 tptp -103.24 -126.72 0.22 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.081 0.552 . . . . 0.0 110.049 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -91.9 64.93 4.81 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 122.231 1.015 . . . . 0.0 109.51 -165.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.66 -24.11 13.73 Favored Glycine 0 CA--C 1.556 2.645 0 N-CA-C 119.045 2.378 . . . . 0.0 119.045 -162.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -129.89 161.16 31.47 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.078 1.939 . . . . 0.0 112.306 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.5 tp -85.02 116.08 23.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.794 -1.191 . . . . 0.0 111.406 -173.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.7 t -91.81 120.2 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 64.0 t -110.34 100.01 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -95.66 102.67 14.49 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.966 0.906 . . . . 0.0 108.972 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.964 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 0.9 OUTLIER -98.85 150.89 21.42 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.1 137.29 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 123.221 0.608 . . . . 0.0 109.609 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.268 10.7 ttt -98.25 -77.35 0.51 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 0.0 111.118 163.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -123.48 -70.89 0.75 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.388 -0.82 . . . . 0.0 110.934 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -99.58 -31.32 11.66 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 170.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.2 t -99.74 129.49 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-N 120.365 1.438 . . . . 0.0 110.148 -164.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.8 p -106.34 154.89 20.14 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.328 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.964 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.6 OUTLIER -130.17 139.16 50.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 112.328 162.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.1 m -106.74 109.43 21.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -107.31 124.82 50.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.331 0.653 . . . . 0.0 110.996 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.8 mm -92.38 122.73 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -113.57 122.78 48.28 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.757 0.823 . . . . 0.0 109.973 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -92.72 137.92 31.94 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -77.52 111.95 13.78 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.72 0.772 . . . . 0.0 112.691 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.9 t -103.95 128.47 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.015 -1.053 . . . . 0.0 108.832 -175.514 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.5 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.503 1.2 p 64.79 -44.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 118.38 2.733 . . . . 0.0 118.38 167.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.37 -36.32 53.52 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 169.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -54.49 -37.06 64.85 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 169.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.9 mt -70.74 -2.58 15.13 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 171.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -81.72 134.84 35.5 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 121.258 1.844 . . . . 0.0 112.937 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.79 177.95 29.51 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 117.757 1.863 . . . . 0.0 117.757 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -93.43 102.54 14.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.096 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.34 101.84 11.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.954 -0.466 . . . . 0.0 110.018 -168.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -90.01 125.82 35.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.206 1.002 . . . . 0.0 113.45 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.9 tp -64.41 125.09 23.53 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.41 -44.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.321 1.048 . . . . 0.0 113.162 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -128.49 155.66 44.49 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 120.291 1.405 . . . . 0.0 111.834 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.5 p -153.62 84.38 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 0.0 111.365 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.14 138.76 39.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.513 -0.742 . . . . 0.0 112.758 176.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.45 23.32 70.19 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 119.693 2.637 . . . . 0.0 119.693 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -85.83 -43.62 13.14 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -168.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -50.13 -46.4 53.82 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 162.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -53.98 -48.98 69.81 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 166.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -61.2 -47.47 85.98 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.05 -32.79 74.46 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 169.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -58.23 -48.44 80.39 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 121.507 1.958 . . . . 0.0 115.814 158.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -60.21 -40.6 90.7 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.5 mt -57.7 -50.3 73.64 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 161.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.14 56.11 0.28 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 124.346 0.974 . . . . 0.0 115.134 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.31 130.28 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-N 117.607 0.703 . . . . 0.0 109.423 -171.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.51 159.87 51.8 Favored Glycine 0 CA--C 1.553 2.431 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.88 -48.65 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -170.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.61 88.72 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 171.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.09 -40.03 94.03 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 170.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.1 mtm-85 -63.69 -42.71 97.96 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 166.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -54.29 -49.82 68.72 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 166.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.6 ttp -52.86 -55.29 24.28 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 164.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.48 -37.73 67.8 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 119.766 2.666 . . . . 0.0 119.766 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.34 -51.04 61.32 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.2 ptp -77.28 -20.44 55.07 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.24 115.22 7.45 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 120.163 1.347 . . . . 0.0 112.184 165.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.93 84.42 3.46 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.139 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.86 151.49 31.46 Favored 'Trans proline' 0 C--N 1.372 1.772 0 N-CA-C 117.395 2.036 . . . . 0.0 117.395 -168.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -84.4 102.38 12.71 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.532 162.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.3 t -77.78 100.53 6.32 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 121.951 0.881 . . . . 0.0 110.76 170.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.7 mt -95.93 101.68 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -170.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 81.2 mt -99.33 130.64 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.6 t -136.23 140.22 43.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.824 -0.548 . . . . 0.0 111.666 157.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 43.0 t -119.65 103.57 9.51 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.683 0.793 . . . . 0.0 111.961 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.65 75.85 9.53 Favored 'General case' 0 CA--C 1.572 1.798 0 CA-C-O 122.189 0.995 . . . . 0.0 110.686 170.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.7 -83.29 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 116.733 1.453 . . . . 0.0 116.733 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -105.59 -16.6 14.66 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -101.9 116.97 33.86 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 122.214 2.279 . . . . 0.0 110.523 175.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -112.43 116.78 30.84 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.947 0.879 . . . . 0.0 109.938 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.6 m -99.4 125.74 45.16 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.987 0.915 . . . . 0.0 109.73 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 mt -119.4 112.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -98.14 109.83 22.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.764 -0.585 . . . . 0.0 109.941 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 m -90.9 103.3 16.03 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.435 -0.79 . . . . 0.0 109.456 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -101.43 116.85 33.72 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -143.24 140.47 30.69 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.087 0.555 . . . . 0.0 110.091 167.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -50.83 -44.33 59.25 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.21 -40.72 97.05 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.34 103.84 1.25 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.47 1.487 . . . . 0.0 111.076 -175.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.0 m -90.25 145.67 24.82 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.991 0.901 . . . . 0.0 111.459 170.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.7 m -148.24 136.14 20.96 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.056 -1.653 . . . . 0.0 110.63 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -126.99 133.37 50.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.413 -0.804 . . . . 0.0 111.75 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -136.38 152.06 50.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 172.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.3 p -117.98 103.95 10.42 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.802 0.841 . . . . 0.0 109.905 170.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 24.1 p -95.34 152.1 18.68 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.8 m -91.37 130.81 37.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.824 -1.172 . . . . 0.0 109.582 168.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tp -69.53 131.31 44.49 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 112.878 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.13 -6.98 8.56 Favored Glycine 0 CA--C 1.553 2.458 0 N-CA-C 119.558 2.583 . . . . 0.0 119.558 -164.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.78 172.02 10.18 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-N 119.303 1.552 . . . . 0.0 112.007 -174.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.448 ' HZ3' ' CD ' ' A' ' 99' ' ' GLU . 8.9 tttp -113.46 110.79 20.87 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.495 -156.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -105.76 160.75 14.98 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.655 0.782 . . . . 0.0 112.296 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.53 106.68 14.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.93 -1.731 . . . . 0.0 111.658 169.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -89.15 102.08 14.74 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 169.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.4 m -77.95 110.82 13.2 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.094 0.949 . . . . 0.0 109.593 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -75.43 134.38 40.9 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.797 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.94 63.77 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 119.721 3.23 . . . . 0.0 119.721 -170.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.31 -27.08 65.98 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.51 -35.7 0.47 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 118.715 2.246 . . . . 0.0 118.715 167.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -75.07 136.54 41.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -163.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -93.55 115.04 27.53 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.173 0.989 . . . . 0.0 109.021 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.4 p -119.36 111.41 18.14 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.784 0.802 . . . . 0.0 111.168 -164.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -71.78 98.27 1.94 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.324 1.05 . . . . 0.0 110.581 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.4 m -112.99 108.47 17.39 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.285 -0.884 . . . . 0.0 109.922 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.258 12.7 p -88.88 122.61 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 122.96 0.504 . . . . 0.0 111.382 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 55.7 m -105.51 88.11 2.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -169.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -102.18 119.34 38.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.541 -1.349 . . . . 0.0 111.941 -168.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -80.17 131.9 35.8 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.004 -1.06 . . . . 0.0 112.712 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -133.11 97.47 4.01 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.583 0.753 . . . . 0.0 110.414 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.331 9.8 t70 68.6 -73.56 0.09 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 172.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.39 35.43 2.17 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 116.587 1.395 . . . . 0.0 116.587 167.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -153.93 139.24 17.58 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 118.581 1.19 . . . . 0.0 112.957 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 tp -97.84 115.4 27.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.68 -0.637 . . . . 0.0 110.854 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -88.01 101.8 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.56 94.52 9.91 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 124.396 1.078 . . . . 0.0 109.009 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -96.1 98.13 10.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.728 . . . . 0.0 112.159 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -71.05 137.42 48.95 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.062 0.945 . . . . 0.0 113.063 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.448 ' CD ' ' HZ3' ' A' ' 72' ' ' LYS . 19.7 mt-10 -136.83 121.61 18.64 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.497 0.719 . . . . 0.0 109.931 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -158.35 127.1 5.5 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.626 -1.296 . . . . 0.0 111.11 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 54.08 37.83 27.77 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 164.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.72 -43.23 3.08 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 -165.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -75.35 154.57 37.2 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -151.58 155.01 37.57 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.059 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 t -144.32 121.87 11.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.219 -0.926 . . . . 0.0 112.897 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.1 p -86.55 131.34 34.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 0.0 111.278 168.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.2 mt -123.32 101.28 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 84.9 m -93.71 108.08 19.87 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.546 0.739 . . . . 0.0 110.056 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -97.98 87.91 4.1 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.268 0.627 . . . . 0.0 110.041 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.18 142.32 29.22 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -171.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 120.86 27.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.505 -0.747 . . . . 0.0 112.366 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.274 41.0 tttm -134.85 -130.92 0.16 Allowed 'General case' 0 CA--C 1.569 1.706 0 O-C-N 121.979 -0.45 . . . . 0.0 112.03 -172.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -82.86 67.91 9.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.497 -1.377 . . . . 0.0 113.464 -161.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.95 16.82 57.72 Favored Glycine 0 CA--C 1.565 3.194 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -157.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -137.86 131.75 31.5 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.098 1.359 . . . . 0.0 108.146 -164.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.3 tp -82.03 108.55 15.61 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 121.701 0.762 . . . . 0.0 109.259 164.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -96.67 110.13 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -175.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.0 t -103.29 100.35 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -167.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -95.62 108.43 20.7 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.545 1.138 . . . . 0.0 108.568 -171.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.918 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.2 p -126.42 129.35 48.57 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 121.921 0.867 . . . . 0.0 112.382 -158.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.37 146.29 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 123.396 0.678 . . . . 0.0 109.964 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.265 18.6 ttt -118.24 -94.16 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.575 -0.703 . . . . 0.0 111.327 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -105.87 -52.21 2.85 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.758 0.823 . . . . 0.0 111.828 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -119.1 -39.32 2.93 Favored 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 125.485 1.514 . . . . 0.0 112.142 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t -87.39 121.8 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 O-C-N 121.274 -0.892 . . . . 0.0 110.364 -164.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 46.7 p -93.34 103.49 15.72 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.914 0.864 . . . . 0.0 110.204 165.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.918 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 18.5 p -85.69 160.94 19.43 Favored 'General case' 0 CA--C 1.57 1.739 0 CA-C-O 122.624 1.202 . . . . 0.0 111.537 163.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.8 m -150.44 119.01 6.48 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 119.26 -2.15 . . . . 0.0 108.031 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -125.78 132.24 52.32 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-O 121.836 0.827 . . . . 0.0 111.757 -168.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.2 mm -111.63 117.43 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -162.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -116.8 129.68 56.24 Favored 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 123.037 0.535 . . . . 0.0 111.216 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -106.63 146.91 30.14 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -71.94 106.09 4.1 Favored 'General case' 0 CA--C 1.57 1.742 0 O-C-N 121.046 -1.034 . . . . 0.0 113.106 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.05 85.56 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--O 1.256 1.446 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -171.456 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.6 p -63.02 -34.81 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 163.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -46.25 -34.06 4.14 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 165.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -63.74 -22.19 66.78 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 172.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.1 mt -74.89 -5.78 45.55 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 117.722 2.49 . . . . 0.0 117.722 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 164.0 26.94 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -172.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.35 -179.37 24.68 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 171.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 -84.22 126.16 32.88 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.153 -0.616 . . . . 0.0 111.201 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -126.31 113.81 17.42 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -89.75 134.9 33.93 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.0 tp -68.61 121.78 17.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -112.28 -55.15 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 123.952 0.901 . . . . 0.0 112.603 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -106.69 140.2 39.92 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 120.244 1.383 . . . . 0.0 110.228 168.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -136.5 79.7 1.78 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.728 1.252 . . . . 0.0 110.167 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -99.03 100.82 12.03 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.562 -0.712 . . . . 0.0 110.938 -158.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.5 22.07 20.08 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 118.309 2.084 . . . . 0.0 118.309 -167.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -74.27 -49.74 21.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -37.9 74.69 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 167.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -57.73 -45.13 86.24 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 166.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -57.3 -49.36 76.35 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 164.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 73.5 mtm -60.76 -35.35 76.2 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 172.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -55.44 -55.23 34.09 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 161.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 31.6 tp10 -64.91 -36.6 84.89 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -53.65 -44.03 69.27 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 159.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.8 56.59 1.22 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -172.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -98.02 137.71 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 123.327 0.651 . . . . 0.0 110.091 -172.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.26 153.33 48.64 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 pt -57.37 -48.82 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 -171.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.58 87.76 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 167.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 mt -66.52 -37.68 85.56 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 169.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -57.65 -48.82 78.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 162.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -57.52 -48.97 77.84 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 169.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -50.7 -51.46 49.46 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 167.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.2 -46.17 93.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 118.116 2.007 . . . . 0.0 118.116 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.47 -45.02 94.94 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -79.81 -5.23 54.99 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 118.048 2.611 . . . . 0.0 118.048 173.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.05 135.8 39.93 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.25 92.33 2.09 Favored Pre-proline 0 CA--C 1.573 1.857 0 O-C-N 121.369 -0.832 . . . . 0.0 110.853 160.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.35 136.53 26.62 Favored 'Trans proline' 0 CA--C 1.559 1.774 0 CA-C-N 122.935 2.084 . . . . 0.0 114.548 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -100.54 101.93 12.98 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.392 167.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.2 t -74.76 111.96 10.49 Favored 'General case' 0 CA--C 1.558 1.274 0 O-C-N 121.627 -0.671 . . . . 0.0 110.689 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mt -104.88 105.16 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 83.9 mt -95.47 129.46 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.0 p -119.0 111.94 18.95 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.5 p -98.56 111.45 23.81 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -170.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -84.78 176.75 8.33 Favored 'General case' 0 CA--C 1.578 2.035 0 CA-C-O 124.106 1.908 . . . . 0.0 110.346 159.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.18 -40.99 92.52 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.402 2.121 . . . . 0.0 118.402 158.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -123.06 -47.77 2.02 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 166.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -86.63 82.74 7.79 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 120.953 1.706 . . . . 0.0 111.518 -166.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.61 112.7 24.34 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.885 -1.134 . . . . 0.0 109.221 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.2 m -98.31 119.62 37.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.532 -0.73 . . . . 0.0 110.576 -168.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.3 mt -112.0 105.76 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -99.99 103.3 14.84 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.3 m -90.56 100.34 13.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.61 -0.681 . . . . 0.0 110.011 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.16 118.8 30.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.6 t -138.21 144.4 40.62 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.197 0.599 . . . . 0.0 110.017 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.5 p -75.78 42.32 0.23 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.1 mt -152.91 -54.64 0.12 Allowed 'General case' 0 CA--C 1.572 1.821 0 C-N-CA 126.791 2.036 . . . . 0.0 108.654 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -143.44 117.0 9.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.024 -1.048 . . . . 0.0 110.838 167.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.3 m -84.75 120.08 26.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.676 -0.64 . . . . 0.0 109.61 166.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.0 p -111.97 103.03 11.23 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -102.72 128.95 49.23 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.35 0.66 . . . . 0.0 111.374 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -145.34 141.6 28.65 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.02 0.914 . . . . 0.0 112.954 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.8 p -97.47 105.29 17.41 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.739 0.816 . . . . 0.0 110.886 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 30.1 p -92.96 122.55 35.44 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.566 0.698 . . . . 0.0 111.99 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.0 m -85.72 115.41 23.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.483 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.27 118.29 19.62 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.541 0.737 . . . . 0.0 112.764 -166.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.1 55.17 8.16 Favored Glycine 0 CA--C 1.549 2.192 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.945 -156.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.49 154.71 2.63 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 124.429 1.092 . . . . 0.0 111.403 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -109.59 123.56 49.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.135 0.974 . . . . 0.0 112.916 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -127.65 164.48 21.95 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 124.17 0.988 . . . . 0.0 112.293 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -78.39 107.73 11.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 119.842 -1.787 . . . . 0.0 111.712 164.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -77.95 147.65 34.85 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.294 155.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.0 m -113.17 114.73 27.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.769 171.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.3 p -70.49 138.68 51.29 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 122.825 0.45 . . . . 0.0 111.62 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.62 -29.45 10.98 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 120.309 3.448 . . . . 0.0 120.309 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -84.15 -29.75 26.43 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 170.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.15 -37.39 0.37 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 119.96 2.744 . . . . 0.0 119.96 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -68.25 127.92 34.68 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 119.578 1.689 . . . . 0.0 112.675 -174.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -93.72 128.84 40.13 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.121 0.486 . . . . 0.0 110.744 171.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.8 p -120.44 126.01 49.36 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.254 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -67.77 103.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.208 1.004 . . . . 0.0 111.319 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.3 m -114.53 101.38 9.07 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -158.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.299 14.6 p -87.05 106.17 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.404 0.621 . . . . 0.0 110.331 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 63.6 m -92.12 120.71 32.98 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -140.01 126.92 20.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.87 -0.519 . . . . 0.0 111.265 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -92.21 123.52 35.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 111.488 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 t -139.51 138.41 36.31 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.235 0.614 . . . . 0.0 109.832 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 61.79 36.93 15.91 Favored 'General case' 0 N--CA 1.506 2.334 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 162.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.7 12.63 83.68 Favored Glycine 0 CA--C 1.557 2.69 0 N-CA-C 119.354 2.502 . . . . 0.0 119.354 -165.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.35 125.47 24.53 Favored 'General case' 0 CA--C 1.561 1.392 0 CA-C-N 119.668 1.734 . . . . 0.0 112.743 -169.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 tp -86.4 106.9 17.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.529 -0.732 . . . . 0.0 110.945 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 66.7 t -92.95 108.66 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.854 0.862 . . . . 0.0 108.765 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -93.27 95.0 9.08 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.627 0.771 . . . . 0.0 110.024 173.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -91.08 102.49 15.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 110.751 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -94.56 126.07 39.61 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.699 1.2 . . . . 0.0 111.31 -172.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -125.26 122.81 38.0 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.341 0.656 . . . . 0.0 110.466 -169.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -157.38 118.81 3.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.807 -1.183 . . . . 0.0 111.32 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 45.14 51.34 9.1 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 168.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.5 -42.77 3.08 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 117.699 1.84 . . . . 0.0 117.699 -171.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -79.49 142.68 35.6 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.15 139.12 39.24 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.131 0.967 . . . . 0.0 113.063 173.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.7 t -120.68 130.08 53.95 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.548 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 67.5 m -117.7 117.07 28.36 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.097 -1.002 . . . . 0.0 108.746 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.2 mt -114.17 104.83 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.2 m -100.69 103.27 14.53 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.88 0.872 . . . . 0.0 109.752 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.8 mtt85 -95.75 104.22 16.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.859 -0.526 . . . . 0.0 110.647 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -121.12 147.14 45.97 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.31 108.78 20.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.827 -0.546 . . . . 0.0 111.611 -171.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -137.02 129.3 29.72 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.343 0.657 . . . . 0.0 109.312 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.0 t0 57.49 44.31 21.45 Favored 'General case' 0 N--CA 1.507 2.404 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 51.82 30.68 29.55 Favored Glycine 0 CA--C 1.559 2.801 0 N-CA-C 119.298 2.479 . . . . 0.0 119.298 -164.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -140.61 149.5 42.41 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.502 1.144 . . . . 0.0 109.537 -167.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.5 tp -92.5 106.12 18.17 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-O 121.912 0.863 . . . . 0.0 109.857 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 82.7 t -93.31 106.07 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.3 t -102.65 90.52 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -170.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -88.28 93.43 9.51 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.717 1.246 . . . . 0.0 110.062 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.922 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 9.4 t -80.64 135.87 36.12 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.823 170.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.6 123.22 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.598 -0.689 . . . . 0.0 109.452 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.415 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 26.8 ttt -117.02 103.97 10.79 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.859 0.464 . . . . 0.0 110.061 175.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.3 76.5 m-20 66.57 -93.57 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.868 0.867 . . . . 0.0 111.297 -174.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -111.89 0.44 16.12 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 162.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.9 t -92.95 105.86 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 120.49 1.495 . . . . 0.0 108.714 -167.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 53.6 p -90.74 140.1 30.1 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.404 1.097 . . . . 0.0 113.02 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.922 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -136.52 85.08 2.12 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -174.056 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 61.7 m -88.98 110.24 20.95 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.514 -1.366 . . . . 0.0 110.286 -171.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -114.4 108.34 16.76 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -168.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.7 mm -92.72 114.64 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -116.41 114.55 24.42 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.197 0.599 . . . . 0.0 109.718 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.68 152.39 22.55 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.447 ' HZ1' ' CD ' ' A' ' 135' ' ' GLU . 6.3 tttt -77.83 127.43 32.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.483 -1.386 . . . . 0.0 114.696 -161.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.74 86.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.447 ' CD ' ' HZ1' ' A' ' 133' ' ' LYS . 97.5 mt-10 . . . . . 0 N--CA 1.489 1.498 0 C-N-CA 123.928 0.891 . . . . 0.0 108.6 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 122.057 0.932 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.265 7.7 p -64.16 -32.47 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -38.58 90.41 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 162.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -63.83 -38.37 90.86 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.5 mt -59.81 -23.79 63.62 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 163.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 107.64 3.93 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.188 1.813 . . . . 0.0 113.426 -171.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.64 -173.85 36.42 Favored Glycine 0 N--CA 1.489 2.215 0 CA-C-O 121.712 0.618 . . . . 0.0 114.628 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -94.92 137.84 33.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.009 -0.701 . . . . 0.0 110.981 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -135.55 116.82 14.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.55 -0.719 . . . . 0.0 110.994 -170.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.9 ttm105 -97.49 134.09 41.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.002 -1.686 . . . . 0.0 113.85 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.1 tp -67.82 123.51 20.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.254 4.4 m -113.06 -60.95 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 123.818 0.847 . . . . 0.0 112.223 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -106.36 151.5 24.79 Favored 'General case' 0 CA--C 1.571 1.782 0 CA-C-N 119.688 1.131 . . . . 0.0 111.006 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -154.28 65.56 0.7 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 136.11 54.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.485 -0.759 . . . . 0.0 112.988 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.74 2.59 51.69 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 120.086 2.794 . . . . 0.0 120.086 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.14 -34.03 72.54 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.27 -54.91 17.87 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 163.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.44 -49.57 72.1 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -57.25 -48.13 79.64 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 76.5 mtm -59.5 -35.27 73.82 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 168.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -64.17 -48.06 77.41 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.405 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 22.0 tp10 -66.0 -37.91 87.16 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 173.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.1 -42.72 66.22 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 159.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.31 53.93 1.21 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 115.137 0.815 . . . . 0.0 115.137 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.18 134.78 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.412 0.685 . . . . 0.0 109.788 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.95 154.09 49.83 Favored Glycine 0 CA--C 1.55 2.244 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.1 pt -55.55 -48.25 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -172.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.61 -43.59 97.28 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.34 -40.0 96.1 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 170.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.9 mtp85 -55.2 -50.33 69.64 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 162.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -56.94 -47.7 80.04 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 170.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.0 mtm -58.0 -55.27 37.07 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 168.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.97 -36.97 76.16 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 119.41 2.524 . . . . 0.0 119.41 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.97 -54.42 30.84 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.8 ptp -85.9 -26.38 25.63 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.01 73.21 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 119.639 3.2 . . . . 0.0 119.639 -168.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt 63.32 66.42 1.16 Allowed Pre-proline 0 CA--C 1.581 2.141 0 C-N-CA 124.437 1.095 . . . . 0.0 113.612 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -73.25 143.77 35.99 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 122.513 2.142 . . . . 0.0 116.869 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.44 101.51 13.21 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.271 1.028 . . . . 0.0 110.045 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.0 116.82 29.25 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 124.378 1.071 . . . . 0.0 112.108 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mp -92.13 119.67 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.9 mt -105.88 117.68 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 168.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.1 m -136.84 130.4 31.74 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 118.879 0.763 . . . . 0.0 111.046 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.6 p -105.98 137.45 43.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -169.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.34 86.37 2.32 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 121.882 0.849 . . . . 0.0 108.878 166.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.57 -99.26 0.45 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -85.15 -25.91 27.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 165.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -86.27 138.17 32.05 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 120.719 1.6 . . . . 0.0 112.001 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.451 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 21.8 tp -133.7 112.98 11.85 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 121.883 0.849 . . . . 0.0 108.787 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -87.29 119.57 27.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.491 0.717 . . . . 0.0 109.567 -175.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mm -111.47 98.73 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HZ2' ' CD ' ' A' ' 57' ' ' GLU . 44.4 tttt -112.53 105.93 14.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.557 -0.714 . . . . 0.0 110.104 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.4 m -93.12 101.24 13.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.399 -0.813 . . . . 0.0 109.817 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' CD ' ' HZ2' ' A' ' 55' ' ' LYS . 40.1 mt-10 -98.24 125.53 43.35 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.023 0.929 . . . . 0.0 110.704 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 t -137.66 160.8 38.19 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.41 1.1 . . . . 0.0 113.437 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.7 p -59.93 -48.25 82.45 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 163.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.7 mt -97.02 -38.86 9.61 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -146.52 105.37 3.85 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 121.187 1.812 . . . . 0.0 112.715 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.419 ' C ' ' HG1' ' A' ' 63' ' ' THR . 32.3 m -86.26 142.44 28.55 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.657 0.783 . . . . 0.0 111.545 172.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.419 ' HG1' ' C ' ' A' ' 62' ' ' THR . 86.5 m -157.89 143.09 16.8 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.235 -1.54 . . . . 0.0 109.839 175.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.51 154.77 51.27 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.285 -1.51 . . . . 0.0 114.229 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -150.65 142.1 23.42 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.553 0.692 . . . . 0.0 111.771 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.0 p -100.26 105.25 16.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.943 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 52' ' ' LEU . 20.9 p -93.79 164.51 13.1 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.5 m -130.43 128.46 41.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.2 111.72 9.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.292 -0.88 . . . . 0.0 111.982 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.37 -62.3 0.54 Allowed Glycine 0 N--CA 1.488 2.11 0 CA-C-O 120.055 -0.303 . . . . 0.0 113.488 -162.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -89.47 162.17 15.86 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 124.068 1.89 . . . . 0.0 114.914 -164.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -106.95 132.86 52.42 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 112.563 -2.108 . . . . 0.0 111.394 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.89 160.38 40.45 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -169.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.99 113.53 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 112.48 167.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -102.2 95.82 6.57 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.1 m -76.96 92.07 3.65 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.341 1.067 . . . . 0.0 110.445 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -67.38 148.28 51.81 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.158 0.983 . . . . 0.0 113.293 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.07 -39.48 5.85 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.948 3.314 . . . . 0.0 119.948 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.95 -34.27 59.84 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.12 -25.32 0.61 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 119.563 2.585 . . . . 0.0 119.563 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.2 mtm-85 -72.65 119.74 17.3 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 120.124 1.962 . . . . 0.0 112.091 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 94.6 9.71 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 167.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.5 p -87.4 149.53 24.4 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.146 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -81.98 87.15 6.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.084 -1.01 . . . . 0.0 109.589 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -88.79 117.35 27.72 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.264 14.9 p -88.97 118.08 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 161.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.3 m -96.21 135.17 38.39 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 120.834 0.35 . . . . 0.0 111.655 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -148.05 121.7 9.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.804 -0.56 . . . . 0.0 109.611 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -83.24 123.39 29.53 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 120.852 -1.155 . . . . 0.0 111.259 169.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -133.31 110.4 10.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 63.69 56.19 1.58 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 148.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.52 -25.94 11.83 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 118.453 2.141 . . . . 0.0 118.453 -164.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.77 135.0 55.03 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 119.909 1.855 . . . . 0.0 114.314 -167.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.9 tp -82.37 113.71 20.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.196 158.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.0 t -88.89 106.73 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -102.04 98.74 8.89 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -99.2 96.31 7.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.638 -0.664 . . . . 0.0 110.561 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -83.4 128.54 34.59 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.683 0.793 . . . . 0.0 111.572 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -130.32 123.94 31.16 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.107 0.563 . . . . 0.0 110.009 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.2 p90 -156.6 119.51 4.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.696 -1.252 . . . . 0.0 112.139 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.263 5.5 t70 34.31 58.16 0.64 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 118.699 2.852 . . . . 0.0 118.699 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.72 -46.94 1.9 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 117.639 1.816 . . . . 0.0 117.639 -172.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -80.51 140.94 35.62 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -133.3 148.38 51.92 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 168.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.6 t -131.99 138.65 48.35 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.688 0.756 . . . . 0.0 111.802 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -111.7 98.11 7.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.71 111.09 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -175.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.7 m -101.71 103.6 14.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.622 -0.673 . . . . 0.0 109.802 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -95.42 101.66 13.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.403 -0.811 . . . . 0.0 109.9 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -132.91 156.9 46.39 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.91 123.22 26.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 111.877 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.09 114.19 24.19 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 159.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.89 51.16 9.39 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 166.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.47 -22.77 5.21 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 119.357 2.503 . . . . 0.0 119.357 -170.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -103.27 140.09 37.86 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.628 1.714 . . . . 0.0 111.21 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.9 tp -75.77 134.79 40.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.96 . . . . 0.0 110.361 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.29 106.78 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.6 t -92.73 102.94 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -111.28 105.18 13.76 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -171.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.951 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 3.1 p -97.08 145.79 25.64 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.51 128.66 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.412 0.625 . . . . 0.0 109.405 162.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.405 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 24.4 ttt -98.21 -88.44 0.32 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.214 0.606 . . . . 0.0 110.253 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -129.89 78.16 1.83 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.052 0.941 . . . . 0.0 108.732 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.283 0.7 OUTLIER 69.4 -26.53 0.15 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 -162.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 82.6 t -75.78 116.41 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 CA-C-N 120.085 1.311 . . . . 0.0 109.835 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.3 p -120.11 134.76 55.17 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 123.638 0.775 . . . . 0.0 112.729 -170.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.951 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.3 p -120.93 128.01 52.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.962 -0.461 . . . . 0.0 111.993 167.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.3 m -109.25 111.45 23.04 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -112.14 118.76 36.24 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.57 0.748 . . . . 0.0 110.248 -172.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mm -96.71 130.47 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 123.455 0.702 . . . . 0.0 109.426 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -130.12 121.63 26.7 Favored 'General case' 0 CA--C 1.572 1.82 0 C-N-CA 123.483 0.713 . . . . 0.0 112.385 -165.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -95.32 134.88 37.61 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.447 ' HZ3' ' CD ' ' A' ' 135' ' ' GLU . 11.7 tttm -80.25 125.29 29.67 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.104 -0.997 . . . . 0.0 113.369 -172.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.6 t -114.79 94.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -168.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.447 ' CD ' ' HZ3' ' A' ' 133' ' ' LYS . 9.6 mm-40 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 122.489 0.315 . . . . 0.0 110.207 -165.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.0 p . . . . . 0 CA--C 1.568 1.663 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.308 12.1 p -154.63 -58.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 120.155 -1.591 . . . . 0.0 110.186 153.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.3 -22.51 63.26 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.592 2.441 . . . . 0.0 117.592 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.1 mp0 -56.96 -27.18 60.97 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 163.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.21 -12.59 61.24 Favored 'General case' 0 CA--C 1.582 2.206 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 164.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.43 114.17 14.84 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 120.774 1.625 . . . . 0.0 113.398 -166.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.45 -166.55 28.63 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 167.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -86.15 129.78 34.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.078 -0.66 . . . . 0.0 112.33 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -127.77 114.73 17.65 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.262 0.625 . . . . 0.0 110.301 -172.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -89.91 133.52 34.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.471 -1.393 . . . . 0.0 113.3 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.6 tp -72.88 131.07 41.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.8 -0.563 . . . . 0.0 112.439 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.277 3.3 m -116.68 -73.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 123.369 0.668 . . . . 0.0 109.895 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -89.68 142.05 28.04 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 118.919 0.781 . . . . 0.0 110.802 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.4 t -148.02 51.96 1.03 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -79.84 134.81 36.34 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.44 -9.43 67.58 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 118.628 2.211 . . . . 0.0 118.628 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -70.69 -42.26 70.91 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -171.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -52.62 -51.66 58.98 Favored 'General case' 0 CA--C 1.579 2.06 0 CA-C-N 120.079 1.309 . . . . 0.0 114.339 167.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.74 -39.51 84.97 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 170.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -58.64 -46.3 87.4 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 169.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.476 ' SD ' ' HA ' ' A' ' 33' ' ' ARG . 16.3 ptp -62.03 -25.79 67.87 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 167.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -58.7 -52.92 63.65 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 157.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.03 -42.05 98.76 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.3 mt -53.28 -38.77 63.39 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 169.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.04 64.62 0.99 Allowed Glycine 0 N--CA 1.486 1.989 0 C-N-CA 123.362 0.506 . . . . 0.0 113.751 -166.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.5 t -114.33 130.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.62 158.65 49.25 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.275 2.4 pp -55.26 -49.02 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -171.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.76 99.34 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 168.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.06 -41.88 89.01 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 20.0 mtp-105 -61.27 -51.05 70.55 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 120.177 1.353 . . . . 0.0 114.546 170.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -54.74 -47.65 73.56 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 170.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.8 ttp -54.42 -60.67 3.03 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 165.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.91 -40.32 92.99 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 119.573 2.589 . . . . 0.0 119.573 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.59 -45.02 88.8 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 172.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -78.26 -29.87 48.29 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 172.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.74 123.22 18.79 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 119.833 1.197 . . . . 0.0 114.17 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -103.5 107.89 57.5 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 117.667 -1.158 . . . . 0.0 109.66 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -92.34 145.73 2.79 Favored 'Trans proline' 0 CA--C 1.563 1.948 0 CA-C-N 122.48 1.921 . . . . 0.0 116.455 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.74 100.53 13.0 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 114.493 -1.231 . . . . 0.0 108.641 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.9 t -91.32 112.83 24.9 Favored 'General case' 0 CA--C 1.557 1.217 0 O-C-N 120.875 -1.141 . . . . 0.0 112.559 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mt -84.14 104.26 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 60.5 mt -99.78 111.49 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.5 m -117.16 102.5 9.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.6 p -113.87 91.4 3.62 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 123.737 0.815 . . . . 0.0 111.424 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -93.54 65.31 3.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.34 -0.85 . . . . 0.0 111.836 -171.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.36 -61.58 1.87 Allowed Glycine 0 N--CA 1.494 2.51 0 O-C-N 120.117 -1.614 . . . . 0.0 117.089 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -121.52 -46.43 2.27 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -71.7 137.59 47.91 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 121.58 1.991 . . . . 0.0 112.925 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -138.52 112.31 8.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.468 -0.77 . . . . 0.0 111.226 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.2 m -114.77 123.53 49.47 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.463 0.705 . . . . 0.0 109.715 -175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.77 109.03 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -114.23 101.61 9.35 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.996 0.918 . . . . 0.0 109.859 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.0 m -87.09 112.48 21.94 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.673 0.789 . . . . 0.0 110.391 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -112.3 100.63 8.95 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 118.773 0.715 . . . . 0.0 112.138 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -123.46 158.34 31.47 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.084 0.945 . . . . 0.0 111.192 163.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.2 p -63.29 -44.82 93.95 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 172.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.3 mt -64.07 -38.04 89.63 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.09 130.64 13.94 Favored 'General case' 0 CA--C 1.563 1.453 0 CA-C-N 119.938 1.244 . . . . 0.0 111.164 166.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 m -113.95 133.75 55.27 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 166.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.1 m -155.6 139.65 16.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.391 -1.443 . . . . 0.0 109.541 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.85 158.39 39.62 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.36 137.5 30.54 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-O 121.991 0.901 . . . . 0.0 110.451 161.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -109.93 105.26 14.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.028 0.931 . . . . 0.0 109.499 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 30.3 p -132.19 -152.51 0.5 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.54 0.736 . . . . 0.0 112.413 -168.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.39 147.42 50.48 Favored 'General case' 0 CA--C 1.571 1.761 0 O-C-N 120.957 -1.089 . . . . 0.0 111.306 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -78.58 148.01 33.49 Favored 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 124.221 1.008 . . . . 0.0 113.045 162.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.35 28.45 73.59 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 117.921 1.928 . . . . 0.0 117.921 -173.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -152.11 141.09 21.16 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-O 121.51 0.671 . . . . 0.0 109.437 -162.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -93.45 124.29 37.34 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.253 174.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -130.92 154.4 48.15 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.043 0.937 . . . . 0.0 111.721 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -80.12 101.31 8.69 Favored 'General case' 0 CA--C 1.569 1.704 0 O-C-N 120.95 -1.094 . . . . 0.0 111.512 172.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -85.32 94.28 8.91 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.997 0.919 . . . . 0.0 110.011 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.8 m -81.64 96.57 7.55 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.925 0.869 . . . . 0.0 110.478 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.9 p -71.14 152.42 43.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.381 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.01 -30.05 14.2 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -54.81 -42.73 72.22 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 118.419 2.748 . . . . 0.0 118.419 162.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.63 -19.49 9.71 Favored Glycine 0 CA--C 1.553 2.466 0 N-CA-C 117.81 1.884 . . . . 0.0 117.81 -155.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -74.47 112.1 10.31 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 121.122 2.461 . . . . 0.0 110.65 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.264 0.1 OUTLIER -102.34 99.48 9.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.655 0.74 . . . . 0.0 111.225 178.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.7 p -99.56 141.88 31.78 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.176 -163.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -77.49 88.49 3.84 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.581 172.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.7 m -97.2 114.52 26.25 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 121.694 -0.629 . . . . 0.0 109.503 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.282 14.2 p -90.56 119.87 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.726 -0.609 . . . . 0.0 110.693 165.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.9 m -98.47 113.21 25.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.189 -0.319 . . . . 0.0 111.673 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -123.68 140.52 52.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.786 -0.571 . . . . 0.0 110.545 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -84.1 127.44 33.91 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 120.877 -1.139 . . . . 0.0 111.469 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -146.06 142.08 28.24 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.394 0.678 . . . . 0.0 110.278 168.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.81 43.58 9.38 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 161.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.14 23.71 69.92 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 118.817 2.287 . . . . 0.0 118.817 -166.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.78 148.47 29.24 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 118.849 1.325 . . . . 0.0 113.608 -166.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.0 tp -89.42 112.33 23.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.559 -0.713 . . . . 0.0 110.254 162.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 p -89.36 125.23 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 CA-C-O 123.038 1.399 . . . . 0.0 109.819 168.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -114.18 103.02 10.69 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.732 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -99.68 93.66 5.95 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 120.999 0.428 . . . . 0.0 111.254 -170.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -79.21 130.26 35.29 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.195 0.998 . . . . 0.0 111.953 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.4 121.72 26.45 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.713 0.688 . . . . 0.0 110.375 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -155.74 130.08 8.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.493 -1.379 . . . . 0.0 112.143 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 t70 51.65 50.09 19.49 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 166.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.48 16.34 58.38 Favored Glycine 0 CA--C 1.561 2.923 0 N-CA-C 120.342 2.897 . . . . 0.0 120.342 -167.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -131.84 150.47 52.14 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.917 1.359 . . . . 0.0 110.276 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.54 151.73 44.98 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.5 t -141.96 138.7 32.13 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.059 0.933 . . . . 0.0 112.61 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 p -110.57 117.18 32.84 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.653 0.781 . . . . 0.0 109.262 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.6 mm -101.8 109.58 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.7 m -96.96 106.33 18.64 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.543 0.687 . . . . 0.0 109.255 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -98.17 84.01 3.19 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.552 0.741 . . . . 0.0 109.972 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -95.67 132.98 40.27 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.9 103.49 12.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.359 -0.838 . . . . 0.0 110.434 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.258 45.6 tttm -117.9 -105.26 0.4 Allowed 'General case' 0 CA--C 1.559 1.301 0 O-C-N 121.933 -0.479 . . . . 0.0 111.071 -164.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.98 60.79 6.05 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-O 122.339 1.066 . . . . 0.0 112.67 -163.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 49.0 37.83 23.31 Favored Glycine 0 CA--C 1.558 2.775 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -153.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.12 139.95 8.72 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -155.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.1 tp -86.34 117.23 25.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.773 -1.204 . . . . 0.0 110.163 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.8 t -103.57 108.68 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.49 104.94 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -170.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -106.28 107.65 18.77 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -169.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.953 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.8 p -101.62 144.71 30.02 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.73 145.2 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 123.034 0.534 . . . . 0.0 110.234 166.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.5 ttt -110.74 -80.33 0.58 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.053 -1.029 . . . . 0.0 110.561 168.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -111.73 -66.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 118.679 0.672 . . . . 0.0 110.912 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -122.52 -14.25 7.83 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -97.98 134.0 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-N 121.403 1.911 . . . . 0.0 110.062 -174.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 77.5 p -112.47 153.2 27.78 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.912 0.885 . . . . 0.0 112.68 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.953 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.8 OUTLIER -130.76 142.17 50.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.311 -0.868 . . . . 0.0 112.391 161.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.6 m -109.64 108.61 19.08 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -104.23 109.72 21.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.617 0.767 . . . . 0.0 109.992 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.2 mm -89.26 124.11 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -120.06 118.53 30.85 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.574 0.749 . . . . 0.0 111.124 -174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -86.79 140.17 29.98 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.117 0.967 . . . . 0.0 112.94 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -78.29 134.78 37.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.266 -1.521 . . . . 0.0 113.62 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.9 95.76 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.981 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.253 9.0 p -67.88 -36.75 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 119.469 1.032 . . . . 0.0 113.675 166.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -58.58 -35.62 72.67 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.315 1.968 . . . . 0.0 116.315 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -64.42 -31.72 73.04 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 165.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.78 -20.56 65.97 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 163.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.2 117.25 22.19 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.285 1.857 . . . . 0.0 112.283 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.71 -178.7 39.78 Favored Glycine 0 N--CA 1.484 1.897 0 CA-C-O 122.098 0.832 . . . . 0.0 114.577 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -84.89 114.8 22.38 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.019 0.528 . . . . 0.0 110.777 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -110.58 104.54 13.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.949 -0.469 . . . . 0.0 111.97 -171.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -82.73 124.26 30.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.365 -0.834 . . . . 0.0 112.424 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.0 130.52 44.37 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.023 -1.048 . . . . 0.0 113.444 173.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.292 15.7 m -120.03 -63.7 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.617 173.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -92.76 149.81 21.06 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.431 1.469 . . . . 0.0 112.007 170.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p -148.34 79.14 1.44 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.912 166.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.44 119.13 19.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.554 -0.716 . . . . 0.0 110.936 -176.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.82 37.06 93.7 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 119.708 2.643 . . . . 0.0 119.708 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.6 -42.61 51.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 175.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -51.94 -50.04 61.97 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 163.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -48.54 -54.58 13.87 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 168.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -55.25 -53.61 53.92 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 170.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 31.7 mtm -67.75 -34.05 76.06 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -47.82 -44.09 28.55 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 158.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -41.72 81.7 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 169.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.3 mt -51.7 -50.42 60.53 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 165.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.44 40.39 0.23 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 m -112.67 144.19 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.686 0 CA-C-N 118.724 1.262 . . . . 0.0 112.463 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.33 -179.64 50.96 Favored Glycine 0 CA--C 1.551 2.33 0 CA-C-O 122.814 1.23 . . . . 0.0 115.989 168.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 pt -57.23 -46.25 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 117.921 2.564 . . . . 0.0 117.921 -171.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.65 -40.63 95.61 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.02 -39.02 86.94 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 -63.78 -42.93 97.66 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 166.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -50.57 -50.49 53.47 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 161.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.6 mtp -72.3 58.37 0.39 Allowed 'General case' 0 CA--C 1.581 2.161 0 CA-C-O 123.028 1.394 . . . . 0.0 114.632 166.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.12 -63.72 0.08 OUTLIER Glycine 0 CA--C 1.543 1.809 0 O-C-N 121.349 -0.845 . . . . 0.0 111.56 -172.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.93 78.48 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 170.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . 0.26 19.2 ptt? -86.44 -17.89 33.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 170.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.07 121.24 22.51 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.172 1.351 . . . . 0.0 113.707 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -96.36 113.46 62.51 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.365 170.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -86.12 146.72 8.91 Favored 'Trans proline' 0 CA--C 1.561 1.828 0 C-N-CA 122.284 1.989 . . . . 0.0 115.052 168.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.57 97.97 10.86 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.265 158.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.8 t -87.65 104.64 16.72 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.139 0.976 . . . . 0.0 111.713 -174.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.0 mt -92.12 106.44 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.6 mt -96.86 128.99 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.4 m -156.46 130.49 8.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.274 -1.516 . . . . 0.0 109.938 171.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.8 p -118.75 130.01 55.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -97.72 93.03 6.16 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 121.802 0.81 . . . . 0.0 108.978 166.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.13 -75.46 1.14 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 116.67 1.428 . . . . 0.0 116.67 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -127.73 -30.63 2.51 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.69 100.99 5.59 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 120.909 1.686 . . . . 0.0 111.757 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -93.84 116.19 28.64 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.341 1.056 . . . . 0.0 109.945 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.3 m -93.38 123.77 36.9 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.662 0.785 . . . . 0.0 109.62 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 mt -115.79 107.38 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -103.68 103.5 13.42 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.646 0.779 . . . . 0.0 109.547 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.6 m -94.18 100.17 12.3 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.322 1.049 . . . . 0.0 110.686 -171.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -100.09 102.55 13.9 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.081 0.553 . . . . 0.0 111.746 -165.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 t -138.7 139.85 38.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.478 -0.764 . . . . 0.0 111.451 173.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.0 p -63.93 -33.55 75.96 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.4 mt -67.26 -45.97 75.09 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 167.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -155.12 114.67 3.69 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.471 1.487 . . . . 0.0 111.376 170.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.8 m -94.24 141.05 29.01 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.586 0.708 . . . . 0.0 111.399 172.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.1 p -138.48 154.97 48.83 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 123.93 0.892 . . . . 0.0 111.112 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.0 146.13 32.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.351 -1.468 . . . . 0.0 112.906 172.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -152.44 151.62 30.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.586 -0.696 . . . . 0.0 112.807 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -110.54 115.73 30.13 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.503 0.721 . . . . 0.0 110.85 166.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.8 p -104.5 134.04 48.35 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.553 -0.717 . . . . 0.0 112.739 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 88.6 m -81.25 113.08 19.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.865 -1.147 . . . . 0.0 110.336 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -69.85 120.83 16.18 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -172.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.7 -36.31 3.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 -166.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.41 -169.92 2.62 Favored 'General case' 0 CA--C 1.575 1.905 0 CA-C-N 119.128 1.464 . . . . 0.0 111.953 -176.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -86.34 142.02 28.79 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -117.24 163.33 16.47 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.38 159.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -82.24 103.56 11.92 Favored 'General case' 0 CA--C 1.565 1.554 0 O-C-N 120.6 -1.312 . . . . 0.0 110.045 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -87.28 104.84 16.78 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.5 m -82.31 104.41 12.59 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 165.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.6 p -76.22 159.16 30.91 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -164.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.46 -38.93 56.19 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 165.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.276 2.7 t0 -44.35 -47.32 9.62 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 157.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.02 -31.75 4.41 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -164.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -62.44 137.01 58.17 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.8 1.8 . . . . 0.0 114.781 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -76.59 121.57 23.38 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.721 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.7 p -132.72 118.46 19.1 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.595 0.712 . . . . 0.0 111.015 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -76.98 101.3 5.93 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.61 0.764 . . . . 0.0 109.442 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.1 m -116.51 107.15 14.4 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.461 -154.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.5 t -81.02 117.56 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 122.893 0.477 . . . . 0.0 109.871 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.4 m -101.46 108.79 20.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.137 -0.352 . . . . 0.0 111.326 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -126.24 124.19 39.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.777 -0.577 . . . . 0.0 111.446 -175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -85.13 126.85 33.96 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.455 -0.778 . . . . 0.0 111.567 168.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -143.02 137.04 29.0 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 122.994 0.518 . . . . 0.0 109.773 165.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.83 39.49 16.98 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 159.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.62 20.27 79.51 Favored Glycine 0 CA--C 1.557 2.669 0 N-CA-C 119.23 2.452 . . . . 0.0 119.23 -166.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.83 131.63 21.42 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 119.295 1.548 . . . . 0.0 112.922 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.9 tp -94.45 109.92 21.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.667 -0.646 . . . . 0.0 110.645 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.18 108.71 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.675 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -95.39 102.4 14.2 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 124.166 0.986 . . . . 0.0 108.961 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -102.04 93.23 5.14 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.404 0.681 . . . . 0.0 111.997 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -77.07 117.07 18.28 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.786 0.834 . . . . 0.0 112.569 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.5 135.56 50.32 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.867 0.842 . . . . 0.0 110.12 166.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -152.28 117.22 5.15 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.256 27.5 t70 49.87 45.06 25.23 Favored 'General case' 0 CA--C 1.587 2.367 0 N-CA-C 117.141 2.275 . . . . 0.0 117.141 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.93 27.1 68.09 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 119.894 2.718 . . . . 0.0 119.894 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -135.43 100.05 4.4 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -172.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -115.3 142.68 46.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -165.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.5 t -117.31 137.28 52.53 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.802 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 p -114.69 109.15 17.77 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.4 mp -103.4 98.11 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 m -94.0 105.57 17.57 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.598 0.759 . . . . 0.0 109.975 -175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -94.3 88.48 5.57 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 123.627 0.771 . . . . 0.0 110.156 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -105.16 137.42 42.96 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -168.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 116.81 29.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.9 -1.125 . . . . 0.0 112.81 -172.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.75 84.27 3.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.591 -0.693 . . . . 0.0 109.714 167.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.276 25.1 m-20 7.5 62.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 120.608 3.559 . . . . 0.0 120.608 -173.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 138.78 -49.38 0.83 Allowed Glycine 0 N--CA 1.49 2.275 0 CA-C-N 114.515 -1.22 . . . . 0.0 115.503 -167.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -112.77 138.55 49.44 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 117.802 0.801 . . . . 0.0 110.557 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.19 116.32 28.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.889 -1.132 . . . . 0.0 109.6 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.9 t -93.95 109.57 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 80.5 t -98.8 105.55 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -96.67 100.78 12.32 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.746 0.819 . . . . 0.0 109.378 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.7 p -97.31 131.59 43.86 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.62 -0.675 . . . . 0.0 111.169 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.87 123.67 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.836 -0.54 . . . . 0.0 110.598 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 10.6 ttt -115.55 114.76 25.39 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 164.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.7 m120 55.23 55.92 7.01 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.297 40.3 m-80 76.65 -30.16 0.18 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -171.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.0 t -86.42 123.63 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 120.885 1.675 . . . . 0.0 109.949 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 72.4 p -113.6 144.28 43.16 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -163.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.5 OUTLIER -111.93 136.56 51.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 0.0 110.939 151.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.1 m -114.4 111.18 21.03 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 170.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.407 ' HG3' ' SG ' ' A' ' 127' ' ' CYS . 74.1 mtp180 -114.69 116.18 28.29 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.741 0.416 . . . . 0.0 110.327 -170.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.86 128.17 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -122.35 140.55 52.54 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.77 0.828 . . . . 0.0 111.879 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.86 135.84 42.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.474 ' HZ3' ' CD ' ' A' ' 135' ' ' GLU . 19.1 tttm -76.78 113.08 14.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.074 -1.016 . . . . 0.0 111.641 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.0 t -106.07 92.86 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -173.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.474 ' CD ' ' HZ3' ' A' ' 133' ' ' LYS . 82.2 mt-10 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.017 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.0 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.478 5.3 p 53.89 -62.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 N-CA-C 118.704 2.853 . . . . 0.0 118.704 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -52.22 -42.64 63.74 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -67.85 -18.79 64.93 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 172.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.54 -9.69 58.61 Favored 'General case' 0 CA--C 1.577 1.999 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 160.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.37 140.64 29.33 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 121.541 1.973 . . . . 0.0 112.944 -171.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.81 -177.82 23.05 Favored Glycine 0 N--CA 1.488 2.162 0 CA-C-O 122.145 0.859 . . . . 0.0 114.607 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -87.9 121.11 29.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.984 -0.715 . . . . 0.0 110.083 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -124.86 110.6 14.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.78 -0.575 . . . . 0.0 110.122 -169.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.3 ttm105 -98.56 134.7 41.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.831 -1.168 . . . . 0.0 113.251 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.91 133.0 49.97 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.28 21.7 m -124.35 -60.5 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 123.722 0.809 . . . . 0.0 112.281 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -89.43 148.35 23.52 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.346 1.43 . . . . 0.0 111.298 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 m -148.7 58.15 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.215 1.007 . . . . 0.0 113.218 165.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -72.88 123.5 23.53 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.294 -0.878 . . . . 0.0 113.083 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.77 2.58 81.43 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 118.85 2.3 . . . . 0.0 118.85 -167.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -72.12 -42.61 65.86 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.406 2.103 . . . . 0.0 116.65 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.62 -49.65 74.32 Favored 'General case' 0 CA--C 1.578 2.057 0 CA-C-N 120.962 1.71 . . . . 0.0 114.563 170.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -49.59 -44.93 47.41 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 164.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 74.5 t80 -59.71 -52.27 66.23 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 170.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.294 18.4 ptt? -70.31 -24.34 63.0 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -63.15 -39.84 95.83 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 121.523 1.965 . . . . 0.0 115.303 154.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -72.64 -40.01 66.73 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.0 mt -50.29 -41.81 51.44 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 117.989 2.588 . . . . 0.0 117.989 168.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.88 66.43 0.8 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 123.443 0.544 . . . . 0.0 113.648 -168.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -128.82 133.53 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -171.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.94 155.3 52.75 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 116.483 1.353 . . . . 0.0 116.483 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.262 2.7 pp -54.14 -44.07 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 N-CA-C 117.898 2.555 . . . . 0.0 117.898 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.99 88.14 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 168.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.36 -42.01 98.0 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 167.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -59.67 -47.51 85.35 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 120.352 1.433 . . . . 0.0 114.398 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.36 -46.83 88.54 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 169.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.1 ttp -52.48 -55.11 24.22 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 165.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.64 74.91 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 119.236 2.455 . . . . 0.0 119.236 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.95 91.21 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.4 ptp -77.24 -27.36 53.27 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.21 108.94 5.63 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.906 1.23 . . . . 0.0 113.731 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -102.3 93.96 4.42 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 118.196 -0.906 . . . . 0.0 110.649 168.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.84 153.31 25.71 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.474 2.116 . . . . 0.0 115.59 -173.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.69 105.27 17.25 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.643 0.735 . . . . 0.0 109.302 165.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.2 t -95.02 110.5 22.41 Favored 'General case' 0 CA--C 1.56 1.344 0 O-C-N 120.909 -1.119 . . . . 0.0 111.735 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mp -89.47 106.83 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.63 126.94 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.1 m -150.75 128.84 11.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.628 -1.295 . . . . 0.0 109.846 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.6 t -120.7 114.23 21.37 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-O 121.899 0.857 . . . . 0.0 112.019 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -79.95 76.08 6.67 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 122.054 0.93 . . . . 0.0 110.45 167.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.73 -82.25 0.09 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -105.23 -16.43 14.77 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 167.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -88.81 106.06 18.13 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 120.982 1.719 . . . . 0.0 109.9 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.49 116.01 31.59 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 111.344 -168.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.9 m -108.37 128.46 54.79 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.041 0.936 . . . . 0.0 109.493 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.73 122.18 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -109.98 111.96 23.67 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.055 0.542 . . . . 0.0 110.073 168.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.8 m -87.87 99.53 12.2 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -86.19 116.91 24.68 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.153 0.978 . . . . 0.0 111.594 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.1 t -147.06 135.05 21.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.85 0.86 . . . . 0.0 109.764 169.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 64.5 p -59.32 -30.37 68.31 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 165.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.3 mt -71.58 -53.06 14.98 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 170.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -153.04 100.04 2.45 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 120.284 1.402 . . . . 0.0 110.593 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.4 ' C ' ' HG1' ' A' ' 63' ' ' THR . 26.6 m -77.83 146.1 35.93 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.012 0.91 . . . . 0.0 111.669 171.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.4 ' HG1' ' C ' ' A' ' 62' ' ' THR . 89.7 m -152.16 134.01 14.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.091 -1.631 . . . . 0.0 109.857 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -131.5 138.77 49.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 111.577 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -141.91 152.63 43.73 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 174.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.7 p -135.78 109.49 8.05 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.924 0.89 . . . . 0.0 110.029 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.2 t -134.82 154.21 51.72 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.556 0.742 . . . . 0.0 112.242 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.92 140.07 47.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.433 -1.417 . . . . 0.0 110.603 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.9 tp -68.89 118.98 12.51 Favored 'General case' 0 CA--C 1.579 2.088 0 O-C-N 120.69 -1.256 . . . . 0.0 111.442 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.35 -40.92 2.34 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 116.988 1.555 . . . . 0.0 116.988 -157.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.8 154.86 24.51 Favored 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 125.194 1.398 . . . . 0.0 113.416 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.3 152.64 21.3 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 166.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -138.62 162.47 34.54 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.761 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.84 100.58 2.93 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.878 0.847 . . . . 0.0 111.519 166.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -92.81 98.27 11.29 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.6 m -79.79 95.73 6.09 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 163.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.2 p -61.75 170.65 1.91 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -160.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.92 -41.04 58.43 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 164.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -50.43 -61.35 2.23 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 159.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.67 -30.49 3.1 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 120.588 -1.32 . . . . 0.0 116.303 -151.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -60.56 134.95 57.58 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 118.703 1.252 . . . . 0.0 112.63 173.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -85.81 129.15 34.91 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.344 0.592 . . . . 0.0 111.197 168.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.4 p -130.29 136.86 49.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.681 0.753 . . . . 0.0 109.217 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -87.62 96.16 10.31 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 120.692 -1.255 . . . . 0.0 108.956 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.9 m -103.64 115.61 30.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.641 -0.662 . . . . 0.0 110.65 -161.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.5 p -85.44 124.5 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-N 118.696 0.68 . . . . 0.0 112.024 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.1 m -94.0 111.85 23.61 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.376 0.67 . . . . 0.0 111.398 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -139.76 124.76 18.63 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 119.828 1.194 . . . . 0.0 112.847 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -95.2 130.36 41.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.136 -0.977 . . . . 0.0 111.71 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 t -147.69 136.33 21.81 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.222 0.609 . . . . 0.0 110.16 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 62.72 33.72 15.27 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 160.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.93 -13.77 55.38 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 -164.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -109.78 128.62 55.42 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 119.644 1.722 . . . . 0.0 113.167 -176.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.7 tp -86.7 108.5 18.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.416 -0.803 . . . . 0.0 109.637 161.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.6 t -91.75 112.19 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 98.73 10.7 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 169.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -91.12 99.39 12.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 111.355 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -70.02 125.3 26.37 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.852 0.861 . . . . 0.0 112.05 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -124.37 117.22 23.99 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -150.18 120.54 7.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.683 -1.261 . . . . 0.0 112.645 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.255 39.1 t70 50.61 44.28 27.43 Favored 'General case' 0 CA--C 1.585 2.317 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.91 -30.32 2.93 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 119.06 2.384 . . . . 0.0 119.06 -166.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -83.63 144.78 29.2 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.696 1.198 . . . . 0.0 112.79 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -140.52 156.82 46.2 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.1 t -146.94 142.28 27.4 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.445 0.698 . . . . 0.0 111.663 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.0 p -102.04 113.5 26.79 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.279 -0.888 . . . . 0.0 110.864 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.4 mm -88.19 95.68 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.1 m -96.67 92.32 6.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.554 -0.716 . . . . 0.0 110.53 -167.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -90.57 97.7 11.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.302 0.641 . . . . 0.0 111.673 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -119.2 137.34 53.7 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.725 0.81 . . . . 0.0 112.742 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.47 121.57 24.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 111.613 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 113' ' ' ASP . 0.0 OUTLIER -109.76 -144.67 0.39 Allowed 'General case' 0 CA--C 1.562 1.404 0 CA-C-O 121.231 0.539 . . . . 0.0 111.868 -171.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.414 ' H ' ' HG3' ' A' ' 112' ' ' LYS . 15.1 m-20 -87.2 66.09 9.1 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 120.973 -1.079 . . . . 0.0 109.954 -167.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.81 -18.11 58.1 Favored Glycine 0 CA--C 1.557 2.664 0 N-CA-C 119.67 2.628 . . . . 0.0 119.67 -168.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.65 166.53 24.34 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.629 2.215 . . . . 0.0 110.986 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.9 tp -87.15 120.68 28.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.061 -1.649 . . . . 0.0 111.318 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 55.8 t -87.15 115.57 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -109.21 93.07 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -84.66 95.09 8.79 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.905 1.336 . . . . 0.0 109.593 173.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.989 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.4 p -89.46 99.72 12.66 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.603 176.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 p -113.56 126.03 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.647 0.737 . . . . 0.0 110.534 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.0 tpt -73.51 -60.76 2.1 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.564 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.258 12.5 p30 -153.46 -80.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -79.77 -32.75 40.99 Favored 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 159.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.25 106.69 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 CA-C-N 120.022 1.283 . . . . 0.0 110.607 -169.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.9 p -102.12 121.55 42.42 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.138 0.975 . . . . 0.0 111.305 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.989 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.3 p -100.9 117.21 34.52 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 118.195 0.452 . . . . 0.0 111.03 162.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 m -89.32 106.78 18.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.594 -0.691 . . . . 0.0 109.173 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -106.68 106.94 17.71 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 34.3 mm -91.28 132.41 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -120.93 131.79 54.56 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 121.267 0.556 . . . . 0.0 112.095 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -81.42 134.13 35.51 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -75.39 117.12 16.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.265 -0.897 . . . . 0.0 111.623 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.5 t -95.29 106.22 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 123.222 0.609 . . . . 0.0 110.264 -170.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . 0.267 66.7 m . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.258 9.3 p -68.95 -38.36 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.904 1.229 . . . . 0.0 114.142 158.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.47 -36.97 56.06 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 162.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -64.59 -26.37 68.38 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.623 2.082 . . . . 0.0 116.623 170.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.1 mt -65.08 -20.77 66.64 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 161.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -76.81 123.13 25.77 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.747 1.612 . . . . 0.0 112.127 -170.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.29 -179.79 26.73 Favored Glycine 0 N--CA 1.489 2.17 0 CA-C-O 122.162 0.868 . . . . 0.0 115.109 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -93.33 132.69 37.31 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.031 0.532 . . . . 0.0 111.042 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -124.98 110.45 14.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.968 -0.457 . . . . 0.0 111.286 -168.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -95.88 128.61 42.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.729 -1.232 . . . . 0.0 113.516 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.19 129.27 38.48 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.277 10.3 m -118.52 -64.23 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 118.51 -0.757 . . . . 0.0 111.749 178.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -101.93 157.3 16.96 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 123.352 1.548 . . . . 0.0 112.158 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -155.95 72.35 0.77 Allowed 'General case' 0 CA--C 1.562 1.438 0 O-C-N 120.891 -1.131 . . . . 0.0 110.878 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.11 129.87 41.3 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.156 -0.965 . . . . 0.0 112.437 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.54 11.06 61.66 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 119.953 2.741 . . . . 0.0 119.953 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -68.79 -35.59 77.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.313 1.968 . . . . 0.0 116.313 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -53.46 -54.81 31.65 Favored 'General case' 0 CA--C 1.575 1.917 0 CA-C-N 119.964 1.256 . . . . 0.0 114.22 167.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -54.44 -40.1 68.03 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 168.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.5 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 78.9 t80 -60.5 -45.51 93.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 166.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.3 9.6 ptt? -73.21 -30.3 63.41 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -42.72 91.58 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-N 121.192 1.814 . . . . 0.0 115.271 155.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -61.48 -42.65 99.11 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.7 mt -58.23 -44.54 88.27 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 165.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.58 44.07 2.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 117.654 1.822 . . . . 0.0 117.654 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.92 139.55 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 C-N-CA 124.054 0.942 . . . . 0.0 110.022 162.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.03 171.68 47.91 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 116.245 1.258 . . . . 0.0 116.245 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 pt -53.07 -47.3 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 -172.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.36 95.9 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.46 -40.33 95.51 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 168.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 mtp-105 -61.0 -44.82 96.86 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 166.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.73 -46.6 81.23 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.8 ttm -51.13 -59.6 4.01 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 163.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.68 -36.45 48.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 119.96 2.744 . . . . 0.0 119.96 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.43 70.43 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 21.4 ptp -85.54 -26.47 26.17 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.93 106.81 3.32 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 120.262 1.392 . . . . 0.0 113.308 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -109.47 90.54 8.73 Favored Pre-proline 0 CA--C 1.571 1.758 0 C-N-CA 123.778 0.831 . . . . 0.0 109.84 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.47 160.92 14.82 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.409 2.073 . . . . 0.0 116.288 -167.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -93.7 97.96 10.8 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.152 166.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.8 t -89.9 110.51 21.45 Favored 'General case' 0 CA--C 1.558 1.273 0 O-C-N 121.185 -0.947 . . . . 0.0 112.087 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 mt -90.4 114.75 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 108.666 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 91.9 mt -94.7 123.74 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 166.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.1 m -150.28 126.71 10.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.98 -1.075 . . . . 0.0 109.846 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -122.08 116.39 24.16 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.08 84.28 7.05 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.347 1.07 . . . . 0.0 110.579 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.6 -75.3 1.24 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -125.23 -20.97 4.71 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 170.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.73 103.89 11.74 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 121.808 2.095 . . . . 0.0 111.222 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tt -98.0 117.71 32.96 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.073 0.949 . . . . 0.0 110.237 -171.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.7 m -96.83 126.41 41.97 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.798 0.839 . . . . 0.0 110.066 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.5 mt -110.03 102.3 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -101.86 104.22 14.94 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.281 0.632 . . . . 0.0 110.115 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.4 m -86.86 106.48 17.77 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.797 0.839 . . . . 0.0 109.984 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -94.79 115.54 27.62 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.535 0.683 . . . . 0.0 111.573 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.2 t -153.59 136.82 15.67 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.422 0.689 . . . . 0.0 110.55 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.2 p -59.32 -33.96 71.76 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 mt -64.44 -50.32 68.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 166.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.06 105.66 2.56 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 119.85 1.204 . . . . 0.0 111.663 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.1 m -90.91 133.87 34.91 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 123.033 0.533 . . . . 0.0 110.636 172.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -137.64 146.69 44.2 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 123.355 0.662 . . . . 0.0 111.149 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 129.55 22.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.744 -1.223 . . . . 0.0 111.483 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.84 143.71 47.17 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.616 0.766 . . . . 0.0 111.102 172.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.6 m -130.05 126.06 36.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 0.0 111.259 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.46 146.26 33.28 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -169.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.51 134.33 43.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.698 -1.251 . . . . 0.0 110.856 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -72.84 117.21 14.27 Favored 'General case' 0 CA--C 1.574 1.883 0 O-C-N 120.671 -1.268 . . . . 0.0 112.88 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.7 -34.93 5.41 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 117.23 1.652 . . . . 0.0 117.23 -158.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.71 158.32 31.06 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 122.787 1.279 . . . . 0.0 113.376 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -115.74 140.97 48.7 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.705 173.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -152.15 153.53 34.05 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.945 0.898 . . . . 0.0 110.917 -162.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -83.14 87.23 6.92 Favored 'General case' 0 CA--C 1.574 1.882 0 O-C-N 120.487 -1.383 . . . . 0.0 113.778 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.38 115.2 12.46 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.151 0.977 . . . . 0.0 110.525 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.8 m -101.12 100.53 11.11 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.488 -170.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 p -73.06 159.86 32.94 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -161.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.73 -32.88 6.32 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 119.123 3.009 . . . . 0.0 119.123 169.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -58.61 -51.23 70.79 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 161.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.02 -30.24 2.85 Favored Glycine 0 CA--C 1.551 2.343 0 N-CA-C 116.96 1.544 . . . . 0.0 116.96 -157.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 -58.65 129.68 43.27 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.351 2.076 . . . . 0.0 114.816 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.86 101.6 11.77 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.803 0.841 . . . . 0.0 109.427 172.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.0 p -109.51 105.58 14.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.048 -1.032 . . . . 0.0 110.088 -168.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -70.38 105.31 2.98 Favored 'General case' 0 CA--C 1.565 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.445 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.0 m -130.85 120.35 23.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.003 . . . . 0.0 110.279 -151.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.76 126.79 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 118.829 0.741 . . . . 0.0 111.736 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.4 m -105.69 112.12 25.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.942 -0.474 . . . . 0.0 111.807 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -125.08 131.03 53.38 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.303 0.641 . . . . 0.0 111.112 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -88.49 127.06 35.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.959 . . . . 0.0 111.617 168.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.1 t -143.22 140.35 30.66 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.157 0.583 . . . . 0.0 110.139 167.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 61.67 36.71 16.4 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 160.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.43 16.84 80.38 Favored Glycine 0 CA--C 1.557 2.691 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -165.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.75 136.07 26.87 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 119.664 1.732 . . . . 0.0 113.919 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.0 tp -92.8 112.42 24.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.699 -0.626 . . . . 0.0 110.916 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.09 109.04 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -89.22 98.79 11.97 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.251 0.62 . . . . 0.0 109.339 167.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -89.84 104.14 16.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.605 -0.684 . . . . 0.0 110.232 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -91.62 131.97 36.65 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.154 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -127.94 126.29 41.17 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 119.035 0.834 . . . . 0.0 110.197 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -148.14 120.81 8.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.575 -1.328 . . . . 0.0 110.451 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.8 t70 49.7 51.06 17.22 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.72 -24.91 2.19 Favored Glycine 0 CA--C 1.557 2.688 0 N-CA-C 119.596 2.598 . . . . 0.0 119.596 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -93.67 140.96 29.02 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.994 1.397 . . . . 0.0 111.55 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -129.32 146.85 51.14 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 175.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.7 t -143.4 111.24 6.01 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.037 0.535 . . . . 0.0 110.385 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.3 t -98.65 146.3 25.98 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.8 mt -127.91 108.31 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -169.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.6 m -97.63 106.23 18.51 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.548 0.739 . . . . 0.0 110.214 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -93.0 85.87 5.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 111.237 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -100.37 130.13 46.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -167.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.89 117.24 21.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 112.288 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -145.78 121.88 10.77 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.519 0.728 . . . . 0.0 109.684 -171.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 59.5 47.99 10.29 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 168.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.75 35.04 80.03 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -166.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.48 139.6 16.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.452 0.701 . . . . 0.0 109.781 -162.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.11 112.46 24.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.172 -0.955 . . . . 0.0 108.757 172.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.2 t -99.16 101.82 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.37 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -165.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -100.1 100.98 11.91 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.987 0.899 . . . . 0.0 109.798 -170.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.994 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.5 p -101.72 127.25 48.57 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.158 0.983 . . . . 0.0 111.517 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.71 143.62 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 123.316 0.646 . . . . 0.0 111.518 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.7 ttt -124.17 -103.13 0.38 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.336 -0.852 . . . . 0.0 108.732 165.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -87.66 70.51 9.71 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 120.571 1.532 . . . . 0.0 111.264 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.253 0.7 OUTLIER 62.88 0.13 0.65 Allowed 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 118.169 2.655 . . . . 0.0 118.169 -165.709 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.47 93.94 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.253 -1.529 . . . . 0.0 108.644 -171.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.6 p -92.62 117.59 30.13 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.252 0.548 . . . . 0.0 111.761 -171.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.994 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 4.1 p -108.12 119.91 40.81 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.437 0.695 . . . . 0.0 111.339 171.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.6 m -101.96 107.57 18.75 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -101.67 114.1 27.84 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.483 0.713 . . . . 0.0 109.833 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.47 124.94 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.344 -0.848 . . . . 0.0 108.924 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -122.95 131.76 53.86 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -86.21 132.13 34.07 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.253 1.421 . . . . 0.0 113.725 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -73.36 111.13 8.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.877 -1.139 . . . . 0.0 112.102 174.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.2 t -103.62 95.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.253 1.286 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.738 -178.039 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.519 3.9 p 58.45 -48.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 -172.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.95 -47.66 84.28 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -64.94 -15.96 62.74 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 171.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.61 -11.74 61.0 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 163.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -83.9 125.25 31.82 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 121.422 1.919 . . . . 0.0 113.091 -165.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.6 -170.6 26.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 115.856 1.102 . . . . 0.0 115.856 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -90.49 122.52 33.41 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.536 0.734 . . . . 0.0 110.894 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -123.55 110.89 15.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.613 -0.679 . . . . 0.0 110.857 -172.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -90.15 130.63 36.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.591 -1.318 . . . . 0.0 113.37 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 46.8 tp -65.0 128.65 36.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 173.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.275 8.8 m -121.46 -61.4 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.129 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -96.43 149.51 21.64 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.491 1.496 . . . . 0.0 111.41 167.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.4 p -145.81 65.76 1.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.166 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.23 126.96 31.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.726 -1.234 . . . . 0.0 112.386 -175.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.64 23.14 62.6 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 119.248 2.459 . . . . 0.0 119.248 -171.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -75.1 -46.81 32.09 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 119.002 1.401 . . . . 0.0 114.455 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.69 -44.14 63.03 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 163.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -52.8 -48.54 66.83 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.499 ' HH ' ' CB ' ' A' ' 105' ' ' SER . 86.7 t80 -58.82 -51.29 70.63 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 167.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 50.0 mtm -68.35 -42.62 78.95 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.34 -37.28 23.93 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 116.207 1.928 . . . . 0.0 116.207 164.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.76 -39.39 76.73 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 171.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.5 mt -51.04 -45.09 61.21 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 162.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.9 46.92 1.06 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 117.114 1.605 . . . . 0.0 117.114 -172.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 m -91.78 143.03 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 C-N-CA 124.519 1.128 . . . . 0.0 110.676 166.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.55 174.5 42.03 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 2.6 pp -55.81 -44.94 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.25 84.32 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.8 mt -64.9 -43.24 93.48 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -52.46 -54.6 30.23 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 164.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -59.49 -52.31 66.14 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.2 ttp -56.15 -49.78 73.02 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 172.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.39 -44.8 97.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 118.23 2.052 . . . . 0.0 118.23 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.23 96.94 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.1 ptp -76.98 -16.72 59.25 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.148 2.648 . . . . 0.0 118.148 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.14 145.39 46.43 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.29 73.07 5.17 Favored Pre-proline 0 CA--C 1.577 1.984 0 CA-C-O 118.546 -0.74 . . . . 0.0 110.627 171.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.32 146.8 57.78 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.134 2.556 . . . . 0.0 116.001 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -83.07 100.8 10.72 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.097 165.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.4 t -79.19 101.9 8.22 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.839 0.828 . . . . 0.0 110.545 167.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mt -96.2 106.36 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.31 128.65 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.0 m -146.32 113.15 6.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.395 -0.816 . . . . 0.0 108.821 170.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.7 95.64 10.0 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 121.276 -0.89 . . . . 0.0 111.062 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.56 76.77 9.98 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-O 122.393 1.092 . . . . 0.0 110.063 -171.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.59 -101.11 1.62 Allowed Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.143 -0.973 . . . . 0.0 113.642 -167.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -94.97 -11.94 27.63 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 156.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -84.57 96.5 9.18 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 122.023 2.192 . . . . 0.0 110.556 -167.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.3 tp -73.22 108.62 6.2 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 121.941 0.876 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.2 m -98.34 105.39 17.53 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.7 103.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -102.85 115.88 31.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.579 0.752 . . . . 0.0 109.687 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.8 m -100.3 97.29 8.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.699 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -89.34 119.72 30.06 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.88 0.848 . . . . 0.0 112.313 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.1 t -150.66 134.76 16.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.673 0.789 . . . . 0.0 110.054 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.4 p -59.12 -33.31 70.71 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.04 -47.84 73.05 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 166.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -158.27 104.94 1.88 Allowed 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.145 1.338 . . . . 0.0 111.173 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.2 m -92.39 137.53 32.28 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.708 -0.62 . . . . 0.0 111.55 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -144.25 164.47 30.65 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.428 0.691 . . . . 0.0 111.686 168.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -154.46 149.72 27.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 119.897 -1.752 . . . . 0.0 114.285 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -138.93 141.21 38.47 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.424 0.63 . . . . 0.0 112.122 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.7 p -126.41 105.15 8.58 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.767 0.827 . . . . 0.0 109.923 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.3 p -136.85 142.13 42.83 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -166.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 m -72.07 118.98 15.62 Favored 'General case' 0 CA--C 1.574 1.871 0 O-C-N 120.575 -1.328 . . . . 0.0 111.768 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 tp -69.48 122.87 19.86 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -166.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.44 -38.08 3.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -158.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -99.23 164.45 12.13 Favored 'General case' 0 CA--C 1.574 1.9 0 CA-C-O 123.519 1.628 . . . . 0.0 113.405 -166.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -103.28 125.69 50.06 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 113.622 -1.626 . . . . 0.0 112.446 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -125.02 164.69 19.61 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.944 0.897 . . . . 0.0 113.377 -174.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -76.64 104.91 7.39 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.71 1.243 . . . . 0.0 111.516 167.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.82 115.89 27.5 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.229 1.012 . . . . 0.0 109.349 175.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.1 m -90.04 97.17 11.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.9 p -71.05 147.76 48.23 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.69 -37.02 7.75 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -65.41 -49.13 70.38 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 166.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.73 -14.26 1.19 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 118.478 2.151 . . . . 0.0 118.478 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -69.5 133.09 47.28 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 120.375 2.088 . . . . 0.0 112.84 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -86.73 102.05 13.87 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.065 165.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.4 p -104.26 143.08 33.44 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.49 -0.756 . . . . 0.0 110.591 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -79.23 95.6 5.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.478 -1.389 . . . . 0.0 110.494 166.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.2 m -92.46 116.65 29.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 0.0 110.132 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.315 11.6 p -87.82 109.46 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 118.264 0.483 . . . . 0.0 109.884 160.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 56.4 m -92.07 110.32 21.69 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -133.41 126.68 31.76 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.007 0.523 . . . . 0.0 111.627 -169.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -90.25 113.44 25.26 Favored 'General case' 0 CA--C 1.563 1.454 0 O-C-N 121.551 -0.718 . . . . 0.0 110.17 170.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 t -97.29 57.99 1.48 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.3 47.8 m-20 45.68 57.32 5.11 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 146.07 -61.13 0.47 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.829 -170.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.59 133.78 51.54 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.841 0.829 . . . . 0.0 112.86 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.7 tp -95.18 107.55 19.64 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.714 0.806 . . . . 0.0 110.669 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.5 114.97 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.569 0.748 . . . . 0.0 109.031 -172.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -89.09 98.18 11.62 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 166.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -95.53 92.22 6.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.854 -0.529 . . . . 0.0 111.354 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -83.23 123.25 29.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.146 0.978 . . . . 0.0 111.389 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -123.29 121.75 36.62 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.392 0.542 . . . . 0.0 110.625 -173.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -150.33 127.1 10.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.667 -1.27 . . . . 0.0 111.613 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.299 17.5 t70 52.85 49.74 19.57 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 162.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.24 0.07 19.72 Favored Glycine 0 CA--C 1.561 2.93 0 N-CA-C 120.145 2.818 . . . . 0.0 120.145 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -123.1 145.25 48.73 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 119.274 1.537 . . . . 0.0 109.854 -173.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -133.43 169.79 16.44 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.499 ' CB ' ' HH ' ' A' ' 22' ' ' TYR . 0.6 OUTLIER -154.03 121.33 5.76 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.751 -1.218 . . . . 0.0 111.596 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.54 103.56 12.46 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -172.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.0 mm -95.57 100.45 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 98.4 m -99.26 101.2 12.44 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.281 0.632 . . . . 0.0 110.252 -168.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -93.36 109.55 21.11 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.724 0.81 . . . . 0.0 110.793 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -125.15 144.35 50.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 112.766 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.75 122.91 28.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.348 -0.845 . . . . 0.0 110.821 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.293 42.0 tttm -124.7 -118.87 0.28 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 122.08 -0.388 . . . . 0.0 109.957 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -84.19 68.23 10.05 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.19 0.995 . . . . 0.0 112.651 -166.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.9 -13.61 5.27 Favored Glycine 0 CA--C 1.556 2.599 0 N-CA-C 119.477 2.551 . . . . 0.0 119.477 -166.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -124.71 158.12 33.99 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 119.096 1.448 . . . . 0.0 110.285 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.52 111.16 19.25 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.651 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 75.4 t -90.13 114.39 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.8 t -115.7 99.69 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 -167.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -99.34 108.6 21.15 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.425 0.69 . . . . 0.0 109.279 -171.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.963 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.7 p -103.74 122.69 45.59 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.71 -0.619 . . . . 0.0 111.938 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.39 136.16 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.385 0.612 . . . . 0.0 110.911 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 12.4 ttt -86.01 -76.1 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 122.722 0.409 . . . . 0.0 110.887 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -126.88 -73.08 0.62 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 166.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -89.97 -30.05 18.06 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.9 t -85.15 107.06 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 119.919 1.236 . . . . 0.0 110.537 -166.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 69.7 p -105.17 113.11 26.51 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.544 0.738 . . . . 0.0 111.344 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.963 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.4 OUTLIER -87.47 157.19 19.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 166.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.0 m -127.97 109.14 11.29 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 166.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -98.38 123.96 42.79 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.527 0.731 . . . . 0.0 110.64 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.9 mm -99.19 116.34 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -114.35 130.86 56.69 Favored 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 122.854 0.462 . . . . 0.0 110.826 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -107.83 143.96 35.68 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -74.28 118.36 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.662 -0.649 . . . . 0.0 112.708 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.3 t -90.06 95.68 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 118.436 -0.792 . . . . 0.0 109.781 -174.253 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.6 m . . . . . 0 CA--C 1.567 1.61 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.01 50.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 C-N-CA 124.848 1.259 . . . . 0.0 109.609 157.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -136.97 70.51 1.4 Allowed 'General case' 0 CA--C 1.57 1.743 0 O-C-N 120.686 -1.259 . . . . 0.0 110.063 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -163.94 -52.33 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 125.87 1.668 . . . . 0.0 110.407 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.3 mt -75.87 0.27 18.78 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.42 143.72 29.24 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-N 120.736 1.607 . . . . 0.0 112.314 -171.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.62 -173.78 17.04 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 115.894 1.117 . . . . 0.0 115.894 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -87.24 112.7 22.28 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.469 0.708 . . . . 0.0 111.596 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -112.61 112.88 24.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 122.122 -0.361 . . . . 0.0 110.718 -175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -94.01 134.09 36.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.635 -1.291 . . . . 0.0 112.746 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.49 126.77 30.77 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.597 -0.689 . . . . 0.0 111.92 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.258 3.6 m -113.1 -66.49 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.836 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -111.43 107.96 17.36 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.575 1.079 . . . . 0.0 110.347 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.6 p -89.56 81.62 6.49 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.617 -0.677 . . . . 0.0 111.449 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.27 107.28 14.83 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -163.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.18 16.43 78.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 118.439 2.136 . . . . 0.0 118.439 -168.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -86.29 68.78 10.35 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-N 120.102 1.951 . . . . 0.0 112.868 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -141.73 -51.7 0.42 Allowed 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.778 153.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -45.1 -46.81 11.94 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 167.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.403 ' CD2' ' SG ' ' A' ' 127' ' ' CYS . 57.9 t80 -54.55 -57.62 10.68 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 171.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 ptt? -61.74 -43.98 97.79 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.33 -46.89 55.92 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 162.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -67.87 -39.13 83.77 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.913 1.819 . . . . 0.0 115.913 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -50.03 -40.83 46.04 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 159.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.15 50.0 0.6 Allowed Glycine 0 N--CA 1.486 2.015 0 C-N-CA 124.738 1.161 . . . . 0.0 114.978 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.8 t -99.78 131.7 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.578 0.751 . . . . 0.0 109.197 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.26 160.74 48.69 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 116.888 1.515 . . . . 0.0 116.888 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.281 2.6 pp -58.23 -46.34 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -173.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.17 95.28 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 167.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -41.23 89.34 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 170.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -54.97 -49.54 71.15 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 162.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -54.88 -49.73 70.45 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 170.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -52.83 -55.93 19.45 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 165.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.02 -43.79 96.69 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 118.85 2.3 . . . . 0.0 118.85 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.04 95.01 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . 0.269 14.4 ptt? -70.23 -40.03 74.73 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 170.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.43 133.93 56.57 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.51 92.75 41.57 Favored Pre-proline 0 CA--C 1.571 1.786 0 CA-C-O 118.027 -0.987 . . . . 0.0 108.564 166.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.84 158.48 27.74 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.505 2.137 . . . . 0.0 115.713 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -94.22 107.41 19.36 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.531 165.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.65 102.5 15.02 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 121.142 -0.973 . . . . 0.0 111.16 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -90.91 119.66 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 81.0 mt -108.81 126.74 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -138.18 116.08 11.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.827 -1.171 . . . . 0.0 109.121 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.8 p -117.97 111.51 19.06 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -89.86 68.43 7.4 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 122.128 0.966 . . . . 0.0 110.594 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.45 -75.68 0.67 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 120.478 -1.389 . . . . 0.0 115.754 -170.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -104.16 -44.16 5.05 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -74.28 110.01 8.23 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 121.281 1.855 . . . . 0.0 111.792 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 tt -112.82 112.85 24.64 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 122.379 1.085 . . . . 0.0 109.053 -172.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.5 m -99.13 115.92 30.15 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.733 0.813 . . . . 0.0 109.108 -172.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mt -106.58 105.89 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -102.72 105.93 16.46 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.285 0.634 . . . . 0.0 109.89 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.0 m -88.68 103.03 15.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.458 -0.776 . . . . 0.0 109.322 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.88 117.19 29.77 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.967 0.889 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -156.4 137.41 13.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.561 0.744 . . . . 0.0 110.055 168.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.3 p -58.57 -34.66 71.3 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 167.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.5 -47.42 73.05 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 168.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -156.35 104.78 2.24 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 120.077 1.308 . . . . 0.0 110.794 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 m -93.06 132.43 37.19 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.137 0.575 . . . . 0.0 110.935 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.1 p -142.53 115.49 8.78 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.767 -0.583 . . . . 0.0 110.668 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -109.96 135.56 50.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.36 0.664 . . . . 0.0 112.016 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -142.17 144.64 33.52 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.815 0.817 . . . . 0.0 112.699 170.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.8 p -106.16 105.75 15.93 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.662 0.785 . . . . 0.0 110.769 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.5 p -102.53 135.35 44.32 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 m -75.73 130.81 39.25 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 120.752 -1.218 . . . . 0.0 110.454 171.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 tp -77.67 124.74 28.34 Favored 'General case' 0 CA--C 1.57 1.736 0 O-C-N 121.377 -0.827 . . . . 0.0 112.377 175.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.98 39.54 11.54 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 117.452 1.741 . . . . 0.0 117.452 -169.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -171.92 147.53 2.18 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.807 1.243 . . . . 0.0 108.522 -167.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.257 11.6 ptpt -100.18 146.97 26.22 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 171.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -137.88 161.08 37.57 Favored 'General case' 0 CA--C 1.571 1.757 0 C-N-CA 124.893 1.277 . . . . 0.0 110.513 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -80.74 104.26 11.14 Favored 'General case' 0 CA--C 1.572 1.825 0 O-C-N 119.972 -1.705 . . . . 0.0 112.228 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -88.16 109.49 19.94 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.14 0.976 . . . . 0.0 110.707 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.3 m -76.08 99.54 4.67 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.772 . . . . 0.0 110.205 170.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 p -69.66 148.12 49.71 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.574 0.749 . . . . 0.0 112.717 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.14 -41.91 18.43 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.42 -43.91 76.17 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 170.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.82 -31.05 0.29 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.8 mtm-85 -67.75 126.86 30.74 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.071 1.936 . . . . 0.0 113.038 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -88.73 117.13 27.49 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.08 0.467 . . . . 0.0 109.777 166.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.0 p -123.82 129.07 50.45 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.479 0.657 . . . . 0.0 110.338 -163.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -83.64 105.4 14.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.525 -1.36 . . . . 0.0 109.679 -170.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.7 m -121.6 105.53 10.53 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.96 -0.463 . . . . 0.0 110.98 -148.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.44 120.84 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 120.89 0.376 . . . . 0.0 111.443 172.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 45.4 m -95.35 109.38 21.55 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.123 0.487 . . . . 0.0 109.732 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -136.31 124.0 22.43 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.141 0.576 . . . . 0.0 110.932 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -85.88 132.69 34.04 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.093 -1.005 . . . . 0.0 112.188 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 t -139.87 143.52 36.77 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.148 0.579 . . . . 0.0 110.101 163.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 62.27 35.69 15.14 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 162.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.14 29.06 73.17 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -164.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.08 134.28 18.27 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 118.519 1.16 . . . . 0.0 112.907 -170.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.9 tp -88.04 115.46 25.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.782 -0.574 . . . . 0.0 111.216 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.31 108.06 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -94.44 90.11 6.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -89.84 108.13 19.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.903 -0.498 . . . . 0.0 110.863 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -106.6 130.5 54.34 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -169.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -129.36 127.48 41.13 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 123.622 0.769 . . . . 0.0 111.747 -166.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -153.04 134.87 14.62 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.274 -1.516 . . . . 0.0 111.159 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.2 t70 48.29 48.3 18.97 Favored 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 166.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.32 19.06 66.04 Favored Glycine 0 CA--C 1.558 2.764 0 N-CA-C 120.384 2.913 . . . . 0.0 120.384 -167.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -136.54 137.1 39.91 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.216 1.508 . . . . 0.0 109.193 -168.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -128.59 143.86 51.04 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 123.13 1.443 . . . . 0.0 114.57 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.6 t -133.2 164.61 26.66 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.473 167.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -142.72 139.07 30.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.013 -1.68 . . . . 0.0 113.234 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.1 mm -104.97 103.27 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.9 m -99.13 102.02 13.57 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.347 0.594 . . . . 0.0 109.628 -175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -93.88 95.64 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.676 -0.64 . . . . 0.0 110.833 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -104.14 134.97 46.49 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 118.514 0.597 . . . . 0.0 112.487 -176.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 109.75 12.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.966 -1.084 . . . . 0.0 110.189 173.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -144.84 128.75 17.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.555 -0.715 . . . . 0.0 110.783 -170.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 60.36 40.71 17.18 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.61 -15.3 25.67 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 119.814 2.686 . . . . 0.0 119.814 -169.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.8 169.2 17.42 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.081 1.94 . . . . 0.0 112.261 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.5 tp -88.06 116.08 25.99 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 120.551 -1.343 . . . . 0.0 110.109 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.6 t -99.03 108.92 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.9 t -102.42 96.51 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -169.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -87.49 100.95 13.14 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.219 1.009 . . . . 0.0 109.673 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.984 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.6 p -107.48 108.4 19.7 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.924 0.889 . . . . 0.0 110.352 -173.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.79 137.71 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.865 0.866 . . . . 0.0 111.618 -168.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.1 ttt -113.93 106.7 14.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 162.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.303 6.3 m120 68.52 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.987 0.915 . . . . 0.0 112.856 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -125.42 -3.12 7.4 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 164.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.7 t -90.32 100.1 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 121.906 2.139 . . . . 0.0 109.567 -170.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.5 p -99.2 123.62 43.63 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.807 0.843 . . . . 0.0 112.8 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.984 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.4 p -103.09 133.06 48.83 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 120.937 0.399 . . . . 0.0 111.349 157.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.7 m -106.49 101.46 10.92 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -95.01 114.7 26.54 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.499 -0.751 . . . . 0.0 110.603 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.4 mm -88.19 124.2 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -123.9 122.44 37.99 Favored 'General case' 0 CA--C 1.569 1.709 0 C-N-CA 123.534 0.734 . . . . 0.0 111.433 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -97.18 142.65 28.83 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -78.58 117.59 19.9 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.702 -1.248 . . . . 0.0 112.568 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 32.9 t -117.21 81.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.653 -0.654 . . . . 0.0 109.337 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.256 1.413 0 C-N-CA 123.558 0.743 . . . . 0.0 110.787 -178.043 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.932 0.872 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.408 HG22 ' SG ' ' A' ' 47' ' ' CYS 0.262 4.6 p -64.23 -39.56 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -177.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -41.78 98.73 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 166.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -57.28 -23.66 49.87 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.41 -6.46 7.24 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 164.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -64.05 161.01 16.83 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 122.615 2.461 . . . . 0.0 115.274 171.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.42 169.3 12.88 Favored Glycine 0 N--CA 1.49 2.272 0 O-C-N 121.264 -0.898 . . . . 0.0 115.28 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -83.73 96.28 8.67 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.936 0.495 . . . . 0.0 110.858 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -97.18 100.16 11.64 Favored 'General case' 0 CA--C 1.566 1.566 0 O-C-N 121.422 -0.799 . . . . 0.0 110.982 -170.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -77.12 127.28 32.37 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.879 -1.138 . . . . 0.0 112.973 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.2 tp -67.07 121.83 16.45 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.985 0.811 . . . . 0.0 113.033 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.56 -46.58 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -120.95 131.42 54.32 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.48 1.112 . . . . 0.0 109.404 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.8 p -131.83 70.79 1.46 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 172.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -82.38 127.23 33.05 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.21 17.35 61.03 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 118.578 2.191 . . . . 0.0 118.578 -170.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -84.93 -42.47 14.94 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -166.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -60.54 -39.25 87.23 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 121.19 1.814 . . . . 0.0 115.073 169.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.251 14.7 pt-20 -59.7 -49.22 78.58 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 167.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.457 ' CD2' ' SG ' ' A' ' 127' ' ' CYS . 76.7 t80 -55.32 -49.84 71.15 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 169.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.2 mtm -64.26 -36.54 84.42 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -58.53 -45.9 87.92 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 121.514 1.961 . . . . 0.0 115.542 162.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.09 -44.1 95.05 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 171.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.4 mt -55.3 -37.78 67.81 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.24 59.19 0.77 Allowed Glycine 0 N--CA 1.487 2.066 0 C-N-CA 124.13 0.871 . . . . 0.0 114.54 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.6 t -115.27 125.13 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -172.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 164.03 50.85 Favored Glycine 0 CA--C 1.551 2.336 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.262 2.4 pp -55.04 -48.75 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 N-CA-C 117.226 2.306 . . . . 0.0 117.226 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.12 94.98 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.81 -44.25 94.09 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -66.0 -44.18 85.53 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 171.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -56.4 -48.88 76.03 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 168.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.9 ttp -52.96 -58.11 8.07 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 163.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.21 -44.06 89.04 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 119.311 2.484 . . . . 0.0 119.311 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.35 -45.24 95.22 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.3 ptp -74.32 -28.79 61.32 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 168.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.58 102.74 1.54 Allowed 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 119.593 1.088 . . . . 0.0 113.035 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -103.09 92.77 3.95 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.449 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -80.48 160.2 22.47 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.222 1.948 . . . . 0.0 116.08 -172.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -85.36 104.48 15.22 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.294 157.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.2 t -86.85 96.31 10.17 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 124.048 0.939 . . . . 0.0 110.872 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.38 106.11 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.2 mt -97.08 144.81 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 CA-C-O 122.814 1.292 . . . . 0.0 108.454 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -147.1 115.43 6.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.06 -1.65 . . . . 0.0 108.522 167.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.408 ' SG ' HG22 ' A' ' 4' ' ' VAL . 38.5 t -114.39 107.12 15.13 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.971 0.508 . . . . 0.0 111.65 174.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -99.63 79.81 2.3 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 122.408 1.099 . . . . 0.0 109.746 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.34 -89.7 0.43 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -99.43 -15.51 18.71 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -106.41 129.21 54.44 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 122.038 2.199 . . . . 0.0 111.113 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 tt -125.5 116.82 22.4 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.295 0.638 . . . . 0.0 110.224 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.1 m -107.58 134.18 50.96 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.917 0.887 . . . . 0.0 109.715 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.9 mt -124.76 111.2 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -87.71 159.57 18.44 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 122.023 0.916 . . . . 0.0 111.182 160.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -148.24 102.86 3.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 119.525 -1.984 . . . . 0.0 107.664 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -98.27 114.31 26.55 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.689 0.795 . . . . 0.0 111.917 -172.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -147.36 140.16 24.93 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.669 0.787 . . . . 0.0 110.484 168.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.0 t -54.4 -28.99 47.38 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 167.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.8 mt -85.14 -47.0 10.58 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 124.122 0.969 . . . . 0.0 113.342 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.1 106.02 3.85 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.881 1.219 . . . . 0.0 110.914 168.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.7 m -90.05 134.66 34.12 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.159 0.584 . . . . 0.0 110.719 170.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -134.83 158.44 44.21 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.931 0.872 . . . . 0.0 111.525 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -150.2 130.93 14.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.538 -1.351 . . . . 0.0 110.802 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -144.2 160.89 40.17 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.881 0.848 . . . . 0.0 112.913 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -139.43 145.83 39.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 112.784 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -132.97 160.04 38.24 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-O 122.448 1.118 . . . . 0.0 112.445 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.7 m -90.56 132.9 35.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 164.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -73.58 128.73 36.3 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -170.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.65 -55.96 0.89 Allowed Glycine 0 N--CA 1.494 2.508 0 O-C-N 121.857 -0.527 . . . . 0.0 114.019 -162.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.26 179.68 7.26 Favored 'General case' 0 CA--C 1.575 1.922 0 CA-C-O 122.94 1.352 . . . . 0.0 113.039 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 149.23 32.74 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -111.64 -172.27 2.0 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.664 164.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -115.41 109.52 18.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.671 -1.268 . . . . 0.0 109.922 163.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -84.37 102.81 13.02 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.746 0.818 . . . . 0.0 109.743 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 75.3 m -77.58 100.29 6.06 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.991 0.901 . . . . 0.0 109.465 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.7 p -72.26 159.67 33.69 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -171.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.1 -41.06 7.47 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 119.233 3.049 . . . . 0.0 119.233 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.27 -39.09 93.6 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 169.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.43 -17.22 5.89 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 118.067 1.987 . . . . 0.0 118.067 -160.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.1 mtm-85 -69.06 118.88 12.53 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.841 2.32 . . . . 0.0 111.05 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -91.61 108.61 20.03 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.237 0.542 . . . . 0.0 109.834 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -111.19 111.46 22.55 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.664 0.745 . . . . 0.0 110.467 -162.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -72.31 97.81 2.09 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.478 1.111 . . . . 0.0 109.643 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.1 m -116.79 119.79 36.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 110.855 -152.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.42 130.05 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.93 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 74.8 m -106.74 95.5 5.78 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.172 0.896 . . . . 0.0 109.947 167.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -126.86 124.65 40.08 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.586 -0.696 . . . . 0.0 111.68 -171.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -89.12 140.79 29.1 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -136.13 115.39 12.54 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.447 0.699 . . . . 0.0 110.988 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.325 21.8 t70 64.26 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 170.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.37 30.32 3.66 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 168.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.51 129.88 15.74 Favored 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 118.8 1.3 . . . . 0.0 112.58 -170.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.7 tp -87.43 120.5 28.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.451 -0.78 . . . . 0.0 110.68 167.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.05 103.07 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.602 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -89.34 88.83 7.64 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -91.8 98.04 11.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.743 . . . . 0.0 110.551 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.6 131.94 36.13 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.097 0.959 . . . . 0.0 111.715 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.84 126.07 33.37 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.982 0.81 . . . . 0.0 109.758 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -143.02 122.21 12.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.838 -1.164 . . . . 0.0 110.393 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.288 38.9 t70 50.4 44.53 26.77 Favored 'General case' 0 CA--C 1.588 2.421 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 173.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.58 25.81 72.82 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 119.812 2.685 . . . . 0.0 119.812 -168.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -135.71 128.71 31.46 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.136 1.374 . . . . 0.0 107.765 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -126.85 146.76 50.16 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.9 t -134.33 126.14 29.06 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.644 0.735 . . . . 0.0 111.031 170.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 m -102.8 129.68 49.54 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 121.178 -0.951 . . . . 0.0 110.067 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.8 mt -120.69 97.99 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -172.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 79.4 m -94.56 103.29 15.24 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.717 . . . . 0.0 109.967 -171.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -93.91 100.21 12.42 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.506 0.723 . . . . 0.0 109.906 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -115.73 138.09 51.45 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.14 112.37 16.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.817 -0.552 . . . . 0.0 111.052 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.269 20.3 tptp -105.62 -138.54 0.36 Allowed 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.619 0.767 . . . . 0.0 111.199 -177.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -90.83 68.08 6.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.521 -1.362 . . . . 0.0 110.225 -159.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.18 36.94 93.86 Favored Glycine 0 CA--C 1.558 2.725 0 N-CA-C 117.577 1.791 . . . . 0.0 117.577 -159.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -165.92 134.39 3.06 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -161.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 21.9 tp -90.22 119.34 30.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.926 -1.734 . . . . 0.0 110.859 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.5 t -94.13 113.87 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.1 t -109.46 101.99 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -89.1 97.39 11.17 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.001 0.905 . . . . 0.0 109.249 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 0.8 OUTLIER -101.1 110.4 22.42 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.195 0.998 . . . . 0.0 110.533 -176.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 p -129.02 144.86 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.751 0.82 . . . . 0.0 110.53 -170.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.284 28.1 ttt -102.98 -104.32 0.28 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.41 -0.806 . . . . 0.0 108.922 166.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -108.02 97.46 7.16 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.644 1.111 . . . . 0.0 108.546 172.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.28 20.0 m120 68.26 -29.04 0.15 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 -172.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.43 107.71 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 CA-C-N 120.203 1.365 . . . . 0.0 109.776 -172.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 68.4 p -107.29 123.1 47.83 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.594 0.758 . . . . 0.0 112.124 -169.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 7.7 p -96.22 129.34 43.56 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 121.268 0.556 . . . . 0.0 111.346 156.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.4 m -105.6 99.45 9.06 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.235 -0.916 . . . . 0.0 108.567 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -96.01 123.19 39.51 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 122.022 -0.424 . . . . 0.0 111.228 -176.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.9 mm -101.44 122.92 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -120.65 148.23 44.19 Favored 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 123.24 0.616 . . . . 0.0 111.794 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -123.0 138.57 54.65 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.408 ' HZ1' ' CD ' ' A' ' 135' ' ' GLU . 19.6 tttm -76.08 111.04 11.07 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.596 0.759 . . . . 0.0 112.139 -172.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.71 94.66 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -171.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.408 ' CD ' ' HZ1' ' A' ' 133' ' ' LYS . 8.6 pt-20 . . . . . 0 C--O 1.256 1.415 0 C-N-CA 123.639 0.775 . . . . 0.0 109.636 -173.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.68 -31.91 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 159.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -57.03 -22.84 41.99 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 171.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -41.92 -43.13 2.98 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 117.333 2.346 . . . . 0.0 117.333 154.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.9 3.12 39.55 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -82.35 129.83 34.96 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 121.256 1.843 . . . . 0.0 111.844 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.98 173.68 26.71 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 118.492 2.157 . . . . 0.0 118.492 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -82.91 103.04 12.07 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.067 0.547 . . . . 0.0 110.256 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -109.43 106.88 16.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 122.043 -0.411 . . . . 0.0 110.556 -172.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -83.72 129.79 34.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.395 -1.441 . . . . 0.0 112.553 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.1 tp -65.75 134.34 52.95 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.082 0.468 . . . . 0.0 112.14 172.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.301 6.8 m -123.91 -78.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -84.59 147.14 27.15 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.776 1.171 . . . . 0.0 111.38 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.5 p -139.79 74.86 1.48 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.035 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 137.73 50.62 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.79 15.77 49.39 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 119.67 2.628 . . . . 0.0 119.67 -170.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -81.67 64.85 6.56 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.979 1.889 . . . . 0.0 112.912 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -153.87 -53.73 0.1 Allowed 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 125.624 1.569 . . . . 0.0 109.36 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.46 -48.72 37.46 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 165.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -52.66 -54.99 25.82 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 169.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.298 23.2 ptt? -69.81 -24.45 63.48 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 174.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -64.43 -48.54 74.93 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 159.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -62.0 -37.99 86.9 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.4 mt -53.74 -40.71 66.38 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 159.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.81 57.78 1.58 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 123.797 0.713 . . . . 0.0 114.348 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.8 t -102.1 132.27 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -169.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.84 153.9 40.5 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.259 2.4 pp -56.39 -47.39 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.28 96.7 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 168.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.9 -39.08 90.28 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.8 mtp-105 -56.16 -48.7 75.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 163.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -54.1 -51.69 63.37 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 167.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -51.19 -52.32 45.43 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 166.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.64 -41.48 93.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 119.003 2.361 . . . . 0.0 119.003 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.06 -47.28 87.11 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -78.93 -28.51 43.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.4 115.19 9.29 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 120.198 1.363 . . . . 0.0 113.469 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.59 84.65 4.16 Favored Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.101 174.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.38 161.56 25.56 Favored 'Trans proline' 0 CA--C 1.563 1.971 0 C-N-CA 122.731 2.287 . . . . 0.0 116.84 -173.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -90.74 100.61 13.44 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.158 0.98 . . . . 0.0 109.794 169.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.44 100.15 10.54 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.5 1.12 . . . . 0.0 112.039 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.08 99.24 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.9 mt -90.74 114.89 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.4 p -115.5 106.78 14.35 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.54 112.73 8.18 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.692 -0.63 . . . . 0.0 111.89 -168.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -82.61 -47.68 11.82 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.77 -69.0 0.04 OUTLIER Glycine 0 N--CA 1.486 1.97 0 O-C-N 121.554 -0.716 . . . . 0.0 112.778 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -102.07 -36.51 8.54 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 166.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -76.24 136.45 39.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 120.053 1.297 . . . . 0.0 113.524 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 tt -142.81 120.71 12.0 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-O 121.411 0.624 . . . . 0.0 110.525 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.5 m -120.0 121.95 40.07 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.492 0.717 . . . . 0.0 109.558 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.3 127.96 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -118.89 102.8 9.06 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.831 0.852 . . . . 0.0 109.787 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.1 m -96.66 107.64 20.13 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.598 0.759 . . . . 0.0 110.781 -173.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -101.94 120.45 40.42 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.474 0.654 . . . . 0.0 112.602 -163.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.7 t -155.8 142.53 18.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.75 0.82 . . . . 0.0 111.208 168.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.4 p -60.23 -29.81 68.99 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.11 -53.09 42.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 167.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.95 115.51 3.29 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.987 1.267 . . . . 0.0 110.379 169.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.8 m -91.97 128.95 38.0 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 123.162 0.585 . . . . 0.0 110.752 173.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.1 p -133.49 116.04 15.5 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.533 -0.729 . . . . 0.0 110.233 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.9 150.25 38.76 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -153.25 149.28 27.78 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.3 p -131.75 115.57 16.17 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.953 0.901 . . . . 0.0 111.751 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.5 t -149.92 157.14 42.87 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.561 1.172 . . . . 0.0 113.926 -176.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -89.27 150.97 22.38 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.936 1.351 . . . . 0.0 111.023 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.84 120.11 11.91 Favored 'General case' 0 CA--C 1.571 1.767 0 O-C-N 120.706 -1.246 . . . . 0.0 112.452 170.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.26 -27.31 19.1 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 -162.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -89.44 143.31 26.92 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 118.731 1.266 . . . . 0.0 112.712 -174.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -94.8 145.65 24.74 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.143 0.973 . . . . 0.0 113.552 167.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -130.63 162.02 30.28 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.115 0.966 . . . . 0.0 111.47 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -80.04 100.81 8.35 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 120.911 -1.118 . . . . 0.0 111.192 167.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -80.49 139.11 36.56 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.87 0.843 . . . . 0.0 109.607 162.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.5 m -117.46 110.49 18.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 170.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 p -64.61 140.87 58.91 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.174 -0.329 . . . . 0.0 111.402 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.14 -24.74 2.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 119.954 3.316 . . . . 0.0 119.954 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.253 1.4 t70 -91.91 -24.35 19.33 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 169.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.65 -49.47 0.22 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 119.996 2.758 . . . . 0.0 119.996 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.2 mtm-85 -64.02 138.62 58.54 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -162.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -87.18 107.69 18.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.589 0.756 . . . . 0.0 110.705 170.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . 0.263 3.0 p -112.95 119.16 36.98 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.499 1.142 . . . . 0.0 111.372 -173.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -71.88 95.09 1.5 Allowed 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.44 1.096 . . . . 0.0 110.481 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.5 m -100.69 101.95 12.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.202 -0.936 . . . . 0.0 109.759 -161.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.97 117.22 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.099 0.476 . . . . 0.0 110.479 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 57.8 m -90.25 113.29 25.08 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 122.789 0.436 . . . . 0.0 110.601 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -128.68 124.49 35.81 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.963 -1.086 . . . . 0.0 111.1 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -86.7 116.74 25.0 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 121.124 -0.985 . . . . 0.0 112.037 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.7 t -156.9 140.12 15.56 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.041 0.936 . . . . 0.0 110.663 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.11 54.84 5.58 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 48.79 38.15 22.45 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 118.517 2.167 . . . . 0.0 118.517 -169.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.72 144.42 20.39 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -161.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.84 106.84 18.79 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 163.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.2 t -80.2 95.79 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -88.2 92.3 9.1 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.41 ' HE2' ' CD ' ' A' ' 104' ' ' GLU . 26.8 t-80 -90.35 106.48 18.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.704 -0.622 . . . . 0.0 110.559 -174.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -89.18 119.97 30.15 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.253 1.021 . . . . 0.0 110.264 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -124.38 124.53 42.56 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.783 0.833 . . . . 0.0 111.012 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -157.49 117.8 3.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.438 -1.414 . . . . 0.0 112.918 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.262 6.5 t70 32.16 56.57 0.36 Allowed 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 118.918 2.933 . . . . 0.0 118.918 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.97 -52.41 1.11 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -77.18 146.68 36.92 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.41 ' CD ' ' HE2' ' A' ' 97' ' ' HIS . 2.6 pt-20 -142.57 153.04 43.17 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 175.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 t -132.96 123.01 25.11 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 74.2 p -88.67 114.02 24.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.631 -0.668 . . . . 0.0 110.174 170.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 36.2 mm -106.51 93.4 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.9 m -94.65 99.44 11.56 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.099 -1.001 . . . . 0.0 110.747 -170.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -88.17 89.15 7.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.585 -0.697 . . . . 0.0 111.276 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.0 141.93 47.92 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -168.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.86 114.23 20.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 111.347 -177.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -134.02 124.28 25.98 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.05 49.75 15.06 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 170.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.32 -34.26 3.09 Favored Glycine 0 CA--C 1.553 2.455 0 N-CA-C 118.917 2.327 . . . . 0.0 118.917 -169.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -115.47 158.93 21.84 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 119.405 1.602 . . . . 0.0 112.781 -165.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.2 tp -83.44 111.11 18.74 Favored 'General case' 0 CA--C 1.561 1.388 0 O-C-N 121.147 -0.971 . . . . 0.0 110.225 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.34 110.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -95.94 96.53 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -87.07 99.25 11.77 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 5.3 p -119.55 95.54 4.83 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.225 -159.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 p -107.75 140.78 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.098 0.951 . . . . 0.0 110.016 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttt -119.41 112.43 19.4 Favored 'General case' 0 CA--C 1.559 1.314 0 O-C-N 121.376 -0.828 . . . . 0.0 109.324 167.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 54.2 50.27 16.84 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.297 3.3 t-20 67.82 -2.93 1.27 Allowed 'General case' 0 CA--C 1.584 2.286 0 N-CA-C 118.435 2.754 . . . . 0.0 118.435 -166.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.77 129.56 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 120.82 1.646 . . . . 0.0 108.138 -175.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.4 p -120.18 137.79 53.98 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.367 1.618 . . . . 0.0 115.367 -144.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 25.1 p -132.82 167.62 19.85 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 123.088 1.423 . . . . 0.0 112.461 153.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.2 m -144.79 123.22 12.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 119.395 -2.066 . . . . 0.0 108.836 167.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -110.36 121.35 45.08 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.464 0.705 . . . . 0.0 110.807 -171.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.3 mm -92.58 118.48 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -118.02 127.47 53.84 Favored 'General case' 0 CA--C 1.569 1.693 0 C-N-CA 123.836 0.855 . . . . 0.0 110.292 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -112.03 144.48 41.31 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.481 ' HZ1' ' CD ' ' A' ' 135' ' ' GLU . 11.0 tttm -76.51 119.94 21.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 112.946 -174.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.7 t -96.16 73.35 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.481 ' CD ' ' HZ1' ' A' ' 133' ' ' LYS . 44.7 mt-10 . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -171.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.699 0.762 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.266 9.7 p -58.19 -34.56 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 167.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.01 -37.29 76.55 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 169.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -30.86 56.64 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 164.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.87 -19.97 61.05 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 162.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.254 5.8 pt-20 -91.06 144.85 25.21 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 121.67 2.032 . . . . 0.0 113.688 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.34 -179.5 19.48 Favored Glycine 0 CA--C 1.55 2.239 0 C-N-CA 123.975 0.798 . . . . 0.0 114.187 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.3 ttm-85 -87.35 110.48 20.27 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.424 -1.045 . . . . 0.0 111.072 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -112.72 107.47 16.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.635 -0.665 . . . . 0.0 111.979 -170.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -90.61 129.53 36.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.981 -1.074 . . . . 0.0 113.429 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.1 tp -72.28 121.69 19.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.256 13.0 m -107.8 -57.44 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.686 0.794 . . . . 0.0 112.007 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.7 133.87 48.81 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 119.806 1.184 . . . . 0.0 110.408 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.5 p -119.21 63.94 0.79 Allowed 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 121.615 0.721 . . . . 0.0 112.71 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -60.54 127.59 32.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 0.0 113.494 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.3 21.1 59.33 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 119.993 2.757 . . . . 0.0 119.993 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.14 -41.64 61.23 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 119.115 1.458 . . . . 0.0 114.87 -173.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -49.63 -46.3 49.32 Favored 'General case' 0 CA--C 1.578 2.019 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 163.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -55.86 -49.55 73.02 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 168.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 68.2 t80 -58.05 -48.34 80.38 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 170.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -59.61 -34.03 72.23 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 168.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -58.75 -52.11 67.12 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 163.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -59.11 -44.67 92.0 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.8 mt -50.31 -50.64 50.13 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 162.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.8 49.52 0.58 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 124.143 0.878 . . . . 0.0 115.219 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.1 t -99.14 145.35 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 123.945 0.898 . . . . 0.0 109.461 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.92 -126.31 0.03 OUTLIER Glycine 0 CA--C 1.553 2.426 0 N-CA-C 117.526 1.77 . . . . 0.0 117.526 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.265 9.9 pt -119.1 -61.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.901 -0.764 . . . . 0.0 112.622 -176.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.72 90.75 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.1 mt -66.84 -34.67 78.32 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 170.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -63.87 -47.3 81.24 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 120.256 1.389 . . . . 0.0 114.371 164.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -53.11 -50.58 64.19 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER -59.43 -49.9 76.0 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 170.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.41 -41.42 97.02 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.585 2.194 . . . . 0.0 118.585 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.79 -46.32 82.57 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 169.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -77.16 -32.46 56.23 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.805 2.521 . . . . 0.0 117.805 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.51 144.92 55.48 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -110.93 86.37 5.88 Favored Pre-proline 0 CA--C 1.57 1.713 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -73.77 143.34 33.36 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 122.458 2.105 . . . . 0.0 116.182 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -90.87 100.47 13.33 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.951 165.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.8 t -81.86 95.9 7.47 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 122.468 1.127 . . . . 0.0 110.759 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mt -91.33 101.83 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 85.6 mt -94.73 133.25 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -149.1 126.16 11.32 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 119.863 -1.773 . . . . 0.0 110.508 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.3 t -103.52 110.97 23.22 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -171.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.08 76.01 9.37 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-O 122.129 0.966 . . . . 0.0 110.206 162.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.86 -90.23 0.16 Allowed Glycine 0 N--CA 1.493 2.466 0 O-C-N 120.994 -1.066 . . . . 0.0 115.681 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -89.93 -25.89 20.7 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 160.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -88.56 99.83 12.61 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.35 1.432 . . . . 0.0 110.177 -165.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.3 tp -94.35 110.87 22.6 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.398 0.679 . . . . 0.0 110.777 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.6 m -89.62 117.41 28.49 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -111.88 102.13 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -94.25 114.98 27.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.856 -0.527 . . . . 0.0 109.873 171.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 m -97.34 88.69 4.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.212 -0.93 . . . . 0.0 109.767 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -80.98 125.55 30.29 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.876 0.87 . . . . 0.0 112.795 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 t -155.28 153.77 31.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.473 -0.767 . . . . 0.0 110.813 165.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.9 p -57.98 -43.41 86.53 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 171.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.78 -32.46 67.67 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 123.07 7.76 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 119.827 1.194 . . . . 0.0 109.376 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 m -119.17 124.66 47.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.325 -0.859 . . . . 0.0 109.756 168.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 t -146.14 167.72 22.73 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.57 -0.707 . . . . 0.0 112.673 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -142.65 140.15 31.49 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.01 -1.056 . . . . 0.0 112.66 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -135.28 156.27 49.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 168.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 90.9 p -128.93 112.92 14.59 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.742 0.817 . . . . 0.0 111.214 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 45.8 t -115.79 132.49 56.62 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.0 m -82.48 117.34 22.42 Favored 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 123.46 0.704 . . . . 0.0 109.912 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mp -59.7 127.61 32.84 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -168.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.94 -33.91 5.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 116.986 1.555 . . . . 0.0 116.986 -164.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -98.7 165.64 11.7 Favored 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 123.797 1.76 . . . . 0.0 113.386 -172.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -82.57 139.88 33.57 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.183 -1.826 . . . . 0.0 113.154 171.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -131.21 162.63 29.55 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 121.657 0.741 . . . . 0.0 111.356 166.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.4 112.0 16.21 Favored 'General case' 0 CA--C 1.568 1.66 0 O-C-N 120.474 -1.391 . . . . 0.0 111.403 170.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -103.73 95.3 5.94 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 121.775 0.798 . . . . 0.0 109.683 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.0 m -72.5 104.73 3.92 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.946 0.879 . . . . 0.0 109.994 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 p -73.5 141.19 46.79 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.336 0.655 . . . . 0.0 111.692 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.85 -29.47 28.14 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 119.614 3.19 . . . . 0.0 119.614 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.79 -28.83 58.52 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 167.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.05 -29.93 0.99 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 118.973 2.349 . . . . 0.0 118.973 172.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.7 mtm-85 -70.48 126.55 29.96 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 119.813 1.807 . . . . 0.0 112.975 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -94.91 106.71 18.72 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.497 0.719 . . . . 0.0 110.052 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.3 p -104.56 122.17 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.457 0.646 . . . . 0.0 110.465 -166.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -77.42 98.52 5.3 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.997 0.903 . . . . 0.0 108.898 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.0 m -111.63 109.68 19.7 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -152.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.4 111.95 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 122.802 0.441 . . . . 0.0 110.853 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.1 m -105.31 105.21 15.15 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -119.37 125.18 48.39 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.467 0.707 . . . . 0.0 112.098 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -91.84 130.09 37.68 Favored 'General case' 0 CA--C 1.564 1.496 0 O-C-N 121.604 -0.685 . . . . 0.0 112.086 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 t -145.63 136.69 24.69 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.339 0.655 . . . . 0.0 109.982 167.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 62.18 34.52 16.11 Favored 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 160.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.27 15.88 80.92 Favored Glycine 0 CA--C 1.558 2.728 0 N-CA-C 119.326 2.49 . . . . 0.0 119.326 -165.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.35 125.2 22.58 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-N 118.616 1.208 . . . . 0.0 110.88 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -97.46 110.59 23.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.492 -0.755 . . . . 0.0 110.3 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.7 t -89.29 104.51 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -86.19 97.1 10.16 Favored 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 124.22 1.008 . . . . 0.0 109.019 171.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -92.66 97.26 10.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.055 -1.028 . . . . 0.0 110.754 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -70.0 127.59 33.38 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.441 0.696 . . . . 0.0 111.698 170.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -135.41 111.81 9.83 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 118.627 0.649 . . . . 0.0 109.96 -171.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.4 p90 -151.92 118.28 5.63 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.659 -1.276 . . . . 0.0 112.269 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.1 t70 39.77 55.16 2.51 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 117.807 2.521 . . . . 0.0 117.807 174.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.98 -44.19 3.32 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 117.755 1.862 . . . . 0.0 117.755 -171.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -78.26 144.3 36.3 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.61 147.18 26.45 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 121.719 0.771 . . . . 0.0 112.998 -175.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 t -134.05 127.39 32.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.714 -0.616 . . . . 0.0 112.549 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.1 p -92.29 129.81 38.14 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.858 0.837 . . . . 0.0 110.891 168.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.1 mt -123.07 97.92 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.2 m -92.81 99.98 12.54 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.843 0.83 . . . . 0.0 109.448 -173.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -89.17 100.46 13.24 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.729 0.812 . . . . 0.0 109.204 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.88 142.63 51.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.41 115.89 21.63 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 121.776 0.798 . . . . 0.0 111.379 -172.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -91.68 -178.17 4.99 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-O 122.302 1.049 . . . . 0.0 112.307 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.62 73.18 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.061 0 CA-C-O 123.426 1.584 . . . . 0.0 115.037 167.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.22 28.6 24.82 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 118.996 2.358 . . . . 0.0 118.996 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -165.44 145.22 6.69 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 119.543 1.671 . . . . 0.0 110.374 -171.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.9 tp -89.86 114.89 26.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 119.905 -1.747 . . . . 0.0 109.316 168.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.2 t -96.05 112.87 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -104.98 95.57 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -85.85 102.16 13.46 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.345 1.069 . . . . 0.0 109.554 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.1 p -115.65 115.42 26.36 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.664 -165.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.58 134.44 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 122.968 0.507 . . . . 0.0 110.119 -169.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.9 ttt -127.19 114.0 17.1 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.275 39.8 m-20 66.2 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.273 1.029 . . . . 0.0 113.237 176.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -118.83 -13.02 9.55 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 166.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.9 t -102.3 112.72 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 121.121 1.782 . . . . 0.0 109.843 -157.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 70.1 p -99.43 107.65 19.93 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.373 0.669 . . . . 0.0 112.705 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.961 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 18.4 p -90.11 151.98 21.34 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 121.725 0.774 . . . . 0.0 111.901 160.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.4 m -129.28 109.68 11.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.876 -1.14 . . . . 0.0 108.002 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -103.35 118.8 37.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.917 -0.489 . . . . 0.0 110.356 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.8 mm -102.83 118.16 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -120.18 143.53 48.18 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -117.92 143.64 46.17 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -80.27 113.21 18.28 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.767 -0.583 . . . . 0.0 112.185 -169.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.7 t -97.71 83.38 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--O 1.257 1.448 0 C-N-CA 124.232 1.013 . . . . 0.0 109.49 -175.574 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.562 1.416 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.543 3.1 p 60.12 -49.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.42 58.16 2.56 Favored 'General case' 0 CA--C 1.578 2.054 0 CA-C-O 122.868 1.318 . . . . 0.0 114.27 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -148.6 -40.31 0.16 Allowed 'General case' 0 CA--C 1.572 1.792 0 C-N-CA 125.876 1.67 . . . . 0.0 111.222 172.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.0 -6.22 12.09 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 166.45 15.92 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.59 179.7 18.71 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.191 -0.943 . . . . 0.0 115.21 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.1 ttm105 -94.37 118.31 31.42 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.2 0.6 . . . . 0.0 109.687 173.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -118.85 110.2 16.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.227 -0.92 . . . . 0.0 110.625 -164.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -99.46 129.72 45.67 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.495 -0.753 . . . . 0.0 112.326 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.8 tp -67.43 126.2 28.55 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 m -115.69 -53.16 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -117.04 118.08 31.4 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 119.373 0.988 . . . . 0.0 108.899 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.4 p -112.91 68.17 0.67 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -79.42 124.05 28.09 Favored 'General case' 0 CA--C 1.567 1.617 0 O-C-N 121.48 -0.762 . . . . 0.0 112.868 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.88 -2.37 85.69 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 118.892 2.317 . . . . 0.0 118.892 -169.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.251 13.3 t80 -68.57 -37.68 80.08 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.651 2.225 . . . . 0.0 116.352 -173.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.47 -47.91 81.94 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-N 121.058 1.754 . . . . 0.0 115.03 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.254 7.5 pt-20 -49.14 -48.98 44.3 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 121.645 2.02 . . . . 0.0 116.0 166.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.43 -44.4 89.09 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.637 1.718 . . . . 0.0 115.637 170.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 76.9 mtm -61.25 -43.77 98.33 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -53.15 -51.61 61.44 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 121.166 1.803 . . . . 0.0 115.116 164.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.82 -37.49 84.6 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.99 -37.89 69.72 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 161.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.33 61.28 0.81 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 123.999 0.809 . . . . 0.0 114.176 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -110.97 125.12 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.57 162.3 50.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.54 -44.8 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -171.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.96 90.32 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 168.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.2 mt -67.59 -37.79 83.09 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -57.74 -49.56 76.15 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 165.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -51.82 -52.14 51.36 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 165.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.5 ttp -52.21 -56.14 16.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 170.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.46 -42.52 89.78 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.78 2.272 . . . . 0.0 118.78 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.83 83.89 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 170.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.4 ptm -76.97 -29.71 55.67 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.19 122.99 22.79 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 119.62 1.1 . . . . 0.0 113.77 175.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.34 92.61 11.82 Favored Pre-proline 0 CA--C 1.568 1.657 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.291 170.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.95 142.62 25.26 Favored 'Trans proline' 0 CA--C 1.562 1.892 0 C-N-CA 122.3 2.0 . . . . 0.0 115.034 -174.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.37 100.62 13.17 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.011 0.91 . . . . 0.0 109.292 170.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.8 t -94.15 104.79 16.8 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.431 -0.793 . . . . 0.0 112.815 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 mt -81.1 106.43 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.4 mt -103.96 117.7 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.5 t -119.28 124.37 46.51 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.4 p -120.42 102.72 8.65 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-O 121.613 0.72 . . . . 0.0 112.751 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.15 69.39 10.77 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 121.846 0.832 . . . . 0.0 111.153 171.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.24 -84.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 117.249 1.66 . . . . 0.0 117.249 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -85.86 -23.52 27.07 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 166.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -103.08 107.75 18.67 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.525 1.511 . . . . 0.0 109.966 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 tt -117.15 125.55 51.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.832 -1.168 . . . . 0.0 111.665 -169.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -113.53 125.76 54.56 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.404 0.682 . . . . 0.0 110.574 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.0 mt -110.28 109.03 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -107.22 89.06 2.88 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.02 0.928 . . . . 0.0 109.284 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.2 m -84.71 103.39 13.76 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 124.034 0.934 . . . . 0.0 110.758 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -102.39 124.85 48.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -171.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.3 t -147.23 141.23 25.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.542 0.687 . . . . 0.0 110.413 167.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.4 p -55.29 -29.49 58.29 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 164.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.0 mt -74.42 -48.2 29.11 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 165.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -157.2 108.4 2.33 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 121.022 1.737 . . . . 0.0 112.533 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.3 m -77.35 135.28 38.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.641 -0.662 . . . . 0.0 111.137 164.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -134.61 120.5 19.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.215 -0.928 . . . . 0.0 108.537 170.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -124.74 128.89 49.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 110.865 -173.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -146.99 152.55 38.79 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.1 p -136.36 118.0 14.95 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.852 0.861 . . . . 0.0 111.268 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.6 t -145.44 153.84 41.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.585 1.183 . . . . 0.0 113.308 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -84.81 149.04 25.99 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 122.431 1.11 . . . . 0.0 110.83 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 mp -67.12 115.79 7.21 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.465 -1.397 . . . . 0.0 112.587 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.77 -30.08 11.06 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 117.937 1.935 . . . . 0.0 117.937 -161.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -82.87 150.24 26.65 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 118.653 1.227 . . . . 0.0 112.443 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -109.78 151.31 27.13 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.518 1.152 . . . . 0.0 114.087 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -138.05 167.17 22.35 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.16 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.69 102.91 11.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.947 -1.095 . . . . 0.0 111.101 170.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -92.04 99.6 12.4 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-O 121.912 0.863 . . . . 0.0 109.757 172.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.2 m -78.81 105.1 9.88 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 166.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -65.94 176.16 1.75 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.86 -41.06 31.92 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.62 -44.94 73.19 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 165.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.71 -11.52 5.17 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 -160.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 68.5 mtm-85 -63.27 131.82 49.61 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 121.331 2.565 . . . . 0.0 112.885 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -79.92 112.46 17.23 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.642 0.777 . . . . 0.0 111.125 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.8 p -123.78 124.22 42.22 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.967 0.507 . . . . 0.0 110.35 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -83.39 96.17 8.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.622 -1.299 . . . . 0.0 110.377 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.3 m -96.74 115.62 27.74 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 122.077 -0.39 . . . . 0.0 110.376 -168.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.69 125.1 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.817 -0.552 . . . . 0.0 111.037 169.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.56 117.07 29.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.801 -0.562 . . . . 0.0 111.756 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -131.49 116.12 17.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.233 -0.917 . . . . 0.0 111.138 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -83.82 134.98 34.69 Favored 'General case' 0 CA--C 1.568 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 111.945 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.1 t -135.89 129.61 32.56 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.02 0.528 . . . . 0.0 109.979 162.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.296 4.2 m-20 72.85 -82.64 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 159.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.9 48.61 0.71 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 123.466 0.555 . . . . 0.0 113.984 159.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -154.63 127.2 8.0 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.723 0.809 . . . . 0.0 110.92 -166.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.7 tp -97.14 113.72 25.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.67 -0.644 . . . . 0.0 110.166 171.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.45 101.7 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.682 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -90.53 99.82 12.78 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -101.93 100.3 10.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.551 -0.718 . . . . 0.0 111.76 -164.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.67 132.39 37.01 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.437 0.695 . . . . 0.0 112.841 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -130.72 118.04 20.3 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 123.224 0.61 . . . . 0.0 109.922 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -159.21 142.12 14.28 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.716 -1.24 . . . . 0.0 112.281 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t0 51.62 41.89 29.18 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 161.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.37 27.18 72.18 Favored Glycine 0 CA--C 1.559 2.782 0 N-CA-C 119.5 2.56 . . . . 0.0 119.5 -167.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -142.83 151.84 41.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 118.787 1.294 . . . . 0.0 109.699 -168.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -134.18 155.44 50.12 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.1 t -147.29 131.42 17.33 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.855 0.836 . . . . 0.0 111.773 172.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 p -105.17 113.76 27.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.856 -0.528 . . . . 0.0 109.928 -169.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.1 mm -98.64 101.75 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.7 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.2 m -95.9 98.53 10.48 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.096 -1.002 . . . . 0.0 110.105 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.1 mtp85 -89.06 102.55 15.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.635 0.774 . . . . 0.0 109.429 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -133.77 147.88 51.33 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.49 114.99 22.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.623 -0.673 . . . . 0.0 112.123 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -131.46 110.81 11.28 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.252 20.1 t70 55.76 57.8 4.96 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.67 -8.61 2.23 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 120.071 2.789 . . . . 0.0 120.071 -170.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -113.45 140.55 48.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.745 1.272 . . . . 0.0 110.618 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -83.22 104.42 13.38 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 122.219 1.009 . . . . 0.0 108.573 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 99.3 t -96.05 106.16 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.1 t -95.7 98.67 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -172.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.74 100.7 12.38 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.857 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.5 p -92.72 144.65 25.09 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.4 p -135.47 136.48 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.611 0.72 . . . . 0.0 110.762 169.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.5 tpt -92.86 -58.43 2.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.48 -0.762 . . . . 0.0 111.94 163.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.256 16.3 p30 -141.71 -90.57 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.004 0.922 . . . . 0.0 108.719 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -90.81 -15.88 29.29 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 153.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.4 t -79.78 129.47 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 CA-C-N 120.044 1.293 . . . . 0.0 109.905 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 61.1 p -137.4 153.59 50.14 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -166.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.958 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 1.9 p -132.92 130.32 39.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.403 -0.811 . . . . 0.0 111.349 163.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.4 m -104.08 101.33 11.09 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -102.99 117.06 33.75 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.141 0.496 . . . . 0.0 111.358 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.1 mm -92.26 120.39 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -113.92 131.02 56.45 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 121.265 0.555 . . . . 0.0 110.865 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -86.6 131.38 34.17 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -74.02 106.27 5.64 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.96 0.886 . . . . 0.0 111.356 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.28 129.24 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -176.083 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 p -60.05 -23.9 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 161.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -56.28 -39.32 72.49 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 159.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -71.12 -30.47 66.54 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 169.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 mt -68.91 -10.22 56.0 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 161.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.87 132.45 34.39 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 120.507 1.503 . . . . 0.0 112.019 -166.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.35 -162.83 20.46 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 115.146 0.818 . . . . 0.0 115.146 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -92.01 130.57 37.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.94 -0.741 . . . . 0.0 112.88 -172.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -134.56 112.23 10.7 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.416 0.687 . . . . 0.0 109.291 -171.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.7 ttp-105 -94.32 133.16 38.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 119.963 -1.711 . . . . 0.0 112.575 173.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.15 131.4 50.7 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.292 16.0 m -130.76 -60.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.637 -0.664 . . . . 0.0 112.201 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.27 106.37 17.17 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 119.601 1.091 . . . . 0.0 109.106 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 p -108.15 68.94 0.71 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -83.17 129.07 34.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.48 2.12 90.38 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 -168.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -70.68 -51.9 24.64 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-N 120.179 1.99 . . . . 0.0 115.856 -169.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -54.38 -39.82 67.56 Favored 'General case' 0 CA--C 1.58 2.096 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 170.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.03 -47.7 77.36 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 164.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -58.42 -51.01 71.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 171.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.347 16.5 ptt? -65.22 -23.74 67.16 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 170.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -59.98 -51.86 67.84 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 154.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -59.21 -43.93 92.28 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 171.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.43 ' HA ' ' SD ' ' A' ' 122' ' ' MET . 83.5 mt -57.2 -44.57 83.77 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 171.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.75 62.15 0.36 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 123.883 0.754 . . . . 0.0 114.388 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.4 t -128.49 127.53 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -166.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.48 164.94 53.83 Favored Glycine 0 CA--C 1.55 2.246 0 N-CA-C 117.611 1.804 . . . . 0.0 117.611 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.9 mp -53.78 -47.97 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -171.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.11 80.7 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 173.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.98 -38.56 91.51 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 169.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -62.74 -48.18 80.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.513 1.506 . . . . 0.0 114.85 168.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.46 -41.99 77.42 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 168.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -58.69 -59.52 5.27 Favored 'General case' 0 CA--C 1.569 1.673 0 CA-C-N 119.784 1.174 . . . . 0.0 113.869 164.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.96 -39.4 78.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 119.622 2.609 . . . . 0.0 119.622 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.31 86.71 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 171.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -83.96 -29.25 27.19 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 167.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.5 106.96 4.17 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-N 119.744 1.156 . . . . 0.0 113.359 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -105.46 91.81 5.23 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.068 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.33 147.77 18.35 Favored 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.313 2.009 . . . . 0.0 115.887 -171.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 99.61 9.29 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 121.681 0.753 . . . . 0.0 109.166 169.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.5 t -101.9 109.68 21.48 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.976 -1.077 . . . . 0.0 112.84 -167.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mt -97.59 104.42 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -170.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 97.0 mt -85.89 104.87 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.5 p -107.08 117.14 33.28 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.29 0.636 . . . . 0.0 109.813 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -113.49 100.07 8.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.022 -1.049 . . . . 0.0 113.179 -173.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.91 65.16 8.86 Favored 'General case' 0 CA--C 1.575 1.938 0 CA-C-O 122.039 0.923 . . . . 0.0 111.381 166.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.52 -88.49 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 116.6 1.4 . . . . 0.0 116.6 -177.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -81.95 -39.29 23.91 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 169.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -90.43 102.27 15.0 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 120.305 1.411 . . . . 0.0 109.786 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 tt -108.69 111.82 23.81 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 121.621 0.724 . . . . 0.0 109.049 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.7 m -105.88 117.08 33.11 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.558 0.743 . . . . 0.0 109.7 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.1 112.01 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -101.89 94.23 5.7 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.508 0.723 . . . . 0.0 110.871 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.6 m -88.58 103.06 15.55 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.315 0.646 . . . . 0.0 110.682 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -100.52 115.4 30.03 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.7 t -147.31 141.54 26.2 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.528 0.731 . . . . 0.0 110.82 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.2 p -58.81 -32.46 69.39 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 165.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.23 -48.81 64.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 167.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.21 108.07 2.53 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.568 1.531 . . . . 0.0 111.354 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.3 m -91.07 128.19 36.8 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.715 -0.616 . . . . 0.0 110.988 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.5 p -131.55 109.06 9.98 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.431 -0.793 . . . . 0.0 110.772 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -104.98 119.94 40.24 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.27 0.628 . . . . 0.0 110.83 175.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -133.13 143.96 49.6 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.7 p -102.04 113.08 26.0 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.882 0.873 . . . . 0.0 111.631 173.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.8 p -102.95 123.96 47.56 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-O 121.516 0.674 . . . . 0.0 111.382 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 m -81.29 121.42 26.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.195 -0.941 . . . . 0.0 109.065 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -73.0 129.65 38.57 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -164.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.1 -41.48 2.97 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 116.812 1.485 . . . . 0.0 116.812 -160.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -89.33 173.15 8.54 Favored 'General case' 0 CA--C 1.572 1.797 0 C-N-CA 124.798 1.239 . . . . 0.0 113.185 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.54 157.69 21.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -142.82 163.72 32.03 Favored 'General case' 0 CA--C 1.573 1.865 0 C-N-CA 124.723 1.209 . . . . 0.0 111.725 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.33 104.96 11.23 Favored 'General case' 0 CA--C 1.569 1.704 0 O-C-N 120.916 -1.115 . . . . 0.0 111.716 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -99.19 114.73 27.66 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.008 0.923 . . . . 0.0 109.678 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.8 m -93.71 106.94 18.87 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.92 -1.112 . . . . 0.0 108.36 166.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -77.66 157.16 30.3 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -169.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.86 -31.98 63.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 168.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.46 10.41 2.6 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 164.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.09 45.57 10.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.08 1.992 . . . . 0.0 118.08 172.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.3 mtm105 -134.01 130.34 37.44 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 117.998 0.899 . . . . 0.0 109.348 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -90.05 112.14 23.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.968 -0.458 . . . . 0.0 110.077 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.2 p -125.3 134.43 52.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.402 0.681 . . . . 0.0 109.667 -169.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -81.85 99.97 9.33 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 171.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.8 m -107.51 112.39 25.13 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.861 -0.524 . . . . 0.0 110.994 -159.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -88.9 124.37 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 122.961 0.504 . . . . 0.0 111.452 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 19.3 m -108.45 114.07 27.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.73 -0.606 . . . . 0.0 111.887 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -124.17 120.66 32.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.789 -0.569 . . . . 0.0 110.589 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -89.32 119.17 29.55 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 111.609 171.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 t -98.91 156.83 16.69 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 122.974 0.51 . . . . 0.0 110.027 155.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.23 95.82 0.04 OUTLIER 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.01 -16.02 20.76 Favored Glycine 0 CA--C 1.553 2.444 0 N-CA-C 118.421 2.128 . . . . 0.0 118.421 -170.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.57 126.01 15.77 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 120.331 2.066 . . . . 0.0 112.927 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.5 tp -90.88 107.39 19.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 110.059 168.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.8 106.91 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -91.12 100.51 13.34 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.152 0.581 . . . . 0.0 109.537 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -93.52 104.19 16.33 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -104.3 125.25 50.39 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -174.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.84 127.19 51.68 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.68 0.792 . . . . 0.0 111.036 -165.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -153.79 125.67 7.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.425 -1.422 . . . . 0.0 112.248 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.0 t70 49.82 51.02 17.36 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.04 -14.17 6.52 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 119.903 2.721 . . . . 0.0 119.903 -167.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -103.81 152.28 22.08 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 119.138 1.469 . . . . 0.0 111.955 -173.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -143.61 150.72 39.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.7 t -136.76 132.65 35.06 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.349 0.66 . . . . 0.0 111.289 174.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.5 p -91.48 130.36 37.32 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.789 0.804 . . . . 0.0 110.455 169.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 80.2 mt -124.38 98.17 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -98.41 101.79 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.781 -0.574 . . . . 0.0 110.141 -170.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -88.04 98.06 11.31 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 121.79 -0.569 . . . . 0.0 110.149 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.11 145.78 47.84 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -171.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.59 113.29 25.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.0 112.363 -171.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -134.22 115.05 13.71 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.597 -0.689 . . . . 0.0 109.164 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 58.0 58.31 3.65 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 47.16 41.53 15.43 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 118.455 2.142 . . . . 0.0 118.455 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.55 128.77 9.75 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -163.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.63 106.2 17.86 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 122.184 0.993 . . . . 0.0 109.674 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.4 t -95.27 109.0 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.7 t -95.04 100.32 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -93.7 101.19 13.32 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.965 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.0 p -120.58 131.49 54.68 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 121.774 0.797 . . . . 0.0 111.991 -163.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.61 140.64 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.464 0.65 . . . . 0.0 110.505 -166.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' A' ' 26' ' ' LEU . 19.3 ttt -106.09 -74.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.759 -0.588 . . . . 0.0 110.567 171.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -129.5 -65.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.654 0.661 . . . . 0.0 110.937 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -94.79 -44.89 7.56 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.06 0.944 . . . . 0.0 112.639 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.68 120.91 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 CA-C-N 119.248 0.931 . . . . 0.0 110.316 -161.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 39.9 p -102.4 114.5 28.74 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.492 0.717 . . . . 0.0 109.959 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.965 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.5 p -98.76 132.86 43.8 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.475 0.71 . . . . 0.0 111.213 171.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.6 m -109.7 104.62 13.65 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -103.68 113.01 26.2 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 122.905 0.482 . . . . 0.0 110.683 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.18 129.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.454 -0.779 . . . . 0.0 109.381 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -118.48 124.39 47.48 Favored 'General case' 0 CA--C 1.571 1.768 0 CA-C-O 121.203 0.525 . . . . 0.0 112.163 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.4 136.49 42.4 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.158 0.983 . . . . 0.0 113.613 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -76.32 116.37 16.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.371 -1.456 . . . . 0.0 111.208 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.36 69.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.209 -0.932 . . . . 0.0 110.84 -171.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.12 -0.987 . . . . 0.0 108.771 -164.138 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.501 2.107 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . 0.252 6.6 tt0 -67.59 -14.86 63.3 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -35.1 71.06 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 155.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.0 mt -82.9 2.87 32.29 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -92.04 148.57 22.09 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 122.089 2.222 . . . . 0.0 113.634 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.31 178.69 15.61 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.8 ttm105 -85.84 122.88 30.54 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.816 -0.814 . . . . 0.0 110.311 166.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.44 ' CH2' HD21 ' A' ' 111' ' ' LEU . 97.5 m95 -119.66 114.4 22.13 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -172.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -105.07 124.41 49.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.751 0.82 . . . . 0.0 112.83 -163.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.1 tp -66.66 128.63 36.99 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.253 6.1 m -115.6 -69.09 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 C-N-CA 124.148 0.979 . . . . 0.0 109.566 173.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -92.57 149.93 21.05 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 124.439 1.096 . . . . 0.0 112.718 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -152.16 59.3 0.84 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.461 -1.399 . . . . 0.0 114.684 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -72.47 133.01 44.61 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.5 -13.99 53.09 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 118.515 2.166 . . . . 0.0 118.515 -166.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -67.39 -35.14 78.72 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.456 ' CG ' HH12 ' A' ' 33' ' ' ARG . 9.2 t70 -53.28 -54.24 39.14 Favored 'General case' 0 CA--C 1.576 1.942 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 166.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -60.77 -46.71 89.42 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -58.52 -47.08 85.36 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.7 mtm -62.44 -40.66 97.31 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 120.784 1.629 . . . . 0.0 114.945 170.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -47.99 -53.2 16.94 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 161.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -74.78 -33.69 62.3 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.8 mt -46.76 -40.33 13.33 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 118.403 2.742 . . . . 0.0 118.403 158.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.07 67.81 1.01 Allowed Glycine 0 N--CA 1.487 2.063 0 CA-C-N 118.34 0.518 . . . . 0.0 113.423 -161.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.86 123.98 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.45 152.04 52.26 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 115.581 0.992 . . . . 0.0 115.581 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 pt -53.48 -44.3 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 117.911 2.559 . . . . 0.0 117.911 -172.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.05 -42.93 86.48 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 166.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.56 -39.6 94.04 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.527 HH11 ' HB3' ' A' ' 33' ' ' ARG . 13.9 mtm105 -59.32 -47.78 84.12 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 168.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -56.81 -51.99 66.8 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 168.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.9 ttp -46.84 -61.16 1.98 Allowed 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.06 -41.91 79.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 118.904 2.322 . . . . 0.0 118.904 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.51 -51.9 51.71 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 169.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.8 ptm -74.0 -31.65 63.04 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.37 -25.1 63.95 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 119.284 3.068 . . . . 0.0 119.284 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.65 67.4 1.55 Allowed Pre-proline 0 CA--C 1.581 2.172 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -66.69 142.41 63.86 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 N-CA-C 119.329 2.78 . . . . 0.0 119.329 -170.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.7 113.5 26.01 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.127 165.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 51.6 t -92.0 110.62 21.99 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.933 0.893 . . . . 0.0 111.261 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.36 110.24 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 87.8 mt -102.4 129.31 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.1 m -150.99 127.04 10.44 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.658 -1.276 . . . . 0.0 110.294 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.6 t -102.14 130.06 48.66 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -82.0 -56.26 4.06 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.733 -0.604 . . . . 0.0 111.993 159.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.71 -84.72 0.05 OUTLIER Glycine 0 N--CA 1.485 1.947 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -83.2 -37.45 23.61 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 161.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -74.65 104.39 5.31 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 121.095 1.771 . . . . 0.0 111.505 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 32.5 tp -99.84 111.9 24.19 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.79 0.836 . . . . 0.0 109.1 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.5 m -81.78 115.87 21.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.786 -0.571 . . . . 0.0 110.401 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.1 mt -119.05 106.2 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.646 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -98.29 127.4 44.21 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.106 0.563 . . . . 0.0 110.658 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -99.27 97.81 8.84 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -89.29 97.2 11.06 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.251 0.62 . . . . 0.0 109.905 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 p -104.32 150.8 24.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.302 -0.874 . . . . 0.0 111.815 171.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.6 p -78.08 49.24 0.79 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 179.72 -61.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.288 1.435 . . . . 0.0 109.404 -164.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -131.04 168.69 16.97 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.356 1.074 . . . . 0.0 111.598 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.4 m -149.62 149.23 30.35 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 119.422 -2.049 . . . . 0.0 110.743 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.9 m -152.95 139.5 18.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.558 -1.338 . . . . 0.0 109.685 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -134.48 131.51 38.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.446 -0.784 . . . . 0.0 110.428 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -147.85 144.78 28.37 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.257 0.551 . . . . 0.0 112.393 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.9 p -99.95 103.05 14.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.374 -0.829 . . . . 0.0 110.635 170.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 52' ' ' LEU . 28.4 p -85.71 124.67 32.49 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -79.41 108.25 12.79 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.618 0.723 . . . . 0.0 110.532 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.3 tp -81.3 119.56 23.81 Favored 'General case' 0 CA--C 1.563 1.444 0 O-C-N 121.591 -0.693 . . . . 0.0 112.543 -167.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.85 50.62 18.11 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 115.228 0.851 . . . . 0.0 115.228 -159.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.48 160.82 0.79 Allowed 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.736 1.615 . . . . 0.0 109.139 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -93.08 153.37 18.73 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 168.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -142.04 161.72 37.27 Favored 'General case' 0 CA--C 1.572 1.792 0 C-N-CA 124.174 0.989 . . . . 0.0 110.286 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -81.58 106.91 13.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.097 -1.627 . . . . 0.0 110.505 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -83.31 144.9 29.39 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 122.685 1.231 . . . . 0.0 111.062 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.8 m -113.05 120.45 41.39 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 162.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 78.1 p -68.22 154.1 42.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.07 -29.06 60.0 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 167.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -68.69 -47.89 65.3 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.89 -33.15 1.53 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 117.337 1.695 . . . . 0.0 117.337 -165.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -63.5 141.19 58.86 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 119.485 1.643 . . . . 0.0 112.923 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -110.58 131.02 55.41 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.166 0.586 . . . . 0.0 109.897 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.1 p -128.5 136.54 50.94 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.551 0.691 . . . . 0.0 111.191 -165.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -83.7 102.74 12.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.586 -1.321 . . . . 0.0 109.729 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.5 m -112.08 109.74 19.64 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.658 -0.651 . . . . 0.0 110.752 -158.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.1 p -86.86 120.92 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 122.714 0.406 . . . . 0.0 111.181 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.4 m -108.77 122.66 47.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -132.95 126.54 32.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.515 -0.741 . . . . 0.0 111.723 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -91.88 112.43 24.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.739 -0.6 . . . . 0.0 110.488 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -102.79 86.79 2.81 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.974 0.51 . . . . 0.0 110.643 171.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.265 12.1 t70 25.4 70.8 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.868 2.914 . . . . 0.0 118.868 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.71 -44.49 1.31 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 -168.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.63 119.93 37.73 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 118.448 1.124 . . . . 0.0 113.556 -172.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.46 107.06 18.92 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.553 0.741 . . . . 0.0 111.136 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.91 109.97 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -94.46 106.37 18.35 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 170.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -100.29 104.95 16.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.722 -0.611 . . . . 0.0 111.403 -171.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -99.6 107.31 19.42 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.459 0.703 . . . . 0.0 111.438 -162.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -102.12 121.33 41.99 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.914 0.779 . . . . 0.0 111.923 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -148.76 129.84 14.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.006 -1.059 . . . . 0.0 110.881 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 52.54 41.11 30.95 Favored 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.56 32.24 82.59 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 119.026 2.37 . . . . 0.0 119.026 -165.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -136.09 124.1 22.85 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 118.371 1.086 . . . . 0.0 108.154 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.44 142.48 32.76 Favored 'General case' 0 CA--C 1.563 1.481 0 CA-C-O 121.878 0.847 . . . . 0.0 112.256 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.9 t -125.13 130.6 52.53 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.941 0.877 . . . . 0.0 109.889 159.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.6 p -113.09 107.95 16.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.3 mm -104.7 102.06 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.011 -1.056 . . . . 0.0 108.686 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 m -97.2 96.25 8.3 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.22 0.918 . . . . 0.0 109.916 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -87.27 110.2 20.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.561 -0.712 . . . . 0.0 110.501 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -134.58 146.14 49.34 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.555 1.07 . . . . 0.0 113.646 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.44 HD21 ' CH2' ' A' ' 11' ' ' TRP . 0.2 OUTLIER -87.43 114.84 24.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.559 -0.713 . . . . 0.0 112.241 -169.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -131.72 113.47 13.59 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.598 0.759 . . . . 0.0 108.995 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.263 35.4 t70 60.57 34.47 20.25 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.47 9.43 61.43 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 119.123 2.409 . . . . 0.0 119.123 -165.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -109.13 143.41 38.54 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 119.26 1.53 . . . . 0.0 108.812 172.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.4 tp -84.03 102.32 12.4 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.808 0.814 . . . . 0.0 108.897 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.7 t -96.31 112.53 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.24 95.94 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -172.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -93.62 94.75 8.79 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.243 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.0 OUTLIER -92.11 148.5 22.12 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 121.36 -0.837 . . . . 0.0 112.025 177.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.3 128.65 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.54 0.686 . . . . 0.0 110.288 166.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.1 tpt -69.0 -65.87 0.65 Allowed 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 123.422 0.689 . . . . 0.0 112.298 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.251 15.5 p30 -143.67 -73.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -86.78 -38.64 16.69 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 159.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.1 t -85.99 128.33 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 119.921 1.237 . . . . 0.0 111.067 -163.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 66.3 p -110.04 156.59 20.32 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.492 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 2.3 p -131.99 133.55 44.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.011 -1.056 . . . . 0.0 111.161 156.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.4 m -109.47 98.0 7.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -102.67 120.76 41.12 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.207 0.603 . . . . 0.0 111.603 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.93 125.12 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -119.75 125.66 49.16 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 123.43 0.692 . . . . 0.0 110.498 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -93.3 143.65 26.06 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -74.82 120.16 19.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.535 -1.353 . . . . 0.0 113.498 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.67 89.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 124.353 1.061 . . . . 0.0 109.657 171.414 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.5 2.044 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.28 -34.16 76.04 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 161.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -66.12 -27.22 67.88 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.3 mt -70.21 -2.4 13.1 Favored 'General case' 0 CA--C 1.581 2.142 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -68.71 138.5 54.97 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 121.054 1.752 . . . . 0.0 114.541 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.33 -178.64 18.25 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 115.814 1.086 . . . . 0.0 115.814 168.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -89.64 125.56 35.29 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.678 -0.761 . . . . 0.0 109.857 169.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -121.1 109.62 15.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.667 -0.646 . . . . 0.0 109.599 -168.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.5 ttm105 -91.64 127.48 37.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.677 -1.264 . . . . 0.0 113.207 -176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.21 126.49 27.56 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.293 9.3 m -110.73 -72.22 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 123.484 0.714 . . . . 0.0 109.158 173.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -87.05 143.58 27.26 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 119.093 0.86 . . . . 0.0 111.785 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.2 p -139.18 65.35 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.334 162.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -72.16 128.02 34.36 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.3 2.12 86.99 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 119.294 2.478 . . . . 0.0 119.294 -169.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -69.79 -48.7 58.21 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -169.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -55.4 -43.3 75.11 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -64.2 -35.99 82.59 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 164.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 59.6 t80 -61.2 -50.78 71.74 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 120.884 1.675 . . . . 0.0 114.499 169.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.9 ptm -61.76 -37.23 83.52 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -50.48 -48.64 56.7 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 158.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.52 -39.94 95.73 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.38 -42.01 77.19 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 163.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.86 69.83 0.45 Allowed Glycine 0 N--CA 1.487 2.039 0 C-N-CA 124.249 0.928 . . . . 0.0 113.029 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.64 126.06 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -171.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.53 164.5 52.23 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 pt -53.73 -47.38 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 118.315 2.709 . . . . 0.0 118.315 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.63 98.34 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 172.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.97 -39.61 93.74 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 167.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -60.15 -49.92 75.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -51.94 -52.15 52.14 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 167.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -53.9 -55.19 29.15 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.98 99.38 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 118.799 2.279 . . . . 0.0 118.799 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.31 83.22 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.0 ptm -71.33 -26.05 62.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.89 127.27 31.38 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.82 77.05 4.52 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 118.224 -0.893 . . . . 0.0 109.525 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.88 140.55 20.58 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.283 1.989 . . . . 0.0 116.617 -167.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.11 91.32 8.67 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.882 162.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -90.05 115.09 27.06 Favored 'General case' 0 CA--C 1.559 1.325 0 O-C-N 120.804 -1.185 . . . . 0.0 112.444 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -92.17 118.7 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 109.406 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.7 mt -105.75 122.31 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m -140.42 134.12 30.34 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.396 0.617 . . . . 0.0 111.512 163.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.5 p -107.44 141.8 38.27 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . 0.268 17.0 t70 -101.37 -116.72 0.18 Allowed 'General case' 0 CA--C 1.578 2.047 0 C-N-CA 123.743 0.817 . . . . 0.0 108.798 166.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.19 -83.98 1.3 Allowed Glycine 0 N--CA 1.492 2.38 0 CA-C-N 120.516 1.507 . . . . 0.0 112.873 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -85.65 -37.7 19.19 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 160.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -72.58 117.16 13.91 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.511 1.505 . . . . 0.0 112.901 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 tt -123.6 118.32 27.04 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.925 0.89 . . . . 0.0 108.718 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.9 m -94.47 123.64 38.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.709 -0.62 . . . . 0.0 110.373 -170.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.8 mt -116.8 106.26 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -109.71 117.83 34.94 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.091 0.556 . . . . 0.0 111.039 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 m -85.94 109.48 18.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.397 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -98.79 92.11 5.41 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.822 1.192 . . . . 0.0 110.912 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -126.96 139.32 53.13 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.906 0.882 . . . . 0.0 110.21 166.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 p -76.86 49.8 0.67 Allowed 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 172.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.7 mt -150.48 -52.01 0.14 Allowed 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 126.231 1.812 . . . . 0.0 109.296 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -153.91 115.78 4.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.143 1.338 . . . . 0.0 110.923 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.6 p -97.42 92.22 5.85 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.293 0.637 . . . . 0.0 110.865 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.0 m -89.11 117.63 28.24 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.042 0.925 . . . . 0.0 108.9 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.21 141.76 50.62 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.8 0.84 . . . . 0.0 111.923 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -156.26 145.31 20.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.567 -0.708 . . . . 0.0 112.734 -174.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.5 p -101.35 108.12 19.65 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.344 0.658 . . . . 0.0 110.093 167.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.1 p -92.47 131.16 37.85 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.65 -0.656 . . . . 0.0 112.367 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.04 122.99 26.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.897 -1.127 . . . . 0.0 110.673 168.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.4 tp -75.91 129.85 37.59 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.56 0.744 . . . . 0.0 112.62 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.44 -28.18 5.92 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 117.606 1.802 . . . . 0.0 117.606 -159.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -105.25 158.34 16.68 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 119.418 1.609 . . . . 0.0 112.908 -166.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -95.65 116.27 28.62 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.914 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -126.96 148.1 50.08 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 124.014 0.926 . . . . 0.0 110.988 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -82.05 101.69 10.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.2 -1.563 . . . . 0.0 113.499 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -88.63 120.42 30.01 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-O 121.973 0.892 . . . . 0.0 110.691 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.8 m -89.43 96.47 10.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.33 -0.856 . . . . 0.0 110.077 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.6 p -69.42 158.13 35.74 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.87 -36.91 12.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 119.529 3.159 . . . . 0.0 119.529 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.3 -36.93 82.51 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 170.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.76 -10.48 9.0 Favored Glycine 0 CA--C 1.552 2.356 0 N-CA-C 118.03 1.972 . . . . 0.0 118.03 -159.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -71.7 115.61 11.1 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 121.085 2.443 . . . . 0.0 110.204 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -87.92 108.6 19.26 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.663 0.744 . . . . 0.0 109.567 172.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.9 p -106.81 111.78 24.45 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.684 0.754 . . . . 0.0 109.609 -166.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -69.12 101.84 1.53 Allowed 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 122.483 1.135 . . . . 0.0 109.807 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.2 m -112.84 112.46 23.96 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -156.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.329 10.4 p -81.36 113.38 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-N 118.996 0.816 . . . . 0.0 110.013 168.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 64.0 m -96.79 109.93 22.51 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 120.58 0.229 . . . . 0.0 110.583 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -133.43 121.42 22.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.549 -0.719 . . . . 0.0 112.006 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -87.59 137.21 32.54 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 121.493 -0.754 . . . . 0.0 112.997 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.0 t -137.75 113.13 9.37 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.384 0.674 . . . . 0.0 111.05 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.322 22.4 t70 66.9 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 171.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.95 43.26 1.28 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 166.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.87 118.33 6.49 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.554 0.741 . . . . 0.0 111.077 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.7 tp -90.23 109.75 20.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 110.089 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.21 108.12 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -86.94 94.17 9.53 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -91.85 97.87 11.25 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.61 -0.681 . . . . 0.0 109.925 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -87.5 116.74 25.81 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.219 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.45 125.68 45.38 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.559 1.072 . . . . 0.0 110.622 -176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -144.54 120.23 10.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.558 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 63.23 14.96 8.2 Favored 'General case' 0 CA--C 1.587 2.368 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.1 -14.64 26.29 Favored Glycine 0 CA--C 1.559 2.833 0 N-CA-C 118.947 2.339 . . . . 0.0 118.947 -156.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -77.33 129.55 35.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.188 1.494 . . . . 0.0 109.056 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -140.85 147.98 39.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -173.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 t -118.61 138.28 52.69 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 122.294 1.045 . . . . 0.0 111.759 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.7 p -110.61 112.5 24.43 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 76.0 mt -120.79 98.17 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -167.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 55.3 m -94.25 101.72 13.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.74 -0.6 . . . . 0.0 110.037 -173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -87.66 96.46 10.43 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 123.397 0.679 . . . . 0.0 110.188 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -127.86 149.52 50.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -172.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.9 123.03 45.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 112.343 -158.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.03 121.94 27.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.74 -0.6 . . . . 0.0 109.492 171.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 58.93 44.49 16.46 Favored 'General case' 0 N--CA 1.509 2.495 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 165.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.57 35.71 74.48 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -163.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -137.67 127.77 25.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 tp -88.15 106.82 18.43 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-O 121.996 0.903 . . . . 0.0 109.287 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.4 t -98.16 106.94 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.51 98.03 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -170.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -91.93 113.12 25.3 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.713 0.805 . . . . 0.0 109.399 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.6 p -126.73 122.1 33.89 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.654 0.781 . . . . 0.0 111.739 -162.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.39 136.95 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.498 -0.751 . . . . 0.0 110.003 -175.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.5 ttt -89.58 -76.73 0.41 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 120.634 0.254 . . . . 0.0 110.59 168.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -140.11 -62.93 0.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.11 0.964 . . . . 0.0 110.247 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -79.36 -54.82 5.57 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 125.015 1.326 . . . . 0.0 113.827 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.78 123.91 49.31 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-N 119.783 1.174 . . . . 0.0 110.984 -164.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.3 p -102.15 114.09 27.92 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.864 0.865 . . . . 0.0 110.496 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 13.4 p -100.45 157.26 16.76 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 122.113 0.958 . . . . 0.0 113.174 170.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.4 m -130.43 118.03 20.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.832 -1.168 . . . . 0.0 109.223 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -107.42 111.76 24.23 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.15 0.58 . . . . 0.0 109.843 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.1 mm -96.47 123.65 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -120.35 127.86 52.71 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 121.939 -0.475 . . . . 0.0 111.467 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -85.14 141.28 30.31 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -75.97 121.04 22.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.296 -0.877 . . . . 0.0 113.065 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.42 99.16 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.272 -173.134 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.26 9.9 p . . . . . 0 N--CA 1.505 2.314 0 CA-C-O 122.657 1.218 . . . . 0.0 114.136 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -113.56 -47.16 3.01 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.848 1.659 . . . . 0.0 111.778 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -58.89 -29.32 66.94 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 171.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.8 mt -66.78 -13.14 61.12 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 164.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -74.22 136.14 42.74 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 120.743 1.61 . . . . 0.0 112.689 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.09 -179.37 25.95 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 117.956 1.942 . . . . 0.0 117.956 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -92.16 116.43 28.93 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.316 -0.942 . . . . 0.0 110.196 169.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -123.88 108.63 12.66 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.794 0.438 . . . . 0.0 109.885 -166.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -94.83 129.57 41.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.419 -1.426 . . . . 0.0 114.078 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.4 tp -63.85 124.82 22.51 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.273 11.0 m -113.09 -65.97 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.938 0.895 . . . . 0.0 110.781 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -101.21 148.15 25.44 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.497 1.498 . . . . 0.0 111.533 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.2 p -133.63 83.08 2.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.662 -0.649 . . . . 0.0 110.615 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.35 96.96 10.81 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.269 0.557 . . . . 0.0 110.452 -166.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.67 10.79 56.34 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 118.914 2.326 . . . . 0.0 118.914 -169.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -71.44 -47.38 56.14 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -170.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -55.96 -43.94 78.01 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -53.64 -47.0 70.71 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 167.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.436 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 67.9 t80 -53.35 -54.58 34.52 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 166.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.285 3.1 ptt? -69.38 -27.39 65.27 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 174.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -54.17 -52.02 62.49 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 154.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -60.9 -38.75 86.8 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -52.5 -52.52 54.08 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.17 -1.581 . . . . 0.0 115.178 163.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.55 69.58 0.72 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 124.403 1.001 . . . . 0.0 112.467 -169.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.1 t -127.57 130.52 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.92 164.39 49.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 117.418 1.727 . . . . 0.0 117.418 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -56.54 -47.46 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.87 94.86 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -67.31 -40.1 85.97 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -57.15 -46.49 82.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 163.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -55.97 -48.51 75.68 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 167.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 46.2 mtp -73.59 51.28 0.35 Allowed 'General case' 0 CA--C 1.583 2.232 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 165.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.69 -61.55 0.04 OUTLIER Glycine 0 N--CA 1.485 1.926 0 O-C-N 121.037 -1.039 . . . . 0.0 111.63 -171.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.5 -47.89 80.71 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 23.1 ptp -95.31 -6.8 40.41 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.82 110.99 16.86 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 120.365 1.439 . . . . 0.0 111.041 168.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -110.17 93.22 14.91 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.871 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.03 156.42 13.23 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.35 2.033 . . . . 0.0 116.811 -167.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.27 97.04 8.08 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.685 161.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.3 t -86.46 107.17 17.95 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 121.116 -0.99 . . . . 0.0 111.928 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.6 mt -91.81 106.51 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.5 mt -96.49 110.08 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -110.47 123.8 50.59 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 122.862 0.465 . . . . 0.0 110.303 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.7 p -116.57 94.3 4.56 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.558 0.743 . . . . 0.0 112.561 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -91.12 74.64 6.28 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 122.306 1.05 . . . . 0.0 110.697 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.17 -84.33 0.12 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 116.47 1.348 . . . . 0.0 116.47 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -101.42 -46.33 5.03 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -76.56 116.06 16.89 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-N 119.213 0.915 . . . . 0.0 112.019 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.4 tt -132.09 112.79 12.64 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.481 0.712 . . . . 0.0 109.577 -161.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.3 m -104.58 126.21 51.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.597 -1.314 . . . . 0.0 111.366 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -113.2 101.18 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.02 105.82 16.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.171 0.988 . . . . 0.0 109.611 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.2 m -97.45 106.47 18.8 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.834 0.854 . . . . 0.0 110.791 -171.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -104.93 98.66 8.34 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 122.924 0.489 . . . . 0.0 111.179 -167.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p -128.66 144.82 51.24 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.235 -0.916 . . . . 0.0 111.647 166.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -62.51 -44.77 95.55 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.9 mt -57.16 -43.57 82.65 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 165.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -155.29 125.33 6.63 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 119.348 0.976 . . . . 0.0 111.002 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.9 m -111.41 141.8 44.49 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.771 0.828 . . . . 0.0 110.251 173.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.4 t -144.7 158.46 43.77 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.824 0.821 . . . . 0.0 112.574 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -142.49 125.41 16.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.679 -1.263 . . . . 0.0 110.016 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -118.43 143.01 46.99 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.52 0.676 . . . . 0.0 111.126 163.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.1 m -112.18 110.99 21.56 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.104 0.954 . . . . 0.0 109.999 174.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.5 t -89.5 157.96 17.88 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.862 1.265 . . . . 0.0 114.02 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.4 m -113.86 119.8 38.55 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 159.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.6 tp -70.62 132.03 44.83 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 123.856 0.862 . . . . 0.0 112.849 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.25 -53.09 1.58 Allowed Glycine 0 N--CA 1.49 2.288 0 O-C-N 121.198 -0.939 . . . . 0.0 114.503 -161.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.99 163.47 15.53 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 124.023 1.868 . . . . 0.0 114.139 -169.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -88.74 108.79 19.68 Favored 'General case' 0 CA--C 1.564 1.489 0 CA-C-N 112.445 -2.161 . . . . 0.0 110.147 169.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -103.12 175.9 5.32 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.855 0.836 . . . . 0.0 112.695 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -92.38 107.04 18.92 Favored 'General case' 0 CA--C 1.568 1.646 0 O-C-N 120.725 -1.234 . . . . 0.0 111.338 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -79.16 129.1 34.11 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 110.094 163.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.8 m -107.51 110.99 23.05 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 165.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.6 p -72.98 162.29 29.67 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.89 -43.83 59.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 167.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.2 -36.09 83.11 Favored 'General case' 0 CA--C 1.573 1.847 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 169.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.73 26.94 1.5 Allowed Glycine 0 CA--C 1.551 2.297 0 N-CA-C 118.09 1.996 . . . . 0.0 118.09 -176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -90.74 140.57 29.66 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.038 1.919 . . . . 0.0 110.94 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -93.3 109.26 20.8 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 162.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . 0.268 0.9 OUTLIER -113.9 119.83 38.62 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.704 0.684 . . . . 0.0 110.383 -179.11 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -73.2 99.54 2.87 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-O 122.087 0.946 . . . . 0.0 110.671 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.9 m -110.07 106.74 16.35 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.199 -0.938 . . . . 0.0 109.872 -156.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.276 7.2 p -88.83 118.56 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.827 -0.546 . . . . 0.0 110.719 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.26 123.62 48.33 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -131.71 131.01 42.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.501 -0.749 . . . . 0.0 111.344 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -85.54 133.69 34.06 Favored 'General case' 0 CA--C 1.569 1.711 0 O-C-N 121.384 -0.823 . . . . 0.0 112.084 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -132.5 131.4 41.59 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.103 0.561 . . . . 0.0 110.342 164.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.277 4.1 m-20 71.74 -86.72 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 161.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.04 52.27 0.64 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 123.439 0.542 . . . . 0.0 113.022 160.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -156.03 124.2 5.75 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.904 0.882 . . . . 0.0 111.086 -164.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.7 tp -95.46 110.69 22.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.588 -0.695 . . . . 0.0 110.207 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.8 t -91.87 105.87 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -99.92 106.98 18.85 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 124.306 1.042 . . . . 0.0 109.466 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -97.45 102.0 13.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.489 -0.757 . . . . 0.0 111.358 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -83.43 125.59 31.86 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 124.768 1.227 . . . . 0.0 111.163 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.15 117.3 21.34 Favored 'General case' 0 CA--C 1.573 1.855 0 CA-C-N 119.459 1.027 . . . . 0.0 111.001 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -165.0 149.14 8.84 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.248 -0.908 . . . . 0.0 112.339 -171.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 48.55 41.94 18.09 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 158.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.8 30.11 71.96 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 119.55 2.58 . . . . 0.0 119.55 -166.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -142.32 138.53 31.34 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.439 1.095 . . . . 0.0 109.394 -166.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -129.81 126.84 39.04 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 121.491 0.662 . . . . 0.0 111.76 171.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.3 t -120.67 119.06 31.74 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.924 0.89 . . . . 0.0 109.572 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 71.6 p -93.01 128.29 38.83 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.184 0.594 . . . . 0.0 110.258 172.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.9 mm -112.93 116.55 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 169.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.4 m -99.79 98.54 9.34 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.43 -0.794 . . . . 0.0 109.046 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -90.84 99.12 12.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.22 147.52 50.58 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -163.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.97 121.46 31.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 112.64 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.328 40.2 mttt -106.16 -113.75 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.315 0.646 . . . . 0.0 109.92 169.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -84.85 51.85 2.26 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -168.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.95 31.76 79.0 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 117.516 1.766 . . . . 0.0 117.516 -156.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -137.27 135.0 36.76 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -169.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 tp -85.93 104.41 15.54 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.434 1.112 . . . . 0.0 108.957 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 87.1 t -99.99 109.42 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.7 t -102.98 106.62 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -116.62 99.16 6.95 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -164.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.8 p -93.31 157.12 16.4 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.57 130.41 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.852 -0.53 . . . . 0.0 109.986 158.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 4.9 ttt -102.81 -102.47 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -106.31 85.12 2.13 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.272 49.8 m-80 75.6 -43.19 0.49 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -169.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.4 t -82.29 123.43 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 111.193 -163.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.2 p -109.65 138.98 45.23 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.775 0.83 . . . . 0.0 112.539 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 11.1 p -127.37 117.4 22.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 169.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.1 m -93.98 105.99 17.98 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 168.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -116.52 129.73 56.36 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 122.044 0.926 . . . . 0.0 111.843 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 24.3 mm -104.38 126.34 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 124.273 1.029 . . . . 0.0 109.299 -159.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -123.08 126.35 46.91 Favored 'General case' 0 CA--C 1.577 1.995 0 O-C-N 121.68 -0.637 . . . . 0.0 112.172 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -87.3 139.96 30.03 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -74.69 118.27 17.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 112.136 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.82 61.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.771 -0.58 . . . . 0.0 110.115 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.029 -1.045 . . . . 0.0 109.03 -158.276 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.257 9.0 p . . . . . 0 N--CA 1.504 2.269 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -52.55 -28.19 19.79 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 167.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -51.69 -39.69 58.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.92 -6.11 42.97 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 171.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -90.74 135.53 33.66 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 121.213 1.824 . . . . 0.0 112.483 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.01 -176.19 29.64 Favored Glycine 0 N--CA 1.485 1.912 0 CA-C-O 122.642 1.134 . . . . 0.0 114.503 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -94.32 119.33 32.92 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.985 -0.608 . . . . 0.0 109.541 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -121.07 118.11 28.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 122.085 -0.385 . . . . 0.0 110.977 -166.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -105.91 126.45 52.19 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.287 -0.883 . . . . 0.0 112.908 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.03 124.56 24.68 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.714 0.769 . . . . 0.0 112.939 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.45 -55.51 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 124.117 0.967 . . . . 0.0 112.229 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -110.12 99.13 8.26 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 119.186 0.903 . . . . 0.0 109.173 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.0 p -113.87 95.68 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.081 0.953 . . . . 0.0 111.887 -174.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -107.41 123.41 48.35 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.139 -0.976 . . . . 0.0 111.736 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.76 66.34 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 119.657 2.623 . . . . 0.0 119.657 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -79.55 -41.2 27.75 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 120.29 2.045 . . . . 0.0 115.671 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.19 -43.23 74.2 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 120.443 1.474 . . . . 0.0 114.594 160.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.71 -47.97 82.73 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -51.27 -55.59 17.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 165.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -61.39 -23.5 65.84 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 171.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -64.53 -46.77 81.43 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 160.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -61.7 -37.59 84.71 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 121.615 2.007 . . . . 0.0 115.116 167.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.65 -51.75 67.52 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 164.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.54 72.33 1.05 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.428 -0.795 . . . . 0.0 112.538 -168.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.9 t -119.83 136.96 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.94 153.12 50.55 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 116.874 1.51 . . . . 0.0 116.874 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 30' ' ' ILE . 2.3 mp -59.11 -48.59 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -168.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.54 88.64 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 167.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.17 -45.98 91.25 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 170.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -61.97 -45.07 95.25 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 167.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -55.34 -42.55 74.0 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 74.4 mtm -62.3 -44.96 95.3 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 165.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -48.54 58.29 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.521 2.168 . . . . 0.0 118.521 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.65 -47.37 86.55 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -85.86 10.27 14.32 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.38 35.29 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 120.463 -1.398 . . . . 0.0 113.65 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -109.42 74.77 0.69 Allowed Pre-proline 0 CA--C 1.575 1.94 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.849 167.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.46 158.22 48.23 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.723 2.282 . . . . 0.0 115.913 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.05 98.24 10.3 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 162.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.2 t -88.84 101.62 14.22 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 122.063 0.935 . . . . 0.0 110.61 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -93.56 113.71 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -113.68 125.08 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -152.17 133.95 14.78 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.778 -1.202 . . . . 0.0 109.5 171.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.7 p -100.41 123.9 45.23 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -82.62 74.9 9.55 Favored 'General case' 0 CA--C 1.576 1.943 0 CA-C-O 122.309 1.052 . . . . 0.0 110.18 162.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.63 -89.04 0.08 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -88.49 -29.06 20.41 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 163.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -81.35 88.3 6.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 121.713 2.052 . . . . 0.0 111.841 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.34 109.45 16.6 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-O 122.125 0.964 . . . . 0.0 110.108 -173.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.1 m -101.33 113.35 26.34 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.332 -162.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.7 mt -111.49 113.1 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -110.77 105.34 14.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.823 -0.548 . . . . 0.0 109.881 170.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.0 m -90.95 101.29 14.05 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.557 0.743 . . . . 0.0 109.204 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -94.25 117.92 30.82 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.622 0.769 . . . . 0.0 111.779 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.9 t -154.49 139.47 17.31 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.704 0.801 . . . . 0.0 111.852 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.4 p -60.53 -34.56 74.29 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 165.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.8 -55.18 18.52 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-N 119.486 1.039 . . . . 0.0 113.671 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.54 110.45 3.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.606 -1.309 . . . . 0.0 111.636 167.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.6 m -80.75 146.32 31.07 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.963 0.887 . . . . 0.0 111.287 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.5 m -155.55 136.61 13.74 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.299 -1.501 . . . . 0.0 109.594 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -142.32 146.32 34.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -158.42 150.87 21.97 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.9 p -108.28 107.43 18.02 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.5 0.72 . . . . 0.0 110.943 169.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.0 p -99.07 115.29 28.65 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.588 0.708 . . . . 0.0 112.698 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.9 m -72.47 110.58 6.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.468 -0.77 . . . . 0.0 110.392 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.5 tp -71.05 110.31 5.66 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -162.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.12 -54.32 0.75 Allowed Glycine 0 CA--C 1.547 2.089 0 C-N-CA 123.594 0.616 . . . . 0.0 114.107 -159.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.91 -177.78 4.0 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 123.712 1.72 . . . . 0.0 113.579 -169.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -99.7 130.45 45.92 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 113.857 -1.52 . . . . 0.0 112.6 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -123.06 -175.8 3.26 Favored 'General case' 0 CA--C 1.578 2.032 0 C-N-CA 125.168 1.387 . . . . 0.0 111.45 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -109.73 119.51 39.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.322 -1.486 . . . . 0.0 111.221 165.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -81.36 131.88 35.31 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 121.368 -0.832 . . . . 0.0 109.051 158.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.0 m -100.7 107.12 18.65 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 167.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.6 p -70.48 162.3 29.0 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.77 -31.91 59.33 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 166.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.17 -47.99 80.29 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.95 57.19 0.25 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 124.104 0.859 . . . . 0.0 113.903 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -131.31 124.32 30.18 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -173.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.53 109.58 17.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.679 -0.638 . . . . 0.0 110.115 171.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.4 p -116.14 112.67 22.03 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.372 0.606 . . . . 0.0 111.018 -169.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -70.82 101.18 2.06 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.279 1.038 . . . . 0.0 110.937 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.8 m -122.71 122.13 38.02 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.138 -153.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.42 125.81 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.651 -0.656 . . . . 0.0 111.476 170.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.9 m -99.5 123.63 43.95 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 173.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -133.0 133.91 43.76 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 118.8 0.727 . . . . 0.0 111.167 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -95.38 130.5 42.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.092 -1.005 . . . . 0.0 111.54 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.9 t -143.47 141.78 30.92 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 122.943 0.497 . . . . 0.0 110.281 165.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 62.11 35.28 15.84 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 160.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.11 25.86 74.87 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -165.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.53 135.59 22.56 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-N 118.909 1.354 . . . . 0.0 113.249 -174.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.12 112.69 22.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.432 -0.793 . . . . 0.0 110.479 166.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 67.0 t -93.68 103.11 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -101.6 103.86 14.7 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.49 0.716 . . . . 0.0 109.981 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -91.22 107.26 19.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.514 -0.741 . . . . 0.0 110.693 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -79.72 144.93 33.22 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.879 0.871 . . . . 0.0 111.975 169.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -143.24 124.69 14.75 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.651 0.781 . . . . 0.0 109.781 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 7.9 p90 -155.3 125.83 6.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.252 30.0 t70 49.14 45.26 23.21 Favored 'General case' 0 CA--C 1.584 2.252 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.63 26.37 66.62 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 119.612 2.605 . . . . 0.0 119.612 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -131.96 130.83 42.0 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.628 1.214 . . . . 0.0 108.462 -171.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.58 150.09 38.58 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -166.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 t -139.17 131.93 29.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.594 -0.691 . . . . 0.0 112.079 164.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.8 p -104.22 109.4 21.21 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.102 0.561 . . . . 0.0 110.106 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.0 mm -95.61 104.04 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.7 m -100.52 102.5 13.7 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.644 -0.66 . . . . 0.0 109.81 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -99.48 87.18 3.53 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.163 0.585 . . . . 0.0 110.454 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -110.08 135.89 50.18 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -166.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.87 113.56 22.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.122 -0.986 . . . . 0.0 112.902 -173.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -141.23 133.56 28.16 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.491 0.717 . . . . 0.0 109.287 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 60.11 39.24 19.83 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.13 13.25 41.21 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 119.635 2.614 . . . . 0.0 119.635 -163.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -133.16 144.18 49.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.628 1.214 . . . . 0.0 110.178 -162.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.0 tp -88.03 103.97 16.21 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.868 0.842 . . . . 0.0 109.734 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.6 t -89.92 103.09 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.5 t -96.57 98.23 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -98.09 106.83 19.18 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.3 p -106.7 121.92 45.31 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.538 0.335 . . . . 0.0 111.839 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 p -121.73 137.1 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.265 0.626 . . . . 0.0 109.936 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.7 ttt -81.08 -79.42 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 122.219 -0.301 . . . . 0.0 110.246 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -122.1 -60.73 1.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.272 0.629 . . . . 0.0 110.885 167.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -97.63 -43.13 7.33 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.58 127.69 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 CA-C-O 122.38 1.086 . . . . 0.0 109.9 -156.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 73.6 p -110.6 139.21 46.07 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.993 -167.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.8 OUTLIER -106.34 132.07 52.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.835 . . . . 0.0 110.633 158.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.5 m -109.1 107.06 17.23 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -110.5 113.49 26.16 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.11 0.564 . . . . 0.0 110.835 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 mm -91.13 116.65 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.192 -0.943 . . . . 0.0 108.567 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -107.66 125.27 51.15 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.206 0.602 . . . . 0.0 110.727 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -92.27 142.65 27.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -81.57 116.32 21.28 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.911 0.885 . . . . 0.0 112.207 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.3 t -101.29 93.13 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -171.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 124.031 0.932 . . . . 0.0 110.451 -174.688 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.522 0.8 OUTLIER . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 118.755 2.872 . . . . 0.0 118.755 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -38.17 90.13 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 174.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -62.36 -25.69 68.05 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 167.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.7 mt -70.36 -7.57 43.88 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 164.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.83 142.59 31.41 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-N 121.319 1.872 . . . . 0.0 112.79 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.56 171.19 18.56 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 -86.98 103.63 15.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 165.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -101.66 101.86 12.45 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -170.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.33 142.58 27.62 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.588 0.755 . . . . 0.0 112.871 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.1 tp -71.01 127.96 34.35 Favored 'General case' 0 CA--C 1.571 1.776 0 O-C-N 120.677 -1.264 . . . . 0.0 113.446 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.95 -55.41 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 C-N-CA 124.082 0.953 . . . . 0.0 112.399 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -117.65 151.28 37.54 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 119.642 1.11 . . . . 0.0 110.567 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -144.47 59.22 1.33 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.997 0.903 . . . . 0.0 113.046 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -75.6 119.62 19.89 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -167.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.52 -6.76 71.22 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 -170.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.252 22.6 t80 -59.27 -31.6 69.25 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.816 2.524 . . . . 0.0 117.816 -174.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -52.46 -54.59 30.33 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 164.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.99 -45.39 83.0 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -58.65 -49.54 77.14 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 19.8 ptp -56.26 -37.65 70.06 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 167.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -63.62 -47.16 82.53 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 168.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.63 -37.95 83.21 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.1 mt -53.45 -35.94 61.06 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 117.576 2.435 . . . . 0.0 117.576 167.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.76 62.79 1.07 Allowed Glycine 0 N--CA 1.487 2.073 0 C-N-CA 123.438 0.542 . . . . 0.0 114.041 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.51 125.12 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -172.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.17 162.16 51.78 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 30' ' ' ILE . 1.8 mp -55.62 -50.97 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -168.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.38 94.86 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.4 mt -57.77 -41.7 82.54 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.734 1.754 . . . . 0.0 115.734 167.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -60.81 -49.68 76.5 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.22 -46.92 87.19 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.5 ttp -53.64 -55.21 27.87 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 167.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.29 96.04 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 118.618 2.207 . . . . 0.0 118.618 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.6 94.59 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.9 ptp -75.47 -22.15 57.48 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 170.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.93 133.1 47.75 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -174.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -103.08 87.28 1.22 Allowed Pre-proline 0 CA--C 1.576 1.945 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.749 166.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.96 142.96 22.63 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.46 2.107 . . . . 0.0 115.168 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -95.44 103.34 15.21 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.18 168.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 50.6 t -81.14 101.11 9.44 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-O 121.836 0.827 . . . . 0.0 110.903 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mt -94.96 104.36 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -170.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.83 130.78 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.258 7.7 t -136.84 149.88 47.98 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.776 -0.577 . . . . 0.0 112.312 159.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.4 t -141.83 128.74 20.63 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -68.68 -46.2 69.7 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 165.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.66 -78.68 0.15 Allowed Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -171.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HE3' HG22 ' A' ' 68' ' ' THR . 43.8 tttp -80.82 -26.07 37.35 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 160.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -88.63 138.75 31.14 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 122.842 2.565 . . . . 0.0 112.931 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -139.57 125.21 19.38 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.436 0.694 . . . . 0.0 110.463 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 m -109.37 133.86 52.53 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.376 1.07 . . . . 0.0 110.433 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.8 mt -123.12 119.68 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -103.94 110.17 22.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.685 -0.634 . . . . 0.0 110.145 163.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.7 m -83.71 99.17 10.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.277 -0.89 . . . . 0.0 109.102 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.44 125.74 35.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.663 0.744 . . . . 0.0 112.24 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 t -147.1 135.28 21.58 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 166.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.4 p -56.39 -26.05 51.79 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.5 mt -73.47 -54.51 8.09 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 165.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.71 114.75 3.54 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.563 1.529 . . . . 0.0 111.612 173.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.4 m -84.19 141.46 31.02 Favored 'General case' 0 CA--C 1.575 1.928 0 C-N-CA 123.457 0.703 . . . . 0.0 111.851 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 t -134.17 145.48 49.29 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.156 -0.965 . . . . 0.0 111.27 164.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -135.47 133.99 39.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.776 -1.202 . . . . 0.0 111.849 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.92 160.62 41.02 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 122.061 0.934 . . . . 0.0 112.964 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 m -139.13 137.49 36.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.089 -1.007 . . . . 0.0 111.153 170.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 36.4 t -135.4 143.0 45.77 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.813 1.292 . . . . 0.0 112.635 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.428 HG22 ' HE3' ' A' ' 50' ' ' LYS . 35.2 m -91.48 115.41 28.02 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.195 171.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -64.38 134.4 54.53 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.95 -49.09 0.87 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 -154.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -98.47 164.98 12.05 Favored 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 123.595 1.664 . . . . 0.0 113.228 -163.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -110.58 128.76 55.8 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.396 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.416 ' HE1' ' SG ' ' A' ' 87' ' ' CYS . 11.7 p90 -129.62 166.14 20.35 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.46 105.99 10.1 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 122.055 0.931 . . . . 0.0 111.467 169.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -103.12 97.43 7.52 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.426 1.091 . . . . 0.0 109.104 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.8 m -80.06 109.12 14.21 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 121.821 0.82 . . . . 0.0 109.471 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.6 p -69.6 176.14 3.71 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.95 -43.28 29.13 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 168.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.76 -43.51 97.92 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.268 2.322 . . . . 0.0 117.268 165.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.98 3.15 13.58 Favored Glycine 0 CA--C 1.556 2.634 0 N-CA-C 119.097 2.399 . . . . 0.0 119.097 -162.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.3 mtm-85 -69.89 128.54 36.72 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 120.979 2.389 . . . . 0.0 112.204 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -86.54 93.54 9.2 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.791 0.805 . . . . 0.0 108.9 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 p -99.28 125.24 44.87 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.712 -170.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -79.92 97.55 6.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.656 -1.278 . . . . 0.0 110.082 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.4 m -104.97 116.7 32.41 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.749 0.42 . . . . 0.0 110.408 -166.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.13 118.91 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.97 -0.456 . . . . 0.0 110.087 167.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.416 ' SG ' ' HE1' ' A' ' 73' ' ' PHE . 70.9 m -100.1 131.42 46.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.967 -0.458 . . . . 0.0 111.58 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -142.04 115.4 8.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 110.265 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -78.96 129.4 34.44 Favored 'General case' 0 CA--C 1.57 1.721 0 O-C-N 120.977 -1.077 . . . . 0.0 111.6 166.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 t -146.1 142.78 28.86 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.251 0.62 . . . . 0.0 110.201 165.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 60.63 36.92 19.55 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 159.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.3 21.15 79.45 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 -166.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.52 139.62 24.33 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-N 119.02 1.41 . . . . 0.0 112.596 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 67.3 tp -96.61 115.13 26.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -0.804 . . . . 0.0 110.615 171.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.9 t -89.28 103.35 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -98.31 95.56 7.46 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -96.72 99.74 11.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.968 . . . . 0.0 110.095 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -100.43 126.9 46.87 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -170.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -129.78 131.1 46.11 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.207 0.603 . . . . 0.0 111.388 -167.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -152.64 120.9 6.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.624 -1.298 . . . . 0.0 111.438 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.6 t70 42.99 54.22 4.86 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.9 -45.43 2.69 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 117.902 1.921 . . . . 0.0 117.902 -169.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -89.92 141.78 28.32 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 118.19 0.995 . . . . 0.0 113.345 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -127.92 159.68 34.19 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.682 0.753 . . . . 0.0 112.991 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.4 t -135.54 141.51 45.24 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.429 1.109 . . . . 0.0 112.01 162.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.6 p -106.38 109.99 22.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 mm -103.09 94.51 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -172.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.1 m -97.82 105.36 17.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.0 109.719 -172.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.9 mtp85 -103.23 89.33 3.37 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.234 0.614 . . . . 0.0 110.544 -167.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -105.86 138.25 42.37 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -168.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.4 123.88 33.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 113.209 -173.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -150.92 121.83 7.61 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.519 0.728 . . . . 0.0 109.266 -170.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.1 t70 61.06 28.2 17.97 Favored 'General case' 0 N--CA 1.514 2.754 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.58 33.12 66.09 Favored Glycine 0 CA--C 1.56 2.849 0 O-C-N 119.274 -2.141 . . . . 0.0 117.584 -158.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -133.08 131.17 40.27 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -174.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.2 tp -86.52 105.12 16.59 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.849 -1.157 . . . . 0.0 109.831 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.2 t -91.95 106.17 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t -100.5 99.29 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -87.52 93.85 9.54 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.471 1.129 . . . . 0.0 108.499 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.938 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.3 p -104.82 97.39 7.28 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.7 -176.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.48 146.34 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.519 1.152 . . . . 0.0 109.927 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.3 ttt -97.71 -60.12 1.63 Allowed 'General case' 0 CA--C 1.565 1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 112.972 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.273 12.9 p30 -139.65 -92.99 0.17 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -81.28 -13.71 58.17 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 154.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -96.73 133.89 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 C-N-CA 124.72 1.208 . . . . 0.0 109.67 -166.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.0 p -132.76 146.83 52.17 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -152.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.938 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 6.1 p -136.92 121.12 17.91 Favored 'General case' 0 CA--C 1.563 1.468 0 O-C-N 121.533 -0.73 . . . . 0.0 110.711 158.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.2 m -97.76 101.7 13.28 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -108.9 110.53 21.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.701 -0.624 . . . . 0.0 110.306 -168.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.9 mm -94.39 124.69 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -122.28 120.38 33.92 Favored 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.04 0.536 . . . . 0.0 110.379 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -90.74 150.51 21.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.781 -1.199 . . . . 0.0 113.447 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -78.4 128.64 33.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.915 -1.116 . . . . 0.0 113.55 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.2 t -86.56 104.65 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 165.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 N--CA 1.487 1.395 0 C-N-CA 123.802 0.841 . . . . 0.0 110.543 178.451 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.274 4.8 p . . . . . 0 N--CA 1.503 2.2 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.53 -33.28 72.42 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 163.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -63.49 -33.83 76.44 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 165.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.94 -4.06 11.85 Favored 'General case' 0 CA--C 1.581 2.151 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 164.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.05 122.02 25.68 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 121.955 2.161 . . . . 0.0 112.596 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.19 -179.95 34.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.3 ttm105 -93.84 108.06 19.88 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.159 0.584 . . . . 0.0 109.592 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -109.94 107.56 17.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.376 -0.827 . . . . 0.0 110.49 -165.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -91.82 130.78 37.53 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.788 -1.195 . . . . 0.0 112.794 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 48.0 tp -64.18 125.53 24.84 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 170.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.261 5.6 m -126.86 -60.01 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 123.097 0.559 . . . . 0.0 112.246 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -104.21 137.23 42.43 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 119.332 0.969 . . . . 0.0 110.338 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 p -147.97 93.57 2.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.477 -0.764 . . . . 0.0 111.725 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.46 128.9 48.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.816 -0.552 . . . . 0.0 111.772 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.6 -1.12 88.58 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 118.901 2.32 . . . . 0.0 118.901 -168.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -71.53 -51.19 24.84 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.046 1.923 . . . . 0.0 115.555 -170.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.09 -38.53 62.64 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 167.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.71 -49.28 75.69 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -54.24 -45.04 72.24 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 164.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.1 mtp -57.84 -42.75 85.02 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 169.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -55.5 -48.63 74.31 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 163.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.8 -43.4 98.19 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 172.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.7 mt -55.23 -38.58 68.65 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 117.889 2.552 . . . . 0.0 117.889 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.6 55.93 1.13 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 -165.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.69 118.57 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.682 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.65 165.29 41.08 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 30' ' ' ILE . 1.9 mp -57.94 -48.92 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.46 98.56 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.45 -42.39 91.85 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -57.53 -51.44 69.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -54.96 -54.3 44.53 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 169.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.2 ttp -52.93 -57.01 11.74 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.81 -40.85 90.3 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 118.926 2.33 . . . . 0.0 118.926 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.54 -51.79 52.75 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 169.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -72.61 -30.36 64.29 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.81 85.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.338 62.7 pttt 47.25 66.39 5.71 Favored Pre-proline 0 CA--C 1.585 2.306 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.79 154.84 23.47 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 N-CA-C 117.025 1.894 . . . . 0.0 117.025 -159.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.83 97.97 7.61 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.028 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.0 t -90.9 103.25 15.98 Favored 'General case' 0 CA--C 1.556 1.183 0 O-C-N 121.148 -0.97 . . . . 0.0 112.198 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.88 110.18 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.8 mt -97.95 114.8 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.2 m -134.63 117.91 16.62 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.5 t -121.82 118.54 29.25 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -172.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -86.19 60.24 6.12 Favored 'General case' 0 CA--C 1.576 1.951 0 CA-C-O 121.991 0.901 . . . . 0.0 111.557 170.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.64 -71.24 0.68 Allowed Glycine 0 N--CA 1.492 2.412 0 O-C-N 120.145 -1.597 . . . . 0.0 116.431 -170.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -99.89 -46.23 5.44 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.76 105.35 10.99 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 121.053 1.752 . . . . 0.0 111.387 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.66 111.61 23.87 Favored 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.139 0.971 . . . . 0.0 109.832 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.1 m -93.98 116.48 28.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.891 0.876 . . . . 0.0 109.165 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.4 104.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -105.43 104.02 13.66 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.321 0.581 . . . . 0.0 109.683 171.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.7 m -89.25 100.16 13.01 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.851 0.86 . . . . 0.0 110.124 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.72 111.84 23.7 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.088 0.947 . . . . 0.0 111.498 -173.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.1 p -148.51 153.12 38.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.628 -0.67 . . . . 0.0 110.601 157.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.6 p -61.98 -43.93 97.81 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 171.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.5 mt -61.97 -41.41 97.98 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 168.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -145.31 110.63 5.28 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.836 1.198 . . . . 0.0 110.72 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.53 118.81 36.14 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.2 p -139.72 142.61 36.83 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.009 -1.057 . . . . 0.0 111.91 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -139.14 133.44 31.48 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.742 -1.224 . . . . 0.0 111.821 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -146.65 147.31 30.9 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.678 0.751 . . . . 0.0 112.887 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.3 p -105.53 106.29 16.72 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.577 0.751 . . . . 0.0 110.846 172.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.3 p -94.45 125.23 38.96 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 121.515 0.674 . . . . 0.0 112.33 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.5 m -77.8 123.17 26.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.318 -0.864 . . . . 0.0 110.068 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.79 132.03 37.87 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -167.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.71 37.38 94.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 116.792 1.477 . . . . 0.0 116.792 -159.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.73 155.75 24.32 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.429 1.109 . . . . 0.0 111.136 -171.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -109.73 121.56 45.5 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.787 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -121.59 162.15 21.15 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.46 0.704 . . . . 0.0 112.502 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -75.84 106.08 7.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.783 -1.198 . . . . 0.0 110.971 166.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -90.98 116.54 28.86 Favored 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.8 m -86.74 93.97 9.39 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.8 p -68.94 159.93 31.77 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -43.46 -42.93 5.06 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.99 -35.8 66.92 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 171.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.91 -14.9 3.32 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 117.94 1.936 . . . . 0.0 117.94 -166.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -71.81 131.34 42.92 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.495 2.147 . . . . 0.0 112.651 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -81.97 110.5 17.29 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.205 0.602 . . . . 0.0 110.364 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.6 p -114.96 128.26 56.17 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.136 0.493 . . . . 0.0 109.816 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -78.82 92.25 4.83 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.759 0.79 . . . . 0.0 109.64 172.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.4 m -98.15 114.31 26.48 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.894 -164.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.264 12.5 p -91.74 117.11 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 122.019 -0.426 . . . . 0.0 110.82 171.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.6 m -101.5 112.99 25.71 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.136 -0.352 . . . . 0.0 111.849 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -123.0 125.56 45.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.656 -0.652 . . . . 0.0 111.114 -171.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -88.33 130.55 35.1 Favored 'General case' 0 CA--C 1.568 1.663 0 O-C-N 121.131 -0.98 . . . . 0.0 112.393 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -141.29 107.61 5.26 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.466 0.706 . . . . 0.0 110.218 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 45.34 70.45 0.35 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 171.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.33 -0.03 60.82 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 119.896 2.718 . . . . 0.0 119.896 -171.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.39 126.58 39.15 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 119.985 1.892 . . . . 0.0 113.009 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.2 tp -93.39 108.82 20.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.614 -0.679 . . . . 0.0 110.621 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -90.29 107.93 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -101.11 98.37 8.81 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.284 1.034 . . . . 0.0 109.521 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -100.3 103.14 14.54 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.565 0.746 . . . . 0.0 110.477 -171.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -100.19 105.97 17.61 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.896 0.878 . . . . 0.0 111.215 -164.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -108.19 126.08 52.38 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.192 -0.942 . . . . 0.0 113.539 -166.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -154.71 141.02 18.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.221 -0.925 . . . . 0.0 110.606 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.2 t70 51.14 45.44 27.83 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 159.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.9 68.63 Favored Glycine 0 CA--C 1.559 2.829 0 N-CA-C 120.238 2.855 . . . . 0.0 120.238 -167.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -137.01 150.06 47.87 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.141 1.471 . . . . 0.0 110.434 -167.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -124.18 147.56 47.91 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.249 0.547 . . . . 0.0 112.374 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.8 t -126.3 115.63 19.99 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 164.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.8 m -123.74 113.14 18.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.067 -1.021 . . . . 0.0 108.732 -160.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.0 mt -122.09 112.17 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -164.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 58.6 m -95.32 101.31 13.03 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.187 0.517 . . . . 0.0 109.666 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -93.08 101.17 13.48 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.376 0.67 . . . . 0.0 109.271 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 pttp -126.39 140.4 52.52 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -169.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.18 116.39 15.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 111.203 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.286 24.9 tptp -103.24 -126.72 0.22 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.081 0.552 . . . . 0.0 110.049 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -91.9 64.93 4.81 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 122.231 1.015 . . . . 0.0 109.51 -165.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.66 -24.11 13.73 Favored Glycine 0 CA--C 1.556 2.645 0 N-CA-C 119.045 2.378 . . . . 0.0 119.045 -162.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -129.89 161.16 31.47 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.078 1.939 . . . . 0.0 112.306 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.5 tp -85.02 116.08 23.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.794 -1.191 . . . . 0.0 111.406 -173.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.7 t -91.81 120.2 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 64.0 t -110.34 100.01 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -95.66 102.67 14.49 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.966 0.906 . . . . 0.0 108.972 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 0.9 OUTLIER -98.85 150.89 21.42 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.1 137.29 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 123.221 0.608 . . . . 0.0 109.609 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.268 10.7 ttt -98.25 -77.35 0.51 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 0.0 111.118 163.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -123.48 -70.89 0.75 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.388 -0.82 . . . . 0.0 110.934 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -99.58 -31.32 11.66 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 170.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.2 t -99.74 129.49 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-N 120.365 1.438 . . . . 0.0 110.148 -164.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.8 p -106.34 154.89 20.14 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.328 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.6 OUTLIER -130.17 139.16 50.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 112.328 162.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.1 m -106.74 109.43 21.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -107.31 124.82 50.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.331 0.653 . . . . 0.0 110.996 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.8 mm -92.38 122.73 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -113.57 122.78 48.28 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.757 0.823 . . . . 0.0 109.973 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -92.72 137.92 31.94 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -77.52 111.95 13.78 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.72 0.772 . . . . 0.0 112.691 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.9 t -103.95 128.47 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.015 -1.053 . . . . 0.0 108.832 -175.514 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.503 1.2 p . . . . . 0 N--CA 1.503 2.181 0 N-CA-C 118.38 2.733 . . . . 0.0 118.38 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.37 -36.32 53.52 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 169.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -54.49 -37.06 64.85 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 169.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.9 mt -70.74 -2.58 15.13 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 171.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -81.72 134.84 35.5 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 121.258 1.844 . . . . 0.0 112.937 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.79 177.95 29.51 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 117.757 1.863 . . . . 0.0 117.757 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -93.43 102.54 14.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.096 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.34 101.84 11.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.954 -0.466 . . . . 0.0 110.018 -168.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -90.01 125.82 35.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.206 1.002 . . . . 0.0 113.45 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.9 tp -64.41 125.09 23.53 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.41 -44.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.321 1.048 . . . . 0.0 113.162 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -128.49 155.66 44.49 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 120.291 1.405 . . . . 0.0 111.834 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.5 p -153.62 84.38 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 0.0 111.365 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.14 138.76 39.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.513 -0.742 . . . . 0.0 112.758 176.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.45 23.32 70.19 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 119.693 2.637 . . . . 0.0 119.693 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -85.83 -43.62 13.14 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -168.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -50.13 -46.4 53.82 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 162.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -53.98 -48.98 69.81 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 166.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -61.2 -47.47 85.98 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.05 -32.79 74.46 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 169.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -58.23 -48.44 80.39 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 121.507 1.958 . . . . 0.0 115.814 158.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -60.21 -40.6 90.7 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.5 mt -57.7 -50.3 73.64 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 161.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.14 56.11 0.28 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 124.346 0.974 . . . . 0.0 115.134 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.31 130.28 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-N 117.607 0.703 . . . . 0.0 109.423 -171.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.51 159.87 51.8 Favored Glycine 0 CA--C 1.553 2.431 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 30' ' ' ILE . 1.8 mp -56.88 -48.65 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -170.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.61 88.72 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 171.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.09 -40.03 94.03 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 170.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.1 mtm-85 -63.69 -42.71 97.96 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 166.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -54.29 -49.82 68.72 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 166.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.6 ttp -52.86 -55.29 24.28 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 164.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.48 -37.73 67.8 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 119.766 2.666 . . . . 0.0 119.766 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.34 -51.04 61.32 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.2 ptp -77.28 -20.44 55.07 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.24 115.22 7.45 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 120.163 1.347 . . . . 0.0 112.184 165.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.93 84.42 3.46 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.139 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.86 151.49 31.46 Favored 'Trans proline' 0 C--N 1.372 1.772 0 N-CA-C 117.395 2.036 . . . . 0.0 117.395 -168.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -84.4 102.38 12.71 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.532 162.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.3 t -77.78 100.53 6.32 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 121.951 0.881 . . . . 0.0 110.76 170.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.7 mt -95.93 101.68 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -170.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 81.2 mt -99.33 130.64 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.6 t -136.23 140.22 43.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.824 -0.548 . . . . 0.0 111.666 157.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 43.0 t -119.65 103.57 9.51 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.683 0.793 . . . . 0.0 111.961 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.65 75.85 9.53 Favored 'General case' 0 CA--C 1.572 1.798 0 CA-C-O 122.189 0.995 . . . . 0.0 110.686 170.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.7 -83.29 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 116.733 1.453 . . . . 0.0 116.733 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -105.59 -16.6 14.66 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -101.9 116.97 33.86 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 122.214 2.279 . . . . 0.0 110.523 175.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -112.43 116.78 30.84 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.947 0.879 . . . . 0.0 109.938 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.6 m -99.4 125.74 45.16 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.987 0.915 . . . . 0.0 109.73 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 mt -119.4 112.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -98.14 109.83 22.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.764 -0.585 . . . . 0.0 109.941 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 m -90.9 103.3 16.03 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.435 -0.79 . . . . 0.0 109.456 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -101.43 116.85 33.72 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -143.24 140.47 30.69 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.087 0.555 . . . . 0.0 110.091 167.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -50.83 -44.33 59.25 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.21 -40.72 97.05 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.34 103.84 1.25 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.47 1.487 . . . . 0.0 111.076 -175.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.0 m -90.25 145.67 24.82 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.991 0.901 . . . . 0.0 111.459 170.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.7 m -148.24 136.14 20.96 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.056 -1.653 . . . . 0.0 110.63 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -126.99 133.37 50.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.413 -0.804 . . . . 0.0 111.75 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -136.38 152.06 50.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 172.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.3 p -117.98 103.95 10.42 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.802 0.841 . . . . 0.0 109.905 170.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 24.1 p -95.34 152.1 18.68 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.8 m -91.37 130.81 37.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.824 -1.172 . . . . 0.0 109.582 168.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tp -69.53 131.31 44.49 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 112.878 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.13 -6.98 8.56 Favored Glycine 0 CA--C 1.553 2.458 0 N-CA-C 119.558 2.583 . . . . 0.0 119.558 -164.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.78 172.02 10.18 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-N 119.303 1.552 . . . . 0.0 112.007 -174.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -113.46 110.79 20.87 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.495 -156.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -105.76 160.75 14.98 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.655 0.782 . . . . 0.0 112.296 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.53 106.68 14.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.93 -1.731 . . . . 0.0 111.658 169.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -89.15 102.08 14.74 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 169.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.4 m -77.95 110.82 13.2 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.094 0.949 . . . . 0.0 109.593 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -75.43 134.38 40.9 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.797 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.94 63.77 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 119.721 3.23 . . . . 0.0 119.721 -170.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.31 -27.08 65.98 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.51 -35.7 0.47 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 118.715 2.246 . . . . 0.0 118.715 167.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -75.07 136.54 41.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -163.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -93.55 115.04 27.53 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.173 0.989 . . . . 0.0 109.021 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.4 p -119.36 111.41 18.14 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.784 0.802 . . . . 0.0 111.168 -164.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -71.78 98.27 1.94 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.324 1.05 . . . . 0.0 110.581 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.4 m -112.99 108.47 17.39 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.285 -0.884 . . . . 0.0 109.922 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.258 12.7 p -88.88 122.61 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 122.96 0.504 . . . . 0.0 111.382 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 55.7 m -105.51 88.11 2.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -169.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -102.18 119.34 38.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.541 -1.349 . . . . 0.0 111.941 -168.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -80.17 131.9 35.8 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.004 -1.06 . . . . 0.0 112.712 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -133.11 97.47 4.01 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.583 0.753 . . . . 0.0 110.414 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.331 9.8 t70 68.6 -73.56 0.09 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 172.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.39 35.43 2.17 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 116.587 1.395 . . . . 0.0 116.587 167.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -153.93 139.24 17.58 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 118.581 1.19 . . . . 0.0 112.957 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 tp -97.84 115.4 27.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.68 -0.637 . . . . 0.0 110.854 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -88.01 101.8 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.56 94.52 9.91 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 124.396 1.078 . . . . 0.0 109.009 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -96.1 98.13 10.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.728 . . . . 0.0 112.159 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -71.05 137.42 48.95 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.062 0.945 . . . . 0.0 113.063 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -136.83 121.61 18.64 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.497 0.719 . . . . 0.0 109.931 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -158.35 127.1 5.5 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.626 -1.296 . . . . 0.0 111.11 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 54.08 37.83 27.77 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 164.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.72 -43.23 3.08 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 -165.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -75.35 154.57 37.2 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -151.58 155.01 37.57 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.059 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 t -144.32 121.87 11.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.219 -0.926 . . . . 0.0 112.897 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.1 p -86.55 131.34 34.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 0.0 111.278 168.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.2 mt -123.32 101.28 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 84.9 m -93.71 108.08 19.87 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.546 0.739 . . . . 0.0 110.056 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -97.98 87.91 4.1 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.268 0.627 . . . . 0.0 110.041 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.18 142.32 29.22 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -171.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 120.86 27.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.505 -0.747 . . . . 0.0 112.366 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.274 41.0 tttm -134.85 -130.92 0.16 Allowed 'General case' 0 CA--C 1.569 1.706 0 O-C-N 121.979 -0.45 . . . . 0.0 112.03 -172.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -82.86 67.91 9.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.497 -1.377 . . . . 0.0 113.464 -161.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.95 16.82 57.72 Favored Glycine 0 CA--C 1.565 3.194 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -157.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -137.86 131.75 31.5 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.098 1.359 . . . . 0.0 108.146 -164.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.3 tp -82.03 108.55 15.61 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 121.701 0.762 . . . . 0.0 109.259 164.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -96.67 110.13 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -175.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.0 t -103.29 100.35 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -167.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -95.62 108.43 20.7 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.545 1.138 . . . . 0.0 108.568 -171.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.2 p -126.42 129.35 48.57 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 121.921 0.867 . . . . 0.0 112.382 -158.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.37 146.29 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 123.396 0.678 . . . . 0.0 109.964 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.265 18.6 ttt -118.24 -94.16 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.575 -0.703 . . . . 0.0 111.327 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -105.87 -52.21 2.85 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.758 0.823 . . . . 0.0 111.828 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -119.1 -39.32 2.93 Favored 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 125.485 1.514 . . . . 0.0 112.142 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t -87.39 121.8 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 O-C-N 121.274 -0.892 . . . . 0.0 110.364 -164.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 46.7 p -93.34 103.49 15.72 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.914 0.864 . . . . 0.0 110.204 165.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 18.5 p -85.69 160.94 19.43 Favored 'General case' 0 CA--C 1.57 1.739 0 CA-C-O 122.624 1.202 . . . . 0.0 111.537 163.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.8 m -150.44 119.01 6.48 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 119.26 -2.15 . . . . 0.0 108.031 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -125.78 132.24 52.32 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-O 121.836 0.827 . . . . 0.0 111.757 -168.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.2 mm -111.63 117.43 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -162.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -116.8 129.68 56.24 Favored 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 123.037 0.535 . . . . 0.0 111.216 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -106.63 146.91 30.14 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -71.94 106.09 4.1 Favored 'General case' 0 CA--C 1.57 1.742 0 O-C-N 121.046 -1.034 . . . . 0.0 113.106 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.05 85.56 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--O 1.256 1.446 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -171.456 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.505 2.289 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -46.25 -34.06 4.14 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 165.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -63.74 -22.19 66.78 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 172.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.1 mt -74.89 -5.78 45.55 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 117.722 2.49 . . . . 0.0 117.722 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 164.0 26.94 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -172.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.35 -179.37 24.68 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 171.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 -84.22 126.16 32.88 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.153 -0.616 . . . . 0.0 111.201 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -126.31 113.81 17.42 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -89.75 134.9 33.93 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.0 tp -68.61 121.78 17.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -112.28 -55.15 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 123.952 0.901 . . . . 0.0 112.603 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -106.69 140.2 39.92 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 120.244 1.383 . . . . 0.0 110.228 168.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -136.5 79.7 1.78 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.728 1.252 . . . . 0.0 110.167 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -99.03 100.82 12.03 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.562 -0.712 . . . . 0.0 110.938 -158.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.5 22.07 20.08 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 118.309 2.084 . . . . 0.0 118.309 -167.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -74.27 -49.74 21.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -37.9 74.69 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 167.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -57.73 -45.13 86.24 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 166.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -57.3 -49.36 76.35 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 164.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 73.5 mtm -60.76 -35.35 76.2 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 172.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -55.44 -55.23 34.09 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 161.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.413 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 31.6 tp10 -64.91 -36.6 84.89 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -53.65 -44.03 69.27 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 159.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.8 56.59 1.22 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -172.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -98.02 137.71 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 123.327 0.651 . . . . 0.0 110.091 -172.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.26 153.33 48.64 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 pt -57.37 -48.82 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 -171.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.58 87.76 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 167.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 mt -66.52 -37.68 85.56 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 169.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -57.65 -48.82 78.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 162.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -57.52 -48.97 77.84 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 169.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -50.7 -51.46 49.46 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 167.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.2 -46.17 93.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 118.116 2.007 . . . . 0.0 118.116 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.47 -45.02 94.94 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -79.81 -5.23 54.99 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 118.048 2.611 . . . . 0.0 118.048 173.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.05 135.8 39.93 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.25 92.33 2.09 Favored Pre-proline 0 CA--C 1.573 1.857 0 O-C-N 121.369 -0.832 . . . . 0.0 110.853 160.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.35 136.53 26.62 Favored 'Trans proline' 0 CA--C 1.559 1.774 0 CA-C-N 122.935 2.084 . . . . 0.0 114.548 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -100.54 101.93 12.98 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.392 167.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.2 t -74.76 111.96 10.49 Favored 'General case' 0 CA--C 1.558 1.274 0 O-C-N 121.627 -0.671 . . . . 0.0 110.689 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mt -104.88 105.16 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 83.9 mt -95.47 129.46 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.0 p -119.0 111.94 18.95 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.5 p -98.56 111.45 23.81 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -170.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -84.78 176.75 8.33 Favored 'General case' 0 CA--C 1.578 2.035 0 CA-C-O 124.106 1.908 . . . . 0.0 110.346 159.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.18 -40.99 92.52 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.402 2.121 . . . . 0.0 118.402 158.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -123.06 -47.77 2.02 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 166.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -86.63 82.74 7.79 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 120.953 1.706 . . . . 0.0 111.518 -166.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.61 112.7 24.34 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.885 -1.134 . . . . 0.0 109.221 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.2 m -98.31 119.62 37.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.532 -0.73 . . . . 0.0 110.576 -168.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.3 mt -112.0 105.76 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -99.99 103.3 14.84 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.3 m -90.56 100.34 13.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.61 -0.681 . . . . 0.0 110.011 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.16 118.8 30.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.6 t -138.21 144.4 40.62 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.197 0.599 . . . . 0.0 110.017 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.5 p -75.78 42.32 0.23 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.1 mt -152.91 -54.64 0.12 Allowed 'General case' 0 CA--C 1.572 1.821 0 C-N-CA 126.791 2.036 . . . . 0.0 108.654 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -143.44 117.0 9.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.024 -1.048 . . . . 0.0 110.838 167.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.3 m -84.75 120.08 26.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.676 -0.64 . . . . 0.0 109.61 166.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.0 p -111.97 103.03 11.23 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -102.72 128.95 49.23 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.35 0.66 . . . . 0.0 111.374 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -145.34 141.6 28.65 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.02 0.914 . . . . 0.0 112.954 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.8 p -97.47 105.29 17.41 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.739 0.816 . . . . 0.0 110.886 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 30.1 p -92.96 122.55 35.44 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.566 0.698 . . . . 0.0 111.99 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.0 m -85.72 115.41 23.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.483 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.27 118.29 19.62 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.541 0.737 . . . . 0.0 112.764 -166.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.1 55.17 8.16 Favored Glycine 0 CA--C 1.549 2.192 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.945 -156.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.49 154.71 2.63 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 124.429 1.092 . . . . 0.0 111.403 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -109.59 123.56 49.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.135 0.974 . . . . 0.0 112.916 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -127.65 164.48 21.95 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 124.17 0.988 . . . . 0.0 112.293 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -78.39 107.73 11.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 119.842 -1.787 . . . . 0.0 111.712 164.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -77.95 147.65 34.85 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.294 155.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.0 m -113.17 114.73 27.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.769 171.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.3 p -70.49 138.68 51.29 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 122.825 0.45 . . . . 0.0 111.62 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.62 -29.45 10.98 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 120.309 3.448 . . . . 0.0 120.309 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -84.15 -29.75 26.43 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 170.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.15 -37.39 0.37 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 119.96 2.744 . . . . 0.0 119.96 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -68.25 127.92 34.68 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 119.578 1.689 . . . . 0.0 112.675 -174.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -93.72 128.84 40.13 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.121 0.486 . . . . 0.0 110.744 171.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.8 p -120.44 126.01 49.36 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.254 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -67.77 103.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.208 1.004 . . . . 0.0 111.319 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.3 m -114.53 101.38 9.07 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -158.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.299 14.6 p -87.05 106.17 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.404 0.621 . . . . 0.0 110.331 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 63.6 m -92.12 120.71 32.98 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -140.01 126.92 20.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.87 -0.519 . . . . 0.0 111.265 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -92.21 123.52 35.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 111.488 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 t -139.51 138.41 36.31 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.235 0.614 . . . . 0.0 109.832 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 61.79 36.93 15.91 Favored 'General case' 0 N--CA 1.506 2.334 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 162.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.7 12.63 83.68 Favored Glycine 0 CA--C 1.557 2.69 0 N-CA-C 119.354 2.502 . . . . 0.0 119.354 -165.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.35 125.47 24.53 Favored 'General case' 0 CA--C 1.561 1.392 0 CA-C-N 119.668 1.734 . . . . 0.0 112.743 -169.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 tp -86.4 106.9 17.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.529 -0.732 . . . . 0.0 110.945 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 66.7 t -92.95 108.66 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.854 0.862 . . . . 0.0 108.765 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -93.27 95.0 9.08 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.627 0.771 . . . . 0.0 110.024 173.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -91.08 102.49 15.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 110.751 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -94.56 126.07 39.61 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.699 1.2 . . . . 0.0 111.31 -172.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -125.26 122.81 38.0 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.341 0.656 . . . . 0.0 110.466 -169.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -157.38 118.81 3.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.807 -1.183 . . . . 0.0 111.32 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 45.14 51.34 9.1 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 168.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.5 -42.77 3.08 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 117.699 1.84 . . . . 0.0 117.699 -171.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -79.49 142.68 35.6 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.15 139.12 39.24 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.131 0.967 . . . . 0.0 113.063 173.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.7 t -120.68 130.08 53.95 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.548 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 67.5 m -117.7 117.07 28.36 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.097 -1.002 . . . . 0.0 108.746 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.2 mt -114.17 104.83 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.2 m -100.69 103.27 14.53 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.88 0.872 . . . . 0.0 109.752 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.8 mtt85 -95.75 104.22 16.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.859 -0.526 . . . . 0.0 110.647 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -121.12 147.14 45.97 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.31 108.78 20.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.827 -0.546 . . . . 0.0 111.611 -171.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -137.02 129.3 29.72 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.343 0.657 . . . . 0.0 109.312 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.0 t0 57.49 44.31 21.45 Favored 'General case' 0 N--CA 1.507 2.404 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 51.82 30.68 29.55 Favored Glycine 0 CA--C 1.559 2.801 0 N-CA-C 119.298 2.479 . . . . 0.0 119.298 -164.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -140.61 149.5 42.41 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.502 1.144 . . . . 0.0 109.537 -167.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.5 tp -92.5 106.12 18.17 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-O 121.912 0.863 . . . . 0.0 109.857 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 82.7 t -93.31 106.07 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.3 t -102.65 90.52 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -170.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -88.28 93.43 9.51 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.717 1.246 . . . . 0.0 110.062 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.636 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 9.4 t -80.64 135.87 36.12 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.823 170.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.6 123.22 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.598 -0.689 . . . . 0.0 109.452 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.413 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 26.8 ttt -117.02 103.97 10.79 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.859 0.464 . . . . 0.0 110.061 175.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.3 76.5 m-20 66.57 -93.57 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.868 0.867 . . . . 0.0 111.297 -174.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -111.89 0.44 16.12 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 162.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.9 t -92.95 105.86 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 120.49 1.495 . . . . 0.0 108.714 -167.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 53.6 p -90.74 140.1 30.1 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.404 1.097 . . . . 0.0 113.02 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.636 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -136.52 85.08 2.12 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -174.056 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 61.7 m -88.98 110.24 20.95 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.514 -1.366 . . . . 0.0 110.286 -171.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -114.4 108.34 16.76 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -168.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.7 mm -92.72 114.64 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -116.41 114.55 24.42 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.197 0.599 . . . . 0.0 109.718 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.68 152.39 22.55 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -77.83 127.43 32.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.483 -1.386 . . . . 0.0 114.696 -161.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.74 86.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.489 1.498 0 C-N-CA 123.928 0.891 . . . . 0.0 108.6 178.795 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.265 7.7 p . . . . . 0 N--CA 1.503 2.179 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -38.58 90.41 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 162.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -63.83 -38.37 90.86 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.5 mt -59.81 -23.79 63.62 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 163.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 107.64 3.93 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.188 1.813 . . . . 0.0 113.426 -171.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.64 -173.85 36.42 Favored Glycine 0 N--CA 1.489 2.215 0 CA-C-O 121.712 0.618 . . . . 0.0 114.628 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -94.92 137.84 33.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.009 -0.701 . . . . 0.0 110.981 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -135.55 116.82 14.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.55 -0.719 . . . . 0.0 110.994 -170.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.9 ttm105 -97.49 134.09 41.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.002 -1.686 . . . . 0.0 113.85 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.1 tp -67.82 123.51 20.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.254 4.4 m -113.06 -60.95 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 123.818 0.847 . . . . 0.0 112.223 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -106.36 151.5 24.79 Favored 'General case' 0 CA--C 1.571 1.782 0 CA-C-N 119.688 1.131 . . . . 0.0 111.006 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -154.28 65.56 0.7 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 136.11 54.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.485 -0.759 . . . . 0.0 112.988 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.74 2.59 51.69 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 120.086 2.794 . . . . 0.0 120.086 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.14 -34.03 72.54 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.27 -54.91 17.87 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 163.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.44 -49.57 72.1 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -57.25 -48.13 79.64 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 76.5 mtm -59.5 -35.27 73.82 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 168.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -64.17 -48.06 77.41 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 22.0 tp10 -66.0 -37.91 87.16 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 173.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.1 -42.72 66.22 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 159.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.31 53.93 1.21 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 115.137 0.815 . . . . 0.0 115.137 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.18 134.78 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.412 0.685 . . . . 0.0 109.788 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.95 154.09 49.83 Favored Glycine 0 CA--C 1.55 2.244 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.1 pt -55.55 -48.25 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -172.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.61 -43.59 97.28 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.34 -40.0 96.1 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 170.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.9 mtp85 -55.2 -50.33 69.64 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 162.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -56.94 -47.7 80.04 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 170.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.0 mtm -58.0 -55.27 37.07 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 168.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.97 -36.97 76.16 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 119.41 2.524 . . . . 0.0 119.41 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.97 -54.42 30.84 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.8 ptp -85.9 -26.38 25.63 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.01 73.21 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 119.639 3.2 . . . . 0.0 119.639 -168.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt 63.32 66.42 1.16 Allowed Pre-proline 0 CA--C 1.581 2.141 0 C-N-CA 124.437 1.095 . . . . 0.0 113.612 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -73.25 143.77 35.99 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 122.513 2.142 . . . . 0.0 116.869 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.44 101.51 13.21 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.271 1.028 . . . . 0.0 110.045 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.0 116.82 29.25 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 124.378 1.071 . . . . 0.0 112.108 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mp -92.13 119.67 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.9 mt -105.88 117.68 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 168.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.1 m -136.84 130.4 31.74 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 118.879 0.763 . . . . 0.0 111.046 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.6 p -105.98 137.45 43.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -169.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.34 86.37 2.32 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 121.882 0.849 . . . . 0.0 108.878 166.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.57 -99.26 0.45 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -85.15 -25.91 27.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 165.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -86.27 138.17 32.05 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 120.719 1.6 . . . . 0.0 112.001 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 21.8 tp -133.7 112.98 11.85 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 121.883 0.849 . . . . 0.0 108.787 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -87.29 119.57 27.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.491 0.717 . . . . 0.0 109.567 -175.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mm -111.47 98.73 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -112.53 105.93 14.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.557 -0.714 . . . . 0.0 110.104 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.4 m -93.12 101.24 13.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.399 -0.813 . . . . 0.0 109.817 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -98.24 125.53 43.35 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.023 0.929 . . . . 0.0 110.704 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 t -137.66 160.8 38.19 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.41 1.1 . . . . 0.0 113.437 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.7 p -59.93 -48.25 82.45 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 163.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.7 mt -97.02 -38.86 9.61 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -146.52 105.37 3.85 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 121.187 1.812 . . . . 0.0 112.715 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.3 m -86.26 142.44 28.55 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.657 0.783 . . . . 0.0 111.545 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.5 m -157.89 143.09 16.8 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.235 -1.54 . . . . 0.0 109.839 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.51 154.77 51.27 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.285 -1.51 . . . . 0.0 114.229 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -150.65 142.1 23.42 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.553 0.692 . . . . 0.0 111.771 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.0 p -100.26 105.25 16.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.943 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 52' ' ' LEU . 20.9 p -93.79 164.51 13.1 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.5 m -130.43 128.46 41.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.2 111.72 9.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.292 -0.88 . . . . 0.0 111.982 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.37 -62.3 0.54 Allowed Glycine 0 N--CA 1.488 2.11 0 CA-C-O 120.055 -0.303 . . . . 0.0 113.488 -162.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -89.47 162.17 15.86 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 124.068 1.89 . . . . 0.0 114.914 -164.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -106.95 132.86 52.42 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 112.563 -2.108 . . . . 0.0 111.394 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.89 160.38 40.45 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -169.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.99 113.53 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 112.48 167.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -102.2 95.82 6.57 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.1 m -76.96 92.07 3.65 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.341 1.067 . . . . 0.0 110.445 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -67.38 148.28 51.81 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.158 0.983 . . . . 0.0 113.293 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.07 -39.48 5.85 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.948 3.314 . . . . 0.0 119.948 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.95 -34.27 59.84 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.12 -25.32 0.61 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 119.563 2.585 . . . . 0.0 119.563 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.2 mtm-85 -72.65 119.74 17.3 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 120.124 1.962 . . . . 0.0 112.091 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 94.6 9.71 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 167.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.5 p -87.4 149.53 24.4 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.146 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -81.98 87.15 6.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.084 -1.01 . . . . 0.0 109.589 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -88.79 117.35 27.72 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.264 14.9 p -88.97 118.08 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 161.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.3 m -96.21 135.17 38.39 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 120.834 0.35 . . . . 0.0 111.655 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -148.05 121.7 9.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.804 -0.56 . . . . 0.0 109.611 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -83.24 123.39 29.53 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 120.852 -1.155 . . . . 0.0 111.259 169.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -133.31 110.4 10.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 63.69 56.19 1.58 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 148.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.52 -25.94 11.83 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 118.453 2.141 . . . . 0.0 118.453 -164.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.77 135.0 55.03 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 119.909 1.855 . . . . 0.0 114.314 -167.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.9 tp -82.37 113.71 20.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.196 158.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.0 t -88.89 106.73 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -102.04 98.74 8.89 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -99.2 96.31 7.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.638 -0.664 . . . . 0.0 110.561 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -83.4 128.54 34.59 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.683 0.793 . . . . 0.0 111.572 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -130.32 123.94 31.16 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.107 0.563 . . . . 0.0 110.009 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.2 p90 -156.6 119.51 4.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.696 -1.252 . . . . 0.0 112.139 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.263 5.5 t70 34.31 58.16 0.64 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 118.699 2.852 . . . . 0.0 118.699 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.72 -46.94 1.9 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 117.639 1.816 . . . . 0.0 117.639 -172.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -80.51 140.94 35.62 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -133.3 148.38 51.92 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 168.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.6 t -131.99 138.65 48.35 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.688 0.756 . . . . 0.0 111.802 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -111.7 98.11 7.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.71 111.09 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -175.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.7 m -101.71 103.6 14.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.622 -0.673 . . . . 0.0 109.802 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -95.42 101.66 13.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.403 -0.811 . . . . 0.0 109.9 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -132.91 156.9 46.39 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.91 123.22 26.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 111.877 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.09 114.19 24.19 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 159.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.89 51.16 9.39 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 166.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.47 -22.77 5.21 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 119.357 2.503 . . . . 0.0 119.357 -170.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -103.27 140.09 37.86 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.628 1.714 . . . . 0.0 111.21 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.9 tp -75.77 134.79 40.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.96 . . . . 0.0 110.361 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.29 106.78 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.6 t -92.73 102.94 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -111.28 105.18 13.76 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -171.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 3.1 p -97.08 145.79 25.64 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.51 128.66 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.412 0.625 . . . . 0.0 109.405 162.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.4 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 24.4 ttt -98.21 -88.44 0.32 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.214 0.606 . . . . 0.0 110.253 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -129.89 78.16 1.83 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.052 0.941 . . . . 0.0 108.732 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.283 0.7 OUTLIER 69.4 -26.53 0.15 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 -162.115 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 82.6 t -75.78 116.41 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 CA-C-N 120.085 1.311 . . . . 0.0 109.835 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.3 p -120.11 134.76 55.17 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 123.638 0.775 . . . . 0.0 112.729 -170.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.3 p -120.93 128.01 52.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.962 -0.461 . . . . 0.0 111.993 167.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.3 m -109.25 111.45 23.04 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -112.14 118.76 36.24 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.57 0.748 . . . . 0.0 110.248 -172.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mm -96.71 130.47 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 123.455 0.702 . . . . 0.0 109.426 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -130.12 121.63 26.7 Favored 'General case' 0 CA--C 1.572 1.82 0 C-N-CA 123.483 0.713 . . . . 0.0 112.385 -165.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -95.32 134.88 37.61 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -80.25 125.29 29.67 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.104 -0.997 . . . . 0.0 113.369 -172.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.6 t -114.79 94.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -168.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 122.489 0.315 . . . . 0.0 110.207 -165.076 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.308 12.1 p . . . . . 0 N--CA 1.501 2.089 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.3 -22.51 63.26 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.592 2.441 . . . . 0.0 117.592 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.1 mp0 -56.96 -27.18 60.97 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 163.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.21 -12.59 61.24 Favored 'General case' 0 CA--C 1.582 2.206 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 164.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.43 114.17 14.84 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 120.774 1.625 . . . . 0.0 113.398 -166.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.45 -166.55 28.63 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 167.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -86.15 129.78 34.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.078 -0.66 . . . . 0.0 112.33 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -127.77 114.73 17.65 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.262 0.625 . . . . 0.0 110.301 -172.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -89.91 133.52 34.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.471 -1.393 . . . . 0.0 113.3 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.6 tp -72.88 131.07 41.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.8 -0.563 . . . . 0.0 112.439 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.277 3.3 m -116.68 -73.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 123.369 0.668 . . . . 0.0 109.895 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -89.68 142.05 28.04 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 118.919 0.781 . . . . 0.0 110.802 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.4 t -148.02 51.96 1.03 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -79.84 134.81 36.34 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.44 -9.43 67.58 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 118.628 2.211 . . . . 0.0 118.628 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -70.69 -42.26 70.91 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -171.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -52.62 -51.66 58.98 Favored 'General case' 0 CA--C 1.579 2.06 0 CA-C-N 120.079 1.309 . . . . 0.0 114.339 167.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.74 -39.51 84.97 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 170.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -58.64 -46.3 87.4 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 169.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 33' ' ' ARG . 16.3 ptp -62.03 -25.79 67.87 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 167.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -58.7 -52.92 63.65 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 157.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.03 -42.05 98.76 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.413 ' HA ' ' SD ' ' A' ' 122' ' ' MET . 69.3 mt -53.28 -38.77 63.39 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 169.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.04 64.62 0.99 Allowed Glycine 0 N--CA 1.486 1.989 0 C-N-CA 123.362 0.506 . . . . 0.0 113.751 -166.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.5 t -114.33 130.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.62 158.65 49.25 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.275 2.4 pp -55.26 -49.02 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -171.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.76 99.34 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 168.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.06 -41.88 89.01 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.427 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 20.0 mtp-105 -61.27 -51.05 70.55 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 120.177 1.353 . . . . 0.0 114.546 170.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -54.74 -47.65 73.56 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 170.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.8 ttp -54.42 -60.67 3.03 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 165.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.91 -40.32 92.99 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 119.573 2.589 . . . . 0.0 119.573 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.59 -45.02 88.8 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 172.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -78.26 -29.87 48.29 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 172.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.74 123.22 18.79 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 119.833 1.197 . . . . 0.0 114.17 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -103.5 107.89 57.5 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 117.667 -1.158 . . . . 0.0 109.66 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -92.34 145.73 2.79 Favored 'Trans proline' 0 CA--C 1.563 1.948 0 CA-C-N 122.48 1.921 . . . . 0.0 116.455 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.74 100.53 13.0 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 114.493 -1.231 . . . . 0.0 108.641 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.9 t -91.32 112.83 24.9 Favored 'General case' 0 CA--C 1.557 1.217 0 O-C-N 120.875 -1.141 . . . . 0.0 112.559 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mt -84.14 104.26 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 60.5 mt -99.78 111.49 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.5 m -117.16 102.5 9.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.6 p -113.87 91.4 3.62 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 123.737 0.815 . . . . 0.0 111.424 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -93.54 65.31 3.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.34 -0.85 . . . . 0.0 111.836 -171.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.36 -61.58 1.87 Allowed Glycine 0 N--CA 1.494 2.51 0 O-C-N 120.117 -1.614 . . . . 0.0 117.089 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -121.52 -46.43 2.27 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -71.7 137.59 47.91 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 121.58 1.991 . . . . 0.0 112.925 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -138.52 112.31 8.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.468 -0.77 . . . . 0.0 111.226 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.2 m -114.77 123.53 49.47 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.463 0.705 . . . . 0.0 109.715 -175.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.77 109.03 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -114.23 101.61 9.35 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.996 0.918 . . . . 0.0 109.859 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.0 m -87.09 112.48 21.94 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.673 0.789 . . . . 0.0 110.391 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -112.3 100.63 8.95 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 118.773 0.715 . . . . 0.0 112.138 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -123.46 158.34 31.47 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.084 0.945 . . . . 0.0 111.192 163.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.2 p -63.29 -44.82 93.95 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 172.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.3 mt -64.07 -38.04 89.63 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.09 130.64 13.94 Favored 'General case' 0 CA--C 1.563 1.453 0 CA-C-N 119.938 1.244 . . . . 0.0 111.164 166.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 m -113.95 133.75 55.27 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 166.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.1 m -155.6 139.65 16.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.391 -1.443 . . . . 0.0 109.541 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.85 158.39 39.62 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.36 137.5 30.54 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-O 121.991 0.901 . . . . 0.0 110.451 161.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -109.93 105.26 14.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.028 0.931 . . . . 0.0 109.499 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 30.3 p -132.19 -152.51 0.5 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.54 0.736 . . . . 0.0 112.413 -168.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.39 147.42 50.48 Favored 'General case' 0 CA--C 1.571 1.761 0 O-C-N 120.957 -1.089 . . . . 0.0 111.306 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -78.58 148.01 33.49 Favored 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 124.221 1.008 . . . . 0.0 113.045 162.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.35 28.45 73.59 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 117.921 1.928 . . . . 0.0 117.921 -173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -152.11 141.09 21.16 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-O 121.51 0.671 . . . . 0.0 109.437 -162.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -93.45 124.29 37.34 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.253 174.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -130.92 154.4 48.15 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.043 0.937 . . . . 0.0 111.721 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -80.12 101.31 8.69 Favored 'General case' 0 CA--C 1.569 1.704 0 O-C-N 120.95 -1.094 . . . . 0.0 111.512 172.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -85.32 94.28 8.91 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.997 0.919 . . . . 0.0 110.011 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.8 m -81.64 96.57 7.55 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.925 0.869 . . . . 0.0 110.478 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.9 p -71.14 152.42 43.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.381 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.01 -30.05 14.2 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -54.81 -42.73 72.22 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 118.419 2.748 . . . . 0.0 118.419 162.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.63 -19.49 9.71 Favored Glycine 0 CA--C 1.553 2.466 0 N-CA-C 117.81 1.884 . . . . 0.0 117.81 -155.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -74.47 112.1 10.31 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 121.122 2.461 . . . . 0.0 110.65 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.264 0.1 OUTLIER -102.34 99.48 9.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.655 0.74 . . . . 0.0 111.225 178.363 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.7 p -99.56 141.88 31.78 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.176 -163.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -77.49 88.49 3.84 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.581 172.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.7 m -97.2 114.52 26.25 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 121.694 -0.629 . . . . 0.0 109.503 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.282 14.2 p -90.56 119.87 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.726 -0.609 . . . . 0.0 110.693 165.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.9 m -98.47 113.21 25.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.189 -0.319 . . . . 0.0 111.673 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -123.68 140.52 52.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.786 -0.571 . . . . 0.0 110.545 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -84.1 127.44 33.91 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 120.877 -1.139 . . . . 0.0 111.469 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -146.06 142.08 28.24 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.394 0.678 . . . . 0.0 110.278 168.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.81 43.58 9.38 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 161.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.14 23.71 69.92 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 118.817 2.287 . . . . 0.0 118.817 -166.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.78 148.47 29.24 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 118.849 1.325 . . . . 0.0 113.608 -166.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.0 tp -89.42 112.33 23.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.559 -0.713 . . . . 0.0 110.254 162.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 p -89.36 125.23 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 CA-C-O 123.038 1.399 . . . . 0.0 109.819 168.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -114.18 103.02 10.69 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.732 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -99.68 93.66 5.95 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 120.999 0.428 . . . . 0.0 111.254 -170.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -79.21 130.26 35.29 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.195 0.998 . . . . 0.0 111.953 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.4 121.72 26.45 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.713 0.688 . . . . 0.0 110.375 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -155.74 130.08 8.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.493 -1.379 . . . . 0.0 112.143 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 t70 51.65 50.09 19.49 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 166.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.48 16.34 58.38 Favored Glycine 0 CA--C 1.561 2.923 0 N-CA-C 120.342 2.897 . . . . 0.0 120.342 -167.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -131.84 150.47 52.14 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.917 1.359 . . . . 0.0 110.276 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.54 151.73 44.98 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.5 t -141.96 138.7 32.13 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.059 0.933 . . . . 0.0 112.61 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 p -110.57 117.18 32.84 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.653 0.781 . . . . 0.0 109.262 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.6 mm -101.8 109.58 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.7 m -96.96 106.33 18.64 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.543 0.687 . . . . 0.0 109.255 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -98.17 84.01 3.19 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.552 0.741 . . . . 0.0 109.972 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -95.67 132.98 40.27 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.9 103.49 12.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.359 -0.838 . . . . 0.0 110.434 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.258 45.6 tttm -117.9 -105.26 0.4 Allowed 'General case' 0 CA--C 1.559 1.301 0 O-C-N 121.933 -0.479 . . . . 0.0 111.071 -164.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.98 60.79 6.05 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-O 122.339 1.066 . . . . 0.0 112.67 -163.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 49.0 37.83 23.31 Favored Glycine 0 CA--C 1.558 2.775 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -153.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.12 139.95 8.72 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -155.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.1 tp -86.34 117.23 25.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.773 -1.204 . . . . 0.0 110.163 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.8 t -103.57 108.68 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.49 104.94 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -170.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -106.28 107.65 18.77 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -169.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.873 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.8 p -101.62 144.71 30.02 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.73 145.2 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 123.034 0.534 . . . . 0.0 110.234 166.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 26' ' ' LEU . 23.5 ttt -110.74 -80.33 0.58 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.053 -1.029 . . . . 0.0 110.561 168.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -111.73 -66.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 118.679 0.672 . . . . 0.0 110.912 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -122.52 -14.25 7.83 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -97.98 134.0 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-N 121.403 1.911 . . . . 0.0 110.062 -174.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 77.5 p -112.47 153.2 27.78 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.912 0.885 . . . . 0.0 112.68 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.873 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.8 OUTLIER -130.76 142.17 50.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.311 -0.868 . . . . 0.0 112.391 161.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.6 m -109.64 108.61 19.08 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -104.23 109.72 21.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.617 0.767 . . . . 0.0 109.992 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.2 mm -89.26 124.11 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -120.06 118.53 30.85 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.574 0.749 . . . . 0.0 111.124 -174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -86.79 140.17 29.98 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.117 0.967 . . . . 0.0 112.94 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -78.29 134.78 37.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.266 -1.521 . . . . 0.0 113.62 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.9 95.76 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.981 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.253 9.0 p . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -58.58 -35.62 72.67 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.315 1.968 . . . . 0.0 116.315 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -64.42 -31.72 73.04 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 165.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.78 -20.56 65.97 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 163.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.2 117.25 22.19 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.285 1.857 . . . . 0.0 112.283 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.71 -178.7 39.78 Favored Glycine 0 N--CA 1.484 1.897 0 CA-C-O 122.098 0.832 . . . . 0.0 114.577 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -84.89 114.8 22.38 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.019 0.528 . . . . 0.0 110.777 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -110.58 104.54 13.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.949 -0.469 . . . . 0.0 111.97 -171.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -82.73 124.26 30.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.365 -0.834 . . . . 0.0 112.424 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.0 130.52 44.37 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.023 -1.048 . . . . 0.0 113.444 173.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.292 15.7 m -120.03 -63.7 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.617 173.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -92.76 149.81 21.06 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.431 1.469 . . . . 0.0 112.007 170.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p -148.34 79.14 1.44 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.912 166.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.44 119.13 19.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.554 -0.716 . . . . 0.0 110.936 -176.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.82 37.06 93.7 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 119.708 2.643 . . . . 0.0 119.708 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.6 -42.61 51.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 175.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -51.94 -50.04 61.97 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 163.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -48.54 -54.58 13.87 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 168.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -55.25 -53.61 53.92 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 170.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 31.7 mtm -67.75 -34.05 76.06 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -47.82 -44.09 28.55 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 158.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -41.72 81.7 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 169.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.3 mt -51.7 -50.42 60.53 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 165.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.44 40.39 0.23 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.408 HG23 ' CG ' ' A' ' 33' ' ' ARG . 6.6 m -112.67 144.19 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.686 0 CA-C-N 118.724 1.262 . . . . 0.0 112.463 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.33 -179.64 50.96 Favored Glycine 0 CA--C 1.551 2.33 0 CA-C-O 122.814 1.23 . . . . 0.0 115.989 168.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 pt -57.23 -46.25 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 117.921 2.564 . . . . 0.0 117.921 -171.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.65 -40.63 95.61 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.02 -39.02 86.94 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' CG ' HG23 ' A' ' 28' ' ' VAL . 20.5 mtm105 -63.78 -42.93 97.66 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 166.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -50.57 -50.49 53.47 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 161.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.6 mtp -72.3 58.37 0.39 Allowed 'General case' 0 CA--C 1.581 2.161 0 CA-C-O 123.028 1.394 . . . . 0.0 114.632 166.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.12 -63.72 0.08 OUTLIER Glycine 0 CA--C 1.543 1.809 0 O-C-N 121.349 -0.845 . . . . 0.0 111.56 -172.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.93 78.48 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 170.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . 0.26 19.2 ptt? -86.44 -17.89 33.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 170.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.07 121.24 22.51 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.172 1.351 . . . . 0.0 113.707 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -96.36 113.46 62.51 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.365 170.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -86.12 146.72 8.91 Favored 'Trans proline' 0 CA--C 1.561 1.828 0 C-N-CA 122.284 1.989 . . . . 0.0 115.052 168.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.57 97.97 10.86 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.265 158.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.8 t -87.65 104.64 16.72 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.139 0.976 . . . . 0.0 111.713 -174.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.0 mt -92.12 106.44 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.6 mt -96.86 128.99 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.4 m -156.46 130.49 8.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.274 -1.516 . . . . 0.0 109.938 171.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.8 p -118.75 130.01 55.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -97.72 93.03 6.16 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 121.802 0.81 . . . . 0.0 108.978 166.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.13 -75.46 1.14 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 116.67 1.428 . . . . 0.0 116.67 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -127.73 -30.63 2.51 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.69 100.99 5.59 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 120.909 1.686 . . . . 0.0 111.757 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -93.84 116.19 28.64 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.341 1.056 . . . . 0.0 109.945 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.3 m -93.38 123.77 36.9 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.662 0.785 . . . . 0.0 109.62 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 mt -115.79 107.38 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -103.68 103.5 13.42 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.646 0.779 . . . . 0.0 109.547 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.6 m -94.18 100.17 12.3 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.322 1.049 . . . . 0.0 110.686 -171.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -100.09 102.55 13.9 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.081 0.553 . . . . 0.0 111.746 -165.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 t -138.7 139.85 38.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.478 -0.764 . . . . 0.0 111.451 173.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.0 p -63.93 -33.55 75.96 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.4 mt -67.26 -45.97 75.09 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 167.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -155.12 114.67 3.69 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.471 1.487 . . . . 0.0 111.376 170.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.8 m -94.24 141.05 29.01 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.586 0.708 . . . . 0.0 111.399 172.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.1 p -138.48 154.97 48.83 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 123.93 0.892 . . . . 0.0 111.112 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.0 146.13 32.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.351 -1.468 . . . . 0.0 112.906 172.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -152.44 151.62 30.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.586 -0.696 . . . . 0.0 112.807 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -110.54 115.73 30.13 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.503 0.721 . . . . 0.0 110.85 166.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.8 p -104.5 134.04 48.35 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.553 -0.717 . . . . 0.0 112.739 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 88.6 m -81.25 113.08 19.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.865 -1.147 . . . . 0.0 110.336 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -69.85 120.83 16.18 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -172.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.7 -36.31 3.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 -166.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.41 -169.92 2.62 Favored 'General case' 0 CA--C 1.575 1.905 0 CA-C-N 119.128 1.464 . . . . 0.0 111.953 -176.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -86.34 142.02 28.79 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -117.24 163.33 16.47 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.38 159.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -82.24 103.56 11.92 Favored 'General case' 0 CA--C 1.565 1.554 0 O-C-N 120.6 -1.312 . . . . 0.0 110.045 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -87.28 104.84 16.78 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.5 m -82.31 104.41 12.59 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 165.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.6 p -76.22 159.16 30.91 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -164.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.46 -38.93 56.19 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 165.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.276 2.7 t0 -44.35 -47.32 9.62 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 157.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.02 -31.75 4.41 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -164.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -62.44 137.01 58.17 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.8 1.8 . . . . 0.0 114.781 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -76.59 121.57 23.38 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.721 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.7 p -132.72 118.46 19.1 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.595 0.712 . . . . 0.0 111.015 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -76.98 101.3 5.93 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.61 0.764 . . . . 0.0 109.442 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.1 m -116.51 107.15 14.4 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.461 -154.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.5 t -81.02 117.56 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 122.893 0.477 . . . . 0.0 109.871 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.4 m -101.46 108.79 20.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.137 -0.352 . . . . 0.0 111.326 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -126.24 124.19 39.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.777 -0.577 . . . . 0.0 111.446 -175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -85.13 126.85 33.96 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.455 -0.778 . . . . 0.0 111.567 168.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -143.02 137.04 29.0 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 122.994 0.518 . . . . 0.0 109.773 165.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.83 39.49 16.98 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 159.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.62 20.27 79.51 Favored Glycine 0 CA--C 1.557 2.669 0 N-CA-C 119.23 2.452 . . . . 0.0 119.23 -166.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.83 131.63 21.42 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 119.295 1.548 . . . . 0.0 112.922 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.9 tp -94.45 109.92 21.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.667 -0.646 . . . . 0.0 110.645 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.18 108.71 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.675 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -95.39 102.4 14.2 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 124.166 0.986 . . . . 0.0 108.961 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -102.04 93.23 5.14 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.404 0.681 . . . . 0.0 111.997 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -77.07 117.07 18.28 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.786 0.834 . . . . 0.0 112.569 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.5 135.56 50.32 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.867 0.842 . . . . 0.0 110.12 166.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -152.28 117.22 5.15 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.256 27.5 t70 49.87 45.06 25.23 Favored 'General case' 0 CA--C 1.587 2.367 0 N-CA-C 117.141 2.275 . . . . 0.0 117.141 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.93 27.1 68.09 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 119.894 2.718 . . . . 0.0 119.894 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -135.43 100.05 4.4 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -172.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -115.3 142.68 46.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -165.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.5 t -117.31 137.28 52.53 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.802 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 p -114.69 109.15 17.77 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.4 mp -103.4 98.11 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 m -94.0 105.57 17.57 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.598 0.759 . . . . 0.0 109.975 -175.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -94.3 88.48 5.57 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 123.627 0.771 . . . . 0.0 110.156 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -105.16 137.42 42.96 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -168.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 116.81 29.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.9 -1.125 . . . . 0.0 112.81 -172.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.75 84.27 3.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.591 -0.693 . . . . 0.0 109.714 167.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.276 25.1 m-20 7.5 62.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 120.608 3.559 . . . . 0.0 120.608 -173.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 138.78 -49.38 0.83 Allowed Glycine 0 N--CA 1.49 2.275 0 CA-C-N 114.515 -1.22 . . . . 0.0 115.503 -167.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -112.77 138.55 49.44 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 117.802 0.801 . . . . 0.0 110.557 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.19 116.32 28.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.889 -1.132 . . . . 0.0 109.6 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.9 t -93.95 109.57 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 80.5 t -98.8 105.55 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -96.67 100.78 12.32 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.746 0.819 . . . . 0.0 109.378 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.7 p -97.31 131.59 43.86 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.62 -0.675 . . . . 0.0 111.169 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.87 123.67 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.836 -0.54 . . . . 0.0 110.598 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 10.6 ttt -115.55 114.76 25.39 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 164.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.7 m120 55.23 55.92 7.01 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.297 40.3 m-80 76.65 -30.16 0.18 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -171.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.0 t -86.42 123.63 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 120.885 1.675 . . . . 0.0 109.949 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 72.4 p -113.6 144.28 43.16 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -163.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.5 OUTLIER -111.93 136.56 51.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 0.0 110.939 151.383 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.1 m -114.4 111.18 21.03 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 170.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -114.69 116.18 28.29 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.741 0.416 . . . . 0.0 110.327 -170.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.86 128.17 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -122.35 140.55 52.54 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.77 0.828 . . . . 0.0 111.879 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.86 135.84 42.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -76.78 113.08 14.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.074 -1.016 . . . . 0.0 111.641 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.0 t -106.07 92.86 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -173.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.017 -174.363 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.478 5.3 p . . . . . 0 N--CA 1.507 2.39 0 N-CA-C 118.704 2.853 . . . . 0.0 118.704 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -52.22 -42.64 63.74 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -67.85 -18.79 64.93 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 172.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.54 -9.69 58.61 Favored 'General case' 0 CA--C 1.577 1.999 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 160.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.37 140.64 29.33 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 121.541 1.973 . . . . 0.0 112.944 -171.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.81 -177.82 23.05 Favored Glycine 0 N--CA 1.488 2.162 0 CA-C-O 122.145 0.859 . . . . 0.0 114.607 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -87.9 121.11 29.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.984 -0.715 . . . . 0.0 110.083 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -124.86 110.6 14.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.78 -0.575 . . . . 0.0 110.122 -169.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.3 ttm105 -98.56 134.7 41.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.831 -1.168 . . . . 0.0 113.251 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.91 133.0 49.97 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.28 21.7 m -124.35 -60.5 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 123.722 0.809 . . . . 0.0 112.281 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -89.43 148.35 23.52 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.346 1.43 . . . . 0.0 111.298 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 m -148.7 58.15 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.215 1.007 . . . . 0.0 113.218 165.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -72.88 123.5 23.53 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.294 -0.878 . . . . 0.0 113.083 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.77 2.58 81.43 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 118.85 2.3 . . . . 0.0 118.85 -167.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -72.12 -42.61 65.86 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.406 2.103 . . . . 0.0 116.65 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.62 -49.65 74.32 Favored 'General case' 0 CA--C 1.578 2.057 0 CA-C-N 120.962 1.71 . . . . 0.0 114.563 170.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -49.59 -44.93 47.41 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 164.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 74.5 t80 -59.71 -52.27 66.23 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 170.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.294 18.4 ptt? -70.31 -24.34 63.0 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -63.15 -39.84 95.83 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 121.523 1.965 . . . . 0.0 115.303 154.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -72.64 -40.01 66.73 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.0 mt -50.29 -41.81 51.44 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 117.989 2.588 . . . . 0.0 117.989 168.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.88 66.43 0.8 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 123.443 0.544 . . . . 0.0 113.648 -168.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -128.82 133.53 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -171.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.94 155.3 52.75 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 116.483 1.353 . . . . 0.0 116.483 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.262 2.7 pp -54.14 -44.07 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 N-CA-C 117.898 2.555 . . . . 0.0 117.898 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.99 88.14 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 168.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.36 -42.01 98.0 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 167.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -59.67 -47.51 85.35 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 120.352 1.433 . . . . 0.0 114.398 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.36 -46.83 88.54 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 169.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.1 ttp -52.48 -55.11 24.22 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 165.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.64 74.91 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 119.236 2.455 . . . . 0.0 119.236 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.95 91.21 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.4 ptp -77.24 -27.36 53.27 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.21 108.94 5.63 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.906 1.23 . . . . 0.0 113.731 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -102.3 93.96 4.42 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 118.196 -0.906 . . . . 0.0 110.649 168.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.84 153.31 25.71 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.474 2.116 . . . . 0.0 115.59 -173.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.69 105.27 17.25 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.643 0.735 . . . . 0.0 109.302 165.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.2 t -95.02 110.5 22.41 Favored 'General case' 0 CA--C 1.56 1.344 0 O-C-N 120.909 -1.119 . . . . 0.0 111.735 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mp -89.47 106.83 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.63 126.94 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.1 m -150.75 128.84 11.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.628 -1.295 . . . . 0.0 109.846 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.6 t -120.7 114.23 21.37 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-O 121.899 0.857 . . . . 0.0 112.019 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -79.95 76.08 6.67 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 122.054 0.93 . . . . 0.0 110.45 167.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.73 -82.25 0.09 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -105.23 -16.43 14.77 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 167.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -88.81 106.06 18.13 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 120.982 1.719 . . . . 0.0 109.9 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.49 116.01 31.59 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 111.344 -168.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.9 m -108.37 128.46 54.79 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.041 0.936 . . . . 0.0 109.493 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.73 122.18 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -109.98 111.96 23.67 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.055 0.542 . . . . 0.0 110.073 168.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.8 m -87.87 99.53 12.2 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -86.19 116.91 24.68 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.153 0.978 . . . . 0.0 111.594 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.1 t -147.06 135.05 21.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.85 0.86 . . . . 0.0 109.764 169.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 64.5 p -59.32 -30.37 68.31 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 165.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.3 mt -71.58 -53.06 14.98 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 170.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -153.04 100.04 2.45 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 120.284 1.402 . . . . 0.0 110.593 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.6 m -77.83 146.1 35.93 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.012 0.91 . . . . 0.0 111.669 171.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.7 m -152.16 134.01 14.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.091 -1.631 . . . . 0.0 109.857 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -131.5 138.77 49.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 111.577 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -141.91 152.63 43.73 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 174.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.7 p -135.78 109.49 8.05 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.924 0.89 . . . . 0.0 110.029 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.2 t -134.82 154.21 51.72 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.556 0.742 . . . . 0.0 112.242 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.92 140.07 47.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.433 -1.417 . . . . 0.0 110.603 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.9 tp -68.89 118.98 12.51 Favored 'General case' 0 CA--C 1.579 2.088 0 O-C-N 120.69 -1.256 . . . . 0.0 111.442 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.35 -40.92 2.34 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 116.988 1.555 . . . . 0.0 116.988 -157.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.8 154.86 24.51 Favored 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 125.194 1.398 . . . . 0.0 113.416 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.3 152.64 21.3 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 166.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -138.62 162.47 34.54 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.761 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.84 100.58 2.93 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.878 0.847 . . . . 0.0 111.519 166.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -92.81 98.27 11.29 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.6 m -79.79 95.73 6.09 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 163.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.2 p -61.75 170.65 1.91 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -160.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.92 -41.04 58.43 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 164.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -50.43 -61.35 2.23 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 159.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.67 -30.49 3.1 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 120.588 -1.32 . . . . 0.0 116.303 -151.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -60.56 134.95 57.58 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 118.703 1.252 . . . . 0.0 112.63 173.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -85.81 129.15 34.91 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.344 0.592 . . . . 0.0 111.197 168.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.4 p -130.29 136.86 49.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.681 0.753 . . . . 0.0 109.217 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -87.62 96.16 10.31 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 120.692 -1.255 . . . . 0.0 108.956 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.9 m -103.64 115.61 30.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.641 -0.662 . . . . 0.0 110.65 -161.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.5 p -85.44 124.5 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-N 118.696 0.68 . . . . 0.0 112.024 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.1 m -94.0 111.85 23.61 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.376 0.67 . . . . 0.0 111.398 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -139.76 124.76 18.63 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 119.828 1.194 . . . . 0.0 112.847 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -95.2 130.36 41.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.136 -0.977 . . . . 0.0 111.71 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 t -147.69 136.33 21.81 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.222 0.609 . . . . 0.0 110.16 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 62.72 33.72 15.27 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 160.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.93 -13.77 55.38 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 -164.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -109.78 128.62 55.42 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 119.644 1.722 . . . . 0.0 113.167 -176.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.7 tp -86.7 108.5 18.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.416 -0.803 . . . . 0.0 109.637 161.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.6 t -91.75 112.19 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 98.73 10.7 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 169.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -91.12 99.39 12.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 111.355 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -70.02 125.3 26.37 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.852 0.861 . . . . 0.0 112.05 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -124.37 117.22 23.99 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -150.18 120.54 7.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.683 -1.261 . . . . 0.0 112.645 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.255 39.1 t70 50.61 44.28 27.43 Favored 'General case' 0 CA--C 1.585 2.317 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.91 -30.32 2.93 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 119.06 2.384 . . . . 0.0 119.06 -166.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -83.63 144.78 29.2 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.696 1.198 . . . . 0.0 112.79 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -140.52 156.82 46.2 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.1 t -146.94 142.28 27.4 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.445 0.698 . . . . 0.0 111.663 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.0 p -102.04 113.5 26.79 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.279 -0.888 . . . . 0.0 110.864 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.4 mm -88.19 95.68 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.1 m -96.67 92.32 6.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.554 -0.716 . . . . 0.0 110.53 -167.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -90.57 97.7 11.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.302 0.641 . . . . 0.0 111.673 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -119.2 137.34 53.7 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.725 0.81 . . . . 0.0 112.742 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.47 121.57 24.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 111.613 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.76 -144.67 0.39 Allowed 'General case' 0 CA--C 1.562 1.404 0 CA-C-O 121.231 0.539 . . . . 0.0 111.868 -171.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -87.2 66.09 9.1 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 120.973 -1.079 . . . . 0.0 109.954 -167.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.81 -18.11 58.1 Favored Glycine 0 CA--C 1.557 2.664 0 N-CA-C 119.67 2.628 . . . . 0.0 119.67 -168.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.65 166.53 24.34 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.629 2.215 . . . . 0.0 110.986 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.9 tp -87.15 120.68 28.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.061 -1.649 . . . . 0.0 111.318 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.405 HG22 ' CD1' ' A' ' 130' ' ' ILE . 55.8 t -87.15 115.57 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -109.21 93.07 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -84.66 95.09 8.79 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.905 1.336 . . . . 0.0 109.593 173.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.4 p -89.46 99.72 12.66 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.603 176.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 p -113.56 126.03 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.647 0.737 . . . . 0.0 110.534 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.0 tpt -73.51 -60.76 2.1 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.564 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.258 12.5 p30 -153.46 -80.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -79.77 -32.75 40.99 Favored 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 159.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.25 106.69 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 CA-C-N 120.022 1.283 . . . . 0.0 110.607 -169.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.9 p -102.12 121.55 42.42 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.138 0.975 . . . . 0.0 111.305 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.3 p -100.9 117.21 34.52 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 118.195 0.452 . . . . 0.0 111.03 162.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 m -89.32 106.78 18.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.594 -0.691 . . . . 0.0 109.173 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -106.68 106.94 17.71 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.405 ' CD1' HG22 ' A' ' 117' ' ' VAL . 34.3 mm -91.28 132.41 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -120.93 131.79 54.56 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 121.267 0.556 . . . . 0.0 112.095 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -81.42 134.13 35.51 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -75.39 117.12 16.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.265 -0.897 . . . . 0.0 111.623 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.5 t -95.29 106.22 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 123.222 0.609 . . . . 0.0 110.264 -170.886 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.258 9.3 p . . . . . 0 N--CA 1.505 2.282 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.47 -36.97 56.06 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 162.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -64.59 -26.37 68.38 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.623 2.082 . . . . 0.0 116.623 170.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.1 mt -65.08 -20.77 66.64 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 161.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -76.81 123.13 25.77 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.747 1.612 . . . . 0.0 112.127 -170.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.29 -179.79 26.73 Favored Glycine 0 N--CA 1.489 2.17 0 CA-C-O 122.162 0.868 . . . . 0.0 115.109 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -93.33 132.69 37.31 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.031 0.532 . . . . 0.0 111.042 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -124.98 110.45 14.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.968 -0.457 . . . . 0.0 111.286 -168.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -95.88 128.61 42.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.729 -1.232 . . . . 0.0 113.516 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.19 129.27 38.48 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.277 10.3 m -118.52 -64.23 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 118.51 -0.757 . . . . 0.0 111.749 178.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -101.93 157.3 16.96 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 123.352 1.548 . . . . 0.0 112.158 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -155.95 72.35 0.77 Allowed 'General case' 0 CA--C 1.562 1.438 0 O-C-N 120.891 -1.131 . . . . 0.0 110.878 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.11 129.87 41.3 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.156 -0.965 . . . . 0.0 112.437 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.54 11.06 61.66 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 119.953 2.741 . . . . 0.0 119.953 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -68.79 -35.59 77.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.313 1.968 . . . . 0.0 116.313 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -53.46 -54.81 31.65 Favored 'General case' 0 CA--C 1.575 1.917 0 CA-C-N 119.964 1.256 . . . . 0.0 114.22 167.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -54.44 -40.1 68.03 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 168.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.5 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 78.9 t80 -60.5 -45.51 93.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 166.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.3 9.6 ptt? -73.21 -30.3 63.41 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -42.72 91.58 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-N 121.192 1.814 . . . . 0.0 115.271 155.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -61.48 -42.65 99.11 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.7 mt -58.23 -44.54 88.27 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 165.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.58 44.07 2.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 117.654 1.822 . . . . 0.0 117.654 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.92 139.55 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 C-N-CA 124.054 0.942 . . . . 0.0 110.022 162.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.03 171.68 47.91 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 116.245 1.258 . . . . 0.0 116.245 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 pt -53.07 -47.3 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 -172.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.36 95.9 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.46 -40.33 95.51 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 168.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 mtp-105 -61.0 -44.82 96.86 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 166.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.73 -46.6 81.23 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.8 ttm -51.13 -59.6 4.01 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 163.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.68 -36.45 48.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 119.96 2.744 . . . . 0.0 119.96 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.43 70.43 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 21.4 ptp -85.54 -26.47 26.17 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.93 106.81 3.32 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 120.262 1.392 . . . . 0.0 113.308 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -109.47 90.54 8.73 Favored Pre-proline 0 CA--C 1.571 1.758 0 C-N-CA 123.778 0.831 . . . . 0.0 109.84 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.47 160.92 14.82 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.409 2.073 . . . . 0.0 116.288 -167.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -93.7 97.96 10.8 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.152 166.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.8 t -89.9 110.51 21.45 Favored 'General case' 0 CA--C 1.558 1.273 0 O-C-N 121.185 -0.947 . . . . 0.0 112.087 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 mt -90.4 114.75 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 108.666 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 91.9 mt -94.7 123.74 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 166.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.1 m -150.28 126.71 10.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.98 -1.075 . . . . 0.0 109.846 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -122.08 116.39 24.16 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.08 84.28 7.05 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.347 1.07 . . . . 0.0 110.579 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.6 -75.3 1.24 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -125.23 -20.97 4.71 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 170.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.73 103.89 11.74 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 121.808 2.095 . . . . 0.0 111.222 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tt -98.0 117.71 32.96 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.073 0.949 . . . . 0.0 110.237 -171.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.7 m -96.83 126.41 41.97 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.798 0.839 . . . . 0.0 110.066 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.5 mt -110.03 102.3 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -101.86 104.22 14.94 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.281 0.632 . . . . 0.0 110.115 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.4 m -86.86 106.48 17.77 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.797 0.839 . . . . 0.0 109.984 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -94.79 115.54 27.62 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.535 0.683 . . . . 0.0 111.573 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.2 t -153.59 136.82 15.67 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.422 0.689 . . . . 0.0 110.55 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.2 p -59.32 -33.96 71.76 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 mt -64.44 -50.32 68.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 166.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.06 105.66 2.56 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 119.85 1.204 . . . . 0.0 111.663 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.1 m -90.91 133.87 34.91 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 123.033 0.533 . . . . 0.0 110.636 172.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -137.64 146.69 44.2 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 123.355 0.662 . . . . 0.0 111.149 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 129.55 22.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.744 -1.223 . . . . 0.0 111.483 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.84 143.71 47.17 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.616 0.766 . . . . 0.0 111.102 172.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.6 m -130.05 126.06 36.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 0.0 111.259 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.46 146.26 33.28 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -169.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.51 134.33 43.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.698 -1.251 . . . . 0.0 110.856 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -72.84 117.21 14.27 Favored 'General case' 0 CA--C 1.574 1.883 0 O-C-N 120.671 -1.268 . . . . 0.0 112.88 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.7 -34.93 5.41 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 117.23 1.652 . . . . 0.0 117.23 -158.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.71 158.32 31.06 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 122.787 1.279 . . . . 0.0 113.376 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -115.74 140.97 48.7 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.705 173.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -152.15 153.53 34.05 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.945 0.898 . . . . 0.0 110.917 -162.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -83.14 87.23 6.92 Favored 'General case' 0 CA--C 1.574 1.882 0 O-C-N 120.487 -1.383 . . . . 0.0 113.778 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.38 115.2 12.46 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.151 0.977 . . . . 0.0 110.525 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.8 m -101.12 100.53 11.11 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.488 -170.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 p -73.06 159.86 32.94 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -161.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.73 -32.88 6.32 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 119.123 3.009 . . . . 0.0 119.123 169.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -58.61 -51.23 70.79 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 161.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.02 -30.24 2.85 Favored Glycine 0 CA--C 1.551 2.343 0 N-CA-C 116.96 1.544 . . . . 0.0 116.96 -157.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 -58.65 129.68 43.27 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.351 2.076 . . . . 0.0 114.816 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.86 101.6 11.77 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.803 0.841 . . . . 0.0 109.427 172.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.0 p -109.51 105.58 14.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.048 -1.032 . . . . 0.0 110.088 -168.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -70.38 105.31 2.98 Favored 'General case' 0 CA--C 1.565 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.445 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.0 m -130.85 120.35 23.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.003 . . . . 0.0 110.279 -151.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.76 126.79 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 118.829 0.741 . . . . 0.0 111.736 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.4 m -105.69 112.12 25.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.942 -0.474 . . . . 0.0 111.807 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -125.08 131.03 53.38 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.303 0.641 . . . . 0.0 111.112 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -88.49 127.06 35.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.959 . . . . 0.0 111.617 168.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.1 t -143.22 140.35 30.66 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.157 0.583 . . . . 0.0 110.139 167.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 61.67 36.71 16.4 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 160.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.43 16.84 80.38 Favored Glycine 0 CA--C 1.557 2.691 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -165.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.75 136.07 26.87 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 119.664 1.732 . . . . 0.0 113.919 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.0 tp -92.8 112.42 24.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.699 -0.626 . . . . 0.0 110.916 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.09 109.04 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -89.22 98.79 11.97 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.251 0.62 . . . . 0.0 109.339 167.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -89.84 104.14 16.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.605 -0.684 . . . . 0.0 110.232 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -91.62 131.97 36.65 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.154 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -127.94 126.29 41.17 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 119.035 0.834 . . . . 0.0 110.197 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -148.14 120.81 8.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.575 -1.328 . . . . 0.0 110.451 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.8 t70 49.7 51.06 17.22 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.72 -24.91 2.19 Favored Glycine 0 CA--C 1.557 2.688 0 N-CA-C 119.596 2.598 . . . . 0.0 119.596 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -93.67 140.96 29.02 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.994 1.397 . . . . 0.0 111.55 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -129.32 146.85 51.14 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 175.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.7 t -143.4 111.24 6.01 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.037 0.535 . . . . 0.0 110.385 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.3 t -98.65 146.3 25.98 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.8 mt -127.91 108.31 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -169.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.6 m -97.63 106.23 18.51 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.548 0.739 . . . . 0.0 110.214 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -93.0 85.87 5.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 111.237 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -100.37 130.13 46.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -167.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.89 117.24 21.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 112.288 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -145.78 121.88 10.77 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.519 0.728 . . . . 0.0 109.684 -171.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 59.5 47.99 10.29 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 168.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.75 35.04 80.03 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -166.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.48 139.6 16.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.452 0.701 . . . . 0.0 109.781 -162.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.11 112.46 24.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.172 -0.955 . . . . 0.0 108.757 172.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.2 t -99.16 101.82 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.37 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -165.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -100.1 100.98 11.91 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.987 0.899 . . . . 0.0 109.798 -170.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.5 p -101.72 127.25 48.57 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.158 0.983 . . . . 0.0 111.517 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.71 143.62 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 123.316 0.646 . . . . 0.0 111.518 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.7 ttt -124.17 -103.13 0.38 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.336 -0.852 . . . . 0.0 108.732 165.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -87.66 70.51 9.71 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 120.571 1.532 . . . . 0.0 111.264 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.253 0.7 OUTLIER 62.88 0.13 0.65 Allowed 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 118.169 2.655 . . . . 0.0 118.169 -165.709 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.47 93.94 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.253 -1.529 . . . . 0.0 108.644 -171.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.6 p -92.62 117.59 30.13 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.252 0.548 . . . . 0.0 111.761 -171.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 4.1 p -108.12 119.91 40.81 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.437 0.695 . . . . 0.0 111.339 171.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.6 m -101.96 107.57 18.75 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -101.67 114.1 27.84 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.483 0.713 . . . . 0.0 109.833 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.47 124.94 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.344 -0.848 . . . . 0.0 108.924 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -122.95 131.76 53.86 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -86.21 132.13 34.07 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.253 1.421 . . . . 0.0 113.725 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -73.36 111.13 8.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.877 -1.139 . . . . 0.0 112.102 174.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.2 t -103.62 95.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.253 1.286 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.738 -178.039 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.519 3.9 p . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.95 -47.66 84.28 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -64.94 -15.96 62.74 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 171.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.61 -11.74 61.0 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 163.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -83.9 125.25 31.82 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 121.422 1.919 . . . . 0.0 113.091 -165.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.6 -170.6 26.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 115.856 1.102 . . . . 0.0 115.856 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -90.49 122.52 33.41 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.536 0.734 . . . . 0.0 110.894 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.449 ' CH2' HD21 ' A' ' 111' ' ' LEU . 95.2 m95 -123.55 110.89 15.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.613 -0.679 . . . . 0.0 110.857 -172.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -90.15 130.63 36.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.591 -1.318 . . . . 0.0 113.37 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 46.8 tp -65.0 128.65 36.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 173.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.275 8.8 m -121.46 -61.4 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.129 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -96.43 149.51 21.64 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.491 1.496 . . . . 0.0 111.41 167.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.4 p -145.81 65.76 1.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.166 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.23 126.96 31.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.726 -1.234 . . . . 0.0 112.386 -175.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.64 23.14 62.6 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 119.248 2.459 . . . . 0.0 119.248 -171.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -75.1 -46.81 32.09 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 119.002 1.401 . . . . 0.0 114.455 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.69 -44.14 63.03 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 163.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -52.8 -48.54 66.83 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -58.82 -51.29 70.63 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 167.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 50.0 mtm -68.35 -42.62 78.95 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.34 -37.28 23.93 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 116.207 1.928 . . . . 0.0 116.207 164.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.76 -39.39 76.73 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 171.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.5 mt -51.04 -45.09 61.21 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 162.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.9 46.92 1.06 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 117.114 1.605 . . . . 0.0 117.114 -172.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 m -91.78 143.03 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 C-N-CA 124.519 1.128 . . . . 0.0 110.676 166.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.55 174.5 42.03 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 2.6 pp -55.81 -44.94 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.25 84.32 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.8 mt -64.9 -43.24 93.48 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -52.46 -54.6 30.23 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 164.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -59.49 -52.31 66.14 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.2 ttp -56.15 -49.78 73.02 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 172.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.39 -44.8 97.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 118.23 2.052 . . . . 0.0 118.23 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.23 96.94 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.1 ptp -76.98 -16.72 59.25 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.148 2.648 . . . . 0.0 118.148 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.14 145.39 46.43 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.29 73.07 5.17 Favored Pre-proline 0 CA--C 1.577 1.984 0 CA-C-O 118.546 -0.74 . . . . 0.0 110.627 171.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.32 146.8 57.78 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.134 2.556 . . . . 0.0 116.001 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -83.07 100.8 10.72 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.097 165.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.4 t -79.19 101.9 8.22 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.839 0.828 . . . . 0.0 110.545 167.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mt -96.2 106.36 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.31 128.65 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.0 m -146.32 113.15 6.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.395 -0.816 . . . . 0.0 108.821 170.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.7 95.64 10.0 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 121.276 -0.89 . . . . 0.0 111.062 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.56 76.77 9.98 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-O 122.393 1.092 . . . . 0.0 110.063 -171.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.59 -101.11 1.62 Allowed Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.143 -0.973 . . . . 0.0 113.642 -167.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -94.97 -11.94 27.63 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 156.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -84.57 96.5 9.18 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 122.023 2.192 . . . . 0.0 110.556 -167.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.3 tp -73.22 108.62 6.2 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 121.941 0.876 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.2 m -98.34 105.39 17.53 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.7 103.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -102.85 115.88 31.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.579 0.752 . . . . 0.0 109.687 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.8 m -100.3 97.29 8.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.699 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -89.34 119.72 30.06 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.88 0.848 . . . . 0.0 112.313 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.1 t -150.66 134.76 16.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.673 0.789 . . . . 0.0 110.054 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.4 p -59.12 -33.31 70.71 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.04 -47.84 73.05 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 166.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -158.27 104.94 1.88 Allowed 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.145 1.338 . . . . 0.0 111.173 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.2 m -92.39 137.53 32.28 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.708 -0.62 . . . . 0.0 111.55 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -144.25 164.47 30.65 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.428 0.691 . . . . 0.0 111.686 168.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -154.46 149.72 27.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 119.897 -1.752 . . . . 0.0 114.285 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -138.93 141.21 38.47 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.424 0.63 . . . . 0.0 112.122 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.7 p -126.41 105.15 8.58 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.767 0.827 . . . . 0.0 109.923 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.3 p -136.85 142.13 42.83 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -166.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 m -72.07 118.98 15.62 Favored 'General case' 0 CA--C 1.574 1.871 0 O-C-N 120.575 -1.328 . . . . 0.0 111.768 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 tp -69.48 122.87 19.86 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -166.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.44 -38.08 3.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -158.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -99.23 164.45 12.13 Favored 'General case' 0 CA--C 1.574 1.9 0 CA-C-O 123.519 1.628 . . . . 0.0 113.405 -166.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -103.28 125.69 50.06 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 113.622 -1.626 . . . . 0.0 112.446 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.401 ' HE1' ' SG ' ' A' ' 87' ' ' CYS . 35.7 p90 -125.02 164.69 19.61 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.944 0.897 . . . . 0.0 113.377 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -76.64 104.91 7.39 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.71 1.243 . . . . 0.0 111.516 167.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.82 115.89 27.5 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.229 1.012 . . . . 0.0 109.349 175.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.1 m -90.04 97.17 11.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.9 p -71.05 147.76 48.23 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.69 -37.02 7.75 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -65.41 -49.13 70.38 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 166.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.73 -14.26 1.19 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 118.478 2.151 . . . . 0.0 118.478 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -69.5 133.09 47.28 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 120.375 2.088 . . . . 0.0 112.84 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -86.73 102.05 13.87 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.065 165.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.4 p -104.26 143.08 33.44 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.49 -0.756 . . . . 0.0 110.591 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -79.23 95.6 5.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.478 -1.389 . . . . 0.0 110.494 166.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.2 m -92.46 116.65 29.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 0.0 110.132 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.315 11.6 p -87.82 109.46 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 118.264 0.483 . . . . 0.0 109.884 160.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.401 ' SG ' ' HE1' ' A' ' 73' ' ' PHE . 56.4 m -92.07 110.32 21.69 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -133.41 126.68 31.76 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.007 0.523 . . . . 0.0 111.627 -169.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -90.25 113.44 25.26 Favored 'General case' 0 CA--C 1.563 1.454 0 O-C-N 121.551 -0.718 . . . . 0.0 110.17 170.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 t -97.29 57.99 1.48 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.3 47.8 m-20 45.68 57.32 5.11 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 146.07 -61.13 0.47 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.829 -170.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.59 133.78 51.54 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.841 0.829 . . . . 0.0 112.86 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.7 tp -95.18 107.55 19.64 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.714 0.806 . . . . 0.0 110.669 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.5 114.97 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.569 0.748 . . . . 0.0 109.031 -172.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -89.09 98.18 11.62 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 166.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -95.53 92.22 6.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.854 -0.529 . . . . 0.0 111.354 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -83.23 123.25 29.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.146 0.978 . . . . 0.0 111.389 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -123.29 121.75 36.62 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.392 0.542 . . . . 0.0 110.625 -173.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -150.33 127.1 10.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.667 -1.27 . . . . 0.0 111.613 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.299 17.5 t70 52.85 49.74 19.57 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 162.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.24 0.07 19.72 Favored Glycine 0 CA--C 1.561 2.93 0 N-CA-C 120.145 2.818 . . . . 0.0 120.145 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -123.1 145.25 48.73 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 119.274 1.537 . . . . 0.0 109.854 -173.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -133.43 169.79 16.44 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.03 121.33 5.76 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.751 -1.218 . . . . 0.0 111.596 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.54 103.56 12.46 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -172.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.0 mm -95.57 100.45 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 98.4 m -99.26 101.2 12.44 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.281 0.632 . . . . 0.0 110.252 -168.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -93.36 109.55 21.11 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.724 0.81 . . . . 0.0 110.793 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -125.15 144.35 50.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 112.766 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.449 HD21 ' CH2' ' A' ' 11' ' ' TRP . 0.2 OUTLIER -82.75 122.91 28.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.348 -0.845 . . . . 0.0 110.821 178.53 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.293 42.0 tttm -124.7 -118.87 0.28 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 122.08 -0.388 . . . . 0.0 109.957 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -84.19 68.23 10.05 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.19 0.995 . . . . 0.0 112.651 -166.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.9 -13.61 5.27 Favored Glycine 0 CA--C 1.556 2.599 0 N-CA-C 119.477 2.551 . . . . 0.0 119.477 -166.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -124.71 158.12 33.99 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 119.096 1.448 . . . . 0.0 110.285 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.52 111.16 19.25 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.651 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 75.4 t -90.13 114.39 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.8 t -115.7 99.69 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 -167.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -99.34 108.6 21.15 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.425 0.69 . . . . 0.0 109.279 -171.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.673 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.7 p -103.74 122.69 45.59 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.71 -0.619 . . . . 0.0 111.938 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.39 136.16 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.385 0.612 . . . . 0.0 110.911 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 12.4 ttt -86.01 -76.1 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 122.722 0.409 . . . . 0.0 110.887 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -126.88 -73.08 0.62 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 166.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -89.97 -30.05 18.06 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.9 t -85.15 107.06 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 119.919 1.236 . . . . 0.0 110.537 -166.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 69.7 p -105.17 113.11 26.51 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.544 0.738 . . . . 0.0 111.344 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.673 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.4 OUTLIER -87.47 157.19 19.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 166.721 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.0 m -127.97 109.14 11.29 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 166.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -98.38 123.96 42.79 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.527 0.731 . . . . 0.0 110.64 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.9 mm -99.19 116.34 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -114.35 130.86 56.69 Favored 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 122.854 0.462 . . . . 0.0 110.826 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -107.83 143.96 35.68 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -74.28 118.36 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.662 -0.649 . . . . 0.0 112.708 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.3 t -90.06 95.68 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 118.436 -0.792 . . . . 0.0 109.781 -174.253 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.581 2.159 0 CA-C-O 121.383 0.611 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -136.97 70.51 1.4 Allowed 'General case' 0 CA--C 1.57 1.743 0 O-C-N 120.686 -1.259 . . . . 0.0 110.063 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -163.94 -52.33 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 125.87 1.668 . . . . 0.0 110.407 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.3 mt -75.87 0.27 18.78 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.42 143.72 29.24 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-N 120.736 1.607 . . . . 0.0 112.314 -171.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.62 -173.78 17.04 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 115.894 1.117 . . . . 0.0 115.894 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -87.24 112.7 22.28 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.469 0.708 . . . . 0.0 111.596 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -112.61 112.88 24.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 122.122 -0.361 . . . . 0.0 110.718 -175.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -94.01 134.09 36.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.635 -1.291 . . . . 0.0 112.746 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.49 126.77 30.77 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.597 -0.689 . . . . 0.0 111.92 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.258 3.6 m -113.1 -66.49 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.836 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -111.43 107.96 17.36 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.575 1.079 . . . . 0.0 110.347 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.6 p -89.56 81.62 6.49 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.617 -0.677 . . . . 0.0 111.449 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.27 107.28 14.83 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -163.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.18 16.43 78.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 118.439 2.136 . . . . 0.0 118.439 -168.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -86.29 68.78 10.35 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-N 120.102 1.951 . . . . 0.0 112.868 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -141.73 -51.7 0.42 Allowed 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.778 153.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -45.1 -46.81 11.94 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 167.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.403 ' CD2' ' SG ' ' A' ' 127' ' ' CYS . 57.9 t80 -54.55 -57.62 10.68 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 171.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 ptt? -61.74 -43.98 97.79 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.33 -46.89 55.92 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 162.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -67.87 -39.13 83.77 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.913 1.819 . . . . 0.0 115.913 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -50.03 -40.83 46.04 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 159.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.15 50.0 0.6 Allowed Glycine 0 N--CA 1.486 2.015 0 C-N-CA 124.738 1.161 . . . . 0.0 114.978 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.8 t -99.78 131.7 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.578 0.751 . . . . 0.0 109.197 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.26 160.74 48.69 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 116.888 1.515 . . . . 0.0 116.888 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.281 2.6 pp -58.23 -46.34 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -173.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.17 95.28 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 167.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -41.23 89.34 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 170.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -54.97 -49.54 71.15 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 162.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -54.88 -49.73 70.45 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 170.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -52.83 -55.93 19.45 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 165.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.02 -43.79 96.69 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 118.85 2.3 . . . . 0.0 118.85 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.04 95.01 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . 0.269 14.4 ptt? -70.23 -40.03 74.73 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 170.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.43 133.93 56.57 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.51 92.75 41.57 Favored Pre-proline 0 CA--C 1.571 1.786 0 CA-C-O 118.027 -0.987 . . . . 0.0 108.564 166.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.84 158.48 27.74 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.505 2.137 . . . . 0.0 115.713 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -94.22 107.41 19.36 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.531 165.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.65 102.5 15.02 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 121.142 -0.973 . . . . 0.0 111.16 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -90.91 119.66 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 81.0 mt -108.81 126.74 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -138.18 116.08 11.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.827 -1.171 . . . . 0.0 109.121 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.8 p -117.97 111.51 19.06 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -89.86 68.43 7.4 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 122.128 0.966 . . . . 0.0 110.594 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.45 -75.68 0.67 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 120.478 -1.389 . . . . 0.0 115.754 -170.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -104.16 -44.16 5.05 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -74.28 110.01 8.23 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 121.281 1.855 . . . . 0.0 111.792 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 tt -112.82 112.85 24.64 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 122.379 1.085 . . . . 0.0 109.053 -172.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.5 m -99.13 115.92 30.15 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.733 0.813 . . . . 0.0 109.108 -172.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mt -106.58 105.89 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -102.72 105.93 16.46 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.285 0.634 . . . . 0.0 109.89 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.0 m -88.68 103.03 15.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.458 -0.776 . . . . 0.0 109.322 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.88 117.19 29.77 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.967 0.889 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -156.4 137.41 13.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.561 0.744 . . . . 0.0 110.055 168.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.3 p -58.57 -34.66 71.3 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 167.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.5 -47.42 73.05 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 168.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -156.35 104.78 2.24 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 120.077 1.308 . . . . 0.0 110.794 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 m -93.06 132.43 37.19 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.137 0.575 . . . . 0.0 110.935 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.1 p -142.53 115.49 8.78 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.767 -0.583 . . . . 0.0 110.668 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -109.96 135.56 50.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.36 0.664 . . . . 0.0 112.016 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -142.17 144.64 33.52 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.815 0.817 . . . . 0.0 112.699 170.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.8 p -106.16 105.75 15.93 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.662 0.785 . . . . 0.0 110.769 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.5 p -102.53 135.35 44.32 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 m -75.73 130.81 39.25 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 120.752 -1.218 . . . . 0.0 110.454 171.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 tp -77.67 124.74 28.34 Favored 'General case' 0 CA--C 1.57 1.736 0 O-C-N 121.377 -0.827 . . . . 0.0 112.377 175.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.98 39.54 11.54 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 117.452 1.741 . . . . 0.0 117.452 -169.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -171.92 147.53 2.18 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.807 1.243 . . . . 0.0 108.522 -167.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.257 11.6 ptpt -100.18 146.97 26.22 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 171.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -137.88 161.08 37.57 Favored 'General case' 0 CA--C 1.571 1.757 0 C-N-CA 124.893 1.277 . . . . 0.0 110.513 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -80.74 104.26 11.14 Favored 'General case' 0 CA--C 1.572 1.825 0 O-C-N 119.972 -1.705 . . . . 0.0 112.228 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -88.16 109.49 19.94 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.14 0.976 . . . . 0.0 110.707 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.3 m -76.08 99.54 4.67 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.772 . . . . 0.0 110.205 170.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 p -69.66 148.12 49.71 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.574 0.749 . . . . 0.0 112.717 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.14 -41.91 18.43 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.42 -43.91 76.17 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 170.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.82 -31.05 0.29 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.8 mtm-85 -67.75 126.86 30.74 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.071 1.936 . . . . 0.0 113.038 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -88.73 117.13 27.49 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.08 0.467 . . . . 0.0 109.777 166.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.0 p -123.82 129.07 50.45 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.479 0.657 . . . . 0.0 110.338 -163.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -83.64 105.4 14.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.525 -1.36 . . . . 0.0 109.679 -170.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.7 m -121.6 105.53 10.53 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.96 -0.463 . . . . 0.0 110.98 -148.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.44 120.84 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 120.89 0.376 . . . . 0.0 111.443 172.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 45.4 m -95.35 109.38 21.55 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.123 0.487 . . . . 0.0 109.732 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -136.31 124.0 22.43 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.141 0.576 . . . . 0.0 110.932 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -85.88 132.69 34.04 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.093 -1.005 . . . . 0.0 112.188 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 t -139.87 143.52 36.77 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.148 0.579 . . . . 0.0 110.101 163.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 62.27 35.69 15.14 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 162.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.14 29.06 73.17 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -164.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.08 134.28 18.27 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 118.519 1.16 . . . . 0.0 112.907 -170.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.9 tp -88.04 115.46 25.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.782 -0.574 . . . . 0.0 111.216 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.31 108.06 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -94.44 90.11 6.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -89.84 108.13 19.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.903 -0.498 . . . . 0.0 110.863 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -106.6 130.5 54.34 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -169.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -129.36 127.48 41.13 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 123.622 0.769 . . . . 0.0 111.747 -166.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -153.04 134.87 14.62 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.274 -1.516 . . . . 0.0 111.159 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.2 t70 48.29 48.3 18.97 Favored 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 166.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.32 19.06 66.04 Favored Glycine 0 CA--C 1.558 2.764 0 N-CA-C 120.384 2.913 . . . . 0.0 120.384 -167.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -136.54 137.1 39.91 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.216 1.508 . . . . 0.0 109.193 -168.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -128.59 143.86 51.04 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 123.13 1.443 . . . . 0.0 114.57 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.6 t -133.2 164.61 26.66 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.473 167.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -142.72 139.07 30.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.013 -1.68 . . . . 0.0 113.234 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.1 mm -104.97 103.27 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.9 m -99.13 102.02 13.57 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.347 0.594 . . . . 0.0 109.628 -175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -93.88 95.64 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.676 -0.64 . . . . 0.0 110.833 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -104.14 134.97 46.49 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 118.514 0.597 . . . . 0.0 112.487 -176.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 109.75 12.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.966 -1.084 . . . . 0.0 110.189 173.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -144.84 128.75 17.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.555 -0.715 . . . . 0.0 110.783 -170.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 60.36 40.71 17.18 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.61 -15.3 25.67 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 119.814 2.686 . . . . 0.0 119.814 -169.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.8 169.2 17.42 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.081 1.94 . . . . 0.0 112.261 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.5 tp -88.06 116.08 25.99 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 120.551 -1.343 . . . . 0.0 110.109 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.6 t -99.03 108.92 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.9 t -102.42 96.51 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -169.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -87.49 100.95 13.14 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.219 1.009 . . . . 0.0 109.673 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.6 p -107.48 108.4 19.7 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.924 0.889 . . . . 0.0 110.352 -173.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.79 137.71 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.865 0.866 . . . . 0.0 111.618 -168.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.1 ttt -113.93 106.7 14.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 162.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.303 6.3 m120 68.52 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.987 0.915 . . . . 0.0 112.856 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -125.42 -3.12 7.4 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 164.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.7 t -90.32 100.1 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 121.906 2.139 . . . . 0.0 109.567 -170.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.5 p -99.2 123.62 43.63 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.807 0.843 . . . . 0.0 112.8 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.4 p -103.09 133.06 48.83 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 120.937 0.399 . . . . 0.0 111.349 157.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.7 m -106.49 101.46 10.92 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -95.01 114.7 26.54 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.499 -0.751 . . . . 0.0 110.603 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.4 mm -88.19 124.2 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -123.9 122.44 37.99 Favored 'General case' 0 CA--C 1.569 1.709 0 C-N-CA 123.534 0.734 . . . . 0.0 111.433 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -97.18 142.65 28.83 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -78.58 117.59 19.9 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.702 -1.248 . . . . 0.0 112.568 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 32.9 t -117.21 81.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.653 -0.654 . . . . 0.0 109.337 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.256 1.413 0 C-N-CA 123.558 0.743 . . . . 0.0 110.787 -178.043 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.262 4.6 p . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -41.78 98.73 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 166.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -57.28 -23.66 49.87 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.41 -6.46 7.24 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 164.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -64.05 161.01 16.83 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 122.615 2.461 . . . . 0.0 115.274 171.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.42 169.3 12.88 Favored Glycine 0 N--CA 1.49 2.272 0 O-C-N 121.264 -0.898 . . . . 0.0 115.28 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -83.73 96.28 8.67 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.936 0.495 . . . . 0.0 110.858 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -97.18 100.16 11.64 Favored 'General case' 0 CA--C 1.566 1.566 0 O-C-N 121.422 -0.799 . . . . 0.0 110.982 -170.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -77.12 127.28 32.37 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.879 -1.138 . . . . 0.0 112.973 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.2 tp -67.07 121.83 16.45 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.985 0.811 . . . . 0.0 113.033 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.56 -46.58 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -120.95 131.42 54.32 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.48 1.112 . . . . 0.0 109.404 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.8 p -131.83 70.79 1.46 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 172.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -82.38 127.23 33.05 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.21 17.35 61.03 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 118.578 2.191 . . . . 0.0 118.578 -170.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -84.93 -42.47 14.94 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -166.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -60.54 -39.25 87.23 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 121.19 1.814 . . . . 0.0 115.073 169.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.251 14.7 pt-20 -59.7 -49.22 78.58 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 167.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.457 ' CD2' ' SG ' ' A' ' 127' ' ' CYS . 76.7 t80 -55.32 -49.84 71.15 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 169.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.2 mtm -64.26 -36.54 84.42 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -58.53 -45.9 87.92 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 121.514 1.961 . . . . 0.0 115.542 162.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.09 -44.1 95.05 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 171.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.4 mt -55.3 -37.78 67.81 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.24 59.19 0.77 Allowed Glycine 0 N--CA 1.487 2.066 0 C-N-CA 124.13 0.871 . . . . 0.0 114.54 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.6 t -115.27 125.13 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -172.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 164.03 50.85 Favored Glycine 0 CA--C 1.551 2.336 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.262 2.4 pp -55.04 -48.75 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 N-CA-C 117.226 2.306 . . . . 0.0 117.226 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.12 94.98 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.81 -44.25 94.09 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -66.0 -44.18 85.53 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 171.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -56.4 -48.88 76.03 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 168.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.9 ttp -52.96 -58.11 8.07 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 163.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.21 -44.06 89.04 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 119.311 2.484 . . . . 0.0 119.311 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.35 -45.24 95.22 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.3 ptp -74.32 -28.79 61.32 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 168.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.58 102.74 1.54 Allowed 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 119.593 1.088 . . . . 0.0 113.035 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -103.09 92.77 3.95 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.449 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -80.48 160.2 22.47 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.222 1.948 . . . . 0.0 116.08 -172.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -85.36 104.48 15.22 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.294 157.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.2 t -86.85 96.31 10.17 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 124.048 0.939 . . . . 0.0 110.872 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.38 106.11 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.2 mt -97.08 144.81 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 CA-C-O 122.814 1.292 . . . . 0.0 108.454 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -147.1 115.43 6.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.06 -1.65 . . . . 0.0 108.522 167.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.5 t -114.39 107.12 15.13 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.971 0.508 . . . . 0.0 111.65 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -99.63 79.81 2.3 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 122.408 1.099 . . . . 0.0 109.746 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.34 -89.7 0.43 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -99.43 -15.51 18.71 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -106.41 129.21 54.44 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 122.038 2.199 . . . . 0.0 111.113 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 tt -125.5 116.82 22.4 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.295 0.638 . . . . 0.0 110.224 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.1 m -107.58 134.18 50.96 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.917 0.887 . . . . 0.0 109.715 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.9 mt -124.76 111.2 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -87.71 159.57 18.44 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 122.023 0.916 . . . . 0.0 111.182 160.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -148.24 102.86 3.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 119.525 -1.984 . . . . 0.0 107.664 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -98.27 114.31 26.55 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.689 0.795 . . . . 0.0 111.917 -172.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -147.36 140.16 24.93 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.669 0.787 . . . . 0.0 110.484 168.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.0 t -54.4 -28.99 47.38 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 167.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.8 mt -85.14 -47.0 10.58 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 124.122 0.969 . . . . 0.0 113.342 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.1 106.02 3.85 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.881 1.219 . . . . 0.0 110.914 168.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.7 m -90.05 134.66 34.12 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.159 0.584 . . . . 0.0 110.719 170.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -134.83 158.44 44.21 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.931 0.872 . . . . 0.0 111.525 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -150.2 130.93 14.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.538 -1.351 . . . . 0.0 110.802 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -144.2 160.89 40.17 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.881 0.848 . . . . 0.0 112.913 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -139.43 145.83 39.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 112.784 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -132.97 160.04 38.24 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-O 122.448 1.118 . . . . 0.0 112.445 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.7 m -90.56 132.9 35.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 164.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -73.58 128.73 36.3 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -170.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.65 -55.96 0.89 Allowed Glycine 0 N--CA 1.494 2.508 0 O-C-N 121.857 -0.527 . . . . 0.0 114.019 -162.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.26 179.68 7.26 Favored 'General case' 0 CA--C 1.575 1.922 0 CA-C-O 122.94 1.352 . . . . 0.0 113.039 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 149.23 32.74 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -111.64 -172.27 2.0 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.664 164.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -115.41 109.52 18.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.671 -1.268 . . . . 0.0 109.922 163.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -84.37 102.81 13.02 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.746 0.818 . . . . 0.0 109.743 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 75.3 m -77.58 100.29 6.06 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.991 0.901 . . . . 0.0 109.465 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.7 p -72.26 159.67 33.69 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -171.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.1 -41.06 7.47 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 119.233 3.049 . . . . 0.0 119.233 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.27 -39.09 93.6 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 169.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.43 -17.22 5.89 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 118.067 1.987 . . . . 0.0 118.067 -160.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.1 mtm-85 -69.06 118.88 12.53 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.841 2.32 . . . . 0.0 111.05 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -91.61 108.61 20.03 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.237 0.542 . . . . 0.0 109.834 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -111.19 111.46 22.55 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.664 0.745 . . . . 0.0 110.467 -162.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -72.31 97.81 2.09 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.478 1.111 . . . . 0.0 109.643 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.1 m -116.79 119.79 36.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 110.855 -152.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.42 130.05 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.93 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 74.8 m -106.74 95.5 5.78 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.172 0.896 . . . . 0.0 109.947 167.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -126.86 124.65 40.08 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.586 -0.696 . . . . 0.0 111.68 -171.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -89.12 140.79 29.1 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -136.13 115.39 12.54 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.447 0.699 . . . . 0.0 110.988 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.325 21.8 t70 64.26 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 170.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.37 30.32 3.66 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 168.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.51 129.88 15.74 Favored 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 118.8 1.3 . . . . 0.0 112.58 -170.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.7 tp -87.43 120.5 28.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.451 -0.78 . . . . 0.0 110.68 167.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.05 103.07 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.602 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -89.34 88.83 7.64 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -91.8 98.04 11.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.743 . . . . 0.0 110.551 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.6 131.94 36.13 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.097 0.959 . . . . 0.0 111.715 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.84 126.07 33.37 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.982 0.81 . . . . 0.0 109.758 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -143.02 122.21 12.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.838 -1.164 . . . . 0.0 110.393 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.288 38.9 t70 50.4 44.53 26.77 Favored 'General case' 0 CA--C 1.588 2.421 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 173.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.58 25.81 72.82 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 119.812 2.685 . . . . 0.0 119.812 -168.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -135.71 128.71 31.46 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.136 1.374 . . . . 0.0 107.765 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -126.85 146.76 50.16 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.9 t -134.33 126.14 29.06 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.644 0.735 . . . . 0.0 111.031 170.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 m -102.8 129.68 49.54 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 121.178 -0.951 . . . . 0.0 110.067 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.8 mt -120.69 97.99 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -172.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 79.4 m -94.56 103.29 15.24 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.717 . . . . 0.0 109.967 -171.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -93.91 100.21 12.42 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.506 0.723 . . . . 0.0 109.906 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -115.73 138.09 51.45 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.14 112.37 16.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.817 -0.552 . . . . 0.0 111.052 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.269 20.3 tptp -105.62 -138.54 0.36 Allowed 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.619 0.767 . . . . 0.0 111.199 -177.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -90.83 68.08 6.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.521 -1.362 . . . . 0.0 110.225 -159.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.18 36.94 93.86 Favored Glycine 0 CA--C 1.558 2.725 0 N-CA-C 117.577 1.791 . . . . 0.0 117.577 -159.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -165.92 134.39 3.06 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -161.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 21.9 tp -90.22 119.34 30.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.926 -1.734 . . . . 0.0 110.859 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.5 t -94.13 113.87 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.1 t -109.46 101.99 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -89.1 97.39 11.17 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.001 0.905 . . . . 0.0 109.249 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 0.8 OUTLIER -101.1 110.4 22.42 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.195 0.998 . . . . 0.0 110.533 -176.423 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 p -129.02 144.86 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.751 0.82 . . . . 0.0 110.53 -170.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.284 28.1 ttt -102.98 -104.32 0.28 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.41 -0.806 . . . . 0.0 108.922 166.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -108.02 97.46 7.16 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.644 1.111 . . . . 0.0 108.546 172.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.28 20.0 m120 68.26 -29.04 0.15 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 -172.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.43 107.71 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 CA-C-N 120.203 1.365 . . . . 0.0 109.776 -172.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 68.4 p -107.29 123.1 47.83 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.594 0.758 . . . . 0.0 112.124 -169.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 7.7 p -96.22 129.34 43.56 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 121.268 0.556 . . . . 0.0 111.346 156.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.4 m -105.6 99.45 9.06 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.235 -0.916 . . . . 0.0 108.567 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -96.01 123.19 39.51 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 122.022 -0.424 . . . . 0.0 111.228 -176.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.9 mm -101.44 122.92 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -120.65 148.23 44.19 Favored 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 123.24 0.616 . . . . 0.0 111.794 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -123.0 138.57 54.65 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -76.08 111.04 11.07 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.596 0.759 . . . . 0.0 112.139 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.71 94.66 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -171.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.256 1.415 0 C-N-CA 123.639 0.775 . . . . 0.0 109.636 -173.086 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.504 2.225 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -57.03 -22.84 41.99 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 171.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -41.92 -43.13 2.98 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 117.333 2.346 . . . . 0.0 117.333 154.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.9 3.12 39.55 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -82.35 129.83 34.96 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 121.256 1.843 . . . . 0.0 111.844 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.98 173.68 26.71 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 118.492 2.157 . . . . 0.0 118.492 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -82.91 103.04 12.07 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.067 0.547 . . . . 0.0 110.256 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -109.43 106.88 16.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 122.043 -0.411 . . . . 0.0 110.556 -172.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -83.72 129.79 34.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.395 -1.441 . . . . 0.0 112.553 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.1 tp -65.75 134.34 52.95 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.082 0.468 . . . . 0.0 112.14 172.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.301 6.8 m -123.91 -78.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -84.59 147.14 27.15 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.776 1.171 . . . . 0.0 111.38 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.5 p -139.79 74.86 1.48 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.035 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 137.73 50.62 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.79 15.77 49.39 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 119.67 2.628 . . . . 0.0 119.67 -170.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -81.67 64.85 6.56 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.979 1.889 . . . . 0.0 112.912 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -153.87 -53.73 0.1 Allowed 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 125.624 1.569 . . . . 0.0 109.36 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.46 -48.72 37.46 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 165.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -52.66 -54.99 25.82 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 169.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.298 23.2 ptt? -69.81 -24.45 63.48 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 174.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -64.43 -48.54 74.93 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 159.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -62.0 -37.99 86.9 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.4 mt -53.74 -40.71 66.38 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 159.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.81 57.78 1.58 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 123.797 0.713 . . . . 0.0 114.348 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.8 t -102.1 132.27 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -169.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.84 153.9 40.5 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.259 2.4 pp -56.39 -47.39 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.28 96.7 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 168.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.9 -39.08 90.28 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.8 mtp-105 -56.16 -48.7 75.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 163.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -54.1 -51.69 63.37 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 167.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -51.19 -52.32 45.43 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 166.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.64 -41.48 93.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 119.003 2.361 . . . . 0.0 119.003 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.06 -47.28 87.11 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -78.93 -28.51 43.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.4 115.19 9.29 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 120.198 1.363 . . . . 0.0 113.469 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.59 84.65 4.16 Favored Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.101 174.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.38 161.56 25.56 Favored 'Trans proline' 0 CA--C 1.563 1.971 0 C-N-CA 122.731 2.287 . . . . 0.0 116.84 -173.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -90.74 100.61 13.44 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.158 0.98 . . . . 0.0 109.794 169.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.44 100.15 10.54 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.5 1.12 . . . . 0.0 112.039 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.08 99.24 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.9 mt -90.74 114.89 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.4 p -115.5 106.78 14.35 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.54 112.73 8.18 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.692 -0.63 . . . . 0.0 111.89 -168.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -82.61 -47.68 11.82 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.77 -69.0 0.04 OUTLIER Glycine 0 N--CA 1.486 1.97 0 O-C-N 121.554 -0.716 . . . . 0.0 112.778 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -102.07 -36.51 8.54 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 166.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -76.24 136.45 39.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 120.053 1.297 . . . . 0.0 113.524 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 tt -142.81 120.71 12.0 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-O 121.411 0.624 . . . . 0.0 110.525 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.5 m -120.0 121.95 40.07 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.492 0.717 . . . . 0.0 109.558 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.3 127.96 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -118.89 102.8 9.06 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.831 0.852 . . . . 0.0 109.787 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.1 m -96.66 107.64 20.13 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.598 0.759 . . . . 0.0 110.781 -173.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -101.94 120.45 40.42 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.474 0.654 . . . . 0.0 112.602 -163.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.7 t -155.8 142.53 18.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.75 0.82 . . . . 0.0 111.208 168.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.4 p -60.23 -29.81 68.99 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.11 -53.09 42.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 167.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.95 115.51 3.29 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.987 1.267 . . . . 0.0 110.379 169.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.8 m -91.97 128.95 38.0 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 123.162 0.585 . . . . 0.0 110.752 173.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.1 p -133.49 116.04 15.5 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.533 -0.729 . . . . 0.0 110.233 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.9 150.25 38.76 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -153.25 149.28 27.78 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.3 p -131.75 115.57 16.17 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.953 0.901 . . . . 0.0 111.751 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.5 t -149.92 157.14 42.87 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.561 1.172 . . . . 0.0 113.926 -176.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -89.27 150.97 22.38 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.936 1.351 . . . . 0.0 111.023 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.84 120.11 11.91 Favored 'General case' 0 CA--C 1.571 1.767 0 O-C-N 120.706 -1.246 . . . . 0.0 112.452 170.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.26 -27.31 19.1 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 -162.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -89.44 143.31 26.92 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 118.731 1.266 . . . . 0.0 112.712 -174.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -94.8 145.65 24.74 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.143 0.973 . . . . 0.0 113.552 167.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -130.63 162.02 30.28 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.115 0.966 . . . . 0.0 111.47 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -80.04 100.81 8.35 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 120.911 -1.118 . . . . 0.0 111.192 167.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -80.49 139.11 36.56 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.87 0.843 . . . . 0.0 109.607 162.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.5 m -117.46 110.49 18.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 170.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 p -64.61 140.87 58.91 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.174 -0.329 . . . . 0.0 111.402 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.14 -24.74 2.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 119.954 3.316 . . . . 0.0 119.954 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.253 1.4 t70 -91.91 -24.35 19.33 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 169.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.65 -49.47 0.22 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 119.996 2.758 . . . . 0.0 119.996 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.2 mtm-85 -64.02 138.62 58.54 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -162.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -87.18 107.69 18.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.589 0.756 . . . . 0.0 110.705 170.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . 0.263 3.0 p -112.95 119.16 36.98 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.499 1.142 . . . . 0.0 111.372 -173.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -71.88 95.09 1.5 Allowed 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.44 1.096 . . . . 0.0 110.481 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.5 m -100.69 101.95 12.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.202 -0.936 . . . . 0.0 109.759 -161.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.97 117.22 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.099 0.476 . . . . 0.0 110.479 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 57.8 m -90.25 113.29 25.08 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 122.789 0.436 . . . . 0.0 110.601 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -128.68 124.49 35.81 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.963 -1.086 . . . . 0.0 111.1 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -86.7 116.74 25.0 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 121.124 -0.985 . . . . 0.0 112.037 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.7 t -156.9 140.12 15.56 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.041 0.936 . . . . 0.0 110.663 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.11 54.84 5.58 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 48.79 38.15 22.45 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 118.517 2.167 . . . . 0.0 118.517 -169.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.72 144.42 20.39 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -161.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.84 106.84 18.79 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 163.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.2 t -80.2 95.79 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -88.2 92.3 9.1 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -90.35 106.48 18.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.704 -0.622 . . . . 0.0 110.559 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -89.18 119.97 30.15 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.253 1.021 . . . . 0.0 110.264 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -124.38 124.53 42.56 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.783 0.833 . . . . 0.0 111.012 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -157.49 117.8 3.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.438 -1.414 . . . . 0.0 112.918 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.262 6.5 t70 32.16 56.57 0.36 Allowed 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 118.918 2.933 . . . . 0.0 118.918 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.97 -52.41 1.11 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -77.18 146.68 36.92 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.57 153.04 43.17 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 175.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 t -132.96 123.01 25.11 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 74.2 p -88.67 114.02 24.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.631 -0.668 . . . . 0.0 110.174 170.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 36.2 mm -106.51 93.4 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.9 m -94.65 99.44 11.56 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.099 -1.001 . . . . 0.0 110.747 -170.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -88.17 89.15 7.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.585 -0.697 . . . . 0.0 111.276 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.0 141.93 47.92 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -168.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.86 114.23 20.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 111.347 -177.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -134.02 124.28 25.98 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.05 49.75 15.06 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 170.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.32 -34.26 3.09 Favored Glycine 0 CA--C 1.553 2.455 0 N-CA-C 118.917 2.327 . . . . 0.0 118.917 -169.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -115.47 158.93 21.84 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 119.405 1.602 . . . . 0.0 112.781 -165.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.2 tp -83.44 111.11 18.74 Favored 'General case' 0 CA--C 1.561 1.388 0 O-C-N 121.147 -0.971 . . . . 0.0 110.225 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.34 110.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -95.94 96.53 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -87.07 99.25 11.77 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.899 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 5.3 p -119.55 95.54 4.83 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.225 -159.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 p -107.75 140.78 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.098 0.951 . . . . 0.0 110.016 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttt -119.41 112.43 19.4 Favored 'General case' 0 CA--C 1.559 1.314 0 O-C-N 121.376 -0.828 . . . . 0.0 109.324 167.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 54.2 50.27 16.84 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.297 3.3 t-20 67.82 -2.93 1.27 Allowed 'General case' 0 CA--C 1.584 2.286 0 N-CA-C 118.435 2.754 . . . . 0.0 118.435 -166.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.77 129.56 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 120.82 1.646 . . . . 0.0 108.138 -175.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.4 p -120.18 137.79 53.98 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.367 1.618 . . . . 0.0 115.367 -144.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.899 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 25.1 p -132.82 167.62 19.85 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 123.088 1.423 . . . . 0.0 112.461 153.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.2 m -144.79 123.22 12.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 119.395 -2.066 . . . . 0.0 108.836 167.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -110.36 121.35 45.08 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.464 0.705 . . . . 0.0 110.807 -171.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.3 mm -92.58 118.48 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -118.02 127.47 53.84 Favored 'General case' 0 CA--C 1.569 1.693 0 C-N-CA 123.836 0.855 . . . . 0.0 110.292 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -112.03 144.48 41.31 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -76.51 119.94 21.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 112.946 -174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.7 t -96.16 73.35 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -171.781 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.266 9.7 p . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.01 -37.29 76.55 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 169.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -30.86 56.64 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 164.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.87 -19.97 61.05 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 162.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.254 5.8 pt-20 -91.06 144.85 25.21 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 121.67 2.032 . . . . 0.0 113.688 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.34 -179.5 19.48 Favored Glycine 0 CA--C 1.55 2.239 0 C-N-CA 123.975 0.798 . . . . 0.0 114.187 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.3 ttm-85 -87.35 110.48 20.27 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.424 -1.045 . . . . 0.0 111.072 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -112.72 107.47 16.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.635 -0.665 . . . . 0.0 111.979 -170.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -90.61 129.53 36.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.981 -1.074 . . . . 0.0 113.429 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.1 tp -72.28 121.69 19.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.256 13.0 m -107.8 -57.44 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.686 0.794 . . . . 0.0 112.007 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.7 133.87 48.81 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 119.806 1.184 . . . . 0.0 110.408 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.5 p -119.21 63.94 0.79 Allowed 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 121.615 0.721 . . . . 0.0 112.71 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -60.54 127.59 32.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 0.0 113.494 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.3 21.1 59.33 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 119.993 2.757 . . . . 0.0 119.993 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.14 -41.64 61.23 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 119.115 1.458 . . . . 0.0 114.87 -173.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -49.63 -46.3 49.32 Favored 'General case' 0 CA--C 1.578 2.019 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 163.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -55.86 -49.55 73.02 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 168.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 68.2 t80 -58.05 -48.34 80.38 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 170.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -59.61 -34.03 72.23 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 168.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -58.75 -52.11 67.12 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 163.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -59.11 -44.67 92.0 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.8 mt -50.31 -50.64 50.13 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 162.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.8 49.52 0.58 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 124.143 0.878 . . . . 0.0 115.219 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.1 t -99.14 145.35 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 123.945 0.898 . . . . 0.0 109.461 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.92 -126.31 0.03 OUTLIER Glycine 0 CA--C 1.553 2.426 0 N-CA-C 117.526 1.77 . . . . 0.0 117.526 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.265 9.9 pt -119.1 -61.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.901 -0.764 . . . . 0.0 112.622 -176.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.72 90.75 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.1 mt -66.84 -34.67 78.32 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 170.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -63.87 -47.3 81.24 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 120.256 1.389 . . . . 0.0 114.371 164.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -53.11 -50.58 64.19 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER -59.43 -49.9 76.0 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 170.802 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.41 -41.42 97.02 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.585 2.194 . . . . 0.0 118.585 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.79 -46.32 82.57 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 169.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -77.16 -32.46 56.23 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.805 2.521 . . . . 0.0 117.805 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.51 144.92 55.48 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -110.93 86.37 5.88 Favored Pre-proline 0 CA--C 1.57 1.713 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -73.77 143.34 33.36 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 122.458 2.105 . . . . 0.0 116.182 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -90.87 100.47 13.33 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.951 165.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.8 t -81.86 95.9 7.47 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 122.468 1.127 . . . . 0.0 110.759 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mt -91.33 101.83 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 85.6 mt -94.73 133.25 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -149.1 126.16 11.32 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 119.863 -1.773 . . . . 0.0 110.508 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.3 t -103.52 110.97 23.22 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -171.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.08 76.01 9.37 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-O 122.129 0.966 . . . . 0.0 110.206 162.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.86 -90.23 0.16 Allowed Glycine 0 N--CA 1.493 2.466 0 O-C-N 120.994 -1.066 . . . . 0.0 115.681 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -89.93 -25.89 20.7 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 160.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -88.56 99.83 12.61 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.35 1.432 . . . . 0.0 110.177 -165.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.3 tp -94.35 110.87 22.6 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.398 0.679 . . . . 0.0 110.777 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.6 m -89.62 117.41 28.49 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -111.88 102.13 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -94.25 114.98 27.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.856 -0.527 . . . . 0.0 109.873 171.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 m -97.34 88.69 4.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.212 -0.93 . . . . 0.0 109.767 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -80.98 125.55 30.29 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.876 0.87 . . . . 0.0 112.795 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 t -155.28 153.77 31.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.473 -0.767 . . . . 0.0 110.813 165.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.9 p -57.98 -43.41 86.53 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 171.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.78 -32.46 67.67 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 123.07 7.76 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 119.827 1.194 . . . . 0.0 109.376 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 m -119.17 124.66 47.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.325 -0.859 . . . . 0.0 109.756 168.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 t -146.14 167.72 22.73 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.57 -0.707 . . . . 0.0 112.673 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -142.65 140.15 31.49 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.01 -1.056 . . . . 0.0 112.66 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -135.28 156.27 49.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 168.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 90.9 p -128.93 112.92 14.59 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.742 0.817 . . . . 0.0 111.214 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.508 ' HG ' ' HD1' ' A' ' 73' ' ' PHE . 45.8 t -115.79 132.49 56.62 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -177.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.0 m -82.48 117.34 22.42 Favored 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 123.46 0.704 . . . . 0.0 109.912 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mp -59.7 127.61 32.84 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -168.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.94 -33.91 5.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 116.986 1.555 . . . . 0.0 116.986 -164.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -98.7 165.64 11.7 Favored 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 123.797 1.76 . . . . 0.0 113.386 -172.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -82.57 139.88 33.57 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.183 -1.826 . . . . 0.0 113.154 171.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.508 ' HD1' ' HG ' ' A' ' 67' ' ' CYS . 9.1 p90 -131.21 162.63 29.55 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 121.657 0.741 . . . . 0.0 111.356 166.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.4 112.0 16.21 Favored 'General case' 0 CA--C 1.568 1.66 0 O-C-N 120.474 -1.391 . . . . 0.0 111.403 170.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -103.73 95.3 5.94 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 121.775 0.798 . . . . 0.0 109.683 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.0 m -72.5 104.73 3.92 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.946 0.879 . . . . 0.0 109.994 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 p -73.5 141.19 46.79 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.336 0.655 . . . . 0.0 111.692 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.85 -29.47 28.14 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 119.614 3.19 . . . . 0.0 119.614 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.79 -28.83 58.52 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 167.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.05 -29.93 0.99 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 118.973 2.349 . . . . 0.0 118.973 172.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.7 mtm-85 -70.48 126.55 29.96 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 119.813 1.807 . . . . 0.0 112.975 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -94.91 106.71 18.72 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.497 0.719 . . . . 0.0 110.052 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.3 p -104.56 122.17 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.457 0.646 . . . . 0.0 110.465 -166.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -77.42 98.52 5.3 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.997 0.903 . . . . 0.0 108.898 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.0 m -111.63 109.68 19.7 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -152.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.4 111.95 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 122.802 0.441 . . . . 0.0 110.853 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.1 m -105.31 105.21 15.15 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -119.37 125.18 48.39 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.467 0.707 . . . . 0.0 112.098 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -91.84 130.09 37.68 Favored 'General case' 0 CA--C 1.564 1.496 0 O-C-N 121.604 -0.685 . . . . 0.0 112.086 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 t -145.63 136.69 24.69 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.339 0.655 . . . . 0.0 109.982 167.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 62.18 34.52 16.11 Favored 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 160.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.27 15.88 80.92 Favored Glycine 0 CA--C 1.558 2.728 0 N-CA-C 119.326 2.49 . . . . 0.0 119.326 -165.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.35 125.2 22.58 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-N 118.616 1.208 . . . . 0.0 110.88 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -97.46 110.59 23.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.492 -0.755 . . . . 0.0 110.3 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.7 t -89.29 104.51 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -86.19 97.1 10.16 Favored 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 124.22 1.008 . . . . 0.0 109.019 171.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -92.66 97.26 10.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.055 -1.028 . . . . 0.0 110.754 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -70.0 127.59 33.38 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.441 0.696 . . . . 0.0 111.698 170.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -135.41 111.81 9.83 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 118.627 0.649 . . . . 0.0 109.96 -171.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.4 p90 -151.92 118.28 5.63 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.659 -1.276 . . . . 0.0 112.269 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.1 t70 39.77 55.16 2.51 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 117.807 2.521 . . . . 0.0 117.807 174.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.98 -44.19 3.32 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 117.755 1.862 . . . . 0.0 117.755 -171.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -78.26 144.3 36.3 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.61 147.18 26.45 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 121.719 0.771 . . . . 0.0 112.998 -175.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 t -134.05 127.39 32.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.714 -0.616 . . . . 0.0 112.549 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.1 p -92.29 129.81 38.14 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.858 0.837 . . . . 0.0 110.891 168.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.1 mt -123.07 97.92 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.2 m -92.81 99.98 12.54 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.843 0.83 . . . . 0.0 109.448 -173.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -89.17 100.46 13.24 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.729 0.812 . . . . 0.0 109.204 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.88 142.63 51.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.41 115.89 21.63 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 121.776 0.798 . . . . 0.0 111.379 -172.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -91.68 -178.17 4.99 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-O 122.302 1.049 . . . . 0.0 112.307 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.62 73.18 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.061 0 CA-C-O 123.426 1.584 . . . . 0.0 115.037 167.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.22 28.6 24.82 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 118.996 2.358 . . . . 0.0 118.996 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -165.44 145.22 6.69 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 119.543 1.671 . . . . 0.0 110.374 -171.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.9 tp -89.86 114.89 26.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 119.905 -1.747 . . . . 0.0 109.316 168.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.2 t -96.05 112.87 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -104.98 95.57 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -85.85 102.16 13.46 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.345 1.069 . . . . 0.0 109.554 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.795 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.1 p -115.65 115.42 26.36 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.664 -165.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.58 134.44 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 122.968 0.507 . . . . 0.0 110.119 -169.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.9 ttt -127.19 114.0 17.1 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.275 8.5 m120 66.2 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.273 1.029 . . . . 0.0 113.237 176.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -118.83 -13.02 9.55 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 166.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.9 t -102.3 112.72 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 121.121 1.782 . . . . 0.0 109.843 -157.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 70.1 p -99.43 107.65 19.93 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.373 0.669 . . . . 0.0 112.705 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.795 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 18.4 p -90.11 151.98 21.34 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 121.725 0.774 . . . . 0.0 111.901 160.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.4 m -129.28 109.68 11.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.876 -1.14 . . . . 0.0 108.002 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -103.35 118.8 37.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.917 -0.489 . . . . 0.0 110.356 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.8 mm -102.83 118.16 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -120.18 143.53 48.18 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -117.92 143.64 46.17 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -80.27 113.21 18.28 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.767 -0.583 . . . . 0.0 112.185 -169.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.7 t -97.71 83.38 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--O 1.257 1.448 0 C-N-CA 124.232 1.013 . . . . 0.0 109.49 -175.574 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.543 3.1 p . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.42 58.16 2.56 Favored 'General case' 0 CA--C 1.578 2.054 0 CA-C-O 122.868 1.318 . . . . 0.0 114.27 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -148.6 -40.31 0.16 Allowed 'General case' 0 CA--C 1.572 1.792 0 C-N-CA 125.876 1.67 . . . . 0.0 111.222 172.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.0 -6.22 12.09 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 166.45 15.92 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.59 179.7 18.71 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.191 -0.943 . . . . 0.0 115.21 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.1 ttm105 -94.37 118.31 31.42 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.2 0.6 . . . . 0.0 109.687 173.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -118.85 110.2 16.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.227 -0.92 . . . . 0.0 110.625 -164.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -99.46 129.72 45.67 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.495 -0.753 . . . . 0.0 112.326 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.8 tp -67.43 126.2 28.55 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 m -115.69 -53.16 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -117.04 118.08 31.4 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 119.373 0.988 . . . . 0.0 108.899 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.4 p -112.91 68.17 0.67 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -79.42 124.05 28.09 Favored 'General case' 0 CA--C 1.567 1.617 0 O-C-N 121.48 -0.762 . . . . 0.0 112.868 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.88 -2.37 85.69 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 118.892 2.317 . . . . 0.0 118.892 -169.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.251 13.3 t80 -68.57 -37.68 80.08 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.651 2.225 . . . . 0.0 116.352 -173.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.47 -47.91 81.94 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-N 121.058 1.754 . . . . 0.0 115.03 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.254 7.5 pt-20 -49.14 -48.98 44.3 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 121.645 2.02 . . . . 0.0 116.0 166.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.43 -44.4 89.09 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.637 1.718 . . . . 0.0 115.637 170.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 76.9 mtm -61.25 -43.77 98.33 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -53.15 -51.61 61.44 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 121.166 1.803 . . . . 0.0 115.116 164.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.82 -37.49 84.6 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.99 -37.89 69.72 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 161.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.33 61.28 0.81 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 123.999 0.809 . . . . 0.0 114.176 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -110.97 125.12 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -176.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.57 162.3 50.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.448 ' H ' HD12 ' A' ' 30' ' ' ILE . 1.6 mp -57.54 -44.8 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -171.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.96 90.32 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 168.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.2 mt -67.59 -37.79 83.09 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -57.74 -49.56 76.15 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 165.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -51.82 -52.14 51.36 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 165.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.5 ttp -52.21 -56.14 16.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 170.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.46 -42.52 89.78 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.78 2.272 . . . . 0.0 118.78 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.83 83.89 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 170.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.4 ptm -76.97 -29.71 55.67 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.19 122.99 22.79 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 119.62 1.1 . . . . 0.0 113.77 175.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.34 92.61 11.82 Favored Pre-proline 0 CA--C 1.568 1.657 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.291 170.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.95 142.62 25.26 Favored 'Trans proline' 0 CA--C 1.562 1.892 0 C-N-CA 122.3 2.0 . . . . 0.0 115.034 -174.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.37 100.62 13.17 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.011 0.91 . . . . 0.0 109.292 170.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.8 t -94.15 104.79 16.8 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.431 -0.793 . . . . 0.0 112.815 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 mt -81.1 106.43 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.4 mt -103.96 117.7 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.5 t -119.28 124.37 46.51 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.4 p -120.42 102.72 8.65 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-O 121.613 0.72 . . . . 0.0 112.751 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.15 69.39 10.77 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 121.846 0.832 . . . . 0.0 111.153 171.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.24 -84.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 117.249 1.66 . . . . 0.0 117.249 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -85.86 -23.52 27.07 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 166.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -103.08 107.75 18.67 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.525 1.511 . . . . 0.0 109.966 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 tt -117.15 125.55 51.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.832 -1.168 . . . . 0.0 111.665 -169.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -113.53 125.76 54.56 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.404 0.682 . . . . 0.0 110.574 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.0 mt -110.28 109.03 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -107.22 89.06 2.88 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.02 0.928 . . . . 0.0 109.284 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.2 m -84.71 103.39 13.76 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 124.034 0.934 . . . . 0.0 110.758 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -102.39 124.85 48.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -171.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.3 t -147.23 141.23 25.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.542 0.687 . . . . 0.0 110.413 167.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.4 p -55.29 -29.49 58.29 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 164.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.0 mt -74.42 -48.2 29.11 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 165.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -157.2 108.4 2.33 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 121.022 1.737 . . . . 0.0 112.533 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.3 m -77.35 135.28 38.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.641 -0.662 . . . . 0.0 111.137 164.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -134.61 120.5 19.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.215 -0.928 . . . . 0.0 108.537 170.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -124.74 128.89 49.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 110.865 -173.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -146.99 152.55 38.79 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.1 p -136.36 118.0 14.95 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.852 0.861 . . . . 0.0 111.268 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.6 t -145.44 153.84 41.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.585 1.183 . . . . 0.0 113.308 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -84.81 149.04 25.99 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 122.431 1.11 . . . . 0.0 110.83 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 mp -67.12 115.79 7.21 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.465 -1.397 . . . . 0.0 112.587 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.77 -30.08 11.06 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 117.937 1.935 . . . . 0.0 117.937 -161.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -82.87 150.24 26.65 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 118.653 1.227 . . . . 0.0 112.443 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -109.78 151.31 27.13 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.518 1.152 . . . . 0.0 114.087 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -138.05 167.17 22.35 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.16 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.69 102.91 11.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.947 -1.095 . . . . 0.0 111.101 170.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -92.04 99.6 12.4 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-O 121.912 0.863 . . . . 0.0 109.757 172.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.2 m -78.81 105.1 9.88 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 166.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -65.94 176.16 1.75 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.86 -41.06 31.92 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.62 -44.94 73.19 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 165.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.71 -11.52 5.17 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 -160.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 68.5 mtm-85 -63.27 131.82 49.61 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 121.331 2.565 . . . . 0.0 112.885 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -79.92 112.46 17.23 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.642 0.777 . . . . 0.0 111.125 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.8 p -123.78 124.22 42.22 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.967 0.507 . . . . 0.0 110.35 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -83.39 96.17 8.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.622 -1.299 . . . . 0.0 110.377 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.3 m -96.74 115.62 27.74 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 122.077 -0.39 . . . . 0.0 110.376 -168.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.69 125.1 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.817 -0.552 . . . . 0.0 111.037 169.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.56 117.07 29.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.801 -0.562 . . . . 0.0 111.756 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -131.49 116.12 17.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.233 -0.917 . . . . 0.0 111.138 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -83.82 134.98 34.69 Favored 'General case' 0 CA--C 1.568 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 111.945 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.1 t -135.89 129.61 32.56 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.02 0.528 . . . . 0.0 109.979 162.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.296 4.2 m-20 72.85 -82.64 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 159.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.9 48.61 0.71 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 123.466 0.555 . . . . 0.0 113.984 159.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -154.63 127.2 8.0 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.723 0.809 . . . . 0.0 110.92 -166.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.7 tp -97.14 113.72 25.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.67 -0.644 . . . . 0.0 110.166 171.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.45 101.7 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.682 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -90.53 99.82 12.78 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -101.93 100.3 10.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.551 -0.718 . . . . 0.0 111.76 -164.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.67 132.39 37.01 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.437 0.695 . . . . 0.0 112.841 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -130.72 118.04 20.3 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 123.224 0.61 . . . . 0.0 109.922 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -159.21 142.12 14.28 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.716 -1.24 . . . . 0.0 112.281 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t0 51.62 41.89 29.18 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 161.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.37 27.18 72.18 Favored Glycine 0 CA--C 1.559 2.782 0 N-CA-C 119.5 2.56 . . . . 0.0 119.5 -167.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -142.83 151.84 41.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 118.787 1.294 . . . . 0.0 109.699 -168.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -134.18 155.44 50.12 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.1 t -147.29 131.42 17.33 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.855 0.836 . . . . 0.0 111.773 172.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 p -105.17 113.76 27.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.856 -0.528 . . . . 0.0 109.928 -169.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.1 mm -98.64 101.75 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.7 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.2 m -95.9 98.53 10.48 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.096 -1.002 . . . . 0.0 110.105 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.1 mtp85 -89.06 102.55 15.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.635 0.774 . . . . 0.0 109.429 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -133.77 147.88 51.33 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.49 114.99 22.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.623 -0.673 . . . . 0.0 112.123 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -131.46 110.81 11.28 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.252 20.1 t70 55.76 57.8 4.96 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.67 -8.61 2.23 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 120.071 2.789 . . . . 0.0 120.071 -170.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -113.45 140.55 48.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.745 1.272 . . . . 0.0 110.618 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -83.22 104.42 13.38 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 122.219 1.009 . . . . 0.0 108.573 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 99.3 t -96.05 106.16 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.1 t -95.7 98.67 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -172.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.74 100.7 12.38 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.857 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.794 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.5 p -92.72 144.65 25.09 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.4 p -135.47 136.48 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.611 0.72 . . . . 0.0 110.762 169.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.5 tpt -92.86 -58.43 2.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.48 -0.762 . . . . 0.0 111.94 163.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.256 16.3 p30 -141.71 -90.57 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.004 0.922 . . . . 0.0 108.719 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -90.81 -15.88 29.29 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 153.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.4 t -79.78 129.47 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 CA-C-N 120.044 1.293 . . . . 0.0 109.905 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 61.1 p -137.4 153.59 50.14 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -166.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.794 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 1.9 p -132.92 130.32 39.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.403 -0.811 . . . . 0.0 111.349 163.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.4 m -104.08 101.33 11.09 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -102.99 117.06 33.75 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.141 0.496 . . . . 0.0 111.358 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.1 mm -92.26 120.39 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -113.92 131.02 56.45 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 121.265 0.555 . . . . 0.0 110.865 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -86.6 131.38 34.17 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -74.02 106.27 5.64 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.96 0.886 . . . . 0.0 111.356 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.28 129.24 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -176.083 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.505 2.276 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -56.28 -39.32 72.49 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 159.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -71.12 -30.47 66.54 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 169.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 mt -68.91 -10.22 56.0 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 161.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.87 132.45 34.39 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 120.507 1.503 . . . . 0.0 112.019 -166.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.35 -162.83 20.46 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 115.146 0.818 . . . . 0.0 115.146 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -92.01 130.57 37.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.94 -0.741 . . . . 0.0 112.88 -172.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -134.56 112.23 10.7 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.416 0.687 . . . . 0.0 109.291 -171.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.7 ttp-105 -94.32 133.16 38.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 119.963 -1.711 . . . . 0.0 112.575 173.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.15 131.4 50.7 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.292 16.0 m -130.76 -60.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.637 -0.664 . . . . 0.0 112.201 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.27 106.37 17.17 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 119.601 1.091 . . . . 0.0 109.106 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 p -108.15 68.94 0.71 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -83.17 129.07 34.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.48 2.12 90.38 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 -168.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -70.68 -51.9 24.64 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-N 120.179 1.99 . . . . 0.0 115.856 -169.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -54.38 -39.82 67.56 Favored 'General case' 0 CA--C 1.58 2.096 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 170.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.03 -47.7 77.36 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 164.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -58.42 -51.01 71.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 171.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.347 16.5 ptt? -65.22 -23.74 67.16 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 170.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -59.98 -51.86 67.84 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 154.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -59.21 -43.93 92.28 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 171.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.447 ' HA ' ' SD ' ' A' ' 122' ' ' MET . 83.5 mt -57.2 -44.57 83.77 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 171.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.75 62.15 0.36 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 123.883 0.754 . . . . 0.0 114.388 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.4 t -128.49 127.53 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -166.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.48 164.94 53.83 Favored Glycine 0 CA--C 1.55 2.246 0 N-CA-C 117.611 1.804 . . . . 0.0 117.611 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 30' ' ' ILE . 1.9 mp -53.78 -47.97 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -171.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.11 80.7 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 173.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.98 -38.56 91.51 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 169.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -62.74 -48.18 80.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.513 1.506 . . . . 0.0 114.85 168.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.46 -41.99 77.42 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 168.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -58.69 -59.52 5.27 Favored 'General case' 0 CA--C 1.569 1.673 0 CA-C-N 119.784 1.174 . . . . 0.0 113.869 164.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.96 -39.4 78.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 119.622 2.609 . . . . 0.0 119.622 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.31 86.71 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 171.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -83.96 -29.25 27.19 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 167.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.5 106.96 4.17 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-N 119.744 1.156 . . . . 0.0 113.359 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -105.46 91.81 5.23 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.068 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.33 147.77 18.35 Favored 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.313 2.009 . . . . 0.0 115.887 -171.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 99.61 9.29 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 121.681 0.753 . . . . 0.0 109.166 169.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.5 t -101.9 109.68 21.48 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.976 -1.077 . . . . 0.0 112.84 -167.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mt -97.59 104.42 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -170.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 97.0 mt -85.89 104.87 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.5 p -107.08 117.14 33.28 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.29 0.636 . . . . 0.0 109.813 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -113.49 100.07 8.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.022 -1.049 . . . . 0.0 113.179 -173.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.91 65.16 8.86 Favored 'General case' 0 CA--C 1.575 1.938 0 CA-C-O 122.039 0.923 . . . . 0.0 111.381 166.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.52 -88.49 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 116.6 1.4 . . . . 0.0 116.6 -177.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -81.95 -39.29 23.91 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 169.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -90.43 102.27 15.0 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 120.305 1.411 . . . . 0.0 109.786 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 tt -108.69 111.82 23.81 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 121.621 0.724 . . . . 0.0 109.049 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.7 m -105.88 117.08 33.11 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.558 0.743 . . . . 0.0 109.7 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.1 112.01 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -101.89 94.23 5.7 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.508 0.723 . . . . 0.0 110.871 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.6 m -88.58 103.06 15.55 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.315 0.646 . . . . 0.0 110.682 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -100.52 115.4 30.03 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.7 t -147.31 141.54 26.2 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.528 0.731 . . . . 0.0 110.82 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.2 p -58.81 -32.46 69.39 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 165.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.23 -48.81 64.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 167.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.21 108.07 2.53 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.568 1.531 . . . . 0.0 111.354 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.3 m -91.07 128.19 36.8 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.715 -0.616 . . . . 0.0 110.988 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.5 p -131.55 109.06 9.98 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.431 -0.793 . . . . 0.0 110.772 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -104.98 119.94 40.24 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.27 0.628 . . . . 0.0 110.83 175.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -133.13 143.96 49.6 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.7 p -102.04 113.08 26.0 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.882 0.873 . . . . 0.0 111.631 173.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.8 p -102.95 123.96 47.56 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-O 121.516 0.674 . . . . 0.0 111.382 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 m -81.29 121.42 26.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.195 -0.941 . . . . 0.0 109.065 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -73.0 129.65 38.57 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -164.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.1 -41.48 2.97 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 116.812 1.485 . . . . 0.0 116.812 -160.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -89.33 173.15 8.54 Favored 'General case' 0 CA--C 1.572 1.797 0 C-N-CA 124.798 1.239 . . . . 0.0 113.185 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.54 157.69 21.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -142.82 163.72 32.03 Favored 'General case' 0 CA--C 1.573 1.865 0 C-N-CA 124.723 1.209 . . . . 0.0 111.725 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.33 104.96 11.23 Favored 'General case' 0 CA--C 1.569 1.704 0 O-C-N 120.916 -1.115 . . . . 0.0 111.716 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -99.19 114.73 27.66 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.008 0.923 . . . . 0.0 109.678 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.8 m -93.71 106.94 18.87 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.92 -1.112 . . . . 0.0 108.36 166.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -77.66 157.16 30.3 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -169.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.86 -31.98 63.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 168.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.46 10.41 2.6 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 164.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.09 45.57 10.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.08 1.992 . . . . 0.0 118.08 172.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.3 mtm105 -134.01 130.34 37.44 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 117.998 0.899 . . . . 0.0 109.348 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -90.05 112.14 23.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.968 -0.458 . . . . 0.0 110.077 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.2 p -125.3 134.43 52.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.402 0.681 . . . . 0.0 109.667 -169.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -81.85 99.97 9.33 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 171.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.8 m -107.51 112.39 25.13 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.861 -0.524 . . . . 0.0 110.994 -159.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -88.9 124.37 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 122.961 0.504 . . . . 0.0 111.452 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 19.3 m -108.45 114.07 27.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.73 -0.606 . . . . 0.0 111.887 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -124.17 120.66 32.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.789 -0.569 . . . . 0.0 110.589 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -89.32 119.17 29.55 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 111.609 171.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 t -98.91 156.83 16.69 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 122.974 0.51 . . . . 0.0 110.027 155.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.23 95.82 0.04 OUTLIER 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.01 -16.02 20.76 Favored Glycine 0 CA--C 1.553 2.444 0 N-CA-C 118.421 2.128 . . . . 0.0 118.421 -170.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.57 126.01 15.77 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 120.331 2.066 . . . . 0.0 112.927 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.5 tp -90.88 107.39 19.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 110.059 168.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.8 106.91 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -91.12 100.51 13.34 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.152 0.581 . . . . 0.0 109.537 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -93.52 104.19 16.33 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -104.3 125.25 50.39 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -174.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.84 127.19 51.68 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.68 0.792 . . . . 0.0 111.036 -165.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -153.79 125.67 7.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.425 -1.422 . . . . 0.0 112.248 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.0 t70 49.82 51.02 17.36 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.04 -14.17 6.52 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 119.903 2.721 . . . . 0.0 119.903 -167.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -103.81 152.28 22.08 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 119.138 1.469 . . . . 0.0 111.955 -173.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -143.61 150.72 39.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.7 t -136.76 132.65 35.06 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.349 0.66 . . . . 0.0 111.289 174.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.5 p -91.48 130.36 37.32 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.789 0.804 . . . . 0.0 110.455 169.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 80.2 mt -124.38 98.17 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -98.41 101.79 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.781 -0.574 . . . . 0.0 110.141 -170.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -88.04 98.06 11.31 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 121.79 -0.569 . . . . 0.0 110.149 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.11 145.78 47.84 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -171.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.59 113.29 25.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.0 112.363 -171.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -134.22 115.05 13.71 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.597 -0.689 . . . . 0.0 109.164 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 58.0 58.31 3.65 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 47.16 41.53 15.43 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 118.455 2.142 . . . . 0.0 118.455 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.55 128.77 9.75 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -163.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.63 106.2 17.86 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 122.184 0.993 . . . . 0.0 109.674 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.4 t -95.27 109.0 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.7 t -95.04 100.32 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -93.7 101.19 13.32 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.0 p -120.58 131.49 54.68 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 121.774 0.797 . . . . 0.0 111.991 -163.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.61 140.64 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.464 0.65 . . . . 0.0 110.505 -166.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.447 ' SD ' ' HA ' ' A' ' 26' ' ' LEU . 19.3 ttt -106.09 -74.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.759 -0.588 . . . . 0.0 110.567 171.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -129.5 -65.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.654 0.661 . . . . 0.0 110.937 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -94.79 -44.89 7.56 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.06 0.944 . . . . 0.0 112.639 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.68 120.91 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 CA-C-N 119.248 0.931 . . . . 0.0 110.316 -161.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 39.9 p -102.4 114.5 28.74 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.492 0.717 . . . . 0.0 109.959 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.5 p -98.76 132.86 43.8 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.475 0.71 . . . . 0.0 111.213 171.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.6 m -109.7 104.62 13.65 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -103.68 113.01 26.2 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 122.905 0.482 . . . . 0.0 110.683 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.18 129.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.454 -0.779 . . . . 0.0 109.381 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -118.48 124.39 47.48 Favored 'General case' 0 CA--C 1.571 1.768 0 CA-C-O 121.203 0.525 . . . . 0.0 112.163 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.4 136.49 42.4 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.158 0.983 . . . . 0.0 113.613 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -76.32 116.37 16.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.371 -1.456 . . . . 0.0 111.208 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.36 69.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.209 -0.932 . . . . 0.0 110.84 -171.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.12 -0.987 . . . . 0.0 108.771 -164.138 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p -63.84 -22.89 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . 0.252 6.6 tt0 -67.59 -14.86 63.3 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -35.1 71.06 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 155.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.0 mt -82.9 2.87 32.29 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -92.04 148.57 22.09 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 122.089 2.222 . . . . 0.0 113.634 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.31 178.69 15.61 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.8 ttm105 -85.84 122.88 30.54 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.816 -0.814 . . . . 0.0 110.311 166.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.44 ' CH2' HD21 ' A' ' 111' ' ' LEU . 97.5 m95 -119.66 114.4 22.13 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -172.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -105.07 124.41 49.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.751 0.82 . . . . 0.0 112.83 -163.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.1 tp -66.66 128.63 36.99 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.253 6.1 m -115.6 -69.09 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 C-N-CA 124.148 0.979 . . . . 0.0 109.566 173.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -92.57 149.93 21.05 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 124.439 1.096 . . . . 0.0 112.718 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -152.16 59.3 0.84 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.461 -1.399 . . . . 0.0 114.684 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -72.47 133.01 44.61 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.5 -13.99 53.09 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 118.515 2.166 . . . . 0.0 118.515 -166.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -67.39 -35.14 78.72 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.456 ' CG ' HH12 ' A' ' 33' ' ' ARG . 9.2 t70 -53.28 -54.24 39.14 Favored 'General case' 0 CA--C 1.576 1.942 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 166.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -60.77 -46.71 89.42 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -58.52 -47.08 85.36 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.7 mtm -62.44 -40.66 97.31 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 120.784 1.629 . . . . 0.0 114.945 170.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -47.99 -53.2 16.94 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 161.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -74.78 -33.69 62.3 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.8 mt -46.76 -40.33 13.33 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 118.403 2.742 . . . . 0.0 118.403 158.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.07 67.81 1.01 Allowed Glycine 0 N--CA 1.487 2.063 0 CA-C-N 118.34 0.518 . . . . 0.0 113.423 -161.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.86 123.98 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.45 152.04 52.26 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 115.581 0.992 . . . . 0.0 115.581 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 pt -53.48 -44.3 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 117.911 2.559 . . . . 0.0 117.911 -172.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.05 -42.93 86.48 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 166.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.56 -39.6 94.04 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.527 HH11 ' HB3' ' A' ' 33' ' ' ARG . 13.9 mtm105 -59.32 -47.78 84.12 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 168.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -56.81 -51.99 66.8 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 168.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.9 ttp -46.84 -61.16 1.98 Allowed 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.06 -41.91 79.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 118.904 2.322 . . . . 0.0 118.904 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.51 -51.9 51.71 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 169.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.8 ptm -74.0 -31.65 63.04 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.37 -25.1 63.95 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 119.284 3.068 . . . . 0.0 119.284 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.65 67.4 1.55 Allowed Pre-proline 0 CA--C 1.581 2.172 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -66.69 142.41 63.86 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 N-CA-C 119.329 2.78 . . . . 0.0 119.329 -170.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.7 113.5 26.01 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.127 165.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 51.6 t -92.0 110.62 21.99 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.933 0.893 . . . . 0.0 111.261 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.36 110.24 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 87.8 mt -102.4 129.31 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.1 m -150.99 127.04 10.44 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.658 -1.276 . . . . 0.0 110.294 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.6 t -102.14 130.06 48.66 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -82.0 -56.26 4.06 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.733 -0.604 . . . . 0.0 111.993 159.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.71 -84.72 0.05 OUTLIER Glycine 0 N--CA 1.485 1.947 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -83.2 -37.45 23.61 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 161.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -74.65 104.39 5.31 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 121.095 1.771 . . . . 0.0 111.505 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 32.5 tp -99.84 111.9 24.19 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.79 0.836 . . . . 0.0 109.1 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.5 m -81.78 115.87 21.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.786 -0.571 . . . . 0.0 110.401 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.1 mt -119.05 106.2 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.646 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -98.29 127.4 44.21 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.106 0.563 . . . . 0.0 110.658 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -99.27 97.81 8.84 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -89.29 97.2 11.06 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.251 0.62 . . . . 0.0 109.905 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 p -104.32 150.8 24.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.302 -0.874 . . . . 0.0 111.815 171.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.6 p -78.08 49.24 0.79 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 179.72 -61.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.288 1.435 . . . . 0.0 109.404 -164.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -131.04 168.69 16.97 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.356 1.074 . . . . 0.0 111.598 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.4 m -149.62 149.23 30.35 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 119.422 -2.049 . . . . 0.0 110.743 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.9 m -152.95 139.5 18.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.558 -1.338 . . . . 0.0 109.685 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -134.48 131.51 38.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.446 -0.784 . . . . 0.0 110.428 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -147.85 144.78 28.37 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.257 0.551 . . . . 0.0 112.393 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.9 p -99.95 103.05 14.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.374 -0.829 . . . . 0.0 110.635 170.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 52' ' ' LEU . 28.4 p -85.71 124.67 32.49 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -79.41 108.25 12.79 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.618 0.723 . . . . 0.0 110.532 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.3 tp -81.3 119.56 23.81 Favored 'General case' 0 CA--C 1.563 1.444 0 O-C-N 121.591 -0.693 . . . . 0.0 112.543 -167.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.85 50.62 18.11 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 115.228 0.851 . . . . 0.0 115.228 -159.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.48 160.82 0.79 Allowed 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.736 1.615 . . . . 0.0 109.139 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -93.08 153.37 18.73 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 168.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -142.04 161.72 37.27 Favored 'General case' 0 CA--C 1.572 1.792 0 C-N-CA 124.174 0.989 . . . . 0.0 110.286 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -81.58 106.91 13.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.097 -1.627 . . . . 0.0 110.505 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -83.31 144.9 29.39 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 122.685 1.231 . . . . 0.0 111.062 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.8 m -113.05 120.45 41.39 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 162.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 78.1 p -68.22 154.1 42.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.07 -29.06 60.0 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 167.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -68.69 -47.89 65.3 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.89 -33.15 1.53 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 117.337 1.695 . . . . 0.0 117.337 -165.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -63.5 141.19 58.86 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 119.485 1.643 . . . . 0.0 112.923 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -110.58 131.02 55.41 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.166 0.586 . . . . 0.0 109.897 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.1 p -128.5 136.54 50.94 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.551 0.691 . . . . 0.0 111.191 -165.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -83.7 102.74 12.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.586 -1.321 . . . . 0.0 109.729 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.5 m -112.08 109.74 19.64 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.658 -0.651 . . . . 0.0 110.752 -158.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.1 p -86.86 120.92 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 122.714 0.406 . . . . 0.0 111.181 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.4 m -108.77 122.66 47.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -132.95 126.54 32.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.515 -0.741 . . . . 0.0 111.723 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -91.88 112.43 24.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.739 -0.6 . . . . 0.0 110.488 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -102.79 86.79 2.81 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.974 0.51 . . . . 0.0 110.643 171.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.265 12.1 t70 25.4 70.8 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.868 2.914 . . . . 0.0 118.868 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.71 -44.49 1.31 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 -168.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.63 119.93 37.73 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 118.448 1.124 . . . . 0.0 113.556 -172.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.46 107.06 18.92 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.553 0.741 . . . . 0.0 111.136 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.91 109.97 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -94.46 106.37 18.35 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 170.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -100.29 104.95 16.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.722 -0.611 . . . . 0.0 111.403 -171.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -99.6 107.31 19.42 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.459 0.703 . . . . 0.0 111.438 -162.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -102.12 121.33 41.99 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.914 0.779 . . . . 0.0 111.923 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -148.76 129.84 14.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.006 -1.059 . . . . 0.0 110.881 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 52.54 41.11 30.95 Favored 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.56 32.24 82.59 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 119.026 2.37 . . . . 0.0 119.026 -165.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -136.09 124.1 22.85 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 118.371 1.086 . . . . 0.0 108.154 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.44 142.48 32.76 Favored 'General case' 0 CA--C 1.563 1.481 0 CA-C-O 121.878 0.847 . . . . 0.0 112.256 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.9 t -125.13 130.6 52.53 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.941 0.877 . . . . 0.0 109.889 159.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.6 p -113.09 107.95 16.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.3 mm -104.7 102.06 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.011 -1.056 . . . . 0.0 108.686 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 m -97.2 96.25 8.3 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.22 0.918 . . . . 0.0 109.916 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -87.27 110.2 20.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.561 -0.712 . . . . 0.0 110.501 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -134.58 146.14 49.34 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.555 1.07 . . . . 0.0 113.646 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.44 HD21 ' CH2' ' A' ' 11' ' ' TRP . 0.2 OUTLIER -87.43 114.84 24.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.559 -0.713 . . . . 0.0 112.241 -169.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -131.72 113.47 13.59 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.598 0.759 . . . . 0.0 108.995 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.263 35.4 t70 60.57 34.47 20.25 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.47 9.43 61.43 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 119.123 2.409 . . . . 0.0 119.123 -165.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -109.13 143.41 38.54 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 119.26 1.53 . . . . 0.0 108.812 172.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.4 tp -84.03 102.32 12.4 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.808 0.814 . . . . 0.0 108.897 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.7 t -96.31 112.53 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.24 95.94 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -172.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -93.62 94.75 8.79 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.243 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.0 OUTLIER -92.11 148.5 22.12 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 121.36 -0.837 . . . . 0.0 112.025 177.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.3 128.65 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.54 0.686 . . . . 0.0 110.288 166.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.1 tpt -69.0 -65.87 0.65 Allowed 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 123.422 0.689 . . . . 0.0 112.298 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.251 15.5 p30 -143.67 -73.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -86.78 -38.64 16.69 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 159.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.1 t -85.99 128.33 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 119.921 1.237 . . . . 0.0 111.067 -163.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 66.3 p -110.04 156.59 20.32 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.492 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 2.3 p -131.99 133.55 44.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.011 -1.056 . . . . 0.0 111.161 156.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.4 m -109.47 98.0 7.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -102.67 120.76 41.12 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.207 0.603 . . . . 0.0 111.603 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.93 125.12 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -119.75 125.66 49.16 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 123.43 0.692 . . . . 0.0 110.498 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -93.3 143.65 26.06 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -74.82 120.16 19.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.535 -1.353 . . . . 0.0 113.498 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.67 89.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 124.353 1.061 . . . . 0.0 109.657 171.414 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.1 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p -67.95 -31.26 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 166.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.28 -34.16 76.04 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 161.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -66.12 -27.22 67.88 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.3 mt -70.21 -2.4 13.1 Favored 'General case' 0 CA--C 1.581 2.142 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -68.71 138.5 54.97 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 121.054 1.752 . . . . 0.0 114.541 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.33 -178.64 18.25 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 115.814 1.086 . . . . 0.0 115.814 168.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -89.64 125.56 35.29 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.678 -0.761 . . . . 0.0 109.857 169.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -121.1 109.62 15.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.667 -0.646 . . . . 0.0 109.599 -168.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.5 ttm105 -91.64 127.48 37.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.677 -1.264 . . . . 0.0 113.207 -176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.21 126.49 27.56 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.293 9.3 m -110.73 -72.22 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 123.484 0.714 . . . . 0.0 109.158 173.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -87.05 143.58 27.26 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 119.093 0.86 . . . . 0.0 111.785 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.2 p -139.18 65.35 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.334 162.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -72.16 128.02 34.36 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.3 2.12 86.99 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 119.294 2.478 . . . . 0.0 119.294 -169.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -69.79 -48.7 58.21 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -169.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -55.4 -43.3 75.11 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -64.2 -35.99 82.59 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 164.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 59.6 t80 -61.2 -50.78 71.74 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 120.884 1.675 . . . . 0.0 114.499 169.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.9 ptm -61.76 -37.23 83.52 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -50.48 -48.64 56.7 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 158.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.52 -39.94 95.73 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.38 -42.01 77.19 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 163.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.86 69.83 0.45 Allowed Glycine 0 N--CA 1.487 2.039 0 C-N-CA 124.249 0.928 . . . . 0.0 113.029 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.64 126.06 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -171.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.53 164.5 52.23 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 pt -53.73 -47.38 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 118.315 2.709 . . . . 0.0 118.315 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.63 98.34 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 172.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.97 -39.61 93.74 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 167.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -60.15 -49.92 75.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -51.94 -52.15 52.14 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 167.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -53.9 -55.19 29.15 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.98 99.38 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 118.799 2.279 . . . . 0.0 118.799 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.31 83.22 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.0 ptm -71.33 -26.05 62.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.89 127.27 31.38 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.82 77.05 4.52 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 118.224 -0.893 . . . . 0.0 109.525 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.88 140.55 20.58 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.283 1.989 . . . . 0.0 116.617 -167.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.11 91.32 8.67 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.882 162.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -90.05 115.09 27.06 Favored 'General case' 0 CA--C 1.559 1.325 0 O-C-N 120.804 -1.185 . . . . 0.0 112.444 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -92.17 118.7 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 109.406 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.7 mt -105.75 122.31 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m -140.42 134.12 30.34 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.396 0.617 . . . . 0.0 111.512 163.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.5 p -107.44 141.8 38.27 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . 0.268 17.0 t70 -101.37 -116.72 0.18 Allowed 'General case' 0 CA--C 1.578 2.047 0 C-N-CA 123.743 0.817 . . . . 0.0 108.798 166.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.19 -83.98 1.3 Allowed Glycine 0 N--CA 1.492 2.38 0 CA-C-N 120.516 1.507 . . . . 0.0 112.873 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -85.65 -37.7 19.19 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 160.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -72.58 117.16 13.91 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.511 1.505 . . . . 0.0 112.901 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 tt -123.6 118.32 27.04 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.925 0.89 . . . . 0.0 108.718 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.9 m -94.47 123.64 38.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.709 -0.62 . . . . 0.0 110.373 -170.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.8 mt -116.8 106.26 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -109.71 117.83 34.94 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.091 0.556 . . . . 0.0 111.039 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 m -85.94 109.48 18.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.397 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -98.79 92.11 5.41 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.822 1.192 . . . . 0.0 110.912 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -126.96 139.32 53.13 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.906 0.882 . . . . 0.0 110.21 166.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 p -76.86 49.8 0.67 Allowed 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 172.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.7 mt -150.48 -52.01 0.14 Allowed 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 126.231 1.812 . . . . 0.0 109.296 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -153.91 115.78 4.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.143 1.338 . . . . 0.0 110.923 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.6 p -97.42 92.22 5.85 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.293 0.637 . . . . 0.0 110.865 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.0 m -89.11 117.63 28.24 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.042 0.925 . . . . 0.0 108.9 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.21 141.76 50.62 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.8 0.84 . . . . 0.0 111.923 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -156.26 145.31 20.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.567 -0.708 . . . . 0.0 112.734 -174.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.5 p -101.35 108.12 19.65 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.344 0.658 . . . . 0.0 110.093 167.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.1 p -92.47 131.16 37.85 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.65 -0.656 . . . . 0.0 112.367 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.04 122.99 26.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.897 -1.127 . . . . 0.0 110.673 168.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.4 tp -75.91 129.85 37.59 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.56 0.744 . . . . 0.0 112.62 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.44 -28.18 5.92 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 117.606 1.802 . . . . 0.0 117.606 -159.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -105.25 158.34 16.68 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 119.418 1.609 . . . . 0.0 112.908 -166.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -95.65 116.27 28.62 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.914 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -126.96 148.1 50.08 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 124.014 0.926 . . . . 0.0 110.988 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -82.05 101.69 10.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.2 -1.563 . . . . 0.0 113.499 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -88.63 120.42 30.01 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-O 121.973 0.892 . . . . 0.0 110.691 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.8 m -89.43 96.47 10.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.33 -0.856 . . . . 0.0 110.077 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.6 p -69.42 158.13 35.74 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.87 -36.91 12.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 119.529 3.159 . . . . 0.0 119.529 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.3 -36.93 82.51 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 170.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.76 -10.48 9.0 Favored Glycine 0 CA--C 1.552 2.356 0 N-CA-C 118.03 1.972 . . . . 0.0 118.03 -159.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -71.7 115.61 11.1 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 121.085 2.443 . . . . 0.0 110.204 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -87.92 108.6 19.26 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.663 0.744 . . . . 0.0 109.567 172.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.9 p -106.81 111.78 24.45 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.684 0.754 . . . . 0.0 109.609 -166.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -69.12 101.84 1.53 Allowed 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 122.483 1.135 . . . . 0.0 109.807 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.2 m -112.84 112.46 23.96 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -156.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.329 10.4 p -81.36 113.38 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-N 118.996 0.816 . . . . 0.0 110.013 168.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 64.0 m -96.79 109.93 22.51 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 120.58 0.229 . . . . 0.0 110.583 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -133.43 121.42 22.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.549 -0.719 . . . . 0.0 112.006 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -87.59 137.21 32.54 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 121.493 -0.754 . . . . 0.0 112.997 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.0 t -137.75 113.13 9.37 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.384 0.674 . . . . 0.0 111.05 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.322 22.4 t70 66.9 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 171.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.95 43.26 1.28 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 166.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.87 118.33 6.49 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.554 0.741 . . . . 0.0 111.077 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.7 tp -90.23 109.75 20.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 110.089 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.21 108.12 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -86.94 94.17 9.53 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -91.85 97.87 11.25 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.61 -0.681 . . . . 0.0 109.925 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -87.5 116.74 25.81 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.219 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.45 125.68 45.38 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.559 1.072 . . . . 0.0 110.622 -176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -144.54 120.23 10.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.558 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 63.23 14.96 8.2 Favored 'General case' 0 CA--C 1.587 2.368 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.1 -14.64 26.29 Favored Glycine 0 CA--C 1.559 2.833 0 N-CA-C 118.947 2.339 . . . . 0.0 118.947 -156.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -77.33 129.55 35.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.188 1.494 . . . . 0.0 109.056 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -140.85 147.98 39.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -173.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 t -118.61 138.28 52.69 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 122.294 1.045 . . . . 0.0 111.759 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.7 p -110.61 112.5 24.43 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 76.0 mt -120.79 98.17 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -167.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 55.3 m -94.25 101.72 13.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.74 -0.6 . . . . 0.0 110.037 -173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -87.66 96.46 10.43 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 123.397 0.679 . . . . 0.0 110.188 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -127.86 149.52 50.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -172.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.9 123.03 45.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 112.343 -158.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.03 121.94 27.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.74 -0.6 . . . . 0.0 109.492 171.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 58.93 44.49 16.46 Favored 'General case' 0 N--CA 1.509 2.495 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 165.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.57 35.71 74.48 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -163.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -137.67 127.77 25.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 tp -88.15 106.82 18.43 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-O 121.996 0.903 . . . . 0.0 109.287 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.4 t -98.16 106.94 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.51 98.03 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -170.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -91.93 113.12 25.3 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.713 0.805 . . . . 0.0 109.399 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.6 p -126.73 122.1 33.89 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.654 0.781 . . . . 0.0 111.739 -162.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.39 136.95 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.498 -0.751 . . . . 0.0 110.003 -175.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.5 ttt -89.58 -76.73 0.41 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 120.634 0.254 . . . . 0.0 110.59 168.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -140.11 -62.93 0.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.11 0.964 . . . . 0.0 110.247 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -79.36 -54.82 5.57 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 125.015 1.326 . . . . 0.0 113.827 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.78 123.91 49.31 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-N 119.783 1.174 . . . . 0.0 110.984 -164.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.3 p -102.15 114.09 27.92 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.864 0.865 . . . . 0.0 110.496 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 13.4 p -100.45 157.26 16.76 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 122.113 0.958 . . . . 0.0 113.174 170.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.4 m -130.43 118.03 20.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.832 -1.168 . . . . 0.0 109.223 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -107.42 111.76 24.23 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.15 0.58 . . . . 0.0 109.843 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.1 mm -96.47 123.65 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -120.35 127.86 52.71 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 121.939 -0.475 . . . . 0.0 111.467 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -85.14 141.28 30.31 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -75.97 121.04 22.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.296 -0.877 . . . . 0.0 113.065 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.42 99.16 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.272 -173.134 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.4 p . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.948 -0.548 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.26 9.9 p -77.88 39.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 CA-C-N 120.102 1.319 . . . . 0.0 114.136 171.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -113.56 -47.16 3.01 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.848 1.659 . . . . 0.0 111.778 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -58.89 -29.32 66.94 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 171.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.8 mt -66.78 -13.14 61.12 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 164.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -74.22 136.14 42.74 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 120.743 1.61 . . . . 0.0 112.689 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.09 -179.37 25.95 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 117.956 1.942 . . . . 0.0 117.956 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -92.16 116.43 28.93 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.316 -0.942 . . . . 0.0 110.196 169.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -123.88 108.63 12.66 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.794 0.438 . . . . 0.0 109.885 -166.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -94.83 129.57 41.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.419 -1.426 . . . . 0.0 114.078 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.4 tp -63.85 124.82 22.51 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.273 11.0 m -113.09 -65.97 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.938 0.895 . . . . 0.0 110.781 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -101.21 148.15 25.44 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.497 1.498 . . . . 0.0 111.533 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.2 p -133.63 83.08 2.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.662 -0.649 . . . . 0.0 110.615 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.35 96.96 10.81 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.269 0.557 . . . . 0.0 110.452 -166.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.67 10.79 56.34 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 118.914 2.326 . . . . 0.0 118.914 -169.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -71.44 -47.38 56.14 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -170.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -55.96 -43.94 78.01 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -53.64 -47.0 70.71 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 167.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.436 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 67.9 t80 -53.35 -54.58 34.52 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 166.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.285 3.1 ptt? -69.38 -27.39 65.27 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 174.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -54.17 -52.02 62.49 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 154.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -60.9 -38.75 86.8 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -52.5 -52.52 54.08 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.17 -1.581 . . . . 0.0 115.178 163.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.55 69.58 0.72 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 124.403 1.001 . . . . 0.0 112.467 -169.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.1 t -127.57 130.52 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.92 164.39 49.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 117.418 1.727 . . . . 0.0 117.418 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -56.54 -47.46 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.87 94.86 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -67.31 -40.1 85.97 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -57.15 -46.49 82.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 163.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -55.97 -48.51 75.68 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 167.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 46.2 mtp -73.59 51.28 0.35 Allowed 'General case' 0 CA--C 1.583 2.232 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 165.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.69 -61.55 0.04 OUTLIER Glycine 0 N--CA 1.485 1.926 0 O-C-N 121.037 -1.039 . . . . 0.0 111.63 -171.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.5 -47.89 80.71 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 23.1 ptp -95.31 -6.8 40.41 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.82 110.99 16.86 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 120.365 1.439 . . . . 0.0 111.041 168.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -110.17 93.22 14.91 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.871 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.03 156.42 13.23 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.35 2.033 . . . . 0.0 116.811 -167.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.27 97.04 8.08 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.685 161.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.3 t -86.46 107.17 17.95 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 121.116 -0.99 . . . . 0.0 111.928 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.6 mt -91.81 106.51 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.5 mt -96.49 110.08 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -110.47 123.8 50.59 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 122.862 0.465 . . . . 0.0 110.303 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.7 p -116.57 94.3 4.56 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.558 0.743 . . . . 0.0 112.561 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -91.12 74.64 6.28 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 122.306 1.05 . . . . 0.0 110.697 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.17 -84.33 0.12 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 116.47 1.348 . . . . 0.0 116.47 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -101.42 -46.33 5.03 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -76.56 116.06 16.89 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-N 119.213 0.915 . . . . 0.0 112.019 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.4 tt -132.09 112.79 12.64 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.481 0.712 . . . . 0.0 109.577 -161.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.3 m -104.58 126.21 51.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.597 -1.314 . . . . 0.0 111.366 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -113.2 101.18 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.02 105.82 16.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.171 0.988 . . . . 0.0 109.611 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.2 m -97.45 106.47 18.8 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.834 0.854 . . . . 0.0 110.791 -171.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -104.93 98.66 8.34 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 122.924 0.489 . . . . 0.0 111.179 -167.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p -128.66 144.82 51.24 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.235 -0.916 . . . . 0.0 111.647 166.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -62.51 -44.77 95.55 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.9 mt -57.16 -43.57 82.65 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 165.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -155.29 125.33 6.63 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 119.348 0.976 . . . . 0.0 111.002 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.9 m -111.41 141.8 44.49 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.771 0.828 . . . . 0.0 110.251 173.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.4 t -144.7 158.46 43.77 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.824 0.821 . . . . 0.0 112.574 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -142.49 125.41 16.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.679 -1.263 . . . . 0.0 110.016 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -118.43 143.01 46.99 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.52 0.676 . . . . 0.0 111.126 163.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.1 m -112.18 110.99 21.56 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.104 0.954 . . . . 0.0 109.999 174.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.5 t -89.5 157.96 17.88 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.862 1.265 . . . . 0.0 114.02 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.4 m -113.86 119.8 38.55 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 159.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.6 tp -70.62 132.03 44.83 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 123.856 0.862 . . . . 0.0 112.849 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.25 -53.09 1.58 Allowed Glycine 0 N--CA 1.49 2.288 0 O-C-N 121.198 -0.939 . . . . 0.0 114.503 -161.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.99 163.47 15.53 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 124.023 1.868 . . . . 0.0 114.139 -169.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -88.74 108.79 19.68 Favored 'General case' 0 CA--C 1.564 1.489 0 CA-C-N 112.445 -2.161 . . . . 0.0 110.147 169.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -103.12 175.9 5.32 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.855 0.836 . . . . 0.0 112.695 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -92.38 107.04 18.92 Favored 'General case' 0 CA--C 1.568 1.646 0 O-C-N 120.725 -1.234 . . . . 0.0 111.338 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -79.16 129.1 34.11 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 110.094 163.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.8 m -107.51 110.99 23.05 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 165.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.6 p -72.98 162.29 29.67 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.89 -43.83 59.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 167.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.2 -36.09 83.11 Favored 'General case' 0 CA--C 1.573 1.847 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 169.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.73 26.94 1.5 Allowed Glycine 0 CA--C 1.551 2.297 0 N-CA-C 118.09 1.996 . . . . 0.0 118.09 -176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -90.74 140.57 29.66 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.038 1.919 . . . . 0.0 110.94 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -93.3 109.26 20.8 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 162.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . 0.268 0.9 OUTLIER -113.9 119.83 38.62 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.704 0.684 . . . . 0.0 110.383 -179.11 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -73.2 99.54 2.87 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-O 122.087 0.946 . . . . 0.0 110.671 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.9 m -110.07 106.74 16.35 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.199 -0.938 . . . . 0.0 109.872 -156.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.276 7.2 p -88.83 118.56 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.827 -0.546 . . . . 0.0 110.719 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.26 123.62 48.33 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -131.71 131.01 42.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.501 -0.749 . . . . 0.0 111.344 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -85.54 133.69 34.06 Favored 'General case' 0 CA--C 1.569 1.711 0 O-C-N 121.384 -0.823 . . . . 0.0 112.084 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -132.5 131.4 41.59 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.103 0.561 . . . . 0.0 110.342 164.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.277 4.1 m-20 71.74 -86.72 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 161.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.04 52.27 0.64 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 123.439 0.542 . . . . 0.0 113.022 160.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -156.03 124.2 5.75 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.904 0.882 . . . . 0.0 111.086 -164.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.7 tp -95.46 110.69 22.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.588 -0.695 . . . . 0.0 110.207 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.8 t -91.87 105.87 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -99.92 106.98 18.85 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 124.306 1.042 . . . . 0.0 109.466 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -97.45 102.0 13.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.489 -0.757 . . . . 0.0 111.358 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -83.43 125.59 31.86 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 124.768 1.227 . . . . 0.0 111.163 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.15 117.3 21.34 Favored 'General case' 0 CA--C 1.573 1.855 0 CA-C-N 119.459 1.027 . . . . 0.0 111.001 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -165.0 149.14 8.84 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.248 -0.908 . . . . 0.0 112.339 -171.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 48.55 41.94 18.09 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 158.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.8 30.11 71.96 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 119.55 2.58 . . . . 0.0 119.55 -166.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -142.32 138.53 31.34 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.439 1.095 . . . . 0.0 109.394 -166.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -129.81 126.84 39.04 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 121.491 0.662 . . . . 0.0 111.76 171.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.3 t -120.67 119.06 31.74 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.924 0.89 . . . . 0.0 109.572 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 71.6 p -93.01 128.29 38.83 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.184 0.594 . . . . 0.0 110.258 172.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.9 mm -112.93 116.55 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 169.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.4 m -99.79 98.54 9.34 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.43 -0.794 . . . . 0.0 109.046 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -90.84 99.12 12.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.22 147.52 50.58 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -163.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.97 121.46 31.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 112.64 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.328 40.2 mttt -106.16 -113.75 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.315 0.646 . . . . 0.0 109.92 169.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -84.85 51.85 2.26 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -168.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.95 31.76 79.0 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 117.516 1.766 . . . . 0.0 117.516 -156.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -137.27 135.0 36.76 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -169.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 tp -85.93 104.41 15.54 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.434 1.112 . . . . 0.0 108.957 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 87.1 t -99.99 109.42 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.7 t -102.98 106.62 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -116.62 99.16 6.95 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -164.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.8 p -93.31 157.12 16.4 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.57 130.41 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.852 -0.53 . . . . 0.0 109.986 158.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 4.9 ttt -102.81 -102.47 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -106.31 85.12 2.13 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.272 49.8 m-80 75.6 -43.19 0.49 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -169.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.4 t -82.29 123.43 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 111.193 -163.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.2 p -109.65 138.98 45.23 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.775 0.83 . . . . 0.0 112.539 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 11.1 p -127.37 117.4 22.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 169.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.1 m -93.98 105.99 17.98 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 168.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -116.52 129.73 56.36 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 122.044 0.926 . . . . 0.0 111.843 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 24.3 mm -104.38 126.34 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 124.273 1.029 . . . . 0.0 109.299 -159.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -123.08 126.35 46.91 Favored 'General case' 0 CA--C 1.577 1.995 0 O-C-N 121.68 -0.637 . . . . 0.0 112.172 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -87.3 139.96 30.03 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -74.69 118.27 17.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 112.136 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.82 61.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.771 -0.58 . . . . 0.0 110.115 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.029 -1.045 . . . . 0.0 109.03 -158.276 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 119.045 -0.502 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.257 9.0 p -67.33 -33.75 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 161.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -52.55 -28.19 19.79 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 167.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -51.69 -39.69 58.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.92 -6.11 42.97 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 171.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -90.74 135.53 33.66 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 121.213 1.824 . . . . 0.0 112.483 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.01 -176.19 29.64 Favored Glycine 0 N--CA 1.485 1.912 0 CA-C-O 122.642 1.134 . . . . 0.0 114.503 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -94.32 119.33 32.92 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.985 -0.608 . . . . 0.0 109.541 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -121.07 118.11 28.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 122.085 -0.385 . . . . 0.0 110.977 -166.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -105.91 126.45 52.19 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.287 -0.883 . . . . 0.0 112.908 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.03 124.56 24.68 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.714 0.769 . . . . 0.0 112.939 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.45 -55.51 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 124.117 0.967 . . . . 0.0 112.229 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -110.12 99.13 8.26 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 119.186 0.903 . . . . 0.0 109.173 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.0 p -113.87 95.68 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.081 0.953 . . . . 0.0 111.887 -174.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -107.41 123.41 48.35 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.139 -0.976 . . . . 0.0 111.736 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.76 66.34 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 119.657 2.623 . . . . 0.0 119.657 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -79.55 -41.2 27.75 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 120.29 2.045 . . . . 0.0 115.671 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.19 -43.23 74.2 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 120.443 1.474 . . . . 0.0 114.594 160.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.71 -47.97 82.73 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -51.27 -55.59 17.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 165.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -61.39 -23.5 65.84 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 171.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -64.53 -46.77 81.43 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 160.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -61.7 -37.59 84.71 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 121.615 2.007 . . . . 0.0 115.116 167.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.65 -51.75 67.52 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 164.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.54 72.33 1.05 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.428 -0.795 . . . . 0.0 112.538 -168.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.9 t -119.83 136.96 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.94 153.12 50.55 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 116.874 1.51 . . . . 0.0 116.874 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 30' ' ' ILE . 2.3 mp -59.11 -48.59 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -168.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.54 88.64 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 167.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.17 -45.98 91.25 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 170.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -61.97 -45.07 95.25 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 167.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -55.34 -42.55 74.0 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 74.4 mtm -62.3 -44.96 95.3 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 165.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -48.54 58.29 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.521 2.168 . . . . 0.0 118.521 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.65 -47.37 86.55 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -85.86 10.27 14.32 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.38 35.29 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 120.463 -1.398 . . . . 0.0 113.65 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -109.42 74.77 0.69 Allowed Pre-proline 0 CA--C 1.575 1.94 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.849 167.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.46 158.22 48.23 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.723 2.282 . . . . 0.0 115.913 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.05 98.24 10.3 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 162.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.2 t -88.84 101.62 14.22 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 122.063 0.935 . . . . 0.0 110.61 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -93.56 113.71 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -113.68 125.08 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -152.17 133.95 14.78 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.778 -1.202 . . . . 0.0 109.5 171.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.7 p -100.41 123.9 45.23 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -82.62 74.9 9.55 Favored 'General case' 0 CA--C 1.576 1.943 0 CA-C-O 122.309 1.052 . . . . 0.0 110.18 162.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.63 -89.04 0.08 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -88.49 -29.06 20.41 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 163.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -81.35 88.3 6.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 121.713 2.052 . . . . 0.0 111.841 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.34 109.45 16.6 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-O 122.125 0.964 . . . . 0.0 110.108 -173.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.1 m -101.33 113.35 26.34 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.332 -162.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.7 mt -111.49 113.1 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -110.77 105.34 14.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.823 -0.548 . . . . 0.0 109.881 170.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.0 m -90.95 101.29 14.05 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.557 0.743 . . . . 0.0 109.204 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -94.25 117.92 30.82 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.622 0.769 . . . . 0.0 111.779 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.9 t -154.49 139.47 17.31 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.704 0.801 . . . . 0.0 111.852 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.4 p -60.53 -34.56 74.29 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 165.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.8 -55.18 18.52 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-N 119.486 1.039 . . . . 0.0 113.671 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.54 110.45 3.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.606 -1.309 . . . . 0.0 111.636 167.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.6 m -80.75 146.32 31.07 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.963 0.887 . . . . 0.0 111.287 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.5 m -155.55 136.61 13.74 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.299 -1.501 . . . . 0.0 109.594 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -142.32 146.32 34.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -158.42 150.87 21.97 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.9 p -108.28 107.43 18.02 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.5 0.72 . . . . 0.0 110.943 169.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.0 p -99.07 115.29 28.65 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.588 0.708 . . . . 0.0 112.698 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.9 m -72.47 110.58 6.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.468 -0.77 . . . . 0.0 110.392 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.5 tp -71.05 110.31 5.66 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -162.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.12 -54.32 0.75 Allowed Glycine 0 CA--C 1.547 2.089 0 C-N-CA 123.594 0.616 . . . . 0.0 114.107 -159.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.91 -177.78 4.0 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 123.712 1.72 . . . . 0.0 113.579 -169.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -99.7 130.45 45.92 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 113.857 -1.52 . . . . 0.0 112.6 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -123.06 -175.8 3.26 Favored 'General case' 0 CA--C 1.578 2.032 0 C-N-CA 125.168 1.387 . . . . 0.0 111.45 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -109.73 119.51 39.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.322 -1.486 . . . . 0.0 111.221 165.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -81.36 131.88 35.31 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 121.368 -0.832 . . . . 0.0 109.051 158.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.0 m -100.7 107.12 18.65 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 167.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.6 p -70.48 162.3 29.0 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.77 -31.91 59.33 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 166.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.17 -47.99 80.29 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.95 57.19 0.25 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 124.104 0.859 . . . . 0.0 113.903 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -131.31 124.32 30.18 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -173.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.53 109.58 17.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.679 -0.638 . . . . 0.0 110.115 171.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.4 p -116.14 112.67 22.03 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.372 0.606 . . . . 0.0 111.018 -169.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -70.82 101.18 2.06 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.279 1.038 . . . . 0.0 110.937 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.8 m -122.71 122.13 38.02 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.138 -153.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.42 125.81 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.651 -0.656 . . . . 0.0 111.476 170.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.9 m -99.5 123.63 43.95 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 173.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -133.0 133.91 43.76 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 118.8 0.727 . . . . 0.0 111.167 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -95.38 130.5 42.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.092 -1.005 . . . . 0.0 111.54 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.9 t -143.47 141.78 30.92 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 122.943 0.497 . . . . 0.0 110.281 165.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 62.11 35.28 15.84 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 160.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.11 25.86 74.87 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -165.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.53 135.59 22.56 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-N 118.909 1.354 . . . . 0.0 113.249 -174.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.12 112.69 22.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.432 -0.793 . . . . 0.0 110.479 166.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 67.0 t -93.68 103.11 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -101.6 103.86 14.7 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.49 0.716 . . . . 0.0 109.981 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -91.22 107.26 19.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.514 -0.741 . . . . 0.0 110.693 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -79.72 144.93 33.22 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.879 0.871 . . . . 0.0 111.975 169.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -143.24 124.69 14.75 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.651 0.781 . . . . 0.0 109.781 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 7.9 p90 -155.3 125.83 6.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.252 30.0 t70 49.14 45.26 23.21 Favored 'General case' 0 CA--C 1.584 2.252 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.63 26.37 66.62 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 119.612 2.605 . . . . 0.0 119.612 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -131.96 130.83 42.0 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.628 1.214 . . . . 0.0 108.462 -171.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.58 150.09 38.58 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -166.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 t -139.17 131.93 29.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.594 -0.691 . . . . 0.0 112.079 164.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.8 p -104.22 109.4 21.21 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.102 0.561 . . . . 0.0 110.106 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.0 mm -95.61 104.04 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.7 m -100.52 102.5 13.7 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.644 -0.66 . . . . 0.0 109.81 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -99.48 87.18 3.53 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.163 0.585 . . . . 0.0 110.454 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -110.08 135.89 50.18 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -166.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.87 113.56 22.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.122 -0.986 . . . . 0.0 112.902 -173.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -141.23 133.56 28.16 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.491 0.717 . . . . 0.0 109.287 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 60.11 39.24 19.83 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.13 13.25 41.21 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 119.635 2.614 . . . . 0.0 119.635 -163.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -133.16 144.18 49.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.628 1.214 . . . . 0.0 110.178 -162.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.0 tp -88.03 103.97 16.21 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.868 0.842 . . . . 0.0 109.734 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.6 t -89.92 103.09 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.5 t -96.57 98.23 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -98.09 106.83 19.18 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.3 p -106.7 121.92 45.31 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.538 0.335 . . . . 0.0 111.839 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 p -121.73 137.1 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.265 0.626 . . . . 0.0 109.936 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.7 ttt -81.08 -79.42 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 122.219 -0.301 . . . . 0.0 110.246 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -122.1 -60.73 1.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.272 0.629 . . . . 0.0 110.885 167.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -97.63 -43.13 7.33 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.58 127.69 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 CA-C-O 122.38 1.086 . . . . 0.0 109.9 -156.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 73.6 p -110.6 139.21 46.07 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.993 -167.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.8 OUTLIER -106.34 132.07 52.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.835 . . . . 0.0 110.633 158.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.5 m -109.1 107.06 17.23 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -110.5 113.49 26.16 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.11 0.564 . . . . 0.0 110.835 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 mm -91.13 116.65 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.192 -0.943 . . . . 0.0 108.567 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -107.66 125.27 51.15 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.206 0.602 . . . . 0.0 110.727 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -92.27 142.65 27.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -81.57 116.32 21.28 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.911 0.885 . . . . 0.0 112.207 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.3 t -101.29 93.13 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -171.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 124.031 0.932 . . . . 0.0 110.451 -174.688 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 119.01 -0.519 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.522 0.8 OUTLIER 63.31 -48.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 118.755 2.872 . . . . 0.0 118.755 178.152 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -38.17 90.13 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 174.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -62.36 -25.69 68.05 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 167.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.7 mt -70.36 -7.57 43.88 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 164.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.83 142.59 31.41 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-N 121.319 1.872 . . . . 0.0 112.79 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.56 171.19 18.56 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 -86.98 103.63 15.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 165.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -101.66 101.86 12.45 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -170.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.33 142.58 27.62 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.588 0.755 . . . . 0.0 112.871 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.1 tp -71.01 127.96 34.35 Favored 'General case' 0 CA--C 1.571 1.776 0 O-C-N 120.677 -1.264 . . . . 0.0 113.446 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.95 -55.41 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 C-N-CA 124.082 0.953 . . . . 0.0 112.399 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -117.65 151.28 37.54 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 119.642 1.11 . . . . 0.0 110.567 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -144.47 59.22 1.33 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.997 0.903 . . . . 0.0 113.046 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -75.6 119.62 19.89 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -167.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.52 -6.76 71.22 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 -170.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.252 22.6 t80 -59.27 -31.6 69.25 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.816 2.524 . . . . 0.0 117.816 -174.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -52.46 -54.59 30.33 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 164.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.99 -45.39 83.0 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -58.65 -49.54 77.14 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 19.8 ptp -56.26 -37.65 70.06 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 167.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -63.62 -47.16 82.53 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 168.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.63 -37.95 83.21 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.1 mt -53.45 -35.94 61.06 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 117.576 2.435 . . . . 0.0 117.576 167.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.76 62.79 1.07 Allowed Glycine 0 N--CA 1.487 2.073 0 C-N-CA 123.438 0.542 . . . . 0.0 114.041 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.51 125.12 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -172.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.17 162.16 51.78 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 30' ' ' ILE . 1.8 mp -55.62 -50.97 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -168.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.38 94.86 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.4 mt -57.77 -41.7 82.54 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.734 1.754 . . . . 0.0 115.734 167.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -60.81 -49.68 76.5 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.22 -46.92 87.19 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.5 ttp -53.64 -55.21 27.87 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 167.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.29 96.04 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 118.618 2.207 . . . . 0.0 118.618 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.6 94.59 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.9 ptp -75.47 -22.15 57.48 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 170.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.93 133.1 47.75 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -174.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -103.08 87.28 1.22 Allowed Pre-proline 0 CA--C 1.576 1.945 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.749 166.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.96 142.96 22.63 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.46 2.107 . . . . 0.0 115.168 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -95.44 103.34 15.21 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.18 168.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 50.6 t -81.14 101.11 9.44 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-O 121.836 0.827 . . . . 0.0 110.903 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mt -94.96 104.36 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -170.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.83 130.78 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.258 7.7 t -136.84 149.88 47.98 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.776 -0.577 . . . . 0.0 112.312 159.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.4 t -141.83 128.74 20.63 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -68.68 -46.2 69.7 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 165.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.66 -78.68 0.15 Allowed Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -171.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HE3' HG22 ' A' ' 68' ' ' THR . 43.8 tttp -80.82 -26.07 37.35 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 160.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -88.63 138.75 31.14 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 122.842 2.565 . . . . 0.0 112.931 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -139.57 125.21 19.38 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.436 0.694 . . . . 0.0 110.463 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 m -109.37 133.86 52.53 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.376 1.07 . . . . 0.0 110.433 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.8 mt -123.12 119.68 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -103.94 110.17 22.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.685 -0.634 . . . . 0.0 110.145 163.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.7 m -83.71 99.17 10.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.277 -0.89 . . . . 0.0 109.102 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.44 125.74 35.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.663 0.744 . . . . 0.0 112.24 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 t -147.1 135.28 21.58 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 166.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.4 p -56.39 -26.05 51.79 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.5 mt -73.47 -54.51 8.09 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 165.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.71 114.75 3.54 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.563 1.529 . . . . 0.0 111.612 173.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.4 m -84.19 141.46 31.02 Favored 'General case' 0 CA--C 1.575 1.928 0 C-N-CA 123.457 0.703 . . . . 0.0 111.851 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 t -134.17 145.48 49.29 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.156 -0.965 . . . . 0.0 111.27 164.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -135.47 133.99 39.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.776 -1.202 . . . . 0.0 111.849 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.92 160.62 41.02 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 122.061 0.934 . . . . 0.0 112.964 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 m -139.13 137.49 36.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.089 -1.007 . . . . 0.0 111.153 170.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 36.4 t -135.4 143.0 45.77 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.813 1.292 . . . . 0.0 112.635 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.428 HG22 ' HE3' ' A' ' 50' ' ' LYS . 35.2 m -91.48 115.41 28.02 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.195 171.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -64.38 134.4 54.53 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.95 -49.09 0.87 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 -154.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -98.47 164.98 12.05 Favored 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 123.595 1.664 . . . . 0.0 113.228 -163.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -110.58 128.76 55.8 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.396 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.416 ' HE1' ' SG ' ' A' ' 87' ' ' CYS . 11.7 p90 -129.62 166.14 20.35 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.46 105.99 10.1 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 122.055 0.931 . . . . 0.0 111.467 169.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -103.12 97.43 7.52 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.426 1.091 . . . . 0.0 109.104 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.8 m -80.06 109.12 14.21 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 121.821 0.82 . . . . 0.0 109.471 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.6 p -69.6 176.14 3.71 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.95 -43.28 29.13 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 168.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.76 -43.51 97.92 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.268 2.322 . . . . 0.0 117.268 165.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.98 3.15 13.58 Favored Glycine 0 CA--C 1.556 2.634 0 N-CA-C 119.097 2.399 . . . . 0.0 119.097 -162.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.3 mtm-85 -69.89 128.54 36.72 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 120.979 2.389 . . . . 0.0 112.204 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -86.54 93.54 9.2 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.791 0.805 . . . . 0.0 108.9 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 p -99.28 125.24 44.87 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.712 -170.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -79.92 97.55 6.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.656 -1.278 . . . . 0.0 110.082 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.4 m -104.97 116.7 32.41 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.749 0.42 . . . . 0.0 110.408 -166.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.13 118.91 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.97 -0.456 . . . . 0.0 110.087 167.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.416 ' SG ' ' HE1' ' A' ' 73' ' ' PHE . 70.9 m -100.1 131.42 46.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.967 -0.458 . . . . 0.0 111.58 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -142.04 115.4 8.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 110.265 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -78.96 129.4 34.44 Favored 'General case' 0 CA--C 1.57 1.721 0 O-C-N 120.977 -1.077 . . . . 0.0 111.6 166.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 t -146.1 142.78 28.86 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.251 0.62 . . . . 0.0 110.201 165.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 60.63 36.92 19.55 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 159.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.3 21.15 79.45 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 -166.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.52 139.62 24.33 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-N 119.02 1.41 . . . . 0.0 112.596 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 67.3 tp -96.61 115.13 26.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -0.804 . . . . 0.0 110.615 171.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.9 t -89.28 103.35 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -98.31 95.56 7.46 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -96.72 99.74 11.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.968 . . . . 0.0 110.095 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -100.43 126.9 46.87 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -170.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -129.78 131.1 46.11 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.207 0.603 . . . . 0.0 111.388 -167.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -152.64 120.9 6.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.624 -1.298 . . . . 0.0 111.438 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.6 t70 42.99 54.22 4.86 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.9 -45.43 2.69 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 117.902 1.921 . . . . 0.0 117.902 -169.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -89.92 141.78 28.32 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 118.19 0.995 . . . . 0.0 113.345 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -127.92 159.68 34.19 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.682 0.753 . . . . 0.0 112.991 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.4 t -135.54 141.51 45.24 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.429 1.109 . . . . 0.0 112.01 162.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.6 p -106.38 109.99 22.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 mm -103.09 94.51 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -172.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.1 m -97.82 105.36 17.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.0 109.719 -172.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.9 mtp85 -103.23 89.33 3.37 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.234 0.614 . . . . 0.0 110.544 -167.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -105.86 138.25 42.37 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -168.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.4 123.88 33.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 113.209 -173.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -150.92 121.83 7.61 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.519 0.728 . . . . 0.0 109.266 -170.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.1 t70 61.06 28.2 17.97 Favored 'General case' 0 N--CA 1.514 2.754 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.58 33.12 66.09 Favored Glycine 0 CA--C 1.56 2.849 0 O-C-N 119.274 -2.141 . . . . 0.0 117.584 -158.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -133.08 131.17 40.27 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -174.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.2 tp -86.52 105.12 16.59 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.849 -1.157 . . . . 0.0 109.831 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.2 t -91.95 106.17 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t -100.5 99.29 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -87.52 93.85 9.54 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.471 1.129 . . . . 0.0 108.499 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.938 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.3 p -104.82 97.39 7.28 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.7 -176.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.48 146.34 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.519 1.152 . . . . 0.0 109.927 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.3 ttt -97.71 -60.12 1.63 Allowed 'General case' 0 CA--C 1.565 1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 112.972 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.273 12.9 p30 -139.65 -92.99 0.17 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -81.28 -13.71 58.17 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 154.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -96.73 133.89 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 C-N-CA 124.72 1.208 . . . . 0.0 109.67 -166.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.0 p -132.76 146.83 52.17 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -152.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.938 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 6.1 p -136.92 121.12 17.91 Favored 'General case' 0 CA--C 1.563 1.468 0 O-C-N 121.533 -0.73 . . . . 0.0 110.711 158.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.2 m -97.76 101.7 13.28 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -108.9 110.53 21.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.701 -0.624 . . . . 0.0 110.306 -168.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.9 mm -94.39 124.69 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -122.28 120.38 33.92 Favored 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.04 0.536 . . . . 0.0 110.379 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -90.74 150.51 21.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.781 -1.199 . . . . 0.0 113.447 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -78.4 128.64 33.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.915 -1.116 . . . . 0.0 113.55 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.2 t -86.56 104.65 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 165.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 N--CA 1.487 1.395 0 C-N-CA 123.802 0.841 . . . . 0.0 110.543 178.451 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 122.04 0.924 . . . . 0.0 112.886 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.274 4.8 p -62.59 -32.15 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.53 -33.28 72.42 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 163.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -63.49 -33.83 76.44 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 165.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.94 -4.06 11.85 Favored 'General case' 0 CA--C 1.581 2.151 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 164.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.05 122.02 25.68 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 121.955 2.161 . . . . 0.0 112.596 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.19 -179.95 34.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.3 ttm105 -93.84 108.06 19.88 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.159 0.584 . . . . 0.0 109.592 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -109.94 107.56 17.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.376 -0.827 . . . . 0.0 110.49 -165.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -91.82 130.78 37.53 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.788 -1.195 . . . . 0.0 112.794 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 48.0 tp -64.18 125.53 24.84 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 170.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.261 5.6 m -126.86 -60.01 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 123.097 0.559 . . . . 0.0 112.246 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -104.21 137.23 42.43 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 119.332 0.969 . . . . 0.0 110.338 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 p -147.97 93.57 2.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.477 -0.764 . . . . 0.0 111.725 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.46 128.9 48.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.816 -0.552 . . . . 0.0 111.772 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.6 -1.12 88.58 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 118.901 2.32 . . . . 0.0 118.901 -168.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -71.53 -51.19 24.84 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.046 1.923 . . . . 0.0 115.555 -170.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.09 -38.53 62.64 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 167.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.71 -49.28 75.69 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -54.24 -45.04 72.24 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 164.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.1 mtp -57.84 -42.75 85.02 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 169.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -55.5 -48.63 74.31 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 163.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.8 -43.4 98.19 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 172.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.7 mt -55.23 -38.58 68.65 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 117.889 2.552 . . . . 0.0 117.889 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.6 55.93 1.13 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 -165.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.69 118.57 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.682 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.65 165.29 41.08 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 30' ' ' ILE . 1.9 mp -57.94 -48.92 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.46 98.56 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.45 -42.39 91.85 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -57.53 -51.44 69.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -54.96 -54.3 44.53 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 169.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.2 ttp -52.93 -57.01 11.74 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.81 -40.85 90.3 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 118.926 2.33 . . . . 0.0 118.926 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.54 -51.79 52.75 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 169.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -72.61 -30.36 64.29 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.81 85.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.338 62.7 pttt 47.25 66.39 5.71 Favored Pre-proline 0 CA--C 1.585 2.306 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.79 154.84 23.47 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 N-CA-C 117.025 1.894 . . . . 0.0 117.025 -159.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.83 97.97 7.61 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.028 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.0 t -90.9 103.25 15.98 Favored 'General case' 0 CA--C 1.556 1.183 0 O-C-N 121.148 -0.97 . . . . 0.0 112.198 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.88 110.18 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.8 mt -97.95 114.8 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.2 m -134.63 117.91 16.62 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.5 t -121.82 118.54 29.25 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -172.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -86.19 60.24 6.12 Favored 'General case' 0 CA--C 1.576 1.951 0 CA-C-O 121.991 0.901 . . . . 0.0 111.557 170.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.64 -71.24 0.68 Allowed Glycine 0 N--CA 1.492 2.412 0 O-C-N 120.145 -1.597 . . . . 0.0 116.431 -170.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -99.89 -46.23 5.44 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.76 105.35 10.99 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 121.053 1.752 . . . . 0.0 111.387 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.66 111.61 23.87 Favored 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.139 0.971 . . . . 0.0 109.832 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.1 m -93.98 116.48 28.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.891 0.876 . . . . 0.0 109.165 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.4 104.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -105.43 104.02 13.66 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.321 0.581 . . . . 0.0 109.683 171.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.7 m -89.25 100.16 13.01 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.851 0.86 . . . . 0.0 110.124 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.72 111.84 23.7 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.088 0.947 . . . . 0.0 111.498 -173.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.1 p -148.51 153.12 38.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.628 -0.67 . . . . 0.0 110.601 157.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.6 p -61.98 -43.93 97.81 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 171.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.5 mt -61.97 -41.41 97.98 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 168.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -145.31 110.63 5.28 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.836 1.198 . . . . 0.0 110.72 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.53 118.81 36.14 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.2 p -139.72 142.61 36.83 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.009 -1.057 . . . . 0.0 111.91 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -139.14 133.44 31.48 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.742 -1.224 . . . . 0.0 111.821 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -146.65 147.31 30.9 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.678 0.751 . . . . 0.0 112.887 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.3 p -105.53 106.29 16.72 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.577 0.751 . . . . 0.0 110.846 172.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.3 p -94.45 125.23 38.96 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 121.515 0.674 . . . . 0.0 112.33 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.5 m -77.8 123.17 26.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.318 -0.864 . . . . 0.0 110.068 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.79 132.03 37.87 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -167.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.71 37.38 94.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 116.792 1.477 . . . . 0.0 116.792 -159.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.73 155.75 24.32 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.429 1.109 . . . . 0.0 111.136 -171.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -109.73 121.56 45.5 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.787 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -121.59 162.15 21.15 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.46 0.704 . . . . 0.0 112.502 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -75.84 106.08 7.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.783 -1.198 . . . . 0.0 110.971 166.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -90.98 116.54 28.86 Favored 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.8 m -86.74 93.97 9.39 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.8 p -68.94 159.93 31.77 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -43.46 -42.93 5.06 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.99 -35.8 66.92 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 171.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.91 -14.9 3.32 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 117.94 1.936 . . . . 0.0 117.94 -166.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -71.81 131.34 42.92 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.495 2.147 . . . . 0.0 112.651 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -81.97 110.5 17.29 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.205 0.602 . . . . 0.0 110.364 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.6 p -114.96 128.26 56.17 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.136 0.493 . . . . 0.0 109.816 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -78.82 92.25 4.83 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.759 0.79 . . . . 0.0 109.64 172.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.4 m -98.15 114.31 26.48 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.894 -164.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.264 12.5 p -91.74 117.11 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 122.019 -0.426 . . . . 0.0 110.82 171.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.6 m -101.5 112.99 25.71 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.136 -0.352 . . . . 0.0 111.849 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -123.0 125.56 45.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.656 -0.652 . . . . 0.0 111.114 -171.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -88.33 130.55 35.1 Favored 'General case' 0 CA--C 1.568 1.663 0 O-C-N 121.131 -0.98 . . . . 0.0 112.393 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -141.29 107.61 5.26 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.466 0.706 . . . . 0.0 110.218 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 45.34 70.45 0.35 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 171.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.33 -0.03 60.82 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 119.896 2.718 . . . . 0.0 119.896 -171.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.39 126.58 39.15 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 119.985 1.892 . . . . 0.0 113.009 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.2 tp -93.39 108.82 20.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.614 -0.679 . . . . 0.0 110.621 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -90.29 107.93 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -101.11 98.37 8.81 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.284 1.034 . . . . 0.0 109.521 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -100.3 103.14 14.54 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.565 0.746 . . . . 0.0 110.477 -171.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -100.19 105.97 17.61 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.896 0.878 . . . . 0.0 111.215 -164.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -108.19 126.08 52.38 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.192 -0.942 . . . . 0.0 113.539 -166.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -154.71 141.02 18.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.221 -0.925 . . . . 0.0 110.606 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.2 t70 51.14 45.44 27.83 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 159.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.9 68.63 Favored Glycine 0 CA--C 1.559 2.829 0 N-CA-C 120.238 2.855 . . . . 0.0 120.238 -167.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -137.01 150.06 47.87 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.141 1.471 . . . . 0.0 110.434 -167.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -124.18 147.56 47.91 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.249 0.547 . . . . 0.0 112.374 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.8 t -126.3 115.63 19.99 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 164.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.8 m -123.74 113.14 18.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.067 -1.021 . . . . 0.0 108.732 -160.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.0 mt -122.09 112.17 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -164.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 58.6 m -95.32 101.31 13.03 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.187 0.517 . . . . 0.0 109.666 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -93.08 101.17 13.48 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.376 0.67 . . . . 0.0 109.271 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 pttp -126.39 140.4 52.52 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -169.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.18 116.39 15.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 111.203 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.286 24.9 tptp -103.24 -126.72 0.22 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.081 0.552 . . . . 0.0 110.049 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -91.9 64.93 4.81 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 122.231 1.015 . . . . 0.0 109.51 -165.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.66 -24.11 13.73 Favored Glycine 0 CA--C 1.556 2.645 0 N-CA-C 119.045 2.378 . . . . 0.0 119.045 -162.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -129.89 161.16 31.47 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.078 1.939 . . . . 0.0 112.306 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.5 tp -85.02 116.08 23.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.794 -1.191 . . . . 0.0 111.406 -173.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.7 t -91.81 120.2 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 64.0 t -110.34 100.01 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -95.66 102.67 14.49 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.966 0.906 . . . . 0.0 108.972 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 0.9 OUTLIER -98.85 150.89 21.42 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.1 137.29 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 123.221 0.608 . . . . 0.0 109.609 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.268 10.7 ttt -98.25 -77.35 0.51 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 0.0 111.118 163.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -123.48 -70.89 0.75 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.388 -0.82 . . . . 0.0 110.934 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -99.58 -31.32 11.66 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 170.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.2 t -99.74 129.49 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-N 120.365 1.438 . . . . 0.0 110.148 -164.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.8 p -106.34 154.89 20.14 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.328 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.6 OUTLIER -130.17 139.16 50.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 112.328 162.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.1 m -106.74 109.43 21.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -107.31 124.82 50.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.331 0.653 . . . . 0.0 110.996 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.8 mm -92.38 122.73 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -113.57 122.78 48.28 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.757 0.823 . . . . 0.0 109.973 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -92.72 137.92 31.94 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -77.52 111.95 13.78 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.72 0.772 . . . . 0.0 112.691 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.9 t -103.95 128.47 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.015 -1.053 . . . . 0.0 108.832 -175.514 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.5 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.503 1.2 p 64.79 -44.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 118.38 2.733 . . . . 0.0 118.38 167.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.37 -36.32 53.52 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 169.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -54.49 -37.06 64.85 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 169.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.9 mt -70.74 -2.58 15.13 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 171.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -81.72 134.84 35.5 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 121.258 1.844 . . . . 0.0 112.937 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.79 177.95 29.51 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 117.757 1.863 . . . . 0.0 117.757 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -93.43 102.54 14.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.096 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.34 101.84 11.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.954 -0.466 . . . . 0.0 110.018 -168.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -90.01 125.82 35.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.206 1.002 . . . . 0.0 113.45 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.9 tp -64.41 125.09 23.53 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.41 -44.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.321 1.048 . . . . 0.0 113.162 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -128.49 155.66 44.49 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 120.291 1.405 . . . . 0.0 111.834 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.5 p -153.62 84.38 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 0.0 111.365 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.14 138.76 39.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.513 -0.742 . . . . 0.0 112.758 176.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.45 23.32 70.19 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 119.693 2.637 . . . . 0.0 119.693 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -85.83 -43.62 13.14 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -168.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -50.13 -46.4 53.82 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 162.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -53.98 -48.98 69.81 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 166.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -61.2 -47.47 85.98 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.05 -32.79 74.46 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 169.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -58.23 -48.44 80.39 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 121.507 1.958 . . . . 0.0 115.814 158.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -60.21 -40.6 90.7 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.5 mt -57.7 -50.3 73.64 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 161.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.14 56.11 0.28 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 124.346 0.974 . . . . 0.0 115.134 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.31 130.28 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-N 117.607 0.703 . . . . 0.0 109.423 -171.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.51 159.87 51.8 Favored Glycine 0 CA--C 1.553 2.431 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 30' ' ' ILE . 1.8 mp -56.88 -48.65 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -170.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.61 88.72 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 171.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.09 -40.03 94.03 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 170.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.1 mtm-85 -63.69 -42.71 97.96 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 166.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -54.29 -49.82 68.72 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 166.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.6 ttp -52.86 -55.29 24.28 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 164.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.48 -37.73 67.8 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 119.766 2.666 . . . . 0.0 119.766 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.34 -51.04 61.32 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.2 ptp -77.28 -20.44 55.07 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.24 115.22 7.45 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 120.163 1.347 . . . . 0.0 112.184 165.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.93 84.42 3.46 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.139 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.86 151.49 31.46 Favored 'Trans proline' 0 C--N 1.372 1.772 0 N-CA-C 117.395 2.036 . . . . 0.0 117.395 -168.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -84.4 102.38 12.71 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.532 162.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.3 t -77.78 100.53 6.32 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 121.951 0.881 . . . . 0.0 110.76 170.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.7 mt -95.93 101.68 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -170.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 81.2 mt -99.33 130.64 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.6 t -136.23 140.22 43.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.824 -0.548 . . . . 0.0 111.666 157.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 43.0 t -119.65 103.57 9.51 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.683 0.793 . . . . 0.0 111.961 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.65 75.85 9.53 Favored 'General case' 0 CA--C 1.572 1.798 0 CA-C-O 122.189 0.995 . . . . 0.0 110.686 170.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.7 -83.29 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 116.733 1.453 . . . . 0.0 116.733 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -105.59 -16.6 14.66 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -101.9 116.97 33.86 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 122.214 2.279 . . . . 0.0 110.523 175.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -112.43 116.78 30.84 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.947 0.879 . . . . 0.0 109.938 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.6 m -99.4 125.74 45.16 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.987 0.915 . . . . 0.0 109.73 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 mt -119.4 112.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -98.14 109.83 22.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.764 -0.585 . . . . 0.0 109.941 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 m -90.9 103.3 16.03 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.435 -0.79 . . . . 0.0 109.456 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -101.43 116.85 33.72 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -143.24 140.47 30.69 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.087 0.555 . . . . 0.0 110.091 167.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -50.83 -44.33 59.25 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.21 -40.72 97.05 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.34 103.84 1.25 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.47 1.487 . . . . 0.0 111.076 -175.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.0 m -90.25 145.67 24.82 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.991 0.901 . . . . 0.0 111.459 170.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.7 m -148.24 136.14 20.96 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.056 -1.653 . . . . 0.0 110.63 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -126.99 133.37 50.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.413 -0.804 . . . . 0.0 111.75 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -136.38 152.06 50.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 172.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.3 p -117.98 103.95 10.42 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.802 0.841 . . . . 0.0 109.905 170.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 24.1 p -95.34 152.1 18.68 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.8 m -91.37 130.81 37.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.824 -1.172 . . . . 0.0 109.582 168.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tp -69.53 131.31 44.49 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 112.878 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.13 -6.98 8.56 Favored Glycine 0 CA--C 1.553 2.458 0 N-CA-C 119.558 2.583 . . . . 0.0 119.558 -164.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.78 172.02 10.18 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-N 119.303 1.552 . . . . 0.0 112.007 -174.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -113.46 110.79 20.87 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.495 -156.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -105.76 160.75 14.98 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.655 0.782 . . . . 0.0 112.296 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.53 106.68 14.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.93 -1.731 . . . . 0.0 111.658 169.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -89.15 102.08 14.74 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 169.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.4 m -77.95 110.82 13.2 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.094 0.949 . . . . 0.0 109.593 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -75.43 134.38 40.9 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.797 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.94 63.77 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 119.721 3.23 . . . . 0.0 119.721 -170.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.31 -27.08 65.98 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.51 -35.7 0.47 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 118.715 2.246 . . . . 0.0 118.715 167.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -75.07 136.54 41.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -163.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -93.55 115.04 27.53 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.173 0.989 . . . . 0.0 109.021 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.4 p -119.36 111.41 18.14 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.784 0.802 . . . . 0.0 111.168 -164.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -71.78 98.27 1.94 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.324 1.05 . . . . 0.0 110.581 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.4 m -112.99 108.47 17.39 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.285 -0.884 . . . . 0.0 109.922 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.258 12.7 p -88.88 122.61 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 122.96 0.504 . . . . 0.0 111.382 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 55.7 m -105.51 88.11 2.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -169.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -102.18 119.34 38.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.541 -1.349 . . . . 0.0 111.941 -168.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -80.17 131.9 35.8 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.004 -1.06 . . . . 0.0 112.712 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -133.11 97.47 4.01 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.583 0.753 . . . . 0.0 110.414 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.331 9.8 t70 68.6 -73.56 0.09 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 172.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.39 35.43 2.17 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 116.587 1.395 . . . . 0.0 116.587 167.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -153.93 139.24 17.58 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 118.581 1.19 . . . . 0.0 112.957 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 tp -97.84 115.4 27.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.68 -0.637 . . . . 0.0 110.854 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -88.01 101.8 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.56 94.52 9.91 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 124.396 1.078 . . . . 0.0 109.009 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -96.1 98.13 10.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.728 . . . . 0.0 112.159 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -71.05 137.42 48.95 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.062 0.945 . . . . 0.0 113.063 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -136.83 121.61 18.64 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.497 0.719 . . . . 0.0 109.931 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -158.35 127.1 5.5 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.626 -1.296 . . . . 0.0 111.11 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 54.08 37.83 27.77 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 164.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.72 -43.23 3.08 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 -165.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -75.35 154.57 37.2 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -151.58 155.01 37.57 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.059 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 t -144.32 121.87 11.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.219 -0.926 . . . . 0.0 112.897 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.1 p -86.55 131.34 34.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 0.0 111.278 168.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.2 mt -123.32 101.28 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 84.9 m -93.71 108.08 19.87 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.546 0.739 . . . . 0.0 110.056 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -97.98 87.91 4.1 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.268 0.627 . . . . 0.0 110.041 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.18 142.32 29.22 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -171.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 120.86 27.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.505 -0.747 . . . . 0.0 112.366 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.274 41.0 tttm -134.85 -130.92 0.16 Allowed 'General case' 0 CA--C 1.569 1.706 0 O-C-N 121.979 -0.45 . . . . 0.0 112.03 -172.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -82.86 67.91 9.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.497 -1.377 . . . . 0.0 113.464 -161.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.95 16.82 57.72 Favored Glycine 0 CA--C 1.565 3.194 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -157.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -137.86 131.75 31.5 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.098 1.359 . . . . 0.0 108.146 -164.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.3 tp -82.03 108.55 15.61 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 121.701 0.762 . . . . 0.0 109.259 164.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -96.67 110.13 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -175.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.0 t -103.29 100.35 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -167.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -95.62 108.43 20.7 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.545 1.138 . . . . 0.0 108.568 -171.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.2 p -126.42 129.35 48.57 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 121.921 0.867 . . . . 0.0 112.382 -158.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.37 146.29 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 123.396 0.678 . . . . 0.0 109.964 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.265 18.6 ttt -118.24 -94.16 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.575 -0.703 . . . . 0.0 111.327 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -105.87 -52.21 2.85 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.758 0.823 . . . . 0.0 111.828 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -119.1 -39.32 2.93 Favored 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 125.485 1.514 . . . . 0.0 112.142 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t -87.39 121.8 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 O-C-N 121.274 -0.892 . . . . 0.0 110.364 -164.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 46.7 p -93.34 103.49 15.72 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.914 0.864 . . . . 0.0 110.204 165.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 18.5 p -85.69 160.94 19.43 Favored 'General case' 0 CA--C 1.57 1.739 0 CA-C-O 122.624 1.202 . . . . 0.0 111.537 163.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.8 m -150.44 119.01 6.48 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 119.26 -2.15 . . . . 0.0 108.031 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -125.78 132.24 52.32 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-O 121.836 0.827 . . . . 0.0 111.757 -168.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.2 mm -111.63 117.43 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -162.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -116.8 129.68 56.24 Favored 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 123.037 0.535 . . . . 0.0 111.216 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -106.63 146.91 30.14 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -71.94 106.09 4.1 Favored 'General case' 0 CA--C 1.57 1.742 0 O-C-N 121.046 -1.034 . . . . 0.0 113.106 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.05 85.56 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--O 1.256 1.446 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -171.456 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.6 p -63.02 -34.81 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 163.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -46.25 -34.06 4.14 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 165.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -63.74 -22.19 66.78 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 172.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.1 mt -74.89 -5.78 45.55 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 117.722 2.49 . . . . 0.0 117.722 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 164.0 26.94 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -172.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.35 -179.37 24.68 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 171.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 -84.22 126.16 32.88 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.153 -0.616 . . . . 0.0 111.201 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -126.31 113.81 17.42 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -89.75 134.9 33.93 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.0 tp -68.61 121.78 17.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -112.28 -55.15 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 123.952 0.901 . . . . 0.0 112.603 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -106.69 140.2 39.92 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 120.244 1.383 . . . . 0.0 110.228 168.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -136.5 79.7 1.78 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.728 1.252 . . . . 0.0 110.167 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -99.03 100.82 12.03 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.562 -0.712 . . . . 0.0 110.938 -158.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.5 22.07 20.08 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 118.309 2.084 . . . . 0.0 118.309 -167.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -74.27 -49.74 21.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -37.9 74.69 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 167.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -57.73 -45.13 86.24 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 166.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -57.3 -49.36 76.35 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 164.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 73.5 mtm -60.76 -35.35 76.2 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 172.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -55.44 -55.23 34.09 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 161.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.413 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 31.6 tp10 -64.91 -36.6 84.89 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -53.65 -44.03 69.27 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 159.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.8 56.59 1.22 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -172.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -98.02 137.71 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 123.327 0.651 . . . . 0.0 110.091 -172.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.26 153.33 48.64 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 pt -57.37 -48.82 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 -171.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.58 87.76 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 167.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 mt -66.52 -37.68 85.56 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 169.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -57.65 -48.82 78.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 162.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -57.52 -48.97 77.84 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 169.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -50.7 -51.46 49.46 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 167.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.2 -46.17 93.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 118.116 2.007 . . . . 0.0 118.116 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.47 -45.02 94.94 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -79.81 -5.23 54.99 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 118.048 2.611 . . . . 0.0 118.048 173.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.05 135.8 39.93 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.25 92.33 2.09 Favored Pre-proline 0 CA--C 1.573 1.857 0 O-C-N 121.369 -0.832 . . . . 0.0 110.853 160.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.35 136.53 26.62 Favored 'Trans proline' 0 CA--C 1.559 1.774 0 CA-C-N 122.935 2.084 . . . . 0.0 114.548 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -100.54 101.93 12.98 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.392 167.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.2 t -74.76 111.96 10.49 Favored 'General case' 0 CA--C 1.558 1.274 0 O-C-N 121.627 -0.671 . . . . 0.0 110.689 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mt -104.88 105.16 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 83.9 mt -95.47 129.46 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.0 p -119.0 111.94 18.95 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.5 p -98.56 111.45 23.81 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -170.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -84.78 176.75 8.33 Favored 'General case' 0 CA--C 1.578 2.035 0 CA-C-O 124.106 1.908 . . . . 0.0 110.346 159.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.18 -40.99 92.52 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.402 2.121 . . . . 0.0 118.402 158.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -123.06 -47.77 2.02 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 166.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -86.63 82.74 7.79 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 120.953 1.706 . . . . 0.0 111.518 -166.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.61 112.7 24.34 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.885 -1.134 . . . . 0.0 109.221 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.2 m -98.31 119.62 37.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.532 -0.73 . . . . 0.0 110.576 -168.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.3 mt -112.0 105.76 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -99.99 103.3 14.84 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.3 m -90.56 100.34 13.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.61 -0.681 . . . . 0.0 110.011 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.16 118.8 30.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.6 t -138.21 144.4 40.62 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.197 0.599 . . . . 0.0 110.017 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.5 p -75.78 42.32 0.23 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.1 mt -152.91 -54.64 0.12 Allowed 'General case' 0 CA--C 1.572 1.821 0 C-N-CA 126.791 2.036 . . . . 0.0 108.654 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -143.44 117.0 9.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.024 -1.048 . . . . 0.0 110.838 167.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.3 m -84.75 120.08 26.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.676 -0.64 . . . . 0.0 109.61 166.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.0 p -111.97 103.03 11.23 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -102.72 128.95 49.23 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.35 0.66 . . . . 0.0 111.374 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -145.34 141.6 28.65 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.02 0.914 . . . . 0.0 112.954 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.8 p -97.47 105.29 17.41 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.739 0.816 . . . . 0.0 110.886 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 30.1 p -92.96 122.55 35.44 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.566 0.698 . . . . 0.0 111.99 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.0 m -85.72 115.41 23.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.483 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.27 118.29 19.62 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.541 0.737 . . . . 0.0 112.764 -166.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.1 55.17 8.16 Favored Glycine 0 CA--C 1.549 2.192 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.945 -156.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.49 154.71 2.63 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 124.429 1.092 . . . . 0.0 111.403 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -109.59 123.56 49.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.135 0.974 . . . . 0.0 112.916 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -127.65 164.48 21.95 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 124.17 0.988 . . . . 0.0 112.293 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -78.39 107.73 11.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 119.842 -1.787 . . . . 0.0 111.712 164.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -77.95 147.65 34.85 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.294 155.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.0 m -113.17 114.73 27.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.769 171.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.3 p -70.49 138.68 51.29 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 122.825 0.45 . . . . 0.0 111.62 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.62 -29.45 10.98 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 120.309 3.448 . . . . 0.0 120.309 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -84.15 -29.75 26.43 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 170.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.15 -37.39 0.37 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 119.96 2.744 . . . . 0.0 119.96 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -68.25 127.92 34.68 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 119.578 1.689 . . . . 0.0 112.675 -174.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -93.72 128.84 40.13 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.121 0.486 . . . . 0.0 110.744 171.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.8 p -120.44 126.01 49.36 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.254 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -67.77 103.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.208 1.004 . . . . 0.0 111.319 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.3 m -114.53 101.38 9.07 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -158.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.299 14.6 p -87.05 106.17 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.404 0.621 . . . . 0.0 110.331 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 63.6 m -92.12 120.71 32.98 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -140.01 126.92 20.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.87 -0.519 . . . . 0.0 111.265 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -92.21 123.52 35.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 111.488 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 t -139.51 138.41 36.31 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.235 0.614 . . . . 0.0 109.832 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 61.79 36.93 15.91 Favored 'General case' 0 N--CA 1.506 2.334 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 162.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.7 12.63 83.68 Favored Glycine 0 CA--C 1.557 2.69 0 N-CA-C 119.354 2.502 . . . . 0.0 119.354 -165.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.35 125.47 24.53 Favored 'General case' 0 CA--C 1.561 1.392 0 CA-C-N 119.668 1.734 . . . . 0.0 112.743 -169.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 tp -86.4 106.9 17.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.529 -0.732 . . . . 0.0 110.945 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 66.7 t -92.95 108.66 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.854 0.862 . . . . 0.0 108.765 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -93.27 95.0 9.08 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.627 0.771 . . . . 0.0 110.024 173.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -91.08 102.49 15.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 110.751 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -94.56 126.07 39.61 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.699 1.2 . . . . 0.0 111.31 -172.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -125.26 122.81 38.0 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.341 0.656 . . . . 0.0 110.466 -169.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -157.38 118.81 3.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.807 -1.183 . . . . 0.0 111.32 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 45.14 51.34 9.1 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 168.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.5 -42.77 3.08 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 117.699 1.84 . . . . 0.0 117.699 -171.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -79.49 142.68 35.6 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.15 139.12 39.24 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.131 0.967 . . . . 0.0 113.063 173.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.7 t -120.68 130.08 53.95 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.548 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 67.5 m -117.7 117.07 28.36 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.097 -1.002 . . . . 0.0 108.746 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.2 mt -114.17 104.83 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.2 m -100.69 103.27 14.53 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.88 0.872 . . . . 0.0 109.752 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.8 mtt85 -95.75 104.22 16.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.859 -0.526 . . . . 0.0 110.647 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -121.12 147.14 45.97 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.31 108.78 20.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.827 -0.546 . . . . 0.0 111.611 -171.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -137.02 129.3 29.72 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.343 0.657 . . . . 0.0 109.312 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.0 t0 57.49 44.31 21.45 Favored 'General case' 0 N--CA 1.507 2.404 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 51.82 30.68 29.55 Favored Glycine 0 CA--C 1.559 2.801 0 N-CA-C 119.298 2.479 . . . . 0.0 119.298 -164.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -140.61 149.5 42.41 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.502 1.144 . . . . 0.0 109.537 -167.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.5 tp -92.5 106.12 18.17 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-O 121.912 0.863 . . . . 0.0 109.857 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 82.7 t -93.31 106.07 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.3 t -102.65 90.52 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -170.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -88.28 93.43 9.51 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.717 1.246 . . . . 0.0 110.062 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.636 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 9.4 t -80.64 135.87 36.12 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.823 170.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.6 123.22 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.598 -0.689 . . . . 0.0 109.452 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.413 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 26.8 ttt -117.02 103.97 10.79 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.859 0.464 . . . . 0.0 110.061 175.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.3 76.5 m-20 66.57 -93.57 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.868 0.867 . . . . 0.0 111.297 -174.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -111.89 0.44 16.12 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 162.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.9 t -92.95 105.86 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 120.49 1.495 . . . . 0.0 108.714 -167.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 53.6 p -90.74 140.1 30.1 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.404 1.097 . . . . 0.0 113.02 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.636 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -136.52 85.08 2.12 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -174.056 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 61.7 m -88.98 110.24 20.95 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.514 -1.366 . . . . 0.0 110.286 -171.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -114.4 108.34 16.76 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -168.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.7 mm -92.72 114.64 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -116.41 114.55 24.42 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.197 0.599 . . . . 0.0 109.718 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.68 152.39 22.55 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -77.83 127.43 32.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.483 -1.386 . . . . 0.0 114.696 -161.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.74 86.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.489 1.498 0 C-N-CA 123.928 0.891 . . . . 0.0 108.6 178.795 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 122.057 0.932 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.265 7.7 p -64.16 -32.47 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -38.58 90.41 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 162.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -63.83 -38.37 90.86 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.5 mt -59.81 -23.79 63.62 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 163.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 107.64 3.93 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.188 1.813 . . . . 0.0 113.426 -171.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.64 -173.85 36.42 Favored Glycine 0 N--CA 1.489 2.215 0 CA-C-O 121.712 0.618 . . . . 0.0 114.628 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -94.92 137.84 33.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.009 -0.701 . . . . 0.0 110.981 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -135.55 116.82 14.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.55 -0.719 . . . . 0.0 110.994 -170.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.9 ttm105 -97.49 134.09 41.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.002 -1.686 . . . . 0.0 113.85 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.1 tp -67.82 123.51 20.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.254 4.4 m -113.06 -60.95 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 123.818 0.847 . . . . 0.0 112.223 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -106.36 151.5 24.79 Favored 'General case' 0 CA--C 1.571 1.782 0 CA-C-N 119.688 1.131 . . . . 0.0 111.006 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -154.28 65.56 0.7 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 136.11 54.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.485 -0.759 . . . . 0.0 112.988 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.74 2.59 51.69 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 120.086 2.794 . . . . 0.0 120.086 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.14 -34.03 72.54 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.27 -54.91 17.87 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 163.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.44 -49.57 72.1 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -57.25 -48.13 79.64 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 76.5 mtm -59.5 -35.27 73.82 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 168.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -64.17 -48.06 77.41 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 22.0 tp10 -66.0 -37.91 87.16 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 173.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.1 -42.72 66.22 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 159.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.31 53.93 1.21 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 115.137 0.815 . . . . 0.0 115.137 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.18 134.78 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.412 0.685 . . . . 0.0 109.788 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.95 154.09 49.83 Favored Glycine 0 CA--C 1.55 2.244 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.1 pt -55.55 -48.25 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -172.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.61 -43.59 97.28 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.34 -40.0 96.1 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 170.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.9 mtp85 -55.2 -50.33 69.64 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 162.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -56.94 -47.7 80.04 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 170.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.0 mtm -58.0 -55.27 37.07 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 168.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.97 -36.97 76.16 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 119.41 2.524 . . . . 0.0 119.41 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.97 -54.42 30.84 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.8 ptp -85.9 -26.38 25.63 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.01 73.21 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 119.639 3.2 . . . . 0.0 119.639 -168.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt 63.32 66.42 1.16 Allowed Pre-proline 0 CA--C 1.581 2.141 0 C-N-CA 124.437 1.095 . . . . 0.0 113.612 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -73.25 143.77 35.99 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 122.513 2.142 . . . . 0.0 116.869 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.44 101.51 13.21 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.271 1.028 . . . . 0.0 110.045 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.0 116.82 29.25 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 124.378 1.071 . . . . 0.0 112.108 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mp -92.13 119.67 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.9 mt -105.88 117.68 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 168.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.1 m -136.84 130.4 31.74 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 118.879 0.763 . . . . 0.0 111.046 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.6 p -105.98 137.45 43.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -169.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.34 86.37 2.32 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 121.882 0.849 . . . . 0.0 108.878 166.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.57 -99.26 0.45 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -85.15 -25.91 27.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 165.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -86.27 138.17 32.05 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 120.719 1.6 . . . . 0.0 112.001 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 21.8 tp -133.7 112.98 11.85 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 121.883 0.849 . . . . 0.0 108.787 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -87.29 119.57 27.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.491 0.717 . . . . 0.0 109.567 -175.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mm -111.47 98.73 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -112.53 105.93 14.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.557 -0.714 . . . . 0.0 110.104 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.4 m -93.12 101.24 13.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.399 -0.813 . . . . 0.0 109.817 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -98.24 125.53 43.35 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.023 0.929 . . . . 0.0 110.704 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 t -137.66 160.8 38.19 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.41 1.1 . . . . 0.0 113.437 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.7 p -59.93 -48.25 82.45 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 163.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.7 mt -97.02 -38.86 9.61 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -146.52 105.37 3.85 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 121.187 1.812 . . . . 0.0 112.715 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.3 m -86.26 142.44 28.55 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.657 0.783 . . . . 0.0 111.545 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.5 m -157.89 143.09 16.8 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.235 -1.54 . . . . 0.0 109.839 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.51 154.77 51.27 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.285 -1.51 . . . . 0.0 114.229 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -150.65 142.1 23.42 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.553 0.692 . . . . 0.0 111.771 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.0 p -100.26 105.25 16.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.943 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 52' ' ' LEU . 20.9 p -93.79 164.51 13.1 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.5 m -130.43 128.46 41.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.2 111.72 9.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.292 -0.88 . . . . 0.0 111.982 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.37 -62.3 0.54 Allowed Glycine 0 N--CA 1.488 2.11 0 CA-C-O 120.055 -0.303 . . . . 0.0 113.488 -162.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -89.47 162.17 15.86 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 124.068 1.89 . . . . 0.0 114.914 -164.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -106.95 132.86 52.42 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 112.563 -2.108 . . . . 0.0 111.394 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.89 160.38 40.45 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -169.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.99 113.53 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 112.48 167.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -102.2 95.82 6.57 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.1 m -76.96 92.07 3.65 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.341 1.067 . . . . 0.0 110.445 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -67.38 148.28 51.81 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.158 0.983 . . . . 0.0 113.293 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.07 -39.48 5.85 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.948 3.314 . . . . 0.0 119.948 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.95 -34.27 59.84 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.12 -25.32 0.61 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 119.563 2.585 . . . . 0.0 119.563 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.2 mtm-85 -72.65 119.74 17.3 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 120.124 1.962 . . . . 0.0 112.091 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 94.6 9.71 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 167.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.5 p -87.4 149.53 24.4 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.146 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -81.98 87.15 6.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.084 -1.01 . . . . 0.0 109.589 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -88.79 117.35 27.72 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.264 14.9 p -88.97 118.08 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 161.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.3 m -96.21 135.17 38.39 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 120.834 0.35 . . . . 0.0 111.655 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -148.05 121.7 9.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.804 -0.56 . . . . 0.0 109.611 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -83.24 123.39 29.53 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 120.852 -1.155 . . . . 0.0 111.259 169.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -133.31 110.4 10.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 63.69 56.19 1.58 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 148.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.52 -25.94 11.83 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 118.453 2.141 . . . . 0.0 118.453 -164.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.77 135.0 55.03 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 119.909 1.855 . . . . 0.0 114.314 -167.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.9 tp -82.37 113.71 20.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.196 158.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.0 t -88.89 106.73 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -102.04 98.74 8.89 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -99.2 96.31 7.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.638 -0.664 . . . . 0.0 110.561 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -83.4 128.54 34.59 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.683 0.793 . . . . 0.0 111.572 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -130.32 123.94 31.16 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.107 0.563 . . . . 0.0 110.009 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.2 p90 -156.6 119.51 4.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.696 -1.252 . . . . 0.0 112.139 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.263 5.5 t70 34.31 58.16 0.64 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 118.699 2.852 . . . . 0.0 118.699 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.72 -46.94 1.9 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 117.639 1.816 . . . . 0.0 117.639 -172.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -80.51 140.94 35.62 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -133.3 148.38 51.92 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 168.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.6 t -131.99 138.65 48.35 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.688 0.756 . . . . 0.0 111.802 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -111.7 98.11 7.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.71 111.09 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -175.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.7 m -101.71 103.6 14.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.622 -0.673 . . . . 0.0 109.802 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -95.42 101.66 13.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.403 -0.811 . . . . 0.0 109.9 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -132.91 156.9 46.39 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.91 123.22 26.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 111.877 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.09 114.19 24.19 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 159.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.89 51.16 9.39 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 166.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.47 -22.77 5.21 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 119.357 2.503 . . . . 0.0 119.357 -170.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -103.27 140.09 37.86 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.628 1.714 . . . . 0.0 111.21 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.9 tp -75.77 134.79 40.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.96 . . . . 0.0 110.361 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.29 106.78 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.6 t -92.73 102.94 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -111.28 105.18 13.76 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -171.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 3.1 p -97.08 145.79 25.64 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.51 128.66 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.412 0.625 . . . . 0.0 109.405 162.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.4 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 24.4 ttt -98.21 -88.44 0.32 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.214 0.606 . . . . 0.0 110.253 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -129.89 78.16 1.83 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.052 0.941 . . . . 0.0 108.732 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.283 0.7 OUTLIER 69.4 -26.53 0.15 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 -162.115 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 82.6 t -75.78 116.41 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 CA-C-N 120.085 1.311 . . . . 0.0 109.835 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.3 p -120.11 134.76 55.17 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 123.638 0.775 . . . . 0.0 112.729 -170.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.3 p -120.93 128.01 52.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.962 -0.461 . . . . 0.0 111.993 167.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.3 m -109.25 111.45 23.04 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -112.14 118.76 36.24 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.57 0.748 . . . . 0.0 110.248 -172.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mm -96.71 130.47 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 123.455 0.702 . . . . 0.0 109.426 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -130.12 121.63 26.7 Favored 'General case' 0 CA--C 1.572 1.82 0 C-N-CA 123.483 0.713 . . . . 0.0 112.385 -165.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -95.32 134.88 37.61 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -80.25 125.29 29.67 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.104 -0.997 . . . . 0.0 113.369 -172.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.6 t -114.79 94.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -168.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 122.489 0.315 . . . . 0.0 110.207 -165.076 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.0 p . . . . . 0 CA--C 1.568 1.663 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.308 12.1 p -154.63 -58.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 120.155 -1.591 . . . . 0.0 110.186 153.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.3 -22.51 63.26 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.592 2.441 . . . . 0.0 117.592 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.1 mp0 -56.96 -27.18 60.97 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 163.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.21 -12.59 61.24 Favored 'General case' 0 CA--C 1.582 2.206 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 164.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.43 114.17 14.84 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 120.774 1.625 . . . . 0.0 113.398 -166.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.45 -166.55 28.63 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 167.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -86.15 129.78 34.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.078 -0.66 . . . . 0.0 112.33 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -127.77 114.73 17.65 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.262 0.625 . . . . 0.0 110.301 -172.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -89.91 133.52 34.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.471 -1.393 . . . . 0.0 113.3 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.6 tp -72.88 131.07 41.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.8 -0.563 . . . . 0.0 112.439 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.277 3.3 m -116.68 -73.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 123.369 0.668 . . . . 0.0 109.895 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -89.68 142.05 28.04 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 118.919 0.781 . . . . 0.0 110.802 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.4 t -148.02 51.96 1.03 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -79.84 134.81 36.34 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.44 -9.43 67.58 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 118.628 2.211 . . . . 0.0 118.628 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -70.69 -42.26 70.91 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -171.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -52.62 -51.66 58.98 Favored 'General case' 0 CA--C 1.579 2.06 0 CA-C-N 120.079 1.309 . . . . 0.0 114.339 167.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.74 -39.51 84.97 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 170.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -58.64 -46.3 87.4 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 169.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 33' ' ' ARG . 16.3 ptp -62.03 -25.79 67.87 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 167.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -58.7 -52.92 63.65 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 157.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.03 -42.05 98.76 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.413 ' HA ' ' SD ' ' A' ' 122' ' ' MET . 69.3 mt -53.28 -38.77 63.39 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 169.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.04 64.62 0.99 Allowed Glycine 0 N--CA 1.486 1.989 0 C-N-CA 123.362 0.506 . . . . 0.0 113.751 -166.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.5 t -114.33 130.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.62 158.65 49.25 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.275 2.4 pp -55.26 -49.02 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -171.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.76 99.34 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 168.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.06 -41.88 89.01 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.427 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 20.0 mtp-105 -61.27 -51.05 70.55 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 120.177 1.353 . . . . 0.0 114.546 170.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -54.74 -47.65 73.56 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 170.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.8 ttp -54.42 -60.67 3.03 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 165.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.91 -40.32 92.99 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 119.573 2.589 . . . . 0.0 119.573 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.59 -45.02 88.8 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 172.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -78.26 -29.87 48.29 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 172.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.74 123.22 18.79 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 119.833 1.197 . . . . 0.0 114.17 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -103.5 107.89 57.5 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 117.667 -1.158 . . . . 0.0 109.66 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -92.34 145.73 2.79 Favored 'Trans proline' 0 CA--C 1.563 1.948 0 CA-C-N 122.48 1.921 . . . . 0.0 116.455 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.74 100.53 13.0 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 114.493 -1.231 . . . . 0.0 108.641 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.9 t -91.32 112.83 24.9 Favored 'General case' 0 CA--C 1.557 1.217 0 O-C-N 120.875 -1.141 . . . . 0.0 112.559 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mt -84.14 104.26 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 60.5 mt -99.78 111.49 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.5 m -117.16 102.5 9.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.6 p -113.87 91.4 3.62 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 123.737 0.815 . . . . 0.0 111.424 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -93.54 65.31 3.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.34 -0.85 . . . . 0.0 111.836 -171.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.36 -61.58 1.87 Allowed Glycine 0 N--CA 1.494 2.51 0 O-C-N 120.117 -1.614 . . . . 0.0 117.089 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -121.52 -46.43 2.27 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -71.7 137.59 47.91 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 121.58 1.991 . . . . 0.0 112.925 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -138.52 112.31 8.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.468 -0.77 . . . . 0.0 111.226 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.2 m -114.77 123.53 49.47 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.463 0.705 . . . . 0.0 109.715 -175.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.77 109.03 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -114.23 101.61 9.35 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.996 0.918 . . . . 0.0 109.859 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.0 m -87.09 112.48 21.94 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.673 0.789 . . . . 0.0 110.391 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -112.3 100.63 8.95 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 118.773 0.715 . . . . 0.0 112.138 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -123.46 158.34 31.47 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.084 0.945 . . . . 0.0 111.192 163.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.2 p -63.29 -44.82 93.95 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 172.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.3 mt -64.07 -38.04 89.63 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.09 130.64 13.94 Favored 'General case' 0 CA--C 1.563 1.453 0 CA-C-N 119.938 1.244 . . . . 0.0 111.164 166.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 m -113.95 133.75 55.27 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 166.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.1 m -155.6 139.65 16.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.391 -1.443 . . . . 0.0 109.541 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.85 158.39 39.62 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.36 137.5 30.54 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-O 121.991 0.901 . . . . 0.0 110.451 161.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -109.93 105.26 14.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.028 0.931 . . . . 0.0 109.499 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 30.3 p -132.19 -152.51 0.5 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.54 0.736 . . . . 0.0 112.413 -168.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.39 147.42 50.48 Favored 'General case' 0 CA--C 1.571 1.761 0 O-C-N 120.957 -1.089 . . . . 0.0 111.306 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -78.58 148.01 33.49 Favored 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 124.221 1.008 . . . . 0.0 113.045 162.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.35 28.45 73.59 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 117.921 1.928 . . . . 0.0 117.921 -173.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -152.11 141.09 21.16 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-O 121.51 0.671 . . . . 0.0 109.437 -162.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -93.45 124.29 37.34 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.253 174.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -130.92 154.4 48.15 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.043 0.937 . . . . 0.0 111.721 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -80.12 101.31 8.69 Favored 'General case' 0 CA--C 1.569 1.704 0 O-C-N 120.95 -1.094 . . . . 0.0 111.512 172.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -85.32 94.28 8.91 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.997 0.919 . . . . 0.0 110.011 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.8 m -81.64 96.57 7.55 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.925 0.869 . . . . 0.0 110.478 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.9 p -71.14 152.42 43.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.381 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.01 -30.05 14.2 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -54.81 -42.73 72.22 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 118.419 2.748 . . . . 0.0 118.419 162.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.63 -19.49 9.71 Favored Glycine 0 CA--C 1.553 2.466 0 N-CA-C 117.81 1.884 . . . . 0.0 117.81 -155.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -74.47 112.1 10.31 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 121.122 2.461 . . . . 0.0 110.65 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.264 0.1 OUTLIER -102.34 99.48 9.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.655 0.74 . . . . 0.0 111.225 178.363 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.7 p -99.56 141.88 31.78 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.176 -163.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -77.49 88.49 3.84 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.581 172.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.7 m -97.2 114.52 26.25 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 121.694 -0.629 . . . . 0.0 109.503 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.282 14.2 p -90.56 119.87 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.726 -0.609 . . . . 0.0 110.693 165.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.9 m -98.47 113.21 25.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.189 -0.319 . . . . 0.0 111.673 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -123.68 140.52 52.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.786 -0.571 . . . . 0.0 110.545 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -84.1 127.44 33.91 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 120.877 -1.139 . . . . 0.0 111.469 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -146.06 142.08 28.24 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.394 0.678 . . . . 0.0 110.278 168.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.81 43.58 9.38 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 161.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.14 23.71 69.92 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 118.817 2.287 . . . . 0.0 118.817 -166.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.78 148.47 29.24 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 118.849 1.325 . . . . 0.0 113.608 -166.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.0 tp -89.42 112.33 23.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.559 -0.713 . . . . 0.0 110.254 162.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 p -89.36 125.23 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 CA-C-O 123.038 1.399 . . . . 0.0 109.819 168.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -114.18 103.02 10.69 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.732 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -99.68 93.66 5.95 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 120.999 0.428 . . . . 0.0 111.254 -170.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -79.21 130.26 35.29 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.195 0.998 . . . . 0.0 111.953 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.4 121.72 26.45 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.713 0.688 . . . . 0.0 110.375 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -155.74 130.08 8.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.493 -1.379 . . . . 0.0 112.143 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 t70 51.65 50.09 19.49 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 166.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.48 16.34 58.38 Favored Glycine 0 CA--C 1.561 2.923 0 N-CA-C 120.342 2.897 . . . . 0.0 120.342 -167.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -131.84 150.47 52.14 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.917 1.359 . . . . 0.0 110.276 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.54 151.73 44.98 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.5 t -141.96 138.7 32.13 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.059 0.933 . . . . 0.0 112.61 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 p -110.57 117.18 32.84 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.653 0.781 . . . . 0.0 109.262 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.6 mm -101.8 109.58 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.7 m -96.96 106.33 18.64 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.543 0.687 . . . . 0.0 109.255 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -98.17 84.01 3.19 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.552 0.741 . . . . 0.0 109.972 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -95.67 132.98 40.27 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.9 103.49 12.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.359 -0.838 . . . . 0.0 110.434 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.258 45.6 tttm -117.9 -105.26 0.4 Allowed 'General case' 0 CA--C 1.559 1.301 0 O-C-N 121.933 -0.479 . . . . 0.0 111.071 -164.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.98 60.79 6.05 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-O 122.339 1.066 . . . . 0.0 112.67 -163.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 49.0 37.83 23.31 Favored Glycine 0 CA--C 1.558 2.775 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -153.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.12 139.95 8.72 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -155.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.1 tp -86.34 117.23 25.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.773 -1.204 . . . . 0.0 110.163 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.8 t -103.57 108.68 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.49 104.94 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -170.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -106.28 107.65 18.77 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -169.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.873 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.8 p -101.62 144.71 30.02 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.73 145.2 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 123.034 0.534 . . . . 0.0 110.234 166.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 26' ' ' LEU . 23.5 ttt -110.74 -80.33 0.58 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.053 -1.029 . . . . 0.0 110.561 168.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -111.73 -66.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 118.679 0.672 . . . . 0.0 110.912 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -122.52 -14.25 7.83 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -97.98 134.0 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-N 121.403 1.911 . . . . 0.0 110.062 -174.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 77.5 p -112.47 153.2 27.78 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.912 0.885 . . . . 0.0 112.68 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.873 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.8 OUTLIER -130.76 142.17 50.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.311 -0.868 . . . . 0.0 112.391 161.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.6 m -109.64 108.61 19.08 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -104.23 109.72 21.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.617 0.767 . . . . 0.0 109.992 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.2 mm -89.26 124.11 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -120.06 118.53 30.85 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.574 0.749 . . . . 0.0 111.124 -174.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -86.79 140.17 29.98 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.117 0.967 . . . . 0.0 112.94 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -78.29 134.78 37.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.266 -1.521 . . . . 0.0 113.62 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.9 95.76 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.981 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.253 9.0 p -67.88 -36.75 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 119.469 1.032 . . . . 0.0 113.675 166.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -58.58 -35.62 72.67 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.315 1.968 . . . . 0.0 116.315 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -64.42 -31.72 73.04 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 165.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.78 -20.56 65.97 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 163.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.2 117.25 22.19 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.285 1.857 . . . . 0.0 112.283 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.71 -178.7 39.78 Favored Glycine 0 N--CA 1.484 1.897 0 CA-C-O 122.098 0.832 . . . . 0.0 114.577 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -84.89 114.8 22.38 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.019 0.528 . . . . 0.0 110.777 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -110.58 104.54 13.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.949 -0.469 . . . . 0.0 111.97 -171.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -82.73 124.26 30.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.365 -0.834 . . . . 0.0 112.424 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.0 130.52 44.37 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.023 -1.048 . . . . 0.0 113.444 173.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.292 15.7 m -120.03 -63.7 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.617 173.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -92.76 149.81 21.06 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.431 1.469 . . . . 0.0 112.007 170.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p -148.34 79.14 1.44 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.912 166.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.44 119.13 19.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.554 -0.716 . . . . 0.0 110.936 -176.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.82 37.06 93.7 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 119.708 2.643 . . . . 0.0 119.708 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.6 -42.61 51.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 175.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -51.94 -50.04 61.97 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 163.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -48.54 -54.58 13.87 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 168.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -55.25 -53.61 53.92 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 170.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 31.7 mtm -67.75 -34.05 76.06 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -47.82 -44.09 28.55 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 158.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -41.72 81.7 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 169.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.3 mt -51.7 -50.42 60.53 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 165.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.44 40.39 0.23 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.408 HG23 ' CG ' ' A' ' 33' ' ' ARG . 6.6 m -112.67 144.19 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.686 0 CA-C-N 118.724 1.262 . . . . 0.0 112.463 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.33 -179.64 50.96 Favored Glycine 0 CA--C 1.551 2.33 0 CA-C-O 122.814 1.23 . . . . 0.0 115.989 168.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 pt -57.23 -46.25 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 117.921 2.564 . . . . 0.0 117.921 -171.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.65 -40.63 95.61 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.02 -39.02 86.94 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' CG ' HG23 ' A' ' 28' ' ' VAL . 20.5 mtm105 -63.78 -42.93 97.66 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 166.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -50.57 -50.49 53.47 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 161.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.6 mtp -72.3 58.37 0.39 Allowed 'General case' 0 CA--C 1.581 2.161 0 CA-C-O 123.028 1.394 . . . . 0.0 114.632 166.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.12 -63.72 0.08 OUTLIER Glycine 0 CA--C 1.543 1.809 0 O-C-N 121.349 -0.845 . . . . 0.0 111.56 -172.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.93 78.48 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 170.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . 0.26 19.2 ptt? -86.44 -17.89 33.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 170.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.07 121.24 22.51 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.172 1.351 . . . . 0.0 113.707 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -96.36 113.46 62.51 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.365 170.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -86.12 146.72 8.91 Favored 'Trans proline' 0 CA--C 1.561 1.828 0 C-N-CA 122.284 1.989 . . . . 0.0 115.052 168.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.57 97.97 10.86 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.265 158.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.8 t -87.65 104.64 16.72 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.139 0.976 . . . . 0.0 111.713 -174.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.0 mt -92.12 106.44 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.6 mt -96.86 128.99 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.4 m -156.46 130.49 8.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.274 -1.516 . . . . 0.0 109.938 171.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.8 p -118.75 130.01 55.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -97.72 93.03 6.16 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 121.802 0.81 . . . . 0.0 108.978 166.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.13 -75.46 1.14 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 116.67 1.428 . . . . 0.0 116.67 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -127.73 -30.63 2.51 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.69 100.99 5.59 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 120.909 1.686 . . . . 0.0 111.757 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -93.84 116.19 28.64 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.341 1.056 . . . . 0.0 109.945 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.3 m -93.38 123.77 36.9 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.662 0.785 . . . . 0.0 109.62 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 mt -115.79 107.38 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -103.68 103.5 13.42 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.646 0.779 . . . . 0.0 109.547 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.6 m -94.18 100.17 12.3 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.322 1.049 . . . . 0.0 110.686 -171.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -100.09 102.55 13.9 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.081 0.553 . . . . 0.0 111.746 -165.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 t -138.7 139.85 38.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.478 -0.764 . . . . 0.0 111.451 173.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.0 p -63.93 -33.55 75.96 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.4 mt -67.26 -45.97 75.09 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 167.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -155.12 114.67 3.69 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.471 1.487 . . . . 0.0 111.376 170.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.8 m -94.24 141.05 29.01 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.586 0.708 . . . . 0.0 111.399 172.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.1 p -138.48 154.97 48.83 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 123.93 0.892 . . . . 0.0 111.112 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.0 146.13 32.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.351 -1.468 . . . . 0.0 112.906 172.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -152.44 151.62 30.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.586 -0.696 . . . . 0.0 112.807 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -110.54 115.73 30.13 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.503 0.721 . . . . 0.0 110.85 166.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.8 p -104.5 134.04 48.35 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.553 -0.717 . . . . 0.0 112.739 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 88.6 m -81.25 113.08 19.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.865 -1.147 . . . . 0.0 110.336 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -69.85 120.83 16.18 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -172.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.7 -36.31 3.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 -166.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.41 -169.92 2.62 Favored 'General case' 0 CA--C 1.575 1.905 0 CA-C-N 119.128 1.464 . . . . 0.0 111.953 -176.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -86.34 142.02 28.79 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -117.24 163.33 16.47 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.38 159.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -82.24 103.56 11.92 Favored 'General case' 0 CA--C 1.565 1.554 0 O-C-N 120.6 -1.312 . . . . 0.0 110.045 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -87.28 104.84 16.78 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.5 m -82.31 104.41 12.59 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 165.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.6 p -76.22 159.16 30.91 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -164.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.46 -38.93 56.19 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 165.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.276 2.7 t0 -44.35 -47.32 9.62 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 157.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.02 -31.75 4.41 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -164.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -62.44 137.01 58.17 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.8 1.8 . . . . 0.0 114.781 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -76.59 121.57 23.38 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.721 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.7 p -132.72 118.46 19.1 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.595 0.712 . . . . 0.0 111.015 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -76.98 101.3 5.93 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.61 0.764 . . . . 0.0 109.442 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.1 m -116.51 107.15 14.4 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.461 -154.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.5 t -81.02 117.56 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 122.893 0.477 . . . . 0.0 109.871 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.4 m -101.46 108.79 20.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.137 -0.352 . . . . 0.0 111.326 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -126.24 124.19 39.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.777 -0.577 . . . . 0.0 111.446 -175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -85.13 126.85 33.96 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.455 -0.778 . . . . 0.0 111.567 168.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -143.02 137.04 29.0 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 122.994 0.518 . . . . 0.0 109.773 165.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.83 39.49 16.98 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 159.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.62 20.27 79.51 Favored Glycine 0 CA--C 1.557 2.669 0 N-CA-C 119.23 2.452 . . . . 0.0 119.23 -166.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.83 131.63 21.42 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 119.295 1.548 . . . . 0.0 112.922 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.9 tp -94.45 109.92 21.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.667 -0.646 . . . . 0.0 110.645 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.18 108.71 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.675 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -95.39 102.4 14.2 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 124.166 0.986 . . . . 0.0 108.961 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -102.04 93.23 5.14 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.404 0.681 . . . . 0.0 111.997 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -77.07 117.07 18.28 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.786 0.834 . . . . 0.0 112.569 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.5 135.56 50.32 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.867 0.842 . . . . 0.0 110.12 166.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -152.28 117.22 5.15 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.256 27.5 t70 49.87 45.06 25.23 Favored 'General case' 0 CA--C 1.587 2.367 0 N-CA-C 117.141 2.275 . . . . 0.0 117.141 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.93 27.1 68.09 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 119.894 2.718 . . . . 0.0 119.894 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -135.43 100.05 4.4 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -172.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -115.3 142.68 46.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -165.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.5 t -117.31 137.28 52.53 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.802 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 p -114.69 109.15 17.77 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.4 mp -103.4 98.11 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 m -94.0 105.57 17.57 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.598 0.759 . . . . 0.0 109.975 -175.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -94.3 88.48 5.57 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 123.627 0.771 . . . . 0.0 110.156 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -105.16 137.42 42.96 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -168.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 116.81 29.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.9 -1.125 . . . . 0.0 112.81 -172.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.75 84.27 3.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.591 -0.693 . . . . 0.0 109.714 167.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.276 25.1 m-20 7.5 62.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 120.608 3.559 . . . . 0.0 120.608 -173.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 138.78 -49.38 0.83 Allowed Glycine 0 N--CA 1.49 2.275 0 CA-C-N 114.515 -1.22 . . . . 0.0 115.503 -167.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -112.77 138.55 49.44 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 117.802 0.801 . . . . 0.0 110.557 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.19 116.32 28.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.889 -1.132 . . . . 0.0 109.6 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.9 t -93.95 109.57 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 80.5 t -98.8 105.55 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -96.67 100.78 12.32 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.746 0.819 . . . . 0.0 109.378 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.7 p -97.31 131.59 43.86 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.62 -0.675 . . . . 0.0 111.169 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.87 123.67 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.836 -0.54 . . . . 0.0 110.598 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 10.6 ttt -115.55 114.76 25.39 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 164.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.7 m120 55.23 55.92 7.01 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.297 40.3 m-80 76.65 -30.16 0.18 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -171.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.0 t -86.42 123.63 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 120.885 1.675 . . . . 0.0 109.949 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 72.4 p -113.6 144.28 43.16 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -163.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.5 OUTLIER -111.93 136.56 51.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 0.0 110.939 151.383 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.1 m -114.4 111.18 21.03 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 170.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -114.69 116.18 28.29 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.741 0.416 . . . . 0.0 110.327 -170.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.86 128.17 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -122.35 140.55 52.54 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.77 0.828 . . . . 0.0 111.879 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.86 135.84 42.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -76.78 113.08 14.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.074 -1.016 . . . . 0.0 111.641 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.0 t -106.07 92.86 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -173.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.017 -174.363 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.0 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.478 5.3 p 53.89 -62.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 N-CA-C 118.704 2.853 . . . . 0.0 118.704 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -52.22 -42.64 63.74 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -67.85 -18.79 64.93 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 172.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.54 -9.69 58.61 Favored 'General case' 0 CA--C 1.577 1.999 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 160.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.37 140.64 29.33 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 121.541 1.973 . . . . 0.0 112.944 -171.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.81 -177.82 23.05 Favored Glycine 0 N--CA 1.488 2.162 0 CA-C-O 122.145 0.859 . . . . 0.0 114.607 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -87.9 121.11 29.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.984 -0.715 . . . . 0.0 110.083 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -124.86 110.6 14.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.78 -0.575 . . . . 0.0 110.122 -169.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.3 ttm105 -98.56 134.7 41.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.831 -1.168 . . . . 0.0 113.251 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.91 133.0 49.97 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.28 21.7 m -124.35 -60.5 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 123.722 0.809 . . . . 0.0 112.281 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -89.43 148.35 23.52 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.346 1.43 . . . . 0.0 111.298 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 m -148.7 58.15 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.215 1.007 . . . . 0.0 113.218 165.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -72.88 123.5 23.53 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.294 -0.878 . . . . 0.0 113.083 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.77 2.58 81.43 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 118.85 2.3 . . . . 0.0 118.85 -167.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -72.12 -42.61 65.86 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.406 2.103 . . . . 0.0 116.65 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.62 -49.65 74.32 Favored 'General case' 0 CA--C 1.578 2.057 0 CA-C-N 120.962 1.71 . . . . 0.0 114.563 170.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -49.59 -44.93 47.41 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 164.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 74.5 t80 -59.71 -52.27 66.23 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 170.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.294 18.4 ptt? -70.31 -24.34 63.0 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -63.15 -39.84 95.83 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 121.523 1.965 . . . . 0.0 115.303 154.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -72.64 -40.01 66.73 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.0 mt -50.29 -41.81 51.44 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 117.989 2.588 . . . . 0.0 117.989 168.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.88 66.43 0.8 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 123.443 0.544 . . . . 0.0 113.648 -168.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -128.82 133.53 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -171.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.94 155.3 52.75 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 116.483 1.353 . . . . 0.0 116.483 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.262 2.7 pp -54.14 -44.07 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 N-CA-C 117.898 2.555 . . . . 0.0 117.898 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.99 88.14 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 168.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.36 -42.01 98.0 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 167.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -59.67 -47.51 85.35 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 120.352 1.433 . . . . 0.0 114.398 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.36 -46.83 88.54 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 169.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.1 ttp -52.48 -55.11 24.22 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 165.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.64 74.91 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 119.236 2.455 . . . . 0.0 119.236 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.95 91.21 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.4 ptp -77.24 -27.36 53.27 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.21 108.94 5.63 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.906 1.23 . . . . 0.0 113.731 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -102.3 93.96 4.42 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 118.196 -0.906 . . . . 0.0 110.649 168.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.84 153.31 25.71 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.474 2.116 . . . . 0.0 115.59 -173.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.69 105.27 17.25 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.643 0.735 . . . . 0.0 109.302 165.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.2 t -95.02 110.5 22.41 Favored 'General case' 0 CA--C 1.56 1.344 0 O-C-N 120.909 -1.119 . . . . 0.0 111.735 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mp -89.47 106.83 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.63 126.94 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.1 m -150.75 128.84 11.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.628 -1.295 . . . . 0.0 109.846 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.6 t -120.7 114.23 21.37 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-O 121.899 0.857 . . . . 0.0 112.019 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -79.95 76.08 6.67 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 122.054 0.93 . . . . 0.0 110.45 167.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.73 -82.25 0.09 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -105.23 -16.43 14.77 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 167.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -88.81 106.06 18.13 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 120.982 1.719 . . . . 0.0 109.9 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.49 116.01 31.59 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 111.344 -168.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.9 m -108.37 128.46 54.79 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.041 0.936 . . . . 0.0 109.493 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.73 122.18 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -109.98 111.96 23.67 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.055 0.542 . . . . 0.0 110.073 168.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.8 m -87.87 99.53 12.2 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -86.19 116.91 24.68 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.153 0.978 . . . . 0.0 111.594 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.1 t -147.06 135.05 21.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.85 0.86 . . . . 0.0 109.764 169.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 64.5 p -59.32 -30.37 68.31 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 165.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.3 mt -71.58 -53.06 14.98 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 170.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -153.04 100.04 2.45 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 120.284 1.402 . . . . 0.0 110.593 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.6 m -77.83 146.1 35.93 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.012 0.91 . . . . 0.0 111.669 171.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.7 m -152.16 134.01 14.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.091 -1.631 . . . . 0.0 109.857 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -131.5 138.77 49.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 111.577 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -141.91 152.63 43.73 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 174.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.7 p -135.78 109.49 8.05 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.924 0.89 . . . . 0.0 110.029 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.2 t -134.82 154.21 51.72 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.556 0.742 . . . . 0.0 112.242 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.92 140.07 47.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.433 -1.417 . . . . 0.0 110.603 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.9 tp -68.89 118.98 12.51 Favored 'General case' 0 CA--C 1.579 2.088 0 O-C-N 120.69 -1.256 . . . . 0.0 111.442 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.35 -40.92 2.34 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 116.988 1.555 . . . . 0.0 116.988 -157.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.8 154.86 24.51 Favored 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 125.194 1.398 . . . . 0.0 113.416 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.3 152.64 21.3 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 166.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -138.62 162.47 34.54 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.761 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.84 100.58 2.93 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.878 0.847 . . . . 0.0 111.519 166.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -92.81 98.27 11.29 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.6 m -79.79 95.73 6.09 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 163.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.2 p -61.75 170.65 1.91 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -160.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.92 -41.04 58.43 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 164.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -50.43 -61.35 2.23 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 159.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.67 -30.49 3.1 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 120.588 -1.32 . . . . 0.0 116.303 -151.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -60.56 134.95 57.58 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 118.703 1.252 . . . . 0.0 112.63 173.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -85.81 129.15 34.91 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.344 0.592 . . . . 0.0 111.197 168.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.4 p -130.29 136.86 49.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.681 0.753 . . . . 0.0 109.217 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -87.62 96.16 10.31 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 120.692 -1.255 . . . . 0.0 108.956 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.9 m -103.64 115.61 30.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.641 -0.662 . . . . 0.0 110.65 -161.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.5 p -85.44 124.5 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-N 118.696 0.68 . . . . 0.0 112.024 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.1 m -94.0 111.85 23.61 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.376 0.67 . . . . 0.0 111.398 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -139.76 124.76 18.63 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 119.828 1.194 . . . . 0.0 112.847 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -95.2 130.36 41.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.136 -0.977 . . . . 0.0 111.71 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 t -147.69 136.33 21.81 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.222 0.609 . . . . 0.0 110.16 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 62.72 33.72 15.27 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 160.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.93 -13.77 55.38 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 -164.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -109.78 128.62 55.42 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 119.644 1.722 . . . . 0.0 113.167 -176.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.7 tp -86.7 108.5 18.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.416 -0.803 . . . . 0.0 109.637 161.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.6 t -91.75 112.19 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 98.73 10.7 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 169.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -91.12 99.39 12.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 111.355 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -70.02 125.3 26.37 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.852 0.861 . . . . 0.0 112.05 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -124.37 117.22 23.99 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -150.18 120.54 7.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.683 -1.261 . . . . 0.0 112.645 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.255 39.1 t70 50.61 44.28 27.43 Favored 'General case' 0 CA--C 1.585 2.317 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.91 -30.32 2.93 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 119.06 2.384 . . . . 0.0 119.06 -166.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -83.63 144.78 29.2 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.696 1.198 . . . . 0.0 112.79 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -140.52 156.82 46.2 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.1 t -146.94 142.28 27.4 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.445 0.698 . . . . 0.0 111.663 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.0 p -102.04 113.5 26.79 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.279 -0.888 . . . . 0.0 110.864 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.4 mm -88.19 95.68 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.1 m -96.67 92.32 6.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.554 -0.716 . . . . 0.0 110.53 -167.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -90.57 97.7 11.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.302 0.641 . . . . 0.0 111.673 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -119.2 137.34 53.7 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.725 0.81 . . . . 0.0 112.742 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.47 121.57 24.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 111.613 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.76 -144.67 0.39 Allowed 'General case' 0 CA--C 1.562 1.404 0 CA-C-O 121.231 0.539 . . . . 0.0 111.868 -171.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -87.2 66.09 9.1 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 120.973 -1.079 . . . . 0.0 109.954 -167.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.81 -18.11 58.1 Favored Glycine 0 CA--C 1.557 2.664 0 N-CA-C 119.67 2.628 . . . . 0.0 119.67 -168.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.65 166.53 24.34 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.629 2.215 . . . . 0.0 110.986 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.9 tp -87.15 120.68 28.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.061 -1.649 . . . . 0.0 111.318 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.405 HG22 ' CD1' ' A' ' 130' ' ' ILE . 55.8 t -87.15 115.57 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -109.21 93.07 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -84.66 95.09 8.79 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.905 1.336 . . . . 0.0 109.593 173.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.4 p -89.46 99.72 12.66 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.603 176.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 p -113.56 126.03 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.647 0.737 . . . . 0.0 110.534 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.0 tpt -73.51 -60.76 2.1 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.564 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.258 12.5 p30 -153.46 -80.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -79.77 -32.75 40.99 Favored 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 159.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.25 106.69 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 CA-C-N 120.022 1.283 . . . . 0.0 110.607 -169.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.9 p -102.12 121.55 42.42 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.138 0.975 . . . . 0.0 111.305 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.3 p -100.9 117.21 34.52 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 118.195 0.452 . . . . 0.0 111.03 162.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 m -89.32 106.78 18.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.594 -0.691 . . . . 0.0 109.173 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -106.68 106.94 17.71 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.405 ' CD1' HG22 ' A' ' 117' ' ' VAL . 34.3 mm -91.28 132.41 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -120.93 131.79 54.56 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 121.267 0.556 . . . . 0.0 112.095 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -81.42 134.13 35.51 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -75.39 117.12 16.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.265 -0.897 . . . . 0.0 111.623 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.5 t -95.29 106.22 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 123.222 0.609 . . . . 0.0 110.264 -170.886 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . 0.267 66.7 m . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.258 9.3 p -68.95 -38.36 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.904 1.229 . . . . 0.0 114.142 158.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.47 -36.97 56.06 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 162.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -64.59 -26.37 68.38 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.623 2.082 . . . . 0.0 116.623 170.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.1 mt -65.08 -20.77 66.64 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 161.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -76.81 123.13 25.77 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.747 1.612 . . . . 0.0 112.127 -170.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.29 -179.79 26.73 Favored Glycine 0 N--CA 1.489 2.17 0 CA-C-O 122.162 0.868 . . . . 0.0 115.109 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -93.33 132.69 37.31 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.031 0.532 . . . . 0.0 111.042 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -124.98 110.45 14.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.968 -0.457 . . . . 0.0 111.286 -168.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -95.88 128.61 42.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.729 -1.232 . . . . 0.0 113.516 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.19 129.27 38.48 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.277 10.3 m -118.52 -64.23 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 118.51 -0.757 . . . . 0.0 111.749 178.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -101.93 157.3 16.96 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 123.352 1.548 . . . . 0.0 112.158 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -155.95 72.35 0.77 Allowed 'General case' 0 CA--C 1.562 1.438 0 O-C-N 120.891 -1.131 . . . . 0.0 110.878 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.11 129.87 41.3 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.156 -0.965 . . . . 0.0 112.437 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.54 11.06 61.66 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 119.953 2.741 . . . . 0.0 119.953 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -68.79 -35.59 77.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.313 1.968 . . . . 0.0 116.313 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -53.46 -54.81 31.65 Favored 'General case' 0 CA--C 1.575 1.917 0 CA-C-N 119.964 1.256 . . . . 0.0 114.22 167.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -54.44 -40.1 68.03 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 168.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.5 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 78.9 t80 -60.5 -45.51 93.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 166.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.3 9.6 ptt? -73.21 -30.3 63.41 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -42.72 91.58 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-N 121.192 1.814 . . . . 0.0 115.271 155.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -61.48 -42.65 99.11 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.7 mt -58.23 -44.54 88.27 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 165.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.58 44.07 2.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 117.654 1.822 . . . . 0.0 117.654 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.92 139.55 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 C-N-CA 124.054 0.942 . . . . 0.0 110.022 162.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.03 171.68 47.91 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 116.245 1.258 . . . . 0.0 116.245 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 pt -53.07 -47.3 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 -172.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.36 95.9 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.46 -40.33 95.51 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 168.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 mtp-105 -61.0 -44.82 96.86 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 166.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.73 -46.6 81.23 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.8 ttm -51.13 -59.6 4.01 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 163.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.68 -36.45 48.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 119.96 2.744 . . . . 0.0 119.96 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.43 70.43 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 21.4 ptp -85.54 -26.47 26.17 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.93 106.81 3.32 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 120.262 1.392 . . . . 0.0 113.308 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -109.47 90.54 8.73 Favored Pre-proline 0 CA--C 1.571 1.758 0 C-N-CA 123.778 0.831 . . . . 0.0 109.84 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.47 160.92 14.82 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.409 2.073 . . . . 0.0 116.288 -167.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -93.7 97.96 10.8 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.152 166.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.8 t -89.9 110.51 21.45 Favored 'General case' 0 CA--C 1.558 1.273 0 O-C-N 121.185 -0.947 . . . . 0.0 112.087 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 mt -90.4 114.75 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 108.666 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 91.9 mt -94.7 123.74 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 166.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.1 m -150.28 126.71 10.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.98 -1.075 . . . . 0.0 109.846 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -122.08 116.39 24.16 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.08 84.28 7.05 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.347 1.07 . . . . 0.0 110.579 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.6 -75.3 1.24 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -125.23 -20.97 4.71 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 170.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.73 103.89 11.74 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 121.808 2.095 . . . . 0.0 111.222 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tt -98.0 117.71 32.96 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.073 0.949 . . . . 0.0 110.237 -171.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.7 m -96.83 126.41 41.97 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.798 0.839 . . . . 0.0 110.066 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.5 mt -110.03 102.3 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -101.86 104.22 14.94 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.281 0.632 . . . . 0.0 110.115 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.4 m -86.86 106.48 17.77 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.797 0.839 . . . . 0.0 109.984 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -94.79 115.54 27.62 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.535 0.683 . . . . 0.0 111.573 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.2 t -153.59 136.82 15.67 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.422 0.689 . . . . 0.0 110.55 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.2 p -59.32 -33.96 71.76 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 mt -64.44 -50.32 68.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 166.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.06 105.66 2.56 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 119.85 1.204 . . . . 0.0 111.663 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.1 m -90.91 133.87 34.91 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 123.033 0.533 . . . . 0.0 110.636 172.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -137.64 146.69 44.2 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 123.355 0.662 . . . . 0.0 111.149 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 129.55 22.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.744 -1.223 . . . . 0.0 111.483 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.84 143.71 47.17 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.616 0.766 . . . . 0.0 111.102 172.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.6 m -130.05 126.06 36.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 0.0 111.259 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.46 146.26 33.28 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -169.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.51 134.33 43.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.698 -1.251 . . . . 0.0 110.856 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -72.84 117.21 14.27 Favored 'General case' 0 CA--C 1.574 1.883 0 O-C-N 120.671 -1.268 . . . . 0.0 112.88 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.7 -34.93 5.41 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 117.23 1.652 . . . . 0.0 117.23 -158.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.71 158.32 31.06 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 122.787 1.279 . . . . 0.0 113.376 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -115.74 140.97 48.7 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.705 173.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -152.15 153.53 34.05 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.945 0.898 . . . . 0.0 110.917 -162.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -83.14 87.23 6.92 Favored 'General case' 0 CA--C 1.574 1.882 0 O-C-N 120.487 -1.383 . . . . 0.0 113.778 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.38 115.2 12.46 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.151 0.977 . . . . 0.0 110.525 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.8 m -101.12 100.53 11.11 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.488 -170.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 p -73.06 159.86 32.94 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -161.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.73 -32.88 6.32 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 119.123 3.009 . . . . 0.0 119.123 169.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -58.61 -51.23 70.79 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 161.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.02 -30.24 2.85 Favored Glycine 0 CA--C 1.551 2.343 0 N-CA-C 116.96 1.544 . . . . 0.0 116.96 -157.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 -58.65 129.68 43.27 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.351 2.076 . . . . 0.0 114.816 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.86 101.6 11.77 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.803 0.841 . . . . 0.0 109.427 172.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.0 p -109.51 105.58 14.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.048 -1.032 . . . . 0.0 110.088 -168.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -70.38 105.31 2.98 Favored 'General case' 0 CA--C 1.565 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.445 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.0 m -130.85 120.35 23.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.003 . . . . 0.0 110.279 -151.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.76 126.79 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 118.829 0.741 . . . . 0.0 111.736 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.4 m -105.69 112.12 25.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.942 -0.474 . . . . 0.0 111.807 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -125.08 131.03 53.38 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.303 0.641 . . . . 0.0 111.112 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -88.49 127.06 35.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.959 . . . . 0.0 111.617 168.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.1 t -143.22 140.35 30.66 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.157 0.583 . . . . 0.0 110.139 167.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 61.67 36.71 16.4 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 160.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.43 16.84 80.38 Favored Glycine 0 CA--C 1.557 2.691 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -165.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.75 136.07 26.87 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 119.664 1.732 . . . . 0.0 113.919 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.0 tp -92.8 112.42 24.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.699 -0.626 . . . . 0.0 110.916 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.09 109.04 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -89.22 98.79 11.97 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.251 0.62 . . . . 0.0 109.339 167.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -89.84 104.14 16.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.605 -0.684 . . . . 0.0 110.232 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -91.62 131.97 36.65 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.154 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -127.94 126.29 41.17 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 119.035 0.834 . . . . 0.0 110.197 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -148.14 120.81 8.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.575 -1.328 . . . . 0.0 110.451 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.8 t70 49.7 51.06 17.22 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.72 -24.91 2.19 Favored Glycine 0 CA--C 1.557 2.688 0 N-CA-C 119.596 2.598 . . . . 0.0 119.596 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -93.67 140.96 29.02 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.994 1.397 . . . . 0.0 111.55 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -129.32 146.85 51.14 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 175.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.7 t -143.4 111.24 6.01 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.037 0.535 . . . . 0.0 110.385 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.3 t -98.65 146.3 25.98 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.8 mt -127.91 108.31 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -169.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.6 m -97.63 106.23 18.51 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.548 0.739 . . . . 0.0 110.214 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -93.0 85.87 5.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 111.237 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -100.37 130.13 46.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -167.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.89 117.24 21.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 112.288 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -145.78 121.88 10.77 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.519 0.728 . . . . 0.0 109.684 -171.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 59.5 47.99 10.29 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 168.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.75 35.04 80.03 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -166.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.48 139.6 16.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.452 0.701 . . . . 0.0 109.781 -162.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.11 112.46 24.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.172 -0.955 . . . . 0.0 108.757 172.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.2 t -99.16 101.82 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.37 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -165.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -100.1 100.98 11.91 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.987 0.899 . . . . 0.0 109.798 -170.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.5 p -101.72 127.25 48.57 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.158 0.983 . . . . 0.0 111.517 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.71 143.62 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 123.316 0.646 . . . . 0.0 111.518 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.7 ttt -124.17 -103.13 0.38 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.336 -0.852 . . . . 0.0 108.732 165.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -87.66 70.51 9.71 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 120.571 1.532 . . . . 0.0 111.264 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.253 0.7 OUTLIER 62.88 0.13 0.65 Allowed 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 118.169 2.655 . . . . 0.0 118.169 -165.709 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.47 93.94 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.253 -1.529 . . . . 0.0 108.644 -171.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.6 p -92.62 117.59 30.13 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.252 0.548 . . . . 0.0 111.761 -171.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 4.1 p -108.12 119.91 40.81 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.437 0.695 . . . . 0.0 111.339 171.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.6 m -101.96 107.57 18.75 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -101.67 114.1 27.84 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.483 0.713 . . . . 0.0 109.833 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.47 124.94 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.344 -0.848 . . . . 0.0 108.924 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -122.95 131.76 53.86 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -86.21 132.13 34.07 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.253 1.421 . . . . 0.0 113.725 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -73.36 111.13 8.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.877 -1.139 . . . . 0.0 112.102 174.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.2 t -103.62 95.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.253 1.286 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.738 -178.039 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.519 3.9 p 58.45 -48.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 -172.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.95 -47.66 84.28 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -64.94 -15.96 62.74 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 171.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.61 -11.74 61.0 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 163.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -83.9 125.25 31.82 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 121.422 1.919 . . . . 0.0 113.091 -165.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.6 -170.6 26.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 115.856 1.102 . . . . 0.0 115.856 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -90.49 122.52 33.41 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.536 0.734 . . . . 0.0 110.894 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.449 ' CH2' HD21 ' A' ' 111' ' ' LEU . 95.2 m95 -123.55 110.89 15.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.613 -0.679 . . . . 0.0 110.857 -172.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -90.15 130.63 36.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.591 -1.318 . . . . 0.0 113.37 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 46.8 tp -65.0 128.65 36.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 173.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.275 8.8 m -121.46 -61.4 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.129 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -96.43 149.51 21.64 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.491 1.496 . . . . 0.0 111.41 167.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.4 p -145.81 65.76 1.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.166 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.23 126.96 31.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.726 -1.234 . . . . 0.0 112.386 -175.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.64 23.14 62.6 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 119.248 2.459 . . . . 0.0 119.248 -171.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -75.1 -46.81 32.09 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 119.002 1.401 . . . . 0.0 114.455 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.69 -44.14 63.03 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 163.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -52.8 -48.54 66.83 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -58.82 -51.29 70.63 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 167.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 50.0 mtm -68.35 -42.62 78.95 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.34 -37.28 23.93 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 116.207 1.928 . . . . 0.0 116.207 164.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.76 -39.39 76.73 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 171.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.5 mt -51.04 -45.09 61.21 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 162.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.9 46.92 1.06 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 117.114 1.605 . . . . 0.0 117.114 -172.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 m -91.78 143.03 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 C-N-CA 124.519 1.128 . . . . 0.0 110.676 166.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.55 174.5 42.03 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 2.6 pp -55.81 -44.94 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.25 84.32 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.8 mt -64.9 -43.24 93.48 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -52.46 -54.6 30.23 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 164.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -59.49 -52.31 66.14 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.2 ttp -56.15 -49.78 73.02 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 172.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.39 -44.8 97.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 118.23 2.052 . . . . 0.0 118.23 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.23 96.94 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.1 ptp -76.98 -16.72 59.25 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.148 2.648 . . . . 0.0 118.148 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.14 145.39 46.43 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.29 73.07 5.17 Favored Pre-proline 0 CA--C 1.577 1.984 0 CA-C-O 118.546 -0.74 . . . . 0.0 110.627 171.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.32 146.8 57.78 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.134 2.556 . . . . 0.0 116.001 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -83.07 100.8 10.72 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.097 165.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.4 t -79.19 101.9 8.22 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.839 0.828 . . . . 0.0 110.545 167.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mt -96.2 106.36 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.31 128.65 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.0 m -146.32 113.15 6.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.395 -0.816 . . . . 0.0 108.821 170.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.7 95.64 10.0 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 121.276 -0.89 . . . . 0.0 111.062 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.56 76.77 9.98 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-O 122.393 1.092 . . . . 0.0 110.063 -171.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.59 -101.11 1.62 Allowed Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.143 -0.973 . . . . 0.0 113.642 -167.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -94.97 -11.94 27.63 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 156.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -84.57 96.5 9.18 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 122.023 2.192 . . . . 0.0 110.556 -167.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.3 tp -73.22 108.62 6.2 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 121.941 0.876 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.2 m -98.34 105.39 17.53 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.7 103.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -102.85 115.88 31.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.579 0.752 . . . . 0.0 109.687 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.8 m -100.3 97.29 8.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.699 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -89.34 119.72 30.06 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.88 0.848 . . . . 0.0 112.313 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.1 t -150.66 134.76 16.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.673 0.789 . . . . 0.0 110.054 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.4 p -59.12 -33.31 70.71 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.04 -47.84 73.05 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 166.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -158.27 104.94 1.88 Allowed 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.145 1.338 . . . . 0.0 111.173 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.2 m -92.39 137.53 32.28 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.708 -0.62 . . . . 0.0 111.55 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -144.25 164.47 30.65 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.428 0.691 . . . . 0.0 111.686 168.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -154.46 149.72 27.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 119.897 -1.752 . . . . 0.0 114.285 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -138.93 141.21 38.47 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.424 0.63 . . . . 0.0 112.122 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.7 p -126.41 105.15 8.58 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.767 0.827 . . . . 0.0 109.923 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.3 p -136.85 142.13 42.83 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -166.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 m -72.07 118.98 15.62 Favored 'General case' 0 CA--C 1.574 1.871 0 O-C-N 120.575 -1.328 . . . . 0.0 111.768 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 tp -69.48 122.87 19.86 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -166.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.44 -38.08 3.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -158.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -99.23 164.45 12.13 Favored 'General case' 0 CA--C 1.574 1.9 0 CA-C-O 123.519 1.628 . . . . 0.0 113.405 -166.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -103.28 125.69 50.06 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 113.622 -1.626 . . . . 0.0 112.446 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.401 ' HE1' ' SG ' ' A' ' 87' ' ' CYS . 35.7 p90 -125.02 164.69 19.61 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.944 0.897 . . . . 0.0 113.377 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -76.64 104.91 7.39 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.71 1.243 . . . . 0.0 111.516 167.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.82 115.89 27.5 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.229 1.012 . . . . 0.0 109.349 175.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.1 m -90.04 97.17 11.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.9 p -71.05 147.76 48.23 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.69 -37.02 7.75 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -65.41 -49.13 70.38 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 166.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.73 -14.26 1.19 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 118.478 2.151 . . . . 0.0 118.478 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -69.5 133.09 47.28 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 120.375 2.088 . . . . 0.0 112.84 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -86.73 102.05 13.87 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.065 165.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.4 p -104.26 143.08 33.44 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.49 -0.756 . . . . 0.0 110.591 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -79.23 95.6 5.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.478 -1.389 . . . . 0.0 110.494 166.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.2 m -92.46 116.65 29.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 0.0 110.132 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.315 11.6 p -87.82 109.46 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 118.264 0.483 . . . . 0.0 109.884 160.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.401 ' SG ' ' HE1' ' A' ' 73' ' ' PHE . 56.4 m -92.07 110.32 21.69 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -133.41 126.68 31.76 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.007 0.523 . . . . 0.0 111.627 -169.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -90.25 113.44 25.26 Favored 'General case' 0 CA--C 1.563 1.454 0 O-C-N 121.551 -0.718 . . . . 0.0 110.17 170.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 t -97.29 57.99 1.48 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.3 47.8 m-20 45.68 57.32 5.11 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 146.07 -61.13 0.47 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.829 -170.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.59 133.78 51.54 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.841 0.829 . . . . 0.0 112.86 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.7 tp -95.18 107.55 19.64 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.714 0.806 . . . . 0.0 110.669 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.5 114.97 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.569 0.748 . . . . 0.0 109.031 -172.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -89.09 98.18 11.62 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 166.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -95.53 92.22 6.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.854 -0.529 . . . . 0.0 111.354 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -83.23 123.25 29.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.146 0.978 . . . . 0.0 111.389 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -123.29 121.75 36.62 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.392 0.542 . . . . 0.0 110.625 -173.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -150.33 127.1 10.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.667 -1.27 . . . . 0.0 111.613 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.299 17.5 t70 52.85 49.74 19.57 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 162.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.24 0.07 19.72 Favored Glycine 0 CA--C 1.561 2.93 0 N-CA-C 120.145 2.818 . . . . 0.0 120.145 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -123.1 145.25 48.73 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 119.274 1.537 . . . . 0.0 109.854 -173.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -133.43 169.79 16.44 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.03 121.33 5.76 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.751 -1.218 . . . . 0.0 111.596 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.54 103.56 12.46 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -172.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.0 mm -95.57 100.45 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 98.4 m -99.26 101.2 12.44 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.281 0.632 . . . . 0.0 110.252 -168.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -93.36 109.55 21.11 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.724 0.81 . . . . 0.0 110.793 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -125.15 144.35 50.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 112.766 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.449 HD21 ' CH2' ' A' ' 11' ' ' TRP . 0.2 OUTLIER -82.75 122.91 28.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.348 -0.845 . . . . 0.0 110.821 178.53 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.293 42.0 tttm -124.7 -118.87 0.28 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 122.08 -0.388 . . . . 0.0 109.957 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -84.19 68.23 10.05 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.19 0.995 . . . . 0.0 112.651 -166.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.9 -13.61 5.27 Favored Glycine 0 CA--C 1.556 2.599 0 N-CA-C 119.477 2.551 . . . . 0.0 119.477 -166.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -124.71 158.12 33.99 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 119.096 1.448 . . . . 0.0 110.285 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.52 111.16 19.25 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.651 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 75.4 t -90.13 114.39 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.8 t -115.7 99.69 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 -167.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -99.34 108.6 21.15 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.425 0.69 . . . . 0.0 109.279 -171.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.673 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.7 p -103.74 122.69 45.59 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.71 -0.619 . . . . 0.0 111.938 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.39 136.16 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.385 0.612 . . . . 0.0 110.911 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 12.4 ttt -86.01 -76.1 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 122.722 0.409 . . . . 0.0 110.887 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -126.88 -73.08 0.62 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 166.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -89.97 -30.05 18.06 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.9 t -85.15 107.06 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 119.919 1.236 . . . . 0.0 110.537 -166.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 69.7 p -105.17 113.11 26.51 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.544 0.738 . . . . 0.0 111.344 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.673 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.4 OUTLIER -87.47 157.19 19.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 166.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.0 m -127.97 109.14 11.29 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 166.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -98.38 123.96 42.79 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.527 0.731 . . . . 0.0 110.64 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.9 mm -99.19 116.34 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -114.35 130.86 56.69 Favored 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 122.854 0.462 . . . . 0.0 110.826 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -107.83 143.96 35.68 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -74.28 118.36 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.662 -0.649 . . . . 0.0 112.708 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.3 t -90.06 95.68 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 118.436 -0.792 . . . . 0.0 109.781 -174.253 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.6 m . . . . . 0 CA--C 1.567 1.61 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.01 50.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 C-N-CA 124.848 1.259 . . . . 0.0 109.609 157.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -136.97 70.51 1.4 Allowed 'General case' 0 CA--C 1.57 1.743 0 O-C-N 120.686 -1.259 . . . . 0.0 110.063 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -163.94 -52.33 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 125.87 1.668 . . . . 0.0 110.407 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.3 mt -75.87 0.27 18.78 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.42 143.72 29.24 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-N 120.736 1.607 . . . . 0.0 112.314 -171.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.62 -173.78 17.04 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 115.894 1.117 . . . . 0.0 115.894 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -87.24 112.7 22.28 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.469 0.708 . . . . 0.0 111.596 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -112.61 112.88 24.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 122.122 -0.361 . . . . 0.0 110.718 -175.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -94.01 134.09 36.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.635 -1.291 . . . . 0.0 112.746 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.49 126.77 30.77 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.597 -0.689 . . . . 0.0 111.92 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.258 3.6 m -113.1 -66.49 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.836 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -111.43 107.96 17.36 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.575 1.079 . . . . 0.0 110.347 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.6 p -89.56 81.62 6.49 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.617 -0.677 . . . . 0.0 111.449 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.27 107.28 14.83 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -163.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.18 16.43 78.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 118.439 2.136 . . . . 0.0 118.439 -168.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -86.29 68.78 10.35 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-N 120.102 1.951 . . . . 0.0 112.868 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -141.73 -51.7 0.42 Allowed 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.778 153.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -45.1 -46.81 11.94 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 167.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.403 ' CD2' ' SG ' ' A' ' 127' ' ' CYS . 57.9 t80 -54.55 -57.62 10.68 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 171.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 ptt? -61.74 -43.98 97.79 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.33 -46.89 55.92 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 162.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -67.87 -39.13 83.77 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.913 1.819 . . . . 0.0 115.913 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -50.03 -40.83 46.04 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 159.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.15 50.0 0.6 Allowed Glycine 0 N--CA 1.486 2.015 0 C-N-CA 124.738 1.161 . . . . 0.0 114.978 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.8 t -99.78 131.7 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.578 0.751 . . . . 0.0 109.197 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.26 160.74 48.69 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 116.888 1.515 . . . . 0.0 116.888 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.281 2.6 pp -58.23 -46.34 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -173.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.17 95.28 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 167.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -41.23 89.34 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 170.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -54.97 -49.54 71.15 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 162.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -54.88 -49.73 70.45 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 170.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -52.83 -55.93 19.45 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 165.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.02 -43.79 96.69 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 118.85 2.3 . . . . 0.0 118.85 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.04 95.01 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . 0.269 14.4 ptt? -70.23 -40.03 74.73 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 170.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.43 133.93 56.57 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.51 92.75 41.57 Favored Pre-proline 0 CA--C 1.571 1.786 0 CA-C-O 118.027 -0.987 . . . . 0.0 108.564 166.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.84 158.48 27.74 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.505 2.137 . . . . 0.0 115.713 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -94.22 107.41 19.36 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.531 165.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.65 102.5 15.02 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 121.142 -0.973 . . . . 0.0 111.16 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -90.91 119.66 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 81.0 mt -108.81 126.74 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -138.18 116.08 11.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.827 -1.171 . . . . 0.0 109.121 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.8 p -117.97 111.51 19.06 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -89.86 68.43 7.4 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 122.128 0.966 . . . . 0.0 110.594 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.45 -75.68 0.67 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 120.478 -1.389 . . . . 0.0 115.754 -170.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -104.16 -44.16 5.05 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -74.28 110.01 8.23 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 121.281 1.855 . . . . 0.0 111.792 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 tt -112.82 112.85 24.64 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 122.379 1.085 . . . . 0.0 109.053 -172.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.5 m -99.13 115.92 30.15 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.733 0.813 . . . . 0.0 109.108 -172.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mt -106.58 105.89 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -102.72 105.93 16.46 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.285 0.634 . . . . 0.0 109.89 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.0 m -88.68 103.03 15.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.458 -0.776 . . . . 0.0 109.322 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.88 117.19 29.77 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.967 0.889 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -156.4 137.41 13.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.561 0.744 . . . . 0.0 110.055 168.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.3 p -58.57 -34.66 71.3 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 167.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.5 -47.42 73.05 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 168.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -156.35 104.78 2.24 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 120.077 1.308 . . . . 0.0 110.794 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 m -93.06 132.43 37.19 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.137 0.575 . . . . 0.0 110.935 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.1 p -142.53 115.49 8.78 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.767 -0.583 . . . . 0.0 110.668 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -109.96 135.56 50.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.36 0.664 . . . . 0.0 112.016 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -142.17 144.64 33.52 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.815 0.817 . . . . 0.0 112.699 170.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.8 p -106.16 105.75 15.93 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.662 0.785 . . . . 0.0 110.769 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.5 p -102.53 135.35 44.32 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 m -75.73 130.81 39.25 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 120.752 -1.218 . . . . 0.0 110.454 171.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 tp -77.67 124.74 28.34 Favored 'General case' 0 CA--C 1.57 1.736 0 O-C-N 121.377 -0.827 . . . . 0.0 112.377 175.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.98 39.54 11.54 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 117.452 1.741 . . . . 0.0 117.452 -169.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -171.92 147.53 2.18 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.807 1.243 . . . . 0.0 108.522 -167.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.257 11.6 ptpt -100.18 146.97 26.22 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 171.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -137.88 161.08 37.57 Favored 'General case' 0 CA--C 1.571 1.757 0 C-N-CA 124.893 1.277 . . . . 0.0 110.513 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -80.74 104.26 11.14 Favored 'General case' 0 CA--C 1.572 1.825 0 O-C-N 119.972 -1.705 . . . . 0.0 112.228 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -88.16 109.49 19.94 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.14 0.976 . . . . 0.0 110.707 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.3 m -76.08 99.54 4.67 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.772 . . . . 0.0 110.205 170.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 p -69.66 148.12 49.71 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.574 0.749 . . . . 0.0 112.717 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.14 -41.91 18.43 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.42 -43.91 76.17 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 170.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.82 -31.05 0.29 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.8 mtm-85 -67.75 126.86 30.74 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.071 1.936 . . . . 0.0 113.038 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -88.73 117.13 27.49 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.08 0.467 . . . . 0.0 109.777 166.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.0 p -123.82 129.07 50.45 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.479 0.657 . . . . 0.0 110.338 -163.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -83.64 105.4 14.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.525 -1.36 . . . . 0.0 109.679 -170.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.7 m -121.6 105.53 10.53 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.96 -0.463 . . . . 0.0 110.98 -148.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.44 120.84 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 120.89 0.376 . . . . 0.0 111.443 172.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 45.4 m -95.35 109.38 21.55 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.123 0.487 . . . . 0.0 109.732 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -136.31 124.0 22.43 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.141 0.576 . . . . 0.0 110.932 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -85.88 132.69 34.04 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.093 -1.005 . . . . 0.0 112.188 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 t -139.87 143.52 36.77 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.148 0.579 . . . . 0.0 110.101 163.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 62.27 35.69 15.14 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 162.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.14 29.06 73.17 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -164.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.08 134.28 18.27 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 118.519 1.16 . . . . 0.0 112.907 -170.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.9 tp -88.04 115.46 25.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.782 -0.574 . . . . 0.0 111.216 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.31 108.06 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -94.44 90.11 6.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -89.84 108.13 19.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.903 -0.498 . . . . 0.0 110.863 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -106.6 130.5 54.34 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -169.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -129.36 127.48 41.13 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 123.622 0.769 . . . . 0.0 111.747 -166.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -153.04 134.87 14.62 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.274 -1.516 . . . . 0.0 111.159 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.2 t70 48.29 48.3 18.97 Favored 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 166.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.32 19.06 66.04 Favored Glycine 0 CA--C 1.558 2.764 0 N-CA-C 120.384 2.913 . . . . 0.0 120.384 -167.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -136.54 137.1 39.91 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.216 1.508 . . . . 0.0 109.193 -168.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -128.59 143.86 51.04 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 123.13 1.443 . . . . 0.0 114.57 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.6 t -133.2 164.61 26.66 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.473 167.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -142.72 139.07 30.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.013 -1.68 . . . . 0.0 113.234 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.1 mm -104.97 103.27 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.9 m -99.13 102.02 13.57 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.347 0.594 . . . . 0.0 109.628 -175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -93.88 95.64 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.676 -0.64 . . . . 0.0 110.833 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -104.14 134.97 46.49 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 118.514 0.597 . . . . 0.0 112.487 -176.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 109.75 12.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.966 -1.084 . . . . 0.0 110.189 173.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -144.84 128.75 17.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.555 -0.715 . . . . 0.0 110.783 -170.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 60.36 40.71 17.18 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.61 -15.3 25.67 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 119.814 2.686 . . . . 0.0 119.814 -169.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.8 169.2 17.42 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.081 1.94 . . . . 0.0 112.261 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.5 tp -88.06 116.08 25.99 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 120.551 -1.343 . . . . 0.0 110.109 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.6 t -99.03 108.92 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.9 t -102.42 96.51 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -169.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -87.49 100.95 13.14 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.219 1.009 . . . . 0.0 109.673 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.6 p -107.48 108.4 19.7 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.924 0.889 . . . . 0.0 110.352 -173.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.79 137.71 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.865 0.866 . . . . 0.0 111.618 -168.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.1 ttt -113.93 106.7 14.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 162.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.303 6.3 m120 68.52 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.987 0.915 . . . . 0.0 112.856 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -125.42 -3.12 7.4 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 164.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.7 t -90.32 100.1 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 121.906 2.139 . . . . 0.0 109.567 -170.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.5 p -99.2 123.62 43.63 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.807 0.843 . . . . 0.0 112.8 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.4 p -103.09 133.06 48.83 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 120.937 0.399 . . . . 0.0 111.349 157.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.7 m -106.49 101.46 10.92 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -95.01 114.7 26.54 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.499 -0.751 . . . . 0.0 110.603 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.4 mm -88.19 124.2 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -123.9 122.44 37.99 Favored 'General case' 0 CA--C 1.569 1.709 0 C-N-CA 123.534 0.734 . . . . 0.0 111.433 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -97.18 142.65 28.83 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -78.58 117.59 19.9 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.702 -1.248 . . . . 0.0 112.568 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 32.9 t -117.21 81.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.653 -0.654 . . . . 0.0 109.337 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.256 1.413 0 C-N-CA 123.558 0.743 . . . . 0.0 110.787 -178.043 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.932 0.872 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.262 4.6 p -64.23 -39.56 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -41.78 98.73 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 166.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -57.28 -23.66 49.87 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.41 -6.46 7.24 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 164.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -64.05 161.01 16.83 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 122.615 2.461 . . . . 0.0 115.274 171.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.42 169.3 12.88 Favored Glycine 0 N--CA 1.49 2.272 0 O-C-N 121.264 -0.898 . . . . 0.0 115.28 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -83.73 96.28 8.67 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.936 0.495 . . . . 0.0 110.858 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -97.18 100.16 11.64 Favored 'General case' 0 CA--C 1.566 1.566 0 O-C-N 121.422 -0.799 . . . . 0.0 110.982 -170.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -77.12 127.28 32.37 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.879 -1.138 . . . . 0.0 112.973 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.2 tp -67.07 121.83 16.45 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.985 0.811 . . . . 0.0 113.033 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.56 -46.58 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -120.95 131.42 54.32 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.48 1.112 . . . . 0.0 109.404 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.8 p -131.83 70.79 1.46 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 172.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -82.38 127.23 33.05 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.21 17.35 61.03 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 118.578 2.191 . . . . 0.0 118.578 -170.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -84.93 -42.47 14.94 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -166.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -60.54 -39.25 87.23 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 121.19 1.814 . . . . 0.0 115.073 169.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.251 14.7 pt-20 -59.7 -49.22 78.58 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 167.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.457 ' CD2' ' SG ' ' A' ' 127' ' ' CYS . 76.7 t80 -55.32 -49.84 71.15 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 169.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.2 mtm -64.26 -36.54 84.42 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -58.53 -45.9 87.92 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 121.514 1.961 . . . . 0.0 115.542 162.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.09 -44.1 95.05 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 171.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.4 mt -55.3 -37.78 67.81 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.24 59.19 0.77 Allowed Glycine 0 N--CA 1.487 2.066 0 C-N-CA 124.13 0.871 . . . . 0.0 114.54 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.6 t -115.27 125.13 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -172.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 164.03 50.85 Favored Glycine 0 CA--C 1.551 2.336 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.262 2.4 pp -55.04 -48.75 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 N-CA-C 117.226 2.306 . . . . 0.0 117.226 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.12 94.98 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.81 -44.25 94.09 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -66.0 -44.18 85.53 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 171.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -56.4 -48.88 76.03 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 168.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.9 ttp -52.96 -58.11 8.07 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 163.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.21 -44.06 89.04 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 119.311 2.484 . . . . 0.0 119.311 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.35 -45.24 95.22 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.3 ptp -74.32 -28.79 61.32 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 168.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.58 102.74 1.54 Allowed 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 119.593 1.088 . . . . 0.0 113.035 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -103.09 92.77 3.95 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.449 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -80.48 160.2 22.47 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.222 1.948 . . . . 0.0 116.08 -172.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -85.36 104.48 15.22 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.294 157.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.2 t -86.85 96.31 10.17 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 124.048 0.939 . . . . 0.0 110.872 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.38 106.11 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.2 mt -97.08 144.81 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 CA-C-O 122.814 1.292 . . . . 0.0 108.454 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -147.1 115.43 6.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.06 -1.65 . . . . 0.0 108.522 167.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.5 t -114.39 107.12 15.13 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.971 0.508 . . . . 0.0 111.65 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -99.63 79.81 2.3 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 122.408 1.099 . . . . 0.0 109.746 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.34 -89.7 0.43 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -99.43 -15.51 18.71 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -106.41 129.21 54.44 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 122.038 2.199 . . . . 0.0 111.113 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 tt -125.5 116.82 22.4 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.295 0.638 . . . . 0.0 110.224 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.1 m -107.58 134.18 50.96 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.917 0.887 . . . . 0.0 109.715 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.9 mt -124.76 111.2 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -87.71 159.57 18.44 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 122.023 0.916 . . . . 0.0 111.182 160.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -148.24 102.86 3.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 119.525 -1.984 . . . . 0.0 107.664 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -98.27 114.31 26.55 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.689 0.795 . . . . 0.0 111.917 -172.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -147.36 140.16 24.93 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.669 0.787 . . . . 0.0 110.484 168.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.0 t -54.4 -28.99 47.38 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 167.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.8 mt -85.14 -47.0 10.58 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 124.122 0.969 . . . . 0.0 113.342 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.1 106.02 3.85 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.881 1.219 . . . . 0.0 110.914 168.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.7 m -90.05 134.66 34.12 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.159 0.584 . . . . 0.0 110.719 170.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -134.83 158.44 44.21 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.931 0.872 . . . . 0.0 111.525 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -150.2 130.93 14.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.538 -1.351 . . . . 0.0 110.802 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -144.2 160.89 40.17 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.881 0.848 . . . . 0.0 112.913 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -139.43 145.83 39.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 112.784 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -132.97 160.04 38.24 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-O 122.448 1.118 . . . . 0.0 112.445 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.7 m -90.56 132.9 35.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 164.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -73.58 128.73 36.3 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -170.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.65 -55.96 0.89 Allowed Glycine 0 N--CA 1.494 2.508 0 O-C-N 121.857 -0.527 . . . . 0.0 114.019 -162.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.26 179.68 7.26 Favored 'General case' 0 CA--C 1.575 1.922 0 CA-C-O 122.94 1.352 . . . . 0.0 113.039 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 149.23 32.74 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -111.64 -172.27 2.0 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.664 164.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -115.41 109.52 18.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.671 -1.268 . . . . 0.0 109.922 163.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -84.37 102.81 13.02 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.746 0.818 . . . . 0.0 109.743 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 75.3 m -77.58 100.29 6.06 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.991 0.901 . . . . 0.0 109.465 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.7 p -72.26 159.67 33.69 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -171.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.1 -41.06 7.47 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 119.233 3.049 . . . . 0.0 119.233 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.27 -39.09 93.6 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 169.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.43 -17.22 5.89 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 118.067 1.987 . . . . 0.0 118.067 -160.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.1 mtm-85 -69.06 118.88 12.53 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.841 2.32 . . . . 0.0 111.05 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -91.61 108.61 20.03 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.237 0.542 . . . . 0.0 109.834 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -111.19 111.46 22.55 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.664 0.745 . . . . 0.0 110.467 -162.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -72.31 97.81 2.09 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.478 1.111 . . . . 0.0 109.643 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.1 m -116.79 119.79 36.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 110.855 -152.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.42 130.05 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.93 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 74.8 m -106.74 95.5 5.78 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.172 0.896 . . . . 0.0 109.947 167.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -126.86 124.65 40.08 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.586 -0.696 . . . . 0.0 111.68 -171.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -89.12 140.79 29.1 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -136.13 115.39 12.54 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.447 0.699 . . . . 0.0 110.988 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.325 21.8 t70 64.26 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 170.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.37 30.32 3.66 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 168.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.51 129.88 15.74 Favored 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 118.8 1.3 . . . . 0.0 112.58 -170.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.7 tp -87.43 120.5 28.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.451 -0.78 . . . . 0.0 110.68 167.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.05 103.07 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.602 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -89.34 88.83 7.64 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -91.8 98.04 11.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.743 . . . . 0.0 110.551 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.6 131.94 36.13 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.097 0.959 . . . . 0.0 111.715 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.84 126.07 33.37 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.982 0.81 . . . . 0.0 109.758 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -143.02 122.21 12.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.838 -1.164 . . . . 0.0 110.393 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.288 38.9 t70 50.4 44.53 26.77 Favored 'General case' 0 CA--C 1.588 2.421 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 173.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.58 25.81 72.82 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 119.812 2.685 . . . . 0.0 119.812 -168.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -135.71 128.71 31.46 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.136 1.374 . . . . 0.0 107.765 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -126.85 146.76 50.16 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.9 t -134.33 126.14 29.06 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.644 0.735 . . . . 0.0 111.031 170.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 m -102.8 129.68 49.54 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 121.178 -0.951 . . . . 0.0 110.067 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.8 mt -120.69 97.99 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -172.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 79.4 m -94.56 103.29 15.24 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.717 . . . . 0.0 109.967 -171.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -93.91 100.21 12.42 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.506 0.723 . . . . 0.0 109.906 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -115.73 138.09 51.45 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.14 112.37 16.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.817 -0.552 . . . . 0.0 111.052 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.269 20.3 tptp -105.62 -138.54 0.36 Allowed 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.619 0.767 . . . . 0.0 111.199 -177.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -90.83 68.08 6.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.521 -1.362 . . . . 0.0 110.225 -159.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.18 36.94 93.86 Favored Glycine 0 CA--C 1.558 2.725 0 N-CA-C 117.577 1.791 . . . . 0.0 117.577 -159.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -165.92 134.39 3.06 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -161.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 21.9 tp -90.22 119.34 30.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.926 -1.734 . . . . 0.0 110.859 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.5 t -94.13 113.87 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.1 t -109.46 101.99 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -89.1 97.39 11.17 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.001 0.905 . . . . 0.0 109.249 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 0.8 OUTLIER -101.1 110.4 22.42 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.195 0.998 . . . . 0.0 110.533 -176.423 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 p -129.02 144.86 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.751 0.82 . . . . 0.0 110.53 -170.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.284 28.1 ttt -102.98 -104.32 0.28 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.41 -0.806 . . . . 0.0 108.922 166.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -108.02 97.46 7.16 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.644 1.111 . . . . 0.0 108.546 172.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.28 20.0 m120 68.26 -29.04 0.15 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 -172.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.43 107.71 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 CA-C-N 120.203 1.365 . . . . 0.0 109.776 -172.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 68.4 p -107.29 123.1 47.83 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.594 0.758 . . . . 0.0 112.124 -169.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 7.7 p -96.22 129.34 43.56 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 121.268 0.556 . . . . 0.0 111.346 156.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.4 m -105.6 99.45 9.06 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.235 -0.916 . . . . 0.0 108.567 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -96.01 123.19 39.51 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 122.022 -0.424 . . . . 0.0 111.228 -176.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.9 mm -101.44 122.92 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -120.65 148.23 44.19 Favored 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 123.24 0.616 . . . . 0.0 111.794 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -123.0 138.57 54.65 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -76.08 111.04 11.07 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.596 0.759 . . . . 0.0 112.139 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.71 94.66 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -171.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.256 1.415 0 C-N-CA 123.639 0.775 . . . . 0.0 109.636 -173.086 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.68 -31.91 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 159.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -57.03 -22.84 41.99 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 171.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -41.92 -43.13 2.98 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 117.333 2.346 . . . . 0.0 117.333 154.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.9 3.12 39.55 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -82.35 129.83 34.96 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 121.256 1.843 . . . . 0.0 111.844 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.98 173.68 26.71 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 118.492 2.157 . . . . 0.0 118.492 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -82.91 103.04 12.07 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.067 0.547 . . . . 0.0 110.256 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -109.43 106.88 16.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 122.043 -0.411 . . . . 0.0 110.556 -172.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -83.72 129.79 34.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.395 -1.441 . . . . 0.0 112.553 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.1 tp -65.75 134.34 52.95 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.082 0.468 . . . . 0.0 112.14 172.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.301 6.8 m -123.91 -78.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -84.59 147.14 27.15 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.776 1.171 . . . . 0.0 111.38 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.5 p -139.79 74.86 1.48 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.035 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 137.73 50.62 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.79 15.77 49.39 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 119.67 2.628 . . . . 0.0 119.67 -170.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -81.67 64.85 6.56 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.979 1.889 . . . . 0.0 112.912 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -153.87 -53.73 0.1 Allowed 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 125.624 1.569 . . . . 0.0 109.36 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.46 -48.72 37.46 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 165.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -52.66 -54.99 25.82 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 169.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.298 23.2 ptt? -69.81 -24.45 63.48 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 174.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -64.43 -48.54 74.93 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 159.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -62.0 -37.99 86.9 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.4 mt -53.74 -40.71 66.38 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 159.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.81 57.78 1.58 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 123.797 0.713 . . . . 0.0 114.348 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.8 t -102.1 132.27 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -169.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.84 153.9 40.5 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.259 2.4 pp -56.39 -47.39 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.28 96.7 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 168.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.9 -39.08 90.28 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.8 mtp-105 -56.16 -48.7 75.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 163.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -54.1 -51.69 63.37 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 167.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -51.19 -52.32 45.43 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 166.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.64 -41.48 93.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 119.003 2.361 . . . . 0.0 119.003 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.06 -47.28 87.11 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -78.93 -28.51 43.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.4 115.19 9.29 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 120.198 1.363 . . . . 0.0 113.469 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.59 84.65 4.16 Favored Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.101 174.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.38 161.56 25.56 Favored 'Trans proline' 0 CA--C 1.563 1.971 0 C-N-CA 122.731 2.287 . . . . 0.0 116.84 -173.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -90.74 100.61 13.44 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.158 0.98 . . . . 0.0 109.794 169.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.44 100.15 10.54 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.5 1.12 . . . . 0.0 112.039 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.08 99.24 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.9 mt -90.74 114.89 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.4 p -115.5 106.78 14.35 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.54 112.73 8.18 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.692 -0.63 . . . . 0.0 111.89 -168.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -82.61 -47.68 11.82 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.77 -69.0 0.04 OUTLIER Glycine 0 N--CA 1.486 1.97 0 O-C-N 121.554 -0.716 . . . . 0.0 112.778 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -102.07 -36.51 8.54 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 166.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -76.24 136.45 39.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 120.053 1.297 . . . . 0.0 113.524 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 tt -142.81 120.71 12.0 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-O 121.411 0.624 . . . . 0.0 110.525 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.5 m -120.0 121.95 40.07 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.492 0.717 . . . . 0.0 109.558 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.3 127.96 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -118.89 102.8 9.06 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.831 0.852 . . . . 0.0 109.787 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.1 m -96.66 107.64 20.13 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.598 0.759 . . . . 0.0 110.781 -173.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -101.94 120.45 40.42 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.474 0.654 . . . . 0.0 112.602 -163.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.7 t -155.8 142.53 18.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.75 0.82 . . . . 0.0 111.208 168.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.4 p -60.23 -29.81 68.99 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.11 -53.09 42.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 167.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.95 115.51 3.29 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.987 1.267 . . . . 0.0 110.379 169.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.8 m -91.97 128.95 38.0 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 123.162 0.585 . . . . 0.0 110.752 173.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.1 p -133.49 116.04 15.5 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.533 -0.729 . . . . 0.0 110.233 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.9 150.25 38.76 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -153.25 149.28 27.78 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.3 p -131.75 115.57 16.17 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.953 0.901 . . . . 0.0 111.751 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.5 t -149.92 157.14 42.87 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.561 1.172 . . . . 0.0 113.926 -176.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -89.27 150.97 22.38 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.936 1.351 . . . . 0.0 111.023 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.84 120.11 11.91 Favored 'General case' 0 CA--C 1.571 1.767 0 O-C-N 120.706 -1.246 . . . . 0.0 112.452 170.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.26 -27.31 19.1 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 -162.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -89.44 143.31 26.92 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 118.731 1.266 . . . . 0.0 112.712 -174.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -94.8 145.65 24.74 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.143 0.973 . . . . 0.0 113.552 167.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -130.63 162.02 30.28 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.115 0.966 . . . . 0.0 111.47 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -80.04 100.81 8.35 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 120.911 -1.118 . . . . 0.0 111.192 167.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -80.49 139.11 36.56 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.87 0.843 . . . . 0.0 109.607 162.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.5 m -117.46 110.49 18.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 170.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 p -64.61 140.87 58.91 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.174 -0.329 . . . . 0.0 111.402 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.14 -24.74 2.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 119.954 3.316 . . . . 0.0 119.954 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.253 1.4 t70 -91.91 -24.35 19.33 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 169.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.65 -49.47 0.22 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 119.996 2.758 . . . . 0.0 119.996 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.2 mtm-85 -64.02 138.62 58.54 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -162.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -87.18 107.69 18.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.589 0.756 . . . . 0.0 110.705 170.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . 0.263 3.0 p -112.95 119.16 36.98 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.499 1.142 . . . . 0.0 111.372 -173.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -71.88 95.09 1.5 Allowed 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.44 1.096 . . . . 0.0 110.481 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.5 m -100.69 101.95 12.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.202 -0.936 . . . . 0.0 109.759 -161.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.97 117.22 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.099 0.476 . . . . 0.0 110.479 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 57.8 m -90.25 113.29 25.08 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 122.789 0.436 . . . . 0.0 110.601 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -128.68 124.49 35.81 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.963 -1.086 . . . . 0.0 111.1 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -86.7 116.74 25.0 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 121.124 -0.985 . . . . 0.0 112.037 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.7 t -156.9 140.12 15.56 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.041 0.936 . . . . 0.0 110.663 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.11 54.84 5.58 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 48.79 38.15 22.45 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 118.517 2.167 . . . . 0.0 118.517 -169.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.72 144.42 20.39 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -161.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.84 106.84 18.79 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 163.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.2 t -80.2 95.79 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -88.2 92.3 9.1 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -90.35 106.48 18.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.704 -0.622 . . . . 0.0 110.559 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -89.18 119.97 30.15 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.253 1.021 . . . . 0.0 110.264 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -124.38 124.53 42.56 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.783 0.833 . . . . 0.0 111.012 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -157.49 117.8 3.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.438 -1.414 . . . . 0.0 112.918 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.262 6.5 t70 32.16 56.57 0.36 Allowed 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 118.918 2.933 . . . . 0.0 118.918 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.97 -52.41 1.11 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -77.18 146.68 36.92 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.57 153.04 43.17 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 175.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 t -132.96 123.01 25.11 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 74.2 p -88.67 114.02 24.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.631 -0.668 . . . . 0.0 110.174 170.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 36.2 mm -106.51 93.4 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.9 m -94.65 99.44 11.56 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.099 -1.001 . . . . 0.0 110.747 -170.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -88.17 89.15 7.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.585 -0.697 . . . . 0.0 111.276 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.0 141.93 47.92 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -168.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.86 114.23 20.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 111.347 -177.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -134.02 124.28 25.98 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.05 49.75 15.06 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 170.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.32 -34.26 3.09 Favored Glycine 0 CA--C 1.553 2.455 0 N-CA-C 118.917 2.327 . . . . 0.0 118.917 -169.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -115.47 158.93 21.84 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 119.405 1.602 . . . . 0.0 112.781 -165.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.2 tp -83.44 111.11 18.74 Favored 'General case' 0 CA--C 1.561 1.388 0 O-C-N 121.147 -0.971 . . . . 0.0 110.225 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.34 110.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -95.94 96.53 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -87.07 99.25 11.77 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.899 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 5.3 p -119.55 95.54 4.83 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.225 -159.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 p -107.75 140.78 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.098 0.951 . . . . 0.0 110.016 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttt -119.41 112.43 19.4 Favored 'General case' 0 CA--C 1.559 1.314 0 O-C-N 121.376 -0.828 . . . . 0.0 109.324 167.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 54.2 50.27 16.84 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.297 3.3 t-20 67.82 -2.93 1.27 Allowed 'General case' 0 CA--C 1.584 2.286 0 N-CA-C 118.435 2.754 . . . . 0.0 118.435 -166.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.77 129.56 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 120.82 1.646 . . . . 0.0 108.138 -175.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.4 p -120.18 137.79 53.98 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.367 1.618 . . . . 0.0 115.367 -144.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.899 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 25.1 p -132.82 167.62 19.85 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 123.088 1.423 . . . . 0.0 112.461 153.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.2 m -144.79 123.22 12.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 119.395 -2.066 . . . . 0.0 108.836 167.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -110.36 121.35 45.08 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.464 0.705 . . . . 0.0 110.807 -171.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.3 mm -92.58 118.48 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -118.02 127.47 53.84 Favored 'General case' 0 CA--C 1.569 1.693 0 C-N-CA 123.836 0.855 . . . . 0.0 110.292 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -112.03 144.48 41.31 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -76.51 119.94 21.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 112.946 -174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.7 t -96.16 73.35 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -171.781 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.699 0.762 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.266 9.7 p -58.19 -34.56 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 167.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.01 -37.29 76.55 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 169.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -30.86 56.64 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 164.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.87 -19.97 61.05 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 162.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.254 5.8 pt-20 -91.06 144.85 25.21 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 121.67 2.032 . . . . 0.0 113.688 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.34 -179.5 19.48 Favored Glycine 0 CA--C 1.55 2.239 0 C-N-CA 123.975 0.798 . . . . 0.0 114.187 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.3 ttm-85 -87.35 110.48 20.27 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.424 -1.045 . . . . 0.0 111.072 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -112.72 107.47 16.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.635 -0.665 . . . . 0.0 111.979 -170.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -90.61 129.53 36.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.981 -1.074 . . . . 0.0 113.429 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.1 tp -72.28 121.69 19.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.256 13.0 m -107.8 -57.44 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.686 0.794 . . . . 0.0 112.007 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.7 133.87 48.81 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 119.806 1.184 . . . . 0.0 110.408 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.5 p -119.21 63.94 0.79 Allowed 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 121.615 0.721 . . . . 0.0 112.71 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -60.54 127.59 32.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 0.0 113.494 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.3 21.1 59.33 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 119.993 2.757 . . . . 0.0 119.993 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.14 -41.64 61.23 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 119.115 1.458 . . . . 0.0 114.87 -173.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -49.63 -46.3 49.32 Favored 'General case' 0 CA--C 1.578 2.019 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 163.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -55.86 -49.55 73.02 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 168.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 68.2 t80 -58.05 -48.34 80.38 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 170.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -59.61 -34.03 72.23 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 168.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -58.75 -52.11 67.12 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 163.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -59.11 -44.67 92.0 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.8 mt -50.31 -50.64 50.13 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 162.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.8 49.52 0.58 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 124.143 0.878 . . . . 0.0 115.219 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.1 t -99.14 145.35 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 123.945 0.898 . . . . 0.0 109.461 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.92 -126.31 0.03 OUTLIER Glycine 0 CA--C 1.553 2.426 0 N-CA-C 117.526 1.77 . . . . 0.0 117.526 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.265 9.9 pt -119.1 -61.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.901 -0.764 . . . . 0.0 112.622 -176.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.72 90.75 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.1 mt -66.84 -34.67 78.32 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 170.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -63.87 -47.3 81.24 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 120.256 1.389 . . . . 0.0 114.371 164.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -53.11 -50.58 64.19 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER -59.43 -49.9 76.0 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 170.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.41 -41.42 97.02 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.585 2.194 . . . . 0.0 118.585 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.79 -46.32 82.57 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 169.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -77.16 -32.46 56.23 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.805 2.521 . . . . 0.0 117.805 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.51 144.92 55.48 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -110.93 86.37 5.88 Favored Pre-proline 0 CA--C 1.57 1.713 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -73.77 143.34 33.36 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 122.458 2.105 . . . . 0.0 116.182 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -90.87 100.47 13.33 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.951 165.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.8 t -81.86 95.9 7.47 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 122.468 1.127 . . . . 0.0 110.759 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mt -91.33 101.83 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 85.6 mt -94.73 133.25 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -149.1 126.16 11.32 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 119.863 -1.773 . . . . 0.0 110.508 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.3 t -103.52 110.97 23.22 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -171.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.08 76.01 9.37 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-O 122.129 0.966 . . . . 0.0 110.206 162.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.86 -90.23 0.16 Allowed Glycine 0 N--CA 1.493 2.466 0 O-C-N 120.994 -1.066 . . . . 0.0 115.681 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -89.93 -25.89 20.7 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 160.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -88.56 99.83 12.61 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.35 1.432 . . . . 0.0 110.177 -165.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.3 tp -94.35 110.87 22.6 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.398 0.679 . . . . 0.0 110.777 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.6 m -89.62 117.41 28.49 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -111.88 102.13 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -94.25 114.98 27.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.856 -0.527 . . . . 0.0 109.873 171.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 m -97.34 88.69 4.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.212 -0.93 . . . . 0.0 109.767 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -80.98 125.55 30.29 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.876 0.87 . . . . 0.0 112.795 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 t -155.28 153.77 31.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.473 -0.767 . . . . 0.0 110.813 165.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.9 p -57.98 -43.41 86.53 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 171.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.78 -32.46 67.67 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 123.07 7.76 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 119.827 1.194 . . . . 0.0 109.376 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 m -119.17 124.66 47.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.325 -0.859 . . . . 0.0 109.756 168.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 t -146.14 167.72 22.73 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.57 -0.707 . . . . 0.0 112.673 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -142.65 140.15 31.49 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.01 -1.056 . . . . 0.0 112.66 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -135.28 156.27 49.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 168.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 90.9 p -128.93 112.92 14.59 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.742 0.817 . . . . 0.0 111.214 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.508 ' HG ' ' HD1' ' A' ' 73' ' ' PHE . 45.8 t -115.79 132.49 56.62 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -177.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.0 m -82.48 117.34 22.42 Favored 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 123.46 0.704 . . . . 0.0 109.912 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mp -59.7 127.61 32.84 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -168.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.94 -33.91 5.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 116.986 1.555 . . . . 0.0 116.986 -164.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -98.7 165.64 11.7 Favored 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 123.797 1.76 . . . . 0.0 113.386 -172.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -82.57 139.88 33.57 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.183 -1.826 . . . . 0.0 113.154 171.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.508 ' HD1' ' HG ' ' A' ' 67' ' ' CYS . 9.1 p90 -131.21 162.63 29.55 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 121.657 0.741 . . . . 0.0 111.356 166.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.4 112.0 16.21 Favored 'General case' 0 CA--C 1.568 1.66 0 O-C-N 120.474 -1.391 . . . . 0.0 111.403 170.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -103.73 95.3 5.94 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 121.775 0.798 . . . . 0.0 109.683 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.0 m -72.5 104.73 3.92 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.946 0.879 . . . . 0.0 109.994 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 p -73.5 141.19 46.79 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.336 0.655 . . . . 0.0 111.692 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.85 -29.47 28.14 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 119.614 3.19 . . . . 0.0 119.614 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.79 -28.83 58.52 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 167.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.05 -29.93 0.99 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 118.973 2.349 . . . . 0.0 118.973 172.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.7 mtm-85 -70.48 126.55 29.96 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 119.813 1.807 . . . . 0.0 112.975 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -94.91 106.71 18.72 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.497 0.719 . . . . 0.0 110.052 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.3 p -104.56 122.17 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.457 0.646 . . . . 0.0 110.465 -166.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -77.42 98.52 5.3 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.997 0.903 . . . . 0.0 108.898 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.0 m -111.63 109.68 19.7 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -152.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.4 111.95 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 122.802 0.441 . . . . 0.0 110.853 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.1 m -105.31 105.21 15.15 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -119.37 125.18 48.39 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.467 0.707 . . . . 0.0 112.098 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -91.84 130.09 37.68 Favored 'General case' 0 CA--C 1.564 1.496 0 O-C-N 121.604 -0.685 . . . . 0.0 112.086 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 t -145.63 136.69 24.69 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.339 0.655 . . . . 0.0 109.982 167.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 62.18 34.52 16.11 Favored 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 160.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.27 15.88 80.92 Favored Glycine 0 CA--C 1.558 2.728 0 N-CA-C 119.326 2.49 . . . . 0.0 119.326 -165.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.35 125.2 22.58 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-N 118.616 1.208 . . . . 0.0 110.88 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -97.46 110.59 23.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.492 -0.755 . . . . 0.0 110.3 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.7 t -89.29 104.51 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -86.19 97.1 10.16 Favored 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 124.22 1.008 . . . . 0.0 109.019 171.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -92.66 97.26 10.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.055 -1.028 . . . . 0.0 110.754 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -70.0 127.59 33.38 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.441 0.696 . . . . 0.0 111.698 170.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -135.41 111.81 9.83 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 118.627 0.649 . . . . 0.0 109.96 -171.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.4 p90 -151.92 118.28 5.63 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.659 -1.276 . . . . 0.0 112.269 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.1 t70 39.77 55.16 2.51 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 117.807 2.521 . . . . 0.0 117.807 174.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.98 -44.19 3.32 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 117.755 1.862 . . . . 0.0 117.755 -171.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -78.26 144.3 36.3 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.61 147.18 26.45 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 121.719 0.771 . . . . 0.0 112.998 -175.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 t -134.05 127.39 32.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.714 -0.616 . . . . 0.0 112.549 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.1 p -92.29 129.81 38.14 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.858 0.837 . . . . 0.0 110.891 168.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.1 mt -123.07 97.92 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.2 m -92.81 99.98 12.54 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.843 0.83 . . . . 0.0 109.448 -173.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -89.17 100.46 13.24 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.729 0.812 . . . . 0.0 109.204 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.88 142.63 51.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.41 115.89 21.63 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 121.776 0.798 . . . . 0.0 111.379 -172.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -91.68 -178.17 4.99 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-O 122.302 1.049 . . . . 0.0 112.307 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.62 73.18 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.061 0 CA-C-O 123.426 1.584 . . . . 0.0 115.037 167.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.22 28.6 24.82 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 118.996 2.358 . . . . 0.0 118.996 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -165.44 145.22 6.69 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 119.543 1.671 . . . . 0.0 110.374 -171.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.9 tp -89.86 114.89 26.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 119.905 -1.747 . . . . 0.0 109.316 168.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.2 t -96.05 112.87 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -104.98 95.57 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -85.85 102.16 13.46 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.345 1.069 . . . . 0.0 109.554 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.795 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.1 p -115.65 115.42 26.36 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.664 -165.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.58 134.44 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 122.968 0.507 . . . . 0.0 110.119 -169.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.9 ttt -127.19 114.0 17.1 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.275 8.5 m120 66.2 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.273 1.029 . . . . 0.0 113.237 176.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -118.83 -13.02 9.55 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 166.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.9 t -102.3 112.72 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 121.121 1.782 . . . . 0.0 109.843 -157.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 70.1 p -99.43 107.65 19.93 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.373 0.669 . . . . 0.0 112.705 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.795 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 18.4 p -90.11 151.98 21.34 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 121.725 0.774 . . . . 0.0 111.901 160.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.4 m -129.28 109.68 11.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.876 -1.14 . . . . 0.0 108.002 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -103.35 118.8 37.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.917 -0.489 . . . . 0.0 110.356 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.8 mm -102.83 118.16 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -120.18 143.53 48.18 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -117.92 143.64 46.17 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -80.27 113.21 18.28 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.767 -0.583 . . . . 0.0 112.185 -169.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.7 t -97.71 83.38 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--O 1.257 1.448 0 C-N-CA 124.232 1.013 . . . . 0.0 109.49 -175.574 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.562 1.416 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.543 3.1 p 60.12 -49.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.42 58.16 2.56 Favored 'General case' 0 CA--C 1.578 2.054 0 CA-C-O 122.868 1.318 . . . . 0.0 114.27 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -148.6 -40.31 0.16 Allowed 'General case' 0 CA--C 1.572 1.792 0 C-N-CA 125.876 1.67 . . . . 0.0 111.222 172.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.0 -6.22 12.09 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 166.45 15.92 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.59 179.7 18.71 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.191 -0.943 . . . . 0.0 115.21 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.1 ttm105 -94.37 118.31 31.42 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.2 0.6 . . . . 0.0 109.687 173.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -118.85 110.2 16.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.227 -0.92 . . . . 0.0 110.625 -164.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -99.46 129.72 45.67 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.495 -0.753 . . . . 0.0 112.326 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.8 tp -67.43 126.2 28.55 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 m -115.69 -53.16 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -117.04 118.08 31.4 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 119.373 0.988 . . . . 0.0 108.899 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.4 p -112.91 68.17 0.67 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -79.42 124.05 28.09 Favored 'General case' 0 CA--C 1.567 1.617 0 O-C-N 121.48 -0.762 . . . . 0.0 112.868 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.88 -2.37 85.69 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 118.892 2.317 . . . . 0.0 118.892 -169.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.251 13.3 t80 -68.57 -37.68 80.08 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.651 2.225 . . . . 0.0 116.352 -173.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.47 -47.91 81.94 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-N 121.058 1.754 . . . . 0.0 115.03 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.254 7.5 pt-20 -49.14 -48.98 44.3 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 121.645 2.02 . . . . 0.0 116.0 166.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.43 -44.4 89.09 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.637 1.718 . . . . 0.0 115.637 170.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 76.9 mtm -61.25 -43.77 98.33 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -53.15 -51.61 61.44 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 121.166 1.803 . . . . 0.0 115.116 164.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.82 -37.49 84.6 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.99 -37.89 69.72 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 161.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.33 61.28 0.81 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 123.999 0.809 . . . . 0.0 114.176 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -110.97 125.12 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -176.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.57 162.3 50.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.448 ' H ' HD12 ' A' ' 30' ' ' ILE . 1.6 mp -57.54 -44.8 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -171.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.96 90.32 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 168.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.2 mt -67.59 -37.79 83.09 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -57.74 -49.56 76.15 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 165.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -51.82 -52.14 51.36 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 165.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.5 ttp -52.21 -56.14 16.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 170.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.46 -42.52 89.78 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.78 2.272 . . . . 0.0 118.78 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.83 83.89 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 170.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.4 ptm -76.97 -29.71 55.67 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.19 122.99 22.79 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 119.62 1.1 . . . . 0.0 113.77 175.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.34 92.61 11.82 Favored Pre-proline 0 CA--C 1.568 1.657 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.291 170.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.95 142.62 25.26 Favored 'Trans proline' 0 CA--C 1.562 1.892 0 C-N-CA 122.3 2.0 . . . . 0.0 115.034 -174.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.37 100.62 13.17 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.011 0.91 . . . . 0.0 109.292 170.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.8 t -94.15 104.79 16.8 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.431 -0.793 . . . . 0.0 112.815 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 mt -81.1 106.43 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.4 mt -103.96 117.7 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.5 t -119.28 124.37 46.51 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.4 p -120.42 102.72 8.65 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-O 121.613 0.72 . . . . 0.0 112.751 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.15 69.39 10.77 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 121.846 0.832 . . . . 0.0 111.153 171.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.24 -84.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 117.249 1.66 . . . . 0.0 117.249 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -85.86 -23.52 27.07 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 166.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -103.08 107.75 18.67 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.525 1.511 . . . . 0.0 109.966 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 tt -117.15 125.55 51.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.832 -1.168 . . . . 0.0 111.665 -169.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -113.53 125.76 54.56 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.404 0.682 . . . . 0.0 110.574 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.0 mt -110.28 109.03 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -107.22 89.06 2.88 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.02 0.928 . . . . 0.0 109.284 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.2 m -84.71 103.39 13.76 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 124.034 0.934 . . . . 0.0 110.758 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -102.39 124.85 48.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -171.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.3 t -147.23 141.23 25.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.542 0.687 . . . . 0.0 110.413 167.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.4 p -55.29 -29.49 58.29 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 164.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.0 mt -74.42 -48.2 29.11 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 165.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -157.2 108.4 2.33 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 121.022 1.737 . . . . 0.0 112.533 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.3 m -77.35 135.28 38.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.641 -0.662 . . . . 0.0 111.137 164.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -134.61 120.5 19.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.215 -0.928 . . . . 0.0 108.537 170.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -124.74 128.89 49.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 110.865 -173.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -146.99 152.55 38.79 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.1 p -136.36 118.0 14.95 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.852 0.861 . . . . 0.0 111.268 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.6 t -145.44 153.84 41.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.585 1.183 . . . . 0.0 113.308 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -84.81 149.04 25.99 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 122.431 1.11 . . . . 0.0 110.83 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 mp -67.12 115.79 7.21 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.465 -1.397 . . . . 0.0 112.587 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.77 -30.08 11.06 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 117.937 1.935 . . . . 0.0 117.937 -161.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -82.87 150.24 26.65 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 118.653 1.227 . . . . 0.0 112.443 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -109.78 151.31 27.13 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.518 1.152 . . . . 0.0 114.087 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -138.05 167.17 22.35 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.16 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.69 102.91 11.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.947 -1.095 . . . . 0.0 111.101 170.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -92.04 99.6 12.4 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-O 121.912 0.863 . . . . 0.0 109.757 172.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.2 m -78.81 105.1 9.88 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 166.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -65.94 176.16 1.75 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.86 -41.06 31.92 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.62 -44.94 73.19 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 165.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.71 -11.52 5.17 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 -160.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 68.5 mtm-85 -63.27 131.82 49.61 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 121.331 2.565 . . . . 0.0 112.885 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -79.92 112.46 17.23 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.642 0.777 . . . . 0.0 111.125 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.8 p -123.78 124.22 42.22 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.967 0.507 . . . . 0.0 110.35 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -83.39 96.17 8.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.622 -1.299 . . . . 0.0 110.377 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.3 m -96.74 115.62 27.74 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 122.077 -0.39 . . . . 0.0 110.376 -168.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.69 125.1 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.817 -0.552 . . . . 0.0 111.037 169.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.56 117.07 29.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.801 -0.562 . . . . 0.0 111.756 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -131.49 116.12 17.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.233 -0.917 . . . . 0.0 111.138 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -83.82 134.98 34.69 Favored 'General case' 0 CA--C 1.568 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 111.945 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.1 t -135.89 129.61 32.56 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.02 0.528 . . . . 0.0 109.979 162.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.296 4.2 m-20 72.85 -82.64 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 159.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.9 48.61 0.71 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 123.466 0.555 . . . . 0.0 113.984 159.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -154.63 127.2 8.0 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.723 0.809 . . . . 0.0 110.92 -166.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.7 tp -97.14 113.72 25.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.67 -0.644 . . . . 0.0 110.166 171.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.45 101.7 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.682 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -90.53 99.82 12.78 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -101.93 100.3 10.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.551 -0.718 . . . . 0.0 111.76 -164.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.67 132.39 37.01 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.437 0.695 . . . . 0.0 112.841 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -130.72 118.04 20.3 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 123.224 0.61 . . . . 0.0 109.922 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -159.21 142.12 14.28 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.716 -1.24 . . . . 0.0 112.281 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t0 51.62 41.89 29.18 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 161.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.37 27.18 72.18 Favored Glycine 0 CA--C 1.559 2.782 0 N-CA-C 119.5 2.56 . . . . 0.0 119.5 -167.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -142.83 151.84 41.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 118.787 1.294 . . . . 0.0 109.699 -168.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -134.18 155.44 50.12 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.1 t -147.29 131.42 17.33 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.855 0.836 . . . . 0.0 111.773 172.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 p -105.17 113.76 27.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.856 -0.528 . . . . 0.0 109.928 -169.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.1 mm -98.64 101.75 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.7 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.2 m -95.9 98.53 10.48 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.096 -1.002 . . . . 0.0 110.105 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.1 mtp85 -89.06 102.55 15.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.635 0.774 . . . . 0.0 109.429 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -133.77 147.88 51.33 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.49 114.99 22.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.623 -0.673 . . . . 0.0 112.123 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -131.46 110.81 11.28 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.252 20.1 t70 55.76 57.8 4.96 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.67 -8.61 2.23 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 120.071 2.789 . . . . 0.0 120.071 -170.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -113.45 140.55 48.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.745 1.272 . . . . 0.0 110.618 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -83.22 104.42 13.38 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 122.219 1.009 . . . . 0.0 108.573 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 99.3 t -96.05 106.16 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.1 t -95.7 98.67 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -172.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.74 100.7 12.38 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.857 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.794 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.5 p -92.72 144.65 25.09 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.4 p -135.47 136.48 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.611 0.72 . . . . 0.0 110.762 169.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.5 tpt -92.86 -58.43 2.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.48 -0.762 . . . . 0.0 111.94 163.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.256 16.3 p30 -141.71 -90.57 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.004 0.922 . . . . 0.0 108.719 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -90.81 -15.88 29.29 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 153.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.4 t -79.78 129.47 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 CA-C-N 120.044 1.293 . . . . 0.0 109.905 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 61.1 p -137.4 153.59 50.14 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -166.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.794 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 1.9 p -132.92 130.32 39.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.403 -0.811 . . . . 0.0 111.349 163.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.4 m -104.08 101.33 11.09 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -102.99 117.06 33.75 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.141 0.496 . . . . 0.0 111.358 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.1 mm -92.26 120.39 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -113.92 131.02 56.45 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 121.265 0.555 . . . . 0.0 110.865 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -86.6 131.38 34.17 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -74.02 106.27 5.64 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.96 0.886 . . . . 0.0 111.356 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.28 129.24 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -176.083 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 p -60.05 -23.9 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 161.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -56.28 -39.32 72.49 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 159.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -71.12 -30.47 66.54 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 169.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 mt -68.91 -10.22 56.0 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 161.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.87 132.45 34.39 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 120.507 1.503 . . . . 0.0 112.019 -166.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.35 -162.83 20.46 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 115.146 0.818 . . . . 0.0 115.146 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -92.01 130.57 37.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.94 -0.741 . . . . 0.0 112.88 -172.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -134.56 112.23 10.7 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.416 0.687 . . . . 0.0 109.291 -171.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.7 ttp-105 -94.32 133.16 38.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 119.963 -1.711 . . . . 0.0 112.575 173.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.15 131.4 50.7 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.292 16.0 m -130.76 -60.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.637 -0.664 . . . . 0.0 112.201 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.27 106.37 17.17 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 119.601 1.091 . . . . 0.0 109.106 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 p -108.15 68.94 0.71 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -83.17 129.07 34.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.48 2.12 90.38 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 -168.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -70.68 -51.9 24.64 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-N 120.179 1.99 . . . . 0.0 115.856 -169.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -54.38 -39.82 67.56 Favored 'General case' 0 CA--C 1.58 2.096 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 170.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.03 -47.7 77.36 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 164.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -58.42 -51.01 71.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 171.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.347 16.5 ptt? -65.22 -23.74 67.16 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 170.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -59.98 -51.86 67.84 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 154.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -59.21 -43.93 92.28 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 171.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.447 ' HA ' ' SD ' ' A' ' 122' ' ' MET . 83.5 mt -57.2 -44.57 83.77 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 171.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.75 62.15 0.36 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 123.883 0.754 . . . . 0.0 114.388 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.4 t -128.49 127.53 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -166.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.48 164.94 53.83 Favored Glycine 0 CA--C 1.55 2.246 0 N-CA-C 117.611 1.804 . . . . 0.0 117.611 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 30' ' ' ILE . 1.9 mp -53.78 -47.97 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -171.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.11 80.7 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 173.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.98 -38.56 91.51 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 169.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -62.74 -48.18 80.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.513 1.506 . . . . 0.0 114.85 168.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.46 -41.99 77.42 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 168.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -58.69 -59.52 5.27 Favored 'General case' 0 CA--C 1.569 1.673 0 CA-C-N 119.784 1.174 . . . . 0.0 113.869 164.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.96 -39.4 78.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 119.622 2.609 . . . . 0.0 119.622 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.31 86.71 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 171.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -83.96 -29.25 27.19 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 167.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.5 106.96 4.17 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-N 119.744 1.156 . . . . 0.0 113.359 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -105.46 91.81 5.23 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.068 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.33 147.77 18.35 Favored 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.313 2.009 . . . . 0.0 115.887 -171.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 99.61 9.29 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 121.681 0.753 . . . . 0.0 109.166 169.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.5 t -101.9 109.68 21.48 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.976 -1.077 . . . . 0.0 112.84 -167.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mt -97.59 104.42 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -170.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 97.0 mt -85.89 104.87 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.5 p -107.08 117.14 33.28 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.29 0.636 . . . . 0.0 109.813 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -113.49 100.07 8.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.022 -1.049 . . . . 0.0 113.179 -173.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.91 65.16 8.86 Favored 'General case' 0 CA--C 1.575 1.938 0 CA-C-O 122.039 0.923 . . . . 0.0 111.381 166.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.52 -88.49 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 116.6 1.4 . . . . 0.0 116.6 -177.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -81.95 -39.29 23.91 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 169.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -90.43 102.27 15.0 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 120.305 1.411 . . . . 0.0 109.786 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 tt -108.69 111.82 23.81 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 121.621 0.724 . . . . 0.0 109.049 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.7 m -105.88 117.08 33.11 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.558 0.743 . . . . 0.0 109.7 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.1 112.01 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -101.89 94.23 5.7 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.508 0.723 . . . . 0.0 110.871 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.6 m -88.58 103.06 15.55 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.315 0.646 . . . . 0.0 110.682 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -100.52 115.4 30.03 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.7 t -147.31 141.54 26.2 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.528 0.731 . . . . 0.0 110.82 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.2 p -58.81 -32.46 69.39 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 165.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.23 -48.81 64.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 167.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.21 108.07 2.53 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.568 1.531 . . . . 0.0 111.354 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.3 m -91.07 128.19 36.8 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.715 -0.616 . . . . 0.0 110.988 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.5 p -131.55 109.06 9.98 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.431 -0.793 . . . . 0.0 110.772 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -104.98 119.94 40.24 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.27 0.628 . . . . 0.0 110.83 175.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -133.13 143.96 49.6 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.7 p -102.04 113.08 26.0 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.882 0.873 . . . . 0.0 111.631 173.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.8 p -102.95 123.96 47.56 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-O 121.516 0.674 . . . . 0.0 111.382 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 m -81.29 121.42 26.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.195 -0.941 . . . . 0.0 109.065 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -73.0 129.65 38.57 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -164.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.1 -41.48 2.97 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 116.812 1.485 . . . . 0.0 116.812 -160.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -89.33 173.15 8.54 Favored 'General case' 0 CA--C 1.572 1.797 0 C-N-CA 124.798 1.239 . . . . 0.0 113.185 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.54 157.69 21.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -142.82 163.72 32.03 Favored 'General case' 0 CA--C 1.573 1.865 0 C-N-CA 124.723 1.209 . . . . 0.0 111.725 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.33 104.96 11.23 Favored 'General case' 0 CA--C 1.569 1.704 0 O-C-N 120.916 -1.115 . . . . 0.0 111.716 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -99.19 114.73 27.66 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.008 0.923 . . . . 0.0 109.678 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.8 m -93.71 106.94 18.87 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.92 -1.112 . . . . 0.0 108.36 166.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -77.66 157.16 30.3 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -169.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.86 -31.98 63.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 168.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.46 10.41 2.6 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 164.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.09 45.57 10.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.08 1.992 . . . . 0.0 118.08 172.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.3 mtm105 -134.01 130.34 37.44 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 117.998 0.899 . . . . 0.0 109.348 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -90.05 112.14 23.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.968 -0.458 . . . . 0.0 110.077 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.2 p -125.3 134.43 52.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.402 0.681 . . . . 0.0 109.667 -169.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -81.85 99.97 9.33 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 171.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.8 m -107.51 112.39 25.13 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.861 -0.524 . . . . 0.0 110.994 -159.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -88.9 124.37 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 122.961 0.504 . . . . 0.0 111.452 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 19.3 m -108.45 114.07 27.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.73 -0.606 . . . . 0.0 111.887 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -124.17 120.66 32.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.789 -0.569 . . . . 0.0 110.589 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -89.32 119.17 29.55 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 111.609 171.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 t -98.91 156.83 16.69 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 122.974 0.51 . . . . 0.0 110.027 155.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.23 95.82 0.04 OUTLIER 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.01 -16.02 20.76 Favored Glycine 0 CA--C 1.553 2.444 0 N-CA-C 118.421 2.128 . . . . 0.0 118.421 -170.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.57 126.01 15.77 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 120.331 2.066 . . . . 0.0 112.927 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.5 tp -90.88 107.39 19.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 110.059 168.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.8 106.91 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -91.12 100.51 13.34 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.152 0.581 . . . . 0.0 109.537 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -93.52 104.19 16.33 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -104.3 125.25 50.39 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -174.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.84 127.19 51.68 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.68 0.792 . . . . 0.0 111.036 -165.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -153.79 125.67 7.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.425 -1.422 . . . . 0.0 112.248 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.0 t70 49.82 51.02 17.36 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.04 -14.17 6.52 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 119.903 2.721 . . . . 0.0 119.903 -167.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -103.81 152.28 22.08 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 119.138 1.469 . . . . 0.0 111.955 -173.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -143.61 150.72 39.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.7 t -136.76 132.65 35.06 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.349 0.66 . . . . 0.0 111.289 174.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.5 p -91.48 130.36 37.32 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.789 0.804 . . . . 0.0 110.455 169.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 80.2 mt -124.38 98.17 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -98.41 101.79 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.781 -0.574 . . . . 0.0 110.141 -170.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -88.04 98.06 11.31 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 121.79 -0.569 . . . . 0.0 110.149 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.11 145.78 47.84 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -171.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.59 113.29 25.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.0 112.363 -171.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -134.22 115.05 13.71 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.597 -0.689 . . . . 0.0 109.164 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 58.0 58.31 3.65 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 47.16 41.53 15.43 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 118.455 2.142 . . . . 0.0 118.455 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.55 128.77 9.75 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -163.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.63 106.2 17.86 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 122.184 0.993 . . . . 0.0 109.674 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.4 t -95.27 109.0 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.7 t -95.04 100.32 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -93.7 101.19 13.32 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.0 p -120.58 131.49 54.68 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 121.774 0.797 . . . . 0.0 111.991 -163.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.61 140.64 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.464 0.65 . . . . 0.0 110.505 -166.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.447 ' SD ' ' HA ' ' A' ' 26' ' ' LEU . 19.3 ttt -106.09 -74.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.759 -0.588 . . . . 0.0 110.567 171.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -129.5 -65.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.654 0.661 . . . . 0.0 110.937 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -94.79 -44.89 7.56 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.06 0.944 . . . . 0.0 112.639 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.68 120.91 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 CA-C-N 119.248 0.931 . . . . 0.0 110.316 -161.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 39.9 p -102.4 114.5 28.74 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.492 0.717 . . . . 0.0 109.959 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.5 p -98.76 132.86 43.8 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.475 0.71 . . . . 0.0 111.213 171.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.6 m -109.7 104.62 13.65 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -103.68 113.01 26.2 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 122.905 0.482 . . . . 0.0 110.683 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.18 129.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.454 -0.779 . . . . 0.0 109.381 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -118.48 124.39 47.48 Favored 'General case' 0 CA--C 1.571 1.768 0 CA-C-O 121.203 0.525 . . . . 0.0 112.163 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.4 136.49 42.4 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.158 0.983 . . . . 0.0 113.613 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -76.32 116.37 16.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.371 -1.456 . . . . 0.0 111.208 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.36 69.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.209 -0.932 . . . . 0.0 110.84 -171.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.12 -0.987 . . . . 0.0 108.771 -164.138 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.501 2.107 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . 0.252 6.6 tt0 -67.59 -14.86 63.3 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -35.1 71.06 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 155.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.0 mt -82.9 2.87 32.29 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -92.04 148.57 22.09 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 122.089 2.222 . . . . 0.0 113.634 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.31 178.69 15.61 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.8 ttm105 -85.84 122.88 30.54 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.816 -0.814 . . . . 0.0 110.311 166.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.44 ' CH2' HD21 ' A' ' 111' ' ' LEU . 97.5 m95 -119.66 114.4 22.13 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -172.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -105.07 124.41 49.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.751 0.82 . . . . 0.0 112.83 -163.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.1 tp -66.66 128.63 36.99 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.253 6.1 m -115.6 -69.09 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 C-N-CA 124.148 0.979 . . . . 0.0 109.566 173.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -92.57 149.93 21.05 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 124.439 1.096 . . . . 0.0 112.718 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -152.16 59.3 0.84 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.461 -1.399 . . . . 0.0 114.684 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -72.47 133.01 44.61 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.5 -13.99 53.09 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 118.515 2.166 . . . . 0.0 118.515 -166.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -67.39 -35.14 78.72 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.456 ' CG ' HH12 ' A' ' 33' ' ' ARG . 9.2 t70 -53.28 -54.24 39.14 Favored 'General case' 0 CA--C 1.576 1.942 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 166.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -60.77 -46.71 89.42 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -58.52 -47.08 85.36 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.7 mtm -62.44 -40.66 97.31 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 120.784 1.629 . . . . 0.0 114.945 170.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -47.99 -53.2 16.94 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 161.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -74.78 -33.69 62.3 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.8 mt -46.76 -40.33 13.33 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 118.403 2.742 . . . . 0.0 118.403 158.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.07 67.81 1.01 Allowed Glycine 0 N--CA 1.487 2.063 0 CA-C-N 118.34 0.518 . . . . 0.0 113.423 -161.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.86 123.98 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.45 152.04 52.26 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 115.581 0.992 . . . . 0.0 115.581 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 pt -53.48 -44.3 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 117.911 2.559 . . . . 0.0 117.911 -172.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.05 -42.93 86.48 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 166.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.56 -39.6 94.04 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.527 ' HB3' HH11 ' A' ' 33' ' ' ARG . 13.9 mtm105 -59.32 -47.78 84.12 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 168.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -56.81 -51.99 66.8 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 168.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.9 ttp -46.84 -61.16 1.98 Allowed 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.06 -41.91 79.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 118.904 2.322 . . . . 0.0 118.904 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.51 -51.9 51.71 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 169.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.8 ptm -74.0 -31.65 63.04 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.37 -25.1 63.95 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 119.284 3.068 . . . . 0.0 119.284 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.65 67.4 1.55 Allowed Pre-proline 0 CA--C 1.581 2.172 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -66.69 142.41 63.86 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 N-CA-C 119.329 2.78 . . . . 0.0 119.329 -170.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.7 113.5 26.01 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.127 165.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 51.6 t -92.0 110.62 21.99 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.933 0.893 . . . . 0.0 111.261 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.36 110.24 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 87.8 mt -102.4 129.31 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.1 m -150.99 127.04 10.44 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.658 -1.276 . . . . 0.0 110.294 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.6 t -102.14 130.06 48.66 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -82.0 -56.26 4.06 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.733 -0.604 . . . . 0.0 111.993 159.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.71 -84.72 0.05 OUTLIER Glycine 0 N--CA 1.485 1.947 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -83.2 -37.45 23.61 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 161.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -74.65 104.39 5.31 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 121.095 1.771 . . . . 0.0 111.505 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 32.5 tp -99.84 111.9 24.19 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.79 0.836 . . . . 0.0 109.1 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.5 m -81.78 115.87 21.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.786 -0.571 . . . . 0.0 110.401 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.1 mt -119.05 106.2 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.646 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -98.29 127.4 44.21 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.106 0.563 . . . . 0.0 110.658 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -99.27 97.81 8.84 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -89.29 97.2 11.06 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.251 0.62 . . . . 0.0 109.905 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 p -104.32 150.8 24.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.302 -0.874 . . . . 0.0 111.815 171.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.6 p -78.08 49.24 0.79 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 179.72 -61.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.288 1.435 . . . . 0.0 109.404 -164.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -131.04 168.69 16.97 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.356 1.074 . . . . 0.0 111.598 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.4 m -149.62 149.23 30.35 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 119.422 -2.049 . . . . 0.0 110.743 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.9 m -152.95 139.5 18.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.558 -1.338 . . . . 0.0 109.685 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -134.48 131.51 38.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.446 -0.784 . . . . 0.0 110.428 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -147.85 144.78 28.37 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.257 0.551 . . . . 0.0 112.393 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.9 p -99.95 103.05 14.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.374 -0.829 . . . . 0.0 110.635 170.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 52' ' ' LEU . 28.4 p -85.71 124.67 32.49 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -79.41 108.25 12.79 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.618 0.723 . . . . 0.0 110.532 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.3 tp -81.3 119.56 23.81 Favored 'General case' 0 CA--C 1.563 1.444 0 O-C-N 121.591 -0.693 . . . . 0.0 112.543 -167.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.85 50.62 18.11 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 115.228 0.851 . . . . 0.0 115.228 -159.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.48 160.82 0.79 Allowed 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.736 1.615 . . . . 0.0 109.139 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -93.08 153.37 18.73 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 168.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -142.04 161.72 37.27 Favored 'General case' 0 CA--C 1.572 1.792 0 C-N-CA 124.174 0.989 . . . . 0.0 110.286 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -81.58 106.91 13.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.097 -1.627 . . . . 0.0 110.505 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -83.31 144.9 29.39 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 122.685 1.231 . . . . 0.0 111.062 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.8 m -113.05 120.45 41.39 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 162.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 78.1 p -68.22 154.1 42.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.07 -29.06 60.0 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 167.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -68.69 -47.89 65.3 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.89 -33.15 1.53 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 117.337 1.695 . . . . 0.0 117.337 -165.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -63.5 141.19 58.86 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 119.485 1.643 . . . . 0.0 112.923 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -110.58 131.02 55.41 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.166 0.586 . . . . 0.0 109.897 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.1 p -128.5 136.54 50.94 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.551 0.691 . . . . 0.0 111.191 -165.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -83.7 102.74 12.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.586 -1.321 . . . . 0.0 109.729 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.5 m -112.08 109.74 19.64 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.658 -0.651 . . . . 0.0 110.752 -158.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.1 p -86.86 120.92 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 122.714 0.406 . . . . 0.0 111.181 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.4 m -108.77 122.66 47.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -132.95 126.54 32.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.515 -0.741 . . . . 0.0 111.723 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -91.88 112.43 24.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.739 -0.6 . . . . 0.0 110.488 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -102.79 86.79 2.81 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.974 0.51 . . . . 0.0 110.643 171.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.265 12.1 t70 25.4 70.8 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.868 2.914 . . . . 0.0 118.868 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.71 -44.49 1.31 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 -168.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.63 119.93 37.73 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 118.448 1.124 . . . . 0.0 113.556 -172.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.46 107.06 18.92 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.553 0.741 . . . . 0.0 111.136 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.91 109.97 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -94.46 106.37 18.35 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 170.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -100.29 104.95 16.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.722 -0.611 . . . . 0.0 111.403 -171.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -99.6 107.31 19.42 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.459 0.703 . . . . 0.0 111.438 -162.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -102.12 121.33 41.99 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.914 0.779 . . . . 0.0 111.923 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -148.76 129.84 14.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.006 -1.059 . . . . 0.0 110.881 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 52.54 41.11 30.95 Favored 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.56 32.24 82.59 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 119.026 2.37 . . . . 0.0 119.026 -165.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -136.09 124.1 22.85 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 118.371 1.086 . . . . 0.0 108.154 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.44 142.48 32.76 Favored 'General case' 0 CA--C 1.563 1.481 0 CA-C-O 121.878 0.847 . . . . 0.0 112.256 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.9 t -125.13 130.6 52.53 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.941 0.877 . . . . 0.0 109.889 159.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.6 p -113.09 107.95 16.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.3 mm -104.7 102.06 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.011 -1.056 . . . . 0.0 108.686 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 m -97.2 96.25 8.3 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.22 0.918 . . . . 0.0 109.916 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -87.27 110.2 20.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.561 -0.712 . . . . 0.0 110.501 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -134.58 146.14 49.34 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.555 1.07 . . . . 0.0 113.646 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.44 HD21 ' CH2' ' A' ' 11' ' ' TRP . 0.2 OUTLIER -87.43 114.84 24.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.559 -0.713 . . . . 0.0 112.241 -169.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -131.72 113.47 13.59 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.598 0.759 . . . . 0.0 108.995 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.263 35.4 t70 60.57 34.47 20.25 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.47 9.43 61.43 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 119.123 2.409 . . . . 0.0 119.123 -165.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -109.13 143.41 38.54 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 119.26 1.53 . . . . 0.0 108.812 172.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.4 tp -84.03 102.32 12.4 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.808 0.814 . . . . 0.0 108.897 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.7 t -96.31 112.53 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.24 95.94 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -172.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -93.62 94.75 8.79 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.243 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.0 OUTLIER -92.11 148.5 22.12 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 121.36 -0.837 . . . . 0.0 112.025 177.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.3 128.65 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.54 0.686 . . . . 0.0 110.288 166.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.1 tpt -69.0 -65.87 0.65 Allowed 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 123.422 0.689 . . . . 0.0 112.298 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.251 15.5 p30 -143.67 -73.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -86.78 -38.64 16.69 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 159.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.1 t -85.99 128.33 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 119.921 1.237 . . . . 0.0 111.067 -163.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 66.3 p -110.04 156.59 20.32 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.492 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 2.3 p -131.99 133.55 44.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.011 -1.056 . . . . 0.0 111.161 156.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.4 m -109.47 98.0 7.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -102.67 120.76 41.12 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.207 0.603 . . . . 0.0 111.603 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.93 125.12 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -119.75 125.66 49.16 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 123.43 0.692 . . . . 0.0 110.498 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -93.3 143.65 26.06 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -74.82 120.16 19.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.535 -1.353 . . . . 0.0 113.498 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.67 89.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 124.353 1.061 . . . . 0.0 109.657 171.414 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.5 2.044 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.28 -34.16 76.04 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 161.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -66.12 -27.22 67.88 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.3 mt -70.21 -2.4 13.1 Favored 'General case' 0 CA--C 1.581 2.142 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -68.71 138.5 54.97 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 121.054 1.752 . . . . 0.0 114.541 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.33 -178.64 18.25 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 115.814 1.086 . . . . 0.0 115.814 168.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -89.64 125.56 35.29 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.678 -0.761 . . . . 0.0 109.857 169.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -121.1 109.62 15.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.667 -0.646 . . . . 0.0 109.599 -168.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.5 ttm105 -91.64 127.48 37.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.677 -1.264 . . . . 0.0 113.207 -176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.21 126.49 27.56 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.293 9.3 m -110.73 -72.22 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 123.484 0.714 . . . . 0.0 109.158 173.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -87.05 143.58 27.26 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 119.093 0.86 . . . . 0.0 111.785 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.2 p -139.18 65.35 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.334 162.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -72.16 128.02 34.36 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.3 2.12 86.99 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 119.294 2.478 . . . . 0.0 119.294 -169.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -69.79 -48.7 58.21 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -169.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -55.4 -43.3 75.11 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -64.2 -35.99 82.59 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 164.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 59.6 t80 -61.2 -50.78 71.74 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 120.884 1.675 . . . . 0.0 114.499 169.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.9 ptm -61.76 -37.23 83.52 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -50.48 -48.64 56.7 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 158.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.52 -39.94 95.73 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.38 -42.01 77.19 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 163.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.86 69.83 0.45 Allowed Glycine 0 N--CA 1.487 2.039 0 C-N-CA 124.249 0.928 . . . . 0.0 113.029 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.64 126.06 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -171.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.53 164.5 52.23 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 pt -53.73 -47.38 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 118.315 2.709 . . . . 0.0 118.315 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.63 98.34 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 172.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.97 -39.61 93.74 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 167.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -60.15 -49.92 75.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -51.94 -52.15 52.14 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 167.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -53.9 -55.19 29.15 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.98 99.38 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 118.799 2.279 . . . . 0.0 118.799 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.31 83.22 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.0 ptm -71.33 -26.05 62.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.89 127.27 31.38 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.82 77.05 4.52 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 118.224 -0.893 . . . . 0.0 109.525 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.88 140.55 20.58 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.283 1.989 . . . . 0.0 116.617 -167.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.11 91.32 8.67 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.882 162.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -90.05 115.09 27.06 Favored 'General case' 0 CA--C 1.559 1.325 0 O-C-N 120.804 -1.185 . . . . 0.0 112.444 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -92.17 118.7 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 109.406 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.7 mt -105.75 122.31 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m -140.42 134.12 30.34 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.396 0.617 . . . . 0.0 111.512 163.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.5 p -107.44 141.8 38.27 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . 0.268 17.0 t70 -101.37 -116.72 0.18 Allowed 'General case' 0 CA--C 1.578 2.047 0 C-N-CA 123.743 0.817 . . . . 0.0 108.798 166.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.19 -83.98 1.3 Allowed Glycine 0 N--CA 1.492 2.38 0 CA-C-N 120.516 1.507 . . . . 0.0 112.873 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -85.65 -37.7 19.19 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 160.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -72.58 117.16 13.91 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.511 1.505 . . . . 0.0 112.901 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 tt -123.6 118.32 27.04 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.925 0.89 . . . . 0.0 108.718 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.9 m -94.47 123.64 38.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.709 -0.62 . . . . 0.0 110.373 -170.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.8 mt -116.8 106.26 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -109.71 117.83 34.94 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.091 0.556 . . . . 0.0 111.039 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 m -85.94 109.48 18.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.397 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -98.79 92.11 5.41 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.822 1.192 . . . . 0.0 110.912 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -126.96 139.32 53.13 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.906 0.882 . . . . 0.0 110.21 166.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 p -76.86 49.8 0.67 Allowed 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 172.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.7 mt -150.48 -52.01 0.14 Allowed 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 126.231 1.812 . . . . 0.0 109.296 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -153.91 115.78 4.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.143 1.338 . . . . 0.0 110.923 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.6 p -97.42 92.22 5.85 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.293 0.637 . . . . 0.0 110.865 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.0 m -89.11 117.63 28.24 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.042 0.925 . . . . 0.0 108.9 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.21 141.76 50.62 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.8 0.84 . . . . 0.0 111.923 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -156.26 145.31 20.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.567 -0.708 . . . . 0.0 112.734 -174.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.5 p -101.35 108.12 19.65 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.344 0.658 . . . . 0.0 110.093 167.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.1 p -92.47 131.16 37.85 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.65 -0.656 . . . . 0.0 112.367 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.04 122.99 26.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.897 -1.127 . . . . 0.0 110.673 168.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.4 tp -75.91 129.85 37.59 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.56 0.744 . . . . 0.0 112.62 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.44 -28.18 5.92 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 117.606 1.802 . . . . 0.0 117.606 -159.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -105.25 158.34 16.68 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 119.418 1.609 . . . . 0.0 112.908 -166.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -95.65 116.27 28.62 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.914 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -126.96 148.1 50.08 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 124.014 0.926 . . . . 0.0 110.988 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -82.05 101.69 10.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.2 -1.563 . . . . 0.0 113.499 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -88.63 120.42 30.01 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-O 121.973 0.892 . . . . 0.0 110.691 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.8 m -89.43 96.47 10.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.33 -0.856 . . . . 0.0 110.077 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.6 p -69.42 158.13 35.74 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.87 -36.91 12.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 119.529 3.159 . . . . 0.0 119.529 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.3 -36.93 82.51 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 170.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.76 -10.48 9.0 Favored Glycine 0 CA--C 1.552 2.356 0 N-CA-C 118.03 1.972 . . . . 0.0 118.03 -159.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -71.7 115.61 11.1 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 121.085 2.443 . . . . 0.0 110.204 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -87.92 108.6 19.26 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.663 0.744 . . . . 0.0 109.567 172.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.9 p -106.81 111.78 24.45 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.684 0.754 . . . . 0.0 109.609 -166.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -69.12 101.84 1.53 Allowed 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 122.483 1.135 . . . . 0.0 109.807 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.2 m -112.84 112.46 23.96 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -156.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.329 10.4 p -81.36 113.38 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-N 118.996 0.816 . . . . 0.0 110.013 168.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 64.0 m -96.79 109.93 22.51 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 120.58 0.229 . . . . 0.0 110.583 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -133.43 121.42 22.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.549 -0.719 . . . . 0.0 112.006 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -87.59 137.21 32.54 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 121.493 -0.754 . . . . 0.0 112.997 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.0 t -137.75 113.13 9.37 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.384 0.674 . . . . 0.0 111.05 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.322 22.4 t70 66.9 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 171.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.95 43.26 1.28 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 166.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.87 118.33 6.49 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.554 0.741 . . . . 0.0 111.077 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.7 tp -90.23 109.75 20.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 110.089 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.21 108.12 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -86.94 94.17 9.53 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -91.85 97.87 11.25 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.61 -0.681 . . . . 0.0 109.925 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -87.5 116.74 25.81 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.219 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.45 125.68 45.38 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.559 1.072 . . . . 0.0 110.622 -176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -144.54 120.23 10.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.558 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 63.23 14.96 8.2 Favored 'General case' 0 CA--C 1.587 2.368 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.1 -14.64 26.29 Favored Glycine 0 CA--C 1.559 2.833 0 N-CA-C 118.947 2.339 . . . . 0.0 118.947 -156.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -77.33 129.55 35.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.188 1.494 . . . . 0.0 109.056 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -140.85 147.98 39.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -173.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 t -118.61 138.28 52.69 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 122.294 1.045 . . . . 0.0 111.759 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.7 p -110.61 112.5 24.43 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 76.0 mt -120.79 98.17 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -167.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 55.3 m -94.25 101.72 13.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.74 -0.6 . . . . 0.0 110.037 -173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -87.66 96.46 10.43 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 123.397 0.679 . . . . 0.0 110.188 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -127.86 149.52 50.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -172.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.9 123.03 45.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 112.343 -158.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.03 121.94 27.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.74 -0.6 . . . . 0.0 109.492 171.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 58.93 44.49 16.46 Favored 'General case' 0 N--CA 1.509 2.495 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 165.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.57 35.71 74.48 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -163.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -137.67 127.77 25.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 tp -88.15 106.82 18.43 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-O 121.996 0.903 . . . . 0.0 109.287 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.4 t -98.16 106.94 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.51 98.03 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -170.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -91.93 113.12 25.3 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.713 0.805 . . . . 0.0 109.399 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.6 p -126.73 122.1 33.89 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.654 0.781 . . . . 0.0 111.739 -162.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.39 136.95 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.498 -0.751 . . . . 0.0 110.003 -175.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.5 ttt -89.58 -76.73 0.41 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 120.634 0.254 . . . . 0.0 110.59 168.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -140.11 -62.93 0.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.11 0.964 . . . . 0.0 110.247 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -79.36 -54.82 5.57 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 125.015 1.326 . . . . 0.0 113.827 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.78 123.91 49.31 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-N 119.783 1.174 . . . . 0.0 110.984 -164.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.3 p -102.15 114.09 27.92 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.864 0.865 . . . . 0.0 110.496 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 13.4 p -100.45 157.26 16.76 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 122.113 0.958 . . . . 0.0 113.174 170.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.4 m -130.43 118.03 20.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.832 -1.168 . . . . 0.0 109.223 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -107.42 111.76 24.23 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.15 0.58 . . . . 0.0 109.843 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.1 mm -96.47 123.65 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -120.35 127.86 52.71 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 121.939 -0.475 . . . . 0.0 111.467 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -85.14 141.28 30.31 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -75.97 121.04 22.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.296 -0.877 . . . . 0.0 113.065 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.42 99.16 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.272 -173.134 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.26 9.9 p . . . . . 0 N--CA 1.505 2.314 0 CA-C-O 122.657 1.218 . . . . 0.0 114.136 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -113.56 -47.16 3.01 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.848 1.659 . . . . 0.0 111.778 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -58.89 -29.32 66.94 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 171.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.8 mt -66.78 -13.14 61.12 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 164.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -74.22 136.14 42.74 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 120.743 1.61 . . . . 0.0 112.689 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.09 -179.37 25.95 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 117.956 1.942 . . . . 0.0 117.956 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -92.16 116.43 28.93 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.316 -0.942 . . . . 0.0 110.196 169.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -123.88 108.63 12.66 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.794 0.438 . . . . 0.0 109.885 -166.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -94.83 129.57 41.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.419 -1.426 . . . . 0.0 114.078 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.4 tp -63.85 124.82 22.51 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.273 11.0 m -113.09 -65.97 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.938 0.895 . . . . 0.0 110.781 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -101.21 148.15 25.44 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.497 1.498 . . . . 0.0 111.533 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.2 p -133.63 83.08 2.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.662 -0.649 . . . . 0.0 110.615 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.35 96.96 10.81 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.269 0.557 . . . . 0.0 110.452 -166.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.67 10.79 56.34 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 118.914 2.326 . . . . 0.0 118.914 -169.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -71.44 -47.38 56.14 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -170.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -55.96 -43.94 78.01 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -53.64 -47.0 70.71 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 167.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.436 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 67.9 t80 -53.35 -54.58 34.52 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 166.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.285 3.1 ptt? -69.38 -27.39 65.27 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 174.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -54.17 -52.02 62.49 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 154.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -60.9 -38.75 86.8 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -52.5 -52.52 54.08 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.17 -1.581 . . . . 0.0 115.178 163.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.55 69.58 0.72 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 124.403 1.001 . . . . 0.0 112.467 -169.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.1 t -127.57 130.52 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.92 164.39 49.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 117.418 1.727 . . . . 0.0 117.418 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -56.54 -47.46 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.87 94.86 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -67.31 -40.1 85.97 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -57.15 -46.49 82.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 163.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -55.97 -48.51 75.68 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 167.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 46.2 mtp -73.59 51.28 0.35 Allowed 'General case' 0 CA--C 1.583 2.232 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 165.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.69 -61.55 0.04 OUTLIER Glycine 0 N--CA 1.485 1.926 0 O-C-N 121.037 -1.039 . . . . 0.0 111.63 -171.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.5 -47.89 80.71 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 23.1 ptp -95.31 -6.8 40.41 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.82 110.99 16.86 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 120.365 1.439 . . . . 0.0 111.041 168.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -110.17 93.22 14.91 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.871 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.03 156.42 13.23 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.35 2.033 . . . . 0.0 116.811 -167.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.27 97.04 8.08 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.685 161.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.3 t -86.46 107.17 17.95 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 121.116 -0.99 . . . . 0.0 111.928 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.6 mt -91.81 106.51 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.5 mt -96.49 110.08 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -110.47 123.8 50.59 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 122.862 0.465 . . . . 0.0 110.303 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.7 p -116.57 94.3 4.56 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.558 0.743 . . . . 0.0 112.561 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -91.12 74.64 6.28 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 122.306 1.05 . . . . 0.0 110.697 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.17 -84.33 0.12 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 116.47 1.348 . . . . 0.0 116.47 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -101.42 -46.33 5.03 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -76.56 116.06 16.89 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-N 119.213 0.915 . . . . 0.0 112.019 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.4 tt -132.09 112.79 12.64 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.481 0.712 . . . . 0.0 109.577 -161.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.3 m -104.58 126.21 51.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.597 -1.314 . . . . 0.0 111.366 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -113.2 101.18 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.02 105.82 16.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.171 0.988 . . . . 0.0 109.611 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.2 m -97.45 106.47 18.8 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.834 0.854 . . . . 0.0 110.791 -171.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -104.93 98.66 8.34 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 122.924 0.489 . . . . 0.0 111.179 -167.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p -128.66 144.82 51.24 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.235 -0.916 . . . . 0.0 111.647 166.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -62.51 -44.77 95.55 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.9 mt -57.16 -43.57 82.65 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 165.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -155.29 125.33 6.63 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 119.348 0.976 . . . . 0.0 111.002 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.9 m -111.41 141.8 44.49 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.771 0.828 . . . . 0.0 110.251 173.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.4 t -144.7 158.46 43.77 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.824 0.821 . . . . 0.0 112.574 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -142.49 125.41 16.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.679 -1.263 . . . . 0.0 110.016 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -118.43 143.01 46.99 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.52 0.676 . . . . 0.0 111.126 163.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.1 m -112.18 110.99 21.56 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.104 0.954 . . . . 0.0 109.999 174.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.5 t -89.5 157.96 17.88 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.862 1.265 . . . . 0.0 114.02 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.4 m -113.86 119.8 38.55 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 159.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.6 tp -70.62 132.03 44.83 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 123.856 0.862 . . . . 0.0 112.849 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.25 -53.09 1.58 Allowed Glycine 0 N--CA 1.49 2.288 0 O-C-N 121.198 -0.939 . . . . 0.0 114.503 -161.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.99 163.47 15.53 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 124.023 1.868 . . . . 0.0 114.139 -169.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -88.74 108.79 19.68 Favored 'General case' 0 CA--C 1.564 1.489 0 CA-C-N 112.445 -2.161 . . . . 0.0 110.147 169.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -103.12 175.9 5.32 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.855 0.836 . . . . 0.0 112.695 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -92.38 107.04 18.92 Favored 'General case' 0 CA--C 1.568 1.646 0 O-C-N 120.725 -1.234 . . . . 0.0 111.338 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -79.16 129.1 34.11 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 110.094 163.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.8 m -107.51 110.99 23.05 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 165.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.6 p -72.98 162.29 29.67 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.89 -43.83 59.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 167.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.2 -36.09 83.11 Favored 'General case' 0 CA--C 1.573 1.847 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 169.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.73 26.94 1.5 Allowed Glycine 0 CA--C 1.551 2.297 0 N-CA-C 118.09 1.996 . . . . 0.0 118.09 -176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -90.74 140.57 29.66 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.038 1.919 . . . . 0.0 110.94 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -93.3 109.26 20.8 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 162.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . 0.268 0.9 OUTLIER -113.9 119.83 38.62 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.704 0.684 . . . . 0.0 110.383 -179.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -73.2 99.54 2.87 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-O 122.087 0.946 . . . . 0.0 110.671 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.9 m -110.07 106.74 16.35 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.199 -0.938 . . . . 0.0 109.872 -156.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.276 7.2 p -88.83 118.56 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.827 -0.546 . . . . 0.0 110.719 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.26 123.62 48.33 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -131.71 131.01 42.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.501 -0.749 . . . . 0.0 111.344 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -85.54 133.69 34.06 Favored 'General case' 0 CA--C 1.569 1.711 0 O-C-N 121.384 -0.823 . . . . 0.0 112.084 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -132.5 131.4 41.59 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.103 0.561 . . . . 0.0 110.342 164.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.277 4.1 m-20 71.74 -86.72 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 161.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.04 52.27 0.64 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 123.439 0.542 . . . . 0.0 113.022 160.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -156.03 124.2 5.75 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.904 0.882 . . . . 0.0 111.086 -164.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.7 tp -95.46 110.69 22.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.588 -0.695 . . . . 0.0 110.207 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.8 t -91.87 105.87 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -99.92 106.98 18.85 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 124.306 1.042 . . . . 0.0 109.466 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -97.45 102.0 13.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.489 -0.757 . . . . 0.0 111.358 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -83.43 125.59 31.86 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 124.768 1.227 . . . . 0.0 111.163 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.15 117.3 21.34 Favored 'General case' 0 CA--C 1.573 1.855 0 CA-C-N 119.459 1.027 . . . . 0.0 111.001 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -165.0 149.14 8.84 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.248 -0.908 . . . . 0.0 112.339 -171.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 48.55 41.94 18.09 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 158.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.8 30.11 71.96 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 119.55 2.58 . . . . 0.0 119.55 -166.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -142.32 138.53 31.34 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.439 1.095 . . . . 0.0 109.394 -166.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -129.81 126.84 39.04 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 121.491 0.662 . . . . 0.0 111.76 171.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.3 t -120.67 119.06 31.74 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.924 0.89 . . . . 0.0 109.572 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 71.6 p -93.01 128.29 38.83 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.184 0.594 . . . . 0.0 110.258 172.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.9 mm -112.93 116.55 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 169.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.4 m -99.79 98.54 9.34 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.43 -0.794 . . . . 0.0 109.046 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -90.84 99.12 12.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.22 147.52 50.58 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -163.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.97 121.46 31.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 112.64 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.328 40.2 mttt -106.16 -113.75 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.315 0.646 . . . . 0.0 109.92 169.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -84.85 51.85 2.26 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -168.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.95 31.76 79.0 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 117.516 1.766 . . . . 0.0 117.516 -156.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -137.27 135.0 36.76 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -169.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 tp -85.93 104.41 15.54 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.434 1.112 . . . . 0.0 108.957 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 87.1 t -99.99 109.42 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.7 t -102.98 106.62 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -116.62 99.16 6.95 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -164.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.8 p -93.31 157.12 16.4 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.57 130.41 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.852 -0.53 . . . . 0.0 109.986 158.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 4.9 ttt -102.81 -102.47 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -106.31 85.12 2.13 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.272 49.8 m-80 75.6 -43.19 0.49 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -169.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.4 t -82.29 123.43 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 111.193 -163.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.2 p -109.65 138.98 45.23 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.775 0.83 . . . . 0.0 112.539 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 11.1 p -127.37 117.4 22.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 169.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.1 m -93.98 105.99 17.98 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 168.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -116.52 129.73 56.36 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 122.044 0.926 . . . . 0.0 111.843 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 24.3 mm -104.38 126.34 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 124.273 1.029 . . . . 0.0 109.299 -159.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -123.08 126.35 46.91 Favored 'General case' 0 CA--C 1.577 1.995 0 O-C-N 121.68 -0.637 . . . . 0.0 112.172 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -87.3 139.96 30.03 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -74.69 118.27 17.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 112.136 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.82 61.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.771 -0.58 . . . . 0.0 110.115 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.029 -1.045 . . . . 0.0 109.03 -158.276 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.257 9.0 p . . . . . 0 N--CA 1.504 2.269 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -52.55 -28.19 19.79 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 167.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -51.69 -39.69 58.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.92 -6.11 42.97 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 171.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -90.74 135.53 33.66 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 121.213 1.824 . . . . 0.0 112.483 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.01 -176.19 29.64 Favored Glycine 0 N--CA 1.485 1.912 0 CA-C-O 122.642 1.134 . . . . 0.0 114.503 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -94.32 119.33 32.92 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.985 -0.608 . . . . 0.0 109.541 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -121.07 118.11 28.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 122.085 -0.385 . . . . 0.0 110.977 -166.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -105.91 126.45 52.19 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.287 -0.883 . . . . 0.0 112.908 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.03 124.56 24.68 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.714 0.769 . . . . 0.0 112.939 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.45 -55.51 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 124.117 0.967 . . . . 0.0 112.229 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -110.12 99.13 8.26 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 119.186 0.903 . . . . 0.0 109.173 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.0 p -113.87 95.68 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.081 0.953 . . . . 0.0 111.887 -174.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -107.41 123.41 48.35 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.139 -0.976 . . . . 0.0 111.736 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.76 66.34 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 119.657 2.623 . . . . 0.0 119.657 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -79.55 -41.2 27.75 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 120.29 2.045 . . . . 0.0 115.671 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.19 -43.23 74.2 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 120.443 1.474 . . . . 0.0 114.594 160.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.71 -47.97 82.73 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -51.27 -55.59 17.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 165.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -61.39 -23.5 65.84 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 171.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -64.53 -46.77 81.43 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 160.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -61.7 -37.59 84.71 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 121.615 2.007 . . . . 0.0 115.116 167.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.65 -51.75 67.52 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 164.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.54 72.33 1.05 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.428 -0.795 . . . . 0.0 112.538 -168.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.9 t -119.83 136.96 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.94 153.12 50.55 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 116.874 1.51 . . . . 0.0 116.874 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 30' ' ' ILE . 2.3 mp -59.11 -48.59 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -168.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.54 88.64 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 167.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.17 -45.98 91.25 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 170.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -61.97 -45.07 95.25 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 167.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -55.34 -42.55 74.0 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 74.4 mtm -62.3 -44.96 95.3 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 165.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -48.54 58.29 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.521 2.168 . . . . 0.0 118.521 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.65 -47.37 86.55 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -85.86 10.27 14.32 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.38 35.29 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 120.463 -1.398 . . . . 0.0 113.65 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -109.42 74.77 0.69 Allowed Pre-proline 0 CA--C 1.575 1.94 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.849 167.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.46 158.22 48.23 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.723 2.282 . . . . 0.0 115.913 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.05 98.24 10.3 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 162.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.2 t -88.84 101.62 14.22 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 122.063 0.935 . . . . 0.0 110.61 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -93.56 113.71 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -113.68 125.08 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -152.17 133.95 14.78 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.778 -1.202 . . . . 0.0 109.5 171.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.7 p -100.41 123.9 45.23 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -82.62 74.9 9.55 Favored 'General case' 0 CA--C 1.576 1.943 0 CA-C-O 122.309 1.052 . . . . 0.0 110.18 162.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.63 -89.04 0.08 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -88.49 -29.06 20.41 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 163.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -81.35 88.3 6.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 121.713 2.052 . . . . 0.0 111.841 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.34 109.45 16.6 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-O 122.125 0.964 . . . . 0.0 110.108 -173.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.1 m -101.33 113.35 26.34 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.332 -162.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.7 mt -111.49 113.1 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -110.77 105.34 14.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.823 -0.548 . . . . 0.0 109.881 170.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.0 m -90.95 101.29 14.05 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.557 0.743 . . . . 0.0 109.204 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -94.25 117.92 30.82 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.622 0.769 . . . . 0.0 111.779 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.9 t -154.49 139.47 17.31 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.704 0.801 . . . . 0.0 111.852 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.4 p -60.53 -34.56 74.29 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 165.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.8 -55.18 18.52 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-N 119.486 1.039 . . . . 0.0 113.671 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.54 110.45 3.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.606 -1.309 . . . . 0.0 111.636 167.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.6 m -80.75 146.32 31.07 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.963 0.887 . . . . 0.0 111.287 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.5 m -155.55 136.61 13.74 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.299 -1.501 . . . . 0.0 109.594 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -142.32 146.32 34.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -158.42 150.87 21.97 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.9 p -108.28 107.43 18.02 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.5 0.72 . . . . 0.0 110.943 169.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.0 p -99.07 115.29 28.65 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.588 0.708 . . . . 0.0 112.698 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.9 m -72.47 110.58 6.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.468 -0.77 . . . . 0.0 110.392 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.5 tp -71.05 110.31 5.66 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -162.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.12 -54.32 0.75 Allowed Glycine 0 CA--C 1.547 2.089 0 C-N-CA 123.594 0.616 . . . . 0.0 114.107 -159.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.91 -177.78 4.0 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 123.712 1.72 . . . . 0.0 113.579 -169.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -99.7 130.45 45.92 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 113.857 -1.52 . . . . 0.0 112.6 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -123.06 -175.8 3.26 Favored 'General case' 0 CA--C 1.578 2.032 0 C-N-CA 125.168 1.387 . . . . 0.0 111.45 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -109.73 119.51 39.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.322 -1.486 . . . . 0.0 111.221 165.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -81.36 131.88 35.31 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 121.368 -0.832 . . . . 0.0 109.051 158.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.0 m -100.7 107.12 18.65 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 167.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.6 p -70.48 162.3 29.0 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.77 -31.91 59.33 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 166.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.17 -47.99 80.29 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.95 57.19 0.25 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 124.104 0.859 . . . . 0.0 113.903 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -131.31 124.32 30.18 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -173.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.53 109.58 17.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.679 -0.638 . . . . 0.0 110.115 171.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.4 p -116.14 112.67 22.03 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.372 0.606 . . . . 0.0 111.018 -169.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -70.82 101.18 2.06 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.279 1.038 . . . . 0.0 110.937 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.8 m -122.71 122.13 38.02 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.138 -153.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.42 125.81 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.651 -0.656 . . . . 0.0 111.476 170.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.9 m -99.5 123.63 43.95 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 173.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -133.0 133.91 43.76 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 118.8 0.727 . . . . 0.0 111.167 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -95.38 130.5 42.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.092 -1.005 . . . . 0.0 111.54 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.9 t -143.47 141.78 30.92 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 122.943 0.497 . . . . 0.0 110.281 165.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 62.11 35.28 15.84 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 160.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.11 25.86 74.87 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -165.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.53 135.59 22.56 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-N 118.909 1.354 . . . . 0.0 113.249 -174.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.12 112.69 22.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.432 -0.793 . . . . 0.0 110.479 166.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 67.0 t -93.68 103.11 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -101.6 103.86 14.7 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.49 0.716 . . . . 0.0 109.981 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -91.22 107.26 19.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.514 -0.741 . . . . 0.0 110.693 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -79.72 144.93 33.22 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.879 0.871 . . . . 0.0 111.975 169.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -143.24 124.69 14.75 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.651 0.781 . . . . 0.0 109.781 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 7.9 p90 -155.3 125.83 6.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.252 30.0 t70 49.14 45.26 23.21 Favored 'General case' 0 CA--C 1.584 2.252 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.63 26.37 66.62 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 119.612 2.605 . . . . 0.0 119.612 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -131.96 130.83 42.0 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.628 1.214 . . . . 0.0 108.462 -171.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.58 150.09 38.58 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -166.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 t -139.17 131.93 29.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.594 -0.691 . . . . 0.0 112.079 164.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.8 p -104.22 109.4 21.21 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.102 0.561 . . . . 0.0 110.106 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.0 mm -95.61 104.04 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.7 m -100.52 102.5 13.7 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.644 -0.66 . . . . 0.0 109.81 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -99.48 87.18 3.53 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.163 0.585 . . . . 0.0 110.454 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -110.08 135.89 50.18 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -166.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.87 113.56 22.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.122 -0.986 . . . . 0.0 112.902 -173.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -141.23 133.56 28.16 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.491 0.717 . . . . 0.0 109.287 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 60.11 39.24 19.83 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.13 13.25 41.21 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 119.635 2.614 . . . . 0.0 119.635 -163.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -133.16 144.18 49.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.628 1.214 . . . . 0.0 110.178 -162.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.0 tp -88.03 103.97 16.21 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.868 0.842 . . . . 0.0 109.734 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.6 t -89.92 103.09 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.5 t -96.57 98.23 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -98.09 106.83 19.18 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.3 p -106.7 121.92 45.31 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.538 0.335 . . . . 0.0 111.839 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 p -121.73 137.1 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.265 0.626 . . . . 0.0 109.936 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.7 ttt -81.08 -79.42 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 122.219 -0.301 . . . . 0.0 110.246 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -122.1 -60.73 1.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.272 0.629 . . . . 0.0 110.885 167.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -97.63 -43.13 7.33 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.58 127.69 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 CA-C-O 122.38 1.086 . . . . 0.0 109.9 -156.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 73.6 p -110.6 139.21 46.07 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.993 -167.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.8 OUTLIER -106.34 132.07 52.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.835 . . . . 0.0 110.633 158.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.5 m -109.1 107.06 17.23 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -110.5 113.49 26.16 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.11 0.564 . . . . 0.0 110.835 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 mm -91.13 116.65 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.192 -0.943 . . . . 0.0 108.567 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -107.66 125.27 51.15 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.206 0.602 . . . . 0.0 110.727 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -92.27 142.65 27.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -81.57 116.32 21.28 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.911 0.885 . . . . 0.0 112.207 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.3 t -101.29 93.13 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -171.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 124.031 0.932 . . . . 0.0 110.451 -174.688 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.522 0.8 OUTLIER . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 118.755 2.872 . . . . 0.0 118.755 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -38.17 90.13 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 174.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -62.36 -25.69 68.05 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 167.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.7 mt -70.36 -7.57 43.88 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 164.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.83 142.59 31.41 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-N 121.319 1.872 . . . . 0.0 112.79 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.56 171.19 18.56 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 -86.98 103.63 15.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 165.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -101.66 101.86 12.45 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -170.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.33 142.58 27.62 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.588 0.755 . . . . 0.0 112.871 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.1 tp -71.01 127.96 34.35 Favored 'General case' 0 CA--C 1.571 1.776 0 O-C-N 120.677 -1.264 . . . . 0.0 113.446 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.95 -55.41 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 C-N-CA 124.082 0.953 . . . . 0.0 112.399 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -117.65 151.28 37.54 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 119.642 1.11 . . . . 0.0 110.567 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -144.47 59.22 1.33 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.997 0.903 . . . . 0.0 113.046 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -75.6 119.62 19.89 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -167.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.52 -6.76 71.22 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 -170.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.252 22.6 t80 -59.27 -31.6 69.25 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.816 2.524 . . . . 0.0 117.816 -174.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -52.46 -54.59 30.33 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 164.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.99 -45.39 83.0 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -58.65 -49.54 77.14 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 19.8 ptp -56.26 -37.65 70.06 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 167.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -63.62 -47.16 82.53 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 168.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.63 -37.95 83.21 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.1 mt -53.45 -35.94 61.06 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 117.576 2.435 . . . . 0.0 117.576 167.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.76 62.79 1.07 Allowed Glycine 0 N--CA 1.487 2.073 0 C-N-CA 123.438 0.542 . . . . 0.0 114.041 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.51 125.12 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -172.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.17 162.16 51.78 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.457 HD12 ' H ' ' A' ' 30' ' ' ILE . 1.8 mp -55.62 -50.97 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -168.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.38 94.86 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.4 mt -57.77 -41.7 82.54 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.734 1.754 . . . . 0.0 115.734 167.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -60.81 -49.68 76.5 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.22 -46.92 87.19 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.5 ttp -53.64 -55.21 27.87 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 167.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.29 96.04 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 118.618 2.207 . . . . 0.0 118.618 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.6 94.59 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.9 ptp -75.47 -22.15 57.48 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 170.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.93 133.1 47.75 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -174.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -103.08 87.28 1.22 Allowed Pre-proline 0 CA--C 1.576 1.945 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.749 166.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.96 142.96 22.63 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.46 2.107 . . . . 0.0 115.168 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -95.44 103.34 15.21 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.18 168.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 50.6 t -81.14 101.11 9.44 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-O 121.836 0.827 . . . . 0.0 110.903 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mt -94.96 104.36 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -170.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.83 130.78 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.258 7.7 t -136.84 149.88 47.98 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.776 -0.577 . . . . 0.0 112.312 159.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.4 t -141.83 128.74 20.63 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -68.68 -46.2 69.7 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 165.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.66 -78.68 0.15 Allowed Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -171.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HE3' HG22 ' A' ' 68' ' ' THR . 43.8 tttp -80.82 -26.07 37.35 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 160.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -88.63 138.75 31.14 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 122.842 2.565 . . . . 0.0 112.931 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -139.57 125.21 19.38 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.436 0.694 . . . . 0.0 110.463 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 m -109.37 133.86 52.53 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.376 1.07 . . . . 0.0 110.433 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.8 mt -123.12 119.68 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -103.94 110.17 22.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.685 -0.634 . . . . 0.0 110.145 163.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.7 m -83.71 99.17 10.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.277 -0.89 . . . . 0.0 109.102 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.44 125.74 35.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.663 0.744 . . . . 0.0 112.24 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 t -147.1 135.28 21.58 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 166.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.4 p -56.39 -26.05 51.79 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.5 mt -73.47 -54.51 8.09 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 165.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.71 114.75 3.54 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.563 1.529 . . . . 0.0 111.612 173.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.4 m -84.19 141.46 31.02 Favored 'General case' 0 CA--C 1.575 1.928 0 C-N-CA 123.457 0.703 . . . . 0.0 111.851 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 t -134.17 145.48 49.29 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.156 -0.965 . . . . 0.0 111.27 164.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -135.47 133.99 39.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.776 -1.202 . . . . 0.0 111.849 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.92 160.62 41.02 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 122.061 0.934 . . . . 0.0 112.964 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 m -139.13 137.49 36.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.089 -1.007 . . . . 0.0 111.153 170.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 36.4 t -135.4 143.0 45.77 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.813 1.292 . . . . 0.0 112.635 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.428 HG22 ' HE3' ' A' ' 50' ' ' LYS . 35.2 m -91.48 115.41 28.02 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.195 171.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -64.38 134.4 54.53 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.95 -49.09 0.87 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 -154.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -98.47 164.98 12.05 Favored 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 123.595 1.664 . . . . 0.0 113.228 -163.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -110.58 128.76 55.8 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.396 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.416 ' HE1' ' SG ' ' A' ' 87' ' ' CYS . 11.7 p90 -129.62 166.14 20.35 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.46 105.99 10.1 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 122.055 0.931 . . . . 0.0 111.467 169.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -103.12 97.43 7.52 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.426 1.091 . . . . 0.0 109.104 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.8 m -80.06 109.12 14.21 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 121.821 0.82 . . . . 0.0 109.471 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.6 p -69.6 176.14 3.71 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.95 -43.28 29.13 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 168.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.76 -43.51 97.92 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.268 2.322 . . . . 0.0 117.268 165.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.98 3.15 13.58 Favored Glycine 0 CA--C 1.556 2.634 0 N-CA-C 119.097 2.399 . . . . 0.0 119.097 -162.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.3 mtm-85 -69.89 128.54 36.72 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 120.979 2.389 . . . . 0.0 112.204 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -86.54 93.54 9.2 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.791 0.805 . . . . 0.0 108.9 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 p -99.28 125.24 44.87 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.712 -170.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -79.92 97.55 6.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.656 -1.278 . . . . 0.0 110.082 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.4 m -104.97 116.7 32.41 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.749 0.42 . . . . 0.0 110.408 -166.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.13 118.91 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.97 -0.456 . . . . 0.0 110.087 167.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.416 ' SG ' ' HE1' ' A' ' 73' ' ' PHE . 70.9 m -100.1 131.42 46.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.967 -0.458 . . . . 0.0 111.58 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -142.04 115.4 8.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 110.265 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -78.96 129.4 34.44 Favored 'General case' 0 CA--C 1.57 1.721 0 O-C-N 120.977 -1.077 . . . . 0.0 111.6 166.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 t -146.1 142.78 28.86 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.251 0.62 . . . . 0.0 110.201 165.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 60.63 36.92 19.55 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 159.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.3 21.15 79.45 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 -166.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.52 139.62 24.33 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-N 119.02 1.41 . . . . 0.0 112.596 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 67.3 tp -96.61 115.13 26.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -0.804 . . . . 0.0 110.615 171.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.9 t -89.28 103.35 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -98.31 95.56 7.46 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -96.72 99.74 11.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.968 . . . . 0.0 110.095 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -100.43 126.9 46.87 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -170.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -129.78 131.1 46.11 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.207 0.603 . . . . 0.0 111.388 -167.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -152.64 120.9 6.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.624 -1.298 . . . . 0.0 111.438 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.6 t70 42.99 54.22 4.86 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.9 -45.43 2.69 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 117.902 1.921 . . . . 0.0 117.902 -169.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -89.92 141.78 28.32 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 118.19 0.995 . . . . 0.0 113.345 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -127.92 159.68 34.19 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.682 0.753 . . . . 0.0 112.991 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.4 t -135.54 141.51 45.24 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.429 1.109 . . . . 0.0 112.01 162.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.6 p -106.38 109.99 22.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 mm -103.09 94.51 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -172.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.1 m -97.82 105.36 17.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.0 109.719 -172.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.9 mtp85 -103.23 89.33 3.37 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.234 0.614 . . . . 0.0 110.544 -167.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -105.86 138.25 42.37 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -168.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.4 123.88 33.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 113.209 -173.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -150.92 121.83 7.61 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.519 0.728 . . . . 0.0 109.266 -170.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.1 t70 61.06 28.2 17.97 Favored 'General case' 0 N--CA 1.514 2.754 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.58 33.12 66.09 Favored Glycine 0 CA--C 1.56 2.849 0 O-C-N 119.274 -2.141 . . . . 0.0 117.584 -158.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -133.08 131.17 40.27 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -174.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.2 tp -86.52 105.12 16.59 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.849 -1.157 . . . . 0.0 109.831 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.2 t -91.95 106.17 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t -100.5 99.29 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -87.52 93.85 9.54 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.471 1.129 . . . . 0.0 108.499 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.938 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.3 p -104.82 97.39 7.28 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.7 -176.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.48 146.34 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.519 1.152 . . . . 0.0 109.927 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.3 ttt -97.71 -60.12 1.63 Allowed 'General case' 0 CA--C 1.565 1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 112.972 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.273 12.9 p30 -139.65 -92.99 0.17 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -81.28 -13.71 58.17 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 154.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -96.73 133.89 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 C-N-CA 124.72 1.208 . . . . 0.0 109.67 -166.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.0 p -132.76 146.83 52.17 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -152.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.938 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 6.1 p -136.92 121.12 17.91 Favored 'General case' 0 CA--C 1.563 1.468 0 O-C-N 121.533 -0.73 . . . . 0.0 110.711 158.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.2 m -97.76 101.7 13.28 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -108.9 110.53 21.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.701 -0.624 . . . . 0.0 110.306 -168.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.9 mm -94.39 124.69 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -122.28 120.38 33.92 Favored 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.04 0.536 . . . . 0.0 110.379 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -90.74 150.51 21.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.781 -1.199 . . . . 0.0 113.447 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -78.4 128.64 33.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.915 -1.116 . . . . 0.0 113.55 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.2 t -86.56 104.65 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 165.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 N--CA 1.487 1.395 0 C-N-CA 123.802 0.841 . . . . 0.0 110.543 178.451 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.274 4.8 p . . . . . 0 N--CA 1.503 2.2 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.53 -33.28 72.42 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 163.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -63.49 -33.83 76.44 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 165.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.94 -4.06 11.85 Favored 'General case' 0 CA--C 1.581 2.151 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 164.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.05 122.02 25.68 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 121.955 2.161 . . . . 0.0 112.596 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.19 -179.95 34.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.3 ttm105 -93.84 108.06 19.88 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.159 0.584 . . . . 0.0 109.592 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -109.94 107.56 17.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.376 -0.827 . . . . 0.0 110.49 -165.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -91.82 130.78 37.53 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.788 -1.195 . . . . 0.0 112.794 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 48.0 tp -64.18 125.53 24.84 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 170.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.261 5.6 m -126.86 -60.01 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 123.097 0.559 . . . . 0.0 112.246 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -104.21 137.23 42.43 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 119.332 0.969 . . . . 0.0 110.338 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 p -147.97 93.57 2.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.477 -0.764 . . . . 0.0 111.725 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.46 128.9 48.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.816 -0.552 . . . . 0.0 111.772 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.6 -1.12 88.58 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 118.901 2.32 . . . . 0.0 118.901 -168.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -71.53 -51.19 24.84 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.046 1.923 . . . . 0.0 115.555 -170.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.09 -38.53 62.64 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 167.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.71 -49.28 75.69 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -54.24 -45.04 72.24 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 164.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.1 mtp -57.84 -42.75 85.02 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 169.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -55.5 -48.63 74.31 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 163.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.8 -43.4 98.19 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 172.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.7 mt -55.23 -38.58 68.65 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 117.889 2.552 . . . . 0.0 117.889 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.6 55.93 1.13 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 -165.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.69 118.57 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.682 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.65 165.29 41.08 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.468 HD12 ' H ' ' A' ' 30' ' ' ILE . 1.9 mp -57.94 -48.92 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.46 98.56 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.45 -42.39 91.85 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -57.53 -51.44 69.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -54.96 -54.3 44.53 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 169.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.2 ttp -52.93 -57.01 11.74 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.81 -40.85 90.3 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 118.926 2.33 . . . . 0.0 118.926 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.54 -51.79 52.75 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 169.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -72.61 -30.36 64.29 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.81 85.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.338 62.7 pttt 47.25 66.39 5.71 Favored Pre-proline 0 CA--C 1.585 2.306 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.79 154.84 23.47 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 N-CA-C 117.025 1.894 . . . . 0.0 117.025 -159.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.83 97.97 7.61 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.028 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.0 t -90.9 103.25 15.98 Favored 'General case' 0 CA--C 1.556 1.183 0 O-C-N 121.148 -0.97 . . . . 0.0 112.198 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.88 110.18 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.8 mt -97.95 114.8 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.2 m -134.63 117.91 16.62 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.5 t -121.82 118.54 29.25 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -172.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -86.19 60.24 6.12 Favored 'General case' 0 CA--C 1.576 1.951 0 CA-C-O 121.991 0.901 . . . . 0.0 111.557 170.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.64 -71.24 0.68 Allowed Glycine 0 N--CA 1.492 2.412 0 O-C-N 120.145 -1.597 . . . . 0.0 116.431 -170.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -99.89 -46.23 5.44 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.76 105.35 10.99 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 121.053 1.752 . . . . 0.0 111.387 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.66 111.61 23.87 Favored 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.139 0.971 . . . . 0.0 109.832 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.1 m -93.98 116.48 28.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.891 0.876 . . . . 0.0 109.165 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.4 104.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -105.43 104.02 13.66 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.321 0.581 . . . . 0.0 109.683 171.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.7 m -89.25 100.16 13.01 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.851 0.86 . . . . 0.0 110.124 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.72 111.84 23.7 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.088 0.947 . . . . 0.0 111.498 -173.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.1 p -148.51 153.12 38.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.628 -0.67 . . . . 0.0 110.601 157.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.6 p -61.98 -43.93 97.81 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 171.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.5 mt -61.97 -41.41 97.98 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 168.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -145.31 110.63 5.28 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.836 1.198 . . . . 0.0 110.72 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.53 118.81 36.14 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.2 p -139.72 142.61 36.83 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.009 -1.057 . . . . 0.0 111.91 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -139.14 133.44 31.48 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.742 -1.224 . . . . 0.0 111.821 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -146.65 147.31 30.9 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.678 0.751 . . . . 0.0 112.887 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.3 p -105.53 106.29 16.72 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.577 0.751 . . . . 0.0 110.846 172.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.3 p -94.45 125.23 38.96 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 121.515 0.674 . . . . 0.0 112.33 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.5 m -77.8 123.17 26.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.318 -0.864 . . . . 0.0 110.068 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.79 132.03 37.87 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -167.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.71 37.38 94.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 116.792 1.477 . . . . 0.0 116.792 -159.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.73 155.75 24.32 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.429 1.109 . . . . 0.0 111.136 -171.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -109.73 121.56 45.5 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.787 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -121.59 162.15 21.15 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.46 0.704 . . . . 0.0 112.502 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -75.84 106.08 7.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.783 -1.198 . . . . 0.0 110.971 166.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -90.98 116.54 28.86 Favored 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.8 m -86.74 93.97 9.39 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.8 p -68.94 159.93 31.77 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -43.46 -42.93 5.06 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.99 -35.8 66.92 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 171.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.91 -14.9 3.32 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 117.94 1.936 . . . . 0.0 117.94 -166.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -71.81 131.34 42.92 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.495 2.147 . . . . 0.0 112.651 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -81.97 110.5 17.29 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.205 0.602 . . . . 0.0 110.364 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.6 p -114.96 128.26 56.17 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.136 0.493 . . . . 0.0 109.816 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -78.82 92.25 4.83 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.759 0.79 . . . . 0.0 109.64 172.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.4 m -98.15 114.31 26.48 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.894 -164.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.264 12.5 p -91.74 117.11 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 122.019 -0.426 . . . . 0.0 110.82 171.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.6 m -101.5 112.99 25.71 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.136 -0.352 . . . . 0.0 111.849 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -123.0 125.56 45.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.656 -0.652 . . . . 0.0 111.114 -171.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -88.33 130.55 35.1 Favored 'General case' 0 CA--C 1.568 1.663 0 O-C-N 121.131 -0.98 . . . . 0.0 112.393 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -141.29 107.61 5.26 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.466 0.706 . . . . 0.0 110.218 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 45.34 70.45 0.35 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 171.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.33 -0.03 60.82 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 119.896 2.718 . . . . 0.0 119.896 -171.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.39 126.58 39.15 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 119.985 1.892 . . . . 0.0 113.009 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.2 tp -93.39 108.82 20.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.614 -0.679 . . . . 0.0 110.621 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -90.29 107.93 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -101.11 98.37 8.81 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.284 1.034 . . . . 0.0 109.521 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -100.3 103.14 14.54 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.565 0.746 . . . . 0.0 110.477 -171.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -100.19 105.97 17.61 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.896 0.878 . . . . 0.0 111.215 -164.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -108.19 126.08 52.38 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.192 -0.942 . . . . 0.0 113.539 -166.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -154.71 141.02 18.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.221 -0.925 . . . . 0.0 110.606 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.2 t70 51.14 45.44 27.83 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 159.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.9 68.63 Favored Glycine 0 CA--C 1.559 2.829 0 N-CA-C 120.238 2.855 . . . . 0.0 120.238 -167.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -137.01 150.06 47.87 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.141 1.471 . . . . 0.0 110.434 -167.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -124.18 147.56 47.91 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.249 0.547 . . . . 0.0 112.374 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.8 t -126.3 115.63 19.99 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 164.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.8 m -123.74 113.14 18.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.067 -1.021 . . . . 0.0 108.732 -160.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.0 mt -122.09 112.17 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -164.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 58.6 m -95.32 101.31 13.03 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.187 0.517 . . . . 0.0 109.666 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -93.08 101.17 13.48 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.376 0.67 . . . . 0.0 109.271 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 pttp -126.39 140.4 52.52 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -169.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.18 116.39 15.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 111.203 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.286 24.9 tptp -103.24 -126.72 0.22 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.081 0.552 . . . . 0.0 110.049 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -91.9 64.93 4.81 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 122.231 1.015 . . . . 0.0 109.51 -165.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.66 -24.11 13.73 Favored Glycine 0 CA--C 1.556 2.645 0 N-CA-C 119.045 2.378 . . . . 0.0 119.045 -162.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -129.89 161.16 31.47 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.078 1.939 . . . . 0.0 112.306 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.5 tp -85.02 116.08 23.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.794 -1.191 . . . . 0.0 111.406 -173.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.7 t -91.81 120.2 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 64.0 t -110.34 100.01 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -95.66 102.67 14.49 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.966 0.906 . . . . 0.0 108.972 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 0.9 OUTLIER -98.85 150.89 21.42 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.1 137.29 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 123.221 0.608 . . . . 0.0 109.609 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.268 10.7 ttt -98.25 -77.35 0.51 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 0.0 111.118 163.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -123.48 -70.89 0.75 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.388 -0.82 . . . . 0.0 110.934 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -99.58 -31.32 11.66 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 170.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.2 t -99.74 129.49 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-N 120.365 1.438 . . . . 0.0 110.148 -164.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.8 p -106.34 154.89 20.14 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.328 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.6 OUTLIER -130.17 139.16 50.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 112.328 162.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.1 m -106.74 109.43 21.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -107.31 124.82 50.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.331 0.653 . . . . 0.0 110.996 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.8 mm -92.38 122.73 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -113.57 122.78 48.28 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.757 0.823 . . . . 0.0 109.973 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -92.72 137.92 31.94 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -77.52 111.95 13.78 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.72 0.772 . . . . 0.0 112.691 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.9 t -103.95 128.47 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.015 -1.053 . . . . 0.0 108.832 -175.514 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.503 1.2 p . . . . . 0 N--CA 1.503 2.181 0 N-CA-C 118.38 2.733 . . . . 0.0 118.38 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.37 -36.32 53.52 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 169.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -54.49 -37.06 64.85 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 169.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.9 mt -70.74 -2.58 15.13 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 171.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -81.72 134.84 35.5 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 121.258 1.844 . . . . 0.0 112.937 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.79 177.95 29.51 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 117.757 1.863 . . . . 0.0 117.757 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -93.43 102.54 14.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.096 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.34 101.84 11.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.954 -0.466 . . . . 0.0 110.018 -168.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -90.01 125.82 35.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.206 1.002 . . . . 0.0 113.45 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.9 tp -64.41 125.09 23.53 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.41 -44.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.321 1.048 . . . . 0.0 113.162 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -128.49 155.66 44.49 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 120.291 1.405 . . . . 0.0 111.834 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.5 p -153.62 84.38 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 0.0 111.365 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.14 138.76 39.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.513 -0.742 . . . . 0.0 112.758 176.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.45 23.32 70.19 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 119.693 2.637 . . . . 0.0 119.693 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -85.83 -43.62 13.14 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -168.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -50.13 -46.4 53.82 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 162.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -53.98 -48.98 69.81 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 166.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -61.2 -47.47 85.98 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.05 -32.79 74.46 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 169.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -58.23 -48.44 80.39 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 121.507 1.958 . . . . 0.0 115.814 158.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -60.21 -40.6 90.7 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.5 mt -57.7 -50.3 73.64 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 161.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.14 56.11 0.28 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 124.346 0.974 . . . . 0.0 115.134 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.31 130.28 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-N 117.607 0.703 . . . . 0.0 109.423 -171.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.51 159.87 51.8 Favored Glycine 0 CA--C 1.553 2.431 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.467 HD12 ' H ' ' A' ' 30' ' ' ILE . 1.8 mp -56.88 -48.65 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -170.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.61 88.72 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 171.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.09 -40.03 94.03 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 170.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.1 mtm-85 -63.69 -42.71 97.96 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 166.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -54.29 -49.82 68.72 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 166.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.6 ttp -52.86 -55.29 24.28 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 164.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.48 -37.73 67.8 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 119.766 2.666 . . . . 0.0 119.766 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.34 -51.04 61.32 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.2 ptp -77.28 -20.44 55.07 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.24 115.22 7.45 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 120.163 1.347 . . . . 0.0 112.184 165.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.93 84.42 3.46 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.139 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.86 151.49 31.46 Favored 'Trans proline' 0 C--N 1.372 1.772 0 N-CA-C 117.395 2.036 . . . . 0.0 117.395 -168.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -84.4 102.38 12.71 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.532 162.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.3 t -77.78 100.53 6.32 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 121.951 0.881 . . . . 0.0 110.76 170.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.7 mt -95.93 101.68 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -170.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 81.2 mt -99.33 130.64 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.6 t -136.23 140.22 43.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.824 -0.548 . . . . 0.0 111.666 157.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 43.0 t -119.65 103.57 9.51 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.683 0.793 . . . . 0.0 111.961 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.65 75.85 9.53 Favored 'General case' 0 CA--C 1.572 1.798 0 CA-C-O 122.189 0.995 . . . . 0.0 110.686 170.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.7 -83.29 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 116.733 1.453 . . . . 0.0 116.733 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -105.59 -16.6 14.66 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -101.9 116.97 33.86 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 122.214 2.279 . . . . 0.0 110.523 175.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -112.43 116.78 30.84 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.947 0.879 . . . . 0.0 109.938 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.6 m -99.4 125.74 45.16 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.987 0.915 . . . . 0.0 109.73 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 mt -119.4 112.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -98.14 109.83 22.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.764 -0.585 . . . . 0.0 109.941 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 m -90.9 103.3 16.03 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.435 -0.79 . . . . 0.0 109.456 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -101.43 116.85 33.72 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -143.24 140.47 30.69 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.087 0.555 . . . . 0.0 110.091 167.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -50.83 -44.33 59.25 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.21 -40.72 97.05 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.34 103.84 1.25 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.47 1.487 . . . . 0.0 111.076 -175.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.0 m -90.25 145.67 24.82 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.991 0.901 . . . . 0.0 111.459 170.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.7 m -148.24 136.14 20.96 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.056 -1.653 . . . . 0.0 110.63 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -126.99 133.37 50.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.413 -0.804 . . . . 0.0 111.75 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -136.38 152.06 50.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 172.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.3 p -117.98 103.95 10.42 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.802 0.841 . . . . 0.0 109.905 170.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 24.1 p -95.34 152.1 18.68 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.8 m -91.37 130.81 37.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.824 -1.172 . . . . 0.0 109.582 168.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tp -69.53 131.31 44.49 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 112.878 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.13 -6.98 8.56 Favored Glycine 0 CA--C 1.553 2.458 0 N-CA-C 119.558 2.583 . . . . 0.0 119.558 -164.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.78 172.02 10.18 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-N 119.303 1.552 . . . . 0.0 112.007 -174.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -113.46 110.79 20.87 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.495 -156.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -105.76 160.75 14.98 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.655 0.782 . . . . 0.0 112.296 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.53 106.68 14.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.93 -1.731 . . . . 0.0 111.658 169.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -89.15 102.08 14.74 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 169.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.4 m -77.95 110.82 13.2 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.094 0.949 . . . . 0.0 109.593 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -75.43 134.38 40.9 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.797 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.94 63.77 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 119.721 3.23 . . . . 0.0 119.721 -170.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.31 -27.08 65.98 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.51 -35.7 0.47 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 118.715 2.246 . . . . 0.0 118.715 167.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -75.07 136.54 41.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -163.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -93.55 115.04 27.53 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.173 0.989 . . . . 0.0 109.021 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.4 p -119.36 111.41 18.14 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.784 0.802 . . . . 0.0 111.168 -164.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -71.78 98.27 1.94 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.324 1.05 . . . . 0.0 110.581 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.4 m -112.99 108.47 17.39 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.285 -0.884 . . . . 0.0 109.922 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.258 12.7 p -88.88 122.61 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 122.96 0.504 . . . . 0.0 111.382 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 55.7 m -105.51 88.11 2.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -169.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -102.18 119.34 38.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.541 -1.349 . . . . 0.0 111.941 -168.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -80.17 131.9 35.8 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.004 -1.06 . . . . 0.0 112.712 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -133.11 97.47 4.01 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.583 0.753 . . . . 0.0 110.414 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.331 9.8 t70 68.6 -73.56 0.09 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 172.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.39 35.43 2.17 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 116.587 1.395 . . . . 0.0 116.587 167.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -153.93 139.24 17.58 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 118.581 1.19 . . . . 0.0 112.957 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 tp -97.84 115.4 27.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.68 -0.637 . . . . 0.0 110.854 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -88.01 101.8 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.56 94.52 9.91 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 124.396 1.078 . . . . 0.0 109.009 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -96.1 98.13 10.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.728 . . . . 0.0 112.159 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -71.05 137.42 48.95 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.062 0.945 . . . . 0.0 113.063 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -136.83 121.61 18.64 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.497 0.719 . . . . 0.0 109.931 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -158.35 127.1 5.5 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.626 -1.296 . . . . 0.0 111.11 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 54.08 37.83 27.77 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 164.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.72 -43.23 3.08 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 -165.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -75.35 154.57 37.2 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -151.58 155.01 37.57 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.059 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 t -144.32 121.87 11.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.219 -0.926 . . . . 0.0 112.897 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.1 p -86.55 131.34 34.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 0.0 111.278 168.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.2 mt -123.32 101.28 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 84.9 m -93.71 108.08 19.87 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.546 0.739 . . . . 0.0 110.056 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -97.98 87.91 4.1 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.268 0.627 . . . . 0.0 110.041 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.18 142.32 29.22 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -171.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 120.86 27.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.505 -0.747 . . . . 0.0 112.366 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.274 41.0 tttm -134.85 -130.92 0.16 Allowed 'General case' 0 CA--C 1.569 1.706 0 O-C-N 121.979 -0.45 . . . . 0.0 112.03 -172.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -82.86 67.91 9.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.497 -1.377 . . . . 0.0 113.464 -161.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.95 16.82 57.72 Favored Glycine 0 CA--C 1.565 3.194 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -157.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -137.86 131.75 31.5 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.098 1.359 . . . . 0.0 108.146 -164.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.3 tp -82.03 108.55 15.61 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 121.701 0.762 . . . . 0.0 109.259 164.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -96.67 110.13 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -175.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.0 t -103.29 100.35 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -167.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -95.62 108.43 20.7 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.545 1.138 . . . . 0.0 108.568 -171.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.2 p -126.42 129.35 48.57 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 121.921 0.867 . . . . 0.0 112.382 -158.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.37 146.29 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 123.396 0.678 . . . . 0.0 109.964 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.265 18.6 ttt -118.24 -94.16 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.575 -0.703 . . . . 0.0 111.327 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -105.87 -52.21 2.85 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.758 0.823 . . . . 0.0 111.828 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -119.1 -39.32 2.93 Favored 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 125.485 1.514 . . . . 0.0 112.142 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t -87.39 121.8 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 O-C-N 121.274 -0.892 . . . . 0.0 110.364 -164.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 46.7 p -93.34 103.49 15.72 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.914 0.864 . . . . 0.0 110.204 165.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 18.5 p -85.69 160.94 19.43 Favored 'General case' 0 CA--C 1.57 1.739 0 CA-C-O 122.624 1.202 . . . . 0.0 111.537 163.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.8 m -150.44 119.01 6.48 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 119.26 -2.15 . . . . 0.0 108.031 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -125.78 132.24 52.32 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-O 121.836 0.827 . . . . 0.0 111.757 -168.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.2 mm -111.63 117.43 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -162.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -116.8 129.68 56.24 Favored 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 123.037 0.535 . . . . 0.0 111.216 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -106.63 146.91 30.14 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -71.94 106.09 4.1 Favored 'General case' 0 CA--C 1.57 1.742 0 O-C-N 121.046 -1.034 . . . . 0.0 113.106 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.05 85.56 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--O 1.256 1.446 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -171.456 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.505 2.289 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -46.25 -34.06 4.14 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 165.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -63.74 -22.19 66.78 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 172.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.1 mt -74.89 -5.78 45.55 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 117.722 2.49 . . . . 0.0 117.722 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 164.0 26.94 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -172.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.35 -179.37 24.68 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 171.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 -84.22 126.16 32.88 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.153 -0.616 . . . . 0.0 111.201 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -126.31 113.81 17.42 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -89.75 134.9 33.93 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.0 tp -68.61 121.78 17.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -112.28 -55.15 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 123.952 0.901 . . . . 0.0 112.603 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -106.69 140.2 39.92 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 120.244 1.383 . . . . 0.0 110.228 168.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -136.5 79.7 1.78 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.728 1.252 . . . . 0.0 110.167 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -99.03 100.82 12.03 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.562 -0.712 . . . . 0.0 110.938 -158.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.5 22.07 20.08 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 118.309 2.084 . . . . 0.0 118.309 -167.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -74.27 -49.74 21.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -37.9 74.69 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 167.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -57.73 -45.13 86.24 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 166.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -57.3 -49.36 76.35 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 164.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 73.5 mtm -60.76 -35.35 76.2 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 172.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -55.44 -55.23 34.09 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 161.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.413 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 31.6 tp10 -64.91 -36.6 84.89 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -53.65 -44.03 69.27 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 159.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.8 56.59 1.22 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -172.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -98.02 137.71 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 123.327 0.651 . . . . 0.0 110.091 -172.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.26 153.33 48.64 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 pt -57.37 -48.82 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 -171.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.58 87.76 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 167.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 mt -66.52 -37.68 85.56 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 169.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -57.65 -48.82 78.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 162.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -57.52 -48.97 77.84 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 169.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -50.7 -51.46 49.46 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 167.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.2 -46.17 93.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 118.116 2.007 . . . . 0.0 118.116 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.47 -45.02 94.94 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -79.81 -5.23 54.99 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 118.048 2.611 . . . . 0.0 118.048 173.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.05 135.8 39.93 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.25 92.33 2.09 Favored Pre-proline 0 CA--C 1.573 1.857 0 O-C-N 121.369 -0.832 . . . . 0.0 110.853 160.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.35 136.53 26.62 Favored 'Trans proline' 0 CA--C 1.559 1.774 0 CA-C-N 122.935 2.084 . . . . 0.0 114.548 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -100.54 101.93 12.98 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.392 167.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.2 t -74.76 111.96 10.49 Favored 'General case' 0 CA--C 1.558 1.274 0 O-C-N 121.627 -0.671 . . . . 0.0 110.689 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mt -104.88 105.16 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 83.9 mt -95.47 129.46 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.0 p -119.0 111.94 18.95 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.5 p -98.56 111.45 23.81 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -170.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -84.78 176.75 8.33 Favored 'General case' 0 CA--C 1.578 2.035 0 CA-C-O 124.106 1.908 . . . . 0.0 110.346 159.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.18 -40.99 92.52 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.402 2.121 . . . . 0.0 118.402 158.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -123.06 -47.77 2.02 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 166.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -86.63 82.74 7.79 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 120.953 1.706 . . . . 0.0 111.518 -166.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.61 112.7 24.34 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.885 -1.134 . . . . 0.0 109.221 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.2 m -98.31 119.62 37.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.532 -0.73 . . . . 0.0 110.576 -168.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.3 mt -112.0 105.76 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -99.99 103.3 14.84 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.3 m -90.56 100.34 13.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.61 -0.681 . . . . 0.0 110.011 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.16 118.8 30.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.6 t -138.21 144.4 40.62 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.197 0.599 . . . . 0.0 110.017 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.5 p -75.78 42.32 0.23 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.1 mt -152.91 -54.64 0.12 Allowed 'General case' 0 CA--C 1.572 1.821 0 C-N-CA 126.791 2.036 . . . . 0.0 108.654 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -143.44 117.0 9.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.024 -1.048 . . . . 0.0 110.838 167.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.3 m -84.75 120.08 26.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.676 -0.64 . . . . 0.0 109.61 166.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.0 p -111.97 103.03 11.23 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -102.72 128.95 49.23 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.35 0.66 . . . . 0.0 111.374 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -145.34 141.6 28.65 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.02 0.914 . . . . 0.0 112.954 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.8 p -97.47 105.29 17.41 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.739 0.816 . . . . 0.0 110.886 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 30.1 p -92.96 122.55 35.44 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.566 0.698 . . . . 0.0 111.99 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.0 m -85.72 115.41 23.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.483 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.27 118.29 19.62 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.541 0.737 . . . . 0.0 112.764 -166.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.1 55.17 8.16 Favored Glycine 0 CA--C 1.549 2.192 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.945 -156.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.49 154.71 2.63 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 124.429 1.092 . . . . 0.0 111.403 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -109.59 123.56 49.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.135 0.974 . . . . 0.0 112.916 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -127.65 164.48 21.95 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 124.17 0.988 . . . . 0.0 112.293 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -78.39 107.73 11.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 119.842 -1.787 . . . . 0.0 111.712 164.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -77.95 147.65 34.85 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.294 155.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.0 m -113.17 114.73 27.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.769 171.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.3 p -70.49 138.68 51.29 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 122.825 0.45 . . . . 0.0 111.62 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.62 -29.45 10.98 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 120.309 3.448 . . . . 0.0 120.309 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -84.15 -29.75 26.43 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 170.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.15 -37.39 0.37 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 119.96 2.744 . . . . 0.0 119.96 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -68.25 127.92 34.68 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 119.578 1.689 . . . . 0.0 112.675 -174.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -93.72 128.84 40.13 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.121 0.486 . . . . 0.0 110.744 171.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.8 p -120.44 126.01 49.36 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.254 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -67.77 103.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.208 1.004 . . . . 0.0 111.319 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.3 m -114.53 101.38 9.07 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -158.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.299 14.6 p -87.05 106.17 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.404 0.621 . . . . 0.0 110.331 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 63.6 m -92.12 120.71 32.98 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -140.01 126.92 20.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.87 -0.519 . . . . 0.0 111.265 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -92.21 123.52 35.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 111.488 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 t -139.51 138.41 36.31 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.235 0.614 . . . . 0.0 109.832 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 61.79 36.93 15.91 Favored 'General case' 0 N--CA 1.506 2.334 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 162.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.7 12.63 83.68 Favored Glycine 0 CA--C 1.557 2.69 0 N-CA-C 119.354 2.502 . . . . 0.0 119.354 -165.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.35 125.47 24.53 Favored 'General case' 0 CA--C 1.561 1.392 0 CA-C-N 119.668 1.734 . . . . 0.0 112.743 -169.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 tp -86.4 106.9 17.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.529 -0.732 . . . . 0.0 110.945 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 66.7 t -92.95 108.66 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.854 0.862 . . . . 0.0 108.765 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -93.27 95.0 9.08 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.627 0.771 . . . . 0.0 110.024 173.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -91.08 102.49 15.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 110.751 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -94.56 126.07 39.61 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.699 1.2 . . . . 0.0 111.31 -172.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -125.26 122.81 38.0 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.341 0.656 . . . . 0.0 110.466 -169.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -157.38 118.81 3.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.807 -1.183 . . . . 0.0 111.32 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 45.14 51.34 9.1 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 168.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.5 -42.77 3.08 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 117.699 1.84 . . . . 0.0 117.699 -171.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -79.49 142.68 35.6 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.15 139.12 39.24 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.131 0.967 . . . . 0.0 113.063 173.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.7 t -120.68 130.08 53.95 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.548 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 67.5 m -117.7 117.07 28.36 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.097 -1.002 . . . . 0.0 108.746 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.2 mt -114.17 104.83 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.2 m -100.69 103.27 14.53 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.88 0.872 . . . . 0.0 109.752 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.8 mtt85 -95.75 104.22 16.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.859 -0.526 . . . . 0.0 110.647 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -121.12 147.14 45.97 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.31 108.78 20.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.827 -0.546 . . . . 0.0 111.611 -171.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -137.02 129.3 29.72 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.343 0.657 . . . . 0.0 109.312 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.0 t0 57.49 44.31 21.45 Favored 'General case' 0 N--CA 1.507 2.404 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 51.82 30.68 29.55 Favored Glycine 0 CA--C 1.559 2.801 0 N-CA-C 119.298 2.479 . . . . 0.0 119.298 -164.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -140.61 149.5 42.41 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.502 1.144 . . . . 0.0 109.537 -167.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.5 tp -92.5 106.12 18.17 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-O 121.912 0.863 . . . . 0.0 109.857 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 82.7 t -93.31 106.07 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.3 t -102.65 90.52 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -170.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -88.28 93.43 9.51 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.717 1.246 . . . . 0.0 110.062 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.636 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 9.4 t -80.64 135.87 36.12 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.823 170.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.6 123.22 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.598 -0.689 . . . . 0.0 109.452 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.413 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 26.8 ttt -117.02 103.97 10.79 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.859 0.464 . . . . 0.0 110.061 175.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.3 76.5 m-20 66.57 -93.57 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.868 0.867 . . . . 0.0 111.297 -174.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -111.89 0.44 16.12 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 162.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.9 t -92.95 105.86 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 120.49 1.495 . . . . 0.0 108.714 -167.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 53.6 p -90.74 140.1 30.1 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.404 1.097 . . . . 0.0 113.02 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.636 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -136.52 85.08 2.12 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -174.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 61.7 m -88.98 110.24 20.95 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.514 -1.366 . . . . 0.0 110.286 -171.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -114.4 108.34 16.76 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -168.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.7 mm -92.72 114.64 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -116.41 114.55 24.42 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.197 0.599 . . . . 0.0 109.718 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.68 152.39 22.55 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -77.83 127.43 32.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.483 -1.386 . . . . 0.0 114.696 -161.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.74 86.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.489 1.498 0 C-N-CA 123.928 0.891 . . . . 0.0 108.6 178.795 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.265 7.7 p . . . . . 0 N--CA 1.503 2.179 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -38.58 90.41 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 162.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -63.83 -38.37 90.86 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.5 mt -59.81 -23.79 63.62 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 163.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 107.64 3.93 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.188 1.813 . . . . 0.0 113.426 -171.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.64 -173.85 36.42 Favored Glycine 0 N--CA 1.489 2.215 0 CA-C-O 121.712 0.618 . . . . 0.0 114.628 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -94.92 137.84 33.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.009 -0.701 . . . . 0.0 110.981 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -135.55 116.82 14.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.55 -0.719 . . . . 0.0 110.994 -170.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.9 ttm105 -97.49 134.09 41.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.002 -1.686 . . . . 0.0 113.85 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.1 tp -67.82 123.51 20.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.254 4.4 m -113.06 -60.95 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 123.818 0.847 . . . . 0.0 112.223 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -106.36 151.5 24.79 Favored 'General case' 0 CA--C 1.571 1.782 0 CA-C-N 119.688 1.131 . . . . 0.0 111.006 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -154.28 65.56 0.7 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 136.11 54.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.485 -0.759 . . . . 0.0 112.988 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.74 2.59 51.69 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 120.086 2.794 . . . . 0.0 120.086 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.14 -34.03 72.54 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.27 -54.91 17.87 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 163.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.44 -49.57 72.1 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -57.25 -48.13 79.64 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 76.5 mtm -59.5 -35.27 73.82 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 168.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -64.17 -48.06 77.41 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 22.0 tp10 -66.0 -37.91 87.16 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 173.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.1 -42.72 66.22 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 159.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.31 53.93 1.21 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 115.137 0.815 . . . . 0.0 115.137 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.18 134.78 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.412 0.685 . . . . 0.0 109.788 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.95 154.09 49.83 Favored Glycine 0 CA--C 1.55 2.244 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.1 pt -55.55 -48.25 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -172.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.61 -43.59 97.28 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.34 -40.0 96.1 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 170.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.9 mtp85 -55.2 -50.33 69.64 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 162.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -56.94 -47.7 80.04 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 170.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.0 mtm -58.0 -55.27 37.07 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 168.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.97 -36.97 76.16 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 119.41 2.524 . . . . 0.0 119.41 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.97 -54.42 30.84 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.8 ptp -85.9 -26.38 25.63 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.01 73.21 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 119.639 3.2 . . . . 0.0 119.639 -168.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt 63.32 66.42 1.16 Allowed Pre-proline 0 CA--C 1.581 2.141 0 C-N-CA 124.437 1.095 . . . . 0.0 113.612 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -73.25 143.77 35.99 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 122.513 2.142 . . . . 0.0 116.869 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.44 101.51 13.21 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.271 1.028 . . . . 0.0 110.045 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.0 116.82 29.25 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 124.378 1.071 . . . . 0.0 112.108 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mp -92.13 119.67 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.9 mt -105.88 117.68 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 168.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.1 m -136.84 130.4 31.74 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 118.879 0.763 . . . . 0.0 111.046 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.6 p -105.98 137.45 43.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -169.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.34 86.37 2.32 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 121.882 0.849 . . . . 0.0 108.878 166.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.57 -99.26 0.45 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -85.15 -25.91 27.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 165.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -86.27 138.17 32.05 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 120.719 1.6 . . . . 0.0 112.001 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 21.8 tp -133.7 112.98 11.85 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 121.883 0.849 . . . . 0.0 108.787 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -87.29 119.57 27.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.491 0.717 . . . . 0.0 109.567 -175.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mm -111.47 98.73 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -112.53 105.93 14.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.557 -0.714 . . . . 0.0 110.104 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.4 m -93.12 101.24 13.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.399 -0.813 . . . . 0.0 109.817 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -98.24 125.53 43.35 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.023 0.929 . . . . 0.0 110.704 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 t -137.66 160.8 38.19 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.41 1.1 . . . . 0.0 113.437 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.7 p -59.93 -48.25 82.45 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 163.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.7 mt -97.02 -38.86 9.61 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -146.52 105.37 3.85 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 121.187 1.812 . . . . 0.0 112.715 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.3 m -86.26 142.44 28.55 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.657 0.783 . . . . 0.0 111.545 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.5 m -157.89 143.09 16.8 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.235 -1.54 . . . . 0.0 109.839 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.51 154.77 51.27 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.285 -1.51 . . . . 0.0 114.229 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -150.65 142.1 23.42 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.553 0.692 . . . . 0.0 111.771 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.0 p -100.26 105.25 16.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.943 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 52' ' ' LEU . 20.9 p -93.79 164.51 13.1 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.5 m -130.43 128.46 41.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.2 111.72 9.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.292 -0.88 . . . . 0.0 111.982 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.37 -62.3 0.54 Allowed Glycine 0 N--CA 1.488 2.11 0 CA-C-O 120.055 -0.303 . . . . 0.0 113.488 -162.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -89.47 162.17 15.86 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 124.068 1.89 . . . . 0.0 114.914 -164.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -106.95 132.86 52.42 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 112.563 -2.108 . . . . 0.0 111.394 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.89 160.38 40.45 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -169.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.99 113.53 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 112.48 167.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -102.2 95.82 6.57 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.1 m -76.96 92.07 3.65 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.341 1.067 . . . . 0.0 110.445 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -67.38 148.28 51.81 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.158 0.983 . . . . 0.0 113.293 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.07 -39.48 5.85 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.948 3.314 . . . . 0.0 119.948 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.95 -34.27 59.84 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.12 -25.32 0.61 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 119.563 2.585 . . . . 0.0 119.563 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.2 mtm-85 -72.65 119.74 17.3 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 120.124 1.962 . . . . 0.0 112.091 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 94.6 9.71 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 167.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.5 p -87.4 149.53 24.4 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.146 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -81.98 87.15 6.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.084 -1.01 . . . . 0.0 109.589 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -88.79 117.35 27.72 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.264 14.9 p -88.97 118.08 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 161.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.3 m -96.21 135.17 38.39 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 120.834 0.35 . . . . 0.0 111.655 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -148.05 121.7 9.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.804 -0.56 . . . . 0.0 109.611 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -83.24 123.39 29.53 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 120.852 -1.155 . . . . 0.0 111.259 169.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -133.31 110.4 10.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 63.69 56.19 1.58 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 148.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.52 -25.94 11.83 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 118.453 2.141 . . . . 0.0 118.453 -164.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.77 135.0 55.03 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 119.909 1.855 . . . . 0.0 114.314 -167.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.9 tp -82.37 113.71 20.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.196 158.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.0 t -88.89 106.73 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -102.04 98.74 8.89 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -99.2 96.31 7.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.638 -0.664 . . . . 0.0 110.561 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -83.4 128.54 34.59 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.683 0.793 . . . . 0.0 111.572 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -130.32 123.94 31.16 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.107 0.563 . . . . 0.0 110.009 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.2 p90 -156.6 119.51 4.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.696 -1.252 . . . . 0.0 112.139 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.263 5.5 t70 34.31 58.16 0.64 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 118.699 2.852 . . . . 0.0 118.699 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.72 -46.94 1.9 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 117.639 1.816 . . . . 0.0 117.639 -172.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -80.51 140.94 35.62 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -133.3 148.38 51.92 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 168.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.6 t -131.99 138.65 48.35 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.688 0.756 . . . . 0.0 111.802 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -111.7 98.11 7.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.71 111.09 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -175.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.7 m -101.71 103.6 14.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.622 -0.673 . . . . 0.0 109.802 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -95.42 101.66 13.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.403 -0.811 . . . . 0.0 109.9 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -132.91 156.9 46.39 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.91 123.22 26.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 111.877 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.09 114.19 24.19 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 159.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.89 51.16 9.39 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 166.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.47 -22.77 5.21 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 119.357 2.503 . . . . 0.0 119.357 -170.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -103.27 140.09 37.86 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.628 1.714 . . . . 0.0 111.21 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.9 tp -75.77 134.79 40.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.96 . . . . 0.0 110.361 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.29 106.78 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.6 t -92.73 102.94 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -111.28 105.18 13.76 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -171.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 3.1 p -97.08 145.79 25.64 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.51 128.66 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.412 0.625 . . . . 0.0 109.405 162.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.4 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 24.4 ttt -98.21 -88.44 0.32 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.214 0.606 . . . . 0.0 110.253 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -129.89 78.16 1.83 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.052 0.941 . . . . 0.0 108.732 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.283 0.7 OUTLIER 69.4 -26.53 0.15 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 -162.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 82.6 t -75.78 116.41 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 CA-C-N 120.085 1.311 . . . . 0.0 109.835 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.3 p -120.11 134.76 55.17 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 123.638 0.775 . . . . 0.0 112.729 -170.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.3 p -120.93 128.01 52.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.962 -0.461 . . . . 0.0 111.993 167.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.3 m -109.25 111.45 23.04 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -112.14 118.76 36.24 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.57 0.748 . . . . 0.0 110.248 -172.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mm -96.71 130.47 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 123.455 0.702 . . . . 0.0 109.426 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -130.12 121.63 26.7 Favored 'General case' 0 CA--C 1.572 1.82 0 C-N-CA 123.483 0.713 . . . . 0.0 112.385 -165.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -95.32 134.88 37.61 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -80.25 125.29 29.67 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.104 -0.997 . . . . 0.0 113.369 -172.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.6 t -114.79 94.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -168.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 122.489 0.315 . . . . 0.0 110.207 -165.076 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.308 12.1 p . . . . . 0 N--CA 1.501 2.089 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.3 -22.51 63.26 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.592 2.441 . . . . 0.0 117.592 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.1 mp0 -56.96 -27.18 60.97 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 163.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.21 -12.59 61.24 Favored 'General case' 0 CA--C 1.582 2.206 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 164.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.43 114.17 14.84 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 120.774 1.625 . . . . 0.0 113.398 -166.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.45 -166.55 28.63 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 167.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -86.15 129.78 34.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.078 -0.66 . . . . 0.0 112.33 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -127.77 114.73 17.65 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.262 0.625 . . . . 0.0 110.301 -172.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -89.91 133.52 34.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.471 -1.393 . . . . 0.0 113.3 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.6 tp -72.88 131.07 41.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.8 -0.563 . . . . 0.0 112.439 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.277 3.3 m -116.68 -73.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 123.369 0.668 . . . . 0.0 109.895 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -89.68 142.05 28.04 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 118.919 0.781 . . . . 0.0 110.802 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.4 t -148.02 51.96 1.03 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -79.84 134.81 36.34 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.44 -9.43 67.58 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 118.628 2.211 . . . . 0.0 118.628 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -70.69 -42.26 70.91 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -171.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -52.62 -51.66 58.98 Favored 'General case' 0 CA--C 1.579 2.06 0 CA-C-N 120.079 1.309 . . . . 0.0 114.339 167.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.74 -39.51 84.97 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 170.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -58.64 -46.3 87.4 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 169.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 33' ' ' ARG . 16.3 ptp -62.03 -25.79 67.87 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 167.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -58.7 -52.92 63.65 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 157.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.03 -42.05 98.76 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.413 ' HA ' ' SD ' ' A' ' 122' ' ' MET . 69.3 mt -53.28 -38.77 63.39 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 169.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.04 64.62 0.99 Allowed Glycine 0 N--CA 1.486 1.989 0 C-N-CA 123.362 0.506 . . . . 0.0 113.751 -166.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.5 t -114.33 130.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.62 158.65 49.25 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.275 2.4 pp -55.26 -49.02 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -171.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.76 99.34 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 168.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.06 -41.88 89.01 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.427 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 20.0 mtp-105 -61.27 -51.05 70.55 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 120.177 1.353 . . . . 0.0 114.546 170.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -54.74 -47.65 73.56 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 170.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.8 ttp -54.42 -60.67 3.03 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 165.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.91 -40.32 92.99 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 119.573 2.589 . . . . 0.0 119.573 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.59 -45.02 88.8 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 172.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -78.26 -29.87 48.29 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 172.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.74 123.22 18.79 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 119.833 1.197 . . . . 0.0 114.17 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -103.5 107.89 57.5 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 117.667 -1.158 . . . . 0.0 109.66 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -92.34 145.73 2.79 Favored 'Trans proline' 0 CA--C 1.563 1.948 0 CA-C-N 122.48 1.921 . . . . 0.0 116.455 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.74 100.53 13.0 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 114.493 -1.231 . . . . 0.0 108.641 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.9 t -91.32 112.83 24.9 Favored 'General case' 0 CA--C 1.557 1.217 0 O-C-N 120.875 -1.141 . . . . 0.0 112.559 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mt -84.14 104.26 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 60.5 mt -99.78 111.49 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.5 m -117.16 102.5 9.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.6 p -113.87 91.4 3.62 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 123.737 0.815 . . . . 0.0 111.424 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -93.54 65.31 3.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.34 -0.85 . . . . 0.0 111.836 -171.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.36 -61.58 1.87 Allowed Glycine 0 N--CA 1.494 2.51 0 O-C-N 120.117 -1.614 . . . . 0.0 117.089 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -121.52 -46.43 2.27 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -71.7 137.59 47.91 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 121.58 1.991 . . . . 0.0 112.925 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -138.52 112.31 8.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.468 -0.77 . . . . 0.0 111.226 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.2 m -114.77 123.53 49.47 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.463 0.705 . . . . 0.0 109.715 -175.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.77 109.03 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -114.23 101.61 9.35 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.996 0.918 . . . . 0.0 109.859 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.0 m -87.09 112.48 21.94 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.673 0.789 . . . . 0.0 110.391 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -112.3 100.63 8.95 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 118.773 0.715 . . . . 0.0 112.138 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -123.46 158.34 31.47 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.084 0.945 . . . . 0.0 111.192 163.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.2 p -63.29 -44.82 93.95 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 172.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.3 mt -64.07 -38.04 89.63 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.09 130.64 13.94 Favored 'General case' 0 CA--C 1.563 1.453 0 CA-C-N 119.938 1.244 . . . . 0.0 111.164 166.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 m -113.95 133.75 55.27 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 166.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.1 m -155.6 139.65 16.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.391 -1.443 . . . . 0.0 109.541 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.85 158.39 39.62 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.36 137.5 30.54 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-O 121.991 0.901 . . . . 0.0 110.451 161.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -109.93 105.26 14.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.028 0.931 . . . . 0.0 109.499 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 30.3 p -132.19 -152.51 0.5 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.54 0.736 . . . . 0.0 112.413 -168.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.39 147.42 50.48 Favored 'General case' 0 CA--C 1.571 1.761 0 O-C-N 120.957 -1.089 . . . . 0.0 111.306 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -78.58 148.01 33.49 Favored 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 124.221 1.008 . . . . 0.0 113.045 162.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.35 28.45 73.59 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 117.921 1.928 . . . . 0.0 117.921 -173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -152.11 141.09 21.16 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-O 121.51 0.671 . . . . 0.0 109.437 -162.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -93.45 124.29 37.34 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.253 174.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -130.92 154.4 48.15 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.043 0.937 . . . . 0.0 111.721 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -80.12 101.31 8.69 Favored 'General case' 0 CA--C 1.569 1.704 0 O-C-N 120.95 -1.094 . . . . 0.0 111.512 172.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -85.32 94.28 8.91 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.997 0.919 . . . . 0.0 110.011 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.8 m -81.64 96.57 7.55 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.925 0.869 . . . . 0.0 110.478 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.9 p -71.14 152.42 43.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.381 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.01 -30.05 14.2 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -54.81 -42.73 72.22 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 118.419 2.748 . . . . 0.0 118.419 162.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.63 -19.49 9.71 Favored Glycine 0 CA--C 1.553 2.466 0 N-CA-C 117.81 1.884 . . . . 0.0 117.81 -155.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -74.47 112.1 10.31 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 121.122 2.461 . . . . 0.0 110.65 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.264 0.1 OUTLIER -102.34 99.48 9.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.655 0.74 . . . . 0.0 111.225 178.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.7 p -99.56 141.88 31.78 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.176 -163.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -77.49 88.49 3.84 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.581 172.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.7 m -97.2 114.52 26.25 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 121.694 -0.629 . . . . 0.0 109.503 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.282 14.2 p -90.56 119.87 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.726 -0.609 . . . . 0.0 110.693 165.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.9 m -98.47 113.21 25.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.189 -0.319 . . . . 0.0 111.673 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -123.68 140.52 52.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.786 -0.571 . . . . 0.0 110.545 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -84.1 127.44 33.91 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 120.877 -1.139 . . . . 0.0 111.469 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -146.06 142.08 28.24 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.394 0.678 . . . . 0.0 110.278 168.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.81 43.58 9.38 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 161.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.14 23.71 69.92 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 118.817 2.287 . . . . 0.0 118.817 -166.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.78 148.47 29.24 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 118.849 1.325 . . . . 0.0 113.608 -166.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.0 tp -89.42 112.33 23.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.559 -0.713 . . . . 0.0 110.254 162.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 p -89.36 125.23 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 CA-C-O 123.038 1.399 . . . . 0.0 109.819 168.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -114.18 103.02 10.69 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.732 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -99.68 93.66 5.95 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 120.999 0.428 . . . . 0.0 111.254 -170.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -79.21 130.26 35.29 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.195 0.998 . . . . 0.0 111.953 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.4 121.72 26.45 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.713 0.688 . . . . 0.0 110.375 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -155.74 130.08 8.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.493 -1.379 . . . . 0.0 112.143 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 t70 51.65 50.09 19.49 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 166.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.48 16.34 58.38 Favored Glycine 0 CA--C 1.561 2.923 0 N-CA-C 120.342 2.897 . . . . 0.0 120.342 -167.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -131.84 150.47 52.14 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.917 1.359 . . . . 0.0 110.276 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.54 151.73 44.98 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.5 t -141.96 138.7 32.13 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.059 0.933 . . . . 0.0 112.61 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 p -110.57 117.18 32.84 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.653 0.781 . . . . 0.0 109.262 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.6 mm -101.8 109.58 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.7 m -96.96 106.33 18.64 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.543 0.687 . . . . 0.0 109.255 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -98.17 84.01 3.19 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.552 0.741 . . . . 0.0 109.972 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -95.67 132.98 40.27 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.9 103.49 12.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.359 -0.838 . . . . 0.0 110.434 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.258 45.6 tttm -117.9 -105.26 0.4 Allowed 'General case' 0 CA--C 1.559 1.301 0 O-C-N 121.933 -0.479 . . . . 0.0 111.071 -164.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.98 60.79 6.05 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-O 122.339 1.066 . . . . 0.0 112.67 -163.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 49.0 37.83 23.31 Favored Glycine 0 CA--C 1.558 2.775 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -153.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.12 139.95 8.72 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -155.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.1 tp -86.34 117.23 25.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.773 -1.204 . . . . 0.0 110.163 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.8 t -103.57 108.68 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.49 104.94 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -170.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -106.28 107.65 18.77 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -169.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.873 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.8 p -101.62 144.71 30.02 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.73 145.2 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 123.034 0.534 . . . . 0.0 110.234 166.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 26' ' ' LEU . 23.5 ttt -110.74 -80.33 0.58 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.053 -1.029 . . . . 0.0 110.561 168.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -111.73 -66.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 118.679 0.672 . . . . 0.0 110.912 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -122.52 -14.25 7.83 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -97.98 134.0 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-N 121.403 1.911 . . . . 0.0 110.062 -174.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 77.5 p -112.47 153.2 27.78 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.912 0.885 . . . . 0.0 112.68 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.873 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.8 OUTLIER -130.76 142.17 50.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.311 -0.868 . . . . 0.0 112.391 161.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.6 m -109.64 108.61 19.08 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -104.23 109.72 21.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.617 0.767 . . . . 0.0 109.992 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.2 mm -89.26 124.11 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -120.06 118.53 30.85 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.574 0.749 . . . . 0.0 111.124 -174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -86.79 140.17 29.98 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.117 0.967 . . . . 0.0 112.94 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -78.29 134.78 37.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.266 -1.521 . . . . 0.0 113.62 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.9 95.76 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.981 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.253 9.0 p . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -58.58 -35.62 72.67 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.315 1.968 . . . . 0.0 116.315 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -64.42 -31.72 73.04 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 165.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.78 -20.56 65.97 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 163.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.2 117.25 22.19 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.285 1.857 . . . . 0.0 112.283 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.71 -178.7 39.78 Favored Glycine 0 N--CA 1.484 1.897 0 CA-C-O 122.098 0.832 . . . . 0.0 114.577 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -84.89 114.8 22.38 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.019 0.528 . . . . 0.0 110.777 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -110.58 104.54 13.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.949 -0.469 . . . . 0.0 111.97 -171.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -82.73 124.26 30.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.365 -0.834 . . . . 0.0 112.424 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.0 130.52 44.37 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.023 -1.048 . . . . 0.0 113.444 173.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.292 15.7 m -120.03 -63.7 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.617 173.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -92.76 149.81 21.06 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.431 1.469 . . . . 0.0 112.007 170.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p -148.34 79.14 1.44 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.912 166.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.44 119.13 19.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.554 -0.716 . . . . 0.0 110.936 -176.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.82 37.06 93.7 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 119.708 2.643 . . . . 0.0 119.708 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.6 -42.61 51.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 175.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -51.94 -50.04 61.97 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 163.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -48.54 -54.58 13.87 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 168.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -55.25 -53.61 53.92 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 170.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 31.7 mtm -67.75 -34.05 76.06 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -47.82 -44.09 28.55 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 158.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -41.72 81.7 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 169.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.3 mt -51.7 -50.42 60.53 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 165.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.44 40.39 0.23 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.408 HG23 ' CG ' ' A' ' 33' ' ' ARG . 6.6 m -112.67 144.19 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.686 0 CA-C-N 118.724 1.262 . . . . 0.0 112.463 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.33 -179.64 50.96 Favored Glycine 0 CA--C 1.551 2.33 0 CA-C-O 122.814 1.23 . . . . 0.0 115.989 168.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 pt -57.23 -46.25 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 117.921 2.564 . . . . 0.0 117.921 -171.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.65 -40.63 95.61 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.02 -39.02 86.94 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' CG ' HG23 ' A' ' 28' ' ' VAL . 20.5 mtm105 -63.78 -42.93 97.66 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 166.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -50.57 -50.49 53.47 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 161.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.6 mtp -72.3 58.37 0.39 Allowed 'General case' 0 CA--C 1.581 2.161 0 CA-C-O 123.028 1.394 . . . . 0.0 114.632 166.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.12 -63.72 0.08 OUTLIER Glycine 0 CA--C 1.543 1.809 0 O-C-N 121.349 -0.845 . . . . 0.0 111.56 -172.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.93 78.48 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 170.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . 0.26 19.2 ptt? -86.44 -17.89 33.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 170.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.07 121.24 22.51 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.172 1.351 . . . . 0.0 113.707 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -96.36 113.46 62.51 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.365 170.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -86.12 146.72 8.91 Favored 'Trans proline' 0 CA--C 1.561 1.828 0 C-N-CA 122.284 1.989 . . . . 0.0 115.052 168.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.57 97.97 10.86 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.265 158.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.8 t -87.65 104.64 16.72 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.139 0.976 . . . . 0.0 111.713 -174.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.0 mt -92.12 106.44 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.6 mt -96.86 128.99 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.4 m -156.46 130.49 8.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.274 -1.516 . . . . 0.0 109.938 171.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.8 p -118.75 130.01 55.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -97.72 93.03 6.16 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 121.802 0.81 . . . . 0.0 108.978 166.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.13 -75.46 1.14 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 116.67 1.428 . . . . 0.0 116.67 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -127.73 -30.63 2.51 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.69 100.99 5.59 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 120.909 1.686 . . . . 0.0 111.757 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -93.84 116.19 28.64 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.341 1.056 . . . . 0.0 109.945 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.3 m -93.38 123.77 36.9 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.662 0.785 . . . . 0.0 109.62 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 mt -115.79 107.38 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -103.68 103.5 13.42 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.646 0.779 . . . . 0.0 109.547 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.6 m -94.18 100.17 12.3 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.322 1.049 . . . . 0.0 110.686 -171.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -100.09 102.55 13.9 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.081 0.553 . . . . 0.0 111.746 -165.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 t -138.7 139.85 38.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.478 -0.764 . . . . 0.0 111.451 173.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.0 p -63.93 -33.55 75.96 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.4 mt -67.26 -45.97 75.09 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 167.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -155.12 114.67 3.69 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.471 1.487 . . . . 0.0 111.376 170.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.8 m -94.24 141.05 29.01 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.586 0.708 . . . . 0.0 111.399 172.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.1 p -138.48 154.97 48.83 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 123.93 0.892 . . . . 0.0 111.112 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.0 146.13 32.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.351 -1.468 . . . . 0.0 112.906 172.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -152.44 151.62 30.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.586 -0.696 . . . . 0.0 112.807 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -110.54 115.73 30.13 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.503 0.721 . . . . 0.0 110.85 166.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.8 p -104.5 134.04 48.35 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.553 -0.717 . . . . 0.0 112.739 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 88.6 m -81.25 113.08 19.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.865 -1.147 . . . . 0.0 110.336 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -69.85 120.83 16.18 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -172.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.7 -36.31 3.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 -166.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.41 -169.92 2.62 Favored 'General case' 0 CA--C 1.575 1.905 0 CA-C-N 119.128 1.464 . . . . 0.0 111.953 -176.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -86.34 142.02 28.79 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -117.24 163.33 16.47 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.38 159.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -82.24 103.56 11.92 Favored 'General case' 0 CA--C 1.565 1.554 0 O-C-N 120.6 -1.312 . . . . 0.0 110.045 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -87.28 104.84 16.78 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.5 m -82.31 104.41 12.59 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 165.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.6 p -76.22 159.16 30.91 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -164.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.46 -38.93 56.19 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 165.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.276 2.7 t0 -44.35 -47.32 9.62 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 157.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.02 -31.75 4.41 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -164.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -62.44 137.01 58.17 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.8 1.8 . . . . 0.0 114.781 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -76.59 121.57 23.38 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.721 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.7 p -132.72 118.46 19.1 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.595 0.712 . . . . 0.0 111.015 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -76.98 101.3 5.93 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.61 0.764 . . . . 0.0 109.442 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.1 m -116.51 107.15 14.4 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.461 -154.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.5 t -81.02 117.56 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 122.893 0.477 . . . . 0.0 109.871 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.4 m -101.46 108.79 20.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.137 -0.352 . . . . 0.0 111.326 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -126.24 124.19 39.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.777 -0.577 . . . . 0.0 111.446 -175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -85.13 126.85 33.96 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.455 -0.778 . . . . 0.0 111.567 168.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -143.02 137.04 29.0 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 122.994 0.518 . . . . 0.0 109.773 165.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.83 39.49 16.98 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 159.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.62 20.27 79.51 Favored Glycine 0 CA--C 1.557 2.669 0 N-CA-C 119.23 2.452 . . . . 0.0 119.23 -166.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.83 131.63 21.42 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 119.295 1.548 . . . . 0.0 112.922 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.9 tp -94.45 109.92 21.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.667 -0.646 . . . . 0.0 110.645 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.18 108.71 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.675 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -95.39 102.4 14.2 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 124.166 0.986 . . . . 0.0 108.961 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -102.04 93.23 5.14 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.404 0.681 . . . . 0.0 111.997 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -77.07 117.07 18.28 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.786 0.834 . . . . 0.0 112.569 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.5 135.56 50.32 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.867 0.842 . . . . 0.0 110.12 166.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -152.28 117.22 5.15 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.256 27.5 t70 49.87 45.06 25.23 Favored 'General case' 0 CA--C 1.587 2.367 0 N-CA-C 117.141 2.275 . . . . 0.0 117.141 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.93 27.1 68.09 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 119.894 2.718 . . . . 0.0 119.894 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -135.43 100.05 4.4 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -172.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -115.3 142.68 46.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -165.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.5 t -117.31 137.28 52.53 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.802 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 p -114.69 109.15 17.77 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.4 mp -103.4 98.11 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 m -94.0 105.57 17.57 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.598 0.759 . . . . 0.0 109.975 -175.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -94.3 88.48 5.57 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 123.627 0.771 . . . . 0.0 110.156 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -105.16 137.42 42.96 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -168.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 116.81 29.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.9 -1.125 . . . . 0.0 112.81 -172.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.75 84.27 3.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.591 -0.693 . . . . 0.0 109.714 167.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.276 25.1 m-20 7.5 62.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 120.608 3.559 . . . . 0.0 120.608 -173.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 138.78 -49.38 0.83 Allowed Glycine 0 N--CA 1.49 2.275 0 CA-C-N 114.515 -1.22 . . . . 0.0 115.503 -167.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -112.77 138.55 49.44 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 117.802 0.801 . . . . 0.0 110.557 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.19 116.32 28.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.889 -1.132 . . . . 0.0 109.6 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.9 t -93.95 109.57 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 80.5 t -98.8 105.55 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -96.67 100.78 12.32 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.746 0.819 . . . . 0.0 109.378 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.7 p -97.31 131.59 43.86 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.62 -0.675 . . . . 0.0 111.169 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.87 123.67 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.836 -0.54 . . . . 0.0 110.598 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 10.6 ttt -115.55 114.76 25.39 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 164.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.7 m120 55.23 55.92 7.01 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.297 40.3 m-80 76.65 -30.16 0.18 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -171.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.0 t -86.42 123.63 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 120.885 1.675 . . . . 0.0 109.949 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 72.4 p -113.6 144.28 43.16 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -163.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.5 OUTLIER -111.93 136.56 51.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 0.0 110.939 151.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.1 m -114.4 111.18 21.03 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 170.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -114.69 116.18 28.29 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.741 0.416 . . . . 0.0 110.327 -170.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.86 128.17 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -122.35 140.55 52.54 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.77 0.828 . . . . 0.0 111.879 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.86 135.84 42.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -76.78 113.08 14.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.074 -1.016 . . . . 0.0 111.641 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.0 t -106.07 92.86 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -173.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.017 -174.363 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.478 5.3 p . . . . . 0 N--CA 1.507 2.39 0 N-CA-C 118.704 2.853 . . . . 0.0 118.704 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -52.22 -42.64 63.74 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -67.85 -18.79 64.93 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 172.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.54 -9.69 58.61 Favored 'General case' 0 CA--C 1.577 1.999 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 160.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.37 140.64 29.33 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 121.541 1.973 . . . . 0.0 112.944 -171.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.81 -177.82 23.05 Favored Glycine 0 N--CA 1.488 2.162 0 CA-C-O 122.145 0.859 . . . . 0.0 114.607 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -87.9 121.11 29.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.984 -0.715 . . . . 0.0 110.083 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -124.86 110.6 14.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.78 -0.575 . . . . 0.0 110.122 -169.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.3 ttm105 -98.56 134.7 41.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.831 -1.168 . . . . 0.0 113.251 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.91 133.0 49.97 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.28 21.7 m -124.35 -60.5 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 123.722 0.809 . . . . 0.0 112.281 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -89.43 148.35 23.52 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.346 1.43 . . . . 0.0 111.298 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 m -148.7 58.15 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.215 1.007 . . . . 0.0 113.218 165.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -72.88 123.5 23.53 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.294 -0.878 . . . . 0.0 113.083 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.77 2.58 81.43 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 118.85 2.3 . . . . 0.0 118.85 -167.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -72.12 -42.61 65.86 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.406 2.103 . . . . 0.0 116.65 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.62 -49.65 74.32 Favored 'General case' 0 CA--C 1.578 2.057 0 CA-C-N 120.962 1.71 . . . . 0.0 114.563 170.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -49.59 -44.93 47.41 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 164.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 74.5 t80 -59.71 -52.27 66.23 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 170.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.294 18.4 ptt? -70.31 -24.34 63.0 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -63.15 -39.84 95.83 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 121.523 1.965 . . . . 0.0 115.303 154.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -72.64 -40.01 66.73 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.0 mt -50.29 -41.81 51.44 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 117.989 2.588 . . . . 0.0 117.989 168.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.88 66.43 0.8 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 123.443 0.544 . . . . 0.0 113.648 -168.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -128.82 133.53 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -171.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.94 155.3 52.75 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 116.483 1.353 . . . . 0.0 116.483 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.262 2.7 pp -54.14 -44.07 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 N-CA-C 117.898 2.555 . . . . 0.0 117.898 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.99 88.14 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 168.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.36 -42.01 98.0 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 167.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -59.67 -47.51 85.35 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 120.352 1.433 . . . . 0.0 114.398 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.36 -46.83 88.54 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 169.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.1 ttp -52.48 -55.11 24.22 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 165.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.64 74.91 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 119.236 2.455 . . . . 0.0 119.236 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.95 91.21 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.4 ptp -77.24 -27.36 53.27 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.21 108.94 5.63 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.906 1.23 . . . . 0.0 113.731 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -102.3 93.96 4.42 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 118.196 -0.906 . . . . 0.0 110.649 168.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.84 153.31 25.71 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.474 2.116 . . . . 0.0 115.59 -173.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.69 105.27 17.25 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.643 0.735 . . . . 0.0 109.302 165.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.2 t -95.02 110.5 22.41 Favored 'General case' 0 CA--C 1.56 1.344 0 O-C-N 120.909 -1.119 . . . . 0.0 111.735 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mp -89.47 106.83 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.63 126.94 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.1 m -150.75 128.84 11.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.628 -1.295 . . . . 0.0 109.846 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.6 t -120.7 114.23 21.37 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-O 121.899 0.857 . . . . 0.0 112.019 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -79.95 76.08 6.67 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 122.054 0.93 . . . . 0.0 110.45 167.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.73 -82.25 0.09 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -105.23 -16.43 14.77 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 167.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -88.81 106.06 18.13 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 120.982 1.719 . . . . 0.0 109.9 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.49 116.01 31.59 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 111.344 -168.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.9 m -108.37 128.46 54.79 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.041 0.936 . . . . 0.0 109.493 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.73 122.18 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -109.98 111.96 23.67 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.055 0.542 . . . . 0.0 110.073 168.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.8 m -87.87 99.53 12.2 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -86.19 116.91 24.68 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.153 0.978 . . . . 0.0 111.594 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.1 t -147.06 135.05 21.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.85 0.86 . . . . 0.0 109.764 169.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 64.5 p -59.32 -30.37 68.31 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 165.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.3 mt -71.58 -53.06 14.98 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 170.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -153.04 100.04 2.45 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 120.284 1.402 . . . . 0.0 110.593 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.6 m -77.83 146.1 35.93 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.012 0.91 . . . . 0.0 111.669 171.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.7 m -152.16 134.01 14.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.091 -1.631 . . . . 0.0 109.857 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -131.5 138.77 49.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 111.577 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -141.91 152.63 43.73 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 174.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.7 p -135.78 109.49 8.05 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.924 0.89 . . . . 0.0 110.029 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.2 t -134.82 154.21 51.72 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.556 0.742 . . . . 0.0 112.242 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.92 140.07 47.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.433 -1.417 . . . . 0.0 110.603 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.9 tp -68.89 118.98 12.51 Favored 'General case' 0 CA--C 1.579 2.088 0 O-C-N 120.69 -1.256 . . . . 0.0 111.442 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.35 -40.92 2.34 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 116.988 1.555 . . . . 0.0 116.988 -157.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.8 154.86 24.51 Favored 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 125.194 1.398 . . . . 0.0 113.416 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.3 152.64 21.3 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 166.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -138.62 162.47 34.54 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.761 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.84 100.58 2.93 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.878 0.847 . . . . 0.0 111.519 166.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -92.81 98.27 11.29 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.6 m -79.79 95.73 6.09 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 163.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.2 p -61.75 170.65 1.91 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -160.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.92 -41.04 58.43 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 164.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -50.43 -61.35 2.23 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 159.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.67 -30.49 3.1 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 120.588 -1.32 . . . . 0.0 116.303 -151.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -60.56 134.95 57.58 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 118.703 1.252 . . . . 0.0 112.63 173.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -85.81 129.15 34.91 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.344 0.592 . . . . 0.0 111.197 168.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.4 p -130.29 136.86 49.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.681 0.753 . . . . 0.0 109.217 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -87.62 96.16 10.31 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 120.692 -1.255 . . . . 0.0 108.956 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.9 m -103.64 115.61 30.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.641 -0.662 . . . . 0.0 110.65 -161.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.5 p -85.44 124.5 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-N 118.696 0.68 . . . . 0.0 112.024 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.1 m -94.0 111.85 23.61 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.376 0.67 . . . . 0.0 111.398 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -139.76 124.76 18.63 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 119.828 1.194 . . . . 0.0 112.847 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -95.2 130.36 41.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.136 -0.977 . . . . 0.0 111.71 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 t -147.69 136.33 21.81 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.222 0.609 . . . . 0.0 110.16 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 62.72 33.72 15.27 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 160.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.93 -13.77 55.38 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 -164.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -109.78 128.62 55.42 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 119.644 1.722 . . . . 0.0 113.167 -176.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.7 tp -86.7 108.5 18.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.416 -0.803 . . . . 0.0 109.637 161.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.6 t -91.75 112.19 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 98.73 10.7 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 169.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -91.12 99.39 12.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 111.355 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -70.02 125.3 26.37 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.852 0.861 . . . . 0.0 112.05 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -124.37 117.22 23.99 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -150.18 120.54 7.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.683 -1.261 . . . . 0.0 112.645 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.255 39.1 t70 50.61 44.28 27.43 Favored 'General case' 0 CA--C 1.585 2.317 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.91 -30.32 2.93 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 119.06 2.384 . . . . 0.0 119.06 -166.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -83.63 144.78 29.2 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.696 1.198 . . . . 0.0 112.79 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -140.52 156.82 46.2 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.1 t -146.94 142.28 27.4 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.445 0.698 . . . . 0.0 111.663 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.0 p -102.04 113.5 26.79 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.279 -0.888 . . . . 0.0 110.864 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.4 mm -88.19 95.68 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.1 m -96.67 92.32 6.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.554 -0.716 . . . . 0.0 110.53 -167.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -90.57 97.7 11.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.302 0.641 . . . . 0.0 111.673 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -119.2 137.34 53.7 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.725 0.81 . . . . 0.0 112.742 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.47 121.57 24.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 111.613 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.76 -144.67 0.39 Allowed 'General case' 0 CA--C 1.562 1.404 0 CA-C-O 121.231 0.539 . . . . 0.0 111.868 -171.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -87.2 66.09 9.1 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 120.973 -1.079 . . . . 0.0 109.954 -167.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.81 -18.11 58.1 Favored Glycine 0 CA--C 1.557 2.664 0 N-CA-C 119.67 2.628 . . . . 0.0 119.67 -168.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.65 166.53 24.34 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.629 2.215 . . . . 0.0 110.986 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.9 tp -87.15 120.68 28.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.061 -1.649 . . . . 0.0 111.318 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.405 HG22 ' CD1' ' A' ' 130' ' ' ILE . 55.8 t -87.15 115.57 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -109.21 93.07 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -84.66 95.09 8.79 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.905 1.336 . . . . 0.0 109.593 173.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.4 p -89.46 99.72 12.66 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.603 176.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 p -113.56 126.03 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.647 0.737 . . . . 0.0 110.534 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.0 tpt -73.51 -60.76 2.1 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.564 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.258 12.5 p30 -153.46 -80.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -79.77 -32.75 40.99 Favored 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 159.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.25 106.69 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 CA-C-N 120.022 1.283 . . . . 0.0 110.607 -169.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.9 p -102.12 121.55 42.42 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.138 0.975 . . . . 0.0 111.305 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.3 p -100.9 117.21 34.52 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 118.195 0.452 . . . . 0.0 111.03 162.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 m -89.32 106.78 18.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.594 -0.691 . . . . 0.0 109.173 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -106.68 106.94 17.71 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.405 ' CD1' HG22 ' A' ' 117' ' ' VAL . 34.3 mm -91.28 132.41 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -120.93 131.79 54.56 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 121.267 0.556 . . . . 0.0 112.095 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -81.42 134.13 35.51 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -75.39 117.12 16.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.265 -0.897 . . . . 0.0 111.623 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.5 t -95.29 106.22 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 123.222 0.609 . . . . 0.0 110.264 -170.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.258 9.3 p . . . . . 0 N--CA 1.505 2.282 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.47 -36.97 56.06 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 162.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -64.59 -26.37 68.38 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.623 2.082 . . . . 0.0 116.623 170.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.1 mt -65.08 -20.77 66.64 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 161.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -76.81 123.13 25.77 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.747 1.612 . . . . 0.0 112.127 -170.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.29 -179.79 26.73 Favored Glycine 0 N--CA 1.489 2.17 0 CA-C-O 122.162 0.868 . . . . 0.0 115.109 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -93.33 132.69 37.31 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.031 0.532 . . . . 0.0 111.042 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -124.98 110.45 14.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.968 -0.457 . . . . 0.0 111.286 -168.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -95.88 128.61 42.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.729 -1.232 . . . . 0.0 113.516 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.19 129.27 38.48 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.277 10.3 m -118.52 -64.23 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 118.51 -0.757 . . . . 0.0 111.749 178.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -101.93 157.3 16.96 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 123.352 1.548 . . . . 0.0 112.158 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -155.95 72.35 0.77 Allowed 'General case' 0 CA--C 1.562 1.438 0 O-C-N 120.891 -1.131 . . . . 0.0 110.878 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.11 129.87 41.3 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.156 -0.965 . . . . 0.0 112.437 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.54 11.06 61.66 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 119.953 2.741 . . . . 0.0 119.953 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -68.79 -35.59 77.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.313 1.968 . . . . 0.0 116.313 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -53.46 -54.81 31.65 Favored 'General case' 0 CA--C 1.575 1.917 0 CA-C-N 119.964 1.256 . . . . 0.0 114.22 167.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -54.44 -40.1 68.03 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 168.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.5 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 78.9 t80 -60.5 -45.51 93.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 166.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.3 9.6 ptt? -73.21 -30.3 63.41 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -42.72 91.58 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-N 121.192 1.814 . . . . 0.0 115.271 155.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -61.48 -42.65 99.11 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.7 mt -58.23 -44.54 88.27 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 165.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.58 44.07 2.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 117.654 1.822 . . . . 0.0 117.654 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.92 139.55 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 C-N-CA 124.054 0.942 . . . . 0.0 110.022 162.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.03 171.68 47.91 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 116.245 1.258 . . . . 0.0 116.245 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 pt -53.07 -47.3 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 -172.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.36 95.9 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.46 -40.33 95.51 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 168.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 mtp-105 -61.0 -44.82 96.86 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 166.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.73 -46.6 81.23 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.8 ttm -51.13 -59.6 4.01 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 163.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.68 -36.45 48.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 119.96 2.744 . . . . 0.0 119.96 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.43 70.43 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 21.4 ptp -85.54 -26.47 26.17 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.93 106.81 3.32 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 120.262 1.392 . . . . 0.0 113.308 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -109.47 90.54 8.73 Favored Pre-proline 0 CA--C 1.571 1.758 0 C-N-CA 123.778 0.831 . . . . 0.0 109.84 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.47 160.92 14.82 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.409 2.073 . . . . 0.0 116.288 -167.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -93.7 97.96 10.8 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.152 166.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.8 t -89.9 110.51 21.45 Favored 'General case' 0 CA--C 1.558 1.273 0 O-C-N 121.185 -0.947 . . . . 0.0 112.087 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 mt -90.4 114.75 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 108.666 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 91.9 mt -94.7 123.74 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 166.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.1 m -150.28 126.71 10.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.98 -1.075 . . . . 0.0 109.846 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -122.08 116.39 24.16 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.08 84.28 7.05 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.347 1.07 . . . . 0.0 110.579 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.6 -75.3 1.24 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -125.23 -20.97 4.71 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 170.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.73 103.89 11.74 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 121.808 2.095 . . . . 0.0 111.222 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tt -98.0 117.71 32.96 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.073 0.949 . . . . 0.0 110.237 -171.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.7 m -96.83 126.41 41.97 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.798 0.839 . . . . 0.0 110.066 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.5 mt -110.03 102.3 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -101.86 104.22 14.94 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.281 0.632 . . . . 0.0 110.115 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.4 m -86.86 106.48 17.77 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.797 0.839 . . . . 0.0 109.984 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -94.79 115.54 27.62 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.535 0.683 . . . . 0.0 111.573 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.2 t -153.59 136.82 15.67 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.422 0.689 . . . . 0.0 110.55 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.2 p -59.32 -33.96 71.76 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 mt -64.44 -50.32 68.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 166.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.06 105.66 2.56 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 119.85 1.204 . . . . 0.0 111.663 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.1 m -90.91 133.87 34.91 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 123.033 0.533 . . . . 0.0 110.636 172.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -137.64 146.69 44.2 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 123.355 0.662 . . . . 0.0 111.149 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 129.55 22.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.744 -1.223 . . . . 0.0 111.483 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.84 143.71 47.17 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.616 0.766 . . . . 0.0 111.102 172.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.6 m -130.05 126.06 36.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 0.0 111.259 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.46 146.26 33.28 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -169.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.51 134.33 43.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.698 -1.251 . . . . 0.0 110.856 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -72.84 117.21 14.27 Favored 'General case' 0 CA--C 1.574 1.883 0 O-C-N 120.671 -1.268 . . . . 0.0 112.88 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.7 -34.93 5.41 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 117.23 1.652 . . . . 0.0 117.23 -158.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.71 158.32 31.06 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 122.787 1.279 . . . . 0.0 113.376 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -115.74 140.97 48.7 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.705 173.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -152.15 153.53 34.05 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.945 0.898 . . . . 0.0 110.917 -162.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -83.14 87.23 6.92 Favored 'General case' 0 CA--C 1.574 1.882 0 O-C-N 120.487 -1.383 . . . . 0.0 113.778 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.38 115.2 12.46 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.151 0.977 . . . . 0.0 110.525 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.8 m -101.12 100.53 11.11 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.488 -170.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 p -73.06 159.86 32.94 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -161.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.73 -32.88 6.32 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 119.123 3.009 . . . . 0.0 119.123 169.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -58.61 -51.23 70.79 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 161.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.02 -30.24 2.85 Favored Glycine 0 CA--C 1.551 2.343 0 N-CA-C 116.96 1.544 . . . . 0.0 116.96 -157.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 -58.65 129.68 43.27 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.351 2.076 . . . . 0.0 114.816 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.86 101.6 11.77 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.803 0.841 . . . . 0.0 109.427 172.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.0 p -109.51 105.58 14.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.048 -1.032 . . . . 0.0 110.088 -168.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -70.38 105.31 2.98 Favored 'General case' 0 CA--C 1.565 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.445 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.0 m -130.85 120.35 23.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.003 . . . . 0.0 110.279 -151.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.76 126.79 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 118.829 0.741 . . . . 0.0 111.736 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.4 m -105.69 112.12 25.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.942 -0.474 . . . . 0.0 111.807 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -125.08 131.03 53.38 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.303 0.641 . . . . 0.0 111.112 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -88.49 127.06 35.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.959 . . . . 0.0 111.617 168.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.1 t -143.22 140.35 30.66 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.157 0.583 . . . . 0.0 110.139 167.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 61.67 36.71 16.4 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 160.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.43 16.84 80.38 Favored Glycine 0 CA--C 1.557 2.691 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -165.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.75 136.07 26.87 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 119.664 1.732 . . . . 0.0 113.919 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.0 tp -92.8 112.42 24.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.699 -0.626 . . . . 0.0 110.916 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.09 109.04 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -89.22 98.79 11.97 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.251 0.62 . . . . 0.0 109.339 167.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -89.84 104.14 16.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.605 -0.684 . . . . 0.0 110.232 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -91.62 131.97 36.65 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.154 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -127.94 126.29 41.17 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 119.035 0.834 . . . . 0.0 110.197 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -148.14 120.81 8.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.575 -1.328 . . . . 0.0 110.451 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.8 t70 49.7 51.06 17.22 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.72 -24.91 2.19 Favored Glycine 0 CA--C 1.557 2.688 0 N-CA-C 119.596 2.598 . . . . 0.0 119.596 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -93.67 140.96 29.02 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.994 1.397 . . . . 0.0 111.55 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -129.32 146.85 51.14 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 175.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.7 t -143.4 111.24 6.01 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.037 0.535 . . . . 0.0 110.385 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.3 t -98.65 146.3 25.98 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.8 mt -127.91 108.31 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -169.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.6 m -97.63 106.23 18.51 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.548 0.739 . . . . 0.0 110.214 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -93.0 85.87 5.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 111.237 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -100.37 130.13 46.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -167.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.89 117.24 21.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 112.288 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -145.78 121.88 10.77 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.519 0.728 . . . . 0.0 109.684 -171.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 59.5 47.99 10.29 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 168.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.75 35.04 80.03 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -166.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.48 139.6 16.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.452 0.701 . . . . 0.0 109.781 -162.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.11 112.46 24.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.172 -0.955 . . . . 0.0 108.757 172.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.2 t -99.16 101.82 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.37 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -165.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -100.1 100.98 11.91 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.987 0.899 . . . . 0.0 109.798 -170.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.5 p -101.72 127.25 48.57 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.158 0.983 . . . . 0.0 111.517 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.71 143.62 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 123.316 0.646 . . . . 0.0 111.518 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.7 ttt -124.17 -103.13 0.38 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.336 -0.852 . . . . 0.0 108.732 165.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -87.66 70.51 9.71 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 120.571 1.532 . . . . 0.0 111.264 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.253 0.7 OUTLIER 62.88 0.13 0.65 Allowed 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 118.169 2.655 . . . . 0.0 118.169 -165.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.47 93.94 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.253 -1.529 . . . . 0.0 108.644 -171.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.6 p -92.62 117.59 30.13 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.252 0.548 . . . . 0.0 111.761 -171.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 4.1 p -108.12 119.91 40.81 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.437 0.695 . . . . 0.0 111.339 171.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.6 m -101.96 107.57 18.75 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -101.67 114.1 27.84 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.483 0.713 . . . . 0.0 109.833 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.47 124.94 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.344 -0.848 . . . . 0.0 108.924 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -122.95 131.76 53.86 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -86.21 132.13 34.07 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.253 1.421 . . . . 0.0 113.725 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -73.36 111.13 8.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.877 -1.139 . . . . 0.0 112.102 174.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.2 t -103.62 95.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.253 1.286 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.738 -178.039 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.519 3.9 p . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.95 -47.66 84.28 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -64.94 -15.96 62.74 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 171.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.61 -11.74 61.0 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 163.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -83.9 125.25 31.82 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 121.422 1.919 . . . . 0.0 113.091 -165.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.6 -170.6 26.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 115.856 1.102 . . . . 0.0 115.856 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -90.49 122.52 33.41 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.536 0.734 . . . . 0.0 110.894 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.449 ' CH2' HD21 ' A' ' 111' ' ' LEU . 95.2 m95 -123.55 110.89 15.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.613 -0.679 . . . . 0.0 110.857 -172.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -90.15 130.63 36.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.591 -1.318 . . . . 0.0 113.37 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 46.8 tp -65.0 128.65 36.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 173.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.275 8.8 m -121.46 -61.4 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.129 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -96.43 149.51 21.64 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.491 1.496 . . . . 0.0 111.41 167.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.4 p -145.81 65.76 1.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.166 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.23 126.96 31.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.726 -1.234 . . . . 0.0 112.386 -175.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.64 23.14 62.6 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 119.248 2.459 . . . . 0.0 119.248 -171.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -75.1 -46.81 32.09 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 119.002 1.401 . . . . 0.0 114.455 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.69 -44.14 63.03 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 163.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -52.8 -48.54 66.83 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -58.82 -51.29 70.63 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 167.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 50.0 mtm -68.35 -42.62 78.95 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.34 -37.28 23.93 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 116.207 1.928 . . . . 0.0 116.207 164.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.76 -39.39 76.73 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 171.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.5 mt -51.04 -45.09 61.21 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 162.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.9 46.92 1.06 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 117.114 1.605 . . . . 0.0 117.114 -172.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 m -91.78 143.03 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 C-N-CA 124.519 1.128 . . . . 0.0 110.676 166.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.55 174.5 42.03 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 2.6 pp -55.81 -44.94 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.25 84.32 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.8 mt -64.9 -43.24 93.48 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -52.46 -54.6 30.23 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 164.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -59.49 -52.31 66.14 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.2 ttp -56.15 -49.78 73.02 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 172.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.39 -44.8 97.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 118.23 2.052 . . . . 0.0 118.23 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.23 96.94 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.1 ptp -76.98 -16.72 59.25 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.148 2.648 . . . . 0.0 118.148 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.14 145.39 46.43 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.29 73.07 5.17 Favored Pre-proline 0 CA--C 1.577 1.984 0 CA-C-O 118.546 -0.74 . . . . 0.0 110.627 171.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.32 146.8 57.78 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.134 2.556 . . . . 0.0 116.001 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -83.07 100.8 10.72 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.097 165.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.4 t -79.19 101.9 8.22 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.839 0.828 . . . . 0.0 110.545 167.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mt -96.2 106.36 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.31 128.65 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.0 m -146.32 113.15 6.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.395 -0.816 . . . . 0.0 108.821 170.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.7 95.64 10.0 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 121.276 -0.89 . . . . 0.0 111.062 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.56 76.77 9.98 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-O 122.393 1.092 . . . . 0.0 110.063 -171.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.59 -101.11 1.62 Allowed Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.143 -0.973 . . . . 0.0 113.642 -167.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -94.97 -11.94 27.63 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 156.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -84.57 96.5 9.18 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 122.023 2.192 . . . . 0.0 110.556 -167.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.3 tp -73.22 108.62 6.2 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 121.941 0.876 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.2 m -98.34 105.39 17.53 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.7 103.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -102.85 115.88 31.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.579 0.752 . . . . 0.0 109.687 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.8 m -100.3 97.29 8.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.699 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -89.34 119.72 30.06 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.88 0.848 . . . . 0.0 112.313 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.1 t -150.66 134.76 16.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.673 0.789 . . . . 0.0 110.054 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.4 p -59.12 -33.31 70.71 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.04 -47.84 73.05 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 166.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -158.27 104.94 1.88 Allowed 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.145 1.338 . . . . 0.0 111.173 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.2 m -92.39 137.53 32.28 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.708 -0.62 . . . . 0.0 111.55 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -144.25 164.47 30.65 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.428 0.691 . . . . 0.0 111.686 168.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -154.46 149.72 27.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 119.897 -1.752 . . . . 0.0 114.285 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -138.93 141.21 38.47 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.424 0.63 . . . . 0.0 112.122 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.7 p -126.41 105.15 8.58 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.767 0.827 . . . . 0.0 109.923 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.3 p -136.85 142.13 42.83 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -166.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 m -72.07 118.98 15.62 Favored 'General case' 0 CA--C 1.574 1.871 0 O-C-N 120.575 -1.328 . . . . 0.0 111.768 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 tp -69.48 122.87 19.86 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -166.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.44 -38.08 3.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -158.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -99.23 164.45 12.13 Favored 'General case' 0 CA--C 1.574 1.9 0 CA-C-O 123.519 1.628 . . . . 0.0 113.405 -166.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -103.28 125.69 50.06 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 113.622 -1.626 . . . . 0.0 112.446 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.401 ' HE1' ' SG ' ' A' ' 87' ' ' CYS . 35.7 p90 -125.02 164.69 19.61 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.944 0.897 . . . . 0.0 113.377 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -76.64 104.91 7.39 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.71 1.243 . . . . 0.0 111.516 167.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.82 115.89 27.5 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.229 1.012 . . . . 0.0 109.349 175.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.1 m -90.04 97.17 11.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.9 p -71.05 147.76 48.23 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.69 -37.02 7.75 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -65.41 -49.13 70.38 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 166.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.73 -14.26 1.19 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 118.478 2.151 . . . . 0.0 118.478 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -69.5 133.09 47.28 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 120.375 2.088 . . . . 0.0 112.84 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -86.73 102.05 13.87 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.065 165.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.4 p -104.26 143.08 33.44 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.49 -0.756 . . . . 0.0 110.591 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -79.23 95.6 5.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.478 -1.389 . . . . 0.0 110.494 166.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.2 m -92.46 116.65 29.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 0.0 110.132 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.315 11.6 p -87.82 109.46 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 118.264 0.483 . . . . 0.0 109.884 160.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.401 ' SG ' ' HE1' ' A' ' 73' ' ' PHE . 56.4 m -92.07 110.32 21.69 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -133.41 126.68 31.76 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.007 0.523 . . . . 0.0 111.627 -169.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -90.25 113.44 25.26 Favored 'General case' 0 CA--C 1.563 1.454 0 O-C-N 121.551 -0.718 . . . . 0.0 110.17 170.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 t -97.29 57.99 1.48 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.3 47.8 m-20 45.68 57.32 5.11 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 146.07 -61.13 0.47 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.829 -170.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.59 133.78 51.54 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.841 0.829 . . . . 0.0 112.86 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.7 tp -95.18 107.55 19.64 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.714 0.806 . . . . 0.0 110.669 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.5 114.97 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.569 0.748 . . . . 0.0 109.031 -172.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -89.09 98.18 11.62 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 166.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -95.53 92.22 6.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.854 -0.529 . . . . 0.0 111.354 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -83.23 123.25 29.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.146 0.978 . . . . 0.0 111.389 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -123.29 121.75 36.62 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.392 0.542 . . . . 0.0 110.625 -173.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -150.33 127.1 10.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.667 -1.27 . . . . 0.0 111.613 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.299 17.5 t70 52.85 49.74 19.57 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 162.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.24 0.07 19.72 Favored Glycine 0 CA--C 1.561 2.93 0 N-CA-C 120.145 2.818 . . . . 0.0 120.145 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -123.1 145.25 48.73 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 119.274 1.537 . . . . 0.0 109.854 -173.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -133.43 169.79 16.44 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.03 121.33 5.76 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.751 -1.218 . . . . 0.0 111.596 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.54 103.56 12.46 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -172.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.0 mm -95.57 100.45 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 98.4 m -99.26 101.2 12.44 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.281 0.632 . . . . 0.0 110.252 -168.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -93.36 109.55 21.11 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.724 0.81 . . . . 0.0 110.793 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -125.15 144.35 50.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 112.766 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.449 HD21 ' CH2' ' A' ' 11' ' ' TRP . 0.2 OUTLIER -82.75 122.91 28.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.348 -0.845 . . . . 0.0 110.821 178.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.293 42.0 tttm -124.7 -118.87 0.28 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 122.08 -0.388 . . . . 0.0 109.957 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -84.19 68.23 10.05 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.19 0.995 . . . . 0.0 112.651 -166.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.9 -13.61 5.27 Favored Glycine 0 CA--C 1.556 2.599 0 N-CA-C 119.477 2.551 . . . . 0.0 119.477 -166.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -124.71 158.12 33.99 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 119.096 1.448 . . . . 0.0 110.285 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.52 111.16 19.25 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.651 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 75.4 t -90.13 114.39 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.8 t -115.7 99.69 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 -167.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -99.34 108.6 21.15 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.425 0.69 . . . . 0.0 109.279 -171.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.673 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.7 p -103.74 122.69 45.59 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.71 -0.619 . . . . 0.0 111.938 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.39 136.16 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.385 0.612 . . . . 0.0 110.911 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 12.4 ttt -86.01 -76.1 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 122.722 0.409 . . . . 0.0 110.887 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -126.88 -73.08 0.62 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 166.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -89.97 -30.05 18.06 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.9 t -85.15 107.06 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 119.919 1.236 . . . . 0.0 110.537 -166.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 69.7 p -105.17 113.11 26.51 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.544 0.738 . . . . 0.0 111.344 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.673 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.4 OUTLIER -87.47 157.19 19.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 166.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.0 m -127.97 109.14 11.29 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 166.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -98.38 123.96 42.79 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.527 0.731 . . . . 0.0 110.64 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.9 mm -99.19 116.34 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -114.35 130.86 56.69 Favored 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 122.854 0.462 . . . . 0.0 110.826 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -107.83 143.96 35.68 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -74.28 118.36 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.662 -0.649 . . . . 0.0 112.708 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.3 t -90.06 95.68 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 118.436 -0.792 . . . . 0.0 109.781 -174.253 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.581 2.159 0 CA-C-O 121.383 0.611 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -136.97 70.51 1.4 Allowed 'General case' 0 CA--C 1.57 1.743 0 O-C-N 120.686 -1.259 . . . . 0.0 110.063 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -163.94 -52.33 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 125.87 1.668 . . . . 0.0 110.407 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.3 mt -75.87 0.27 18.78 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.42 143.72 29.24 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-N 120.736 1.607 . . . . 0.0 112.314 -171.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.62 -173.78 17.04 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 115.894 1.117 . . . . 0.0 115.894 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -87.24 112.7 22.28 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.469 0.708 . . . . 0.0 111.596 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -112.61 112.88 24.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 122.122 -0.361 . . . . 0.0 110.718 -175.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -94.01 134.09 36.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.635 -1.291 . . . . 0.0 112.746 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.49 126.77 30.77 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.597 -0.689 . . . . 0.0 111.92 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.258 3.6 m -113.1 -66.49 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.836 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -111.43 107.96 17.36 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.575 1.079 . . . . 0.0 110.347 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.6 p -89.56 81.62 6.49 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.617 -0.677 . . . . 0.0 111.449 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.27 107.28 14.83 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -163.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.18 16.43 78.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 118.439 2.136 . . . . 0.0 118.439 -168.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -86.29 68.78 10.35 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-N 120.102 1.951 . . . . 0.0 112.868 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -141.73 -51.7 0.42 Allowed 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.778 153.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -45.1 -46.81 11.94 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 167.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.403 ' CD2' ' SG ' ' A' ' 127' ' ' CYS . 57.9 t80 -54.55 -57.62 10.68 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 171.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 ptt? -61.74 -43.98 97.79 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.33 -46.89 55.92 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 162.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -67.87 -39.13 83.77 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.913 1.819 . . . . 0.0 115.913 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -50.03 -40.83 46.04 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 159.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.15 50.0 0.6 Allowed Glycine 0 N--CA 1.486 2.015 0 C-N-CA 124.738 1.161 . . . . 0.0 114.978 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.8 t -99.78 131.7 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.578 0.751 . . . . 0.0 109.197 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.26 160.74 48.69 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 116.888 1.515 . . . . 0.0 116.888 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.281 2.6 pp -58.23 -46.34 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -173.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.17 95.28 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 167.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -41.23 89.34 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 170.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -54.97 -49.54 71.15 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 162.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -54.88 -49.73 70.45 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 170.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -52.83 -55.93 19.45 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 165.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.02 -43.79 96.69 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 118.85 2.3 . . . . 0.0 118.85 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.04 95.01 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . 0.269 14.4 ptt? -70.23 -40.03 74.73 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 170.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.43 133.93 56.57 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.51 92.75 41.57 Favored Pre-proline 0 CA--C 1.571 1.786 0 CA-C-O 118.027 -0.987 . . . . 0.0 108.564 166.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.84 158.48 27.74 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.505 2.137 . . . . 0.0 115.713 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -94.22 107.41 19.36 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.531 165.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.65 102.5 15.02 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 121.142 -0.973 . . . . 0.0 111.16 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -90.91 119.66 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 81.0 mt -108.81 126.74 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -138.18 116.08 11.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.827 -1.171 . . . . 0.0 109.121 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.8 p -117.97 111.51 19.06 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -89.86 68.43 7.4 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 122.128 0.966 . . . . 0.0 110.594 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.45 -75.68 0.67 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 120.478 -1.389 . . . . 0.0 115.754 -170.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -104.16 -44.16 5.05 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -74.28 110.01 8.23 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 121.281 1.855 . . . . 0.0 111.792 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 tt -112.82 112.85 24.64 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 122.379 1.085 . . . . 0.0 109.053 -172.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.5 m -99.13 115.92 30.15 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.733 0.813 . . . . 0.0 109.108 -172.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mt -106.58 105.89 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -102.72 105.93 16.46 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.285 0.634 . . . . 0.0 109.89 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.0 m -88.68 103.03 15.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.458 -0.776 . . . . 0.0 109.322 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.88 117.19 29.77 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.967 0.889 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -156.4 137.41 13.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.561 0.744 . . . . 0.0 110.055 168.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.3 p -58.57 -34.66 71.3 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 167.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.5 -47.42 73.05 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 168.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -156.35 104.78 2.24 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 120.077 1.308 . . . . 0.0 110.794 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 m -93.06 132.43 37.19 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.137 0.575 . . . . 0.0 110.935 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.1 p -142.53 115.49 8.78 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.767 -0.583 . . . . 0.0 110.668 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -109.96 135.56 50.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.36 0.664 . . . . 0.0 112.016 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -142.17 144.64 33.52 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.815 0.817 . . . . 0.0 112.699 170.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.8 p -106.16 105.75 15.93 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.662 0.785 . . . . 0.0 110.769 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.5 p -102.53 135.35 44.32 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 m -75.73 130.81 39.25 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 120.752 -1.218 . . . . 0.0 110.454 171.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 tp -77.67 124.74 28.34 Favored 'General case' 0 CA--C 1.57 1.736 0 O-C-N 121.377 -0.827 . . . . 0.0 112.377 175.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.98 39.54 11.54 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 117.452 1.741 . . . . 0.0 117.452 -169.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -171.92 147.53 2.18 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.807 1.243 . . . . 0.0 108.522 -167.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.257 11.6 ptpt -100.18 146.97 26.22 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 171.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -137.88 161.08 37.57 Favored 'General case' 0 CA--C 1.571 1.757 0 C-N-CA 124.893 1.277 . . . . 0.0 110.513 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -80.74 104.26 11.14 Favored 'General case' 0 CA--C 1.572 1.825 0 O-C-N 119.972 -1.705 . . . . 0.0 112.228 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -88.16 109.49 19.94 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.14 0.976 . . . . 0.0 110.707 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.3 m -76.08 99.54 4.67 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.772 . . . . 0.0 110.205 170.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 p -69.66 148.12 49.71 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.574 0.749 . . . . 0.0 112.717 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.14 -41.91 18.43 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.42 -43.91 76.17 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 170.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.82 -31.05 0.29 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.8 mtm-85 -67.75 126.86 30.74 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.071 1.936 . . . . 0.0 113.038 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -88.73 117.13 27.49 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.08 0.467 . . . . 0.0 109.777 166.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.0 p -123.82 129.07 50.45 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.479 0.657 . . . . 0.0 110.338 -163.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -83.64 105.4 14.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.525 -1.36 . . . . 0.0 109.679 -170.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.7 m -121.6 105.53 10.53 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.96 -0.463 . . . . 0.0 110.98 -148.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.44 120.84 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 120.89 0.376 . . . . 0.0 111.443 172.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 45.4 m -95.35 109.38 21.55 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.123 0.487 . . . . 0.0 109.732 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -136.31 124.0 22.43 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.141 0.576 . . . . 0.0 110.932 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -85.88 132.69 34.04 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.093 -1.005 . . . . 0.0 112.188 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 t -139.87 143.52 36.77 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.148 0.579 . . . . 0.0 110.101 163.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 62.27 35.69 15.14 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 162.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.14 29.06 73.17 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -164.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.08 134.28 18.27 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 118.519 1.16 . . . . 0.0 112.907 -170.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.9 tp -88.04 115.46 25.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.782 -0.574 . . . . 0.0 111.216 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.31 108.06 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -94.44 90.11 6.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -89.84 108.13 19.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.903 -0.498 . . . . 0.0 110.863 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -106.6 130.5 54.34 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -169.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -129.36 127.48 41.13 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 123.622 0.769 . . . . 0.0 111.747 -166.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -153.04 134.87 14.62 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.274 -1.516 . . . . 0.0 111.159 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.2 t70 48.29 48.3 18.97 Favored 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 166.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.32 19.06 66.04 Favored Glycine 0 CA--C 1.558 2.764 0 N-CA-C 120.384 2.913 . . . . 0.0 120.384 -167.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -136.54 137.1 39.91 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.216 1.508 . . . . 0.0 109.193 -168.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -128.59 143.86 51.04 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 123.13 1.443 . . . . 0.0 114.57 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.6 t -133.2 164.61 26.66 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.473 167.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -142.72 139.07 30.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.013 -1.68 . . . . 0.0 113.234 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.1 mm -104.97 103.27 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.9 m -99.13 102.02 13.57 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.347 0.594 . . . . 0.0 109.628 -175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -93.88 95.64 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.676 -0.64 . . . . 0.0 110.833 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -104.14 134.97 46.49 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 118.514 0.597 . . . . 0.0 112.487 -176.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 109.75 12.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.966 -1.084 . . . . 0.0 110.189 173.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -144.84 128.75 17.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.555 -0.715 . . . . 0.0 110.783 -170.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 60.36 40.71 17.18 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.61 -15.3 25.67 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 119.814 2.686 . . . . 0.0 119.814 -169.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.8 169.2 17.42 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.081 1.94 . . . . 0.0 112.261 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.5 tp -88.06 116.08 25.99 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 120.551 -1.343 . . . . 0.0 110.109 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.6 t -99.03 108.92 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.9 t -102.42 96.51 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -169.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -87.49 100.95 13.14 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.219 1.009 . . . . 0.0 109.673 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.6 p -107.48 108.4 19.7 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.924 0.889 . . . . 0.0 110.352 -173.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.79 137.71 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.865 0.866 . . . . 0.0 111.618 -168.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.1 ttt -113.93 106.7 14.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 162.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.303 6.3 m120 68.52 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.987 0.915 . . . . 0.0 112.856 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -125.42 -3.12 7.4 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 164.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.7 t -90.32 100.1 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 121.906 2.139 . . . . 0.0 109.567 -170.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.5 p -99.2 123.62 43.63 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.807 0.843 . . . . 0.0 112.8 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.4 p -103.09 133.06 48.83 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 120.937 0.399 . . . . 0.0 111.349 157.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.7 m -106.49 101.46 10.92 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -95.01 114.7 26.54 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.499 -0.751 . . . . 0.0 110.603 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.4 mm -88.19 124.2 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -123.9 122.44 37.99 Favored 'General case' 0 CA--C 1.569 1.709 0 C-N-CA 123.534 0.734 . . . . 0.0 111.433 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -97.18 142.65 28.83 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -78.58 117.59 19.9 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.702 -1.248 . . . . 0.0 112.568 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 32.9 t -117.21 81.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.653 -0.654 . . . . 0.0 109.337 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.256 1.413 0 C-N-CA 123.558 0.743 . . . . 0.0 110.787 -178.043 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.262 4.6 p . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -41.78 98.73 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 166.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -57.28 -23.66 49.87 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.41 -6.46 7.24 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 164.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -64.05 161.01 16.83 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 122.615 2.461 . . . . 0.0 115.274 171.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.42 169.3 12.88 Favored Glycine 0 N--CA 1.49 2.272 0 O-C-N 121.264 -0.898 . . . . 0.0 115.28 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -83.73 96.28 8.67 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.936 0.495 . . . . 0.0 110.858 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -97.18 100.16 11.64 Favored 'General case' 0 CA--C 1.566 1.566 0 O-C-N 121.422 -0.799 . . . . 0.0 110.982 -170.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -77.12 127.28 32.37 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.879 -1.138 . . . . 0.0 112.973 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.2 tp -67.07 121.83 16.45 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.985 0.811 . . . . 0.0 113.033 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.56 -46.58 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -120.95 131.42 54.32 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.48 1.112 . . . . 0.0 109.404 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.8 p -131.83 70.79 1.46 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 172.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -82.38 127.23 33.05 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.21 17.35 61.03 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 118.578 2.191 . . . . 0.0 118.578 -170.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -84.93 -42.47 14.94 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -166.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -60.54 -39.25 87.23 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 121.19 1.814 . . . . 0.0 115.073 169.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.251 14.7 pt-20 -59.7 -49.22 78.58 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 167.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.457 ' CD2' ' SG ' ' A' ' 127' ' ' CYS . 76.7 t80 -55.32 -49.84 71.15 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 169.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.2 mtm -64.26 -36.54 84.42 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -58.53 -45.9 87.92 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 121.514 1.961 . . . . 0.0 115.542 162.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.09 -44.1 95.05 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 171.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.4 mt -55.3 -37.78 67.81 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.24 59.19 0.77 Allowed Glycine 0 N--CA 1.487 2.066 0 C-N-CA 124.13 0.871 . . . . 0.0 114.54 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.6 t -115.27 125.13 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -172.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 164.03 50.85 Favored Glycine 0 CA--C 1.551 2.336 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.262 2.4 pp -55.04 -48.75 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 N-CA-C 117.226 2.306 . . . . 0.0 117.226 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.12 94.98 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.81 -44.25 94.09 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -66.0 -44.18 85.53 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 171.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -56.4 -48.88 76.03 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 168.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.9 ttp -52.96 -58.11 8.07 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 163.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.21 -44.06 89.04 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 119.311 2.484 . . . . 0.0 119.311 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.35 -45.24 95.22 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.3 ptp -74.32 -28.79 61.32 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 168.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.58 102.74 1.54 Allowed 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 119.593 1.088 . . . . 0.0 113.035 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -103.09 92.77 3.95 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.449 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -80.48 160.2 22.47 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.222 1.948 . . . . 0.0 116.08 -172.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -85.36 104.48 15.22 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.294 157.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.2 t -86.85 96.31 10.17 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 124.048 0.939 . . . . 0.0 110.872 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.38 106.11 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.2 mt -97.08 144.81 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 CA-C-O 122.814 1.292 . . . . 0.0 108.454 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -147.1 115.43 6.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.06 -1.65 . . . . 0.0 108.522 167.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.5 t -114.39 107.12 15.13 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.971 0.508 . . . . 0.0 111.65 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -99.63 79.81 2.3 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 122.408 1.099 . . . . 0.0 109.746 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.34 -89.7 0.43 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -99.43 -15.51 18.71 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -106.41 129.21 54.44 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 122.038 2.199 . . . . 0.0 111.113 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 tt -125.5 116.82 22.4 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.295 0.638 . . . . 0.0 110.224 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.1 m -107.58 134.18 50.96 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.917 0.887 . . . . 0.0 109.715 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.9 mt -124.76 111.2 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -87.71 159.57 18.44 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 122.023 0.916 . . . . 0.0 111.182 160.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -148.24 102.86 3.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 119.525 -1.984 . . . . 0.0 107.664 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -98.27 114.31 26.55 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.689 0.795 . . . . 0.0 111.917 -172.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -147.36 140.16 24.93 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.669 0.787 . . . . 0.0 110.484 168.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.0 t -54.4 -28.99 47.38 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 167.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.8 mt -85.14 -47.0 10.58 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 124.122 0.969 . . . . 0.0 113.342 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.1 106.02 3.85 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.881 1.219 . . . . 0.0 110.914 168.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.7 m -90.05 134.66 34.12 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.159 0.584 . . . . 0.0 110.719 170.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -134.83 158.44 44.21 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.931 0.872 . . . . 0.0 111.525 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -150.2 130.93 14.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.538 -1.351 . . . . 0.0 110.802 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -144.2 160.89 40.17 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.881 0.848 . . . . 0.0 112.913 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -139.43 145.83 39.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 112.784 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -132.97 160.04 38.24 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-O 122.448 1.118 . . . . 0.0 112.445 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.7 m -90.56 132.9 35.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 164.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -73.58 128.73 36.3 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -170.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.65 -55.96 0.89 Allowed Glycine 0 N--CA 1.494 2.508 0 O-C-N 121.857 -0.527 . . . . 0.0 114.019 -162.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.26 179.68 7.26 Favored 'General case' 0 CA--C 1.575 1.922 0 CA-C-O 122.94 1.352 . . . . 0.0 113.039 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 149.23 32.74 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -111.64 -172.27 2.0 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.664 164.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -115.41 109.52 18.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.671 -1.268 . . . . 0.0 109.922 163.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -84.37 102.81 13.02 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.746 0.818 . . . . 0.0 109.743 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 75.3 m -77.58 100.29 6.06 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.991 0.901 . . . . 0.0 109.465 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.7 p -72.26 159.67 33.69 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -171.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.1 -41.06 7.47 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 119.233 3.049 . . . . 0.0 119.233 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.27 -39.09 93.6 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 169.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.43 -17.22 5.89 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 118.067 1.987 . . . . 0.0 118.067 -160.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.1 mtm-85 -69.06 118.88 12.53 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.841 2.32 . . . . 0.0 111.05 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -91.61 108.61 20.03 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.237 0.542 . . . . 0.0 109.834 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -111.19 111.46 22.55 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.664 0.745 . . . . 0.0 110.467 -162.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -72.31 97.81 2.09 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.478 1.111 . . . . 0.0 109.643 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.1 m -116.79 119.79 36.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 110.855 -152.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.42 130.05 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.93 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 74.8 m -106.74 95.5 5.78 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.172 0.896 . . . . 0.0 109.947 167.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -126.86 124.65 40.08 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.586 -0.696 . . . . 0.0 111.68 -171.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -89.12 140.79 29.1 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -136.13 115.39 12.54 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.447 0.699 . . . . 0.0 110.988 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.325 21.8 t70 64.26 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 170.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.37 30.32 3.66 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 168.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.51 129.88 15.74 Favored 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 118.8 1.3 . . . . 0.0 112.58 -170.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.7 tp -87.43 120.5 28.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.451 -0.78 . . . . 0.0 110.68 167.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.05 103.07 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.602 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -89.34 88.83 7.64 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -91.8 98.04 11.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.743 . . . . 0.0 110.551 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.6 131.94 36.13 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.097 0.959 . . . . 0.0 111.715 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.84 126.07 33.37 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.982 0.81 . . . . 0.0 109.758 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -143.02 122.21 12.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.838 -1.164 . . . . 0.0 110.393 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.288 38.9 t70 50.4 44.53 26.77 Favored 'General case' 0 CA--C 1.588 2.421 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 173.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.58 25.81 72.82 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 119.812 2.685 . . . . 0.0 119.812 -168.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -135.71 128.71 31.46 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.136 1.374 . . . . 0.0 107.765 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -126.85 146.76 50.16 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.9 t -134.33 126.14 29.06 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.644 0.735 . . . . 0.0 111.031 170.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 m -102.8 129.68 49.54 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 121.178 -0.951 . . . . 0.0 110.067 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.8 mt -120.69 97.99 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -172.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 79.4 m -94.56 103.29 15.24 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.717 . . . . 0.0 109.967 -171.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -93.91 100.21 12.42 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.506 0.723 . . . . 0.0 109.906 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -115.73 138.09 51.45 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.14 112.37 16.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.817 -0.552 . . . . 0.0 111.052 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.269 20.3 tptp -105.62 -138.54 0.36 Allowed 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.619 0.767 . . . . 0.0 111.199 -177.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -90.83 68.08 6.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.521 -1.362 . . . . 0.0 110.225 -159.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.18 36.94 93.86 Favored Glycine 0 CA--C 1.558 2.725 0 N-CA-C 117.577 1.791 . . . . 0.0 117.577 -159.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -165.92 134.39 3.06 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -161.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 21.9 tp -90.22 119.34 30.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.926 -1.734 . . . . 0.0 110.859 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.5 t -94.13 113.87 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.1 t -109.46 101.99 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -89.1 97.39 11.17 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.001 0.905 . . . . 0.0 109.249 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 0.8 OUTLIER -101.1 110.4 22.42 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.195 0.998 . . . . 0.0 110.533 -176.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 p -129.02 144.86 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.751 0.82 . . . . 0.0 110.53 -170.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.284 28.1 ttt -102.98 -104.32 0.28 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.41 -0.806 . . . . 0.0 108.922 166.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -108.02 97.46 7.16 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.644 1.111 . . . . 0.0 108.546 172.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.28 20.0 m120 68.26 -29.04 0.15 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 -172.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.43 107.71 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 CA-C-N 120.203 1.365 . . . . 0.0 109.776 -172.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 68.4 p -107.29 123.1 47.83 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.594 0.758 . . . . 0.0 112.124 -169.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 7.7 p -96.22 129.34 43.56 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 121.268 0.556 . . . . 0.0 111.346 156.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.4 m -105.6 99.45 9.06 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.235 -0.916 . . . . 0.0 108.567 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -96.01 123.19 39.51 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 122.022 -0.424 . . . . 0.0 111.228 -176.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.9 mm -101.44 122.92 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -120.65 148.23 44.19 Favored 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 123.24 0.616 . . . . 0.0 111.794 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -123.0 138.57 54.65 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -76.08 111.04 11.07 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.596 0.759 . . . . 0.0 112.139 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.71 94.66 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -171.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.256 1.415 0 C-N-CA 123.639 0.775 . . . . 0.0 109.636 -173.086 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.504 2.225 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -57.03 -22.84 41.99 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 171.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -41.92 -43.13 2.98 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 117.333 2.346 . . . . 0.0 117.333 154.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.9 3.12 39.55 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -82.35 129.83 34.96 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 121.256 1.843 . . . . 0.0 111.844 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.98 173.68 26.71 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 118.492 2.157 . . . . 0.0 118.492 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -82.91 103.04 12.07 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.067 0.547 . . . . 0.0 110.256 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -109.43 106.88 16.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 122.043 -0.411 . . . . 0.0 110.556 -172.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -83.72 129.79 34.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.395 -1.441 . . . . 0.0 112.553 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.1 tp -65.75 134.34 52.95 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.082 0.468 . . . . 0.0 112.14 172.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.301 6.8 m -123.91 -78.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -84.59 147.14 27.15 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.776 1.171 . . . . 0.0 111.38 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.5 p -139.79 74.86 1.48 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.035 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 137.73 50.62 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.79 15.77 49.39 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 119.67 2.628 . . . . 0.0 119.67 -170.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -81.67 64.85 6.56 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.979 1.889 . . . . 0.0 112.912 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -153.87 -53.73 0.1 Allowed 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 125.624 1.569 . . . . 0.0 109.36 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.46 -48.72 37.46 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 165.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -52.66 -54.99 25.82 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 169.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.298 23.2 ptt? -69.81 -24.45 63.48 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 174.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -64.43 -48.54 74.93 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 159.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -62.0 -37.99 86.9 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.4 mt -53.74 -40.71 66.38 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 159.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.81 57.78 1.58 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 123.797 0.713 . . . . 0.0 114.348 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.8 t -102.1 132.27 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -169.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.84 153.9 40.5 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.259 2.4 pp -56.39 -47.39 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.28 96.7 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 168.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.9 -39.08 90.28 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.8 mtp-105 -56.16 -48.7 75.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 163.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -54.1 -51.69 63.37 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 167.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -51.19 -52.32 45.43 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 166.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.64 -41.48 93.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 119.003 2.361 . . . . 0.0 119.003 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.06 -47.28 87.11 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -78.93 -28.51 43.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.4 115.19 9.29 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 120.198 1.363 . . . . 0.0 113.469 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.59 84.65 4.16 Favored Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.101 174.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.38 161.56 25.56 Favored 'Trans proline' 0 CA--C 1.563 1.971 0 C-N-CA 122.731 2.287 . . . . 0.0 116.84 -173.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -90.74 100.61 13.44 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.158 0.98 . . . . 0.0 109.794 169.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.44 100.15 10.54 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.5 1.12 . . . . 0.0 112.039 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.08 99.24 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.9 mt -90.74 114.89 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.4 p -115.5 106.78 14.35 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.54 112.73 8.18 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.692 -0.63 . . . . 0.0 111.89 -168.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -82.61 -47.68 11.82 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.77 -69.0 0.04 OUTLIER Glycine 0 N--CA 1.486 1.97 0 O-C-N 121.554 -0.716 . . . . 0.0 112.778 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -102.07 -36.51 8.54 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 166.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -76.24 136.45 39.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 120.053 1.297 . . . . 0.0 113.524 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 tt -142.81 120.71 12.0 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-O 121.411 0.624 . . . . 0.0 110.525 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.5 m -120.0 121.95 40.07 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.492 0.717 . . . . 0.0 109.558 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.3 127.96 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -118.89 102.8 9.06 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.831 0.852 . . . . 0.0 109.787 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.1 m -96.66 107.64 20.13 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.598 0.759 . . . . 0.0 110.781 -173.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -101.94 120.45 40.42 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.474 0.654 . . . . 0.0 112.602 -163.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.7 t -155.8 142.53 18.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.75 0.82 . . . . 0.0 111.208 168.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.4 p -60.23 -29.81 68.99 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.11 -53.09 42.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 167.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.95 115.51 3.29 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.987 1.267 . . . . 0.0 110.379 169.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.8 m -91.97 128.95 38.0 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 123.162 0.585 . . . . 0.0 110.752 173.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.1 p -133.49 116.04 15.5 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.533 -0.729 . . . . 0.0 110.233 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.9 150.25 38.76 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -153.25 149.28 27.78 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.3 p -131.75 115.57 16.17 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.953 0.901 . . . . 0.0 111.751 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.5 t -149.92 157.14 42.87 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.561 1.172 . . . . 0.0 113.926 -176.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -89.27 150.97 22.38 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.936 1.351 . . . . 0.0 111.023 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.84 120.11 11.91 Favored 'General case' 0 CA--C 1.571 1.767 0 O-C-N 120.706 -1.246 . . . . 0.0 112.452 170.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.26 -27.31 19.1 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 -162.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -89.44 143.31 26.92 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 118.731 1.266 . . . . 0.0 112.712 -174.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -94.8 145.65 24.74 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.143 0.973 . . . . 0.0 113.552 167.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -130.63 162.02 30.28 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.115 0.966 . . . . 0.0 111.47 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -80.04 100.81 8.35 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 120.911 -1.118 . . . . 0.0 111.192 167.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -80.49 139.11 36.56 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.87 0.843 . . . . 0.0 109.607 162.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.5 m -117.46 110.49 18.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 170.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 p -64.61 140.87 58.91 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.174 -0.329 . . . . 0.0 111.402 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.14 -24.74 2.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 119.954 3.316 . . . . 0.0 119.954 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.253 1.4 t70 -91.91 -24.35 19.33 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 169.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.65 -49.47 0.22 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 119.996 2.758 . . . . 0.0 119.996 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.2 mtm-85 -64.02 138.62 58.54 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -162.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -87.18 107.69 18.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.589 0.756 . . . . 0.0 110.705 170.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . 0.263 3.0 p -112.95 119.16 36.98 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.499 1.142 . . . . 0.0 111.372 -173.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -71.88 95.09 1.5 Allowed 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.44 1.096 . . . . 0.0 110.481 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.5 m -100.69 101.95 12.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.202 -0.936 . . . . 0.0 109.759 -161.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.97 117.22 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.099 0.476 . . . . 0.0 110.479 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 57.8 m -90.25 113.29 25.08 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 122.789 0.436 . . . . 0.0 110.601 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -128.68 124.49 35.81 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.963 -1.086 . . . . 0.0 111.1 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -86.7 116.74 25.0 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 121.124 -0.985 . . . . 0.0 112.037 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.7 t -156.9 140.12 15.56 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.041 0.936 . . . . 0.0 110.663 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.11 54.84 5.58 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 48.79 38.15 22.45 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 118.517 2.167 . . . . 0.0 118.517 -169.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.72 144.42 20.39 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -161.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.84 106.84 18.79 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 163.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.2 t -80.2 95.79 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -88.2 92.3 9.1 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -90.35 106.48 18.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.704 -0.622 . . . . 0.0 110.559 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -89.18 119.97 30.15 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.253 1.021 . . . . 0.0 110.264 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -124.38 124.53 42.56 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.783 0.833 . . . . 0.0 111.012 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -157.49 117.8 3.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.438 -1.414 . . . . 0.0 112.918 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.262 6.5 t70 32.16 56.57 0.36 Allowed 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 118.918 2.933 . . . . 0.0 118.918 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.97 -52.41 1.11 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -77.18 146.68 36.92 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.57 153.04 43.17 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 175.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 t -132.96 123.01 25.11 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 74.2 p -88.67 114.02 24.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.631 -0.668 . . . . 0.0 110.174 170.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 36.2 mm -106.51 93.4 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.9 m -94.65 99.44 11.56 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.099 -1.001 . . . . 0.0 110.747 -170.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -88.17 89.15 7.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.585 -0.697 . . . . 0.0 111.276 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.0 141.93 47.92 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -168.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.86 114.23 20.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 111.347 -177.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -134.02 124.28 25.98 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.05 49.75 15.06 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 170.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.32 -34.26 3.09 Favored Glycine 0 CA--C 1.553 2.455 0 N-CA-C 118.917 2.327 . . . . 0.0 118.917 -169.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -115.47 158.93 21.84 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 119.405 1.602 . . . . 0.0 112.781 -165.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.2 tp -83.44 111.11 18.74 Favored 'General case' 0 CA--C 1.561 1.388 0 O-C-N 121.147 -0.971 . . . . 0.0 110.225 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.34 110.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -95.94 96.53 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -87.07 99.25 11.77 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.899 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 5.3 p -119.55 95.54 4.83 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.225 -159.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 p -107.75 140.78 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.098 0.951 . . . . 0.0 110.016 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttt -119.41 112.43 19.4 Favored 'General case' 0 CA--C 1.559 1.314 0 O-C-N 121.376 -0.828 . . . . 0.0 109.324 167.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 54.2 50.27 16.84 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.297 3.3 t-20 67.82 -2.93 1.27 Allowed 'General case' 0 CA--C 1.584 2.286 0 N-CA-C 118.435 2.754 . . . . 0.0 118.435 -166.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.77 129.56 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 120.82 1.646 . . . . 0.0 108.138 -175.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.4 p -120.18 137.79 53.98 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.367 1.618 . . . . 0.0 115.367 -144.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.899 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 25.1 p -132.82 167.62 19.85 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 123.088 1.423 . . . . 0.0 112.461 153.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.2 m -144.79 123.22 12.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 119.395 -2.066 . . . . 0.0 108.836 167.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -110.36 121.35 45.08 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.464 0.705 . . . . 0.0 110.807 -171.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.3 mm -92.58 118.48 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -118.02 127.47 53.84 Favored 'General case' 0 CA--C 1.569 1.693 0 C-N-CA 123.836 0.855 . . . . 0.0 110.292 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -112.03 144.48 41.31 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -76.51 119.94 21.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 112.946 -174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.7 t -96.16 73.35 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -171.781 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.266 9.7 p . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.01 -37.29 76.55 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 169.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -30.86 56.64 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 164.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.87 -19.97 61.05 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 162.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.254 5.8 pt-20 -91.06 144.85 25.21 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 121.67 2.032 . . . . 0.0 113.688 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.34 -179.5 19.48 Favored Glycine 0 CA--C 1.55 2.239 0 C-N-CA 123.975 0.798 . . . . 0.0 114.187 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.3 ttm-85 -87.35 110.48 20.27 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.424 -1.045 . . . . 0.0 111.072 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -112.72 107.47 16.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.635 -0.665 . . . . 0.0 111.979 -170.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -90.61 129.53 36.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.981 -1.074 . . . . 0.0 113.429 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.1 tp -72.28 121.69 19.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.256 13.0 m -107.8 -57.44 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.686 0.794 . . . . 0.0 112.007 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.7 133.87 48.81 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 119.806 1.184 . . . . 0.0 110.408 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.5 p -119.21 63.94 0.79 Allowed 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 121.615 0.721 . . . . 0.0 112.71 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -60.54 127.59 32.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 0.0 113.494 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.3 21.1 59.33 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 119.993 2.757 . . . . 0.0 119.993 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.14 -41.64 61.23 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 119.115 1.458 . . . . 0.0 114.87 -173.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -49.63 -46.3 49.32 Favored 'General case' 0 CA--C 1.578 2.019 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 163.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -55.86 -49.55 73.02 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 168.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 68.2 t80 -58.05 -48.34 80.38 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 170.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -59.61 -34.03 72.23 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 168.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -58.75 -52.11 67.12 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 163.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -59.11 -44.67 92.0 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.8 mt -50.31 -50.64 50.13 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 162.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.8 49.52 0.58 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 124.143 0.878 . . . . 0.0 115.219 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.1 t -99.14 145.35 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 123.945 0.898 . . . . 0.0 109.461 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.92 -126.31 0.03 OUTLIER Glycine 0 CA--C 1.553 2.426 0 N-CA-C 117.526 1.77 . . . . 0.0 117.526 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.265 9.9 pt -119.1 -61.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.901 -0.764 . . . . 0.0 112.622 -176.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.72 90.75 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.1 mt -66.84 -34.67 78.32 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 170.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -63.87 -47.3 81.24 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 120.256 1.389 . . . . 0.0 114.371 164.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -53.11 -50.58 64.19 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER -59.43 -49.9 76.0 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 170.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.41 -41.42 97.02 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.585 2.194 . . . . 0.0 118.585 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.79 -46.32 82.57 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 169.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -77.16 -32.46 56.23 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.805 2.521 . . . . 0.0 117.805 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.51 144.92 55.48 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -110.93 86.37 5.88 Favored Pre-proline 0 CA--C 1.57 1.713 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -73.77 143.34 33.36 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 122.458 2.105 . . . . 0.0 116.182 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -90.87 100.47 13.33 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.951 165.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.8 t -81.86 95.9 7.47 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 122.468 1.127 . . . . 0.0 110.759 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mt -91.33 101.83 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 85.6 mt -94.73 133.25 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -149.1 126.16 11.32 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 119.863 -1.773 . . . . 0.0 110.508 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.3 t -103.52 110.97 23.22 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -171.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.08 76.01 9.37 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-O 122.129 0.966 . . . . 0.0 110.206 162.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.86 -90.23 0.16 Allowed Glycine 0 N--CA 1.493 2.466 0 O-C-N 120.994 -1.066 . . . . 0.0 115.681 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -89.93 -25.89 20.7 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 160.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -88.56 99.83 12.61 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.35 1.432 . . . . 0.0 110.177 -165.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.3 tp -94.35 110.87 22.6 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.398 0.679 . . . . 0.0 110.777 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.6 m -89.62 117.41 28.49 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -111.88 102.13 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -94.25 114.98 27.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.856 -0.527 . . . . 0.0 109.873 171.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 m -97.34 88.69 4.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.212 -0.93 . . . . 0.0 109.767 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -80.98 125.55 30.29 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.876 0.87 . . . . 0.0 112.795 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 t -155.28 153.77 31.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.473 -0.767 . . . . 0.0 110.813 165.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.9 p -57.98 -43.41 86.53 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 171.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.78 -32.46 67.67 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 123.07 7.76 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 119.827 1.194 . . . . 0.0 109.376 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 m -119.17 124.66 47.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.325 -0.859 . . . . 0.0 109.756 168.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 t -146.14 167.72 22.73 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.57 -0.707 . . . . 0.0 112.673 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -142.65 140.15 31.49 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.01 -1.056 . . . . 0.0 112.66 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -135.28 156.27 49.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 168.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 90.9 p -128.93 112.92 14.59 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.742 0.817 . . . . 0.0 111.214 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.508 ' HG ' ' HD1' ' A' ' 73' ' ' PHE . 45.8 t -115.79 132.49 56.62 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -177.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.0 m -82.48 117.34 22.42 Favored 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 123.46 0.704 . . . . 0.0 109.912 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mp -59.7 127.61 32.84 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -168.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.94 -33.91 5.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 116.986 1.555 . . . . 0.0 116.986 -164.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -98.7 165.64 11.7 Favored 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 123.797 1.76 . . . . 0.0 113.386 -172.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -82.57 139.88 33.57 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.183 -1.826 . . . . 0.0 113.154 171.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.508 ' HD1' ' HG ' ' A' ' 67' ' ' CYS . 9.1 p90 -131.21 162.63 29.55 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 121.657 0.741 . . . . 0.0 111.356 166.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.4 112.0 16.21 Favored 'General case' 0 CA--C 1.568 1.66 0 O-C-N 120.474 -1.391 . . . . 0.0 111.403 170.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -103.73 95.3 5.94 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 121.775 0.798 . . . . 0.0 109.683 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.0 m -72.5 104.73 3.92 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.946 0.879 . . . . 0.0 109.994 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 p -73.5 141.19 46.79 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.336 0.655 . . . . 0.0 111.692 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.85 -29.47 28.14 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 119.614 3.19 . . . . 0.0 119.614 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.79 -28.83 58.52 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 167.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.05 -29.93 0.99 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 118.973 2.349 . . . . 0.0 118.973 172.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.7 mtm-85 -70.48 126.55 29.96 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 119.813 1.807 . . . . 0.0 112.975 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -94.91 106.71 18.72 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.497 0.719 . . . . 0.0 110.052 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.3 p -104.56 122.17 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.457 0.646 . . . . 0.0 110.465 -166.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -77.42 98.52 5.3 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.997 0.903 . . . . 0.0 108.898 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.0 m -111.63 109.68 19.7 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -152.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.4 111.95 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 122.802 0.441 . . . . 0.0 110.853 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.1 m -105.31 105.21 15.15 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -119.37 125.18 48.39 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.467 0.707 . . . . 0.0 112.098 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -91.84 130.09 37.68 Favored 'General case' 0 CA--C 1.564 1.496 0 O-C-N 121.604 -0.685 . . . . 0.0 112.086 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 t -145.63 136.69 24.69 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.339 0.655 . . . . 0.0 109.982 167.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 62.18 34.52 16.11 Favored 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 160.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.27 15.88 80.92 Favored Glycine 0 CA--C 1.558 2.728 0 N-CA-C 119.326 2.49 . . . . 0.0 119.326 -165.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.35 125.2 22.58 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-N 118.616 1.208 . . . . 0.0 110.88 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -97.46 110.59 23.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.492 -0.755 . . . . 0.0 110.3 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.7 t -89.29 104.51 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -86.19 97.1 10.16 Favored 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 124.22 1.008 . . . . 0.0 109.019 171.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -92.66 97.26 10.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.055 -1.028 . . . . 0.0 110.754 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -70.0 127.59 33.38 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.441 0.696 . . . . 0.0 111.698 170.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -135.41 111.81 9.83 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 118.627 0.649 . . . . 0.0 109.96 -171.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.4 p90 -151.92 118.28 5.63 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.659 -1.276 . . . . 0.0 112.269 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.1 t70 39.77 55.16 2.51 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 117.807 2.521 . . . . 0.0 117.807 174.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.98 -44.19 3.32 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 117.755 1.862 . . . . 0.0 117.755 -171.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -78.26 144.3 36.3 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.61 147.18 26.45 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 121.719 0.771 . . . . 0.0 112.998 -175.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 t -134.05 127.39 32.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.714 -0.616 . . . . 0.0 112.549 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.1 p -92.29 129.81 38.14 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.858 0.837 . . . . 0.0 110.891 168.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.1 mt -123.07 97.92 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.2 m -92.81 99.98 12.54 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.843 0.83 . . . . 0.0 109.448 -173.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -89.17 100.46 13.24 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.729 0.812 . . . . 0.0 109.204 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.88 142.63 51.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.41 115.89 21.63 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 121.776 0.798 . . . . 0.0 111.379 -172.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -91.68 -178.17 4.99 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-O 122.302 1.049 . . . . 0.0 112.307 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.62 73.18 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.061 0 CA-C-O 123.426 1.584 . . . . 0.0 115.037 167.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.22 28.6 24.82 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 118.996 2.358 . . . . 0.0 118.996 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -165.44 145.22 6.69 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 119.543 1.671 . . . . 0.0 110.374 -171.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.9 tp -89.86 114.89 26.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 119.905 -1.747 . . . . 0.0 109.316 168.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.2 t -96.05 112.87 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -104.98 95.57 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -85.85 102.16 13.46 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.345 1.069 . . . . 0.0 109.554 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.795 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.1 p -115.65 115.42 26.36 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.664 -165.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.58 134.44 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 122.968 0.507 . . . . 0.0 110.119 -169.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.9 ttt -127.19 114.0 17.1 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.275 39.8 m-20 66.2 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.273 1.029 . . . . 0.0 113.237 176.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -118.83 -13.02 9.55 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 166.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.9 t -102.3 112.72 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 121.121 1.782 . . . . 0.0 109.843 -157.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 70.1 p -99.43 107.65 19.93 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.373 0.669 . . . . 0.0 112.705 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.795 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 18.4 p -90.11 151.98 21.34 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 121.725 0.774 . . . . 0.0 111.901 160.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.4 m -129.28 109.68 11.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.876 -1.14 . . . . 0.0 108.002 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -103.35 118.8 37.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.917 -0.489 . . . . 0.0 110.356 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.8 mm -102.83 118.16 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -120.18 143.53 48.18 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -117.92 143.64 46.17 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -80.27 113.21 18.28 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.767 -0.583 . . . . 0.0 112.185 -169.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.7 t -97.71 83.38 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--O 1.257 1.448 0 C-N-CA 124.232 1.013 . . . . 0.0 109.49 -175.574 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.543 3.1 p . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.42 58.16 2.56 Favored 'General case' 0 CA--C 1.578 2.054 0 CA-C-O 122.868 1.318 . . . . 0.0 114.27 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -148.6 -40.31 0.16 Allowed 'General case' 0 CA--C 1.572 1.792 0 C-N-CA 125.876 1.67 . . . . 0.0 111.222 172.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.0 -6.22 12.09 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 166.45 15.92 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.59 179.7 18.71 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.191 -0.943 . . . . 0.0 115.21 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.1 ttm105 -94.37 118.31 31.42 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.2 0.6 . . . . 0.0 109.687 173.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -118.85 110.2 16.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.227 -0.92 . . . . 0.0 110.625 -164.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -99.46 129.72 45.67 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.495 -0.753 . . . . 0.0 112.326 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.8 tp -67.43 126.2 28.55 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 m -115.69 -53.16 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -117.04 118.08 31.4 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 119.373 0.988 . . . . 0.0 108.899 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.4 p -112.91 68.17 0.67 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -79.42 124.05 28.09 Favored 'General case' 0 CA--C 1.567 1.617 0 O-C-N 121.48 -0.762 . . . . 0.0 112.868 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.88 -2.37 85.69 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 118.892 2.317 . . . . 0.0 118.892 -169.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.251 13.3 t80 -68.57 -37.68 80.08 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.651 2.225 . . . . 0.0 116.352 -173.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.47 -47.91 81.94 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-N 121.058 1.754 . . . . 0.0 115.03 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.254 7.5 pt-20 -49.14 -48.98 44.3 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 121.645 2.02 . . . . 0.0 116.0 166.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.43 -44.4 89.09 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.637 1.718 . . . . 0.0 115.637 170.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 76.9 mtm -61.25 -43.77 98.33 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -53.15 -51.61 61.44 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 121.166 1.803 . . . . 0.0 115.116 164.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.82 -37.49 84.6 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.99 -37.89 69.72 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 161.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.33 61.28 0.81 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 123.999 0.809 . . . . 0.0 114.176 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -110.97 125.12 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -176.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.57 162.3 50.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.448 HD12 ' H ' ' A' ' 30' ' ' ILE . 1.6 mp -57.54 -44.8 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -171.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.96 90.32 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 168.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.2 mt -67.59 -37.79 83.09 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -57.74 -49.56 76.15 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 165.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -51.82 -52.14 51.36 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 165.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.5 ttp -52.21 -56.14 16.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 170.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.46 -42.52 89.78 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.78 2.272 . . . . 0.0 118.78 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.83 83.89 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 170.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.4 ptm -76.97 -29.71 55.67 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.19 122.99 22.79 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 119.62 1.1 . . . . 0.0 113.77 175.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.34 92.61 11.82 Favored Pre-proline 0 CA--C 1.568 1.657 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.291 170.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.95 142.62 25.26 Favored 'Trans proline' 0 CA--C 1.562 1.892 0 C-N-CA 122.3 2.0 . . . . 0.0 115.034 -174.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.37 100.62 13.17 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.011 0.91 . . . . 0.0 109.292 170.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.8 t -94.15 104.79 16.8 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.431 -0.793 . . . . 0.0 112.815 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 mt -81.1 106.43 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.4 mt -103.96 117.7 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.5 t -119.28 124.37 46.51 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.4 p -120.42 102.72 8.65 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-O 121.613 0.72 . . . . 0.0 112.751 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.15 69.39 10.77 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 121.846 0.832 . . . . 0.0 111.153 171.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.24 -84.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 117.249 1.66 . . . . 0.0 117.249 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -85.86 -23.52 27.07 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 166.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -103.08 107.75 18.67 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.525 1.511 . . . . 0.0 109.966 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 tt -117.15 125.55 51.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.832 -1.168 . . . . 0.0 111.665 -169.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -113.53 125.76 54.56 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.404 0.682 . . . . 0.0 110.574 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.0 mt -110.28 109.03 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -107.22 89.06 2.88 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.02 0.928 . . . . 0.0 109.284 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.2 m -84.71 103.39 13.76 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 124.034 0.934 . . . . 0.0 110.758 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -102.39 124.85 48.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -171.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.3 t -147.23 141.23 25.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.542 0.687 . . . . 0.0 110.413 167.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.4 p -55.29 -29.49 58.29 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 164.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.0 mt -74.42 -48.2 29.11 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 165.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -157.2 108.4 2.33 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 121.022 1.737 . . . . 0.0 112.533 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.3 m -77.35 135.28 38.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.641 -0.662 . . . . 0.0 111.137 164.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -134.61 120.5 19.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.215 -0.928 . . . . 0.0 108.537 170.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -124.74 128.89 49.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 110.865 -173.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -146.99 152.55 38.79 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.1 p -136.36 118.0 14.95 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.852 0.861 . . . . 0.0 111.268 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.6 t -145.44 153.84 41.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.585 1.183 . . . . 0.0 113.308 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -84.81 149.04 25.99 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 122.431 1.11 . . . . 0.0 110.83 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 mp -67.12 115.79 7.21 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.465 -1.397 . . . . 0.0 112.587 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.77 -30.08 11.06 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 117.937 1.935 . . . . 0.0 117.937 -161.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -82.87 150.24 26.65 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 118.653 1.227 . . . . 0.0 112.443 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -109.78 151.31 27.13 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.518 1.152 . . . . 0.0 114.087 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -138.05 167.17 22.35 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.16 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.69 102.91 11.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.947 -1.095 . . . . 0.0 111.101 170.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -92.04 99.6 12.4 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-O 121.912 0.863 . . . . 0.0 109.757 172.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.2 m -78.81 105.1 9.88 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 166.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -65.94 176.16 1.75 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.86 -41.06 31.92 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.62 -44.94 73.19 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 165.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.71 -11.52 5.17 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 -160.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 68.5 mtm-85 -63.27 131.82 49.61 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 121.331 2.565 . . . . 0.0 112.885 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -79.92 112.46 17.23 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.642 0.777 . . . . 0.0 111.125 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.8 p -123.78 124.22 42.22 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.967 0.507 . . . . 0.0 110.35 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -83.39 96.17 8.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.622 -1.299 . . . . 0.0 110.377 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.3 m -96.74 115.62 27.74 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 122.077 -0.39 . . . . 0.0 110.376 -168.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.69 125.1 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.817 -0.552 . . . . 0.0 111.037 169.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.56 117.07 29.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.801 -0.562 . . . . 0.0 111.756 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -131.49 116.12 17.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.233 -0.917 . . . . 0.0 111.138 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -83.82 134.98 34.69 Favored 'General case' 0 CA--C 1.568 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 111.945 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.1 t -135.89 129.61 32.56 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.02 0.528 . . . . 0.0 109.979 162.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.296 4.2 m-20 72.85 -82.64 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 159.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.9 48.61 0.71 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 123.466 0.555 . . . . 0.0 113.984 159.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -154.63 127.2 8.0 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.723 0.809 . . . . 0.0 110.92 -166.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.7 tp -97.14 113.72 25.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.67 -0.644 . . . . 0.0 110.166 171.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.45 101.7 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.682 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -90.53 99.82 12.78 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -101.93 100.3 10.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.551 -0.718 . . . . 0.0 111.76 -164.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.67 132.39 37.01 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.437 0.695 . . . . 0.0 112.841 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -130.72 118.04 20.3 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 123.224 0.61 . . . . 0.0 109.922 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -159.21 142.12 14.28 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.716 -1.24 . . . . 0.0 112.281 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t0 51.62 41.89 29.18 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 161.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.37 27.18 72.18 Favored Glycine 0 CA--C 1.559 2.782 0 N-CA-C 119.5 2.56 . . . . 0.0 119.5 -167.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -142.83 151.84 41.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 118.787 1.294 . . . . 0.0 109.699 -168.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -134.18 155.44 50.12 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.1 t -147.29 131.42 17.33 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.855 0.836 . . . . 0.0 111.773 172.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 p -105.17 113.76 27.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.856 -0.528 . . . . 0.0 109.928 -169.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.1 mm -98.64 101.75 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.7 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.2 m -95.9 98.53 10.48 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.096 -1.002 . . . . 0.0 110.105 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.1 mtp85 -89.06 102.55 15.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.635 0.774 . . . . 0.0 109.429 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -133.77 147.88 51.33 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.49 114.99 22.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.623 -0.673 . . . . 0.0 112.123 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -131.46 110.81 11.28 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.252 20.1 t70 55.76 57.8 4.96 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.67 -8.61 2.23 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 120.071 2.789 . . . . 0.0 120.071 -170.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -113.45 140.55 48.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.745 1.272 . . . . 0.0 110.618 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -83.22 104.42 13.38 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 122.219 1.009 . . . . 0.0 108.573 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 99.3 t -96.05 106.16 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.1 t -95.7 98.67 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -172.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.74 100.7 12.38 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.857 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.794 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.5 p -92.72 144.65 25.09 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.4 p -135.47 136.48 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.611 0.72 . . . . 0.0 110.762 169.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.5 tpt -92.86 -58.43 2.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.48 -0.762 . . . . 0.0 111.94 163.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.256 16.3 p30 -141.71 -90.57 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.004 0.922 . . . . 0.0 108.719 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -90.81 -15.88 29.29 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 153.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.4 t -79.78 129.47 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 CA-C-N 120.044 1.293 . . . . 0.0 109.905 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 61.1 p -137.4 153.59 50.14 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -166.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.794 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 1.9 p -132.92 130.32 39.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.403 -0.811 . . . . 0.0 111.349 163.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.4 m -104.08 101.33 11.09 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -102.99 117.06 33.75 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.141 0.496 . . . . 0.0 111.358 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.1 mm -92.26 120.39 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -113.92 131.02 56.45 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 121.265 0.555 . . . . 0.0 110.865 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -86.6 131.38 34.17 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -74.02 106.27 5.64 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.96 0.886 . . . . 0.0 111.356 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.28 129.24 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -176.083 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.505 2.276 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -56.28 -39.32 72.49 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 159.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -71.12 -30.47 66.54 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 169.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 mt -68.91 -10.22 56.0 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 161.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.87 132.45 34.39 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 120.507 1.503 . . . . 0.0 112.019 -166.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.35 -162.83 20.46 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 115.146 0.818 . . . . 0.0 115.146 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -92.01 130.57 37.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.94 -0.741 . . . . 0.0 112.88 -172.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -134.56 112.23 10.7 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.416 0.687 . . . . 0.0 109.291 -171.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.7 ttp-105 -94.32 133.16 38.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 119.963 -1.711 . . . . 0.0 112.575 173.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.15 131.4 50.7 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.292 16.0 m -130.76 -60.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.637 -0.664 . . . . 0.0 112.201 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.27 106.37 17.17 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 119.601 1.091 . . . . 0.0 109.106 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 p -108.15 68.94 0.71 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -83.17 129.07 34.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.48 2.12 90.38 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 -168.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -70.68 -51.9 24.64 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-N 120.179 1.99 . . . . 0.0 115.856 -169.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -54.38 -39.82 67.56 Favored 'General case' 0 CA--C 1.58 2.096 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 170.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.03 -47.7 77.36 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 164.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -58.42 -51.01 71.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 171.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.347 16.5 ptt? -65.22 -23.74 67.16 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 170.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -59.98 -51.86 67.84 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 154.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -59.21 -43.93 92.28 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 171.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.447 ' HA ' ' SD ' ' A' ' 122' ' ' MET . 83.5 mt -57.2 -44.57 83.77 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 171.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.75 62.15 0.36 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 123.883 0.754 . . . . 0.0 114.388 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.4 t -128.49 127.53 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -166.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.48 164.94 53.83 Favored Glycine 0 CA--C 1.55 2.246 0 N-CA-C 117.611 1.804 . . . . 0.0 117.611 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.465 HD12 ' H ' ' A' ' 30' ' ' ILE . 1.9 mp -53.78 -47.97 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -171.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.11 80.7 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 173.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.98 -38.56 91.51 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 169.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -62.74 -48.18 80.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.513 1.506 . . . . 0.0 114.85 168.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.46 -41.99 77.42 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 168.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -58.69 -59.52 5.27 Favored 'General case' 0 CA--C 1.569 1.673 0 CA-C-N 119.784 1.174 . . . . 0.0 113.869 164.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.96 -39.4 78.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 119.622 2.609 . . . . 0.0 119.622 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.31 86.71 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 171.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -83.96 -29.25 27.19 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 167.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.5 106.96 4.17 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-N 119.744 1.156 . . . . 0.0 113.359 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -105.46 91.81 5.23 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.068 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.33 147.77 18.35 Favored 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.313 2.009 . . . . 0.0 115.887 -171.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 99.61 9.29 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 121.681 0.753 . . . . 0.0 109.166 169.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.5 t -101.9 109.68 21.48 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.976 -1.077 . . . . 0.0 112.84 -167.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mt -97.59 104.42 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -170.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 97.0 mt -85.89 104.87 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.5 p -107.08 117.14 33.28 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.29 0.636 . . . . 0.0 109.813 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -113.49 100.07 8.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.022 -1.049 . . . . 0.0 113.179 -173.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.91 65.16 8.86 Favored 'General case' 0 CA--C 1.575 1.938 0 CA-C-O 122.039 0.923 . . . . 0.0 111.381 166.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.52 -88.49 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 116.6 1.4 . . . . 0.0 116.6 -177.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -81.95 -39.29 23.91 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 169.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -90.43 102.27 15.0 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 120.305 1.411 . . . . 0.0 109.786 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 tt -108.69 111.82 23.81 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 121.621 0.724 . . . . 0.0 109.049 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.7 m -105.88 117.08 33.11 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.558 0.743 . . . . 0.0 109.7 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.1 112.01 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -101.89 94.23 5.7 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.508 0.723 . . . . 0.0 110.871 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.6 m -88.58 103.06 15.55 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.315 0.646 . . . . 0.0 110.682 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -100.52 115.4 30.03 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.7 t -147.31 141.54 26.2 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.528 0.731 . . . . 0.0 110.82 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.2 p -58.81 -32.46 69.39 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 165.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.23 -48.81 64.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 167.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.21 108.07 2.53 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.568 1.531 . . . . 0.0 111.354 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.3 m -91.07 128.19 36.8 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.715 -0.616 . . . . 0.0 110.988 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.5 p -131.55 109.06 9.98 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.431 -0.793 . . . . 0.0 110.772 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -104.98 119.94 40.24 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.27 0.628 . . . . 0.0 110.83 175.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -133.13 143.96 49.6 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.7 p -102.04 113.08 26.0 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.882 0.873 . . . . 0.0 111.631 173.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.8 p -102.95 123.96 47.56 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-O 121.516 0.674 . . . . 0.0 111.382 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 m -81.29 121.42 26.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.195 -0.941 . . . . 0.0 109.065 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -73.0 129.65 38.57 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -164.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.1 -41.48 2.97 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 116.812 1.485 . . . . 0.0 116.812 -160.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -89.33 173.15 8.54 Favored 'General case' 0 CA--C 1.572 1.797 0 C-N-CA 124.798 1.239 . . . . 0.0 113.185 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.54 157.69 21.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -142.82 163.72 32.03 Favored 'General case' 0 CA--C 1.573 1.865 0 C-N-CA 124.723 1.209 . . . . 0.0 111.725 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.33 104.96 11.23 Favored 'General case' 0 CA--C 1.569 1.704 0 O-C-N 120.916 -1.115 . . . . 0.0 111.716 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -99.19 114.73 27.66 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.008 0.923 . . . . 0.0 109.678 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.8 m -93.71 106.94 18.87 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.92 -1.112 . . . . 0.0 108.36 166.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -77.66 157.16 30.3 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -169.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.86 -31.98 63.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 168.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.46 10.41 2.6 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 164.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.09 45.57 10.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.08 1.992 . . . . 0.0 118.08 172.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.3 mtm105 -134.01 130.34 37.44 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 117.998 0.899 . . . . 0.0 109.348 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -90.05 112.14 23.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.968 -0.458 . . . . 0.0 110.077 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.2 p -125.3 134.43 52.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.402 0.681 . . . . 0.0 109.667 -169.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -81.85 99.97 9.33 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 171.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.8 m -107.51 112.39 25.13 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.861 -0.524 . . . . 0.0 110.994 -159.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -88.9 124.37 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 122.961 0.504 . . . . 0.0 111.452 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 19.3 m -108.45 114.07 27.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.73 -0.606 . . . . 0.0 111.887 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -124.17 120.66 32.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.789 -0.569 . . . . 0.0 110.589 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -89.32 119.17 29.55 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 111.609 171.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 t -98.91 156.83 16.69 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 122.974 0.51 . . . . 0.0 110.027 155.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.23 95.82 0.04 OUTLIER 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.01 -16.02 20.76 Favored Glycine 0 CA--C 1.553 2.444 0 N-CA-C 118.421 2.128 . . . . 0.0 118.421 -170.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.57 126.01 15.77 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 120.331 2.066 . . . . 0.0 112.927 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.5 tp -90.88 107.39 19.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 110.059 168.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.8 106.91 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -91.12 100.51 13.34 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.152 0.581 . . . . 0.0 109.537 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -93.52 104.19 16.33 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -104.3 125.25 50.39 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -174.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.84 127.19 51.68 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.68 0.792 . . . . 0.0 111.036 -165.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -153.79 125.67 7.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.425 -1.422 . . . . 0.0 112.248 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.0 t70 49.82 51.02 17.36 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.04 -14.17 6.52 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 119.903 2.721 . . . . 0.0 119.903 -167.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -103.81 152.28 22.08 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 119.138 1.469 . . . . 0.0 111.955 -173.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -143.61 150.72 39.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.7 t -136.76 132.65 35.06 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.349 0.66 . . . . 0.0 111.289 174.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.5 p -91.48 130.36 37.32 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.789 0.804 . . . . 0.0 110.455 169.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 80.2 mt -124.38 98.17 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -98.41 101.79 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.781 -0.574 . . . . 0.0 110.141 -170.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -88.04 98.06 11.31 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 121.79 -0.569 . . . . 0.0 110.149 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.11 145.78 47.84 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -171.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.59 113.29 25.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.0 112.363 -171.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -134.22 115.05 13.71 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.597 -0.689 . . . . 0.0 109.164 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 58.0 58.31 3.65 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 47.16 41.53 15.43 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 118.455 2.142 . . . . 0.0 118.455 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.55 128.77 9.75 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -163.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.63 106.2 17.86 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 122.184 0.993 . . . . 0.0 109.674 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.4 t -95.27 109.0 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.7 t -95.04 100.32 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -93.7 101.19 13.32 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.0 p -120.58 131.49 54.68 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 121.774 0.797 . . . . 0.0 111.991 -163.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.61 140.64 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.464 0.65 . . . . 0.0 110.505 -166.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.447 ' SD ' ' HA ' ' A' ' 26' ' ' LEU . 19.3 ttt -106.09 -74.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.759 -0.588 . . . . 0.0 110.567 171.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -129.5 -65.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.654 0.661 . . . . 0.0 110.937 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -94.79 -44.89 7.56 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.06 0.944 . . . . 0.0 112.639 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.68 120.91 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 CA-C-N 119.248 0.931 . . . . 0.0 110.316 -161.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 39.9 p -102.4 114.5 28.74 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.492 0.717 . . . . 0.0 109.959 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.5 p -98.76 132.86 43.8 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.475 0.71 . . . . 0.0 111.213 171.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.6 m -109.7 104.62 13.65 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -103.68 113.01 26.2 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 122.905 0.482 . . . . 0.0 110.683 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.18 129.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.454 -0.779 . . . . 0.0 109.381 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -118.48 124.39 47.48 Favored 'General case' 0 CA--C 1.571 1.768 0 CA-C-O 121.203 0.525 . . . . 0.0 112.163 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.4 136.49 42.4 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.158 0.983 . . . . 0.0 113.613 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -76.32 116.37 16.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.371 -1.456 . . . . 0.0 111.208 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.36 69.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.209 -0.932 . . . . 0.0 110.84 -171.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.12 -0.987 . . . . 0.0 108.771 -164.138 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p -63.84 -22.89 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . 0.252 6.6 tt0 -67.59 -14.86 63.3 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 117.909 2.559 . . . . 0.0 117.909 172.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.16 -35.1 71.06 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 155.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 23.0 mt -82.9 2.87 32.29 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 116.861 2.171 . . . . 0.0 116.861 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -92.04 148.57 22.09 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 122.089 2.222 . . . . 0.0 113.634 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.31 178.69 15.61 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -174.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.8 ttm105 -85.84 122.88 30.54 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.816 -0.814 . . . . 0.0 110.311 166.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.44 ' CH2' HD21 ' A' ' 111' ' ' LEU . 97.5 m95 -119.66 114.4 22.13 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -172.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -105.07 124.41 49.48 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.751 0.82 . . . . 0.0 112.83 -163.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.1 tp -66.66 128.63 36.99 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -172.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.253 6.1 m -115.6 -69.09 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.685 0 C-N-CA 124.148 0.979 . . . . 0.0 109.566 173.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -92.57 149.93 21.05 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 124.439 1.096 . . . . 0.0 112.718 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -152.16 59.3 0.84 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.461 -1.399 . . . . 0.0 114.684 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -72.47 133.01 44.61 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.5 -13.99 53.09 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 118.515 2.166 . . . . 0.0 118.515 -166.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -67.39 -35.14 78.72 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.456 ' CG ' HH12 ' A' ' 33' ' ' ARG . 9.2 t70 -53.28 -54.24 39.14 Favored 'General case' 0 CA--C 1.576 1.942 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 166.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -60.77 -46.71 89.42 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 172.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -58.52 -47.08 85.36 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 171.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.7 mtm -62.44 -40.66 97.31 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 120.784 1.629 . . . . 0.0 114.945 170.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -47.99 -53.2 16.94 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 161.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -74.78 -33.69 62.3 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.8 mt -46.76 -40.33 13.33 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 118.403 2.742 . . . . 0.0 118.403 158.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.07 67.81 1.01 Allowed Glycine 0 N--CA 1.487 2.063 0 CA-C-N 118.34 0.518 . . . . 0.0 113.423 -161.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.86 123.98 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.45 152.04 52.26 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 115.581 0.992 . . . . 0.0 115.581 173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 pt -53.48 -44.3 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 117.911 2.559 . . . . 0.0 117.911 -172.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.05 -42.93 86.48 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 166.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.56 -39.6 94.04 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.034 1.494 . . . . 0.0 115.034 168.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.527 ' HB3' HH11 ' A' ' 33' ' ' ARG . 13.9 mtm105 -59.32 -47.78 84.12 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 168.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -56.81 -51.99 66.8 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 168.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 28.9 ttp -46.84 -61.16 1.98 Allowed 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 167.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.06 -41.91 79.4 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 118.904 2.322 . . . . 0.0 118.904 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.51 -51.9 51.71 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 169.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.8 ptm -74.0 -31.65 63.04 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 117.537 2.421 . . . . 0.0 117.537 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -59.37 -25.1 63.95 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 119.284 3.068 . . . . 0.0 119.284 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 60.65 67.4 1.55 Allowed Pre-proline 0 CA--C 1.581 2.172 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -66.69 142.41 63.86 Favored 'Trans proline' 0 CA--C 1.562 1.902 0 N-CA-C 119.329 2.78 . . . . 0.0 119.329 -170.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.7 113.5 26.01 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 114.34 -1.3 . . . . 0.0 109.127 165.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 51.6 t -92.0 110.62 21.99 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.933 0.893 . . . . 0.0 111.261 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mp -101.36 110.24 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 87.8 mt -102.4 129.31 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 85.1 m -150.99 127.04 10.44 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.658 -1.276 . . . . 0.0 110.294 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.6 t -102.14 130.06 48.66 Favored 'General case' 0 CA--C 1.562 1.414 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -172.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -82.0 -56.26 4.06 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.733 -0.604 . . . . 0.0 111.993 159.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -161.71 -84.72 0.05 OUTLIER Glycine 0 N--CA 1.485 1.947 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 172.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -83.2 -37.45 23.61 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 161.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -74.65 104.39 5.31 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 121.095 1.771 . . . . 0.0 111.505 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 32.5 tp -99.84 111.9 24.19 Favored 'General case' 0 CA--C 1.558 1.288 0 C-N-CA 123.79 0.836 . . . . 0.0 109.1 -175.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.5 m -81.78 115.87 21.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.786 -0.571 . . . . 0.0 110.401 -173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.1 mt -119.05 106.2 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.646 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -98.29 127.4 44.21 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.106 0.563 . . . . 0.0 110.658 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.2 m -99.27 97.81 8.84 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 171.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -89.29 97.2 11.06 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.251 0.62 . . . . 0.0 109.905 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.2 p -104.32 150.8 24.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.302 -0.874 . . . . 0.0 111.815 171.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.6 p -78.08 49.24 0.79 Allowed 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 179.72 -61.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.288 1.435 . . . . 0.0 109.404 -164.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -131.04 168.69 16.97 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.356 1.074 . . . . 0.0 111.598 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.4 m -149.62 149.23 30.35 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 119.422 -2.049 . . . . 0.0 110.743 -174.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.9 m -152.95 139.5 18.73 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.558 -1.338 . . . . 0.0 109.685 175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -134.48 131.51 38.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.446 -0.784 . . . . 0.0 110.428 -176.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -147.85 144.78 28.37 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.257 0.551 . . . . 0.0 112.393 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 77.9 p -99.95 103.05 14.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.374 -0.829 . . . . 0.0 110.635 170.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 52' ' ' LEU . 28.4 p -85.71 124.67 32.49 Favored 'General case' 0 CA--C 1.558 1.276 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.7 m -79.41 108.25 12.79 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.618 0.723 . . . . 0.0 110.532 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.3 tp -81.3 119.56 23.81 Favored 'General case' 0 CA--C 1.563 1.444 0 O-C-N 121.591 -0.693 . . . . 0.0 112.543 -167.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.85 50.62 18.11 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 115.228 0.851 . . . . 0.0 115.228 -159.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.48 160.82 0.79 Allowed 'General case' 0 CA--C 1.574 1.879 0 C-N-CA 125.736 1.615 . . . . 0.0 109.139 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -93.08 153.37 18.73 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 168.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -142.04 161.72 37.27 Favored 'General case' 0 CA--C 1.572 1.792 0 C-N-CA 124.174 0.989 . . . . 0.0 110.286 170.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -81.58 106.91 13.9 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.097 -1.627 . . . . 0.0 110.505 166.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -83.31 144.9 29.39 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 122.685 1.231 . . . . 0.0 111.062 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.8 m -113.05 120.45 41.39 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 162.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 78.1 p -68.22 154.1 42.41 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.07 -29.06 60.0 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 167.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -68.69 -47.89 65.3 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 170.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 145.89 -33.15 1.53 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 117.337 1.695 . . . . 0.0 117.337 -165.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -63.5 141.19 58.86 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 119.485 1.643 . . . . 0.0 112.923 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -110.58 131.02 55.41 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.166 0.586 . . . . 0.0 109.897 175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.1 p -128.5 136.54 50.94 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.551 0.691 . . . . 0.0 111.191 -165.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -83.7 102.74 12.47 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.586 -1.321 . . . . 0.0 109.729 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 50.5 m -112.08 109.74 19.64 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.658 -0.651 . . . . 0.0 110.752 -158.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.1 p -86.86 120.92 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 C-N-CA 122.714 0.406 . . . . 0.0 111.181 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.4 m -108.77 122.66 47.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -132.95 126.54 32.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.515 -0.741 . . . . 0.0 111.723 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -91.88 112.43 24.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.739 -0.6 . . . . 0.0 110.488 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -102.79 86.79 2.81 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 122.974 0.51 . . . . 0.0 110.643 171.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.265 12.1 t70 25.4 70.8 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.868 2.914 . . . . 0.0 118.868 178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.71 -44.49 1.31 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 115.95 1.14 . . . . 0.0 115.95 -168.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -115.63 119.93 37.73 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 118.448 1.124 . . . . 0.0 113.556 -172.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.6 tp -90.46 107.06 18.92 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.553 0.741 . . . . 0.0 111.136 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.91 109.97 22.41 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -94.46 106.37 18.35 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 170.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -100.29 104.95 16.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.722 -0.611 . . . . 0.0 111.403 -171.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -99.6 107.31 19.42 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 123.459 0.703 . . . . 0.0 111.438 -162.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -102.12 121.33 41.99 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.914 0.779 . . . . 0.0 111.923 -174.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 9.5 p90 -148.76 129.84 14.47 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.006 -1.059 . . . . 0.0 110.881 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 52.54 41.11 30.95 Favored 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.56 32.24 82.59 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 119.026 2.37 . . . . 0.0 119.026 -165.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -136.09 124.1 22.85 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 118.371 1.086 . . . . 0.0 108.154 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.44 142.48 32.76 Favored 'General case' 0 CA--C 1.563 1.481 0 CA-C-O 121.878 0.847 . . . . 0.0 112.256 175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 46.9 t -125.13 130.6 52.53 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.941 0.877 . . . . 0.0 109.889 159.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.6 p -113.09 107.95 16.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -169.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.3 mm -104.7 102.06 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.011 -1.056 . . . . 0.0 108.686 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 38.2 m -97.2 96.25 8.3 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 119.22 0.918 . . . . 0.0 109.916 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.3 mtt85 -87.27 110.2 20.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.561 -0.712 . . . . 0.0 110.501 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.9 pttt -134.58 146.14 49.34 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.555 1.07 . . . . 0.0 113.646 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.44 HD21 ' CH2' ' A' ' 11' ' ' TRP . 0.2 OUTLIER -87.43 114.84 24.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.559 -0.713 . . . . 0.0 112.241 -169.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -131.72 113.47 13.59 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 123.598 0.759 . . . . 0.0 108.995 -176.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.263 35.4 t70 60.57 34.47 20.25 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 69.47 9.43 61.43 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 119.123 2.409 . . . . 0.0 119.123 -165.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -109.13 143.41 38.54 Favored 'General case' 0 CA--C 1.563 1.461 0 CA-C-N 119.26 1.53 . . . . 0.0 108.812 172.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.4 tp -84.03 102.32 12.4 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.808 0.814 . . . . 0.0 108.897 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.7 t -96.31 112.53 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.24 95.94 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.29 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -172.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -93.62 94.75 8.79 Favored 'General case' 0 CA--C 1.559 1.293 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.243 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.0 OUTLIER -92.11 148.5 22.12 Favored 'General case' 0 CA--C 1.56 1.334 0 O-C-N 121.36 -0.837 . . . . 0.0 112.025 177.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.3 128.65 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.54 0.686 . . . . 0.0 110.288 166.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.1 tpt -69.0 -65.87 0.65 Allowed 'General case' 0 CA--C 1.569 1.687 0 C-N-CA 123.422 0.689 . . . . 0.0 112.298 169.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.251 15.5 p30 -143.67 -73.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -86.78 -38.64 16.69 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 159.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 78.1 t -85.99 128.33 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 119.921 1.237 . . . . 0.0 111.067 -163.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 66.3 p -110.04 156.59 20.32 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.492 -169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.779 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 2.3 p -131.99 133.55 44.59 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.011 -1.056 . . . . 0.0 111.161 156.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 90.4 m -109.47 98.0 7.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 173.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 86.2 mtm-85 -102.67 120.76 41.12 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.207 0.603 . . . . 0.0 111.603 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.93 125.12 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -119.75 125.66 49.16 Favored 'General case' 0 CA--C 1.572 1.825 0 C-N-CA 123.43 0.692 . . . . 0.0 110.498 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -93.3 143.65 26.06 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -74.82 120.16 19.98 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.535 -1.353 . . . . 0.0 113.498 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 78.9 t -93.67 89.12 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 176.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 124.353 1.061 . . . . 0.0 109.657 171.414 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.1 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p -67.95 -31.26 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 166.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -62.28 -34.16 76.04 Favored 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 161.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -66.12 -27.22 67.88 Favored 'General case' 0 CA--C 1.577 1.995 0 N-CA-C 116.247 1.943 . . . . 0.0 116.247 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.3 mt -70.21 -2.4 13.1 Favored 'General case' 0 CA--C 1.581 2.142 0 N-CA-C 117.313 2.338 . . . . 0.0 117.313 165.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -68.71 138.5 54.97 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 121.054 1.752 . . . . 0.0 114.541 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.33 -178.64 18.25 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 115.814 1.086 . . . . 0.0 115.814 168.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -89.64 125.56 35.29 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.678 -0.761 . . . . 0.0 109.857 169.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -121.1 109.62 15.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.667 -0.646 . . . . 0.0 109.599 -168.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.5 ttm105 -91.64 127.48 37.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.677 -1.264 . . . . 0.0 113.207 -176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.21 126.49 27.56 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.293 9.3 m -110.73 -72.22 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 123.484 0.714 . . . . 0.0 109.158 173.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -87.05 143.58 27.26 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 119.093 0.86 . . . . 0.0 111.785 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.2 p -139.18 65.35 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.334 162.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -72.16 128.02 34.36 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.3 2.12 86.99 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 119.294 2.478 . . . . 0.0 119.294 -169.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -69.79 -48.7 58.21 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -169.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -55.4 -43.3 75.11 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 174.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -64.2 -35.99 82.59 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 164.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.444 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 59.6 t80 -61.2 -50.78 71.74 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 120.884 1.675 . . . . 0.0 114.499 169.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.9 ptm -61.76 -37.23 83.52 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 169.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -50.48 -48.64 56.7 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 158.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.52 -39.94 95.73 Favored 'General case' 0 CA--C 1.579 2.069 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.2 mt -56.38 -42.01 77.19 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 163.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.86 69.83 0.45 Allowed Glycine 0 N--CA 1.487 2.039 0 C-N-CA 124.249 0.928 . . . . 0.0 113.029 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.3 t -133.64 126.06 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -171.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.53 164.5 52.23 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 116.438 1.335 . . . . 0.0 116.438 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.3 pt -53.73 -47.38 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 118.315 2.709 . . . . 0.0 118.315 -170.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.63 98.34 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 172.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.97 -39.61 93.74 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 167.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -60.15 -49.92 75.75 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -51.94 -52.15 52.14 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 167.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -53.9 -55.19 29.15 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 169.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.48 -40.98 99.38 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 118.799 2.279 . . . . 0.0 118.799 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.43 -44.31 83.22 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 171.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.0 ptm -71.33 -26.05 62.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.89 127.27 31.38 Favored 'General case' 0 CA--C 1.561 1.394 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.82 77.05 4.52 Favored Pre-proline 0 CA--C 1.575 1.926 0 CA-C-O 118.224 -0.893 . . . . 0.0 109.525 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.88 140.55 20.58 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.283 1.989 . . . . 0.0 116.617 -167.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.11 91.32 8.67 Favored 'General case' 0 CA--C 1.575 1.915 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.882 162.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -90.05 115.09 27.06 Favored 'General case' 0 CA--C 1.559 1.325 0 O-C-N 120.804 -1.185 . . . . 0.0 112.444 -172.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -92.17 118.7 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 109.406 -173.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 76.7 mt -105.75 122.31 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m -140.42 134.12 30.34 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.396 0.617 . . . . 0.0 111.512 163.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.5 p -107.44 141.8 38.27 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . 0.268 17.0 t70 -101.37 -116.72 0.18 Allowed 'General case' 0 CA--C 1.578 2.047 0 C-N-CA 123.743 0.817 . . . . 0.0 108.798 166.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.19 -83.98 1.3 Allowed Glycine 0 N--CA 1.492 2.38 0 CA-C-N 120.516 1.507 . . . . 0.0 112.873 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -85.65 -37.7 19.19 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 160.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -72.58 117.16 13.91 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.511 1.505 . . . . 0.0 112.901 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 tt -123.6 118.32 27.04 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.925 0.89 . . . . 0.0 108.718 -174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.9 m -94.47 123.64 38.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.709 -0.62 . . . . 0.0 110.373 -170.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 89.8 mt -116.8 106.26 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -109.71 117.83 34.94 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.091 0.556 . . . . 0.0 111.039 176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 m -85.94 109.48 18.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.397 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -98.79 92.11 5.41 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 119.822 1.192 . . . . 0.0 110.912 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.5 t -126.96 139.32 53.13 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.906 0.882 . . . . 0.0 110.21 166.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.5 p -76.86 49.8 0.67 Allowed 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 172.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.7 mt -150.48 -52.01 0.14 Allowed 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 126.231 1.812 . . . . 0.0 109.296 176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -153.91 115.78 4.25 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.143 1.338 . . . . 0.0 110.923 173.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 67.6 p -97.42 92.22 5.85 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.293 0.637 . . . . 0.0 110.865 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.0 m -89.11 117.63 28.24 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.042 0.925 . . . . 0.0 108.9 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.21 141.76 50.62 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.8 0.84 . . . . 0.0 111.923 -175.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -156.26 145.31 20.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.567 -0.708 . . . . 0.0 112.734 -174.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 80.5 p -101.35 108.12 19.65 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.344 0.658 . . . . 0.0 110.093 167.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.1 p -92.47 131.16 37.85 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.65 -0.656 . . . . 0.0 112.367 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.04 122.99 26.3 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.897 -1.127 . . . . 0.0 110.673 168.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.4 tp -75.91 129.85 37.59 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.56 0.744 . . . . 0.0 112.62 -176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.44 -28.18 5.92 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 117.606 1.802 . . . . 0.0 117.606 -159.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -105.25 158.34 16.68 Favored 'General case' 0 CA--C 1.568 1.67 0 CA-C-N 119.418 1.609 . . . . 0.0 112.908 -166.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 37.5 tttt -95.65 116.27 28.62 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.914 176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -126.96 148.1 50.08 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 124.014 0.926 . . . . 0.0 110.988 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -82.05 101.69 10.51 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.2 -1.563 . . . . 0.0 113.499 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -88.63 120.42 30.01 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-O 121.973 0.892 . . . . 0.0 110.691 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 88.8 m -89.43 96.47 10.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.33 -0.856 . . . . 0.0 110.077 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.6 p -69.42 158.13 35.74 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.87 -36.91 12.9 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 119.529 3.159 . . . . 0.0 119.529 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -67.3 -36.93 82.51 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 170.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 122.76 -10.48 9.0 Favored Glycine 0 CA--C 1.552 2.356 0 N-CA-C 118.03 1.972 . . . . 0.0 118.03 -159.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -71.7 115.61 11.1 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 121.085 2.443 . . . . 0.0 110.204 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -87.92 108.6 19.26 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.663 0.744 . . . . 0.0 109.567 172.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.9 p -106.81 111.78 24.45 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.684 0.754 . . . . 0.0 109.609 -166.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -69.12 101.84 1.53 Allowed 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 122.483 1.135 . . . . 0.0 109.807 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.2 m -112.84 112.46 23.96 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -156.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.329 10.4 p -81.36 113.38 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-N 118.996 0.816 . . . . 0.0 110.013 168.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 64.0 m -96.79 109.93 22.51 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 120.58 0.229 . . . . 0.0 110.583 176.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -133.43 121.42 22.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.549 -0.719 . . . . 0.0 112.006 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -87.59 137.21 32.54 Favored 'General case' 0 CA--C 1.568 1.654 0 O-C-N 121.493 -0.754 . . . . 0.0 112.997 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.0 t -137.75 113.13 9.37 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.384 0.674 . . . . 0.0 111.05 171.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.322 22.4 t70 66.9 -82.96 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 171.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.95 43.26 1.28 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 166.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.87 118.33 6.49 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.554 0.741 . . . . 0.0 111.077 -169.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.7 tp -90.23 109.75 20.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.588 -0.695 . . . . 0.0 110.089 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.5 t -86.21 108.12 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -86.94 94.17 9.53 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 167.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -91.85 97.87 11.25 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.61 -0.681 . . . . 0.0 109.925 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -87.5 116.74 25.81 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.219 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -123.45 125.68 45.38 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.559 1.072 . . . . 0.0 110.622 -176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -144.54 120.23 10.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.558 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 63.23 14.96 8.2 Favored 'General case' 0 CA--C 1.587 2.368 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 -176.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.1 -14.64 26.29 Favored Glycine 0 CA--C 1.559 2.833 0 N-CA-C 118.947 2.339 . . . . 0.0 118.947 -156.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -77.33 129.55 35.99 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 119.188 1.494 . . . . 0.0 109.056 168.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -140.85 147.98 39.81 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -173.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.7 t -118.61 138.28 52.69 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 122.294 1.045 . . . . 0.0 111.759 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 38.7 p -110.61 112.5 24.43 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 76.0 mt -120.79 98.17 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 -167.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 55.3 m -94.25 101.72 13.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.74 -0.6 . . . . 0.0 110.037 -173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -87.66 96.46 10.43 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 123.397 0.679 . . . . 0.0 110.188 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -127.86 149.52 50.25 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -172.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.9 123.03 45.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.248 -0.907 . . . . 0.0 112.343 -158.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.03 121.94 27.44 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.74 -0.6 . . . . 0.0 109.492 171.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 58.93 44.49 16.46 Favored 'General case' 0 N--CA 1.509 2.495 0 N-CA-C 116.577 2.065 . . . . 0.0 116.577 165.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.57 35.71 74.48 Favored Glycine 0 CA--C 1.555 2.592 0 N-CA-C 118.382 2.113 . . . . 0.0 118.382 -163.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -137.67 127.77 25.96 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -175.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 tp -88.15 106.82 18.43 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-O 121.996 0.903 . . . . 0.0 109.287 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.4 t -98.16 106.94 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -175.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.5 t -104.51 98.03 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -170.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -91.93 113.12 25.3 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 123.713 0.805 . . . . 0.0 109.399 -177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.6 p -126.73 122.1 33.89 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.654 0.781 . . . . 0.0 111.739 -162.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.2 p -140.39 136.95 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.498 -0.751 . . . . 0.0 110.003 -175.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.5 ttt -89.58 -76.73 0.41 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 120.634 0.254 . . . . 0.0 110.59 168.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -140.11 -62.93 0.5 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.11 0.964 . . . . 0.0 110.247 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -79.36 -54.82 5.57 Favored 'General case' 0 CA--C 1.569 1.699 0 C-N-CA 125.015 1.326 . . . . 0.0 113.827 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.3 t -96.78 123.91 49.31 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-N 119.783 1.174 . . . . 0.0 110.984 -164.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.3 p -102.15 114.09 27.92 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.864 0.865 . . . . 0.0 110.496 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.868 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 13.4 p -100.45 157.26 16.76 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 122.113 0.958 . . . . 0.0 113.174 170.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.4 m -130.43 118.03 20.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.832 -1.168 . . . . 0.0 109.223 174.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -107.42 111.76 24.23 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.15 0.58 . . . . 0.0 109.843 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 29.1 mm -96.47 123.65 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -120.35 127.86 52.71 Favored 'General case' 0 CA--C 1.573 1.856 0 O-C-N 121.939 -0.475 . . . . 0.0 111.467 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -85.14 141.28 30.31 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -75.97 121.04 22.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.296 -0.877 . . . . 0.0 113.065 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.42 99.16 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.48 -0.771 . . . . 0.0 110.272 -173.134 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.4 p . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 118.948 -0.548 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.26 9.9 p -77.88 39.44 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 CA-C-N 120.102 1.319 . . . . 0.0 114.136 171.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -113.56 -47.16 3.01 Favored 'General case' 0 CA--C 1.565 1.543 0 C-N-CA 125.848 1.659 . . . . 0.0 111.778 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -58.89 -29.32 66.94 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 171.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.8 mt -66.78 -13.14 61.12 Favored 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 117.31 2.337 . . . . 0.0 117.31 164.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -74.22 136.14 42.74 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 120.743 1.61 . . . . 0.0 112.689 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 149.09 -179.37 25.95 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 117.956 1.942 . . . . 0.0 117.956 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -92.16 116.43 28.93 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.316 -0.942 . . . . 0.0 110.196 169.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.2 m95 -123.88 108.63 12.66 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 122.794 0.438 . . . . 0.0 109.885 -166.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -94.83 129.57 41.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.419 -1.426 . . . . 0.0 114.078 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.4 tp -63.85 124.82 22.51 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.273 11.0 m -113.09 -65.97 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 123.938 0.895 . . . . 0.0 110.781 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -101.21 148.15 25.44 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.497 1.498 . . . . 0.0 111.533 171.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 39.2 p -133.63 83.08 2.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.662 -0.649 . . . . 0.0 110.615 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -91.35 96.96 10.81 Favored 'General case' 0 CA--C 1.564 1.512 0 CA-C-O 121.269 0.557 . . . . 0.0 110.452 -166.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.67 10.79 56.34 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 118.914 2.326 . . . . 0.0 118.914 -169.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -71.44 -47.38 56.14 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 -170.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -55.96 -43.94 78.01 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 169.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -53.64 -47.0 70.71 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 116.053 1.871 . . . . 0.0 116.053 167.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.436 ' CD1' ' SG ' ' A' ' 120' ' ' CYS . 67.9 t80 -53.35 -54.58 34.52 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 166.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.285 3.1 ptt? -69.38 -27.39 65.27 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 117.794 2.516 . . . . 0.0 117.794 174.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -54.17 -52.02 62.49 Favored 'General case' 0 CA--C 1.577 2.009 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 154.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -60.9 -38.75 86.8 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -52.5 -52.52 54.08 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.17 -1.581 . . . . 0.0 115.178 163.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.55 69.58 0.72 Allowed Glycine 0 N--CA 1.485 1.947 0 C-N-CA 124.403 1.001 . . . . 0.0 112.467 -169.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.1 t -127.57 130.52 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.92 164.39 49.65 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 117.418 1.727 . . . . 0.0 117.418 -177.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.4 pt -56.54 -47.46 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.87 94.86 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -67.31 -40.1 85.97 Favored 'General case' 0 CA--C 1.572 1.819 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.8 mtp180 -57.15 -46.49 82.68 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 163.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -55.97 -48.51 75.68 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 167.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 46.2 mtp -73.59 51.28 0.35 Allowed 'General case' 0 CA--C 1.583 2.232 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 165.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -170.69 -61.55 0.04 OUTLIER Glycine 0 N--CA 1.485 1.926 0 O-C-N 121.037 -1.039 . . . . 0.0 111.63 -171.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.5 -47.89 80.71 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 23.1 ptp -95.31 -6.8 40.41 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 117.212 2.301 . . . . 0.0 117.212 169.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.82 110.99 16.86 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 120.365 1.439 . . . . 0.0 111.041 168.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -110.17 93.22 14.91 Favored Pre-proline 0 CA--C 1.571 1.771 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.871 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.03 156.42 13.23 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.35 2.033 . . . . 0.0 116.811 -167.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -82.27 97.04 8.08 Favored 'General case' 0 CA--C 1.571 1.787 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.685 161.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.3 t -86.46 107.17 17.95 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 121.116 -0.99 . . . . 0.0 111.928 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.6 mt -91.81 106.51 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.5 mt -96.49 110.08 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -110.47 123.8 50.59 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 122.862 0.465 . . . . 0.0 110.303 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.7 p -116.57 94.3 4.56 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.558 0.743 . . . . 0.0 112.561 -171.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -91.12 74.64 6.28 Favored 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 122.306 1.05 . . . . 0.0 110.697 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.17 -84.33 0.12 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 116.47 1.348 . . . . 0.0 116.47 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -101.42 -46.33 5.03 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -76.56 116.06 16.89 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-N 119.213 0.915 . . . . 0.0 112.019 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.4 tt -132.09 112.79 12.64 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.481 0.712 . . . . 0.0 109.577 -161.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.3 m -104.58 126.21 51.46 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.597 -1.314 . . . . 0.0 111.366 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -113.2 101.18 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -104.02 105.82 16.13 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.171 0.988 . . . . 0.0 109.611 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.2 m -97.45 106.47 18.8 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.834 0.854 . . . . 0.0 110.791 -171.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -104.93 98.66 8.34 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 122.924 0.489 . . . . 0.0 111.179 -167.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.5 p -128.66 144.82 51.24 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.235 -0.916 . . . . 0.0 111.647 166.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.2 p -62.51 -44.77 95.55 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.9 mt -57.16 -43.57 82.65 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 165.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.8 tptt -155.29 125.33 6.63 Favored 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 119.348 0.976 . . . . 0.0 111.002 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.9 m -111.41 141.8 44.49 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.771 0.828 . . . . 0.0 110.251 173.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.4 t -144.7 158.46 43.77 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 121.824 0.821 . . . . 0.0 112.574 175.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -142.49 125.41 16.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.679 -1.263 . . . . 0.0 110.016 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -118.43 143.01 46.99 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.52 0.676 . . . . 0.0 111.126 163.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 75.1 m -112.18 110.99 21.56 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 122.104 0.954 . . . . 0.0 109.999 174.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 43.5 t -89.5 157.96 17.88 Favored 'General case' 0 CA--C 1.558 1.287 0 C-N-CA 124.862 1.265 . . . . 0.0 114.02 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 60.4 m -113.86 119.8 38.55 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 159.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.6 tp -70.62 132.03 44.83 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 123.856 0.862 . . . . 0.0 112.849 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 96.25 -53.09 1.58 Allowed Glycine 0 N--CA 1.49 2.288 0 O-C-N 121.198 -0.939 . . . . 0.0 114.503 -161.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -88.99 163.47 15.53 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-O 124.023 1.868 . . . . 0.0 114.139 -169.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -88.74 108.79 19.68 Favored 'General case' 0 CA--C 1.564 1.489 0 CA-C-N 112.445 -2.161 . . . . 0.0 110.147 169.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -103.12 175.9 5.32 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.855 0.836 . . . . 0.0 112.695 174.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -92.38 107.04 18.92 Favored 'General case' 0 CA--C 1.568 1.646 0 O-C-N 120.725 -1.234 . . . . 0.0 111.338 170.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -79.16 129.1 34.11 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 110.094 163.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.8 m -107.51 110.99 23.05 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 165.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.6 p -72.98 162.29 29.67 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.89 -43.83 59.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 167.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.2 -36.09 83.11 Favored 'General case' 0 CA--C 1.573 1.847 0 N-CA-C 117.783 2.512 . . . . 0.0 117.783 169.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 123.73 26.94 1.5 Allowed Glycine 0 CA--C 1.551 2.297 0 N-CA-C 118.09 1.996 . . . . 0.0 118.09 -176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 31.4 mtt85 -90.74 140.57 29.66 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 120.038 1.919 . . . . 0.0 110.94 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -93.3 109.26 20.8 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 162.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . 0.268 0.9 OUTLIER -113.9 119.83 38.62 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 118.704 0.684 . . . . 0.0 110.383 -179.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -73.2 99.54 2.87 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-O 122.087 0.946 . . . . 0.0 110.671 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.9 m -110.07 106.74 16.35 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.199 -0.938 . . . . 0.0 109.872 -156.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.276 7.2 p -88.83 118.56 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.827 -0.546 . . . . 0.0 110.719 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 5.8 m -106.26 123.62 48.33 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -131.71 131.01 42.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.501 -0.749 . . . . 0.0 111.344 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -85.54 133.69 34.06 Favored 'General case' 0 CA--C 1.569 1.711 0 O-C-N 121.384 -0.823 . . . . 0.0 112.084 171.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 t -132.5 131.4 41.59 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 123.103 0.561 . . . . 0.0 110.342 164.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.277 4.1 m-20 71.74 -86.72 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 161.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -143.04 52.27 0.64 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 123.439 0.542 . . . . 0.0 113.022 160.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -156.03 124.2 5.75 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.904 0.882 . . . . 0.0 111.086 -164.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.7 tp -95.46 110.69 22.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.588 -0.695 . . . . 0.0 110.207 172.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.8 t -91.87 105.87 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -99.92 106.98 18.85 Favored 'General case' 0 CA--C 1.565 1.539 0 C-N-CA 124.306 1.042 . . . . 0.0 109.466 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -97.45 102.0 13.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.489 -0.757 . . . . 0.0 111.358 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -83.43 125.59 31.86 Favored 'General case' 0 CA--C 1.565 1.53 0 C-N-CA 124.768 1.227 . . . . 0.0 111.163 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -128.15 117.3 21.34 Favored 'General case' 0 CA--C 1.573 1.855 0 CA-C-N 119.459 1.027 . . . . 0.0 111.001 -173.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -165.0 149.14 8.84 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.248 -0.908 . . . . 0.0 112.339 -171.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 48.55 41.94 18.09 Favored 'General case' 0 N--CA 1.512 2.641 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 158.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 60.8 30.11 71.96 Favored Glycine 0 N--CA 1.5 2.919 0 N-CA-C 119.55 2.58 . . . . 0.0 119.55 -166.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -142.32 138.53 31.34 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.439 1.095 . . . . 0.0 109.394 -166.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -129.81 126.84 39.04 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 121.491 0.662 . . . . 0.0 111.76 171.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.3 t -120.67 119.06 31.74 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.924 0.89 . . . . 0.0 109.572 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 71.6 p -93.01 128.29 38.83 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.184 0.594 . . . . 0.0 110.258 172.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 9.9 mm -112.93 116.55 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 169.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 31.4 m -99.79 98.54 9.34 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.43 -0.794 . . . . 0.0 109.046 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -90.84 99.12 12.21 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 -176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.22 147.52 50.58 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -163.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.97 121.46 31.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 112.64 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.328 40.2 mttt -106.16 -113.75 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.315 0.646 . . . . 0.0 109.92 169.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -84.85 51.85 2.26 Favored 'General case' 0 N--CA 1.503 2.219 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -168.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.95 31.76 79.0 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 117.516 1.766 . . . . 0.0 117.516 -156.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -137.27 135.0 36.76 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -169.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.5 tp -85.93 104.41 15.54 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.434 1.112 . . . . 0.0 108.957 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 87.1 t -99.99 109.42 24.82 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.447 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.7 t -102.98 106.62 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -168.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -116.62 99.16 6.95 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -164.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.8 p -93.31 157.12 16.4 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -174.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.57 130.41 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.852 -0.53 . . . . 0.0 109.986 158.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 4.9 ttt -102.81 -102.47 0.28 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 167.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -106.31 85.12 2.13 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.272 49.8 m-80 75.6 -43.19 0.49 Allowed 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 -169.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 83.4 t -82.29 123.43 38.24 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.698 0 O-C-N 121.294 -0.879 . . . . 0.0 111.193 -163.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.2 p -109.65 138.98 45.23 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.775 0.83 . . . . 0.0 112.539 -172.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.902 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 11.1 p -127.37 117.4 22.13 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 169.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 21.1 m -93.98 105.99 17.98 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 168.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . 0.263 0.0 OUTLIER -116.52 129.73 56.36 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 122.044 0.926 . . . . 0.0 111.843 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 24.3 mm -104.38 126.34 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 124.273 1.029 . . . . 0.0 109.299 -159.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -123.08 126.35 46.91 Favored 'General case' 0 CA--C 1.577 1.995 0 O-C-N 121.68 -0.637 . . . . 0.0 112.172 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -87.3 139.96 30.03 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.4 tttm -74.69 118.27 17.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.115 -0.99 . . . . 0.0 112.136 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.82 61.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.771 -0.58 . . . . 0.0 110.115 -176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.029 -1.045 . . . . 0.0 109.03 -158.276 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 119.045 -0.502 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.257 9.0 p -67.33 -33.75 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 161.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -52.55 -28.19 19.79 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 117.692 2.479 . . . . 0.0 117.692 167.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -51.69 -39.69 58.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 mt -72.92 -6.11 42.97 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 171.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -90.74 135.53 33.66 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 121.213 1.824 . . . . 0.0 112.483 -174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 151.01 -176.19 29.64 Favored Glycine 0 N--CA 1.485 1.912 0 CA-C-O 122.642 1.134 . . . . 0.0 114.503 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.0 ttm-85 -94.32 119.33 32.92 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.985 -0.608 . . . . 0.0 109.541 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -121.07 118.11 28.93 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 122.085 -0.385 . . . . 0.0 110.977 -166.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.2 ttm-85 -105.91 126.45 52.19 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.287 -0.883 . . . . 0.0 112.908 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.4 tp -71.03 124.56 24.68 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.714 0.769 . . . . 0.0 112.939 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.7 m -120.45 -55.51 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 124.117 0.967 . . . . 0.0 112.229 -175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -110.12 99.13 8.26 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 119.186 0.903 . . . . 0.0 109.173 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.0 p -113.87 95.68 5.44 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.081 0.953 . . . . 0.0 111.887 -174.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -107.41 123.41 48.35 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.139 -0.976 . . . . 0.0 111.736 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.76 66.34 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 119.657 2.623 . . . . 0.0 119.657 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -79.55 -41.2 27.75 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 120.29 2.045 . . . . 0.0 115.671 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.19 -43.23 74.2 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-N 120.443 1.474 . . . . 0.0 114.594 160.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -58.71 -47.97 82.73 Favored 'General case' 0 CA--C 1.57 1.713 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -51.27 -55.59 17.41 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 165.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -61.39 -23.5 65.84 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 171.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -64.53 -46.77 81.43 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 160.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -61.7 -37.59 84.71 Favored 'General case' 0 N--CA 1.502 2.155 0 CA-C-N 121.615 2.007 . . . . 0.0 115.116 167.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.1 mt -56.65 -51.75 67.52 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 164.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.54 72.33 1.05 Allowed Glycine 0 N--CA 1.486 1.979 0 O-C-N 121.428 -0.795 . . . . 0.0 112.538 -168.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.9 t -119.83 136.96 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -173.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.94 153.12 50.55 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 116.874 1.51 . . . . 0.0 116.874 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 30' ' ' ILE . 2.3 mp -59.11 -48.59 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 -168.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.4 -43.54 88.64 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 167.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.17 -45.98 91.25 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 170.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.9 mtm-85 -61.97 -45.07 95.25 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 167.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -55.34 -42.55 74.0 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 74.4 mtm -62.3 -44.96 95.3 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 165.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.23 -48.54 58.29 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.521 2.168 . . . . 0.0 118.521 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.65 -47.37 86.55 Favored 'General case' 0 CA--C 1.565 1.531 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -85.86 10.27 14.32 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 117.504 2.409 . . . . 0.0 117.504 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.29 131.38 35.29 Favored 'General case' 0 CA--C 1.558 1.265 0 O-C-N 120.463 -1.398 . . . . 0.0 113.65 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -109.42 74.77 0.69 Allowed Pre-proline 0 CA--C 1.575 1.94 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.849 167.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.46 158.22 48.23 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.723 2.282 . . . . 0.0 115.913 -172.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.05 98.24 10.3 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 162.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.2 t -88.84 101.62 14.22 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 122.063 0.935 . . . . 0.0 110.61 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -93.56 113.71 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.4 mt -113.68 125.08 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -152.17 133.95 14.78 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.778 -1.202 . . . . 0.0 109.5 171.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 19.7 p -100.41 123.9 45.23 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -82.62 74.9 9.55 Favored 'General case' 0 CA--C 1.576 1.943 0 CA-C-O 122.309 1.052 . . . . 0.0 110.18 162.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.63 -89.04 0.08 OUTLIER Glycine 0 N--CA 1.491 2.347 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 -175.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -88.49 -29.06 20.41 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 163.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -81.35 88.3 6.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 121.713 2.052 . . . . 0.0 111.841 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.8 tt -82.34 109.45 16.6 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-O 122.125 0.964 . . . . 0.0 110.108 -173.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.1 m -101.33 113.35 26.34 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.332 -162.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 37.7 mt -111.49 113.1 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -110.77 105.34 14.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.823 -0.548 . . . . 0.0 109.881 170.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.0 m -90.95 101.29 14.05 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.557 0.743 . . . . 0.0 109.204 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -94.25 117.92 30.82 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.622 0.769 . . . . 0.0 111.779 -175.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.9 t -154.49 139.47 17.31 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.704 0.801 . . . . 0.0 111.852 174.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 75.4 p -60.53 -34.56 74.29 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 165.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.8 -55.18 18.52 Favored 'General case' 0 CA--C 1.569 1.705 0 CA-C-N 119.486 1.039 . . . . 0.0 113.671 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.54 110.45 3.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.606 -1.309 . . . . 0.0 111.636 167.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.6 m -80.75 146.32 31.07 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.963 0.887 . . . . 0.0 111.287 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.5 m -155.55 136.61 13.74 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.299 -1.501 . . . . 0.0 109.594 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -142.32 146.32 34.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -158.42 150.87 21.97 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.145 0.795 . . . . 0.0 113.145 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.9 p -108.28 107.43 18.02 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.5 0.72 . . . . 0.0 110.943 169.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 29.0 p -99.07 115.29 28.65 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 121.588 0.708 . . . . 0.0 112.698 -177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.9 m -72.47 110.58 6.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.468 -0.77 . . . . 0.0 110.392 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.5 tp -71.05 110.31 5.66 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -162.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.12 -54.32 0.75 Allowed Glycine 0 CA--C 1.547 2.089 0 C-N-CA 123.594 0.616 . . . . 0.0 114.107 -159.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -96.91 -177.78 4.0 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 123.712 1.72 . . . . 0.0 113.579 -169.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -99.7 130.45 45.92 Favored 'General case' 0 CA--C 1.571 1.773 0 CA-C-N 113.857 -1.52 . . . . 0.0 112.6 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -123.06 -175.8 3.26 Favored 'General case' 0 CA--C 1.578 2.032 0 C-N-CA 125.168 1.387 . . . . 0.0 111.45 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -109.73 119.51 39.59 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.322 -1.486 . . . . 0.0 111.221 165.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -81.36 131.88 35.31 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 121.368 -0.832 . . . . 0.0 109.051 158.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 38.0 m -100.7 107.12 18.65 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 167.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.6 p -70.48 162.3 29.0 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -169.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.77 -31.91 59.33 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 166.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.17 -47.99 80.29 Favored 'General case' 0 CA--C 1.576 1.954 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.95 57.19 0.25 Allowed Glycine 0 N--CA 1.489 2.217 0 C-N-CA 124.104 0.859 . . . . 0.0 113.903 -172.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.9 mtp85 -131.31 124.32 30.18 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 -173.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.53 109.58 17.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.679 -0.638 . . . . 0.0 110.115 171.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.4 p -116.14 112.67 22.03 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.372 0.606 . . . . 0.0 111.018 -169.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -70.82 101.18 2.06 Favored 'General case' 0 CA--C 1.564 1.503 0 CA-C-O 122.279 1.038 . . . . 0.0 110.937 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.8 m -122.71 122.13 38.02 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.138 -153.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.42 125.81 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.651 -0.656 . . . . 0.0 111.476 170.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.9 m -99.5 123.63 43.95 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 173.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -133.0 133.91 43.76 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 118.8 0.727 . . . . 0.0 111.167 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -95.38 130.5 42.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.092 -1.005 . . . . 0.0 111.54 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.9 t -143.47 141.78 30.92 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 122.943 0.497 . . . . 0.0 110.281 165.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 62.11 35.28 15.84 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 160.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.11 25.86 74.87 Favored Glycine 0 N--CA 1.497 2.759 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -165.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -146.53 135.59 22.56 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-N 118.909 1.354 . . . . 0.0 113.249 -174.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.0 tp -87.12 112.69 22.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.432 -0.793 . . . . 0.0 110.479 166.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 67.0 t -93.68 103.11 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 173.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -101.6 103.86 14.7 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 123.49 0.716 . . . . 0.0 109.981 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -91.22 107.26 19.09 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.514 -0.741 . . . . 0.0 110.693 175.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -79.72 144.93 33.22 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.879 0.871 . . . . 0.0 111.975 169.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -143.24 124.69 14.75 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 123.651 0.781 . . . . 0.0 109.781 176.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 7.9 p90 -155.3 125.83 6.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.252 30.0 t70 49.14 45.26 23.21 Favored 'General case' 0 CA--C 1.584 2.252 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.63 26.37 66.62 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 119.612 2.605 . . . . 0.0 119.612 -169.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -131.96 130.83 42.0 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 118.628 1.214 . . . . 0.0 108.462 -171.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.58 150.09 38.58 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -166.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 32.4 t -139.17 131.93 29.11 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.594 -0.691 . . . . 0.0 112.079 164.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.8 p -104.22 109.4 21.21 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.102 0.561 . . . . 0.0 110.106 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.0 mm -95.61 104.04 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.7 m -100.52 102.5 13.7 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.644 -0.66 . . . . 0.0 109.81 -173.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 35.4 mtt180 -99.48 87.18 3.53 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.163 0.585 . . . . 0.0 110.454 -171.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -110.08 135.89 50.18 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -166.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.87 113.56 22.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.122 -0.986 . . . . 0.0 112.902 -173.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -141.23 133.56 28.16 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 123.491 0.717 . . . . 0.0 109.287 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 31.3 t70 60.11 39.24 19.83 Favored 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.13 13.25 41.21 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 119.635 2.614 . . . . 0.0 119.635 -163.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -133.16 144.18 49.71 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 118.628 1.214 . . . . 0.0 110.178 -162.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.0 tp -88.03 103.97 16.21 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.868 0.842 . . . . 0.0 109.734 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.6 t -89.92 103.09 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 -177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.5 t -96.57 98.23 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -98.09 106.83 19.18 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.3 p -106.7 121.92 45.31 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.538 0.335 . . . . 0.0 111.839 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 p -121.73 137.1 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.265 0.626 . . . . 0.0 109.936 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.7 ttt -81.08 -79.42 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 122.219 -0.301 . . . . 0.0 110.246 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -122.1 -60.73 1.55 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.272 0.629 . . . . 0.0 110.885 167.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -97.63 -43.13 7.33 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.58 127.69 53.41 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.525 0 CA-C-O 122.38 1.086 . . . . 0.0 109.9 -156.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 73.6 p -110.6 139.21 46.07 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.993 -167.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.857 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.8 OUTLIER -106.34 132.07 52.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.363 -0.835 . . . . 0.0 110.633 158.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.5 m -109.1 107.06 17.23 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 169.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -110.5 113.49 26.16 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.11 0.564 . . . . 0.0 110.835 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 10.5 mm -91.13 116.65 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.192 -0.943 . . . . 0.0 108.567 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -107.66 125.27 51.15 Favored 'General case' 0 CA--C 1.567 1.612 0 C-N-CA 123.206 0.602 . . . . 0.0 110.727 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -92.27 142.65 27.24 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -81.57 116.32 21.28 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.911 0.885 . . . . 0.0 112.207 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.3 t -101.29 93.13 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -171.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--O 1.256 1.396 0 C-N-CA 124.031 0.932 . . . . 0.0 110.451 -174.688 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 119.01 -0.519 . . . . 0.0 112.232 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.522 0.8 OUTLIER 63.31 -48.71 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 N-CA-C 118.755 2.872 . . . . 0.0 118.755 178.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -38.17 90.13 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 174.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -62.36 -25.69 68.05 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 167.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.7 mt -70.36 -7.57 43.88 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 164.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.83 142.59 31.41 Favored 'General case' 0 CA--C 1.564 1.481 0 CA-C-N 121.319 1.872 . . . . 0.0 112.79 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.56 171.19 18.56 Favored Glycine 0 N--CA 1.485 1.921 0 N-CA-C 115.425 0.93 . . . . 0.0 115.425 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.5 ttm-85 -86.98 103.63 15.52 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 165.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -101.66 101.86 12.45 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -170.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.33 142.58 27.62 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.588 0.755 . . . . 0.0 112.871 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.1 tp -71.01 127.96 34.35 Favored 'General case' 0 CA--C 1.571 1.776 0 O-C-N 120.677 -1.264 . . . . 0.0 113.446 -178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.95 -55.41 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 C-N-CA 124.082 0.953 . . . . 0.0 112.399 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -117.65 151.28 37.54 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 119.642 1.11 . . . . 0.0 110.567 173.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -144.47 59.22 1.33 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.997 0.903 . . . . 0.0 113.046 175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -75.6 119.62 19.89 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -167.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.52 -6.76 71.22 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 118.512 2.165 . . . . 0.0 118.512 -170.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.252 22.6 t80 -59.27 -31.6 69.25 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.816 2.524 . . . . 0.0 117.816 -174.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -52.46 -54.59 30.33 Favored 'General case' 0 CA--C 1.578 2.036 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 164.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.99 -45.39 83.0 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 170.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -58.65 -49.54 77.14 Favored 'General case' 0 CA--C 1.568 1.665 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 19.8 ptp -56.26 -37.65 70.06 Favored 'General case' 0 CA--C 1.575 1.918 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 167.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -63.62 -47.16 82.53 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 168.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -67.63 -37.95 83.21 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 170.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.1 mt -53.45 -35.94 61.06 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 117.576 2.435 . . . . 0.0 117.576 167.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.76 62.79 1.07 Allowed Glycine 0 N--CA 1.487 2.073 0 C-N-CA 123.438 0.542 . . . . 0.0 114.041 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.8 t -113.51 125.12 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -172.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.17 162.16 51.78 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 116.682 1.433 . . . . 0.0 116.682 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.457 HD12 ' H ' ' A' ' 30' ' ' ILE . 1.8 mp -55.62 -50.97 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 -168.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.09 -44.38 94.86 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 116.237 1.94 . . . . 0.0 116.237 169.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 79.4 mt -57.77 -41.7 82.54 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.734 1.754 . . . . 0.0 115.734 167.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 87.2 mtm-85 -60.81 -49.68 76.5 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 170.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.22 -46.92 87.19 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.5 ttp -53.64 -55.21 27.87 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 167.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.29 96.04 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 118.618 2.207 . . . . 0.0 118.618 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.06 -44.6 94.59 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.9 ptp -75.47 -22.15 57.48 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 117.734 2.494 . . . . 0.0 117.734 170.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.93 133.1 47.75 Favored 'General case' 0 CA--C 1.563 1.466 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -174.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -103.08 87.28 1.22 Allowed Pre-proline 0 CA--C 1.576 1.945 0 CA-C-O 118.57 -0.729 . . . . 0.0 110.749 166.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.96 142.96 22.63 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 C-N-CA 122.46 2.107 . . . . 0.0 115.168 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -95.44 103.34 15.21 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.18 168.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 50.6 t -81.14 101.11 9.44 Favored 'General case' 0 CA--C 1.562 1.407 0 CA-C-O 121.836 0.827 . . . . 0.0 110.903 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.1 mt -94.96 104.36 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -170.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 69.7 mt -102.83 130.78 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.258 7.7 t -136.84 149.88 47.98 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.776 -0.577 . . . . 0.0 112.312 159.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.4 t -141.83 128.74 20.63 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -68.68 -46.2 69.7 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 165.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 162.66 -78.68 0.15 Allowed Glycine 0 N--CA 1.484 1.863 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -171.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' HE3' HG22 ' A' ' 68' ' ' THR . 43.8 tttp -80.82 -26.07 37.35 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 160.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -88.63 138.75 31.14 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 122.842 2.565 . . . . 0.0 112.931 171.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -139.57 125.21 19.38 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 123.436 0.694 . . . . 0.0 110.463 174.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 33.5 m -109.37 133.86 52.53 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.376 1.07 . . . . 0.0 110.433 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 12.8 mt -123.12 119.68 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -103.94 110.17 22.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.685 -0.634 . . . . 0.0 110.145 163.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.7 m -83.71 99.17 10.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.277 -0.89 . . . . 0.0 109.102 170.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.44 125.74 35.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.663 0.744 . . . . 0.0 112.24 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.4 t -147.1 135.28 21.58 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 166.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.4 p -56.39 -26.05 51.79 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 116.61 2.078 . . . . 0.0 116.61 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.5 mt -73.47 -54.51 8.09 Favored 'General case' 0 CA--C 1.57 1.74 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 165.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.71 114.75 3.54 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 120.563 1.529 . . . . 0.0 111.612 173.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.4 m -84.19 141.46 31.02 Favored 'General case' 0 CA--C 1.575 1.928 0 C-N-CA 123.457 0.703 . . . . 0.0 111.851 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 t -134.17 145.48 49.29 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.156 -0.965 . . . . 0.0 111.27 164.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -135.47 133.99 39.11 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.776 -1.202 . . . . 0.0 111.849 -174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -144.92 160.62 41.02 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 122.061 0.934 . . . . 0.0 112.964 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 m -139.13 137.49 36.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.089 -1.007 . . . . 0.0 111.153 170.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 36.4 t -135.4 143.0 45.77 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 122.813 1.292 . . . . 0.0 112.635 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.428 HG22 ' HE3' ' A' ' 50' ' ' LYS . 35.2 m -91.48 115.41 28.02 Favored 'General case' 0 CA--C 1.575 1.913 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.195 171.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -64.38 134.4 54.53 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -166.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.95 -49.09 0.87 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 -154.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -98.47 164.98 12.05 Favored 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 123.595 1.664 . . . . 0.0 113.228 -163.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -110.58 128.76 55.8 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-N 113.676 -1.602 . . . . 0.0 111.396 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.416 ' HE1' ' SG ' ' A' ' 87' ' ' CYS . 11.7 p90 -129.62 166.14 20.35 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.46 105.99 10.1 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 122.055 0.931 . . . . 0.0 111.467 169.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -103.12 97.43 7.52 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 124.426 1.091 . . . . 0.0 109.104 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.8 m -80.06 109.12 14.21 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 121.821 0.82 . . . . 0.0 109.471 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.6 p -69.6 176.14 3.71 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -171.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.95 -43.28 29.13 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 168.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -60.76 -43.51 97.92 Favored 'General case' 0 CA--C 1.573 1.835 0 N-CA-C 117.268 2.322 . . . . 0.0 117.268 165.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.98 3.15 13.58 Favored Glycine 0 CA--C 1.556 2.634 0 N-CA-C 119.097 2.399 . . . . 0.0 119.097 -162.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.3 mtm-85 -69.89 128.54 36.72 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 120.979 2.389 . . . . 0.0 112.204 175.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -86.54 93.54 9.2 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.791 0.805 . . . . 0.0 108.9 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 p -99.28 125.24 44.87 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.712 -170.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -79.92 97.55 6.77 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.656 -1.278 . . . . 0.0 110.082 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.4 m -104.97 116.7 32.41 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.749 0.42 . . . . 0.0 110.408 -166.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.13 118.91 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.97 -0.456 . . . . 0.0 110.087 167.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.416 ' SG ' ' HE1' ' A' ' 73' ' ' PHE . 70.9 m -100.1 131.42 46.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.967 -0.458 . . . . 0.0 111.58 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -142.04 115.4 8.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.732 . . . . 0.0 110.265 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -78.96 129.4 34.44 Favored 'General case' 0 CA--C 1.57 1.721 0 O-C-N 120.977 -1.077 . . . . 0.0 111.6 166.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.9 t -146.1 142.78 28.86 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.251 0.62 . . . . 0.0 110.201 165.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 60.63 36.92 19.55 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 159.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.3 21.15 79.45 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 -166.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.52 139.62 24.33 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-N 119.02 1.41 . . . . 0.0 112.596 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 67.3 tp -96.61 115.13 26.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.413 -0.804 . . . . 0.0 110.615 171.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.9 t -89.28 103.35 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -98.31 95.56 7.46 Favored 'General case' 0 CA--C 1.57 1.716 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -96.72 99.74 11.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.152 -0.968 . . . . 0.0 110.095 -172.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -100.43 126.9 46.87 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -170.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -129.78 131.1 46.11 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.207 0.603 . . . . 0.0 111.388 -167.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -152.64 120.9 6.28 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.624 -1.298 . . . . 0.0 111.438 -177.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.6 t70 42.99 54.22 4.86 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 170.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.9 -45.43 2.69 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 117.902 1.921 . . . . 0.0 117.902 -169.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -89.92 141.78 28.32 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 118.19 0.995 . . . . 0.0 113.345 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -127.92 159.68 34.19 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.682 0.753 . . . . 0.0 112.991 173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 28.4 t -135.54 141.51 45.24 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.429 1.109 . . . . 0.0 112.01 162.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.6 p -106.38 109.99 22.08 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 mm -103.09 94.51 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -172.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 99.1 m -97.82 105.36 17.5 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.43 -0.794 . . . . 0.0 109.719 -172.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.9 mtp85 -103.23 89.33 3.37 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.234 0.614 . . . . 0.0 110.544 -167.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -105.86 138.25 42.37 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -168.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.4 123.88 33.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.233 -0.917 . . . . 0.0 113.209 -173.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -150.92 121.83 7.61 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.519 0.728 . . . . 0.0 109.266 -170.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.1 t70 61.06 28.2 17.97 Favored 'General case' 0 N--CA 1.514 2.754 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 57.58 33.12 66.09 Favored Glycine 0 CA--C 1.56 2.849 0 O-C-N 119.274 -2.141 . . . . 0.0 117.584 -158.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -133.08 131.17 40.27 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -174.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.2 tp -86.52 105.12 16.59 Favored 'General case' 0 CA--C 1.563 1.464 0 O-C-N 120.849 -1.157 . . . . 0.0 109.831 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.2 t -91.95 106.17 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.0 t -100.5 99.29 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -87.52 93.85 9.54 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 122.471 1.129 . . . . 0.0 108.499 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.938 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.3 p -104.82 97.39 7.28 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.7 -176.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.48 146.34 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-O 122.519 1.152 . . . . 0.0 109.927 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 11.3 ttt -97.71 -60.12 1.63 Allowed 'General case' 0 CA--C 1.565 1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 112.972 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.273 12.9 p30 -139.65 -92.99 0.17 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 171.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -81.28 -13.71 58.17 Favored 'General case' 0 CA--C 1.578 2.023 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 154.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 39.7 t -96.73 133.89 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 C-N-CA 124.72 1.208 . . . . 0.0 109.67 -166.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.0 p -132.76 146.83 52.17 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -152.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.938 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 6.1 p -136.92 121.12 17.91 Favored 'General case' 0 CA--C 1.563 1.468 0 O-C-N 121.533 -0.73 . . . . 0.0 110.711 158.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.2 m -97.76 101.7 13.28 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 173.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -108.9 110.53 21.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.701 -0.624 . . . . 0.0 110.306 -168.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 19.9 mm -94.39 124.69 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -122.28 120.38 33.92 Favored 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.04 0.536 . . . . 0.0 110.379 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -90.74 150.51 21.6 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.781 -1.199 . . . . 0.0 113.447 174.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -78.4 128.64 33.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.915 -1.116 . . . . 0.0 113.55 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 42.2 t -86.56 104.65 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 165.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 N--CA 1.487 1.395 0 C-N-CA 123.802 0.841 . . . . 0.0 110.543 178.451 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 122.04 0.924 . . . . 0.0 112.886 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.274 4.8 p -62.59 -32.15 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 177.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.53 -33.28 72.42 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 163.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -63.49 -33.83 76.44 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 165.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.8 mt -67.94 -4.06 11.85 Favored 'General case' 0 CA--C 1.581 2.151 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 164.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.05 122.02 25.68 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-N 121.955 2.161 . . . . 0.0 112.596 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.19 -179.95 34.44 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.3 ttm105 -93.84 108.06 19.88 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.159 0.584 . . . . 0.0 109.592 176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -109.94 107.56 17.52 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.376 -0.827 . . . . 0.0 110.49 -165.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -91.82 130.78 37.53 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.788 -1.195 . . . . 0.0 112.794 -177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 48.0 tp -64.18 125.53 24.84 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 170.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.261 5.6 m -126.86 -60.01 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 123.097 0.559 . . . . 0.0 112.246 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -104.21 137.23 42.43 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 119.332 0.969 . . . . 0.0 110.338 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.1 p -147.97 93.57 2.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.477 -0.764 . . . . 0.0 111.725 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.46 128.9 48.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.816 -0.552 . . . . 0.0 111.772 176.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.6 -1.12 88.58 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 118.901 2.32 . . . . 0.0 118.901 -168.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -71.53 -51.19 24.84 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.046 1.923 . . . . 0.0 115.555 -170.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.09 -38.53 62.64 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 167.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.71 -49.28 75.69 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 115.375 1.62 . . . . 0.0 115.375 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -54.24 -45.04 72.24 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 164.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 15.1 mtp -57.84 -42.75 85.02 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 169.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 69.3 mttt -55.5 -48.63 74.31 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.028 1.492 . . . . 0.0 115.028 163.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.8 -43.4 98.19 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 172.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.7 mt -55.23 -38.58 68.65 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 117.889 2.552 . . . . 0.0 117.889 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.6 55.93 1.13 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 114.883 0.713 . . . . 0.0 114.883 -165.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.6 t -102.69 118.57 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.682 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.65 165.29 41.08 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.468 HD12 ' H ' ' A' ' 30' ' ' ILE . 1.9 mp -57.94 -48.92 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -169.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.1 -42.46 98.56 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 116.304 1.964 . . . . 0.0 116.304 168.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.45 -42.39 91.85 Favored 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 167.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -57.53 -51.44 69.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 168.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -54.96 -54.3 44.53 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 169.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.2 ttp -52.93 -57.01 11.74 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.81 -40.85 90.3 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 118.926 2.33 . . . . 0.0 118.926 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.54 -51.79 52.75 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 169.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 12.3 ptt? -72.61 -30.36 64.29 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 117.66 2.467 . . . . 0.0 117.66 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.81 85.68 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.82 2.526 . . . . 0.0 117.82 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.338 62.7 pttt 47.25 66.39 5.71 Favored Pre-proline 0 CA--C 1.585 2.306 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.79 154.84 23.47 Favored 'Trans proline' 0 CA--C 1.561 1.827 0 N-CA-C 117.025 1.894 . . . . 0.0 117.025 -159.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.83 97.97 7.61 Favored 'General case' 0 CA--C 1.57 1.737 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.028 169.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.0 t -90.9 103.25 15.98 Favored 'General case' 0 CA--C 1.556 1.183 0 O-C-N 121.148 -0.97 . . . . 0.0 112.198 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.88 110.18 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.8 mt -97.95 114.8 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 171.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.2 m -134.63 117.91 16.62 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.5 t -121.82 118.54 29.25 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -172.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -86.19 60.24 6.12 Favored 'General case' 0 CA--C 1.576 1.951 0 CA-C-O 121.991 0.901 . . . . 0.0 111.557 170.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.64 -71.24 0.68 Allowed Glycine 0 N--CA 1.492 2.412 0 O-C-N 120.145 -1.597 . . . . 0.0 116.431 -170.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.3 mmmt -99.89 -46.23 5.44 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.76 105.35 10.99 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 121.053 1.752 . . . . 0.0 111.387 177.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.7 tt -100.66 111.61 23.87 Favored 'General case' 0 CA--C 1.561 1.365 0 CA-C-O 122.139 0.971 . . . . 0.0 109.832 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.1 m -93.98 116.48 28.92 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.891 0.876 . . . . 0.0 109.165 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.4 104.94 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 174.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.2 tttt -105.43 104.02 13.66 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.321 0.581 . . . . 0.0 109.683 171.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.7 m -89.25 100.16 13.01 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.851 0.86 . . . . 0.0 110.124 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.72 111.84 23.7 Favored 'General case' 0 CA--C 1.563 1.48 0 CA-C-O 122.088 0.947 . . . . 0.0 111.498 -173.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 84.1 p -148.51 153.12 38.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.628 -0.67 . . . . 0.0 110.601 157.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 62.6 p -61.98 -43.93 97.81 Favored 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 171.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.5 mt -61.97 -41.41 97.98 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 168.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -145.31 110.63 5.28 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.836 1.198 . . . . 0.0 110.72 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.53 118.81 36.14 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.2 p -139.72 142.61 36.83 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.009 -1.057 . . . . 0.0 111.91 -177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -139.14 133.44 31.48 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.742 -1.224 . . . . 0.0 111.821 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -146.65 147.31 30.9 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.678 0.751 . . . . 0.0 112.887 170.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 86.3 p -105.53 106.29 16.72 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.577 0.751 . . . . 0.0 110.846 172.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.3 p -94.45 125.23 38.96 Favored 'General case' 0 CA--C 1.56 1.334 0 CA-C-O 121.515 0.674 . . . . 0.0 112.33 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.5 m -77.8 123.17 26.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.318 -0.864 . . . . 0.0 110.068 177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.79 132.03 37.87 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -167.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.71 37.38 94.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 116.792 1.477 . . . . 0.0 116.792 -159.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.73 155.75 24.32 Favored 'General case' 0 CA--C 1.57 1.719 0 CA-C-O 122.429 1.109 . . . . 0.0 111.136 -171.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -109.73 121.56 45.5 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.787 -169.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -121.59 162.15 21.15 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.46 0.704 . . . . 0.0 112.502 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -75.84 106.08 7.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.783 -1.198 . . . . 0.0 110.971 166.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -90.98 116.54 28.86 Favored 'General case' 0 CA--C 1.561 1.372 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 169.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.8 m -86.74 93.97 9.39 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 169.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 73.8 p -68.94 159.93 31.77 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -169.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -43.46 -42.93 5.06 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 119.741 3.237 . . . . 0.0 119.741 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -72.99 -35.8 66.92 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 171.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 138.91 -14.9 3.32 Favored Glycine 0 CA--C 1.552 2.405 0 N-CA-C 117.94 1.936 . . . . 0.0 117.94 -166.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 66.7 mtm-85 -71.81 131.34 42.92 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 120.495 2.147 . . . . 0.0 112.651 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -81.97 110.5 17.29 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.205 0.602 . . . . 0.0 110.364 170.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.6 p -114.96 128.26 56.17 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.136 0.493 . . . . 0.0 109.816 -177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -78.82 92.25 4.83 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.759 0.79 . . . . 0.0 109.64 172.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.4 m -98.15 114.31 26.48 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.894 -164.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.264 12.5 p -91.74 117.11 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 122.019 -0.426 . . . . 0.0 110.82 171.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.6 m -101.5 112.99 25.71 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.136 -0.352 . . . . 0.0 111.849 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -123.0 125.56 45.47 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.656 -0.652 . . . . 0.0 111.114 -171.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -88.33 130.55 35.1 Favored 'General case' 0 CA--C 1.568 1.663 0 O-C-N 121.131 -0.98 . . . . 0.0 112.393 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.6 t -141.29 107.61 5.26 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.466 0.706 . . . . 0.0 110.218 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 45.34 70.45 0.35 Allowed 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 171.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.33 -0.03 60.82 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 119.896 2.718 . . . . 0.0 119.896 -171.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -129.39 126.58 39.15 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 119.985 1.892 . . . . 0.0 113.009 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 43.2 tp -93.39 108.82 20.42 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.614 -0.679 . . . . 0.0 110.621 171.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 94.1 t -90.29 107.93 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -101.11 98.37 8.81 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 124.284 1.034 . . . . 0.0 109.521 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -100.3 103.14 14.54 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 123.565 0.746 . . . . 0.0 110.477 -171.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -100.19 105.97 17.61 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 123.896 0.878 . . . . 0.0 111.215 -164.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -108.19 126.08 52.38 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.192 -0.942 . . . . 0.0 113.539 -166.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 5.1 p90 -154.71 141.02 18.64 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.221 -0.925 . . . . 0.0 110.606 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.2 t70 51.14 45.44 27.83 Favored 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 117.344 2.35 . . . . 0.0 117.344 159.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.18 19.9 68.63 Favored Glycine 0 CA--C 1.559 2.829 0 N-CA-C 120.238 2.855 . . . . 0.0 120.238 -167.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.6 mttt -137.01 150.06 47.87 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 119.141 1.471 . . . . 0.0 110.434 -167.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -124.18 147.56 47.91 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.249 0.547 . . . . 0.0 112.374 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 11.8 t -126.3 115.63 19.99 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 164.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.8 m -123.74 113.14 18.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.067 -1.021 . . . . 0.0 108.732 -160.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 38.0 mt -122.09 112.17 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -164.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 58.6 m -95.32 101.31 13.03 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.187 0.517 . . . . 0.0 109.666 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -93.08 101.17 13.48 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.376 0.67 . . . . 0.0 109.271 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 6.7 pttp -126.39 140.4 52.52 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -169.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.18 116.39 15.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 111.203 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.286 24.9 tptp -103.24 -126.72 0.22 Allowed 'General case' 0 CA--C 1.558 1.266 0 C-N-CA 123.081 0.552 . . . . 0.0 110.049 -177.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -91.9 64.93 4.81 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-O 122.231 1.015 . . . . 0.0 109.51 -165.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.66 -24.11 13.73 Favored Glycine 0 CA--C 1.556 2.645 0 N-CA-C 119.045 2.378 . . . . 0.0 119.045 -162.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -129.89 161.16 31.47 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 120.078 1.939 . . . . 0.0 112.306 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.5 tp -85.02 116.08 23.21 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.794 -1.191 . . . . 0.0 111.406 -173.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.7 t -91.81 120.2 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 64.0 t -110.34 100.01 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 -177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -95.66 102.67 14.49 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.966 0.906 . . . . 0.0 108.972 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 0.9 OUTLIER -98.85 150.89 21.42 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.1 137.29 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 123.221 0.608 . . . . 0.0 109.609 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.268 10.7 ttt -98.25 -77.35 0.51 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 0.0 111.118 163.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -123.48 -70.89 0.75 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.388 -0.82 . . . . 0.0 110.934 -177.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -99.58 -31.32 11.66 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 170.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.2 t -99.74 129.49 50.26 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 CA-C-N 120.365 1.438 . . . . 0.0 110.148 -164.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 74.8 p -106.34 154.89 20.14 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.328 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.881 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.6 OUTLIER -130.17 139.16 50.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.198 -0.938 . . . . 0.0 112.328 162.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.1 m -106.74 109.43 21.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 76.9 mtm180 -107.31 124.82 50.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.331 0.653 . . . . 0.0 110.996 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 14.8 mm -92.38 122.73 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 174.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -113.57 122.78 48.28 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 123.757 0.823 . . . . 0.0 109.973 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -92.72 137.92 31.94 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -77.52 111.95 13.78 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.72 0.772 . . . . 0.0 112.691 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.9 t -103.95 128.47 57.25 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.015 -1.053 . . . . 0.0 108.832 -175.514 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.5 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.503 1.2 p 64.79 -44.37 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 118.38 2.733 . . . . 0.0 118.38 167.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.37 -36.32 53.52 Favored 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 169.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -54.49 -37.06 64.85 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 169.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 43.9 mt -70.74 -2.58 15.13 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 171.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -81.72 134.84 35.5 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 121.258 1.844 . . . . 0.0 112.937 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.79 177.95 29.51 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 117.757 1.863 . . . . 0.0 117.757 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -93.43 102.54 14.77 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.096 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -108.34 101.84 11.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.954 -0.466 . . . . 0.0 110.018 -168.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -90.01 125.82 35.53 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.206 1.002 . . . . 0.0 113.45 -171.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.9 tp -64.41 125.09 23.53 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.41 -44.8 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 124.321 1.048 . . . . 0.0 113.162 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -128.49 155.66 44.49 Favored 'General case' 0 CA--C 1.573 1.846 0 CA-C-N 120.291 1.405 . . . . 0.0 111.834 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 54.5 p -153.62 84.38 1.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 0.0 111.365 175.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.14 138.76 39.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.513 -0.742 . . . . 0.0 112.758 176.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.45 23.32 70.19 Favored Glycine 0 N--CA 1.5 2.916 0 N-CA-C 119.693 2.637 . . . . 0.0 119.693 -174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -85.83 -43.62 13.14 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -168.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -50.13 -46.4 53.82 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 162.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -53.98 -48.98 69.81 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 115.629 1.714 . . . . 0.0 115.629 166.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -61.2 -47.47 85.98 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -64.05 -32.79 74.46 Favored 'General case' 0 CA--C 1.574 1.876 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 169.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -58.23 -48.44 80.39 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 121.507 1.958 . . . . 0.0 115.814 158.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -60.21 -40.6 90.7 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.5 mt -57.7 -50.3 73.64 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.764 1.764 . . . . 0.0 115.764 161.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.14 56.11 0.28 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 124.346 0.974 . . . . 0.0 115.134 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -112.31 130.28 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-N 117.607 0.703 . . . . 0.0 109.423 -171.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.51 159.87 51.8 Favored Glycine 0 CA--C 1.553 2.431 0 N-CA-C 116.909 1.524 . . . . 0.0 116.909 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.467 HD12 ' H ' ' A' ' 30' ' ' ILE . 1.8 mp -56.88 -48.65 81.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 -170.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.61 88.72 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 171.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.5 mt -65.09 -40.03 94.03 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 170.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.1 mtm-85 -63.69 -42.71 97.96 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 166.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -54.29 -49.82 68.72 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 166.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.6 ttp -52.86 -55.29 24.28 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 164.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.48 -37.73 67.8 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 119.766 2.666 . . . . 0.0 119.766 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.34 -51.04 61.32 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 172.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 22.2 ptp -77.28 -20.44 55.07 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 173.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.24 115.22 7.45 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 120.163 1.347 . . . . 0.0 112.184 165.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.93 84.42 3.46 Favored Pre-proline 0 CA--C 1.572 1.826 0 CA-C-O 118.416 -0.802 . . . . 0.0 110.139 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -76.86 151.49 31.46 Favored 'Trans proline' 0 C--N 1.372 1.772 0 N-CA-C 117.395 2.036 . . . . 0.0 117.395 -168.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -84.4 102.38 12.71 Favored 'General case' 0 CA--C 1.562 1.41 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.532 162.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.3 t -77.78 100.53 6.32 Favored 'General case' 0 CA--C 1.563 1.465 0 CA-C-O 121.951 0.881 . . . . 0.0 110.76 170.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.7 mt -95.93 101.68 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -170.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 81.2 mt -99.33 130.64 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.6 t -136.23 140.22 43.35 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.824 -0.548 . . . . 0.0 111.666 157.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 43.0 t -119.65 103.57 9.51 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.683 0.793 . . . . 0.0 111.961 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -82.65 75.85 9.53 Favored 'General case' 0 CA--C 1.572 1.798 0 CA-C-O 122.189 0.995 . . . . 0.0 110.686 170.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.7 -83.29 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 116.733 1.453 . . . . 0.0 116.733 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -105.59 -16.6 14.66 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.346 1.98 . . . . 0.0 116.346 173.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -101.9 116.97 33.86 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 122.214 2.279 . . . . 0.0 110.523 175.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -112.43 116.78 30.84 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.947 0.879 . . . . 0.0 109.938 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.6 m -99.4 125.74 45.16 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.987 0.915 . . . . 0.0 109.73 -176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 mt -119.4 112.3 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -98.14 109.83 22.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.764 -0.585 . . . . 0.0 109.941 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.5 m -90.9 103.3 16.03 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.435 -0.79 . . . . 0.0 109.456 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -101.43 116.85 33.72 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -171.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -143.24 140.47 30.69 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.087 0.555 . . . . 0.0 110.091 167.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.6 p -50.83 -44.33 59.25 Favored 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 173.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.7 mt -62.21 -40.72 97.05 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.34 103.84 1.25 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.47 1.487 . . . . 0.0 111.076 -175.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.0 m -90.25 145.67 24.82 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.991 0.901 . . . . 0.0 111.459 170.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.7 m -148.24 136.14 20.96 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.056 -1.653 . . . . 0.0 110.63 172.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -126.99 133.37 50.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.413 -0.804 . . . . 0.0 111.75 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -136.38 152.06 50.22 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 172.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.3 p -117.98 103.95 10.42 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.802 0.841 . . . . 0.0 109.905 170.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 24.1 p -95.34 152.1 18.68 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 64.8 m -91.37 130.81 37.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.824 -1.172 . . . . 0.0 109.582 168.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tp -69.53 131.31 44.49 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.392 -0.817 . . . . 0.0 112.878 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 72.13 -6.98 8.56 Favored Glycine 0 CA--C 1.553 2.458 0 N-CA-C 119.558 2.583 . . . . 0.0 119.558 -164.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.78 172.02 10.18 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-N 119.303 1.552 . . . . 0.0 112.007 -174.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -113.46 110.79 20.87 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.495 -156.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -105.76 160.75 14.98 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 123.655 0.782 . . . . 0.0 112.296 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.53 106.68 14.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 119.93 -1.731 . . . . 0.0 111.658 169.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -89.15 102.08 14.74 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 169.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 99.4 m -77.95 110.82 13.2 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 122.094 0.949 . . . . 0.0 109.593 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.1 p -75.43 134.38 40.9 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.797 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.86 -25.94 63.77 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 119.721 3.23 . . . . 0.0 119.721 -170.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.31 -27.08 65.98 Favored 'General case' 0 CA--C 1.584 2.261 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 163.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 159.51 -35.7 0.47 Allowed Glycine 0 N--CA 1.493 2.465 0 N-CA-C 118.715 2.246 . . . . 0.0 118.715 167.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.1 mtm-85 -75.07 136.54 41.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -163.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -93.55 115.04 27.53 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.173 0.989 . . . . 0.0 109.021 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.4 p -119.36 111.41 18.14 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.784 0.802 . . . . 0.0 111.168 -164.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -71.78 98.27 1.94 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.324 1.05 . . . . 0.0 110.581 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.4 m -112.99 108.47 17.39 Favored 'General case' 0 N--CA 1.483 1.176 0 O-C-N 121.285 -0.884 . . . . 0.0 109.922 -156.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.258 12.7 p -88.88 122.61 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 122.96 0.504 . . . . 0.0 111.382 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 55.7 m -105.51 88.11 2.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -169.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -102.18 119.34 38.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.541 -1.349 . . . . 0.0 111.941 -168.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -80.17 131.9 35.8 Favored 'General case' 0 CA--C 1.569 1.697 0 O-C-N 121.004 -1.06 . . . . 0.0 112.712 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.2 t -133.11 97.47 4.01 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.583 0.753 . . . . 0.0 110.414 177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.331 9.8 t70 68.6 -73.56 0.09 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 172.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -135.39 35.43 2.17 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 116.587 1.395 . . . . 0.0 116.587 167.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -153.93 139.24 17.58 Favored 'General case' 0 CA--C 1.561 1.381 0 CA-C-N 118.581 1.19 . . . . 0.0 112.957 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 tp -97.84 115.4 27.99 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.68 -0.637 . . . . 0.0 110.854 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.8 t -88.01 101.8 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -88.56 94.52 9.91 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 124.396 1.078 . . . . 0.0 109.009 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -96.1 98.13 10.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.534 -0.728 . . . . 0.0 112.159 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -71.05 137.42 48.95 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 124.062 0.945 . . . . 0.0 113.063 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -136.83 121.61 18.64 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 123.497 0.719 . . . . 0.0 109.931 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -158.35 127.1 5.5 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.626 -1.296 . . . . 0.0 111.11 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 54.08 37.83 27.77 Favored 'General case' 0 N--CA 1.505 2.323 0 N-CA-C 117.528 2.418 . . . . 0.0 117.528 164.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.72 -43.23 3.08 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 117.497 1.759 . . . . 0.0 117.497 -165.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -75.35 154.57 37.2 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -151.58 155.01 37.57 Favored 'General case' 0 CA--C 1.566 1.586 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.059 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 23.2 t -144.32 121.87 11.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.219 -0.926 . . . . 0.0 112.897 176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 34.1 p -86.55 131.34 34.2 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.46 -0.775 . . . . 0.0 111.278 168.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 45.2 mt -123.32 101.28 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 84.9 m -93.71 108.08 19.87 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.546 0.739 . . . . 0.0 110.056 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 mtp85 -97.98 87.91 4.1 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.268 0.627 . . . . 0.0 110.041 -171.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.18 142.32 29.22 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -171.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 120.86 27.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.505 -0.747 . . . . 0.0 112.366 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.274 41.0 tttm -134.85 -130.92 0.16 Allowed 'General case' 0 CA--C 1.569 1.706 0 O-C-N 121.979 -0.45 . . . . 0.0 112.03 -172.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -82.86 67.91 9.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.497 -1.377 . . . . 0.0 113.464 -161.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.95 16.82 57.72 Favored Glycine 0 CA--C 1.565 3.194 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 -157.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -137.86 131.75 31.5 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.098 1.359 . . . . 0.0 108.146 -164.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.3 tp -82.03 108.55 15.61 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-O 121.701 0.762 . . . . 0.0 109.259 164.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 53.6 t -96.67 110.13 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -175.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.0 t -103.29 100.35 10.25 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.499 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -167.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -95.62 108.43 20.7 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.545 1.138 . . . . 0.0 108.568 -171.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.2 p -126.42 129.35 48.57 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-O 121.921 0.867 . . . . 0.0 112.382 -158.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.2 p -141.37 146.29 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 C-N-CA 123.396 0.678 . . . . 0.0 109.964 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.265 18.6 ttt -118.24 -94.16 0.5 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.575 -0.703 . . . . 0.0 111.327 175.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -105.87 -52.21 2.85 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.758 0.823 . . . . 0.0 111.828 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -119.1 -39.32 2.93 Favored 'General case' 0 CA--C 1.57 1.748 0 C-N-CA 125.485 1.514 . . . . 0.0 112.142 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.4 t -87.39 121.8 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 O-C-N 121.274 -0.892 . . . . 0.0 110.364 -164.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 46.7 p -93.34 103.49 15.72 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.914 0.864 . . . . 0.0 110.204 165.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.729 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 18.5 p -85.69 160.94 19.43 Favored 'General case' 0 CA--C 1.57 1.739 0 CA-C-O 122.624 1.202 . . . . 0.0 111.537 163.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 42.8 m -150.44 119.01 6.48 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 119.26 -2.15 . . . . 0.0 108.031 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -125.78 132.24 52.32 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-O 121.836 0.827 . . . . 0.0 111.757 -168.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.2 mm -111.63 117.43 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -162.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -116.8 129.68 56.24 Favored 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 123.037 0.535 . . . . 0.0 111.216 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -106.63 146.91 30.14 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.9 tttm -71.94 106.09 4.1 Favored 'General case' 0 CA--C 1.57 1.742 0 O-C-N 121.046 -1.034 . . . . 0.0 113.106 -178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.6 t -100.05 85.56 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 C--O 1.256 1.446 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -171.456 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.3 m . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.6 p -63.02 -34.81 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.289 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 163.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -46.25 -34.06 4.14 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 117.86 2.541 . . . . 0.0 117.86 165.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -63.74 -22.19 66.78 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 117.228 2.307 . . . . 0.0 117.228 172.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.1 mt -74.89 -5.78 45.55 Favored 'General case' 0 CA--C 1.574 1.9 0 N-CA-C 117.722 2.49 . . . . 0.0 117.722 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.11 164.0 26.94 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -172.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.35 -179.37 24.68 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.42 0.928 . . . . 0.0 115.42 171.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 -84.22 126.16 32.88 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.153 -0.616 . . . . 0.0 111.201 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -126.31 113.81 17.42 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -89.75 134.9 33.93 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 32.0 tp -68.61 121.78 17.15 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 m -112.28 -55.15 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 123.952 0.901 . . . . 0.0 112.603 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -106.69 140.2 39.92 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 120.244 1.383 . . . . 0.0 110.228 168.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -136.5 79.7 1.78 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.728 1.252 . . . . 0.0 110.167 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -99.03 100.82 12.03 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.562 -0.712 . . . . 0.0 110.938 -158.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 96.5 22.07 20.08 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 118.309 2.084 . . . . 0.0 118.309 -167.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -74.27 -49.74 21.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -175.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -57.84 -37.9 74.69 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 167.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -57.73 -45.13 86.24 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 166.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -57.3 -49.36 76.35 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 164.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 73.5 mtm -60.76 -35.35 76.2 Favored 'General case' 0 CA--C 1.576 1.959 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 172.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -55.44 -55.23 34.09 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 161.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.413 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 31.6 tp10 -64.91 -36.6 84.89 Favored 'General case' 0 N--CA 1.501 2.125 0 N-CA-C 116.393 1.997 . . . . 0.0 116.393 175.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 91.8 mt -53.65 -44.03 69.27 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 159.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.8 56.59 1.22 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 115.028 0.771 . . . . 0.0 115.028 -172.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.3 t -98.02 137.71 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 123.327 0.651 . . . . 0.0 110.091 -172.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.26 153.33 48.64 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 116.414 1.326 . . . . 0.0 116.414 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.9 pt -57.37 -48.82 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 117.394 2.368 . . . . 0.0 117.394 -171.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.47 -38.58 87.76 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 167.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.2 mt -66.52 -37.68 85.56 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 169.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -57.65 -48.82 78.4 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 162.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -57.52 -48.97 77.84 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 169.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -50.7 -51.46 49.46 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 167.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -58.2 -46.17 93.13 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 118.116 2.007 . . . . 0.0 118.116 169.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.47 -45.02 94.94 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 117.1 2.259 . . . . 0.0 117.1 175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -79.81 -5.23 54.99 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 118.048 2.611 . . . . 0.0 118.048 173.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.05 135.8 39.93 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.25 92.33 2.09 Favored Pre-proline 0 CA--C 1.573 1.857 0 O-C-N 121.369 -0.832 . . . . 0.0 110.853 160.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.35 136.53 26.62 Favored 'Trans proline' 0 CA--C 1.559 1.774 0 CA-C-N 122.935 2.084 . . . . 0.0 114.548 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -100.54 101.93 12.98 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-N 114.227 -1.351 . . . . 0.0 108.392 167.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.2 t -74.76 111.96 10.49 Favored 'General case' 0 CA--C 1.558 1.274 0 O-C-N 121.627 -0.671 . . . . 0.0 110.689 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mt -104.88 105.16 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 83.9 mt -95.47 129.46 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.0 p -119.0 111.94 18.95 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 167.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 24.5 p -98.56 111.45 23.81 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -170.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -84.78 176.75 8.33 Favored 'General case' 0 CA--C 1.578 2.035 0 CA-C-O 124.106 1.908 . . . . 0.0 110.346 159.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.18 -40.99 92.52 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.402 2.121 . . . . 0.0 118.402 158.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -123.06 -47.77 2.02 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.709 1.744 . . . . 0.0 115.709 166.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -86.63 82.74 7.79 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 120.953 1.706 . . . . 0.0 111.518 -166.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 tt -96.61 112.7 24.34 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 120.885 -1.134 . . . . 0.0 109.221 -166.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.2 m -98.31 119.62 37.31 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.532 -0.73 . . . . 0.0 110.576 -168.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 46.3 mt -112.0 105.76 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -176.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -99.99 103.3 14.84 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.3 m -90.56 100.34 13.2 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.61 -0.681 . . . . 0.0 110.011 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -91.16 118.8 30.74 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.6 t -138.21 144.4 40.62 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.197 0.599 . . . . 0.0 110.017 171.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.5 p -75.78 42.32 0.23 Allowed 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.1 mt -152.91 -54.64 0.12 Allowed 'General case' 0 CA--C 1.572 1.821 0 C-N-CA 126.791 2.036 . . . . 0.0 108.654 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -143.44 117.0 9.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.024 -1.048 . . . . 0.0 110.838 167.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.3 m -84.75 120.08 26.01 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.676 -0.64 . . . . 0.0 109.61 166.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.0 p -111.97 103.03 11.23 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -102.72 128.95 49.23 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.35 0.66 . . . . 0.0 111.374 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -145.34 141.6 28.65 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.02 0.914 . . . . 0.0 112.954 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 93.8 p -97.47 105.29 17.41 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.739 0.816 . . . . 0.0 110.886 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 30.1 p -92.96 122.55 35.44 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.566 0.698 . . . . 0.0 111.99 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 63.0 m -85.72 115.41 23.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.581 -0.699 . . . . 0.0 109.483 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.27 118.29 19.62 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 123.541 0.737 . . . . 0.0 112.764 -166.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 71.1 55.17 8.16 Favored Glycine 0 CA--C 1.549 2.192 0 CA-C-O 119.108 -0.829 . . . . 0.0 114.945 -156.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.49 154.71 2.63 Favored 'General case' 0 CA--C 1.573 1.828 0 C-N-CA 124.429 1.092 . . . . 0.0 111.403 177.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -109.59 123.56 49.65 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.135 0.974 . . . . 0.0 112.916 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -127.65 164.48 21.95 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 124.17 0.988 . . . . 0.0 112.293 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -78.39 107.73 11.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 119.842 -1.787 . . . . 0.0 111.712 164.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -77.95 147.65 34.85 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.294 155.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.0 m -113.17 114.73 27.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.132 -0.98 . . . . 0.0 109.769 171.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 80.3 p -70.49 138.68 51.29 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 122.825 0.45 . . . . 0.0 111.62 175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.62 -29.45 10.98 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 120.309 3.448 . . . . 0.0 120.309 -175.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -84.15 -29.75 26.43 Favored 'General case' 0 CA--C 1.578 2.046 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 170.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.15 -37.39 0.37 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 119.96 2.744 . . . . 0.0 119.96 174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.7 mtm-85 -68.25 127.92 34.68 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 119.578 1.689 . . . . 0.0 112.675 -174.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -93.72 128.84 40.13 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.121 0.486 . . . . 0.0 110.744 171.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.8 p -120.44 126.01 49.36 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 120.998 0.428 . . . . 0.0 111.254 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -67.77 103.59 1.46 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.208 1.004 . . . . 0.0 111.319 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.3 m -114.53 101.38 9.07 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -158.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.299 14.6 p -87.05 106.17 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.404 0.621 . . . . 0.0 110.331 175.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 63.6 m -92.12 120.71 32.98 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -140.01 126.92 20.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.87 -0.519 . . . . 0.0 111.265 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -92.21 123.52 35.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.284 -0.885 . . . . 0.0 111.488 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 t -139.51 138.41 36.31 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.235 0.614 . . . . 0.0 109.832 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 61.79 36.93 15.91 Favored 'General case' 0 N--CA 1.506 2.334 0 N-CA-C 116.71 2.115 . . . . 0.0 116.71 162.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.7 12.63 83.68 Favored Glycine 0 CA--C 1.557 2.69 0 N-CA-C 119.354 2.502 . . . . 0.0 119.354 -165.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.35 125.47 24.53 Favored 'General case' 0 CA--C 1.561 1.392 0 CA-C-N 119.668 1.734 . . . . 0.0 112.743 -169.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.4 tp -86.4 106.9 17.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.529 -0.732 . . . . 0.0 110.945 171.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 66.7 t -92.95 108.66 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 123.854 0.862 . . . . 0.0 108.765 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -93.27 95.0 9.08 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 123.627 0.771 . . . . 0.0 110.024 173.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -91.08 102.49 15.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.665 -0.647 . . . . 0.0 110.751 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -94.56 126.07 39.61 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 124.699 1.2 . . . . 0.0 111.31 -172.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -125.26 122.81 38.0 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 123.341 0.656 . . . . 0.0 110.466 -169.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -157.38 118.81 3.67 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.807 -1.183 . . . . 0.0 111.32 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 45.14 51.34 9.1 Favored 'General case' 0 N--CA 1.505 2.318 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 168.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.5 -42.77 3.08 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 117.699 1.84 . . . . 0.0 117.699 -171.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.3 mttm -79.49 142.68 35.6 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.15 139.12 39.24 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.131 0.967 . . . . 0.0 113.063 173.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 45.7 t -120.68 130.08 53.95 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.548 174.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 67.5 m -117.7 117.07 28.36 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.097 -1.002 . . . . 0.0 108.746 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 15.2 mt -114.17 104.83 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -171.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.2 m -100.69 103.27 14.53 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.88 0.872 . . . . 0.0 109.752 -170.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.8 mtt85 -95.75 104.22 16.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.859 -0.526 . . . . 0.0 110.647 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -121.12 147.14 45.97 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.31 108.78 20.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.827 -0.546 . . . . 0.0 111.611 -171.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -137.02 129.3 29.72 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.343 0.657 . . . . 0.0 109.312 -174.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 26.0 t0 57.49 44.31 21.45 Favored 'General case' 0 N--CA 1.507 2.404 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -178.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 51.82 30.68 29.55 Favored Glycine 0 CA--C 1.559 2.801 0 N-CA-C 119.298 2.479 . . . . 0.0 119.298 -164.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -140.61 149.5 42.41 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.502 1.144 . . . . 0.0 109.537 -167.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.5 tp -92.5 106.12 18.17 Favored 'General case' 0 CA--C 1.561 1.393 0 CA-C-O 121.912 0.863 . . . . 0.0 109.857 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 82.7 t -93.31 106.07 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 76.3 t -102.65 90.52 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 -170.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -88.28 93.43 9.51 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.717 1.246 . . . . 0.0 110.062 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.636 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 9.4 t -80.64 135.87 36.12 Favored 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.823 170.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.0 p -143.6 123.22 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.598 -0.689 . . . . 0.0 109.452 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.413 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 26.8 ttt -117.02 103.97 10.79 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 122.859 0.464 . . . . 0.0 110.061 175.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.3 76.5 m-20 66.57 -93.57 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 123.868 0.867 . . . . 0.0 111.297 -174.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -111.89 0.44 16.12 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 162.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 97.9 t -92.95 105.86 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-N 120.49 1.495 . . . . 0.0 108.714 -167.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 53.6 p -90.74 140.1 30.1 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.404 1.097 . . . . 0.0 113.02 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.636 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -136.52 85.08 2.12 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -174.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 61.7 m -88.98 110.24 20.95 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.514 -1.366 . . . . 0.0 110.286 -171.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -114.4 108.34 16.76 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -168.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.7 mm -92.72 114.64 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -116.41 114.55 24.42 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.197 0.599 . . . . 0.0 109.718 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.68 152.39 22.55 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -175.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -77.83 127.43 32.38 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.483 -1.386 . . . . 0.0 114.696 -161.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.74 86.98 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.489 1.498 0 C-N-CA 123.928 0.891 . . . . 0.0 108.6 178.795 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 122.057 0.932 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.265 7.7 p -64.16 -32.47 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 175.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.47 -38.58 90.41 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 162.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -63.83 -38.37 90.86 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 20.5 mt -59.81 -23.79 63.62 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 163.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 107.64 3.93 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 121.188 1.813 . . . . 0.0 113.426 -171.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 159.64 -173.85 36.42 Favored Glycine 0 N--CA 1.489 2.215 0 CA-C-O 121.712 0.618 . . . . 0.0 114.628 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.7 ttm105 -94.92 137.84 33.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 122.009 -0.701 . . . . 0.0 110.981 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -135.55 116.82 14.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.55 -0.719 . . . . 0.0 110.994 -170.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.9 ttm105 -97.49 134.09 41.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.002 -1.686 . . . . 0.0 113.85 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.1 tp -67.82 123.51 20.75 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.254 4.4 m -113.06 -60.95 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 C-N-CA 123.818 0.847 . . . . 0.0 112.223 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -106.36 151.5 24.79 Favored 'General case' 0 CA--C 1.571 1.782 0 CA-C-N 119.688 1.131 . . . . 0.0 111.006 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -154.28 65.56 0.7 Allowed 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.07 136.11 54.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.485 -0.759 . . . . 0.0 112.988 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.74 2.59 51.69 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 120.086 2.794 . . . . 0.0 120.086 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.14 -34.03 72.54 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -50.27 -54.91 17.87 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 163.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -55.44 -49.57 72.1 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 170.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -57.25 -48.13 79.64 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 173.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 76.5 mtm -59.5 -35.27 73.82 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 168.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -64.17 -48.06 77.41 Favored 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 168.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HG3' ' SD ' ' A' ' 122' ' ' MET . 22.0 tp10 -66.0 -37.91 87.16 Favored 'General case' 0 N--CA 1.503 2.205 0 N-CA-C 116.39 1.996 . . . . 0.0 116.39 173.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.5 mt -53.1 -42.72 66.22 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 116.512 2.041 . . . . 0.0 116.512 159.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.31 53.93 1.21 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 115.137 0.815 . . . . 0.0 115.137 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -94.18 134.78 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 123.412 0.685 . . . . 0.0 109.788 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.95 154.09 49.83 Favored Glycine 0 CA--C 1.55 2.244 0 N-CA-C 116.274 1.27 . . . . 0.0 116.274 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.1 pt -55.55 -48.25 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 N-CA-C 117.398 2.37 . . . . 0.0 117.398 -172.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.61 -43.59 97.28 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mt -63.34 -40.0 96.1 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 170.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.9 mtp85 -55.2 -50.33 69.64 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 162.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -56.94 -47.7 80.04 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 170.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.0 mtm -58.0 -55.27 37.07 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 168.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.97 -36.97 76.16 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 119.41 2.524 . . . . 0.0 119.41 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.97 -54.42 30.84 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 172.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.8 ptp -85.9 -26.38 25.63 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 -175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.01 73.21 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 119.639 3.2 . . . . 0.0 119.639 -168.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt 63.32 66.42 1.16 Allowed Pre-proline 0 CA--C 1.581 2.141 0 C-N-CA 124.437 1.095 . . . . 0.0 113.612 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -73.25 143.77 35.99 Favored 'Trans proline' 0 CA--C 1.561 1.867 0 C-N-CA 122.513 2.142 . . . . 0.0 116.869 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.44 101.51 13.21 Favored 'General case' 0 CA--C 1.57 1.73 0 C-N-CA 124.271 1.028 . . . . 0.0 110.045 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -92.0 116.82 29.25 Favored 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 124.378 1.071 . . . . 0.0 112.108 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mp -92.13 119.67 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.9 mt -105.88 117.68 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 168.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.1 m -136.84 130.4 31.74 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 118.879 0.763 . . . . 0.0 111.046 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 27.6 p -105.98 137.45 43.87 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -169.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -132.34 86.37 2.32 Favored 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 121.882 0.849 . . . . 0.0 108.878 166.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.57 -99.26 0.45 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 177.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -85.15 -25.91 27.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 165.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -86.27 138.17 32.05 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 120.719 1.6 . . . . 0.0 112.001 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 67' ' ' CYS . 21.8 tp -133.7 112.98 11.85 Favored 'General case' 0 CA--C 1.561 1.382 0 CA-C-O 121.883 0.849 . . . . 0.0 108.787 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 85.6 m -87.29 119.57 27.68 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.491 0.717 . . . . 0.0 109.567 -175.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 35.6 mm -111.47 98.73 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 44.4 tttt -112.53 105.93 14.27 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.557 -0.714 . . . . 0.0 110.104 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.4 m -93.12 101.24 13.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.399 -0.813 . . . . 0.0 109.817 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -98.24 125.53 43.35 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.023 0.929 . . . . 0.0 110.704 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.7 t -137.66 160.8 38.19 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 122.41 1.1 . . . . 0.0 113.437 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 48.7 p -59.93 -48.25 82.45 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 163.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 42.7 mt -97.02 -38.86 9.61 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -146.52 105.37 3.85 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 121.187 1.812 . . . . 0.0 112.715 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.3 m -86.26 142.44 28.55 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.657 0.783 . . . . 0.0 111.545 172.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.5 m -157.89 143.09 16.8 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 120.235 -1.54 . . . . 0.0 109.839 175.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.51 154.77 51.27 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.285 -1.51 . . . . 0.0 114.229 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -150.65 142.1 23.42 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.553 0.692 . . . . 0.0 111.771 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.0 p -100.26 105.25 16.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 110.943 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 52' ' ' LEU . 20.9 p -93.79 164.51 13.1 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.5 m -130.43 128.46 41.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.2 111.72 9.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.292 -0.88 . . . . 0.0 111.982 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.37 -62.3 0.54 Allowed Glycine 0 N--CA 1.488 2.11 0 CA-C-O 120.055 -0.303 . . . . 0.0 113.488 -162.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -89.47 162.17 15.86 Favored 'General case' 0 CA--C 1.572 1.79 0 CA-C-O 124.068 1.89 . . . . 0.0 114.914 -164.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -106.95 132.86 52.42 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-N 112.563 -2.108 . . . . 0.0 111.394 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.89 160.38 40.45 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -169.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -70.99 113.53 8.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.176 -0.952 . . . . 0.0 112.48 167.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -102.2 95.82 6.57 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.1 m -76.96 92.07 3.65 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.341 1.067 . . . . 0.0 110.445 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.1 p -67.38 148.28 51.81 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.158 0.983 . . . . 0.0 113.293 -175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.07 -39.48 5.85 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 119.948 3.314 . . . . 0.0 119.948 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -75.95 -34.27 59.84 Favored 'General case' 0 CA--C 1.575 1.928 0 N-CA-C 116.652 2.093 . . . . 0.0 116.652 171.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.12 -25.32 0.61 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 119.563 2.585 . . . . 0.0 119.563 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.2 mtm-85 -72.65 119.74 17.3 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 120.124 1.962 . . . . 0.0 112.091 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.98 94.6 9.71 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 167.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.5 p -87.4 149.53 24.4 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.146 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -81.98 87.15 6.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.084 -1.01 . . . . 0.0 109.589 173.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 60.3 m -88.79 117.35 27.72 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.264 14.9 p -88.97 118.08 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 161.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.3 m -96.21 135.17 38.39 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 120.834 0.35 . . . . 0.0 111.655 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -148.05 121.7 9.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.804 -0.56 . . . . 0.0 109.611 177.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -83.24 123.39 29.53 Favored 'General case' 0 CA--C 1.568 1.637 0 O-C-N 120.852 -1.155 . . . . 0.0 111.259 169.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.5 t -133.31 110.4 10.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 63.69 56.19 1.58 Allowed 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 148.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.52 -25.94 11.83 Favored Glycine 0 CA--C 1.553 2.424 0 N-CA-C 118.453 2.141 . . . . 0.0 118.453 -164.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -119.77 135.0 55.03 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 119.909 1.855 . . . . 0.0 114.314 -167.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.9 tp -82.37 113.71 20.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 110.196 158.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.0 t -88.89 106.73 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 169.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -102.04 98.74 8.89 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 -99.2 96.31 7.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.638 -0.664 . . . . 0.0 110.561 -172.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -83.4 128.54 34.59 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.683 0.793 . . . . 0.0 111.572 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -130.32 123.94 31.16 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 123.107 0.563 . . . . 0.0 110.009 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.2 p90 -156.6 119.51 4.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.696 -1.252 . . . . 0.0 112.139 -176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.263 5.5 t70 34.31 58.16 0.64 Allowed 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 118.699 2.852 . . . . 0.0 118.699 175.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 95.72 -46.94 1.9 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 117.639 1.816 . . . . 0.0 117.639 -172.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.1 mttm -80.51 140.94 35.62 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -133.3 148.38 51.92 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 168.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.6 t -131.99 138.65 48.35 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.688 0.756 . . . . 0.0 111.802 171.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.8 p -111.7 98.11 7.19 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 mp -93.71 111.09 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -175.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.7 m -101.71 103.6 14.37 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.622 -0.673 . . . . 0.0 109.802 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.5 mtt180 -95.42 101.66 13.39 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.403 -0.811 . . . . 0.0 109.9 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.9 ptpt -132.91 156.9 46.39 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.91 123.22 26.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.449 -0.782 . . . . 0.0 111.877 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.09 114.19 24.19 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 159.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 57.89 51.16 9.39 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 166.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.47 -22.77 5.21 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 119.357 2.503 . . . . 0.0 119.357 -170.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -103.27 140.09 37.86 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 119.628 1.714 . . . . 0.0 111.21 -176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.9 tp -75.77 134.79 40.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.96 . . . . 0.0 110.361 169.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.4 t -129.29 106.78 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -176.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.6 t -92.73 102.94 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -111.28 105.18 13.76 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -171.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 3.1 p -97.08 145.79 25.64 Favored 'General case' 0 CA--C 1.557 1.226 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.51 128.66 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.412 0.625 . . . . 0.0 109.405 162.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.4 ' SD ' ' HG3' ' A' ' 25' ' ' GLU . 24.4 ttt -98.21 -88.44 0.32 Allowed 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.214 0.606 . . . . 0.0 110.253 171.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 26.3 p30 -129.89 78.16 1.83 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.052 0.941 . . . . 0.0 108.732 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.283 0.7 OUTLIER 69.4 -26.53 0.15 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 -162.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 82.6 t -75.78 116.41 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.884 0 CA-C-N 120.085 1.311 . . . . 0.0 109.835 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 63.3 p -120.11 134.76 55.17 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 123.638 0.775 . . . . 0.0 112.729 -170.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.3 p -120.93 128.01 52.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.962 -0.461 . . . . 0.0 111.993 167.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.3 m -109.25 111.45 23.04 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -112.14 118.76 36.24 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.57 0.748 . . . . 0.0 110.248 -172.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mm -96.71 130.47 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 123.455 0.702 . . . . 0.0 109.426 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -130.12 121.63 26.7 Favored 'General case' 0 CA--C 1.572 1.82 0 C-N-CA 123.483 0.713 . . . . 0.0 112.385 -165.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -95.32 134.88 37.61 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -80.25 125.29 29.67 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.104 -0.997 . . . . 0.0 113.369 -172.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 88.6 t -114.79 94.13 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -168.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 N--CA 1.49 1.549 0 C-N-CA 122.489 0.315 . . . . 0.0 110.207 -165.076 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 32.0 p . . . . . 0 CA--C 1.568 1.663 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.308 12.1 p -154.63 -58.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 120.155 -1.591 . . . . 0.0 110.186 153.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -60.3 -22.51 63.26 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 117.592 2.441 . . . . 0.0 117.592 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.1 mp0 -56.96 -27.18 60.97 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.7 2.111 . . . . 0.0 116.7 163.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.0 mt -72.21 -12.59 61.24 Favored 'General case' 0 CA--C 1.582 2.206 0 N-CA-C 116.592 2.071 . . . . 0.0 116.592 164.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.43 114.17 14.84 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 120.774 1.625 . . . . 0.0 113.398 -166.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 147.45 -166.55 28.63 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 115.401 0.92 . . . . 0.0 115.401 167.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -86.15 129.78 34.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 122.078 -0.66 . . . . 0.0 112.33 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -127.77 114.73 17.65 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.262 0.625 . . . . 0.0 110.301 -172.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -89.91 133.52 34.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.471 -1.393 . . . . 0.0 113.3 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.6 tp -72.88 131.07 41.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.8 -0.563 . . . . 0.0 112.439 175.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.277 3.3 m -116.68 -73.32 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 C-N-CA 123.369 0.668 . . . . 0.0 109.895 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -89.68 142.05 28.04 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 118.919 0.781 . . . . 0.0 110.802 172.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.4 t -148.02 51.96 1.03 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.5 pttt -79.84 134.81 36.34 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.44 -9.43 67.58 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 118.628 2.211 . . . . 0.0 118.628 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -70.69 -42.26 70.91 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -171.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -52.62 -51.66 58.98 Favored 'General case' 0 CA--C 1.579 2.06 0 CA-C-N 120.079 1.309 . . . . 0.0 114.339 167.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -59.74 -39.51 84.97 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 170.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -58.64 -46.3 87.4 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 169.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.427 ' SD ' ' HA ' ' A' ' 33' ' ' ARG . 16.3 ptp -62.03 -25.79 67.87 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 167.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -58.7 -52.92 63.65 Favored 'General case' 0 CA--C 1.576 1.96 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 157.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -62.03 -42.05 98.76 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.413 ' HA ' ' SD ' ' A' ' 122' ' ' MET . 69.3 mt -53.28 -38.77 63.39 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 169.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.04 64.62 0.99 Allowed Glycine 0 N--CA 1.486 1.989 0 C-N-CA 123.362 0.506 . . . . 0.0 113.751 -166.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.5 t -114.33 130.97 67.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.62 158.65 49.25 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.275 2.4 pp -55.26 -49.02 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.439 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -171.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.76 99.34 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 168.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.0 mt -59.06 -41.88 89.01 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 167.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.427 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 20.0 mtp-105 -61.27 -51.05 70.55 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 120.177 1.353 . . . . 0.0 114.546 170.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -54.74 -47.65 73.56 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 170.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.8 ttp -54.42 -60.67 3.03 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 165.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.91 -40.32 92.99 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 119.573 2.589 . . . . 0.0 119.573 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.59 -45.02 88.8 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.115 1.894 . . . . 0.0 116.115 172.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.9 ptt? -78.26 -29.87 48.29 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 172.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.74 123.22 18.79 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 119.833 1.197 . . . . 0.0 114.17 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -103.5 107.89 57.5 Favored Pre-proline 0 CA--C 1.571 1.773 0 CA-C-O 117.667 -1.158 . . . . 0.0 109.66 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -92.34 145.73 2.79 Favored 'Trans proline' 0 CA--C 1.563 1.948 0 CA-C-N 122.48 1.921 . . . . 0.0 116.455 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.74 100.53 13.0 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 114.493 -1.231 . . . . 0.0 108.641 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.9 t -91.32 112.83 24.9 Favored 'General case' 0 CA--C 1.557 1.217 0 O-C-N 120.875 -1.141 . . . . 0.0 112.559 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mt -84.14 104.26 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 60.5 mt -99.78 111.49 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 25.5 m -117.16 102.5 9.35 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.6 p -113.87 91.4 3.62 Favored 'General case' 0 CA--C 1.562 1.436 0 C-N-CA 123.737 0.815 . . . . 0.0 111.424 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -93.54 65.31 3.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.34 -0.85 . . . . 0.0 111.836 -171.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.36 -61.58 1.87 Allowed Glycine 0 N--CA 1.494 2.51 0 O-C-N 120.117 -1.614 . . . . 0.0 117.089 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.0 mmmt -121.52 -46.43 2.27 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -71.7 137.59 47.91 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 121.58 1.991 . . . . 0.0 112.925 174.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -138.52 112.31 8.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.468 -0.77 . . . . 0.0 111.226 -171.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.2 m -114.77 123.53 49.47 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.463 0.705 . . . . 0.0 109.715 -175.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 96.6 mt -115.77 109.03 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -114.23 101.61 9.35 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.996 0.918 . . . . 0.0 109.859 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.0 m -87.09 112.48 21.94 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 123.673 0.789 . . . . 0.0 110.391 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -112.3 100.63 8.95 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 118.773 0.715 . . . . 0.0 112.138 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.6 t -123.46 158.34 31.47 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 122.084 0.945 . . . . 0.0 111.192 163.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.2 p -63.29 -44.82 93.95 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 172.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.3 mt -64.07 -38.04 89.63 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 170.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.09 130.64 13.94 Favored 'General case' 0 CA--C 1.563 1.453 0 CA-C-N 119.938 1.244 . . . . 0.0 111.164 166.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 m -113.95 133.75 55.27 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 166.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 87.1 m -155.6 139.65 16.43 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.391 -1.443 . . . . 0.0 109.541 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.85 158.39 39.62 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -142.36 137.5 30.54 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-O 121.991 0.901 . . . . 0.0 110.451 161.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -109.93 105.26 14.36 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.028 0.931 . . . . 0.0 109.499 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 30.3 p -132.19 -152.51 0.5 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.54 0.736 . . . . 0.0 112.413 -168.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.39 147.42 50.48 Favored 'General case' 0 CA--C 1.571 1.761 0 O-C-N 120.957 -1.089 . . . . 0.0 111.306 -175.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.4 tp -78.58 148.01 33.49 Favored 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 124.221 1.008 . . . . 0.0 113.045 162.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.35 28.45 73.59 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 117.921 1.928 . . . . 0.0 117.921 -173.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -152.11 141.09 21.16 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-O 121.51 0.671 . . . . 0.0 109.437 -162.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -93.45 124.29 37.34 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.253 174.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -130.92 154.4 48.15 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 124.043 0.937 . . . . 0.0 111.721 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -80.12 101.31 8.69 Favored 'General case' 0 CA--C 1.569 1.704 0 O-C-N 120.95 -1.094 . . . . 0.0 111.512 172.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -85.32 94.28 8.91 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.997 0.919 . . . . 0.0 110.011 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 90.8 m -81.64 96.57 7.55 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.925 0.869 . . . . 0.0 110.478 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.9 p -71.14 152.42 43.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.381 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.01 -30.05 14.2 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 118.941 2.941 . . . . 0.0 118.941 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -54.81 -42.73 72.22 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 118.419 2.748 . . . . 0.0 118.419 162.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.63 -19.49 9.71 Favored Glycine 0 CA--C 1.553 2.466 0 N-CA-C 117.81 1.884 . . . . 0.0 117.81 -155.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.6 mtm-85 -74.47 112.1 10.31 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 121.122 2.461 . . . . 0.0 110.65 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.264 0.1 OUTLIER -102.34 99.48 9.56 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.655 0.74 . . . . 0.0 111.225 178.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 51.7 p -99.56 141.88 31.78 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.176 -163.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -77.49 88.49 3.84 Favored 'General case' 0 CA--C 1.564 1.487 0 O-C-N 121.263 -0.898 . . . . 0.0 109.581 172.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.7 m -97.2 114.52 26.25 Favored 'General case' 0 CA--C 1.559 1.297 0 O-C-N 121.694 -0.629 . . . . 0.0 109.503 -169.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.282 14.2 p -90.56 119.87 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.726 -0.609 . . . . 0.0 110.693 165.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 47.9 m -98.47 113.21 25.13 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 122.189 -0.319 . . . . 0.0 111.673 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -123.68 140.52 52.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.786 -0.571 . . . . 0.0 110.545 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -84.1 127.44 33.91 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 120.877 -1.139 . . . . 0.0 111.469 168.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.7 t -146.06 142.08 28.24 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.394 0.678 . . . . 0.0 110.278 168.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.81 43.58 9.38 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 116.816 2.154 . . . . 0.0 116.816 161.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.14 23.71 69.92 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 118.817 2.287 . . . . 0.0 118.817 -166.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.78 148.47 29.24 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 118.849 1.325 . . . . 0.0 113.608 -166.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.0 tp -89.42 112.33 23.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.559 -0.713 . . . . 0.0 110.254 162.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 p -89.36 125.23 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.733 0 CA-C-O 123.038 1.399 . . . . 0.0 109.819 168.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -114.18 103.02 10.69 Favored 'General case' 0 CA--C 1.559 1.302 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.732 -174.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -99.68 93.66 5.95 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 120.999 0.428 . . . . 0.0 111.254 -170.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -79.21 130.26 35.29 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.195 0.998 . . . . 0.0 111.953 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.4 121.72 26.45 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.713 0.688 . . . . 0.0 110.375 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -155.74 130.08 8.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.493 -1.379 . . . . 0.0 112.143 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 35.6 t70 51.65 50.09 19.49 Favored 'General case' 0 N--CA 1.507 2.399 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 166.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 63.48 16.34 58.38 Favored Glycine 0 CA--C 1.561 2.923 0 N-CA-C 120.342 2.897 . . . . 0.0 120.342 -167.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -131.84 150.47 52.14 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.917 1.359 . . . . 0.0 110.276 -173.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.54 151.73 44.98 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 19.5 t -141.96 138.7 32.13 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.059 0.933 . . . . 0.0 112.61 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.2 p -110.57 117.18 32.84 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.653 0.781 . . . . 0.0 109.262 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.6 mm -101.8 109.58 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.7 m -96.96 106.33 18.64 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.543 0.687 . . . . 0.0 109.255 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -98.17 84.01 3.19 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.552 0.741 . . . . 0.0 109.972 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -95.67 132.98 40.27 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -170.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.9 103.49 12.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.359 -0.838 . . . . 0.0 110.434 176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.258 45.6 tttm -117.9 -105.26 0.4 Allowed 'General case' 0 CA--C 1.559 1.301 0 O-C-N 121.933 -0.479 . . . . 0.0 111.071 -164.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.98 60.79 6.05 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-O 122.339 1.066 . . . . 0.0 112.67 -163.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 49.0 37.83 23.31 Favored Glycine 0 CA--C 1.558 2.775 0 N-CA-C 118.084 1.994 . . . . 0.0 118.084 -153.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.12 139.95 8.72 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -155.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.1 tp -86.34 117.23 25.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.773 -1.204 . . . . 0.0 110.163 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 71.8 t -103.57 108.68 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.49 104.94 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -170.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -106.28 107.65 18.77 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -169.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.873 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.8 p -101.62 144.71 30.02 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.6 p -146.73 145.2 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 C-N-CA 123.034 0.534 . . . . 0.0 110.234 166.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.413 ' SD ' ' HA ' ' A' ' 26' ' ' LEU . 23.5 ttt -110.74 -80.33 0.58 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.053 -1.029 . . . . 0.0 110.561 168.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -111.73 -66.22 1.1 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 118.679 0.672 . . . . 0.0 110.912 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -122.52 -14.25 7.83 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 170.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -97.98 134.0 37.92 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-N 121.403 1.911 . . . . 0.0 110.062 -174.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 77.5 p -112.47 153.2 27.78 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.912 0.885 . . . . 0.0 112.68 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.873 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.8 OUTLIER -130.76 142.17 50.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.311 -0.868 . . . . 0.0 112.391 161.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 32.6 m -109.64 108.61 19.08 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 171.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -104.23 109.72 21.65 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.617 0.767 . . . . 0.0 109.992 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 30.2 mm -89.26 124.11 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -120.06 118.53 30.85 Favored 'General case' 0 CA--C 1.567 1.631 0 C-N-CA 123.574 0.749 . . . . 0.0 111.124 -174.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -86.79 140.17 29.98 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.117 0.967 . . . . 0.0 112.94 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -78.29 134.78 37.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.266 -1.521 . . . . 0.0 113.62 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.9 95.76 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.981 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.253 9.0 p -67.88 -36.75 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-N 119.469 1.032 . . . . 0.0 113.675 166.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -58.58 -35.62 72.67 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 116.315 1.968 . . . . 0.0 116.315 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -64.42 -31.72 73.04 Favored 'General case' 0 CA--C 1.577 1.997 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 165.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.7 mt -66.78 -20.56 65.97 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 116.858 2.17 . . . . 0.0 116.858 163.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.2 117.25 22.19 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 121.285 1.857 . . . . 0.0 112.283 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.71 -178.7 39.78 Favored Glycine 0 N--CA 1.484 1.897 0 CA-C-O 122.098 0.832 . . . . 0.0 114.577 178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -84.89 114.8 22.38 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 123.019 0.528 . . . . 0.0 110.777 176.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -110.58 104.54 13.26 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.949 -0.469 . . . . 0.0 111.97 -171.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -82.73 124.26 30.07 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.365 -0.834 . . . . 0.0 112.424 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.8 tp -64.0 130.52 44.37 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.023 -1.048 . . . . 0.0 113.444 173.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.292 15.7 m -120.03 -63.7 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.617 173.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -92.76 149.81 21.06 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.431 1.469 . . . . 0.0 112.007 170.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.4 p -148.34 79.14 1.44 Allowed 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.912 166.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.44 119.13 19.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.554 -0.716 . . . . 0.0 110.936 -176.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.82 37.06 93.7 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 119.708 2.643 . . . . 0.0 119.708 -175.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -75.6 -42.61 51.45 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 175.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -51.94 -50.04 61.97 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 163.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -48.54 -54.58 13.87 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 168.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -55.25 -53.61 53.92 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 170.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 31.7 mtm -67.75 -34.05 76.06 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -47.82 -44.09 28.55 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 158.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.03 -41.72 81.7 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 169.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 77.3 mt -51.7 -50.42 60.53 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 165.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 131.44 40.39 0.23 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 118.079 1.992 . . . . 0.0 118.079 172.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.408 HG23 ' CG ' ' A' ' 33' ' ' ARG . 6.6 m -112.67 144.19 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.686 0 CA-C-N 118.724 1.262 . . . . 0.0 112.463 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.33 -179.64 50.96 Favored Glycine 0 CA--C 1.551 2.33 0 CA-C-O 122.814 1.23 . . . . 0.0 115.989 168.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 pt -57.23 -46.25 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 117.921 2.564 . . . . 0.0 117.921 -171.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.65 -40.63 95.61 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.02 -39.02 86.94 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.251 1.575 . . . . 0.0 115.251 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' CG ' HG23 ' A' ' 28' ' ' VAL . 20.5 mtm105 -63.78 -42.93 97.66 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 166.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -50.57 -50.49 53.47 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 161.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.6 mtp -72.3 58.37 0.39 Allowed 'General case' 0 CA--C 1.581 2.161 0 CA-C-O 123.028 1.394 . . . . 0.0 114.632 166.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 178.12 -63.72 0.08 OUTLIER Glycine 0 CA--C 1.543 1.809 0 O-C-N 121.349 -0.845 . . . . 0.0 111.56 -172.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.93 78.48 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 170.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . 0.26 19.2 ptt? -86.44 -17.89 33.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 170.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.07 121.24 22.51 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.172 1.351 . . . . 0.0 113.707 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -96.36 113.46 62.51 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.365 170.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -86.12 146.72 8.91 Favored 'Trans proline' 0 CA--C 1.561 1.828 0 C-N-CA 122.284 1.989 . . . . 0.0 115.052 168.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.57 97.97 10.86 Favored 'General case' 0 CA--C 1.567 1.633 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.265 158.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.8 t -87.65 104.64 16.72 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.139 0.976 . . . . 0.0 111.713 -174.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.0 mt -92.12 106.44 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -171.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 95.6 mt -96.86 128.99 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.4 m -156.46 130.49 8.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.274 -1.516 . . . . 0.0 109.938 171.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 16.8 p -118.75 130.01 55.57 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -97.72 93.03 6.16 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 121.802 0.81 . . . . 0.0 108.978 166.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.13 -75.46 1.14 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 116.67 1.428 . . . . 0.0 116.67 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -127.73 -30.63 2.51 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.69 100.99 5.59 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-N 120.909 1.686 . . . . 0.0 111.757 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 tt -93.84 116.19 28.64 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.341 1.056 . . . . 0.0 109.945 -177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.3 m -93.38 123.77 36.9 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.662 0.785 . . . . 0.0 109.62 -176.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 mt -115.79 107.38 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 174.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -103.68 103.5 13.42 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.646 0.779 . . . . 0.0 109.547 176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.6 m -94.18 100.17 12.3 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.322 1.049 . . . . 0.0 110.686 -171.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -100.09 102.55 13.9 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.081 0.553 . . . . 0.0 111.746 -165.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.8 t -138.7 139.85 38.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.478 -0.764 . . . . 0.0 111.451 173.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.0 p -63.93 -33.55 75.96 Favored 'General case' 0 N--CA 1.502 2.157 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.4 mt -67.26 -45.97 75.09 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 167.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -155.12 114.67 3.69 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 120.471 1.487 . . . . 0.0 111.376 170.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.8 m -94.24 141.05 29.01 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.586 0.708 . . . . 0.0 111.399 172.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.1 p -138.48 154.97 48.83 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 123.93 0.892 . . . . 0.0 111.112 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.0 146.13 32.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.351 -1.468 . . . . 0.0 112.906 172.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -152.44 151.62 30.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.586 -0.696 . . . . 0.0 112.807 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.0 p -110.54 115.73 30.13 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.503 0.721 . . . . 0.0 110.85 166.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.8 p -104.5 134.04 48.35 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.553 -0.717 . . . . 0.0 112.739 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 88.6 m -81.25 113.08 19.14 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.865 -1.147 . . . . 0.0 110.336 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.9 tp -69.85 120.83 16.18 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -172.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.7 -36.31 3.92 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 117.136 1.614 . . . . 0.0 117.136 -166.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.41 -169.92 2.62 Favored 'General case' 0 CA--C 1.575 1.905 0 CA-C-N 119.128 1.464 . . . . 0.0 111.953 -176.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 ptpp? -86.34 142.02 28.79 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -117.24 163.33 16.47 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.38 159.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -82.24 103.56 11.92 Favored 'General case' 0 CA--C 1.565 1.554 0 O-C-N 120.6 -1.312 . . . . 0.0 110.045 167.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -87.28 104.84 16.78 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 170.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 26.5 m -82.31 104.41 12.59 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 165.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.6 p -76.22 159.16 30.91 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -164.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.46 -38.93 56.19 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 165.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.276 2.7 t0 -44.35 -47.32 9.62 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 157.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 124.02 -31.75 4.41 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 116.765 1.466 . . . . 0.0 116.765 -164.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.7 mtm105 -62.44 137.01 58.17 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 119.8 1.8 . . . . 0.0 114.781 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -76.59 121.57 23.38 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.721 160.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.7 p -132.72 118.46 19.1 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.595 0.712 . . . . 0.0 111.015 -174.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -76.98 101.3 5.93 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.61 0.764 . . . . 0.0 109.442 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.1 m -116.51 107.15 14.4 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.461 -154.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.5 t -81.02 117.56 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 122.893 0.477 . . . . 0.0 109.871 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.4 m -101.46 108.79 20.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.137 -0.352 . . . . 0.0 111.326 178.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -126.24 124.19 39.85 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.777 -0.577 . . . . 0.0 111.446 -175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -85.13 126.85 33.96 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.455 -0.778 . . . . 0.0 111.567 168.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.1 t -143.02 137.04 29.0 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 122.994 0.518 . . . . 0.0 109.773 165.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.83 39.49 16.98 Favored 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 159.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.62 20.27 79.51 Favored Glycine 0 CA--C 1.557 2.669 0 N-CA-C 119.23 2.452 . . . . 0.0 119.23 -166.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.83 131.63 21.42 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 119.295 1.548 . . . . 0.0 112.922 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.9 tp -94.45 109.92 21.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.667 -0.646 . . . . 0.0 110.645 171.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.18 108.71 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.675 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -95.39 102.4 14.2 Favored 'General case' 0 CA--C 1.568 1.661 0 C-N-CA 124.166 0.986 . . . . 0.0 108.961 173.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -102.04 93.23 5.14 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.404 0.681 . . . . 0.0 111.997 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -77.07 117.07 18.28 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.786 0.834 . . . . 0.0 112.569 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.5 135.56 50.32 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.867 0.842 . . . . 0.0 110.12 166.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -152.28 117.22 5.15 Favored 'General case' 0 CA--C 1.565 1.536 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.256 27.5 t70 49.87 45.06 25.23 Favored 'General case' 0 CA--C 1.587 2.367 0 N-CA-C 117.141 2.275 . . . . 0.0 117.141 177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 61.93 27.1 68.09 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 119.894 2.718 . . . . 0.0 119.894 -170.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -135.43 100.05 4.4 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 -172.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -115.3 142.68 46.36 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 -165.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.5 t -117.31 137.28 52.53 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.802 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.2 p -114.69 109.15 17.77 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.4 mp -103.4 98.11 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -173.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 76.6 m -94.0 105.57 17.57 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.598 0.759 . . . . 0.0 109.975 -175.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 -94.3 88.48 5.57 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 123.627 0.771 . . . . 0.0 110.156 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -105.16 137.42 42.96 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -168.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 116.81 29.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.9 -1.125 . . . . 0.0 112.81 -172.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.75 84.27 3.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.591 -0.693 . . . . 0.0 109.714 167.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.276 25.1 m-20 7.5 62.57 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.298 0 N-CA-C 120.608 3.559 . . . . 0.0 120.608 -173.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 138.78 -49.38 0.83 Allowed Glycine 0 N--CA 1.49 2.275 0 CA-C-N 114.515 -1.22 . . . . 0.0 115.503 -167.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -112.77 138.55 49.44 Favored 'General case' 0 CA--C 1.566 1.592 0 CA-C-N 117.802 0.801 . . . . 0.0 110.557 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.1 tp -93.19 116.32 28.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.889 -1.132 . . . . 0.0 109.6 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 79.9 t -93.95 109.57 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 80.5 t -98.8 105.55 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -96.67 100.78 12.32 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.746 0.819 . . . . 0.0 109.378 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.7 p -97.31 131.59 43.86 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.62 -0.675 . . . . 0.0 111.169 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.6 p -134.87 123.67 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.836 -0.54 . . . . 0.0 110.598 176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 10.6 ttt -115.55 114.76 25.39 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 164.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.7 m120 55.23 55.92 7.01 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 173.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.297 40.3 m-80 76.65 -30.16 0.18 Allowed 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 117.16 2.281 . . . . 0.0 117.16 -171.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 88.0 t -86.42 123.63 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 CA-C-N 120.885 1.675 . . . . 0.0 109.949 -171.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 72.4 p -113.6 144.28 43.16 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -163.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 1.009 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.5 OUTLIER -111.93 136.56 51.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.426 -0.796 . . . . 0.0 110.939 151.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 27.1 m -114.4 111.18 21.03 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 170.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -114.69 116.18 28.29 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.741 0.416 . . . . 0.0 110.327 -170.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.3 mp -91.86 128.17 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -122.35 140.55 52.54 Favored 'General case' 0 CA--C 1.569 1.69 0 C-N-CA 123.77 0.828 . . . . 0.0 111.879 -177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.86 135.84 42.71 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -76.78 113.08 14.05 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.074 -1.016 . . . . 0.0 111.641 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.0 t -106.07 92.86 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -173.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.017 -174.363 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.0 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.478 5.3 p 53.89 -62.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.39 0 N-CA-C 118.704 2.853 . . . . 0.0 118.704 176.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -52.22 -42.64 63.74 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -67.85 -18.79 64.93 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 172.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 38.1 mt -71.54 -9.69 58.61 Favored 'General case' 0 CA--C 1.577 1.999 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 160.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.37 140.64 29.33 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 121.541 1.973 . . . . 0.0 112.944 -171.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 144.81 -177.82 23.05 Favored Glycine 0 N--CA 1.488 2.162 0 CA-C-O 122.145 0.859 . . . . 0.0 114.607 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -87.9 121.11 29.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.984 -0.715 . . . . 0.0 110.083 169.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -124.86 110.6 14.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.78 -0.575 . . . . 0.0 110.122 -169.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.3 ttm105 -98.56 134.7 41.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.831 -1.168 . . . . 0.0 113.251 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 40.5 tp -65.91 133.0 49.97 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.28 21.7 m -124.35 -60.5 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 C-N-CA 123.722 0.809 . . . . 0.0 112.281 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -89.43 148.35 23.52 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 120.346 1.43 . . . . 0.0 111.298 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 m -148.7 58.15 1.05 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.215 1.007 . . . . 0.0 113.218 165.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -72.88 123.5 23.53 Favored 'General case' 0 CA--C 1.568 1.64 0 O-C-N 121.294 -0.878 . . . . 0.0 113.083 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.77 2.58 81.43 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 118.85 2.3 . . . . 0.0 118.85 -167.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -72.12 -42.61 65.86 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.406 2.103 . . . . 0.0 116.65 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -56.62 -49.65 74.32 Favored 'General case' 0 CA--C 1.578 2.057 0 CA-C-N 120.962 1.71 . . . . 0.0 114.563 170.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -49.59 -44.93 47.41 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 164.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.411 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 74.5 t80 -59.71 -52.27 66.23 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 170.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.294 18.4 ptt? -70.31 -24.34 63.0 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 118.647 2.832 . . . . 0.0 118.647 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -63.15 -39.84 95.83 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 121.523 1.965 . . . . 0.0 115.303 154.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -72.64 -40.01 66.73 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.0 mt -50.29 -41.81 51.44 Favored 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 117.989 2.588 . . . . 0.0 117.989 168.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.88 66.43 0.8 Allowed Glycine 0 N--CA 1.489 2.214 0 C-N-CA 123.443 0.544 . . . . 0.0 113.648 -168.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -128.82 133.53 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -171.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.94 155.3 52.75 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 116.483 1.353 . . . . 0.0 116.483 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.262 2.7 pp -54.14 -44.07 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 N-CA-C 117.898 2.555 . . . . 0.0 117.898 -173.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.66 -45.99 88.14 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 116.107 1.892 . . . . 0.0 116.107 168.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.36 -42.01 98.0 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 167.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 mtp-105 -59.67 -47.51 85.35 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 120.352 1.433 . . . . 0.0 114.398 170.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.36 -46.83 88.54 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 169.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 36.1 ttp -52.48 -55.11 24.22 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 165.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.86 -38.64 74.91 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 119.236 2.455 . . . . 0.0 119.236 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.08 -45.95 91.21 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 169.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.4 ptp -77.24 -27.36 53.27 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.21 108.94 5.63 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-N 119.906 1.23 . . . . 0.0 113.731 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -102.3 93.96 4.42 Favored Pre-proline 0 CA--C 1.574 1.894 0 CA-C-O 118.196 -0.906 . . . . 0.0 110.649 168.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.84 153.31 25.71 Favored 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 122.474 2.116 . . . . 0.0 115.59 -173.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -87.69 105.27 17.25 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 121.643 0.735 . . . . 0.0 109.302 165.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.2 t -95.02 110.5 22.41 Favored 'General case' 0 CA--C 1.56 1.344 0 O-C-N 120.909 -1.119 . . . . 0.0 111.735 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mp -89.47 106.83 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.0 mt -95.63 126.94 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.1 m -150.75 128.84 11.85 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.628 -1.295 . . . . 0.0 109.846 176.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.6 t -120.7 114.23 21.37 Favored 'General case' 0 CA--C 1.561 1.367 0 CA-C-O 121.899 0.857 . . . . 0.0 112.019 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -79.95 76.08 6.67 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 122.054 0.93 . . . . 0.0 110.45 167.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.73 -82.25 0.09 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 -176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -105.23 -16.43 14.77 Favored 'General case' 0 CA--C 1.569 1.71 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 167.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -88.81 106.06 18.13 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 120.982 1.719 . . . . 0.0 109.9 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 tt -103.49 116.01 31.59 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.29 -0.881 . . . . 0.0 111.344 -168.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 94.9 m -108.37 128.46 54.79 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.041 0.936 . . . . 0.0 109.493 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -124.73 122.18 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -109.98 111.96 23.67 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.055 0.542 . . . . 0.0 110.073 168.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.8 m -87.87 99.53 12.2 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 172.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -86.19 116.91 24.68 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.153 0.978 . . . . 0.0 111.594 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.1 t -147.06 135.05 21.42 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.85 0.86 . . . . 0.0 109.764 169.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 64.5 p -59.32 -30.37 68.31 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 165.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.3 mt -71.58 -53.06 14.98 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 170.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -153.04 100.04 2.45 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 120.284 1.402 . . . . 0.0 110.593 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.6 m -77.83 146.1 35.93 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.012 0.91 . . . . 0.0 111.669 171.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.7 m -152.16 134.01 14.84 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.091 -1.631 . . . . 0.0 109.857 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -131.5 138.77 49.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.369 -0.832 . . . . 0.0 111.577 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -141.91 152.63 43.73 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 174.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 89.7 p -135.78 109.49 8.05 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.924 0.89 . . . . 0.0 110.029 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.2 t -134.82 154.21 51.72 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.556 0.742 . . . . 0.0 112.242 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.92 140.07 47.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.433 -1.417 . . . . 0.0 110.603 175.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.9 tp -68.89 118.98 12.51 Favored 'General case' 0 CA--C 1.579 2.088 0 O-C-N 120.69 -1.256 . . . . 0.0 111.442 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 107.35 -40.92 2.34 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 116.988 1.555 . . . . 0.0 116.988 -157.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -82.8 154.86 24.51 Favored 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 125.194 1.398 . . . . 0.0 113.416 -176.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.3 152.64 21.3 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 166.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -138.62 162.47 34.54 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.761 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.84 100.58 2.93 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.878 0.847 . . . . 0.0 111.519 166.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 -92.81 98.27 11.29 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.6 m -79.79 95.73 6.09 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 163.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.2 p -61.75 170.65 1.91 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -160.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.92 -41.04 58.43 Favored 'General case' 0 CA--C 1.572 1.803 0 N-CA-C 116.791 2.145 . . . . 0.0 116.791 164.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -50.43 -61.35 2.23 Favored 'General case' 0 CA--C 1.574 1.882 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 159.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.67 -30.49 3.1 Favored Glycine 0 N--CA 1.493 2.471 0 O-C-N 120.588 -1.32 . . . . 0.0 116.303 -151.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -60.56 134.95 57.58 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 118.703 1.252 . . . . 0.0 112.63 173.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -85.81 129.15 34.91 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 121.344 0.592 . . . . 0.0 111.197 168.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 69.4 p -130.29 136.86 49.6 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.681 0.753 . . . . 0.0 109.217 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -87.62 96.16 10.31 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 120.692 -1.255 . . . . 0.0 108.956 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.9 m -103.64 115.61 30.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.641 -0.662 . . . . 0.0 110.65 -161.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.5 p -85.44 124.5 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 CA-C-N 118.696 0.68 . . . . 0.0 112.024 173.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 36.1 m -94.0 111.85 23.61 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.376 0.67 . . . . 0.0 111.398 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -139.76 124.76 18.63 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 119.828 1.194 . . . . 0.0 112.847 -172.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -95.2 130.36 41.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.136 -0.977 . . . . 0.0 111.71 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.8 t -147.69 136.33 21.81 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.222 0.609 . . . . 0.0 110.16 170.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 62.72 33.72 15.27 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 117.284 2.328 . . . . 0.0 117.284 160.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.93 -13.77 55.38 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 -164.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -109.78 128.62 55.42 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-N 119.644 1.722 . . . . 0.0 113.167 -176.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.7 tp -86.7 108.5 18.69 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.416 -0.803 . . . . 0.0 109.637 161.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.6 t -91.75 112.19 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.476 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.69 98.73 10.7 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 169.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 -91.12 99.39 12.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 111.355 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -70.02 125.3 26.37 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.852 0.861 . . . . 0.0 112.05 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -124.37 117.22 23.99 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -150.18 120.54 7.36 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.683 -1.261 . . . . 0.0 112.645 -176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.255 39.1 t70 50.61 44.28 27.43 Favored 'General case' 0 CA--C 1.585 2.317 0 N-CA-C 116.712 2.116 . . . . 0.0 116.712 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.91 -30.32 2.93 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 119.06 2.384 . . . . 0.0 119.06 -166.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -83.63 144.78 29.2 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 124.696 1.198 . . . . 0.0 112.79 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -140.52 156.82 46.2 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 34.1 t -146.94 142.28 27.4 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.445 0.698 . . . . 0.0 111.663 173.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.0 p -102.04 113.5 26.79 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.279 -0.888 . . . . 0.0 110.864 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 19.4 mm -88.19 95.68 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 40.1 m -96.67 92.32 6.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.554 -0.716 . . . . 0.0 110.53 -167.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -90.57 97.7 11.34 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.302 0.641 . . . . 0.0 111.673 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -119.2 137.34 53.7 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.725 0.81 . . . . 0.0 112.742 -176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.47 121.57 24.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.26 -0.9 . . . . 0.0 111.613 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.76 -144.67 0.39 Allowed 'General case' 0 CA--C 1.562 1.404 0 CA-C-O 121.231 0.539 . . . . 0.0 111.868 -171.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -87.2 66.09 9.1 Favored 'General case' 0 CA--C 1.571 1.784 0 O-C-N 120.973 -1.079 . . . . 0.0 109.954 -167.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.81 -18.11 58.1 Favored Glycine 0 CA--C 1.557 2.664 0 N-CA-C 119.67 2.628 . . . . 0.0 119.67 -168.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -139.65 166.53 24.34 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 120.629 2.215 . . . . 0.0 110.986 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.9 tp -87.15 120.68 28.68 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.061 -1.649 . . . . 0.0 111.318 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.405 HG22 ' CD1' ' A' ' 130' ' ' ILE . 55.8 t -87.15 115.57 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.7 t -109.21 93.07 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 174.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -84.66 95.09 8.79 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 122.905 1.336 . . . . 0.0 109.593 173.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.4 p -89.46 99.72 12.66 Favored 'General case' 0 CA--C 1.56 1.328 0 CA-C-N 114.418 -1.265 . . . . 0.0 109.603 176.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 p -113.56 126.03 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.647 0.737 . . . . 0.0 110.534 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.0 tpt -73.51 -60.76 2.1 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.564 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.258 12.5 p30 -153.46 -80.02 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -79.77 -32.75 40.99 Favored 'General case' 0 CA--C 1.576 1.95 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 159.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.25 106.69 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.755 0 CA-C-N 120.022 1.283 . . . . 0.0 110.607 -169.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.9 p -102.12 121.55 42.42 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.138 0.975 . . . . 0.0 111.305 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.797 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.3 p -100.9 117.21 34.52 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 118.195 0.452 . . . . 0.0 111.03 162.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.1 m -89.32 106.78 18.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.594 -0.691 . . . . 0.0 109.173 176.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 28.8 mtm180 -106.68 106.94 17.71 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.405 ' CD1' HG22 ' A' ' 117' ' ' VAL . 34.3 mm -91.28 132.41 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -120.93 131.79 54.56 Favored 'General case' 0 CA--C 1.572 1.809 0 CA-C-O 121.267 0.556 . . . . 0.0 112.095 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -81.42 134.13 35.51 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 174.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -75.39 117.12 16.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.265 -0.897 . . . . 0.0 111.623 174.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 52.5 t -95.29 106.22 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 123.222 0.609 . . . . 0.0 110.264 -170.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . 0.267 66.7 m . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.258 9.3 p -68.95 -38.36 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 CA-C-N 119.904 1.229 . . . . 0.0 114.142 158.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -52.47 -36.97 56.06 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 162.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -64.59 -26.37 68.38 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.623 2.082 . . . . 0.0 116.623 170.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.1 mt -65.08 -20.77 66.64 Favored 'General case' 0 CA--C 1.576 1.963 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 161.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -76.81 123.13 25.77 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.747 1.612 . . . . 0.0 112.127 -170.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.29 -179.79 26.73 Favored Glycine 0 N--CA 1.489 2.17 0 CA-C-O 122.162 0.868 . . . . 0.0 115.109 -175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -93.33 132.69 37.31 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.031 0.532 . . . . 0.0 111.042 173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -124.98 110.45 14.22 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.968 -0.457 . . . . 0.0 111.286 -168.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -95.88 128.61 42.91 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.729 -1.232 . . . . 0.0 113.516 -176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.19 129.27 38.48 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.277 10.3 m -118.52 -64.23 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 118.51 -0.757 . . . . 0.0 111.749 178.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -101.93 157.3 16.96 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 123.352 1.548 . . . . 0.0 112.158 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.4 m -155.95 72.35 0.77 Allowed 'General case' 0 CA--C 1.562 1.438 0 O-C-N 120.891 -1.131 . . . . 0.0 110.878 172.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.11 129.87 41.3 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.156 -0.965 . . . . 0.0 112.437 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.54 11.06 61.66 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 119.953 2.741 . . . . 0.0 119.953 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -68.79 -35.59 77.23 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 116.313 1.968 . . . . 0.0 116.313 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -53.46 -54.81 31.65 Favored 'General case' 0 CA--C 1.575 1.917 0 CA-C-N 119.964 1.256 . . . . 0.0 114.22 167.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -54.44 -40.1 68.03 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 168.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.5 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 78.9 t80 -60.5 -45.51 93.54 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 166.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.3 9.6 ptt? -73.21 -30.3 63.41 Favored 'General case' 0 CA--C 1.574 1.88 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.2 -42.72 91.58 Favored 'General case' 0 N--CA 1.507 2.411 0 CA-C-N 121.192 1.814 . . . . 0.0 115.271 155.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -61.48 -42.65 99.11 Favored 'General case' 0 CA--C 1.574 1.897 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 174.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.7 mt -58.23 -44.54 88.27 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 165.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.58 44.07 2.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 117.654 1.822 . . . . 0.0 117.654 -174.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.92 139.55 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 C-N-CA 124.054 0.942 . . . . 0.0 110.022 162.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.03 171.68 47.91 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 116.245 1.258 . . . . 0.0 116.245 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.5 pt -53.07 -47.3 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 117.774 2.509 . . . . 0.0 117.774 -172.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.36 95.9 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 47.2 mt -64.46 -40.33 95.51 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 168.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 mtp-105 -61.0 -44.82 96.86 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 166.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -56.73 -46.6 81.23 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 167.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.8 ttm -51.13 -59.6 4.01 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 163.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.68 -36.45 48.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 119.96 2.744 . . . . 0.0 119.96 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.43 70.43 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 21.4 ptp -85.54 -26.47 26.17 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 175.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.93 106.81 3.32 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-N 120.262 1.392 . . . . 0.0 113.308 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -109.47 90.54 8.73 Favored Pre-proline 0 CA--C 1.571 1.758 0 C-N-CA 123.778 0.831 . . . . 0.0 109.84 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.47 160.92 14.82 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.409 2.073 . . . . 0.0 116.288 -167.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -93.7 97.96 10.8 Favored 'General case' 0 CA--C 1.569 1.68 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.152 166.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.8 t -89.9 110.51 21.45 Favored 'General case' 0 CA--C 1.558 1.273 0 O-C-N 121.185 -0.947 . . . . 0.0 112.087 -176.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.2 mt -90.4 114.75 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 108.666 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 91.9 mt -94.7 123.74 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 166.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.1 m -150.28 126.71 10.78 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.98 -1.075 . . . . 0.0 109.846 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -122.08 116.39 24.16 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -175.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -82.08 84.28 7.05 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.347 1.07 . . . . 0.0 110.579 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.6 -75.3 1.24 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 115.592 0.997 . . . . 0.0 115.592 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -125.23 -20.97 4.71 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 116.342 1.978 . . . . 0.0 116.342 170.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -81.73 103.89 11.74 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 121.808 2.095 . . . . 0.0 111.222 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 tt -98.0 117.71 32.96 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.073 0.949 . . . . 0.0 110.237 -171.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.7 m -96.83 126.41 41.97 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.798 0.839 . . . . 0.0 110.066 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 36.5 mt -110.03 102.3 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 171.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -101.86 104.22 14.94 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.281 0.632 . . . . 0.0 110.115 176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.4 m -86.86 106.48 17.77 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.797 0.839 . . . . 0.0 109.984 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -94.79 115.54 27.62 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.535 0.683 . . . . 0.0 111.573 -175.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.2 t -153.59 136.82 15.67 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.422 0.689 . . . . 0.0 110.55 169.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 57.2 p -59.32 -33.96 71.76 Favored 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 167.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.1 mt -64.44 -50.32 68.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 166.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.06 105.66 2.56 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 119.85 1.204 . . . . 0.0 111.663 174.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.1 m -90.91 133.87 34.91 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 123.033 0.533 . . . . 0.0 110.636 172.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -137.64 146.69 44.2 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 123.355 0.662 . . . . 0.0 111.149 175.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 129.55 22.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.744 -1.223 . . . . 0.0 111.483 177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -134.84 143.71 47.17 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.616 0.766 . . . . 0.0 111.102 172.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.6 m -130.05 126.06 36.73 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 0.0 111.259 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 26.3 p -143.46 146.26 33.28 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -169.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.51 134.33 43.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.698 -1.251 . . . . 0.0 110.856 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -72.84 117.21 14.27 Favored 'General case' 0 CA--C 1.574 1.883 0 O-C-N 120.671 -1.268 . . . . 0.0 112.88 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 104.7 -34.93 5.41 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 117.23 1.652 . . . . 0.0 117.23 -158.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -76.71 158.32 31.06 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 122.787 1.279 . . . . 0.0 113.376 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.295 0.0 OUTLIER -115.74 140.97 48.7 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.705 173.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -152.15 153.53 34.05 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 123.945 0.898 . . . . 0.0 110.917 -162.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -83.14 87.23 6.92 Favored 'General case' 0 CA--C 1.574 1.882 0 O-C-N 120.487 -1.383 . . . . 0.0 113.778 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.38 115.2 12.46 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 122.151 0.977 . . . . 0.0 110.525 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 51.8 m -101.12 100.53 11.11 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.488 -170.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.3 p -73.06 159.86 32.94 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -161.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.73 -32.88 6.32 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 119.123 3.009 . . . . 0.0 119.123 169.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -58.61 -51.23 70.79 Favored 'General case' 0 CA--C 1.573 1.844 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 161.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.02 -30.24 2.85 Favored Glycine 0 CA--C 1.551 2.343 0 N-CA-C 116.96 1.544 . . . . 0.0 116.96 -157.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.2 mtm-85 -58.65 129.68 43.27 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 120.351 2.076 . . . . 0.0 114.816 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.86 101.6 11.77 Favored 'General case' 0 CA--C 1.566 1.561 0 C-N-CA 123.803 0.841 . . . . 0.0 109.427 172.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.0 p -109.51 105.58 14.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.048 -1.032 . . . . 0.0 110.088 -168.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 49.7 mm-40 -70.38 105.31 2.98 Favored 'General case' 0 CA--C 1.565 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.445 174.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.0 m -130.85 120.35 23.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.003 . . . . 0.0 110.279 -151.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.6 p -92.76 126.79 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 CA-C-N 118.829 0.741 . . . . 0.0 111.736 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.4 m -105.69 112.12 25.06 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.942 -0.474 . . . . 0.0 111.807 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -125.08 131.03 53.38 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.303 0.641 . . . . 0.0 111.112 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -88.49 127.06 35.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.959 . . . . 0.0 111.617 168.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.1 t -143.22 140.35 30.66 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.157 0.583 . . . . 0.0 110.139 167.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 61.67 36.71 16.4 Favored 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 160.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.43 16.84 80.38 Favored Glycine 0 CA--C 1.557 2.691 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -165.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.75 136.07 26.87 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 119.664 1.732 . . . . 0.0 113.919 -172.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 63.0 tp -92.8 112.42 24.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.699 -0.626 . . . . 0.0 110.916 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -94.09 109.04 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -89.22 98.79 11.97 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.251 0.62 . . . . 0.0 109.339 167.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -89.84 104.14 16.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.605 -0.684 . . . . 0.0 110.232 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -91.62 131.97 36.65 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.154 -174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -127.94 126.29 41.17 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 119.035 0.834 . . . . 0.0 110.197 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -148.14 120.81 8.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.575 -1.328 . . . . 0.0 110.451 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.8 t70 49.7 51.06 17.22 Favored 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 116.478 2.029 . . . . 0.0 116.478 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.72 -24.91 2.19 Favored Glycine 0 CA--C 1.557 2.688 0 N-CA-C 119.596 2.598 . . . . 0.0 119.596 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -93.67 140.96 29.02 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 118.994 1.397 . . . . 0.0 111.55 -175.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -129.32 146.85 51.14 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 175.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 47.7 t -143.4 111.24 6.01 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.037 0.535 . . . . 0.0 110.385 172.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 12.3 t -98.65 146.3 25.98 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.8 mt -127.91 108.31 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -169.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 81.6 m -97.63 106.23 18.51 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.548 0.739 . . . . 0.0 110.214 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -93.0 85.87 5.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 111.237 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -100.37 130.13 46.44 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -167.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.89 117.24 21.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 112.288 -176.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -145.78 121.88 10.77 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 123.519 0.728 . . . . 0.0 109.684 -171.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 59.5 47.99 10.29 Favored 'General case' 0 N--CA 1.505 2.292 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 168.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.75 35.04 80.03 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 118.576 2.19 . . . . 0.0 118.576 -166.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -155.48 139.6 16.49 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.452 0.701 . . . . 0.0 109.781 -162.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.8 tp -95.11 112.46 24.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.172 -0.955 . . . . 0.0 108.757 172.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.2 t -99.16 101.82 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.7 t -99.37 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -165.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -100.1 100.98 11.91 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.987 0.899 . . . . 0.0 109.798 -170.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.5 p -101.72 127.25 48.57 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.158 0.983 . . . . 0.0 111.517 -175.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.8 p -135.71 143.62 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 123.316 0.646 . . . . 0.0 111.518 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 25.7 ttt -124.17 -103.13 0.38 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.336 -0.852 . . . . 0.0 108.732 165.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -87.66 70.51 9.71 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 120.571 1.532 . . . . 0.0 111.264 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.253 0.7 OUTLIER 62.88 0.13 0.65 Allowed 'General case' 0 CA--C 1.583 2.219 0 N-CA-C 118.169 2.655 . . . . 0.0 118.169 -165.709 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.47 93.94 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.253 -1.529 . . . . 0.0 108.644 -171.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.6 p -92.62 117.59 30.13 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.252 0.548 . . . . 0.0 111.761 -171.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.872 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 4.1 p -108.12 119.91 40.81 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 123.437 0.695 . . . . 0.0 111.339 171.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.6 m -101.96 107.57 18.75 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 -176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -101.67 114.1 27.84 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.483 0.713 . . . . 0.0 109.833 -173.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.47 124.94 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.344 -0.848 . . . . 0.0 108.924 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -122.95 131.76 53.86 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -86.21 132.13 34.07 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.253 1.421 . . . . 0.0 113.725 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 tttm -73.36 111.13 8.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.877 -1.139 . . . . 0.0 112.102 174.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.2 t -103.62 95.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -173.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 C--O 1.253 1.286 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.738 -178.039 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 118.592 -0.718 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.519 3.9 p 58.45 -48.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 -172.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -58.95 -47.66 84.28 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -64.94 -15.96 62.74 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 117.044 2.239 . . . . 0.0 117.044 171.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.61 -11.74 61.0 Favored 'General case' 0 CA--C 1.578 2.034 0 N-CA-C 116.657 2.095 . . . . 0.0 116.657 163.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -83.9 125.25 31.82 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 121.422 1.919 . . . . 0.0 113.091 -165.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.6 -170.6 26.85 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 115.856 1.102 . . . . 0.0 115.856 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -90.49 122.52 33.41 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.536 0.734 . . . . 0.0 110.894 176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.449 ' CH2' HD21 ' A' ' 111' ' ' LEU . 95.2 m95 -123.55 110.89 15.61 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.613 -0.679 . . . . 0.0 110.857 -172.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -90.15 130.63 36.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.591 -1.318 . . . . 0.0 113.37 -178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 46.8 tp -65.0 128.65 36.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 173.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.275 8.8 m -121.46 -61.4 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 118.246 -0.883 . . . . 0.0 112.129 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -96.43 149.51 21.64 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 120.491 1.496 . . . . 0.0 111.41 167.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.4 p -145.81 65.76 1.22 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.166 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.23 126.96 31.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.726 -1.234 . . . . 0.0 112.386 -175.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.64 23.14 62.6 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 119.248 2.459 . . . . 0.0 119.248 -171.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -75.1 -46.81 32.09 Favored 'General case' 0 CA--C 1.563 1.473 0 CA-C-N 119.002 1.401 . . . . 0.0 114.455 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.69 -44.14 63.03 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 115.81 1.782 . . . . 0.0 115.81 163.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -52.8 -48.54 66.83 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -58.82 -51.29 70.63 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 167.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 50.0 mtm -68.35 -42.62 78.95 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.34 -37.28 23.93 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 116.207 1.928 . . . . 0.0 116.207 164.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.76 -39.39 76.73 Favored 'General case' 0 CA--C 1.573 1.841 0 N-CA-C 115.945 1.831 . . . . 0.0 115.945 171.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.5 mt -51.04 -45.09 61.21 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 162.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.9 46.92 1.06 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 117.114 1.605 . . . . 0.0 117.114 -172.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 m -91.78 143.03 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.667 0 C-N-CA 124.519 1.128 . . . . 0.0 110.676 166.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.55 174.5 42.03 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 169.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 2.6 pp -55.81 -44.94 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 N-CA-C 117.054 2.242 . . . . 0.0 117.054 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.61 -46.25 84.32 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 167.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.8 mt -64.9 -43.24 93.48 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 171.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -52.46 -54.6 30.23 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 164.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.4 ttpp -59.49 -52.31 66.14 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.2 ttp -56.15 -49.78 73.02 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 172.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.39 -44.8 97.22 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 118.23 2.052 . . . . 0.0 118.23 172.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.79 -43.23 96.94 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 117.053 2.242 . . . . 0.0 117.053 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 20.1 ptp -76.98 -16.72 59.25 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 118.148 2.648 . . . . 0.0 118.148 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.14 145.39 46.43 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.29 73.07 5.17 Favored Pre-proline 0 CA--C 1.577 1.984 0 CA-C-O 118.546 -0.74 . . . . 0.0 110.627 171.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.32 146.8 57.78 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 123.134 2.556 . . . . 0.0 116.001 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -83.07 100.8 10.72 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.097 165.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 52.4 t -79.19 101.9 8.22 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.839 0.828 . . . . 0.0 110.545 167.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mt -96.2 106.36 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -171.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.31 128.65 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 97.0 m -146.32 113.15 6.06 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.395 -0.816 . . . . 0.0 108.821 170.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.1 t -91.7 95.64 10.0 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 121.276 -0.89 . . . . 0.0 111.062 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.56 76.77 9.98 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-O 122.393 1.092 . . . . 0.0 110.063 -171.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.59 -101.11 1.62 Allowed Glycine 0 N--CA 1.492 2.388 0 O-C-N 121.143 -0.973 . . . . 0.0 113.642 -167.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -94.97 -11.94 27.63 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 156.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -84.57 96.5 9.18 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 122.023 2.192 . . . . 0.0 110.556 -167.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 21.3 tp -73.22 108.62 6.2 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 121.941 0.876 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 31.2 m -98.34 105.39 17.53 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 69.2 mt -110.7 103.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 172.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -102.85 115.88 31.47 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.579 0.752 . . . . 0.0 109.687 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.8 m -100.3 97.29 8.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 0.0 109.699 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -89.34 119.72 30.06 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.88 0.848 . . . . 0.0 112.313 -177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.1 t -150.66 134.76 16.87 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.673 0.789 . . . . 0.0 110.054 168.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 59.4 p -59.12 -33.31 70.71 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 167.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.9 mt -66.04 -47.84 73.05 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 166.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -158.27 104.94 1.88 Allowed 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 120.145 1.338 . . . . 0.0 111.173 177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.2 m -92.39 137.53 32.28 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.708 -0.62 . . . . 0.0 111.55 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.8 t -144.25 164.47 30.65 Favored 'General case' 0 N--CA 1.501 2.095 0 C-N-CA 123.428 0.691 . . . . 0.0 111.686 168.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -154.46 149.72 27.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 119.897 -1.752 . . . . 0.0 114.285 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -138.93 141.21 38.47 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.424 0.63 . . . . 0.0 112.122 173.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 88.7 p -126.41 105.15 8.58 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.767 0.827 . . . . 0.0 109.923 177.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 28.3 p -136.85 142.13 42.83 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -166.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 m -72.07 118.98 15.62 Favored 'General case' 0 CA--C 1.574 1.871 0 O-C-N 120.575 -1.328 . . . . 0.0 111.768 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.1 tp -69.48 122.87 19.86 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -166.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.44 -38.08 3.43 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 115.846 1.098 . . . . 0.0 115.846 -158.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -99.23 164.45 12.13 Favored 'General case' 0 CA--C 1.574 1.9 0 CA-C-O 123.519 1.628 . . . . 0.0 113.405 -166.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -103.28 125.69 50.06 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 113.622 -1.626 . . . . 0.0 112.446 -177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.401 ' HE1' ' SG ' ' A' ' 87' ' ' CYS . 35.7 p90 -125.02 164.69 19.61 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 123.944 0.897 . . . . 0.0 113.377 -174.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -76.64 104.91 7.39 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.71 1.243 . . . . 0.0 111.516 167.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.82 115.89 27.5 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.229 1.012 . . . . 0.0 109.349 175.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.1 m -90.04 97.17 11.03 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.9 p -71.05 147.76 48.23 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -175.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -46.69 -37.02 7.75 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -65.41 -49.13 70.38 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 166.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.73 -14.26 1.19 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 118.478 2.151 . . . . 0.0 118.478 -172.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.8 mtm-85 -69.5 133.09 47.28 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 120.375 2.088 . . . . 0.0 112.84 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -86.73 102.05 13.87 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.065 165.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.4 p -104.26 143.08 33.44 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.49 -0.756 . . . . 0.0 110.591 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -79.23 95.6 5.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.478 -1.389 . . . . 0.0 110.494 166.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.2 m -92.46 116.65 29.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.296 -0.877 . . . . 0.0 110.132 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . 0.315 11.6 p -87.82 109.46 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 118.264 0.483 . . . . 0.0 109.884 160.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.401 ' SG ' ' HE1' ' A' ' 73' ' ' PHE . 56.4 m -92.07 110.32 21.69 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -133.41 126.68 31.76 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.007 0.523 . . . . 0.0 111.627 -169.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -90.25 113.44 25.26 Favored 'General case' 0 CA--C 1.563 1.454 0 O-C-N 121.551 -0.718 . . . . 0.0 110.17 170.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 t -97.29 57.99 1.48 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.3 47.8 m-20 45.68 57.32 5.11 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 146.07 -61.13 0.47 Allowed Glycine 0 N--CA 1.486 1.971 0 CA-C-N 115.298 -0.865 . . . . 0.0 113.829 -170.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -107.59 133.78 51.54 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 121.841 0.829 . . . . 0.0 112.86 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.7 tp -95.18 107.55 19.64 Favored 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 123.714 0.806 . . . . 0.0 110.669 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.5 114.97 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 123.569 0.748 . . . . 0.0 109.031 -172.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -89.09 98.18 11.62 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 166.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -95.53 92.22 6.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.854 -0.529 . . . . 0.0 111.354 -175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -83.23 123.25 29.4 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.146 0.978 . . . . 0.0 111.389 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -123.29 121.75 36.62 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 118.392 0.542 . . . . 0.0 110.625 -173.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -150.33 127.1 10.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.667 -1.27 . . . . 0.0 111.613 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.299 17.5 t70 52.85 49.74 19.57 Favored 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 162.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.24 0.07 19.72 Favored Glycine 0 CA--C 1.561 2.93 0 N-CA-C 120.145 2.818 . . . . 0.0 120.145 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm -123.1 145.25 48.73 Favored 'General case' 0 CA--C 1.567 1.6 0 CA-C-N 119.274 1.537 . . . . 0.0 109.854 -173.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -133.43 169.79 16.44 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.03 121.33 5.76 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 120.751 -1.218 . . . . 0.0 111.596 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.54 103.56 12.46 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -172.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.0 mm -95.57 100.45 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 98.4 m -99.26 101.2 12.44 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 123.281 0.632 . . . . 0.0 110.252 -168.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -93.36 109.55 21.11 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.724 0.81 . . . . 0.0 110.793 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.6 pttm -125.15 144.35 50.48 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 112.766 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.449 HD21 ' CH2' ' A' ' 11' ' ' TRP . 0.2 OUTLIER -82.75 122.91 28.79 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.348 -0.845 . . . . 0.0 110.821 178.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.293 42.0 tttm -124.7 -118.87 0.28 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 122.08 -0.388 . . . . 0.0 109.957 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -84.19 68.23 10.05 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 122.19 0.995 . . . . 0.0 112.651 -166.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 74.9 -13.61 5.27 Favored Glycine 0 CA--C 1.556 2.599 0 N-CA-C 119.477 2.551 . . . . 0.0 119.477 -166.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -124.71 158.12 33.99 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 119.096 1.448 . . . . 0.0 110.285 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.52 111.16 19.25 Favored 'General case' 0 CA--C 1.566 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.651 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 75.4 t -90.13 114.39 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.8 t -115.7 99.69 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 -167.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -99.34 108.6 21.15 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.425 0.69 . . . . 0.0 109.279 -171.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.673 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.7 p -103.74 122.69 45.59 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.71 -0.619 . . . . 0.0 111.938 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.39 136.16 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 CA-C-O 121.385 0.612 . . . . 0.0 110.911 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 12.4 ttt -86.01 -76.1 0.35 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 122.722 0.409 . . . . 0.0 110.887 167.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -126.88 -73.08 0.62 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 166.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -89.97 -30.05 18.06 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.624 1.712 . . . . 0.0 115.624 172.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.9 t -85.15 107.06 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 119.919 1.236 . . . . 0.0 110.537 -166.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 69.7 p -105.17 113.11 26.51 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 123.544 0.738 . . . . 0.0 111.344 -175.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.673 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 0.4 OUTLIER -87.47 157.19 19.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 166.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 31.0 m -127.97 109.14 11.29 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 166.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -98.38 123.96 42.79 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.527 0.731 . . . . 0.0 110.64 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 38.9 mm -99.19 116.34 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -114.35 130.86 56.69 Favored 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 122.854 0.462 . . . . 0.0 110.826 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -107.83 143.96 35.68 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 31.6 tttm -74.28 118.36 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.662 -0.649 . . . . 0.0 112.708 -172.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.3 t -90.06 95.68 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 118.436 -0.792 . . . . 0.0 109.781 -174.253 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.6 m . . . . . 0 CA--C 1.567 1.61 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.01 50.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 C-N-CA 124.848 1.259 . . . . 0.0 109.609 157.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -136.97 70.51 1.4 Allowed 'General case' 0 CA--C 1.57 1.743 0 O-C-N 120.686 -1.259 . . . . 0.0 110.063 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -163.94 -52.33 0.03 OUTLIER 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 125.87 1.668 . . . . 0.0 110.407 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 48.3 mt -75.87 0.27 18.78 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -84.42 143.72 29.24 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-N 120.736 1.607 . . . . 0.0 112.314 -171.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.62 -173.78 17.04 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 115.894 1.117 . . . . 0.0 115.894 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -87.24 112.7 22.28 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.469 0.708 . . . . 0.0 111.596 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -112.61 112.88 24.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 122.122 -0.361 . . . . 0.0 110.718 -175.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -94.01 134.09 36.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.635 -1.291 . . . . 0.0 112.746 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.49 126.77 30.77 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.597 -0.689 . . . . 0.0 111.92 175.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.258 3.6 m -113.1 -66.49 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.836 176.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -111.43 107.96 17.36 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.575 1.079 . . . . 0.0 110.347 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.6 p -89.56 81.62 6.49 Favored 'General case' 0 CA--C 1.564 1.502 0 O-C-N 121.617 -0.677 . . . . 0.0 111.449 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -82.27 107.28 14.83 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -163.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.18 16.43 78.55 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 118.439 2.136 . . . . 0.0 118.439 -168.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -86.29 68.78 10.35 Favored 'General case' 0 CA--C 1.569 1.697 0 CA-C-N 120.102 1.951 . . . . 0.0 112.868 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -141.73 -51.7 0.42 Allowed 'General case' 0 CA--C 1.565 1.549 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.778 153.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -45.1 -46.81 11.94 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 167.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.403 ' CD2' ' SG ' ' A' ' 127' ' ' CYS . 57.9 t80 -54.55 -57.62 10.68 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 171.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 ptt? -61.74 -43.98 97.79 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 116.126 1.899 . . . . 0.0 116.126 174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.33 -46.89 55.92 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 162.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -67.87 -39.13 83.77 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.913 1.819 . . . . 0.0 115.913 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -50.03 -40.83 46.04 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 116.446 2.017 . . . . 0.0 116.446 159.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.15 50.0 0.6 Allowed Glycine 0 N--CA 1.486 2.015 0 C-N-CA 124.738 1.161 . . . . 0.0 114.978 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.8 t -99.78 131.7 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.578 0.751 . . . . 0.0 109.197 -174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.26 160.74 48.69 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 116.888 1.515 . . . . 0.0 116.888 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.281 2.6 pp -58.23 -46.34 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -173.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.17 95.28 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 167.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.47 -41.23 89.34 Favored 'General case' 0 CA--C 1.577 2.016 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 170.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -54.97 -49.54 71.15 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 162.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -54.88 -49.73 70.45 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 170.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -52.83 -55.93 19.45 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 165.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.02 -43.79 96.69 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 118.85 2.3 . . . . 0.0 118.85 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.65 -44.04 95.01 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 172.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . 0.269 14.4 ptt? -70.23 -40.03 74.73 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 116.223 1.934 . . . . 0.0 116.223 170.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.43 133.93 56.57 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.51 92.75 41.57 Favored Pre-proline 0 CA--C 1.571 1.786 0 CA-C-O 118.027 -0.987 . . . . 0.0 108.564 166.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.84 158.48 27.74 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.505 2.137 . . . . 0.0 115.713 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -94.22 107.41 19.36 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.531 165.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.65 102.5 15.02 Favored 'General case' 0 CA--C 1.562 1.406 0 O-C-N 121.142 -0.973 . . . . 0.0 111.16 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -90.91 119.66 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 81.0 mt -108.81 126.74 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.6 m -138.18 116.08 11.57 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.827 -1.171 . . . . 0.0 109.121 176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 28.8 p -117.97 111.51 19.06 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -175.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -89.86 68.43 7.4 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 122.128 0.966 . . . . 0.0 110.594 174.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.45 -75.68 0.67 Allowed Glycine 0 N--CA 1.491 2.355 0 O-C-N 120.478 -1.389 . . . . 0.0 115.754 -170.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -104.16 -44.16 5.05 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -74.28 110.01 8.23 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 121.281 1.855 . . . . 0.0 111.792 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 tt -112.82 112.85 24.64 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-O 122.379 1.085 . . . . 0.0 109.053 -172.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.5 m -99.13 115.92 30.15 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.733 0.813 . . . . 0.0 109.108 -172.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mt -106.58 105.89 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 40.3 tttp -102.72 105.93 16.46 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.285 0.634 . . . . 0.0 109.89 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 26.0 m -88.68 103.03 15.56 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.458 -0.776 . . . . 0.0 109.322 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -92.88 117.19 29.77 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.967 0.889 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.3 t -156.4 137.41 13.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.561 0.744 . . . . 0.0 110.055 168.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.3 p -58.57 -34.66 71.3 Favored 'General case' 0 N--CA 1.502 2.125 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 167.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 89.0 mt -66.5 -47.42 73.05 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 168.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -156.35 104.78 2.24 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 120.077 1.308 . . . . 0.0 110.794 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 m -93.06 132.43 37.19 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.137 0.575 . . . . 0.0 110.935 173.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.1 p -142.53 115.49 8.78 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.767 -0.583 . . . . 0.0 110.668 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -109.96 135.56 50.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.36 0.664 . . . . 0.0 112.016 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -142.17 144.64 33.52 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.815 0.817 . . . . 0.0 112.699 170.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 85.8 p -106.16 105.75 15.93 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.662 0.785 . . . . 0.0 110.769 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 31.5 p -102.53 135.35 44.32 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.8 m -75.73 130.81 39.25 Favored 'General case' 0 CA--C 1.57 1.723 0 O-C-N 120.752 -1.218 . . . . 0.0 110.454 171.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 tp -77.67 124.74 28.34 Favored 'General case' 0 CA--C 1.57 1.736 0 O-C-N 121.377 -0.827 . . . . 0.0 112.377 175.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.98 39.54 11.54 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 117.452 1.741 . . . . 0.0 117.452 -169.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -171.92 147.53 2.18 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 124.807 1.243 . . . . 0.0 108.522 -167.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.257 11.6 ptpt -100.18 146.97 26.22 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 171.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -137.88 161.08 37.57 Favored 'General case' 0 CA--C 1.571 1.757 0 C-N-CA 124.893 1.277 . . . . 0.0 110.513 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -80.74 104.26 11.14 Favored 'General case' 0 CA--C 1.572 1.825 0 O-C-N 119.972 -1.705 . . . . 0.0 112.228 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -88.16 109.49 19.94 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.14 0.976 . . . . 0.0 110.707 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.3 m -76.08 99.54 4.67 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.772 . . . . 0.0 110.205 170.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 p -69.66 148.12 49.71 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.574 0.749 . . . . 0.0 112.717 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -47.14 -41.91 18.43 Favored 'General case' 0 CA--C 1.572 1.797 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 -174.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.42 -43.91 76.17 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 170.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.82 -31.05 0.29 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 22.8 mtm-85 -67.75 126.86 30.74 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 120.071 1.936 . . . . 0.0 113.038 -177.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -88.73 117.13 27.49 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.08 0.467 . . . . 0.0 109.777 166.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.0 p -123.82 129.07 50.45 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.479 0.657 . . . . 0.0 110.338 -163.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -83.64 105.4 14.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.525 -1.36 . . . . 0.0 109.679 -170.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.7 m -121.6 105.53 10.53 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.96 -0.463 . . . . 0.0 110.98 -148.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.44 120.84 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 120.89 0.376 . . . . 0.0 111.443 172.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 45.4 m -95.35 109.38 21.55 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.123 0.487 . . . . 0.0 109.732 171.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -136.31 124.0 22.43 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.141 0.576 . . . . 0.0 110.932 -171.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -85.88 132.69 34.04 Favored 'General case' 0 CA--C 1.566 1.576 0 O-C-N 121.093 -1.005 . . . . 0.0 112.188 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 t -139.87 143.52 36.77 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.148 0.579 . . . . 0.0 110.101 163.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 62.27 35.69 15.14 Favored 'General case' 0 N--CA 1.506 2.356 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 162.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.14 29.06 73.17 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 118.54 2.176 . . . . 0.0 118.54 -164.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -149.08 134.28 18.27 Favored 'General case' 0 CA--C 1.556 1.204 0 CA-C-N 118.519 1.16 . . . . 0.0 112.907 -170.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.9 tp -88.04 115.46 25.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.782 -0.574 . . . . 0.0 111.216 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.9 t -92.31 108.06 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 172.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -94.44 90.11 6.1 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 170.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -89.84 108.13 19.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.903 -0.498 . . . . 0.0 110.863 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -106.6 130.5 54.34 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -169.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -129.36 127.48 41.13 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 123.622 0.769 . . . . 0.0 111.747 -166.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -153.04 134.87 14.62 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.274 -1.516 . . . . 0.0 111.159 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.2 t70 48.29 48.3 18.97 Favored 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 117.169 2.285 . . . . 0.0 117.169 166.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.32 19.06 66.04 Favored Glycine 0 CA--C 1.558 2.764 0 N-CA-C 120.384 2.913 . . . . 0.0 120.384 -167.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -136.54 137.1 39.91 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 119.216 1.508 . . . . 0.0 109.193 -168.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -128.59 143.86 51.04 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 123.13 1.443 . . . . 0.0 114.57 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.6 t -133.2 164.61 26.66 Favored 'General case' 0 CA--C 1.562 1.425 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.473 167.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.1 t -142.72 139.07 30.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.013 -1.68 . . . . 0.0 113.234 171.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 16.1 mm -104.97 103.27 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 176.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 59.9 m -99.13 102.02 13.57 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.347 0.594 . . . . 0.0 109.628 -175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 -93.88 95.64 9.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.676 -0.64 . . . . 0.0 110.833 -177.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -104.14 134.97 46.49 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 118.514 0.597 . . . . 0.0 112.487 -176.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.96 109.75 12.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.966 -1.084 . . . . 0.0 110.189 173.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.5 ttpp -144.84 128.75 17.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.555 -0.715 . . . . 0.0 110.783 -170.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 60.36 40.71 17.18 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 115.673 1.731 . . . . 0.0 115.673 171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 81.61 -15.3 25.67 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 119.814 2.686 . . . . 0.0 119.814 -169.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -133.8 169.2 17.42 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.081 1.94 . . . . 0.0 112.261 -172.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 17.5 tp -88.06 116.08 25.99 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 120.551 -1.343 . . . . 0.0 110.109 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.6 t -99.03 108.92 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.9 t -102.42 96.51 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -169.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -87.49 100.95 13.14 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 122.219 1.009 . . . . 0.0 109.673 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 1.6 p -107.48 108.4 19.7 Favored 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 123.924 0.889 . . . . 0.0 110.352 -173.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.79 137.71 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.865 0.866 . . . . 0.0 111.618 -168.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.1 ttt -113.93 106.7 14.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 162.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.303 6.3 m120 68.52 -79.5 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 123.987 0.915 . . . . 0.0 112.856 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -125.42 -3.12 7.4 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 164.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.7 t -90.32 100.1 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 121.906 2.139 . . . . 0.0 109.567 -170.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 81.5 p -99.2 123.62 43.63 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.807 0.843 . . . . 0.0 112.8 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.916 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.4 p -103.09 133.06 48.83 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 120.937 0.399 . . . . 0.0 111.349 157.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.7 m -106.49 101.46 10.92 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -95.01 114.7 26.54 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.499 -0.751 . . . . 0.0 110.603 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 39.4 mm -88.19 124.2 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -123.9 122.44 37.99 Favored 'General case' 0 CA--C 1.569 1.709 0 C-N-CA 123.534 0.734 . . . . 0.0 111.433 -171.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -97.18 142.65 28.83 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -78.58 117.59 19.9 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.702 -1.248 . . . . 0.0 112.568 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 32.9 t -117.21 81.86 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.653 -0.654 . . . . 0.0 109.337 -175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.256 1.413 0 C-N-CA 123.558 0.743 . . . . 0.0 110.787 -178.043 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.932 0.872 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.262 4.6 p -64.23 -39.56 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -177.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.41 -41.78 98.73 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 166.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -57.28 -23.66 49.87 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.41 -6.46 7.24 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 164.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -64.05 161.01 16.83 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 122.615 2.461 . . . . 0.0 115.274 171.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.42 169.3 12.88 Favored Glycine 0 N--CA 1.49 2.272 0 O-C-N 121.264 -0.898 . . . . 0.0 115.28 172.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -83.73 96.28 8.67 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.936 0.495 . . . . 0.0 110.858 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -97.18 100.16 11.64 Favored 'General case' 0 CA--C 1.566 1.566 0 O-C-N 121.422 -0.799 . . . . 0.0 110.982 -170.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -77.12 127.28 32.37 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.879 -1.138 . . . . 0.0 112.973 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 39.2 tp -67.07 121.83 16.45 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 118.985 0.811 . . . . 0.0 113.033 172.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.8 m -111.56 -46.58 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -120.95 131.42 54.32 Favored 'General case' 0 CA--C 1.565 1.536 0 C-N-CA 124.48 1.112 . . . . 0.0 109.404 -176.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 51.8 p -131.83 70.79 1.46 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 172.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.1 pttt -82.38 127.23 33.05 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.21 17.35 61.03 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 118.578 2.191 . . . . 0.0 118.578 -170.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -84.93 -42.47 14.94 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -166.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -60.54 -39.25 87.23 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 121.19 1.814 . . . . 0.0 115.073 169.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.251 14.7 pt-20 -59.7 -49.22 78.58 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 167.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.457 ' CD2' ' SG ' ' A' ' 127' ' ' CYS . 76.7 t80 -55.32 -49.84 71.15 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 169.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 78.2 mtm -64.26 -36.54 84.42 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -58.53 -45.9 87.92 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 121.514 1.961 . . . . 0.0 115.542 162.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -60.09 -44.1 95.05 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 171.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 72.4 mt -55.3 -37.78 67.81 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 163.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.24 59.19 0.77 Allowed Glycine 0 N--CA 1.487 2.066 0 C-N-CA 124.13 0.871 . . . . 0.0 114.54 -175.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.6 t -115.27 125.13 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -172.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.36 164.03 50.85 Favored Glycine 0 CA--C 1.551 2.336 0 N-CA-C 117.068 1.587 . . . . 0.0 117.068 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.262 2.4 pp -55.04 -48.75 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 N-CA-C 117.226 2.306 . . . . 0.0 117.226 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.12 94.98 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 169.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.1 mt -59.81 -44.25 94.09 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 58.0 mtm-85 -66.0 -44.18 85.53 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 171.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -56.4 -48.88 76.03 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 168.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 44.9 ttp -52.96 -58.11 8.07 Favored 'General case' 0 CA--C 1.572 1.805 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 163.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.21 -44.06 89.04 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 119.311 2.484 . . . . 0.0 119.311 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.35 -45.24 95.22 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.3 ptp -74.32 -28.79 61.32 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 116.92 2.192 . . . . 0.0 116.92 168.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.58 102.74 1.54 Allowed 'General case' 0 CA--C 1.561 1.374 0 CA-C-N 119.593 1.088 . . . . 0.0 113.035 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -103.09 92.77 3.95 Favored Pre-proline 0 CA--C 1.572 1.807 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.449 177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -80.48 160.2 22.47 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.222 1.948 . . . . 0.0 116.08 -172.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -85.36 104.48 15.22 Favored 'General case' 0 CA--C 1.566 1.563 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.294 157.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.2 t -86.85 96.31 10.17 Favored 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 124.048 0.939 . . . . 0.0 110.872 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mp -89.38 106.11 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 72.2 mt -97.08 144.81 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.712 0 CA-C-O 122.814 1.292 . . . . 0.0 108.454 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 91.8 m -147.1 115.43 6.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.06 -1.65 . . . . 0.0 108.522 167.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.5 t -114.39 107.12 15.13 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 122.971 0.508 . . . . 0.0 111.65 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -99.63 79.81 2.3 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 122.408 1.099 . . . . 0.0 109.746 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.34 -89.7 0.43 Allowed Glycine 0 N--CA 1.489 2.191 0 N-CA-C 115.822 1.089 . . . . 0.0 115.822 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.6 mmmt -99.43 -15.51 18.71 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -106.41 129.21 54.44 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 122.038 2.199 . . . . 0.0 111.113 176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 tt -125.5 116.82 22.4 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.295 0.638 . . . . 0.0 110.224 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 95.1 m -107.58 134.18 50.96 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 123.917 0.887 . . . . 0.0 109.715 178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.9 mt -124.76 111.2 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 172.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -87.71 159.57 18.44 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 122.023 0.916 . . . . 0.0 111.182 160.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.1 m -148.24 102.86 3.4 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 119.525 -1.984 . . . . 0.0 107.664 -178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -98.27 114.31 26.55 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.689 0.795 . . . . 0.0 111.917 -172.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -147.36 140.16 24.93 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.669 0.787 . . . . 0.0 110.484 168.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.0 t -54.4 -28.99 47.38 Favored 'General case' 0 N--CA 1.504 2.229 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 167.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.8 mt -85.14 -47.0 10.58 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 124.122 0.969 . . . . 0.0 113.342 177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.1 106.02 3.85 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.881 1.219 . . . . 0.0 110.914 168.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.7 m -90.05 134.66 34.12 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.159 0.584 . . . . 0.0 110.719 170.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -134.83 158.44 44.21 Favored 'General case' 0 N--CA 1.502 2.131 0 CA-C-O 121.931 0.872 . . . . 0.0 111.525 176.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -150.2 130.93 14.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.538 -1.351 . . . . 0.0 110.802 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -144.2 160.89 40.17 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.881 0.848 . . . . 0.0 112.913 178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 91.4 p -139.43 145.83 39.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.222 -0.924 . . . . 0.0 112.784 171.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 22.2 t -132.97 160.04 38.24 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-O 122.448 1.118 . . . . 0.0 112.445 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 45.7 m -90.56 132.9 35.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 0.0 109.565 164.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -73.58 128.73 36.3 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 -170.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.65 -55.96 0.89 Allowed Glycine 0 N--CA 1.494 2.508 0 O-C-N 121.857 -0.527 . . . . 0.0 114.019 -162.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -79.26 179.68 7.26 Favored 'General case' 0 CA--C 1.575 1.922 0 CA-C-O 122.94 1.352 . . . . 0.0 113.039 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.34 149.23 32.74 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -111.64 -172.27 2.0 Favored 'General case' 0 CA--C 1.571 1.777 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.664 164.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -115.41 109.52 18.0 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.671 -1.268 . . . . 0.0 109.922 163.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -84.37 102.81 13.02 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.746 0.818 . . . . 0.0 109.743 174.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 75.3 m -77.58 100.29 6.06 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.991 0.901 . . . . 0.0 109.465 171.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.7 p -72.26 159.67 33.69 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -171.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.1 -41.06 7.47 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 119.233 3.049 . . . . 0.0 119.233 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.27 -39.09 93.6 Favored 'General case' 0 CA--C 1.573 1.836 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 169.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.43 -17.22 5.89 Favored Glycine 0 CA--C 1.552 2.403 0 N-CA-C 118.067 1.987 . . . . 0.0 118.067 -160.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 73.1 mtm-85 -69.06 118.88 12.53 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.841 2.32 . . . . 0.0 111.05 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -91.61 108.61 20.03 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.237 0.542 . . . . 0.0 109.834 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -111.19 111.46 22.55 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.664 0.745 . . . . 0.0 110.467 -162.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -72.31 97.81 2.09 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.478 1.111 . . . . 0.0 109.643 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.1 m -116.79 119.79 36.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.443 -0.786 . . . . 0.0 110.855 -152.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.0 t -80.42 130.05 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.154 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.93 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 74.8 m -106.74 95.5 5.78 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.172 0.896 . . . . 0.0 109.947 167.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -126.86 124.65 40.08 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.586 -0.696 . . . . 0.0 111.68 -171.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -89.12 140.79 29.1 Favored 'General case' 0 CA--C 1.569 1.685 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -136.13 115.39 12.54 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.447 0.699 . . . . 0.0 110.988 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.325 21.8 t70 64.26 -82.79 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 170.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.37 30.32 3.66 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 168.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -147.51 129.88 15.74 Favored 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 118.8 1.3 . . . . 0.0 112.58 -170.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.7 tp -87.43 120.5 28.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.451 -0.78 . . . . 0.0 110.68 167.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.5 t -89.05 103.07 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.602 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -89.34 88.83 7.64 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -91.8 98.04 11.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.743 . . . . 0.0 110.551 -174.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -79.6 131.94 36.13 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.097 0.959 . . . . 0.0 111.715 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.84 126.07 33.37 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.982 0.81 . . . . 0.0 109.758 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -143.02 122.21 12.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.838 -1.164 . . . . 0.0 110.393 177.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.288 38.9 t70 50.4 44.53 26.77 Favored 'General case' 0 CA--C 1.588 2.421 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 173.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.58 25.81 72.82 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 119.812 2.685 . . . . 0.0 119.812 -168.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.6 mtmm -135.71 128.71 31.46 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.136 1.374 . . . . 0.0 107.765 -177.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -126.85 146.76 50.16 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.9 t -134.33 126.14 29.06 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.644 0.735 . . . . 0.0 111.031 170.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 m -102.8 129.68 49.54 Favored 'General case' 0 CA--C 1.561 1.375 0 O-C-N 121.178 -0.951 . . . . 0.0 110.067 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 93.8 mt -120.69 97.99 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -172.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 79.4 m -94.56 103.29 15.24 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.717 . . . . 0.0 109.967 -171.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.5 mtt-85 -93.91 100.21 12.42 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.506 0.723 . . . . 0.0 109.906 -176.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -115.73 138.09 51.45 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -173.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.14 112.37 16.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.817 -0.552 . . . . 0.0 111.052 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . 0.269 20.3 tptp -105.62 -138.54 0.36 Allowed 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.619 0.767 . . . . 0.0 111.199 -177.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -90.83 68.08 6.3 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.521 -1.362 . . . . 0.0 110.225 -159.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.18 36.94 93.86 Favored Glycine 0 CA--C 1.558 2.725 0 N-CA-C 117.577 1.791 . . . . 0.0 117.577 -159.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -165.92 134.39 3.06 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -161.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 21.9 tp -90.22 119.34 30.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 119.926 -1.734 . . . . 0.0 110.859 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 68.5 t -94.13 113.87 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 85.1 t -109.46 101.99 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -89.1 97.39 11.17 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.001 0.905 . . . . 0.0 109.249 177.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 0.8 OUTLIER -101.1 110.4 22.42 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.195 0.998 . . . . 0.0 110.533 -176.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.3 p -129.02 144.86 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 123.751 0.82 . . . . 0.0 110.53 -170.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . 0.284 28.1 ttt -102.98 -104.32 0.28 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.41 -0.806 . . . . 0.0 108.922 166.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -108.02 97.46 7.16 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 119.644 1.111 . . . . 0.0 108.546 172.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.28 20.0 m120 68.26 -29.04 0.15 Allowed 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 118.15 2.648 . . . . 0.0 118.15 -172.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.43 107.71 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.778 0 CA-C-N 120.203 1.365 . . . . 0.0 109.776 -172.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 68.4 p -107.29 123.1 47.83 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.594 0.758 . . . . 0.0 112.124 -169.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.98 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 7.7 p -96.22 129.34 43.56 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 121.268 0.556 . . . . 0.0 111.346 156.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 58.4 m -105.6 99.45 9.06 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.235 -0.916 . . . . 0.0 108.567 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -96.01 123.19 39.51 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 122.022 -0.424 . . . . 0.0 111.228 -176.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.9 mm -101.44 122.92 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -120.65 148.23 44.19 Favored 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 123.24 0.616 . . . . 0.0 111.794 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -123.0 138.57 54.65 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 116.763 2.134 . . . . 0.0 116.763 -174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.6 tttm -76.08 111.04 11.07 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 123.596 0.759 . . . . 0.0 112.139 -172.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.71 94.66 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -171.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.256 1.415 0 C-N-CA 123.639 0.775 . . . . 0.0 109.636 -173.086 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.953 -0.546 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.5 p -64.68 -31.91 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 159.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -57.03 -22.84 41.99 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 171.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -41.92 -43.13 2.98 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 117.333 2.346 . . . . 0.0 117.333 154.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.9 3.12 39.55 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -82.35 129.83 34.96 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 121.256 1.843 . . . . 0.0 111.844 -173.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.98 173.68 26.71 Favored Glycine 0 N--CA 1.486 2.026 0 N-CA-C 118.492 2.157 . . . . 0.0 118.492 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -82.91 103.04 12.07 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.067 0.547 . . . . 0.0 110.256 166.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -109.43 106.88 16.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 122.043 -0.411 . . . . 0.0 110.556 -172.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -83.72 129.79 34.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.395 -1.441 . . . . 0.0 112.553 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.1 tp -65.75 134.34 52.95 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.082 0.468 . . . . 0.0 112.14 172.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.301 6.8 m -123.91 -78.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -84.59 147.14 27.15 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.776 1.171 . . . . 0.0 111.38 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.5 p -139.79 74.86 1.48 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.035 173.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 137.73 50.62 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.79 15.77 49.39 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 119.67 2.628 . . . . 0.0 119.67 -170.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -81.67 64.85 6.56 Favored 'General case' 0 CA--C 1.568 1.654 0 CA-C-N 119.979 1.889 . . . . 0.0 112.912 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -153.87 -53.73 0.1 Allowed 'General case' 0 CA--C 1.568 1.648 0 C-N-CA 125.624 1.569 . . . . 0.0 109.36 172.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -48.46 -48.72 37.46 Favored 'General case' 0 CA--C 1.576 1.97 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 165.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -52.66 -54.99 25.82 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 169.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.298 23.2 ptt? -69.81 -24.45 63.48 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 174.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -64.43 -48.54 74.93 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 159.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -62.0 -37.99 86.9 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 171.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 76.4 mt -53.74 -40.71 66.38 Favored 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 159.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.81 57.78 1.58 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 123.797 0.713 . . . . 0.0 114.348 -176.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.8 t -102.1 132.27 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -169.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.84 153.9 40.5 Favored Glycine 0 CA--C 1.551 2.326 0 N-CA-C 116.573 1.389 . . . . 0.0 116.573 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.259 2.4 pp -56.39 -47.39 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 N-CA-C 117.766 2.506 . . . . 0.0 117.766 -170.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.28 96.7 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 168.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.9 -39.08 90.28 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.8 mtp-105 -56.16 -48.7 75.8 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 163.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -54.1 -51.69 63.37 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 167.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -51.19 -52.32 45.43 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 166.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.64 -41.48 93.71 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 119.003 2.361 . . . . 0.0 119.003 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.06 -47.28 87.11 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 168.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -78.93 -28.51 43.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.4 115.19 9.29 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-N 120.198 1.363 . . . . 0.0 113.469 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.59 84.65 4.16 Favored Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.101 174.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.38 161.56 25.56 Favored 'Trans proline' 0 CA--C 1.563 1.971 0 C-N-CA 122.731 2.287 . . . . 0.0 116.84 -173.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -90.74 100.61 13.44 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.158 0.98 . . . . 0.0 109.794 169.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.6 t -83.44 100.15 10.54 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.5 1.12 . . . . 0.0 112.039 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.08 99.24 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 64.9 mt -90.74 114.89 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.4 p -115.5 106.78 14.35 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p -139.54 112.73 8.18 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.692 -0.63 . . . . 0.0 111.89 -168.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -82.61 -47.68 11.82 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.77 -69.0 0.04 OUTLIER Glycine 0 N--CA 1.486 1.97 0 O-C-N 121.554 -0.716 . . . . 0.0 112.778 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -102.07 -36.51 8.54 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 166.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -76.24 136.45 39.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 120.053 1.297 . . . . 0.0 113.524 174.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.1 tt -142.81 120.71 12.0 Favored 'General case' 0 CA--C 1.564 1.514 0 CA-C-O 121.411 0.624 . . . . 0.0 110.525 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.5 m -120.0 121.95 40.07 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 123.492 0.717 . . . . 0.0 109.558 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.1 mt -107.3 127.96 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -118.89 102.8 9.06 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.831 0.852 . . . . 0.0 109.787 175.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 81.1 m -96.66 107.64 20.13 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 123.598 0.759 . . . . 0.0 110.781 -173.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -101.94 120.45 40.42 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.474 0.654 . . . . 0.0 112.602 -163.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.7 t -155.8 142.53 18.81 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.75 0.82 . . . . 0.0 111.208 168.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.4 p -60.23 -29.81 68.99 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 116.234 1.938 . . . . 0.0 116.234 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.7 mt -66.11 -53.09 42.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 167.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.95 115.51 3.29 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 119.987 1.267 . . . . 0.0 110.379 169.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.8 m -91.97 128.95 38.0 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 123.162 0.585 . . . . 0.0 110.752 173.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.1 p -133.49 116.04 15.5 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.533 -0.729 . . . . 0.0 110.233 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.9 150.25 38.76 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -153.25 149.28 27.78 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 94.3 p -131.75 115.57 16.17 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.953 0.901 . . . . 0.0 111.751 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.5 t -149.92 157.14 42.87 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 122.561 1.172 . . . . 0.0 113.926 -176.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 m -89.27 150.97 22.38 Favored 'General case' 0 CA--C 1.568 1.651 0 CA-C-O 122.936 1.351 . . . . 0.0 111.023 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.84 120.11 11.91 Favored 'General case' 0 CA--C 1.571 1.767 0 O-C-N 120.706 -1.246 . . . . 0.0 112.452 170.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.26 -27.31 19.1 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 118.026 1.97 . . . . 0.0 118.026 -162.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -89.44 143.31 26.92 Favored 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 118.731 1.266 . . . . 0.0 112.712 -174.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -94.8 145.65 24.74 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.143 0.973 . . . . 0.0 113.552 167.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -130.63 162.02 30.28 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.115 0.966 . . . . 0.0 111.47 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -80.04 100.81 8.35 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 120.911 -1.118 . . . . 0.0 111.192 167.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -80.49 139.11 36.56 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-O 121.87 0.843 . . . . 0.0 109.607 162.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.5 m -117.46 110.49 18.06 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 170.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.3 p -64.61 140.87 58.91 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.174 -0.329 . . . . 0.0 111.402 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -50.14 -24.74 2.95 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 119.954 3.316 . . . . 0.0 119.954 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.253 1.4 t70 -91.91 -24.35 19.33 Favored 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 169.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 168.65 -49.47 0.22 Allowed Glycine 0 N--CA 1.495 2.583 0 N-CA-C 119.996 2.758 . . . . 0.0 119.996 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.2 mtm-85 -64.02 138.62 58.54 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 -162.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -87.18 107.69 18.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.589 0.756 . . . . 0.0 110.705 170.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . 0.263 3.0 p -112.95 119.16 36.98 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.499 1.142 . . . . 0.0 111.372 -173.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -71.88 95.09 1.5 Allowed 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.44 1.096 . . . . 0.0 110.481 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 94.5 m -100.69 101.95 12.96 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.202 -0.936 . . . . 0.0 109.759 -161.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.97 117.22 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 121.099 0.476 . . . . 0.0 110.479 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 57.8 m -90.25 113.29 25.08 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 122.789 0.436 . . . . 0.0 110.601 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -128.68 124.49 35.81 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.963 -1.086 . . . . 0.0 111.1 -176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -86.7 116.74 25.0 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 121.124 -0.985 . . . . 0.0 112.037 175.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.7 t -156.9 140.12 15.56 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.041 0.936 . . . . 0.0 110.663 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t70 58.11 54.84 5.58 Favored 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 48.79 38.15 22.45 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 118.517 2.167 . . . . 0.0 118.517 -169.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -155.72 144.42 20.39 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -161.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.7 tp -90.84 106.84 18.79 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 163.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.2 t -80.2 95.79 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -88.2 92.3 9.1 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -90.35 106.48 18.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.704 -0.622 . . . . 0.0 110.559 -174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -89.18 119.97 30.15 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.253 1.021 . . . . 0.0 110.264 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -124.38 124.53 42.56 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 123.783 0.833 . . . . 0.0 111.012 -168.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -157.49 117.8 3.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.438 -1.414 . . . . 0.0 112.918 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.262 6.5 t70 32.16 56.57 0.36 Allowed 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 118.918 2.933 . . . . 0.0 118.918 174.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.97 -52.41 1.11 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 116.916 1.527 . . . . 0.0 116.916 -172.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -77.18 146.68 36.92 Favored 'General case' 0 CA--C 1.567 1.6 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -142.57 153.04 43.17 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 175.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.8 t -132.96 123.01 25.11 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 74.2 p -88.67 114.02 24.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.631 -0.668 . . . . 0.0 110.174 170.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 36.2 mm -106.51 93.4 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 97.9 m -94.65 99.44 11.56 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.099 -1.001 . . . . 0.0 110.747 -170.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -88.17 89.15 7.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.585 -0.697 . . . . 0.0 111.276 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.0 141.93 47.92 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -168.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.86 114.23 20.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 111.347 -177.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -134.02 124.28 25.98 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 56.05 49.75 15.06 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 170.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.32 -34.26 3.09 Favored Glycine 0 CA--C 1.553 2.455 0 N-CA-C 118.917 2.327 . . . . 0.0 118.917 -169.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -115.47 158.93 21.84 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 119.405 1.602 . . . . 0.0 112.781 -165.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.2 tp -83.44 111.11 18.74 Favored 'General case' 0 CA--C 1.561 1.388 0 O-C-N 121.147 -0.971 . . . . 0.0 110.225 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.34 110.98 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -95.94 96.53 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -87.07 99.25 11.77 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -174.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.899 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 5.3 p -119.55 95.54 4.83 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.225 -159.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 p -107.75 140.78 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.098 0.951 . . . . 0.0 110.016 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 17.6 ttt -119.41 112.43 19.4 Favored 'General case' 0 CA--C 1.559 1.314 0 O-C-N 121.376 -0.828 . . . . 0.0 109.324 167.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 54.2 50.27 16.84 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . 0.297 3.3 t-20 67.82 -2.93 1.27 Allowed 'General case' 0 CA--C 1.584 2.286 0 N-CA-C 118.435 2.754 . . . . 0.0 118.435 -166.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.77 129.56 60.13 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 CA-C-N 120.82 1.646 . . . . 0.0 108.138 -175.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 62.4 p -120.18 137.79 53.98 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.367 1.618 . . . . 0.0 115.367 -144.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.899 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 25.1 p -132.82 167.62 19.85 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-O 123.088 1.423 . . . . 0.0 112.461 153.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.2 m -144.79 123.22 12.36 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 119.395 -2.066 . . . . 0.0 108.836 167.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -110.36 121.35 45.08 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.464 0.705 . . . . 0.0 110.807 -171.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 32.3 mm -92.58 118.48 38.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -118.02 127.47 53.84 Favored 'General case' 0 CA--C 1.569 1.693 0 C-N-CA 123.836 0.855 . . . . 0.0 110.292 -177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -112.03 144.48 41.31 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.0 tttm -76.51 119.94 21.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 112.946 -174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 53.7 t -96.16 73.35 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -171.781 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.699 0.762 . . . . 0.0 112.233 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.266 9.7 p -58.19 -34.56 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 167.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -59.01 -37.29 76.55 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 169.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -30.86 56.64 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 164.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.87 -19.97 61.05 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 162.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.254 5.8 pt-20 -91.06 144.85 25.21 Favored 'General case' 0 CA--C 1.57 1.735 0 CA-C-N 121.67 2.032 . . . . 0.0 113.688 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 141.34 -179.5 19.48 Favored Glycine 0 CA--C 1.55 2.239 0 C-N-CA 123.975 0.798 . . . . 0.0 114.187 -170.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.3 ttm-85 -87.35 110.48 20.27 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.424 -1.045 . . . . 0.0 111.072 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -112.72 107.47 16.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.635 -0.665 . . . . 0.0 111.979 -170.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -90.61 129.53 36.73 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.981 -1.074 . . . . 0.0 113.429 -175.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.1 tp -72.28 121.69 19.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.256 13.0 m -107.8 -57.44 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 123.686 0.794 . . . . 0.0 112.007 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -104.7 133.87 48.81 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 119.806 1.184 . . . . 0.0 110.408 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.5 p -119.21 63.94 0.79 Allowed 'General case' 0 CA--C 1.566 1.596 0 CA-C-O 121.615 0.721 . . . . 0.0 112.71 168.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -60.54 127.59 32.45 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 0.0 113.494 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.3 21.1 59.33 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 119.993 2.757 . . . . 0.0 119.993 -178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -74.14 -41.64 61.23 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 119.115 1.458 . . . . 0.0 114.87 -173.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -49.63 -46.3 49.32 Favored 'General case' 0 CA--C 1.578 2.019 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 163.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -55.86 -49.55 73.02 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 168.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.424 ' CG ' ' SG ' ' A' ' 127' ' ' CYS . 68.2 t80 -58.05 -48.34 80.38 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 170.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -59.61 -34.03 72.23 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 168.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -58.75 -52.11 67.12 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 163.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -59.11 -44.67 92.0 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.8 mt -50.31 -50.64 50.13 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.166 1.913 . . . . 0.0 116.166 162.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.8 49.52 0.58 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 124.143 0.878 . . . . 0.0 115.219 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.1 t -99.14 145.35 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 123.945 0.898 . . . . 0.0 109.461 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.92 -126.31 0.03 OUTLIER Glycine 0 CA--C 1.553 2.426 0 N-CA-C 117.526 1.77 . . . . 0.0 117.526 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.265 9.9 pt -119.1 -61.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.901 -0.764 . . . . 0.0 112.622 -176.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.13 -40.72 90.75 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.1 mt -66.84 -34.67 78.32 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 170.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 -63.87 -47.3 81.24 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 120.256 1.389 . . . . 0.0 114.371 164.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -53.11 -50.58 64.19 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 115.24 1.571 . . . . 0.0 115.24 168.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER -59.43 -49.9 76.0 Favored 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 170.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.41 -41.42 97.02 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.585 2.194 . . . . 0.0 118.585 174.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.79 -46.32 82.57 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 169.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.8 ptt? -77.16 -32.46 56.23 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 117.805 2.521 . . . . 0.0 117.805 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.51 144.92 55.48 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -110.93 86.37 5.88 Favored Pre-proline 0 CA--C 1.57 1.713 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -73.77 143.34 33.36 Favored 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 122.458 2.105 . . . . 0.0 116.182 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -90.87 100.47 13.33 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.951 165.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.8 t -81.86 95.9 7.47 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-O 122.468 1.127 . . . . 0.0 110.759 175.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mt -91.33 101.83 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 85.6 mt -94.73 133.25 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.864 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.8 m -149.1 126.16 11.32 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 119.863 -1.773 . . . . 0.0 110.508 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.3 t -103.52 110.97 23.22 Favored 'General case' 0 CA--C 1.565 1.525 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -171.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -87.08 76.01 9.37 Favored 'General case' 0 CA--C 1.574 1.88 0 CA-C-O 122.129 0.966 . . . . 0.0 110.206 162.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.86 -90.23 0.16 Allowed Glycine 0 N--CA 1.493 2.466 0 O-C-N 120.994 -1.066 . . . . 0.0 115.681 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -89.93 -25.89 20.7 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 160.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -88.56 99.83 12.61 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 120.35 1.432 . . . . 0.0 110.177 -165.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.3 tp -94.35 110.87 22.6 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 123.398 0.679 . . . . 0.0 110.777 -175.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.6 m -89.62 117.41 28.49 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 27.1 mt -111.88 102.13 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.575 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -94.25 114.98 27.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.856 -0.527 . . . . 0.0 109.873 171.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 m -97.34 88.69 4.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.212 -0.93 . . . . 0.0 109.767 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -80.98 125.55 30.29 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.876 0.87 . . . . 0.0 112.795 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 t -155.28 153.77 31.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.473 -0.767 . . . . 0.0 110.813 165.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 69.9 p -57.98 -43.41 86.53 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 171.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.78 -32.46 67.67 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 171.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 123.07 7.76 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 119.827 1.194 . . . . 0.0 109.376 175.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 m -119.17 124.66 47.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.325 -0.859 . . . . 0.0 109.756 168.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 t -146.14 167.72 22.73 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.57 -0.707 . . . . 0.0 112.673 175.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -142.65 140.15 31.49 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.01 -1.056 . . . . 0.0 112.66 -178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -135.28 156.27 49.24 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 168.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 90.9 p -128.93 112.92 14.59 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.742 0.817 . . . . 0.0 111.214 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.508 ' HG ' ' HD1' ' A' ' 73' ' ' PHE . 45.8 t -115.79 132.49 56.62 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -177.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.0 m -82.48 117.34 22.42 Favored 'General case' 0 CA--C 1.572 1.813 0 C-N-CA 123.46 0.704 . . . . 0.0 109.912 174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.8 mp -59.7 127.61 32.84 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.559 2.059 . . . . 0.0 116.559 -168.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.94 -33.91 5.76 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 116.986 1.555 . . . . 0.0 116.986 -164.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -98.7 165.64 11.7 Favored 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 123.797 1.76 . . . . 0.0 113.386 -172.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -82.57 139.88 33.57 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.183 -1.826 . . . . 0.0 113.154 171.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.508 ' HD1' ' HG ' ' A' ' 67' ' ' CYS . 9.1 p90 -131.21 162.63 29.55 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-O 121.657 0.741 . . . . 0.0 111.356 166.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.4 112.0 16.21 Favored 'General case' 0 CA--C 1.568 1.66 0 O-C-N 120.474 -1.391 . . . . 0.0 111.403 170.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -103.73 95.3 5.94 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 121.775 0.798 . . . . 0.0 109.683 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.0 m -72.5 104.73 3.92 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.946 0.879 . . . . 0.0 109.994 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 p -73.5 141.19 46.79 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.336 0.655 . . . . 0.0 111.692 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.85 -29.47 28.14 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 119.614 3.19 . . . . 0.0 119.614 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -75.79 -28.83 58.52 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 167.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 151.05 -29.93 0.99 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 118.973 2.349 . . . . 0.0 118.973 172.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.7 mtm-85 -70.48 126.55 29.96 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 119.813 1.807 . . . . 0.0 112.975 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.1 mttt -94.91 106.71 18.72 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.497 0.719 . . . . 0.0 110.052 177.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.3 p -104.56 122.17 45.02 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.457 0.646 . . . . 0.0 110.465 -166.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -77.42 98.52 5.3 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.997 0.903 . . . . 0.0 108.898 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.0 m -111.63 109.68 19.7 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -152.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.5 p -88.4 111.95 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 C-N-CA 122.802 0.441 . . . . 0.0 110.853 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 71.1 m -105.31 105.21 15.15 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -119.37 125.18 48.39 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.467 0.707 . . . . 0.0 112.098 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -91.84 130.09 37.68 Favored 'General case' 0 CA--C 1.564 1.496 0 O-C-N 121.604 -0.685 . . . . 0.0 112.086 177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 t -145.63 136.69 24.69 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.339 0.655 . . . . 0.0 109.982 167.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 62.18 34.52 16.11 Favored 'General case' 0 N--CA 1.508 2.43 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 160.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.27 15.88 80.92 Favored Glycine 0 CA--C 1.558 2.728 0 N-CA-C 119.326 2.49 . . . . 0.0 119.326 -165.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -137.35 125.2 22.58 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-N 118.616 1.208 . . . . 0.0 110.88 -175.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -97.46 110.59 23.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.492 -0.755 . . . . 0.0 110.3 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.7 t -89.29 104.51 15.06 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -86.19 97.1 10.16 Favored 'General case' 0 CA--C 1.571 1.78 0 C-N-CA 124.22 1.008 . . . . 0.0 109.019 171.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -92.66 97.26 10.68 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.055 -1.028 . . . . 0.0 110.754 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -70.0 127.59 33.38 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.441 0.696 . . . . 0.0 111.698 170.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -135.41 111.81 9.83 Favored 'General case' 0 CA--C 1.565 1.543 0 CA-C-N 118.627 0.649 . . . . 0.0 109.96 -171.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 10.4 p90 -151.92 118.28 5.63 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.659 -1.276 . . . . 0.0 112.269 -171.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.1 t70 39.77 55.16 2.51 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 117.807 2.521 . . . . 0.0 117.807 174.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.98 -44.19 3.32 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 117.755 1.862 . . . . 0.0 117.755 -171.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -78.26 144.3 36.3 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 177.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.61 147.18 26.45 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 121.719 0.771 . . . . 0.0 112.998 -175.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.7 t -134.05 127.39 32.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.714 -0.616 . . . . 0.0 112.549 176.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 36.1 p -92.29 129.81 38.14 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.858 0.837 . . . . 0.0 110.891 168.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 56.1 mt -123.07 97.92 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 96.2 m -92.81 99.98 12.54 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.843 0.83 . . . . 0.0 109.448 -173.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -89.17 100.46 13.24 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 123.729 0.812 . . . . 0.0 109.204 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.88 142.63 51.22 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -173.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.41 115.89 21.63 Favored 'General case' 0 CA--C 1.565 1.549 0 CA-C-O 121.776 0.798 . . . . 0.0 111.379 -172.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -91.68 -178.17 4.99 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-O 122.302 1.049 . . . . 0.0 112.307 176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.62 73.18 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.061 0 CA-C-O 123.426 1.584 . . . . 0.0 115.037 167.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.22 28.6 24.82 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 118.996 2.358 . . . . 0.0 118.996 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.0 tppt? -165.44 145.22 6.69 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 119.543 1.671 . . . . 0.0 110.374 -171.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.9 tp -89.86 114.89 26.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 119.905 -1.747 . . . . 0.0 109.316 168.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 78.2 t -96.05 112.87 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -104.98 95.57 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -85.85 102.16 13.46 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 122.345 1.069 . . . . 0.0 109.554 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.795 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.1 p -115.65 115.42 26.36 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.664 -165.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.58 134.44 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 122.968 0.507 . . . . 0.0 110.119 -169.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 18.9 ttt -127.19 114.0 17.1 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.275 39.8 m-20 66.2 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 124.273 1.029 . . . . 0.0 113.237 176.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -118.83 -13.02 9.55 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 166.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 67.9 t -102.3 112.72 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-N 121.121 1.782 . . . . 0.0 109.843 -157.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 70.1 p -99.43 107.65 19.93 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.373 0.669 . . . . 0.0 112.705 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.795 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 18.4 p -90.11 151.98 21.34 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 121.725 0.774 . . . . 0.0 111.901 160.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.4 m -129.28 109.68 11.32 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.876 -1.14 . . . . 0.0 108.002 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -103.35 118.8 37.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.917 -0.489 . . . . 0.0 110.356 -176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 26.8 mm -102.83 118.16 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -174.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -120.18 143.53 48.18 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -117.92 143.64 46.17 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -80.27 113.21 18.28 Favored 'General case' 0 CA--C 1.563 1.474 0 O-C-N 121.767 -0.583 . . . . 0.0 112.185 -169.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 74.7 t -97.71 83.38 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--O 1.257 1.448 0 C-N-CA 124.232 1.013 . . . . 0.0 109.49 -175.574 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.562 1.416 0 CA-C-O 119.246 -0.407 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . 0.543 3.1 p 60.12 -49.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 118.739 2.866 . . . . 0.0 118.739 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.42 58.16 2.56 Favored 'General case' 0 CA--C 1.578 2.054 0 CA-C-O 122.868 1.318 . . . . 0.0 114.27 176.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -148.6 -40.31 0.16 Allowed 'General case' 0 CA--C 1.572 1.792 0 C-N-CA 125.876 1.67 . . . . 0.0 111.222 172.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 14.3 mt -66.0 -6.22 12.09 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.05 166.45 15.92 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 173.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.59 179.7 18.71 Favored Glycine 0 N--CA 1.49 2.281 0 O-C-N 121.191 -0.943 . . . . 0.0 115.21 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.1 ttm105 -94.37 118.31 31.42 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 123.2 0.6 . . . . 0.0 109.687 173.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 95.7 m95 -118.85 110.2 16.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.227 -0.92 . . . . 0.0 110.625 -164.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.1 ttm180 -99.46 129.72 45.67 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.495 -0.753 . . . . 0.0 112.326 -177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.8 tp -67.43 126.2 28.55 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 178.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.7 m -115.69 -53.16 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -117.04 118.08 31.4 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 119.373 0.988 . . . . 0.0 108.899 178.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.4 p -112.91 68.17 0.67 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 175.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -79.42 124.05 28.09 Favored 'General case' 0 CA--C 1.567 1.617 0 O-C-N 121.48 -0.762 . . . . 0.0 112.868 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.88 -2.37 85.69 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 118.892 2.317 . . . . 0.0 118.892 -169.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.251 13.3 t80 -68.57 -37.68 80.08 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.651 2.225 . . . . 0.0 116.352 -173.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -62.47 -47.91 81.94 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-N 121.058 1.754 . . . . 0.0 115.03 172.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.254 7.5 pt-20 -49.14 -48.98 44.3 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 121.645 2.02 . . . . 0.0 116.0 166.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.43 -44.4 89.09 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.637 1.718 . . . . 0.0 115.637 170.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 76.9 mtm -61.25 -43.77 98.33 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 168.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -53.15 -51.61 61.44 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 121.166 1.803 . . . . 0.0 115.116 164.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.82 -37.49 84.6 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.0 mt -55.99 -37.89 69.72 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 117.284 2.327 . . . . 0.0 117.284 161.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.33 61.28 0.81 Allowed Glycine 0 N--CA 1.487 2.041 0 C-N-CA 123.999 0.809 . . . . 0.0 114.176 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -110.97 125.12 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -176.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.57 162.3 50.36 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 116.332 1.293 . . . . 0.0 116.332 174.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.448 HD12 ' H ' ' A' ' 30' ' ' ILE . 1.6 mp -57.54 -44.8 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -171.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.73 -43.96 90.32 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 168.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.2 mt -67.59 -37.79 83.09 Favored 'General case' 0 CA--C 1.573 1.855 0 N-CA-C 115.385 1.624 . . . . 0.0 115.385 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -57.74 -49.56 76.15 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 165.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -51.82 -52.14 51.36 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 165.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.5 ttp -52.21 -56.14 16.58 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 170.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.46 -42.52 89.78 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 118.78 2.272 . . . . 0.0 118.78 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.02 -45.83 83.89 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 170.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 14.4 ptm -76.97 -29.71 55.67 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -73.19 122.99 22.79 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-N 119.62 1.1 . . . . 0.0 113.77 175.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.34 92.61 11.82 Favored Pre-proline 0 CA--C 1.568 1.657 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.291 170.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.95 142.62 25.26 Favored 'Trans proline' 0 CA--C 1.562 1.892 0 C-N-CA 122.3 2.0 . . . . 0.0 115.034 -174.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.37 100.62 13.17 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.011 0.91 . . . . 0.0 109.292 170.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.8 t -94.15 104.79 16.8 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.431 -0.793 . . . . 0.0 112.815 -173.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.0 mt -81.1 106.43 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.538 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.4 mt -103.96 117.7 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.5 t -119.28 124.37 46.51 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.4 p -120.42 102.72 8.65 Favored 'General case' 0 CA--C 1.561 1.38 0 CA-C-O 121.613 0.72 . . . . 0.0 112.751 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -85.15 69.39 10.77 Favored 'General case' 0 CA--C 1.575 1.923 0 CA-C-O 121.846 0.832 . . . . 0.0 111.153 171.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.24 -84.9 0.03 OUTLIER Glycine 0 N--CA 1.492 2.417 0 N-CA-C 117.249 1.66 . . . . 0.0 117.249 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -85.86 -23.52 27.07 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 116.404 2.002 . . . . 0.0 116.404 166.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -103.08 107.75 18.67 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.525 1.511 . . . . 0.0 109.966 -169.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 tt -117.15 125.55 51.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.832 -1.168 . . . . 0.0 111.665 -169.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 89.4 m -113.53 125.76 54.56 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 123.404 0.682 . . . . 0.0 110.574 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.0 mt -110.28 109.03 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -107.22 89.06 2.88 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 124.02 0.928 . . . . 0.0 109.284 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.2 m -84.71 103.39 13.76 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 124.034 0.934 . . . . 0.0 110.758 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -102.39 124.85 48.7 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -171.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.3 t -147.23 141.23 25.96 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.542 0.687 . . . . 0.0 110.413 167.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.4 p -55.29 -29.49 58.29 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 164.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.0 mt -74.42 -48.2 29.11 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 165.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -157.2 108.4 2.33 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 121.022 1.737 . . . . 0.0 112.533 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 12.3 m -77.35 135.28 38.35 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.641 -0.662 . . . . 0.0 111.137 164.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -134.61 120.5 19.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.215 -0.928 . . . . 0.0 108.537 170.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -124.74 128.89 49.46 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.426 -0.796 . . . . 0.0 110.865 -173.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -146.99 152.55 38.79 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.1 p -136.36 118.0 14.95 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.852 0.861 . . . . 0.0 111.268 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 32.6 t -145.44 153.84 41.61 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 122.585 1.183 . . . . 0.0 113.308 -175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.3 m -84.81 149.04 25.99 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 122.431 1.11 . . . . 0.0 110.83 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 mp -67.12 115.79 7.21 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.465 -1.397 . . . . 0.0 112.587 176.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.77 -30.08 11.06 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 117.937 1.935 . . . . 0.0 117.937 -161.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -82.87 150.24 26.65 Favored 'General case' 0 CA--C 1.567 1.614 0 CA-C-N 118.653 1.227 . . . . 0.0 112.443 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -109.78 151.31 27.13 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 122.518 1.152 . . . . 0.0 114.087 170.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -138.05 167.17 22.35 Favored 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.16 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.69 102.91 11.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.947 -1.095 . . . . 0.0 111.101 170.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -92.04 99.6 12.4 Favored 'General case' 0 CA--C 1.563 1.443 0 CA-C-O 121.912 0.863 . . . . 0.0 109.757 172.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 60.2 m -78.81 105.1 9.88 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 166.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -65.94 176.16 1.75 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -48.86 -41.06 31.92 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 172.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.62 -44.94 73.19 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 165.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 132.71 -11.52 5.17 Favored Glycine 0 CA--C 1.553 2.459 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 -160.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 68.5 mtm-85 -63.27 131.82 49.61 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 121.331 2.565 . . . . 0.0 112.885 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -79.92 112.46 17.23 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.642 0.777 . . . . 0.0 111.125 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.8 p -123.78 124.22 42.22 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.967 0.507 . . . . 0.0 110.35 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.6 mm100 -83.39 96.17 8.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.622 -1.299 . . . . 0.0 110.377 175.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.3 m -96.74 115.62 27.74 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 122.077 -0.39 . . . . 0.0 110.376 -168.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.5 p -89.69 125.1 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.817 -0.552 . . . . 0.0 111.037 169.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.56 117.07 29.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.801 -0.562 . . . . 0.0 111.756 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -131.49 116.12 17.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.233 -0.917 . . . . 0.0 111.138 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -83.82 134.98 34.69 Favored 'General case' 0 CA--C 1.568 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 111.945 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.1 t -135.89 129.61 32.56 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.02 0.528 . . . . 0.0 109.979 162.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . 0.296 4.2 m-20 72.85 -82.64 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 159.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -144.9 48.61 0.71 Allowed Glycine 0 N--CA 1.492 2.397 0 C-N-CA 123.466 0.555 . . . . 0.0 113.984 159.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -154.63 127.2 8.0 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 123.723 0.809 . . . . 0.0 110.92 -166.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.7 tp -97.14 113.72 25.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.67 -0.644 . . . . 0.0 110.166 171.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.45 101.7 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.682 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 172.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -90.53 99.82 12.78 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -101.93 100.3 10.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.551 -0.718 . . . . 0.0 111.76 -164.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -78.67 132.39 37.01 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.437 0.695 . . . . 0.0 112.841 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -130.72 118.04 20.3 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 123.224 0.61 . . . . 0.0 109.922 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 4.0 p90 -159.21 142.12 14.28 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.716 -1.24 . . . . 0.0 112.281 -174.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.1 t0 51.62 41.89 29.18 Favored 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 117.704 2.483 . . . . 0.0 117.704 161.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.37 27.18 72.18 Favored Glycine 0 CA--C 1.559 2.782 0 N-CA-C 119.5 2.56 . . . . 0.0 119.5 -167.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -142.83 151.84 41.55 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 118.787 1.294 . . . . 0.0 109.699 -168.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -134.18 155.44 50.12 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 29.1 t -147.29 131.42 17.33 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.855 0.836 . . . . 0.0 111.773 172.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 p -105.17 113.76 27.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.856 -0.528 . . . . 0.0 109.928 -169.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 22.1 mm -98.64 101.75 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.7 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 87.2 m -95.9 98.53 10.48 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.096 -1.002 . . . . 0.0 110.105 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.1 mtp85 -89.06 102.55 15.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.635 0.774 . . . . 0.0 109.429 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -133.77 147.88 51.33 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.49 114.99 22.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.623 -0.673 . . . . 0.0 112.123 -174.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -131.46 110.81 11.28 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . 0.252 20.1 t70 55.76 57.8 4.96 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 68.67 -8.61 2.23 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 120.071 2.789 . . . . 0.0 120.071 -170.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.9 mmtp -113.45 140.55 48.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 118.745 1.272 . . . . 0.0 110.618 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -83.22 104.42 13.38 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 122.219 1.009 . . . . 0.0 108.573 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 99.3 t -96.05 106.16 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.1 t -95.7 98.67 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -172.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -95.74 100.7 12.38 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.857 -176.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.794 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.5 p -92.72 144.65 25.09 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 177.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.4 p -135.47 136.48 50.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-O 121.611 0.72 . . . . 0.0 110.762 169.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 14.5 tpt -92.86 -58.43 2.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.48 -0.762 . . . . 0.0 111.94 163.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . 0.256 16.3 p30 -141.71 -90.57 0.14 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.004 0.922 . . . . 0.0 108.719 178.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -90.81 -15.88 29.29 Favored 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 153.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.4 t -79.78 129.47 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 CA-C-N 120.044 1.293 . . . . 0.0 109.905 -176.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 61.1 p -137.4 153.59 50.14 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -166.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.794 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 1.9 p -132.92 130.32 39.47 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.403 -0.811 . . . . 0.0 111.349 163.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 88.4 m -104.08 101.33 11.09 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 64.6 mtm180 -102.99 117.06 33.75 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.141 0.496 . . . . 0.0 111.358 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.1 mm -92.26 120.39 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -113.92 131.02 56.45 Favored 'General case' 0 CA--C 1.569 1.684 0 CA-C-O 121.265 0.555 . . . . 0.0 110.865 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -86.6 131.38 34.17 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -74.02 106.27 5.64 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.96 0.886 . . . . 0.0 111.356 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.28 129.24 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 175.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.488 1.445 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -176.083 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 p -60.05 -23.9 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 114.965 1.468 . . . . 0.0 114.965 161.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -56.28 -39.32 72.49 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 159.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -71.12 -30.47 66.54 Favored 'General case' 0 CA--C 1.577 1.982 0 N-CA-C 116.08 1.881 . . . . 0.0 116.08 169.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 mt -68.91 -10.22 56.0 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 116.927 2.195 . . . . 0.0 116.927 161.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.87 132.45 34.39 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 120.507 1.503 . . . . 0.0 112.019 -166.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.35 -162.83 20.46 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 115.146 0.818 . . . . 0.0 115.146 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -92.01 130.57 37.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.94 -0.741 . . . . 0.0 112.88 -172.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -134.56 112.23 10.7 Favored 'General case' 0 CA--C 1.561 1.377 0 C-N-CA 123.416 0.687 . . . . 0.0 109.291 -171.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 29.7 ttp-105 -94.32 133.16 38.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 119.963 -1.711 . . . . 0.0 112.575 173.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.15 131.4 50.7 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.292 16.0 m -130.76 -60.28 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.637 -0.664 . . . . 0.0 112.201 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -102.27 106.37 17.17 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 119.601 1.091 . . . . 0.0 109.106 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.2 p -108.15 68.94 0.71 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -83.17 129.07 34.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.48 2.12 90.38 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 -168.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -70.68 -51.9 24.64 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-N 120.179 1.99 . . . . 0.0 115.856 -169.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -54.38 -39.82 67.56 Favored 'General case' 0 CA--C 1.58 2.096 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 170.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -56.03 -47.7 77.36 Favored 'General case' 0 CA--C 1.573 1.842 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 164.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -58.42 -51.01 71.62 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 171.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . 0.347 16.5 ptt? -65.22 -23.74 67.16 Favored 'General case' 0 CA--C 1.576 1.972 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 170.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.6 mtmm -59.98 -51.86 67.84 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 154.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -59.21 -43.93 92.28 Favored 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 171.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.447 ' HA ' ' SD ' ' A' ' 122' ' ' MET . 83.5 mt -57.2 -44.57 83.77 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 171.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 115.75 62.15 0.36 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 123.883 0.754 . . . . 0.0 114.388 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.4 t -128.49 127.53 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -166.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.48 164.94 53.83 Favored Glycine 0 CA--C 1.55 2.246 0 N-CA-C 117.611 1.804 . . . . 0.0 117.611 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.465 HD12 ' H ' ' A' ' 30' ' ' ILE . 1.9 mp -53.78 -47.97 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 -171.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.82 -48.11 80.7 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 116.538 2.051 . . . . 0.0 116.538 173.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.6 mt -63.98 -38.56 91.51 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 169.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 68.2 mtm-85 -62.74 -48.18 80.33 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 120.513 1.506 . . . . 0.0 114.85 168.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.46 -41.99 77.42 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 168.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -58.69 -59.52 5.27 Favored 'General case' 0 CA--C 1.569 1.673 0 CA-C-N 119.784 1.174 . . . . 0.0 113.869 164.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.96 -39.4 78.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 119.622 2.609 . . . . 0.0 119.622 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.31 86.71 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 117.031 2.234 . . . . 0.0 117.031 171.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 17.4 ptt? -83.96 -29.25 27.19 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 116.977 2.214 . . . . 0.0 116.977 167.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.5 106.96 4.17 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-N 119.744 1.156 . . . . 0.0 113.359 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -105.46 91.81 5.23 Favored Pre-proline 0 CA--C 1.572 1.825 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.068 174.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.33 147.77 18.35 Favored 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.313 2.009 . . . . 0.0 115.887 -171.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.08 99.61 9.29 Favored 'General case' 0 CA--C 1.573 1.862 0 CA-C-O 121.681 0.753 . . . . 0.0 109.166 169.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.5 t -101.9 109.68 21.48 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 120.976 -1.077 . . . . 0.0 112.84 -167.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.2 mt -97.59 104.42 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -170.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 97.0 mt -85.89 104.87 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.5 p -107.08 117.14 33.28 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.29 0.636 . . . . 0.0 109.813 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.1 t -113.49 100.07 8.24 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.022 -1.049 . . . . 0.0 113.179 -173.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -86.91 65.16 8.86 Favored 'General case' 0 CA--C 1.575 1.938 0 CA-C-O 122.039 0.923 . . . . 0.0 111.381 166.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.52 -88.49 0.04 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 116.6 1.4 . . . . 0.0 116.6 -177.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 15.6 mmmt -81.95 -39.29 23.91 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 116.088 1.884 . . . . 0.0 116.088 169.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -90.43 102.27 15.0 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 120.305 1.411 . . . . 0.0 109.786 -175.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 tt -108.69 111.82 23.81 Favored 'General case' 0 CA--C 1.56 1.349 0 CA-C-O 121.621 0.724 . . . . 0.0 109.049 -173.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.7 m -105.88 117.08 33.11 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.558 0.743 . . . . 0.0 109.7 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.1 112.01 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -101.89 94.23 5.7 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.508 0.723 . . . . 0.0 110.871 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.6 m -88.58 103.06 15.55 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.315 0.646 . . . . 0.0 110.682 -176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -100.52 115.4 30.03 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.7 t -147.31 141.54 26.2 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.528 0.731 . . . . 0.0 110.82 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 67.2 p -58.81 -32.46 69.39 Favored 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 165.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 82.0 mt -68.23 -48.81 64.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 167.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.21 108.07 2.53 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.568 1.531 . . . . 0.0 111.354 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.3 m -91.07 128.19 36.8 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.715 -0.616 . . . . 0.0 110.988 173.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.5 p -131.55 109.06 9.98 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.431 -0.793 . . . . 0.0 110.772 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -104.98 119.94 40.24 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.27 0.628 . . . . 0.0 110.83 175.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -133.13 143.96 49.6 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.7 p -102.04 113.08 26.0 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.882 0.873 . . . . 0.0 111.631 173.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 21.8 p -102.95 123.96 47.56 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-O 121.516 0.674 . . . . 0.0 111.382 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 m -81.29 121.42 26.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.195 -0.941 . . . . 0.0 109.065 173.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -73.0 129.65 38.57 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -164.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 90.1 -41.48 2.97 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 116.812 1.485 . . . . 0.0 116.812 -160.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -89.33 173.15 8.54 Favored 'General case' 0 CA--C 1.572 1.797 0 C-N-CA 124.798 1.239 . . . . 0.0 113.185 -178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.54 157.69 21.71 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 175.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -142.82 163.72 32.03 Favored 'General case' 0 CA--C 1.573 1.865 0 C-N-CA 124.723 1.209 . . . . 0.0 111.725 -176.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.33 104.96 11.23 Favored 'General case' 0 CA--C 1.569 1.704 0 O-C-N 120.916 -1.115 . . . . 0.0 111.716 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -99.19 114.73 27.66 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.008 0.923 . . . . 0.0 109.678 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.8 m -93.71 106.94 18.87 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.92 -1.112 . . . . 0.0 108.36 166.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.9 p -77.66 157.16 30.3 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -169.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.86 -31.98 63.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 168.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.46 10.41 2.6 Favored 'General case' 0 CA--C 1.578 2.027 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 164.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.09 45.57 10.14 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 118.08 1.992 . . . . 0.0 118.08 172.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.3 mtm105 -134.01 130.34 37.44 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 117.998 0.899 . . . . 0.0 109.348 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -90.05 112.14 23.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.968 -0.458 . . . . 0.0 110.077 171.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 35.2 p -125.3 134.43 52.26 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.402 0.681 . . . . 0.0 109.667 -169.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -81.85 99.97 9.33 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.364 -0.835 . . . . 0.0 109.467 171.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.8 m -107.51 112.39 25.13 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.861 -0.524 . . . . 0.0 110.994 -159.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.0 p -88.9 124.37 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 122.961 0.504 . . . . 0.0 111.452 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 19.3 m -108.45 114.07 27.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.73 -0.606 . . . . 0.0 111.887 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -124.17 120.66 32.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.789 -0.569 . . . . 0.0 110.589 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -89.32 119.17 29.55 Favored 'General case' 0 CA--C 1.566 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 111.609 171.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 t -98.91 156.83 16.69 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 122.974 0.51 . . . . 0.0 110.027 155.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.23 95.82 0.04 OUTLIER 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -169.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 114.01 -16.02 20.76 Favored Glycine 0 CA--C 1.553 2.444 0 N-CA-C 118.421 2.128 . . . . 0.0 118.421 -170.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -143.57 126.01 15.77 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 120.331 2.066 . . . . 0.0 112.927 -173.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.5 tp -90.88 107.39 19.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.602 -0.686 . . . . 0.0 110.059 168.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.4 t -89.8 106.91 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -91.12 100.51 13.34 Favored 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 123.152 0.581 . . . . 0.0 109.537 170.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -93.52 104.19 16.33 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 174.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -104.3 125.25 50.39 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -174.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.84 127.19 51.68 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.68 0.792 . . . . 0.0 111.036 -165.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.3 p90 -153.79 125.67 7.76 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.425 -1.422 . . . . 0.0 112.248 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.0 t70 49.82 51.02 17.36 Favored 'General case' 0 N--CA 1.506 2.357 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 170.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.04 -14.17 6.52 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 119.903 2.721 . . . . 0.0 119.903 -167.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mptt -103.81 152.28 22.08 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-N 119.138 1.469 . . . . 0.0 111.955 -173.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -143.61 150.72 39.2 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 35.7 t -136.76 132.65 35.06 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.349 0.66 . . . . 0.0 111.289 174.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 39.5 p -91.48 130.36 37.32 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.789 0.804 . . . . 0.0 110.455 169.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 80.2 mt -124.38 98.17 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -98.41 101.79 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.781 -0.574 . . . . 0.0 110.141 -170.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 75.6 mtt85 -88.04 98.06 11.31 Favored 'General case' 0 CA--C 1.564 1.509 0 O-C-N 121.79 -0.569 . . . . 0.0 110.149 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.11 145.78 47.84 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -171.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.59 113.29 25.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.0 112.363 -171.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -134.22 115.05 13.71 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.597 -0.689 . . . . 0.0 109.164 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.4 t70 58.0 58.31 3.65 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 47.16 41.53 15.43 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 118.455 2.142 . . . . 0.0 118.455 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.55 128.77 9.75 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -163.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.3 tp -87.63 106.2 17.86 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 122.184 0.993 . . . . 0.0 109.674 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 76.4 t -95.27 109.0 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 82.7 t -95.04 100.32 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -175.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -93.7 101.19 13.32 Favored 'General case' 0 CA--C 1.56 1.359 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 127' ' ' CYS . 2.0 p -120.58 131.49 54.68 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 121.774 0.797 . . . . 0.0 111.991 -163.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.61 140.64 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.464 0.65 . . . . 0.0 110.505 -166.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.447 ' SD ' ' HA ' ' A' ' 26' ' ' LEU . 19.3 ttt -106.09 -74.43 0.65 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.759 -0.588 . . . . 0.0 110.567 171.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -129.5 -65.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 118.654 0.661 . . . . 0.0 110.937 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -94.79 -44.89 7.56 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 124.06 0.944 . . . . 0.0 112.639 176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.6 t -91.68 120.91 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 CA-C-N 119.248 0.931 . . . . 0.0 110.316 -161.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 39.9 p -102.4 114.5 28.74 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.492 0.717 . . . . 0.0 109.959 174.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 120' ' ' CYS . 5.5 p -98.76 132.86 43.8 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 123.475 0.71 . . . . 0.0 111.213 171.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 43.6 m -109.7 104.62 13.65 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -103.68 113.01 26.2 Favored 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 122.905 0.482 . . . . 0.0 110.683 -176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 18.8 mm -92.18 129.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.454 -0.779 . . . . 0.0 109.381 -176.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -118.48 124.39 47.48 Favored 'General case' 0 CA--C 1.571 1.768 0 CA-C-O 121.203 0.525 . . . . 0.0 112.163 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -74.4 136.49 42.4 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.158 0.983 . . . . 0.0 113.613 169.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 22.7 tttm -76.32 116.37 16.94 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.371 -1.456 . . . . 0.0 111.208 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.36 69.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.209 -0.932 . . . . 0.0 110.84 -171.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.12 -0.987 . . . . 0.0 108.771 -164.138 . . . . . . . . 0 0 . 1 stop_ save_